data_2jnf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jnf _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.5 t . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 120.217 0.056 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -54.88 -53.63 52.96 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.694 0.283 . . . . 0.0 110.744 173.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.6 mp -59.09 -44.48 91.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.99 0.424 . . . . 0.0 110.325 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.448 HD22 HD22 ' A' ' 80' ' ' LEU . 82.1 mt -57.63 -57.66 11.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.189 178.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -58.9 -41.34 86.98 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.568 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.0 m -63.88 -41.13 97.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 0.0 111.289 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.11 -27.64 32.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.029 0.443 . . . . 0.0 110.469 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.499 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 71.8 t80 -57.31 -54.59 45.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.398 177.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.491 ' HA ' ' HB2' ' A' ' 23' ' ' GLU . 26.2 mmt180 -71.36 -21.65 62.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.117 -177.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.65 -44.21 74.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.915 -175.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.618 ' CD1' HG12 ' A' ' 39' ' ' ILE . 52.6 m-85 -106.44 17.16 23.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.473 0.654 . . . . 0.0 110.124 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.567 ' HG2' ' N ' ' A' ' 24' ' ' THR . 10.2 tt0 -71.43 152.84 42.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.334 -172.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.567 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.4 OUTLIER 75.05 138.1 0.06 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 158.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -88.74 -43.42 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.588 2.858 . . . . 0.0 111.652 172.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -156.02 25.08 0.37 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.671 0.748 . . . . 0.0 109.415 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.59 63.36 0.76 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.592 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.1 t -105.46 -30.1 9.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.921 0.391 . . . . 0.0 110.763 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.58 -11.36 66.71 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.873 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.728 ' HB2' ' OD2' ' A' ' 66' ' ' ASP . 3.3 mpt_? -110.95 172.22 7.0 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.455 HG23 HD11 ' A' ' 39' ' ' ILE . 12.8 p -108.03 129.59 61.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-O 121.941 0.877 . . . . 0.0 110.201 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.463 ' HA ' ' HB3' ' A' ' 66' ' ' ASP . 44.3 t -57.25 141.3 47.1 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 113.593 -1.64 . . . . 0.0 111.856 -175.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.554 ' HB ' HG12 ' A' ' 56' ' ' ILE . 28.4 p -67.74 -19.37 65.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.407 -178.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -76.2 -21.78 56.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.317 0.579 . . . . 0.0 109.758 175.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.492 ' O ' HG13 ' A' ' 39' ' ' ILE . 34.1 mm-40 -91.96 -21.65 20.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.939 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.61 HG22 HD23 ' A' ' 40' ' ' LEU . 71.3 mt -54.68 -46.67 73.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.673 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.98 -22.5 68.72 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.261 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.599 ' O ' HG12 ' A' ' 42' ' ' VAL . 25.8 mt -77.86 -54.85 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.708 ' HA ' HG12 ' A' ' 42' ' ' VAL . 36.5 mt -60.92 -37.89 77.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.203 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.61 HD23 HG22 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -60.49 -24.64 65.45 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.09 0.472 . . . . 0.0 110.181 176.191 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 39.2 tt0 -82.56 -39.73 21.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.819 172.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.708 HG12 ' HA ' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -62.03 -31.45 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 121.771 0.796 . . . . 0.0 110.865 177.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.46 HD12 ' HZ ' ' A' ' 72' ' ' PHE . 50.8 mt -92.79 -6.35 49.13 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.958 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.01 39.49 96.46 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.494 -0.775 . . . . 0.0 113.518 176.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pt -113.35 -83.41 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.34 179.67 3.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.558 0.694 . . . . 0.0 112.672 -174.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -102.05 -171.0 1.9 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.552 -175.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.427 ' O ' HG12 ' A' ' 52' ' ' ILE . 14.3 t -62.81 -179.46 0.27 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -52.28 -34.57 47.15 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -170.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.1 m -52.19 -40.2 61.18 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.152 0.501 . . . . 0.0 111.049 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 53.4 m -81.75 -34.59 30.36 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.659 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 48' ' ' THR . 42.0 mm -64.67 -27.38 42.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.283 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -57.5 -32.99 67.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.98 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.7 mm-40 -65.66 -49.44 68.6 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.651 HD13 ' CE2' ' A' ' 79' ' ' PHE . 3.0 mm? -53.67 -52.43 59.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.994 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.554 HG12 ' HB ' ' A' ' 33' ' ' THR . 60.2 mt -63.26 -44.84 99.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.409 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -59.59 -30.96 69.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.189 0.519 . . . . 0.0 110.757 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -84.21 -51.71 6.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.208 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.424 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 80.3 m-85 -90.59 -17.18 27.39 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -172.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.45 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 51.6 t0 -129.55 65.88 75.71 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 121.069 0.461 . . . . 0.0 110.88 175.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 22.9 Cg_exo -70.06 -17.25 36.32 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.913 2.409 . . . . 0.0 111.419 175.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -80.09 -17.86 51.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.116 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.97 40.73 73.3 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.778 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -76.0 -41.39 51.33 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.098 0.475 . . . . 0.0 110.423 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 117.83 -33.96 4.69 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.112 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.728 ' OD2' ' HB2' ' A' ' 30' ' ' ARG . 2.3 p-10 -139.47 148.43 42.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.151 0.501 . . . . 0.0 111.004 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.493 ' O ' ' HB3' ' A' ' 30' ' ' ARG . 44.1 pt -114.34 143.66 23.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.036 -174.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.458 ' HA ' ' HG3' ' A' ' 30' ' ' ARG . 1.9 p30 -74.36 174.08 9.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.826 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' A' ' 73' ' ' LYS . 5.0 t80 -63.55 -37.81 88.73 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.119 -175.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.497 ' O ' HG13 ' A' ' 74' ' ' ILE . 38.3 t70 -61.64 -42.68 99.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.925 0.393 . . . . 0.0 110.628 -176.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.7 m -65.53 -42.86 91.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.331 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.46 ' HZ ' HD12 ' A' ' 43' ' ' LEU . 75.8 t80 -69.11 -32.27 71.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.465 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 69' ' ' PHE . 40.8 ttmt -63.29 -44.04 96.18 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.61 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 70' ' ' ASP . 64.7 mt -62.29 -40.75 88.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.127 0.489 . . . . 0.0 110.05 176.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.578 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 78.6 mt -58.22 -51.09 75.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.128 175.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.491 ' CA ' HD21 ' A' ' 80' ' ' LEU . . . -62.52 -41.55 99.78 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.3 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.35 -25.72 67.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.953 0.406 . . . . 0.0 111.591 -174.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 11.8 ptm180 -93.08 -12.67 29.95 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.768 -176.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.651 ' CE2' HD13 ' A' ' 55' ' ' LEU . 23.9 m-85 -120.71 -37.35 3.01 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -174.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.491 HD21 ' CA ' ' A' ' 76' ' ' GLY . 3.2 mm? . . . . . 0 N--CA 1.467 0.425 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -173.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 N--CA 1.465 0.289 0 CA-C-O 121.015 0.436 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.719 HD23 ' HE3' ' A' ' 150' ' ' MET . 1.2 mm? -52.65 -28.11 20.07 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.126 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.644 ' HD3' ' HE2' ' A' ' 97' ' ' PHE . 30.7 mmt180 -57.0 -51.39 69.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.063 0.459 . . . . 0.0 111.361 177.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -77.74 -21.7 51.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.059 0.456 . . . . 0.0 110.327 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.453 ' HB2' ' HA ' ' A' ' 93' ' ' LEU . . . -77.51 -13.73 59.85 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.048 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.644 ' HE2' ' HD3' ' A' ' 94' ' ' ARG . 21.0 m-85 -61.4 -48.23 82.16 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.641 176.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.4 mtm-85 -67.17 -23.73 65.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.205 0.526 . . . . 0.0 110.386 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.9 tp -67.76 -37.31 81.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.753 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.668 ' O ' ' HD2' ' A' ' 102' ' ' LYS . 85.6 m-85 -104.12 -5.7 21.78 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.122 -176.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -78.27 80.32 4.68 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.461 0.648 . . . . 0.0 111.528 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.668 ' HD2' ' O ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -60.71 -39.75 89.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.002 173.27 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -72.27 -37.13 69.12 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.498 -169.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.18 48.46 2.23 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.91 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -113.18 -17.22 12.41 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.973 0.416 . . . . 0.0 110.526 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.12 -24.91 13.69 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -170.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.534 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 4.0 m-85 -109.37 150.9 27.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 173.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.679 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 14.8 pt -91.81 131.17 39.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.748 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.5 m -69.3 170.05 11.04 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.312 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.429 ' HB ' ' CG2' ' A' ' 133' ' ' ILE . 36.8 p -67.59 -23.72 65.42 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 121.846 -0.534 . . . . 0.0 110.724 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 114' ' ' ARG . 29.6 m-20 -62.43 -50.49 71.29 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 176.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.679 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.4 p -71.69 -35.0 54.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.719 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.65 ' SD ' HG11 ' A' ' 144' ' ' VAL . 2.9 tpt -57.37 -40.06 77.34 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.494 ' HB2' ' O ' ' A' ' 111' ' ' ASP . 76.0 mtt180 -53.04 -56.9 12.6 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.636 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 112' ' ' VAL . 13.3 pt-20 -65.23 -30.4 71.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.433 -175.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 112' ' ' VAL . 57.1 mt -63.43 -47.72 90.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.705 0.288 . . . . 0.0 110.798 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 113' ' ' MET . 9.6 mt -58.49 -55.63 32.55 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.168 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -49.19 -37.77 23.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.408 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -65.23 -56.57 12.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.909 0.385 . . . . 0.0 110.751 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -66.76 -44.53 81.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.079 0.466 . . . . 0.0 111.19 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.522 ' HB3' HD23 ' A' ' 124' ' ' LEU . 5.7 m-20 -119.46 88.01 2.85 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.531 -178.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -76.02 23.0 0.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.321 0.581 . . . . 0.0 111.589 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' ' 121' ' ' ASP . 39.6 p -102.77 -13.46 17.02 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.916 0.865 . . . . 0.0 109.227 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.522 HD23 ' HB3' ' A' ' 121' ' ' ASP . 4.0 mm? -85.06 115.63 22.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.373 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.446 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 42.7 m -77.08 172.19 13.62 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.9 p -56.75 -43.49 80.79 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.692 0.282 . . . . 0.0 111.581 -174.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -68.8 -40.08 79.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.0 110.751 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.428 ' HB3' ' CD1' ' A' ' 124' ' ' LEU . 5.6 m-20 -59.34 -42.36 91.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.465 176.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.606 ' O ' HG12 ' A' ' 133' ' ' ILE . 95.8 mt -54.63 -43.39 72.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.75 175.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.476 ' O ' ' HB ' ' A' ' 133' ' ' ILE . 31.5 t70 -63.2 -40.25 96.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.268 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.2 -40.58 82.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.164 177.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.408 ' O ' HG13 ' A' ' 136' ' ' ILE . 9.1 mtt -57.77 -43.51 85.54 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 173.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.606 HG12 ' O ' ' A' ' 129' ' ' LEU . 21.5 mm -51.69 -49.94 33.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.066 176.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -58.98 -43.32 91.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.733 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -72.11 -35.02 69.06 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.567 -176.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.589 HD13 HD23 ' A' ' 117' ' ' LEU . 67.6 mt -65.81 -58.79 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.983 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -68.22 93.78 0.48 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.581 0.705 . . . . 0.0 110.102 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.91 -29.51 50.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.961 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -88.19 -14.4 38.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.274 0.559 . . . . 0.0 110.862 -174.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 69.22 28.29 72.88 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.273 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 6.5 t -80.67 -18.28 48.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.083 0.468 . . . . 0.0 110.15 -175.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.71 -31.31 8.73 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.287 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 21.9 p -114.87 143.14 45.6 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.65 HG11 ' SD ' ' A' ' 113' ' ' MET . 61.0 t -89.04 118.3 34.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.534 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 28.5 t70 -144.17 -73.26 0.27 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.762 -178.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.623 ' O ' ' HG2' ' A' ' 150' ' ' MET . 0.1 OUTLIER -79.28 -97.17 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.122 -166.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -82.95 -11.78 57.87 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 121.583 -0.698 . . . . 0.0 110.94 -173.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' A' ' 148' ' ' GLU . 3.9 mp0 -61.81 -58.42 8.06 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.9 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.616 ' HA ' HG12 ' A' ' 152' ' ' VAL . 10.7 t80 -73.82 -46.73 43.37 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.677 -176.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' MET . . . . . 0.719 ' HE3' HD23 ' A' ' 93' ' ' LEU . 46.8 mmm -61.12 -18.41 57.84 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.742 0.306 . . . . 0.0 110.964 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -95.97 -20.3 26.41 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.066 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.616 HG12 ' HA ' ' A' ' 149' ' ' PHE . 9.1 p -95.72 -36.31 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 117.314 0.557 . . . . 0.0 111.067 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.457 ' SD ' HG22 ' A' ' 154' ' ' THR . 0.9 OUTLIER -90.74 -47.55 7.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.055 -177.307 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.457 HG22 ' SD ' ' A' ' 153' ' ' MET . 25.6 p . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.039 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.427 ' HA ' HD11 ' A' ' 15' ' ' LEU . 26.8 t . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.707 0.289 . . . . 0.0 111.066 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -62.16 -47.45 84.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.661 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.53 -45.21 92.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.904 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.646 HD21 ' CD1' ' A' ' 80' ' ' LEU . 84.5 mt -56.08 -52.7 63.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.773 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -62.52 -38.86 91.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.773 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 91.0 m -59.03 -52.21 66.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.735 0.302 . . . . 0.0 110.483 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.421 ' HB3' HG22 ' A' ' 39' ' ' ILE . . . -69.55 -33.77 73.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.139 0.495 . . . . 0.0 110.366 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.684 ' CE1' HG22 ' A' ' 31' ' ' VAL . 86.1 t80 -53.67 -58.78 5.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.584 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -61.27 -31.62 71.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.799 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -69.09 -43.91 73.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.834 0.35 . . . . 0.0 111.245 -175.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.468 ' CD2' HG12 ' A' ' 39' ' ' ILE . 56.0 m-85 -100.64 8.69 43.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.342 0.592 . . . . 0.0 110.132 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.559 ' HG2' ' N ' ' A' ' 24' ' ' THR . 3.9 tt0 -69.25 154.12 42.55 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.19 -177.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.775 HG23 ' H ' ' A' ' 27' ' ' GLY . 0.6 OUTLIER 79.75 131.78 0.04 OUTLIER Pre-proline 0 N--CA 1.437 -1.118 0 O-C-N 124.301 1.001 . . . . 0.0 112.863 161.582 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.86 -34.7 0.19 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.328 2.686 . . . . 0.0 111.163 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -165.52 32.1 0.05 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.041 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.775 ' H ' HG23 ' A' ' 24' ' ' THR . . . 98.32 66.41 0.88 Allowed Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.831 -175.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.7 t -111.68 -31.09 7.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.814 0.34 . . . . 0.0 111.002 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.02 -14.21 65.71 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.523 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.542 ' HG3' ' HA ' ' A' ' 68' ' ' ASP . 4.8 mpt_? -106.72 172.49 6.79 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.684 HG22 ' CE1' ' A' ' 19' ' ' PHE . 0.1 OUTLIER -105.19 129.93 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.568 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.272 172.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.6 t -54.0 138.88 36.05 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.994 -1.457 . . . . 0.0 108.723 171.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.58 ' HB ' HG12 ' A' ' 56' ' ' ILE . 2.9 p -67.03 -12.86 61.08 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.056 -174.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -72.05 -42.59 66.09 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.632 ' HA ' HD11 ' A' ' 38' ' ' ILE . 33.3 mm-40 -74.03 -16.22 61.06 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.438 -174.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.634 HG21 HD21 ' A' ' 40' ' ' LEU . 47.1 mt -59.01 -34.21 52.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.4 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -74.17 -36.98 49.77 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.328 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.641 ' O ' HG21 ' A' ' 42' ' ' VAL . 1.3 mp -58.79 -55.28 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-O 121.5 0.666 . . . . 0.0 109.762 174.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 35' ' ' GLN . 53.7 mt -63.14 -43.54 98.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.451 -176.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.634 HD21 HG21 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -61.91 -27.42 68.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.935 0.398 . . . . 0.0 110.713 177.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.66 -43.61 46.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.175 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 38' ' ' ILE . 64.0 t -54.78 -47.72 73.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.56 176.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.578 HD11 HD23 ' A' ' 15' ' ' LEU . 58.0 mt -86.58 4.3 40.73 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.358 -173.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.24 41.71 99.57 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.19 -0.914 . . . . 0.0 113.71 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -116.12 -77.3 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.559 ' HG2' HD21 ' A' ' 55' ' ' LEU . 0.7 OUTLIER -81.57 -176.49 6.07 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.418 0.627 . . . . 0.0 112.46 -176.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.411 ' HB2' ' CB ' ' A' ' 51' ' ' THR . 45.2 mt-30 -110.62 -170.38 1.63 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.505 -174.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.451 ' O ' HG12 ' A' ' 52' ' ' ILE . 13.5 t -56.89 176.97 0.09 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.49 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 63.0 mttm -52.24 -35.31 49.4 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.85 0.46 . . . . 0.0 112.155 -173.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.8 m -54.6 -34.31 61.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.251 0.548 . . . . 0.0 111.185 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.411 ' CB ' ' HB2' ' A' ' 47' ' ' GLN . 60.5 m -85.98 -34.23 20.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.483 0.658 . . . . 0.0 110.41 177.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.822 ' HA ' HD23 ' A' ' 55' ' ' LEU . 44.1 mm -63.4 -23.53 33.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.343 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 34.5 mmt180 -50.8 -38.69 49.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.558 173.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.461 ' HA ' ' OD2' ' A' ' 57' ' ' ASP . 7.3 mm-40 -60.54 -43.83 96.77 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.713 0.633 . . . . 0.0 110.653 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.822 HD23 ' HA ' ' A' ' 52' ' ' ILE . 3.1 mm? -62.21 -46.33 89.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.386 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.58 HG12 ' HB ' ' A' ' 33' ' ' THR . 64.1 mt -66.81 -47.66 82.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.304 -176.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.461 ' OD2' ' HA ' ' A' ' 54' ' ' GLN . 1.7 p30 -66.28 -19.75 65.91 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.059 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -85.11 -53.75 5.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.37 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -95.1 -17.0 22.22 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -171.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.406 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 21.0 t0 -128.22 68.25 76.35 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.09 0.471 . . . . 0.0 111.317 176.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 24.3 Cg_exo -69.75 -17.83 37.42 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.504 2.136 . . . . 0.0 110.492 171.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -69.88 -17.96 63.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.993 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.32 30.39 77.4 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -81.36 -27.31 34.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.273 -0.464 . . . . 0.0 110.868 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.5 -19.44 39.41 Favored Glycine 0 CA--C 1.509 -0.312 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.122 173.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -145.83 158.02 43.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.89 0.376 . . . . 0.0 110.933 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.431 ' O ' ' HB3' ' A' ' 30' ' ' ARG . 28.8 pt -126.92 142.54 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.556 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.542 ' HA ' ' HG3' ' A' ' 30' ' ' ARG . 0.5 OUTLIER -75.13 175.94 7.76 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.514 -176.877 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -60.66 -39.69 89.31 Favored 'General case' 0 C--O 1.213 -0.829 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.081 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.487 ' O ' HG13 ' A' ' 74' ' ' ILE . 19.7 t70 -60.75 -39.91 90.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.997 0.427 . . . . 0.0 109.964 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.425 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 17.0 m -67.61 -43.62 80.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.749 176.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -69.38 -32.46 71.5 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.259 0.552 . . . . 0.0 110.223 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -62.32 -42.4 99.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.099 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 70' ' ' ASP . 67.2 mt -65.41 -40.19 87.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.027 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.551 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 66.8 mt -56.38 -53.03 45.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.249 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.94 -41.05 99.62 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.151 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.04 -26.07 66.57 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 122.578 -0.366 . . . . 0.0 111.44 -174.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 15.8 ptm180 -89.92 -18.56 25.88 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.768 ' HE2' HD11 ' A' ' 55' ' ' LEU . 23.6 m-85 -108.52 -43.85 4.21 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.272 -174.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.646 ' CD1' HD21 ' A' ' 15' ' ' LEU . 2.4 mp . . . . . 0 N--CA 1.448 -0.568 0 CA-C-O 120.459 0.171 . . . . 0.0 110.858 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 . . . . . 0 CA--C 1.521 -0.14 0 CA-C-O 121.216 0.532 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.911 HD21 ' HE1' ' A' ' 149' ' ' PHE . 44.7 mt -42.74 -41.59 3.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.62 -1.173 . . . . 0.0 112.269 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.755 ' HD2' ' HE2' ' A' ' 97' ' ' PHE . 18.5 mmm180 -59.53 -39.96 85.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -176.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -86.07 -18.28 32.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.125 0.488 . . . . 0.0 110.249 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.491 ' HA ' HD11 ' A' ' 99' ' ' LEU . . . -80.25 -19.9 45.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.678 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.755 ' HE2' ' HD2' ' A' ' 94' ' ' ARG . 23.0 m-85 -59.1 -44.45 91.96 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -70.96 -13.06 61.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.822 0.344 . . . . 0.0 111.358 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.491 HD11 ' HA ' ' A' ' 96' ' ' ALA . 97.0 mt -86.92 -27.55 23.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.89 0.376 . . . . 0.0 110.772 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.464 ' O ' HG23 ' A' ' 112' ' ' VAL . 76.2 m-85 -103.69 -14.63 16.03 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 97' ' ' PHE . 55.2 t0 -64.57 86.53 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.83 0.824 . . . . 0.0 111.197 -176.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -64.27 -18.33 64.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.655 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -96.18 -36.87 10.79 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.975 0.417 . . . . 0.0 112.119 -171.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.08 39.46 5.44 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.491 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -114.82 -15.33 11.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.871 0.367 . . . . 0.0 111.807 -176.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.83 -22.31 35.79 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.198 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -100.22 167.55 10.37 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 172.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.577 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 8.3 pt -111.03 118.85 58.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.291 166.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.2 m -62.73 166.53 5.37 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.952 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.7 p -57.29 -32.91 67.13 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.9 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.494 ' O ' ' HG3' ' A' ' 115' ' ' GLU . 28.0 m-20 -61.59 -50.19 73.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.046 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.577 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 1.8 p -68.65 -37.43 77.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.854 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.687 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 2.8 tpt -56.66 -43.29 80.21 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 174.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.427 ' HA ' HD12 ' A' ' 117' ' ' LEU . 15.9 ttt180 -55.22 -48.52 73.77 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.448 175.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 111' ' ' ASP . 47.3 mt-10 -60.33 -41.73 94.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.684 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 70.6 mt -59.17 -50.34 80.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.03 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.687 ' HG ' ' O ' ' A' ' 113' ' ' MET . 11.0 mt -56.58 -60.18 3.91 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.43 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.01 -22.01 47.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.746 -177.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -82.51 -41.08 20.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.676 0.274 . . . . 0.0 110.876 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.7 mp -79.52 -47.66 15.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.049 0.452 . . . . 0.0 110.762 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.621 ' HB3' HD21 ' A' ' 124' ' ' LEU . 3.1 m-20 -105.84 99.37 8.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.057 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -84.56 4.34 32.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.338 -173.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 71.0 p -90.38 -10.97 41.98 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.376 0.608 . . . . 0.0 110.203 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.754 ' HB3' HD21 ' A' ' 129' ' ' LEU . 3.7 mm? -77.14 146.33 37.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.071 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.472 ' HB2' ' OD1' ' A' ' 128' ' ' ASP . 21.4 m -115.68 171.7 7.58 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.254 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.8 m -47.31 -46.34 25.11 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -173.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -79.32 -32.43 43.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.814 0.34 . . . . 0.0 111.2 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.472 ' OD1' ' HB2' ' A' ' 125' ' ' SER . 2.7 m-20 -64.61 -40.32 95.29 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.754 HD21 ' HB3' ' A' ' 124' ' ' LEU . 2.7 mm? -51.66 -43.24 62.61 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.148 173.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -65.22 -42.48 93.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.612 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.42 -45.52 91.3 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.361 0.6 . . . . 0.0 110.032 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 58.0 mmm -54.9 -53.73 51.7 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.681 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 20.1 mm -55.02 -46.39 77.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.583 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -56.44 -41.2 76.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.774 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -79.49 -31.04 42.21 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.161 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.42 HG12 ' CG2' ' A' ' 152' ' ' VAL . 49.3 mt -67.74 -58.39 6.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.134 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.408 ' HA ' ' HB3' ' A' ' 148' ' ' GLU . 37.0 t0 -69.76 93.87 0.77 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.592 0.71 . . . . 0.0 110.288 -177.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.57 -40.26 42.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.807 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -82.85 -13.97 55.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.204 0.526 . . . . 0.0 111.065 -173.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 70.89 24.34 77.16 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.8 t -74.79 -18.26 60.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.387 0.613 . . . . 0.0 109.853 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.56 -26.97 9.25 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 25.3 p -114.59 128.92 56.58 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 175.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.673 HG11 ' SD ' ' A' ' 113' ' ' MET . 64.2 t -83.34 119.33 32.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.266 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.433 ' HB3' ' CD1' ' A' ' 146' ' ' PHE . 8.0 t70 -145.59 -55.58 0.3 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.128 0.489 . . . . 0.0 111.437 -175.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 145' ' ' ASP . 0.4 OUTLIER -105.55 -97.14 0.34 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.815 -168.653 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -38.33 90.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.794 0.331 . . . . 0.0 111.069 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.593 ' CD ' ' H ' ' A' ' 148' ' ' GLU . 3.4 mp0 -50.46 -53.09 32.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.222 177.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.911 ' HE1' HD21 ' A' ' 93' ' ' LEU . 31.8 t80 -76.93 -38.74 52.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.013 -175.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 42.2 tpp -62.68 -43.57 98.46 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.375 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -70.26 -16.11 73.0 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.496 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.42 ' CG2' HG12 ' A' ' 136' ' ' ILE . 12.1 p -101.41 -40.57 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 117.391 0.595 . . . . 0.0 111.805 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.423 ' HG2' ' CD2' ' A' ' 93' ' ' LEU . 15.4 tpt -81.18 -49.14 11.17 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -172.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 80.5 p . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 121.142 0.496 . . . . 0.0 110.843 -175.674 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.3 t . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.501 ' HD2' ' HA ' ' A' ' 13' ' ' LYS . 27.1 tptt -61.14 -41.34 96.55 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-O 120.756 0.312 . . . . 0.0 111.543 176.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.41 -42.58 83.01 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.769 HD22 HD13 ' A' ' 80' ' ' LEU . 84.3 mt -58.3 -48.96 78.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.869 177.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -57.32 -54.98 40.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.326 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.564 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 27.8 m -59.83 -41.24 90.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.358 -175.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.633 ' HB3' HG23 ' A' ' 39' ' ' ILE . . . -74.83 -37.89 62.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.761 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.432 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 54.6 t80 -56.32 -59.19 5.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.979 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.11 -12.61 61.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.047 -174.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.564 ' HB2' ' O ' ' A' ' 17' ' ' THR . 2.1 t70 -80.29 -40.04 27.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.942 0.401 . . . . 0.0 110.531 -175.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.434 ' CD2' HG12 ' A' ' 39' ' ' ILE . 87.3 m-85 -105.99 6.9 31.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.408 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.462 ' HG2' ' N ' ' A' ' 24' ' ' THR . 3.8 tm-20 -62.82 152.49 35.92 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.262 -176.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.462 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER 86.24 130.86 0.03 OUTLIER Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 114.29 -1.323 . . . . 0.0 113.219 166.388 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -86.71 -40.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.441 2.761 . . . . 0.0 110.797 169.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -159.91 33.69 0.18 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.148 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.41 67.59 1.03 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.411 -176.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.5 t -112.22 -24.82 9.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.869 0.366 . . . . 0.0 111.328 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.09 -14.49 61.98 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -175.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.528 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 86.1 mtt180 -112.09 163.08 14.7 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.014 -0.593 . . . . 0.0 110.041 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.469 HG22 HD13 ' A' ' 39' ' ' ILE . 13.7 p -105.99 126.7 61.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 121.501 0.667 . . . . 0.0 110.093 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.2 t -53.6 139.51 31.6 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.029 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.559 ' HB ' HG12 ' A' ' 56' ' ' ILE . 1.7 p -63.05 -18.85 63.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.04 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.48 ' CG ' ' HZ1' ' A' ' 49' ' ' LYS . 21.4 t70 -73.8 -28.71 61.78 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.234 0.54 . . . . 0.0 110.375 177.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -86.98 -16.88 34.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.532 -177.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.662 HG21 HD21 ' A' ' 40' ' ' LEU . 52.6 mt -55.39 -41.4 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.817 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.432 ' CA ' HG13 ' A' ' 52' ' ' ILE . . . -61.97 -38.73 96.53 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.413 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.609 ' O ' HG23 ' A' ' 42' ' ' VAL . 31.5 mt -63.56 -52.18 61.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.302 0.572 . . . . 0.0 109.595 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.633 HG23 ' HB3' ' A' ' 18' ' ' ALA . 69.6 mt -60.09 -44.49 95.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.52 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.662 HD21 HG21 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -60.63 -25.41 66.27 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.808 178.55 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -80.02 -40.6 27.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.001 174.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 38' ' ' ILE . 43.1 t -53.88 -43.91 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.924 0.868 . . . . 0.0 109.79 174.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.7 mt -86.38 -4.02 59.1 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.939 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.9 39.48 89.48 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-N 115.444 -0.798 . . . . 0.0 113.705 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pt -116.17 -84.8 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.25 -171.42 2.38 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.248 0.547 . . . . 0.0 112.41 -177.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -123.33 -170.79 2.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.434 -172.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.1 t -54.94 170.87 0.16 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.835 0.826 . . . . 0.0 112.968 -176.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.48 ' HZ1' ' CG ' ' A' ' 34' ' ' ASP . 63.8 mttm -51.32 -34.52 33.89 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.344 -1.298 . . . . 0.0 113.204 -167.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 m -58.94 -32.39 69.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.084 0.468 . . . . 0.0 110.845 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -82.42 -32.76 28.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.392 0.615 . . . . 0.0 110.018 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.885 ' HA ' HD21 ' A' ' 55' ' ' LEU . 44.4 mm -68.7 -23.62 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.221 -177.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -50.17 -30.98 12.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.42 173.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -65.92 -55.19 18.18 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.306 0.574 . . . . 0.0 109.834 174.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.885 HD21 ' HA ' ' A' ' 52' ' ' ILE . 2.5 mm? -52.76 -50.06 64.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.435 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.559 HG12 ' HB ' ' A' ' 33' ' ' THR . 61.0 mt -63.52 -46.89 93.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.926 -177.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -61.39 -24.68 66.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.508 0.671 . . . . 0.0 110.727 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.465 ' CD ' HH12 ' A' ' 78' ' ' ARG . 29.6 tt0 -87.98 -51.28 5.91 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.226 -177.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.478 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 90.1 m-85 -94.53 -17.1 22.72 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -173.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.461 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 46.5 t0 -129.99 62.67 65.23 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-O 121.171 0.51 . . . . 0.0 110.181 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.478 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 31.3 Cg_exo -63.11 -24.86 73.14 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.032 2.488 . . . . 0.0 112.159 -178.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -76.68 -17.29 59.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.569 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.28 41.32 59.56 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.688 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -67.71 -39.89 84.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.673 0.273 . . . . 0.0 110.751 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.18 -22.31 9.04 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.672 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -139.79 178.49 7.21 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 27.2 pt -142.12 143.73 26.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.886 0.374 . . . . 0.0 110.331 177.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.528 ' HA ' ' HG2' ' A' ' 30' ' ' ARG . 25.6 t70 -83.39 166.9 18.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.807 176.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.47 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -56.09 -27.35 53.36 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 176.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -49.35 -51.44 34.54 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.87 0.367 . . . . 0.0 111.256 174.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.442 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 23.2 m -82.41 -36.88 26.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.924 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.47 ' HB3' ' HA ' ' A' ' 69' ' ' PHE . 89.8 t80 -64.83 -36.28 83.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.123 -178.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -62.32 -38.6 90.04 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.219 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.421 ' HB ' ' CE1' ' A' ' 59' ' ' PHE . 40.7 mt -69.48 -40.1 79.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.84 0.352 . . . . 0.0 110.105 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.584 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 78.1 mt -57.3 -48.48 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-O 121.41 0.624 . . . . 0.0 109.717 173.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.488 ' HA2' ' CD1' ' A' ' 80' ' ' LEU . . . -62.48 -45.19 96.39 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.065 177.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.97 -20.39 65.04 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -174.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 9.9 ptm180 -91.28 -16.7 27.13 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.527 -177.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.499 ' CE2' HD13 ' A' ' 55' ' ' LEU . 21.1 m-85 -118.34 -46.49 2.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.754 0.311 . . . . 0.0 110.921 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.769 HD13 HD22 ' A' ' 15' ' ' LEU . 3.2 mp . . . . . 0 CA--C 1.514 -0.426 0 CA-C-O 121.329 0.585 . . . . 0.0 111.199 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 CA--C 1.52 -0.193 0 CA-C-O 121.056 0.455 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.548 HD22 ' H ' ' A' ' 93' ' ' LEU . 0.9 OUTLIER -54.27 -26.93 31.77 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.302 -179.7 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.721 ' HD2' ' HE2' ' A' ' 97' ' ' PHE . 28.9 mmm180 -59.74 -35.63 74.95 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 120.807 0.337 . . . . 0.0 111.583 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -86.53 -26.93 24.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.253 0.549 . . . . 0.0 109.899 176.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 93' ' ' LEU . . . -72.73 -11.05 60.47 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.937 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.721 ' HE2' ' HD2' ' A' ' 94' ' ' ARG . 21.3 m-85 -61.72 -52.22 65.15 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.727 -0.389 . . . . 0.0 109.963 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 98' ' ' ARG . 42.2 mtm180 -65.66 -17.96 64.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.212 0.529 . . . . 0.0 110.88 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.4 tp -73.6 -38.63 65.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.826 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.643 ' O ' ' HD2' ' A' ' 102' ' ' LYS . 77.2 m-85 -100.16 -24.55 14.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.906 -176.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -69.3 82.68 0.37 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.413 0.625 . . . . 0.0 111.223 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.643 ' HD2' ' O ' ' A' ' 100' ' ' TYR . 9.8 mptt -56.53 -45.78 80.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.913 173.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.51 ' HB2' ' ND2' ' A' ' 105' ' ' ASN . 41.6 mt-10 -66.65 -37.23 84.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.432 -168.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.53 47.41 2.55 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.419 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.51 ' ND2' ' HB2' ' A' ' 103' ' ' GLU . 39.8 m-80 -100.1 -17.46 17.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.692 0.282 . . . . 0.0 110.68 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.9 -24.99 15.16 Favored Glycine 0 N--CA 1.453 -0.188 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -172.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -113.53 162.38 16.24 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 171.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.609 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 10.2 pt -97.22 128.16 48.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.298 173.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.463 ' HA ' HG23 ' A' ' 143' ' ' THR . 49.1 m -69.45 166.97 17.64 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.317 -177.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.2 p -62.95 -24.88 68.09 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.992 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -64.78 -51.8 60.33 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.258 176.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.609 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.0 p -68.72 -35.06 68.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.727 0.299 . . . . 0.0 110.36 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.65 ' HE1' ' HA ' ' A' ' 113' ' ' MET . 2.8 tpt -58.3 -40.18 81.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.099 0.476 . . . . 0.0 109.8 173.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.526 ' HA ' HD13 ' A' ' 133' ' ' ILE . 17.7 ttp180 -58.88 -46.03 88.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.162 176.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.459 ' OE1' ' HA ' ' A' ' 112' ' ' VAL . 34.6 mt-10 -60.68 -50.47 73.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.58 177.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 112' ' ' VAL . 63.6 mt -56.25 -53.6 37.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.43 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.611 HD11 ' SD ' ' A' ' 132' ' ' MET . 1.0 OUTLIER -57.33 -53.31 59.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.005 -178.316 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.481 ' HB2' HD23 ' A' ' 129' ' ' LEU . . . -64.33 -17.54 63.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.03 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -83.8 -53.26 5.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.682 0.277 . . . . 0.0 110.319 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.58 -44.04 79.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.991 0.424 . . . . 0.0 110.313 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.619 ' HB3' HD23 ' A' ' 124' ' ' LEU . 6.2 m-20 -112.19 84.85 2.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.254 0.549 . . . . 0.0 109.969 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -79.79 12.63 2.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.626 0.727 . . . . 0.0 110.908 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.403 ' H ' ' C ' ' A' ' 121' ' ' ASP . 69.8 p -95.44 -5.56 42.82 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.194 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.619 HD23 ' HB3' ' A' ' 121' ' ' ASP . 4.2 mm? -78.82 149.42 32.57 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.315 174.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.0 m -116.93 170.18 8.82 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.6 p -48.1 -48.43 33.75 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -73.45 -40.05 64.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.727 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -67.41 -43.42 81.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.649 0.738 . . . . 0.0 110.077 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.51 ' CD2' ' HG2' ' A' ' 114' ' ' ARG . 45.2 tp -63.33 -38.4 91.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.925 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.28 -41.46 99.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.897 0.379 . . . . 0.0 110.223 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.86 -45.69 92.66 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.331 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.611 ' SD ' HD11 ' A' ' 117' ' ' LEU . 33.5 mtt -60.38 -42.98 97.0 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.385 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.526 HD13 ' HA ' ' A' ' 114' ' ' ARG . 21.2 mm -54.44 -50.21 59.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.081 0.467 . . . . 0.0 110.647 174.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.15 -44.7 75.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.788 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -80.78 -26.42 37.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.83 -175.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.493 HG12 ' CG2' ' A' ' 152' ' ' VAL . 51.9 mt -64.38 -54.81 26.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.73 0.3 . . . . 0.0 110.589 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -76.63 85.12 3.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.966 0.888 . . . . 0.0 109.554 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.58 -35.0 53.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.465 -1.243 . . . . 0.0 112.319 -173.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -91.58 -10.59 40.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.042 0.449 . . . . 0.0 110.851 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.58 38.7 13.62 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.197 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.49 -18.75 56.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.263 0.554 . . . . 0.0 110.495 -177.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.29 -40.9 3.08 Favored Glycine 0 C--O 1.23 -0.106 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.216 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.463 HG23 ' HA ' ' A' ' 109' ' ' SER . 13.0 p -114.77 137.68 51.65 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 173.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.595 HG11 ' SD ' ' A' ' 113' ' ' MET . 57.8 t -82.06 124.98 39.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 O-C-N 123.611 0.57 . . . . 0.0 109.8 -176.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -145.53 -78.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.222 0.534 . . . . 0.0 112.206 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -76.74 -86.31 0.05 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -168.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -94.35 -14.39 25.4 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.983 -172.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.555 ' HB2' HG13 ' A' ' 144' ' ' VAL . 3.0 mp0 -64.24 -50.05 69.49 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.108 0.48 . . . . 0.0 109.945 174.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.543 ' HA ' HG11 ' A' ' 152' ' ' VAL . 19.1 t80 -75.43 -42.62 53.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.584 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' MET . . . . . 0.597 ' HA ' ' HE3' ' A' ' 150' ' ' MET . 0.0 OUTLIER -55.85 -46.17 78.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.935 0.398 . . . . 0.0 110.121 178.007 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -69.64 -28.46 72.18 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.965 -0.561 . . . . 0.0 113.506 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.543 HG11 ' HA ' ' A' ' 149' ' ' PHE . 14.6 p -87.62 -37.18 10.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 117.359 0.58 . . . . 0.0 111.495 -176.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -86.64 -53.92 4.68 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.006 -174.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 50.1 p . . . . . 0 C--N 1.327 -0.37 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.148 -179.002 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.685 ' HA ' HD23 ' A' ' 15' ' ' LEU . 39.6 t . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 120.902 0.382 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.479 ' HD2' ' HA ' ' A' ' 13' ' ' LYS . 37.8 tptt -55.5 -52.34 63.99 Favored 'General case' 0 N--CA 1.425 -1.702 0 C-N-CA 123.106 0.562 . . . . 0.0 111.347 174.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.53 -37.66 88.15 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.685 HD23 ' HA ' ' A' ' 12' ' ' VAL . 3.0 mp -52.99 -59.36 4.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.487 173.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -58.38 -39.0 78.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.085 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.2 m -60.05 -46.08 90.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.941 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.527 ' HB2' HG22 ' A' ' 39' ' ' ILE . . . -80.05 -29.63 39.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.553 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.53 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 57.7 t80 -56.91 -56.01 27.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.192 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -71.7 -20.04 61.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.572 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -72.33 -35.12 68.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.862 0.363 . . . . 0.0 110.864 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.486 ' CD2' HG12 ' A' ' 39' ' ' ILE . 71.9 m-85 -115.5 16.88 16.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.26 0.552 . . . . 0.0 110.574 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' ' 19' ' ' PHE . 2.9 tt0 -76.45 152.21 36.24 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.459 -172.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.529 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER 78.8 133.64 0.04 OUTLIER Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.642 159.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -87.07 -53.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.347 2.698 . . . . 0.0 111.127 172.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 15.6 tt0 -129.4 3.43 5.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.653 0.739 . . . . 0.0 109.592 176.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.79 67.73 0.51 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -169.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -109.15 -6.78 15.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.609 0.243 . . . . 0.0 111.028 -172.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.6 0.08 52.5 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.09 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.475 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 93.7 mtt180 -124.59 164.12 20.49 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.551 HG23 HD13 ' A' ' 39' ' ' ILE . 11.3 p -104.94 131.34 54.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.536 0.684 . . . . 0.0 109.495 177.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.0 t -59.39 140.17 56.38 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.851 -175.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.551 ' HA ' HG13 ' A' ' 36' ' ' ILE . 3.5 p -62.7 -19.87 64.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.024 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -75.94 -18.37 59.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.456 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.479 ' OE1' HD11 ' A' ' 38' ' ' ILE . 78.3 mm-40 -96.54 -15.8 21.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.585 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.664 HG23 HD23 ' A' ' 40' ' ' LEU . 55.8 mt -57.02 -41.87 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.61 -175.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.403 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -64.27 -38.38 95.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.022 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.614 ' O ' HG21 ' A' ' 42' ' ' VAL . 15.9 mt -61.47 -52.09 65.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.204 0.526 . . . . 0.0 109.648 176.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.551 HD13 HG23 ' A' ' 31' ' ' VAL . 66.8 mt -59.79 -42.62 89.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.5 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.664 HD23 HG23 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -65.5 -22.1 66.7 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.053 0.454 . . . . 0.0 110.763 -179.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 15.4 tp10 -78.49 -42.85 28.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.347 172.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.614 HG21 ' O ' ' A' ' 38' ' ' ILE . 47.0 t -53.08 -46.01 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.865 0.84 . . . . 0.0 110.161 175.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.5 mt -85.61 -6.51 59.15 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.637 -174.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.52 43.27 87.01 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.598 174.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.435 HD12 HD23 ' A' ' 80' ' ' LEU . 1.9 pt -119.6 -73.28 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -176.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.76 -175.05 5.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -173.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -107.08 -170.52 1.72 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.866 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.506 ' O ' HG12 ' A' ' 52' ' ' ILE . 14.8 t -60.47 177.45 0.28 Allowed 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -176.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.407 ' HA ' ' HB ' ' A' ' 52' ' ' ILE . 37.2 mtmm -55.11 -34.57 63.8 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -172.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.7 m -53.96 -37.78 64.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.871 0.367 . . . . 0.0 110.862 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.1 m -82.0 -34.18 29.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.374 176.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.513 ' HA ' HD23 ' A' ' 55' ' ' LEU . 49.3 mm -65.79 -24.31 34.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.873 -176.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.547 ' HA ' HD11 ' A' ' 56' ' ' ILE . 12.2 tpp180 -62.12 -28.51 69.68 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 177.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -68.0 -44.9 75.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.389 0.614 . . . . 0.0 109.685 173.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.631 HD12 ' CE2' ' A' ' 79' ' ' PHE . 3.1 mm? -54.66 -47.31 73.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.528 174.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.547 HD11 ' HA ' ' A' ' 53' ' ' ARG . 61.7 mt -62.2 -47.58 92.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.828 177.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -55.71 -32.56 63.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.149 0.5 . . . . 0.0 110.819 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -76.36 -54.33 6.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.832 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.508 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 98.4 m-85 -100.64 -11.4 20.04 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -169.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.422 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 48.2 t0 -125.54 66.81 56.23 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-O 121.335 0.588 . . . . 0.0 110.612 176.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.508 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 27.2 Cg_exo -67.9 -23.9 40.51 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.83 2.354 . . . . 0.0 111.755 177.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -78.74 -19.59 51.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.174 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.56 38.62 51.3 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -71.56 -33.94 69.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 122.469 0.308 . . . . 0.0 110.945 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.85 -21.02 39.57 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.003 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -139.85 167.11 22.87 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.1 pt -129.27 143.87 39.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.02 0.438 . . . . 0.0 110.108 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.475 ' HA ' ' HG2' ' A' ' 30' ' ' ARG . 18.1 t70 -78.1 165.94 23.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.522 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -58.64 -33.26 69.87 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 118.521 0.6 . . . . 0.0 109.759 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.484 ' O ' HG13 ' A' ' 74' ' ' ILE . 29.0 t70 -52.79 -43.5 65.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.728 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.506 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 28.6 m -79.08 -40.49 31.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.199 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -69.67 -32.33 70.9 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.947 0.403 . . . . 0.0 110.654 -177.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -62.35 -39.62 93.72 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.676 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 70' ' ' ASP . 44.3 mt -65.69 -38.7 82.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-O 121.132 0.491 . . . . 0.0 109.86 176.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.501 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 58.6 mt -57.11 -56.12 16.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.391 175.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.666 ' CA ' HD21 ' A' ' 80' ' ' LEU . . . -62.48 -35.19 91.39 Favored Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.016 177.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.61 -25.89 64.17 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 122.608 -0.349 . . . . 0.0 111.385 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 15.0 ptm180 -91.93 -14.42 29.6 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.78 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.631 ' CE2' HD12 ' A' ' 55' ' ' LEU . 22.9 m-85 -117.76 -44.1 2.75 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.991 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.666 HD21 ' CA ' ' A' ' 76' ' ' GLY . 4.2 mm? . . . . . 0 N--CA 1.467 0.409 0 CA-C-O 121.01 0.433 . . . . 0.0 111.207 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 . . . . . 0 C--O 1.23 0.031 0 CA-C-O 120.69 0.281 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.565 HD22 ' H ' ' A' ' 93' ' ' LEU . 0.5 OUTLIER -52.81 -36.44 58.44 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.655 -178.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.825 ' HD2' ' HE2' ' A' ' 97' ' ' PHE . 25.7 mmm180 -62.69 -32.55 73.65 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.874 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -86.09 -32.45 21.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.063 0.458 . . . . 0.0 109.912 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.655 ' HA ' HD23 ' A' ' 99' ' ' LEU . . . -66.59 -18.44 65.37 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.692 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.825 ' HE2' ' HD2' ' A' ' 94' ' ' ARG . 21.5 m-85 -58.55 -46.06 87.63 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.05 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 98' ' ' ARG . 33.7 mtp180 -70.85 -14.34 62.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.857 0.361 . . . . 0.0 110.908 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.655 HD23 ' HA ' ' A' ' 96' ' ' ALA . 0.5 OUTLIER -81.21 -37.21 29.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.806 176.249 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -95.82 -28.82 14.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.608 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.89 78.53 1.63 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.121 0.962 . . . . 0.0 110.929 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -76.97 -6.5 52.83 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.304 171.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -83.89 -37.37 22.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.983 -175.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.65 46.6 1.38 Allowed Glycine 0 C--O 1.228 -0.26 0 C-N-CA 121.098 -0.573 . . . . 0.0 113.259 171.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.443 ' C ' ' H ' ' A' ' 107' ' ' TYR . 21.3 m-80 -113.92 -17.92 11.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.777 0.323 . . . . 0.0 110.66 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.5 -20.78 12.65 Favored Glycine 0 C--O 1.228 -0.233 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -170.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.782 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 4.4 m-85 -116.71 147.54 41.9 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.683 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 9.3 pt -92.56 131.13 40.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.266 176.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.0 m -71.44 171.01 12.04 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.296 -176.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.483 ' HB ' HG21 ' A' ' 133' ' ' ILE . 16.4 p -61.78 -28.14 69.24 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.0 0.429 . . . . 0.0 110.721 178.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -60.36 -57.22 13.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.069 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.683 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.2 p -63.94 -35.45 73.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.815 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.589 ' SD ' HG12 ' A' ' 144' ' ' VAL . 0.7 OUTLIER -59.39 -40.08 85.44 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.754 176.639 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -51.98 -50.93 60.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.812 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.22 -42.94 96.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.094 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.2 mt -57.1 -48.99 80.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 121.071 0.462 . . . . 0.0 110.24 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.528 HD12 ' SD ' ' A' ' 132' ' ' MET . 0.8 OUTLIER -57.29 -54.17 49.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.438 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.57 -15.86 63.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.853 -176.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -78.63 -29.43 45.85 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.8 mp -80.63 -61.63 1.91 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.615 173.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.571 ' CG ' HD21 ' A' ' 124' ' ' LEU . 9.4 t70 -92.01 139.46 30.62 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.054 0.454 . . . . 0.0 110.498 -176.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -108.68 -2.54 18.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.683 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.4 p -104.08 -22.69 13.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.359 0.599 . . . . 0.0 109.516 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.571 HD21 ' CG ' ' A' ' 121' ' ' ASP . 4.1 mm? -62.81 100.86 0.22 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.609 169.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.413 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 15.5 t -71.69 171.89 10.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.56 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.8 p -53.51 -44.3 69.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.978 0.418 . . . . 0.0 110.884 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -66.3 -41.1 90.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.935 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.545 ' HB3' HD13 ' A' ' 124' ' ' LEU . 6.1 m-20 -66.29 -43.33 86.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.654 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.538 ' O ' HG12 ' A' ' 133' ' ' ILE . 95.7 mt -51.36 -44.4 62.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.961 172.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.404 ' O ' ' HB ' ' A' ' 133' ' ' ILE . 11.9 t70 -61.64 -41.26 97.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.892 0.377 . . . . 0.0 110.44 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.01 -37.04 78.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.382 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.528 ' SD ' HD12 ' A' ' 117' ' ' LEU . 7.1 mtt -65.82 -32.15 73.51 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.665 175.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.538 HG12 ' O ' ' A' ' 129' ' ' LEU . 19.4 mm -59.13 -45.87 92.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.954 0.407 . . . . 0.0 110.306 175.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -64.73 -35.53 81.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.891 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -72.23 -42.86 65.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.987 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.413 HG12 ' CG2' ' A' ' 152' ' ' VAL . 62.7 mt -65.36 -56.57 14.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.01 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.502 ' HA ' ' CG ' ' A' ' 148' ' ' GLU . 46.8 t0 -80.64 82.97 6.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 122.005 0.907 . . . . 0.0 109.374 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.27 -35.9 76.54 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.967 -1.469 . . . . 0.0 112.336 -173.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -87.07 -13.56 43.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.246 0.546 . . . . 0.0 110.99 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 72.07 42.83 50.4 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.0 t -83.14 -17.83 41.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.394 0.616 . . . . 0.0 109.966 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.15 -33.42 4.72 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.366 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 39.5 p -114.23 141.88 46.99 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.001 0.429 . . . . 0.0 110.096 176.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.589 HG12 ' SD ' ' A' ' 113' ' ' MET . 46.6 t -99.26 109.22 23.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.782 ' HB3' ' HB3' ' A' ' 107' ' ' TYR . 4.8 p-10 -153.91 -42.98 0.09 Allowed 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.404 -171.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.59 ' HD2' ' HG2' ' A' ' 147' ' ' GLU . 2.9 p90 -96.63 -93.07 0.22 Allowed 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.202 -0.999 . . . . 0.0 112.205 -176.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.59 ' HG2' ' HD2' ' A' ' 146' ' ' PHE . 22.0 mm-40 -81.19 -28.89 34.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.362 0.601 . . . . 0.0 109.947 -175.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.502 ' CG ' ' HA ' ' A' ' 137' ' ' ASP . 25.9 mp0 -60.14 -51.82 67.96 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.939 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.612 ' HA ' HG11 ' A' ' 152' ' ' VAL . 16.0 t80 -72.15 -38.12 69.25 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.07 -47.64 71.46 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.599 176.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -76.1 -22.07 74.65 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.893 -175.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.612 HG11 ' HA ' ' A' ' 149' ' ' PHE . 11.7 p -92.13 -37.34 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 117.545 0.672 . . . . 0.0 111.327 -176.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.87 ' HE2' ' HA ' ' A' ' 153' ' ' MET . 2.4 tpt -89.53 -56.81 3.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.827 0.346 . . . . 0.0 110.672 -176.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.8 p . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 121.31 0.576 . . . . 0.0 110.354 -179.708 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.3 t . . . . . 0 C--O 1.215 -0.754 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HD2' ' HA ' ' A' ' 13' ' ' LYS . 8.3 mptt -67.57 -37.75 83.08 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.56 -44.27 96.74 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 172.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.42 ' HB3' ' HE2' ' A' ' 72' ' ' PHE . 85.5 mt -59.99 -45.63 92.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.671 175.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -64.94 -46.28 82.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.632 -175.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.9 m -61.31 -34.98 76.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.079 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.55 ' HB3' HG23 ' A' ' 39' ' ' ILE . . . -81.1 -38.5 27.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.331 177.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.539 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 51.7 t80 -54.8 -55.03 34.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.72 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -67.39 -21.89 65.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.131 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -77.31 -36.4 54.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.856 0.36 . . . . 0.0 111.098 -174.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.443 ' CD2' HG12 ' A' ' 39' ' ' ILE . 65.9 m-85 -110.74 16.2 21.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.283 0.563 . . . . 0.0 110.423 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.61 ' HG2' ' N ' ' A' ' 24' ' ' THR . 4.3 tt0 -78.67 156.44 29.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.22 -172.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.61 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER 80.25 127.15 0.03 OUTLIER Pre-proline 0 N--CA 1.444 -0.762 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.334 160.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -90.12 -45.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.79 2.993 . . . . 0.0 111.947 173.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -142.77 24.69 1.85 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.38 62.84 1.14 Allowed Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -174.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.0 t -100.35 -28.04 13.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.927 0.394 . . . . 0.0 111.109 -172.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.19 -16.16 56.45 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -172.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.488 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 92.8 mtt180 -103.43 164.23 11.78 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.896 -0.652 . . . . 0.0 109.874 175.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' A' ' 23' ' ' GLU . 13.6 p -108.05 131.77 57.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.384 0.612 . . . . 0.0 109.639 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.1 t -62.69 144.39 56.39 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.372 -175.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.56 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . 2.8 p -66.52 -18.35 65.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.851 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -70.73 -36.11 73.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.307 0.575 . . . . 0.0 109.934 176.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -89.23 -14.48 35.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.533 -175.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.651 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 71.3 mt -53.35 -47.75 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.764 0.316 . . . . 0.0 110.644 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.41 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -58.54 -38.49 91.33 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.756 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.652 ' O ' HG21 ' A' ' 42' ' ' VAL . 36.8 mt -61.25 -49.46 84.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.25 0.547 . . . . 0.0 109.604 176.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.55 HG23 ' HB3' ' A' ' 18' ' ' ALA . 65.5 mt -60.43 -45.41 96.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.578 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.788 HD11 HD11 ' A' ' 52' ' ' ILE . 46.2 mt -61.7 -25.09 67.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.364 0.602 . . . . 0.0 110.761 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.514 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 8.6 tp10 -76.49 -42.22 44.28 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.719 173.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.652 HG21 ' O ' ' A' ' 38' ' ' ILE . 39.4 t -54.22 -42.71 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.888 0.851 . . . . 0.0 109.878 174.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 29.1 mt -83.49 -11.46 57.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.153 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.57 32.22 67.69 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.578 -0.737 . . . . 0.0 113.362 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.408 ' HB ' ' HB3' ' A' ' 79' ' ' PHE . 1.9 pt -109.74 -61.36 2.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -177.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.7 -177.75 4.16 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -174.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -104.74 -170.61 1.79 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.004 -172.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.536 ' O ' HG12 ' A' ' 52' ' ' ILE . 15.2 t -62.04 179.06 0.31 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -57.74 -29.8 65.05 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -172.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.0 m -52.39 -45.55 65.88 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.297 0.57 . . . . 0.0 110.691 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.6 m -77.43 -34.3 54.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.474 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.788 HD11 HD11 ' A' ' 40' ' ' LEU . 42.1 mm -64.84 -24.49 35.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.31 -178.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -51.52 -38.09 52.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 172.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -75.16 -38.16 61.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.265 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.505 HD13 ' CE2' ' A' ' 79' ' ' PHE . 2.2 mm? -56.01 -48.42 75.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.226 174.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.546 HG12 ' HB ' ' A' ' 33' ' ' THR . 59.8 mt -62.96 -45.84 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.917 176.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -56.77 -29.81 62.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.273 0.559 . . . . 0.0 110.718 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -77.04 -54.51 6.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.55 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -101.24 -13.47 18.08 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -170.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.452 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 48.1 t0 -134.18 64.67 66.49 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.172 0.511 . . . . 0.0 111.194 176.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 24.6 Cg_exo -69.0 -18.42 40.6 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.769 2.313 . . . . 0.0 111.493 175.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -78.88 -17.51 55.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.244 -176.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.74 40.08 46.45 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.215 -177.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.4 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 1.2 t-20 -66.18 -43.97 85.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.917 0.487 . . . . 0.0 110.687 -176.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.91 -22.28 14.67 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.623 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -149.39 171.44 16.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.945 0.402 . . . . 0.0 110.377 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.408 ' C ' ' HD3' ' A' ' 30' ' ' ARG . 30.0 pt -135.27 145.42 31.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.555 ' HB3' ' HB3' ' A' ' 70' ' ' ASP . 15.2 t70 -83.01 171.55 13.69 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.474 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -62.18 -22.67 66.09 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 173.547 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.555 ' HB3' ' HB3' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -45.41 -53.23 8.97 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.597 170.617 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.7 m -87.38 -33.77 19.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.968 0.413 . . . . 0.0 111.249 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.474 ' HB3' ' HA ' ' A' ' 69' ' ' PHE . 73.4 t80 -65.29 -33.14 75.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.365 -176.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -65.28 -37.26 86.62 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.073 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.2 mt -68.1 -37.56 78.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.975 0.417 . . . . 0.0 109.928 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.532 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 61.2 mt -58.15 -53.62 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.004 174.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.511 ' O ' HD23 ' A' ' 80' ' ' LEU . . . -60.96 -39.64 97.3 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.207 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.92 -28.83 69.8 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.906 0.384 . . . . 0.0 111.68 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.532 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 16.3 ptm180 -90.68 -13.04 34.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.009 -175.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.505 ' CE2' HD13 ' A' ' 55' ' ' LEU . 23.8 m-85 -119.35 -37.01 3.24 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.131 -0.627 . . . . 0.0 112.547 -175.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.511 HD23 ' O ' ' A' ' 76' ' ' GLY . 4.1 mm? . . . . . 0 N--CA 1.466 0.327 0 O-C-N 123.218 0.324 . . . . 0.0 111.101 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 . . . . . 0 N--CA 1.464 0.225 0 CA-C-O 121.585 0.707 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.713 ' HB2' ' HE3' ' A' ' 150' ' ' MET . 0.9 OUTLIER -58.58 -34.4 71.03 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.985 -177.145 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.711 ' HA ' ' CE2' ' A' ' 97' ' ' PHE . 52.7 mmm-85 -62.72 -36.9 84.47 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.084 -177.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -84.55 -15.12 46.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.094 0.473 . . . . 0.0 110.86 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.479 ' HA ' HD12 ' A' ' 99' ' ' LEU . . . -82.55 -14.04 55.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.008 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.711 ' CE2' ' HA ' ' A' ' 94' ' ' ARG . 20.9 m-85 -62.46 -46.24 89.41 Favored 'General case' 0 C--O 1.215 -0.711 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 176.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -66.83 -12.41 58.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.82 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 96' ' ' ALA . 96.3 mt -83.66 -43.78 15.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.954 175.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -93.12 -24.01 18.42 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.417 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -71.89 80.19 0.9 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.922 0.868 . . . . 0.0 110.1 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -74.67 -16.93 60.75 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.476 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.471 ' HB2' ' ND2' ' A' ' 105' ' ' ASN . 22.7 mt-10 -83.61 -37.59 22.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.964 -173.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.25 34.83 3.29 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.763 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.471 ' ND2' ' HB2' ' A' ' 103' ' ' GLU . 21.1 m-80 -88.91 -18.74 26.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.895 0.378 . . . . 0.0 110.523 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.4 -25.79 4.83 Favored Glycine 0 N--CA 1.454 -0.147 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -171.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.482 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 1.7 m-85 -111.33 173.45 6.34 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 171.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.632 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 11.8 pt -109.39 126.64 66.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 119.364 -0.935 . . . . 0.0 109.611 171.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.423 ' HA ' HG22 ' A' ' 143' ' ' THR . 33.1 m -64.44 165.01 10.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.684 -177.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.1 p -59.65 -31.98 70.03 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.779 -0.576 . . . . 0.0 110.206 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -58.23 -51.62 69.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.699 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.632 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.3 p -69.73 -36.02 68.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.639 ' HE1' ' HA ' ' A' ' 113' ' ' MET . 1.3 tpt -58.27 -45.1 88.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.049 0.452 . . . . 0.0 110.243 176.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.558 ' HG2' HD12 ' A' ' 129' ' ' LEU . 33.2 ttp180 -51.56 -50.79 59.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.975 175.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -65.18 -39.37 92.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.084 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 112' ' ' VAL . 43.6 mt -58.99 -46.32 91.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 111.173 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.449 HD12 ' HG ' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -63.65 -54.0 42.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.162 0.506 . . . . 0.0 109.946 -178.411 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.425 ' HB1' HD22 ' A' ' 129' ' ' LEU . . . -63.92 -19.86 65.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.713 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -69.03 -40.56 78.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.94 0.4 . . . . 0.0 110.258 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -75.84 -51.32 12.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.01 174.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.566 ' HB3' HD23 ' A' ' 124' ' ' LEU . 2.1 m-20 -107.73 96.82 6.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.431 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -79.72 15.14 1.45 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.511 -171.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 41.7 p -112.34 -4.65 14.25 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.493 0.663 . . . . 0.0 110.882 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.566 HD23 ' HB3' ' A' ' 121' ' ' ASP . 3.7 mm? -70.09 114.27 8.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.65 174.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.3 m -90.3 176.5 6.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.002 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.7 p -52.49 -44.37 65.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.872 0.367 . . . . 0.0 111.691 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -65.14 -41.4 94.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.954 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.432 ' HB3' HD13 ' A' ' 124' ' ' LEU . 34.3 m-20 -69.85 -49.77 49.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.448 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.558 HD12 ' HG2' ' A' ' 114' ' ' ARG . 79.2 mt -56.28 -38.28 70.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.685 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -55.95 -46.28 78.58 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.988 0.423 . . . . 0.0 110.704 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.66 -41.44 98.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.101 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 48.8 mtt -68.88 -38.97 80.02 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.006 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 133' ' ' ILE . 13.6 mm -59.02 -45.89 92.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.133 0.492 . . . . 0.0 110.005 174.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -55.34 -43.61 75.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.744 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -73.08 -45.64 56.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.246 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.614 HG12 HG11 ' A' ' 152' ' ' VAL . 69.8 mt -59.53 -57.1 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.729 -178.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -76.71 82.57 3.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.033 0.921 . . . . 0.0 109.83 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.39 -35.39 54.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.663 -1.153 . . . . 0.0 112.238 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -90.31 -10.53 43.79 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.383 -175.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 72.79 37.49 57.21 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.742 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.3 m -83.3 -19.29 36.53 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.418 0.628 . . . . 0.0 110.733 -178.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 93.42 -29.99 7.75 Favored Glycine 0 CA--C 1.51 -0.257 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.494 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.423 HG22 ' HA ' ' A' ' 109' ' ' SER . 2.7 p -118.39 132.59 56.25 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 174.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.525 HG13 ' SD ' ' A' ' 113' ' ' MET . 96.5 t -82.76 115.89 26.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.767 -177.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.482 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 22.3 t70 -139.12 -61.53 0.56 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.028 0.442 . . . . 0.0 111.661 -174.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.58 ' O ' ' HG2' ' A' ' 150' ' ' MET . 2.3 p90 -94.84 -112.74 0.12 Allowed 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.519 -172.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.461 ' H ' ' HD1' ' A' ' 146' ' ' PHE . 6.3 mp0 -64.71 -11.22 33.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.904 0.383 . . . . 0.0 111.265 -176.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -66.84 -52.07 48.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.332 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.477 ' CG ' ' HE1' ' A' ' 97' ' ' PHE . 14.3 t80 -77.19 -33.8 56.33 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.009 0.433 . . . . 0.0 110.303 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' MET . . . . . 0.713 ' HE3' ' HB2' ' A' ' 93' ' ' LEU . 6.9 mmt -64.13 -23.44 67.32 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.25 -21.93 66.38 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.66 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.614 HG11 HG12 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -91.31 -71.82 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 CA-C-O 121.813 0.816 . . . . 0.0 110.727 -178.41 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 47.5 tpp -83.49 -37.45 23.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.8 -166.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.594 ' OG1' ' HA ' ' A' ' 150' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.442 -0.87 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.219 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.413 ' HA ' HD13 ' A' ' 15' ' ' LEU . 59.8 t . . . . . 0 N--CA 1.45 -0.441 0 CA-C-O 120.759 0.314 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -70.37 -37.48 74.58 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.009 173.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.0 mp -58.7 -48.92 79.47 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.468 HD12 ' HA3' ' A' ' 76' ' ' GLY . 84.8 mt -54.76 -47.85 73.39 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.758 175.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.71 -49.69 75.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.2 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.6 m -59.69 -41.3 90.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.968 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.609 ' HB2' HG22 ' A' ' 39' ' ' ILE . . . -76.27 -39.78 53.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.554 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -53.43 -56.14 19.31 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.643 175.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.432 ' HD2' ' OE1' ' A' ' 23' ' ' GLU . 28.1 mmm180 -66.96 -16.91 64.66 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.356 -174.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -87.6 -34.88 18.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.918 0.39 . . . . 0.0 111.354 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.445 ' HB2' HD12 ' A' ' 39' ' ' ILE . 78.8 m-85 -109.69 13.2 23.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.282 0.563 . . . . 0.0 110.227 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.684 ' HG2' ' HB ' ' A' ' 24' ' ' THR . 27.0 tt0 -71.21 148.28 47.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.811 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.684 ' HB ' ' HG2' ' A' ' 23' ' ' GLU . 0.4 OUTLIER 78.8 140.88 0.07 OUTLIER Pre-proline 0 N--CA 1.447 -0.623 0 O-C-N 124.664 1.227 . . . . 0.0 113.527 162.505 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -84.62 -36.69 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.265 2.643 . . . . 0.0 110.014 166.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -178.07 47.59 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.39 174.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.2 63.7 0.95 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.849 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.8 t -107.24 -18.29 13.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.005 0.431 . . . . 0.0 111.003 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.72 12.92 84.0 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -175.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.9 mtm-85 -140.54 168.46 19.75 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.567 -0.817 . . . . 0.0 109.597 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.525 HG21 ' HA ' ' A' ' 23' ' ' GLU . 12.3 p -107.7 127.66 63.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 173.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.8 m -55.45 138.5 46.04 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.852 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.555 ' HA ' HG13 ' A' ' 36' ' ' ILE . 1.5 p -64.53 -26.96 68.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.196 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -65.63 -27.85 68.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.109 0.48 . . . . 0.0 110.256 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -92.15 -13.52 30.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.47 -176.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.694 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 69.7 mt -53.86 -48.71 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 O-C-N 123.215 0.322 . . . . 0.0 110.773 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.73 -34.73 83.51 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.613 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.634 ' O ' HG22 ' A' ' 42' ' ' VAL . 50.3 mt -62.66 -49.71 82.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.4 0.619 . . . . 0.0 109.581 175.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.609 HG22 ' HB2' ' A' ' 18' ' ' ALA . 71.3 mt -61.64 -45.92 97.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.667 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.908 HD13 HD12 ' A' ' 52' ' ' ILE . 41.1 mt -61.91 -24.62 67.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.341 0.591 . . . . 0.0 110.423 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -75.97 -43.92 42.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.268 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 38' ' ' ILE . 47.8 t -53.85 -44.35 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.687 0.756 . . . . 0.0 110.264 175.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 22.2 mt -81.14 -12.1 59.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.275 -175.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.59 40.61 66.72 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.825 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 pt -118.76 -76.85 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.582 ' HG2' HD11 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -80.72 177.08 9.26 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -174.458 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -100.27 -171.18 1.99 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.126 -170.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.1 t -52.15 165.85 0.2 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.705 0.764 . . . . 0.0 111.762 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.523 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 59.4 mtpt -61.92 -20.56 63.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.349 -171.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.0 m -61.95 -31.21 71.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.208 0.528 . . . . 0.0 110.455 174.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.6 m -84.77 -31.48 23.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.334 176.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.908 HD12 HD13 ' A' ' 40' ' ' LEU . 28.3 mm -67.51 -25.3 32.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.009 -176.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -46.21 -45.28 16.82 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.922 173.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -62.29 -49.74 74.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.131 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.641 HD12 ' HA ' ' A' ' 52' ' ' ILE . 1.0 OUTLIER -58.14 -38.4 76.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.396 178.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.505 HG21 HG22 ' A' ' 33' ' ' THR . 75.2 mt -65.95 -46.67 87.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.044 177.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -62.42 -27.65 69.25 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.195 0.521 . . . . 0.0 110.289 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -76.0 -54.85 6.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.528 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.553 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 87.4 m-85 -97.57 -15.36 20.54 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -171.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.4 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 39.8 t0 -122.72 68.7 33.29 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 121.222 0.534 . . . . 0.0 110.358 174.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.553 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 20.7 Cg_exo -71.87 -18.12 28.39 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.032 2.488 . . . . 0.0 111.756 176.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -79.88 -17.62 52.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.712 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.38 37.46 53.98 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.781 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -72.59 -43.3 63.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.784 0.326 . . . . 0.0 111.237 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.97 -16.09 20.8 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.893 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -137.19 176.69 8.48 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.0 pt -136.9 152.64 28.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.894 0.378 . . . . 0.0 110.272 174.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -90.07 166.59 13.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.844 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.416 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -63.0 -21.69 66.32 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 178.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -57.61 -52.35 65.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.027 0.442 . . . . 0.0 109.986 174.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.484 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 3.4 m -70.72 -44.96 65.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.526 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.416 ' HB3' ' HA ' ' A' ' 69' ' ' PHE . 84.5 t80 -64.5 -34.77 79.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.651 -176.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -64.81 -35.84 82.39 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.6 mt -67.46 -43.9 87.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.555 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 88.8 mt -55.08 -47.55 77.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.275 175.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.781 ' HA2' HD23 ' A' ' 80' ' ' LEU . . . -67.52 -43.9 84.92 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.608 -0.805 . . . . 0.0 112.524 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.55 -24.33 67.57 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.894 0.378 . . . . 0.0 111.701 -174.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 10.7 ptm180 -89.1 -15.16 34.58 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.844 -175.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -124.34 -36.75 2.61 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.406 -0.518 . . . . 0.0 112.139 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.781 HD23 ' HA2' ' A' ' 76' ' ' GLY . 4.6 mm? . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 . . . . . 0 CA--C 1.52 -0.195 0 CA-C-O 121.308 0.575 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.657 HD11 ' HE1' ' A' ' 149' ' ' PHE . 0.9 OUTLIER -62.02 -35.58 78.99 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.894 -173.108 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.566 ' HD3' ' CE2' ' A' ' 97' ' ' PHE . 29.5 mmt180 -62.48 -41.69 98.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.086 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -74.62 -30.91 61.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.204 0.526 . . . . 0.0 110.818 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.501 ' HA ' HD12 ' A' ' 99' ' ' LEU . . . -74.95 -20.22 59.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.935 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.566 ' CE2' ' HD3' ' A' ' 94' ' ' ARG . 17.0 m-30 -56.57 -44.62 81.18 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.372 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.3 mtm-85 -72.02 -19.52 61.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.027 0.442 . . . . 0.0 110.906 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 96' ' ' ALA . 94.2 mt -80.09 -43.87 21.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.654 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.632 ' O ' ' HD2' ' A' ' 102' ' ' LYS . 79.9 m-85 -89.59 -5.61 57.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.397 -177.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 97' ' ' PHE . 55.8 t0 -76.82 76.28 3.43 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.512 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.632 ' HD2' ' O ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -57.04 -42.33 80.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.601 174.548 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -67.75 -36.75 81.1 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.214 -171.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.96 37.15 7.97 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -171.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -96.06 -18.37 20.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.49 -0.855 . . . . 0.0 111.174 -168.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.9 -24.91 10.83 Favored Glycine 0 CA--C 1.517 0.194 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.436 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 4.2 m-85 -116.75 176.93 4.89 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 173.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.615 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 6.3 pt -117.84 121.94 68.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.239 169.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.3 m -65.91 174.75 2.28 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.149 0.5 . . . . 0.0 111.556 -175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.2 p -67.36 -26.76 66.64 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.953 0.406 . . . . 0.0 110.754 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -60.59 -58.09 9.95 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.851 176.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.615 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.4 p -63.26 -38.36 81.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.843 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.555 ' SD ' HG12 ' A' ' 144' ' ' VAL . 2.7 tpt -56.5 -40.89 75.73 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.827 0.346 . . . . 0.0 110.648 177.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -61.02 -45.19 95.79 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.991 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -58.99 -46.49 88.0 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.411 0.444 . . . . 0.0 110.215 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 63.7 mt -57.45 -53.83 38.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.567 177.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.4 tp -54.66 -60.29 3.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.36 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.08 -27.15 52.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.433 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -75.45 -44.15 45.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.616 0.246 . . . . 0.0 110.348 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.32 -55.7 7.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.141 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.627 ' HB3' HD22 ' A' ' 124' ' ' LEU . 5.3 m-20 -103.01 111.97 24.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.478 0.656 . . . . 0.0 110.649 -178.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 122' ' ' GLU . 0.3 OUTLIER -89.17 -5.41 57.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.717 -173.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.7 p -88.61 -2.98 58.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.339 0.59 . . . . 0.0 110.765 -174.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.627 HD22 ' HB3' ' A' ' 121' ' ' ASP . 4.2 mm? -84.87 129.03 34.87 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.854 176.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.479 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 92.0 p -89.69 -179.01 5.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 175.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.5 t -58.75 -48.49 81.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.692 0.282 . . . . 0.0 110.795 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -71.08 -35.86 72.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.828 0.347 . . . . 0.0 111.161 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -66.28 -38.14 87.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.45 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.499 ' O ' HG12 ' A' ' 133' ' ' ILE . 85.5 mt -58.65 -44.46 90.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.151 172.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -58.99 -46.24 88.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.616 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.45 -42.71 98.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.723 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.553 ' HE3' HD11 ' A' ' 124' ' ' LEU . 9.0 mtt -64.06 -37.26 86.8 Favored 'General case' 0 C--O 1.215 -0.731 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.923 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 129' ' ' LEU . 15.8 mm -57.41 -43.88 83.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.188 0.518 . . . . 0.0 110.419 174.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.4 -36.98 84.04 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.262 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -72.79 -39.5 66.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.517 -1.219 . . . . 0.0 111.242 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 132' ' ' MET . 66.8 mt -71.11 -57.11 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.993 -176.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -75.64 63.58 1.58 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 122.396 1.094 . . . . 0.0 108.621 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -78.37 -22.33 48.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.489 -1.232 . . . . 0.0 112.161 -174.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -88.23 -11.99 45.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.368 0.604 . . . . 0.0 110.202 -178.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 79.53 34.99 30.3 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.488 174.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.471 ' C ' ' H ' ' A' ' 143' ' ' THR . 46.9 t -78.74 -21.16 48.42 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.197 0.522 . . . . 0.0 110.406 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.67 -28.36 3.54 Favored Glycine 0 C--O 1.234 0.121 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.471 ' H ' ' C ' ' A' ' 141' ' ' SER . 19.5 p -124.3 128.27 48.87 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 172.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.555 HG12 ' SD ' ' A' ' 113' ' ' MET . 58.8 t -80.71 127.3 39.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -173.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 17.8 t70 -157.2 -77.63 0.08 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.872 0.844 . . . . 0.0 110.176 -175.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.402 ' HB3' HH22 ' A' ' 94' ' ' ARG . 20.7 p90 -92.65 136.42 33.24 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.072 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 146' ' ' PHE . 42.0 mm-40 64.86 -54.44 0.3 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.526 0.73 . . . . 0.0 112.204 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -54.66 -51.02 66.78 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.818 0.847 . . . . 0.0 112.144 -176.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.657 ' HE1' HD11 ' A' ' 93' ' ' LEU . 11.4 t80 -75.41 -37.0 60.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.125 0.488 . . . . 0.0 110.341 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' MET . . . . . 0.499 ' HE1' ' OG1' ' A' ' 154' ' ' THR . 0.0 OUTLIER -58.14 -43.15 87.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.347 178.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.24 -35.62 56.73 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.455 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' A' ' 149' ' ' PHE . 9.3 p -75.59 -38.9 39.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 117.112 0.456 . . . . 0.0 111.511 -175.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 16.0 tpt -93.88 -39.92 10.44 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.879 -174.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.499 ' OG1' ' HE1' ' A' ' 150' ' ' MET . 64.9 p . . . . . 0 C--N 1.324 -0.5 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -172.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.431 HG11 ' CE2' ' A' ' 69' ' ' PHE . 89.2 t . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.833 0.349 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.501 ' HD3' ' C ' ' A' ' 13' ' ' LYS . 1.1 tmtp? -62.82 -40.93 98.92 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 123.181 0.592 . . . . 0.0 110.854 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.424 ' N ' ' HD3' ' A' ' 13' ' ' LYS . 6.4 mp -69.92 -42.45 73.31 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.636 HD21 ' CD1' ' A' ' 80' ' ' LEU . 80.8 mt -59.97 -53.98 51.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.624 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.437 ' HA ' ' HE1' ' A' ' 69' ' ' PHE . 37.7 tt0 -64.65 -35.89 82.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.359 -175.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.1 m -59.82 -42.16 92.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 110.745 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.529 ' HB1' HG22 ' A' ' 39' ' ' ILE . . . -80.48 -33.12 36.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.146 0.498 . . . . 0.0 110.278 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.435 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 35.7 t80 -56.44 -55.04 38.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.35 177.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -69.08 -19.79 64.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.522 -174.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.61 -42.86 40.86 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.744 0.307 . . . . 0.0 110.908 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -103.77 14.01 31.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.137 0.494 . . . . 0.0 110.444 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.719 ' HG2' ' HB ' ' A' ' 24' ' ' THR . 10.3 tt0 -71.85 154.65 41.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.38 -176.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.719 ' HB ' ' HG2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER 76.01 137.77 0.05 OUTLIER Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-O 122.462 1.125 . . . . 0.0 113.812 158.637 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.32 -52.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.911 2.408 . . . . 0.0 109.835 168.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -138.83 -25.81 0.88 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.625 172.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.66 50.0 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -176.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 t -89.78 -29.77 18.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.807 0.337 . . . . 0.0 111.39 -174.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.88 -6.33 75.03 Favored Glycine 0 N--CA 1.453 -0.179 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 -175.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' A' ' 67' ' ' ILE . 61.0 mtt85 -115.25 163.7 15.29 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.207 -0.496 . . . . 0.0 109.745 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.519 HG23 HD12 ' A' ' 39' ' ' ILE . 13.3 p -106.18 126.61 61.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 121.86 0.838 . . . . 0.0 110.269 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 31.1 m -53.79 140.61 29.45 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.847 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.576 ' HB ' HG12 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -66.69 -25.31 66.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.85 -174.538 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -69.36 -26.08 64.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.589 0.709 . . . . 0.0 109.727 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -82.06 -22.4 36.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.661 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.477 HG13 ' HA ' ' A' ' 33' ' ' THR . 60.2 mt -55.61 -43.33 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 120.959 0.409 . . . . 0.0 110.143 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.417 ' CA ' HG13 ' A' ' 52' ' ' ILE . . . -65.24 -25.43 71.11 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.634 177.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.642 ' O ' HG21 ' A' ' 42' ' ' VAL . 39.3 mt -75.21 -51.97 19.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.529 HG22 ' HB1' ' A' ' 18' ' ' ALA . 63.5 mt -60.96 -44.83 98.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.839 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.423 HD22 HG21 ' A' ' 36' ' ' ILE . 1.6 mp -57.54 -39.26 76.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.352 0.596 . . . . 0.0 109.685 176.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -65.64 -38.44 89.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.769 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.642 HG21 ' O ' ' A' ' 38' ' ' ILE . 60.8 t -60.69 -50.38 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.622 0.725 . . . . 0.0 110.671 175.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.5 mt -83.35 -1.54 53.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.653 -171.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.55 35.19 42.12 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.403 172.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.5 pt -129.02 166.65 26.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.628 0.214 . . . . 0.0 110.468 176.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.29 -166.67 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -120.22 -171.88 2.25 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.975 -173.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.9 t -63.7 171.33 2.74 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.451 0.643 . . . . 0.0 111.437 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.446 ' HB3' ' HZ2' ' A' ' 49' ' ' LYS . 7.3 mtpm? -59.0 -24.6 62.92 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.317 -165.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.3 t -57.29 -44.8 84.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.931 0.396 . . . . 0.0 110.35 173.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.3 m -72.26 -34.42 68.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.433 0.635 . . . . 0.0 110.293 176.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.417 HG13 ' CA ' ' A' ' 37' ' ' GLY . 44.9 mm -63.41 -24.42 35.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.479 -176.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -50.83 -38.02 46.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.886 172.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.883 HE21 ' HA ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -74.44 -28.82 61.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.051 -179.051 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.401 HD11 ' CE2' ' A' ' 79' ' ' PHE . 2.3 mm? -65.35 -43.34 91.14 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.576 HG12 ' HB ' ' A' ' 33' ' ' THR . 71.8 mt -65.2 -45.42 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.96 177.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.03 -27.99 22.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.294 0.569 . . . . 0.0 111.076 176.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -83.31 -53.65 5.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.663 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.445 ' CE2' HG12 ' A' ' 75' ' ' ILE . 97.1 m-85 -100.87 -10.66 20.48 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -169.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.48 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 51.3 t0 -136.25 63.82 51.03 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 121.208 0.527 . . . . 0.0 110.458 174.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 24.6 Cg_exo -68.42 -20.56 41.87 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.841 2.361 . . . . 0.0 111.592 177.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -78.45 -17.48 56.28 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.757 -176.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.97 43.02 50.65 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.518 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -74.89 -38.04 61.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.216 0.532 . . . . 0.0 109.942 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 110.68 -5.37 29.43 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.961 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -161.32 175.77 11.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.405 ' O ' ' HB3' ' A' ' 30' ' ' ARG . 34.6 pt -143.19 146.71 21.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.371 -177.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -75.88 163.19 27.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.934 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.437 ' HE1' ' HA ' ' A' ' 16' ' ' GLU . 16.0 t80 -56.49 -35.65 68.23 Favored 'General case' 0 C--O 1.214 -0.772 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.075 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -62.18 -22.41 65.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.869 0.366 . . . . 0.0 111.029 -175.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.3 m -85.82 -41.26 15.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.905 0.383 . . . . 0.0 110.504 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.433 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 89.7 t80 -70.1 -30.56 67.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.467 0.651 . . . . 0.0 109.717 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -55.51 -50.53 69.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.871 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.0 -42.82 98.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.364 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.588 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 65.5 mt -54.34 -55.45 14.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.482 0.658 . . . . 0.0 110.068 176.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.69 -42.86 99.82 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.259 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.06 -28.03 69.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.854 0.359 . . . . 0.0 111.16 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.588 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 13.8 ptm180 -89.64 -10.74 44.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.867 -176.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.504 ' CE1' ' HG3' ' A' ' 78' ' ' ARG . 22.6 m-85 -116.28 -40.14 3.3 Favored 'General case' 0 C--N 1.337 0.061 0 C-N-CA 120.66 -0.416 . . . . 0.0 112.105 -176.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.636 ' CD1' HD21 ' A' ' 15' ' ' LEU . 2.3 mp . . . . . 0 C--N 1.326 -0.45 0 CA-C-O 120.912 0.387 . . . . 0.0 110.828 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 CA--C 1.52 -0.187 0 CA-C-O 120.932 0.396 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.664 HD12 ' CD1' ' A' ' 149' ' ' PHE . 77.6 mt -57.83 -38.29 75.34 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.731 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.727 ' HA ' ' CD2' ' A' ' 97' ' ' PHE . 5.6 mpt_? -58.84 -46.27 88.09 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.755 0.312 . . . . 0.0 111.689 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -76.03 -17.08 59.82 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.13 0.49 . . . . 0.0 110.291 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.19 -18.04 33.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.182 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.727 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 22.4 m-85 -59.57 -45.5 91.66 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 98' ' ' ARG . 47.8 mtp180 -69.68 -13.86 62.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.156 0.503 . . . . 0.0 111.033 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.4 mt -84.35 -35.51 23.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.501 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -96.38 -11.55 25.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.182 0.515 . . . . 0.0 110.298 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -72.54 77.56 1.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.877 0.846 . . . . 0.0 110.337 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -75.65 -9.49 58.63 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.923 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -88.88 -37.11 15.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.654 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.95 30.55 7.05 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.676 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.412 ' C ' ' H ' ' A' ' 107' ' ' TYR . 92.2 m-20 -98.96 -17.48 18.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.848 0.356 . . . . 0.0 111.544 -175.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.57 -26.18 4.18 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.521 -0.631 . . . . 0.0 111.521 -174.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.529 ' HD2' ' CB ' ' A' ' 145' ' ' ASP . 30.5 m-85 -103.92 144.77 31.07 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 171.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.637 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 7.0 pt -93.11 120.8 43.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 118.591 -1.243 . . . . 0.0 108.977 174.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.5 m -67.76 172.12 5.7 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.96 -174.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.43 ' HB ' HG22 ' A' ' 133' ' ' ILE . 34.3 p -60.79 -29.06 69.21 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.211 0.529 . . . . 0.0 110.845 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.58 ' O ' ' HB2' ' A' ' 114' ' ' ARG . 2.0 t70 -62.97 -50.72 69.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.403 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.637 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.4 p -70.82 -35.28 59.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.933 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.717 ' SD ' HG11 ' A' ' 144' ' ' VAL . 1.4 tpt -59.66 -37.72 79.51 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.763 0.316 . . . . 0.0 110.205 176.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.58 ' HB2' ' O ' ' A' ' 111' ' ' ASP . 36.7 mtt180 -50.55 -59.55 3.93 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.407 172.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.0 -41.69 92.66 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.768 -176.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 53.6 mt -58.09 -46.89 88.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.148 0.499 . . . . 0.0 110.9 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.425 HD11 ' CD2' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -70.57 -47.39 60.5 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.128 -179.257 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.799 ' HB2' HD22 ' A' ' 129' ' ' LEU . . . -53.21 -25.81 15.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.753 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -68.34 -26.68 65.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.195 0.521 . . . . 0.0 110.247 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.401 HD12 ' N ' ' A' ' 120' ' ' LEU . 9.4 mp -89.55 -47.77 7.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.022 174.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.826 ' HB3' ' HB2' ' A' ' 124' ' ' LEU . 1.3 m-20 -90.57 93.57 9.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.3 0.572 . . . . 0.0 110.471 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -79.61 -13.84 59.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.728 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.5 p -96.79 -14.04 22.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 122.724 1.25 . . . . 0.0 108.607 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.884 ' HG ' HD23 ' A' ' 129' ' ' LEU . 36.9 tp -69.83 116.21 9.96 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 112.991 -1.913 . . . . 0.0 110.426 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 93.9 p -91.61 -179.71 5.43 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.622 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 24.9 m -58.73 -37.36 75.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.889 0.376 . . . . 0.0 110.911 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -74.58 -42.05 59.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.634 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.636 ' CB ' HD12 ' A' ' 124' ' ' LEU . 59.4 m-20 -64.35 -50.46 67.63 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.884 HD23 ' HG ' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -42.25 -48.41 4.93 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.835 169.646 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -62.19 -41.31 98.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.662 0.268 . . . . 0.0 111.219 -175.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.89 -41.6 97.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.101 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.418 ' O ' HG13 ' A' ' 136' ' ' ILE . 36.2 mtt -63.05 -39.21 94.05 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.624 176.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 129' ' ' LEU . 24.5 mm -57.91 -45.2 87.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.144 0.497 . . . . 0.0 110.382 175.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -61.02 -34.92 75.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.43 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -73.87 -38.52 64.4 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.849 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.524 HG12 ' HB ' ' A' ' 152' ' ' VAL . 59.8 mt -70.43 -49.41 53.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.385 -176.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.73 95.93 0.93 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 123.023 1.392 . . . . 0.0 110.713 -174.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.29 -54.95 5.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.208 -1.36 . . . . 0.0 112.337 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -84.23 -10.35 57.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.441 0.639 . . . . 0.0 110.979 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 61.55 40.95 99.41 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.621 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.1 t -89.89 5.04 48.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.079 0.466 . . . . 0.0 110.66 -176.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.56 -31.01 4.68 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.177 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 35.3 p -117.81 143.27 46.42 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.439 -0.381 . . . . 0.0 109.998 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.717 HG11 ' SD ' ' A' ' 113' ' ' MET . 71.7 t -91.88 111.41 24.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.529 ' CB ' ' HD2' ' A' ' 107' ' ' TYR . 22.6 t70 -146.37 -69.16 0.26 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.687 0.756 . . . . 0.0 111.574 -175.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.852 ' HD2' ' HG2' ' A' ' 147' ' ' GLU . 4.0 p90 -97.92 -53.44 3.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.02 -164.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.852 ' HG2' ' HD2' ' A' ' 146' ' ' PHE . 40.2 mm-40 -98.86 -36.17 9.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.496 0.665 . . . . 0.0 110.157 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 148' ' ' GLU . 40.9 mp0 -63.5 -54.95 28.37 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.038 -175.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.664 ' CD1' HD12 ' A' ' 93' ' ' LEU . 2.3 t80 -66.27 -45.98 78.6 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.793 -175.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' MET . . . . . 0.409 ' HG2' ' O ' ' A' ' 146' ' ' PHE . 52.4 mmm -61.47 -19.53 62.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.278 177.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -90.92 -17.54 51.11 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.878 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.524 ' HB ' HG12 ' A' ' 136' ' ' ILE . 6.6 p -98.31 -47.26 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 117.019 0.41 . . . . 0.0 111.393 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.409 ' N ' HG11 ' A' ' 152' ' ' VAL . 49.9 tpp -81.08 -56.46 4.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.881 0.372 . . . . 0.0 110.785 -176.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.1 p . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.78 -178.556 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.1 t . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.614 0.245 . . . . 0.0 110.462 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.473 ' HD2' ' HA ' ' A' ' 13' ' ' LYS . 12.0 tptt -61.64 -42.64 99.18 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 120.782 0.325 . . . . 0.0 110.642 173.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.9 mt -57.23 -48.7 78.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.426 0.631 . . . . 0.0 109.617 173.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.9 mt -56.18 -51.34 68.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.261 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -61.08 -41.87 97.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.652 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.8 m -61.24 -39.28 89.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.063 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.437 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -84.2 -31.33 25.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.931 0.396 . . . . 0.0 110.616 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.584 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 65.3 t80 -57.95 -56.79 17.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.411 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -71.95 -0.96 12.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.468 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -93.79 -52.43 4.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.788 0.327 . . . . 0.0 110.746 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.601 ' CD1' HG12 ' A' ' 39' ' ' ILE . 64.5 m-85 -95.71 11.11 34.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.02 0.438 . . . . 0.0 110.455 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.61 ' HA ' HG23 ' A' ' 31' ' ' VAL . 11.1 tt0 -62.32 155.12 25.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.513 -174.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.581 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.4 OUTLIER 77.81 138.52 0.06 OUTLIER Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 114.128 -1.396 . . . . 0.0 113.737 161.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -88.32 -44.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.553 2.835 . . . . 0.0 110.799 170.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -164.3 47.03 0.11 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.494 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.78 66.67 1.27 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.808 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.0 t -113.14 -27.19 8.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -176.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.13 -4.76 82.45 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -171.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.446 ' HD2' ' OD2' ' A' ' 66' ' ' ASP . 25.5 mtt85 -115.25 160.22 20.03 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 114.068 -1.066 . . . . 0.0 109.565 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.61 HG23 ' HA ' ' A' ' 23' ' ' GLU . 10.2 p -106.8 126.98 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 121.697 0.76 . . . . 0.0 109.099 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.442 ' HA ' ' HB3' ' A' ' 66' ' ' ASP . 32.8 t -55.63 140.64 40.53 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.941 -1.481 . . . . 0.0 111.372 -177.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.596 ' HB ' HG12 ' A' ' 56' ' ' ILE . 7.0 p -66.5 -19.63 65.83 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.01 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.406 ' O ' ' HE2' ' A' ' 49' ' ' LYS . 32.9 t70 -70.9 -27.39 63.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.72 176.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.678 ' HA ' HD12 ' A' ' 38' ' ' ILE . 15.8 mm100 -95.06 -13.96 24.7 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.05 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.62 HG22 HD22 ' A' ' 40' ' ' LEU . 63.1 mt -56.93 -34.06 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.614 0.245 . . . . 0.0 110.665 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.425 ' CA ' HG13 ' A' ' 52' ' ' ILE . . . -73.12 -36.1 56.81 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.338 -177.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 35' ' ' GLN . 1.3 mp -59.81 -56.13 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 174.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.714 ' HA ' HG13 ' A' ' 42' ' ' VAL . 36.0 mt -64.08 -39.24 84.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.645 -176.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.62 HD22 HG22 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -60.83 -23.71 65.31 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.301 -0.56 . . . . 0.0 109.992 176.337 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 35.0 tt0 -81.74 -41.63 20.96 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.402 173.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.714 HG13 ' HA ' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -58.78 -38.74 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 121.572 0.701 . . . . 0.0 110.406 177.563 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.473 ' HG ' HG22 ' A' ' 42' ' ' VAL . 45.6 mt -83.52 -11.9 56.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.841 -178.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.91 32.52 56.76 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.269 175.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pt -110.96 -86.09 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -177.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -79.03 177.34 8.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.257 0.551 . . . . 0.0 112.362 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -100.79 -171.95 2.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.371 -174.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.2 t -64.38 175.81 1.24 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.444 0.64 . . . . 0.0 111.862 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 96.8 mttt -53.61 -30.42 42.48 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -165.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.4 m -55.7 -33.48 64.22 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.073 0.463 . . . . 0.0 111.058 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.7 m -84.25 -33.77 23.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.557 0.694 . . . . 0.0 110.3 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.454 HD13 HD22 ' A' ' 40' ' ' LEU . 36.9 mm -66.92 -23.98 31.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.497 -175.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 30.7 mmt180 -52.71 -33.1 46.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.923 0.392 . . . . 0.0 110.742 176.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -70.86 -51.05 28.84 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.164 0.507 . . . . 0.0 109.735 175.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.474 HD13 ' CE2' ' A' ' 79' ' ' PHE . 3.3 mm? -51.26 -45.92 62.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.249 177.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.596 HG12 ' HB ' ' A' ' 33' ' ' THR . 73.1 mt -62.97 -50.0 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.486 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -62.92 -25.39 68.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.197 0.523 . . . . 0.0 110.713 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -69.24 -55.02 11.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.236 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.531 ' HB3' ' HB3' ' A' ' 71' ' ' SER . 94.6 m-85 -100.92 -20.76 15.32 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -171.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -126.67 67.59 67.5 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-O 121.2 0.524 . . . . 0.0 110.615 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.438 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 31.3 Cg_exo -62.66 -17.16 57.34 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.862 2.374 . . . . 0.0 111.628 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -69.74 -18.34 63.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.279 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.9 32.44 84.19 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -173.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -75.41 -40.93 57.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.928 -0.636 . . . . 0.0 111.087 -170.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.01 -14.95 10.33 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.017 -1.087 . . . . 0.0 113.788 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.446 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 5.7 p-10 -154.75 157.9 38.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 117.171 0.486 . . . . 0.0 110.875 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.8 pt -133.59 149.11 30.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.255 -175.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -81.11 167.99 19.09 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.657 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.3 -26.63 52.79 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -42.89 -54.29 4.26 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.468 172.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.531 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 13.5 m -86.51 -37.17 18.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.819 -176.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -63.94 -35.26 80.1 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.129 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -63.87 -36.27 83.36 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.438 ' HB ' ' CE1' ' A' ' 59' ' ' PHE . 34.6 mt -72.44 -37.25 57.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 177.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.544 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 61.7 mt -57.78 -51.21 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.285 0.564 . . . . 0.0 109.654 173.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.483 ' O ' HD22 ' A' ' 80' ' ' LEU . . . -63.18 -42.78 99.32 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.893 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.95 -37.58 74.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.385 0.612 . . . . 0.0 111.329 -175.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 15.0 ptm180 -81.83 -9.3 59.65 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.969 -173.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.474 ' CE2' HD13 ' A' ' 55' ' ' LEU . 22.2 m-85 -124.02 -31.56 3.36 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.72 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.483 HD22 ' O ' ' A' ' 76' ' ' GLY . 4.1 mm? . . . . . 0 CA--C 1.513 -0.448 0 CA-C-O 121.155 0.503 . . . . 0.0 110.904 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 121.075 0.464 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.566 HD23 ' H ' ' A' ' 93' ' ' LEU . 0.6 OUTLIER -56.81 -38.18 72.23 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.037 -176.562 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.688 ' HA ' ' CE2' ' A' ' 97' ' ' PHE . 30.1 mmm180 -62.44 -34.85 77.59 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.485 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -86.96 -23.44 25.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.881 0.372 . . . . 0.0 110.652 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.0 -16.03 62.06 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.608 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.688 ' CE2' ' HA ' ' A' ' 94' ' ' ARG . 20.1 m-85 -61.71 -40.86 96.51 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -66.46 -17.74 64.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.323 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.2 mt -88.06 -30.72 19.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.321 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -104.28 -24.12 13.15 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -175.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -72.97 79.88 1.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.562 0.696 . . . . 0.0 109.982 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -69.72 -19.43 63.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.628 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.457 ' HB2' ' ND2' ' A' ' 105' ' ' ASN . 12.5 mt-10 -90.91 -37.01 13.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.279 -172.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.81 42.15 3.66 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.024 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' A' ' 103' ' ' GLU . 24.5 m-80 -87.53 -19.65 27.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 0.0 110.693 -176.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.54 1.9 82.86 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -169.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.54 ' HD2' ' CB ' ' A' ' 145' ' ' ASP . 4.7 m-85 -148.22 165.26 31.47 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.649 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 11.3 pt -102.46 120.48 52.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 C-N-CA 119.278 -0.969 . . . . 0.0 109.1 170.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.6 m -60.97 161.59 8.11 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.685 -176.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.0 p -58.34 -26.61 63.32 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.765 -0.584 . . . . 0.0 110.642 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -62.05 -51.03 69.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.78 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.649 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.1 p -70.37 -36.71 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.156 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.632 ' SD ' HG13 ' A' ' 144' ' ' VAL . 2.7 tpt -59.23 -38.34 79.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.103 0.477 . . . . 0.0 109.782 175.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -56.34 -53.48 56.83 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.125 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.62 -29.42 66.91 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.996 -178.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.601 HG13 ' O ' ' A' ' 112' ' ' VAL . 57.4 mt -63.52 -50.2 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 121.205 0.526 . . . . 0.0 110.021 174.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.682 HD12 ' SD ' ' A' ' 132' ' ' MET . 0.7 OUTLIER -58.7 -50.61 73.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.835 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.65 -27.82 68.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.775 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -69.97 -39.92 75.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.911 0.386 . . . . 0.0 110.14 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.44 -56.72 5.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.828 175.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.608 ' CG ' HD22 ' A' ' 124' ' ' LEU . 7.5 t70 -102.82 119.97 39.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.077 0.465 . . . . 0.0 110.881 -177.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -101.87 15.79 27.92 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.805 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 61.8 p -116.17 -17.0 10.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.477 0.656 . . . . 0.0 109.767 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.608 HD22 ' CG ' ' A' ' 121' ' ' ASP . 1.4 mm? -55.42 146.85 18.73 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.909 169.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.425 ' H ' ' HB2' ' A' ' 128' ' ' ASP . 27.3 t -107.85 162.46 13.98 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.601 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.1 m -51.76 -36.51 47.6 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 118.204 0.456 . . . . 0.0 111.396 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -76.38 -45.69 30.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.295 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.425 ' HB2' ' H ' ' A' ' 125' ' ' SER . 3.0 m-20 -63.35 -42.51 98.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.053 0.454 . . . . 0.0 110.487 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.6 HD12 ' HB3' ' A' ' 117' ' ' LEU . 26.6 tp -56.39 -39.5 73.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.528 176.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.449 ' O ' ' HB ' ' A' ' 133' ' ' ILE . 23.7 t70 -63.88 -41.7 97.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.234 177.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.48 -38.06 89.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.686 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.682 ' SD ' HD12 ' A' ' 117' ' ' LEU . 28.7 mtt -65.23 -34.04 77.43 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.59 175.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.449 ' HB ' ' O ' ' A' ' 130' ' ' ASP . 15.2 mm -58.54 -47.79 87.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.978 0.418 . . . . 0.0 110.312 173.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.66 -45.08 77.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.409 175.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -66.95 -37.12 83.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.253 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.451 HG23 ' SD ' ' A' ' 113' ' ' MET . 51.9 mt -69.41 -58.65 5.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.16 -178.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -71.29 96.26 1.41 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.7 0.762 . . . . 0.0 110.206 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -75.19 -42.97 54.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.736 -175.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -81.94 -15.14 54.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.491 0.662 . . . . 0.0 110.979 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 70.71 26.03 74.73 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.195 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.0 t -74.68 -18.25 60.55 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.428 0.633 . . . . 0.0 109.723 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.22 -23.94 24.64 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.534 ' HB ' ' HB2' ' A' ' 107' ' ' TYR . 24.6 p -116.93 128.92 55.69 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.632 HG13 ' SD ' ' A' ' 113' ' ' MET . 94.1 t -86.13 121.92 37.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.292 -176.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.54 ' CB ' ' HD2' ' A' ' 107' ' ' TYR . 22.7 t70 -150.43 -68.99 0.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.325 0.584 . . . . 0.0 111.867 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 146' ' ' PHE . 0.6 OUTLIER -85.23 -88.28 0.11 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.067 -167.185 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -78.31 -28.22 47.4 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.063 0.459 . . . . 0.0 110.823 -175.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.603 ' CD ' ' H ' ' A' ' 148' ' ' GLU . 3.0 mp0 -57.94 -64.11 1.02 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.588 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.522 ' CD2' HD11 ' A' ' 108' ' ' ILE . 19.8 t80 -66.97 -43.74 82.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.979 -174.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' MET . . . . . 0.563 ' HE1' HD21 ' A' ' 93' ' ' LEU . 40.7 tpp -62.43 -33.56 75.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.152 0.501 . . . . 0.0 109.797 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.55 -26.81 66.72 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 116.033 -0.53 . . . . 0.0 113.133 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.485 HG11 ' HA ' ' A' ' 149' ' ' PHE . 6.5 p -89.17 -42.51 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 117.238 0.519 . . . . 0.0 111.665 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -82.34 -57.89 3.17 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.543 -174.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 45.3 p . . . . . 0 C--N 1.331 -0.238 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.585 -178.938 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.418 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 93.3 t . . . . . 0 CA--C 1.531 0.233 0 CA-C-O 120.623 0.249 . . . . 0.0 111.403 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.488 ' HD2' ' HA ' ' A' ' 13' ' ' LYS . 11.9 tptt -62.08 -42.51 99.28 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-O 120.886 0.374 . . . . 0.0 111.223 177.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.6 mt -60.41 -41.61 94.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.407 0.622 . . . . 0.0 109.491 174.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.939 HD21 HD11 ' A' ' 80' ' ' LEU . 77.3 mt -61.16 -49.27 77.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.692 176.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -61.34 -43.47 98.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.461 -178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 57.9 m -58.6 -38.27 77.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.116 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.532 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -86.0 -35.67 20.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.042 0.449 . . . . 0.0 110.382 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.644 ' CE1' HG23 ' A' ' 31' ' ' VAL . 88.0 t80 -55.15 -49.58 71.46 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.096 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -81.35 -6.52 58.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.765 -175.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -87.58 -46.47 9.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.09 0.472 . . . . 0.0 110.318 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.56 ' HB3' ' HB3' ' A' ' 35' ' ' GLN . 68.4 m-85 -98.97 25.74 6.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.81 0.814 . . . . 0.0 109.461 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.965 ' HG2' ' HB ' ' A' ' 24' ' ' THR . 1.7 tt0 -78.42 139.48 38.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.249 -1.341 . . . . 0.0 112.8 -172.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.965 ' HB ' ' HG2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER 76.27 144.69 0.1 Allowed Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 155.515 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 24' ' ' THR . 7.1 Cg_exo -74.8 -53.71 0.1 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.531 2.821 . . . . 0.0 110.084 165.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -136.5 -39.61 0.65 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.69 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.3 38.55 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.9 t -76.37 -27.18 56.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.374 -0.413 . . . . 0.0 111.161 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.93 4.6 86.97 Favored Glycine 0 C--N 1.335 0.479 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.431 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 11.8 mtt180 -122.06 168.3 12.1 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.758 -0.721 . . . . 0.0 110.305 -175.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.644 HG23 ' CE1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -105.66 127.34 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.536 0 CA-C-O 121.446 0.641 . . . . 0.0 110.926 174.626 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.0 t -53.74 139.32 33.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.797 -1.547 . . . . 0.0 109.1 171.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.625 HG23 HG21 ' A' ' 56' ' ' ILE . 3.9 p -70.46 -13.04 61.96 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.869 0.366 . . . . 0.0 111.586 -176.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.71 -29.47 62.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.717 172.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.56 ' HB3' ' HB3' ' A' ' 22' ' ' PHE . 84.3 mm-40 -81.56 -23.54 37.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.977 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.479 HD12 HG22 ' A' ' 33' ' ' THR . 61.0 mt -57.18 -44.34 83.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.524 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.82 -20.73 70.7 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.366 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.609 ' O ' HG22 ' A' ' 42' ' ' VAL . 15.0 mt -81.9 -51.36 15.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.532 HG23 ' HB1' ' A' ' 18' ' ' ALA . 73.2 mt -57.66 -46.57 86.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.499 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.418 HD22 HG21 ' A' ' 36' ' ' ILE . 1.3 mp -56.81 -40.91 76.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.246 0.546 . . . . 0.0 109.928 177.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 32.8 tt0 -61.28 -43.96 98.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.566 175.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.609 HG22 ' O ' ' A' ' 38' ' ' ILE . 78.8 t -55.57 -48.03 77.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.814 0.816 . . . . 0.0 110.552 175.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.2 mt -83.14 -2.45 55.49 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.365 -172.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.8 26.84 59.84 Favored Glycine 0 N--CA 1.453 -0.188 0 CA-C-N 115.944 -0.571 . . . . 0.0 113.129 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.9 pt -122.45 167.74 15.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 O-C-N 122.708 -0.29 . . . . 0.0 111.066 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.62 -171.37 0.02 OUTLIER 'General case' 0 C--O 1.233 0.227 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -178.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -119.6 -170.88 2.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.938 -173.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.3 t -56.51 167.38 0.72 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.324 0.583 . . . . 0.0 111.149 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.484 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 55.9 mttp -57.36 -23.66 50.39 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -166.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.4 t -54.73 -47.84 73.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.093 0.473 . . . . 0.0 110.358 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.7 m -70.39 -35.27 73.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.63 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.484 ' CG1' ' HA ' ' A' ' 49' ' ' LYS . 44.4 mm -60.54 -29.2 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.359 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.522 ' HA ' HD11 ' A' ' 56' ' ' ILE . 34.5 mmt180 -56.5 -28.2 59.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.155 176.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -75.2 -35.22 61.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.884 0.373 . . . . 0.0 110.611 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -62.6 -43.82 97.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.416 0.627 . . . . 0.0 109.484 175.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.625 HG21 HG23 ' A' ' 33' ' ' THR . 52.6 mt -63.6 -43.64 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.839 176.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -55.75 -35.5 66.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.19 0.519 . . . . 0.0 110.897 176.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -71.68 -54.68 9.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.735 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.485 ' CE2' HG12 ' A' ' 75' ' ' ILE . 96.0 m-85 -100.62 -12.9 18.82 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -128.1 66.9 73.5 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-O 121.063 0.458 . . . . 0.0 110.606 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 33.1 Cg_exo -62.6 -29.75 78.37 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.795 2.33 . . . . 0.0 112.338 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -77.34 -17.62 58.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.387 -175.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.35 47.08 60.1 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -175.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -78.92 -26.98 43.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.111 0.482 . . . . 0.0 110.131 -174.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.3 -25.35 13.95 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.847 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' ' 30' ' ' ARG . 53.1 p-10 -146.06 168.48 20.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.918 0.39 . . . . 0.0 110.536 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.444 ' HB ' ' HB2' ' A' ' 71' ' ' SER . 36.6 pt -138.82 147.41 25.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.344 -178.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.431 ' HA ' ' HG2' ' A' ' 30' ' ' ARG . 28.7 t70 -80.8 170.27 16.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.316 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.26 -26.56 61.0 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 176.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -48.1 -52.89 18.47 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.822 173.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 2.2 m -78.3 -43.46 27.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.663 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -63.11 -36.76 84.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.599 -175.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -66.67 -35.45 80.17 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 56.2 mt -69.74 -39.2 77.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.603 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 62.6 mt -58.14 -52.57 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-O 121.373 0.606 . . . . 0.0 109.594 173.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.14 -38.89 96.88 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.237 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.06 -30.18 70.65 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.82 0.343 . . . . 0.0 111.427 -174.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 16.4 ptm180 -85.14 -7.48 59.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.787 -175.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.444 ' CE1' ' HG3' ' A' ' 78' ' ' ARG . 19.9 m-85 -124.97 -48.58 1.75 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 120.874 -0.331 . . . . 0.0 111.047 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.939 HD11 HD21 ' A' ' 15' ' ' LEU . 3.3 mp . . . . . 0 CA--C 1.513 -0.444 0 CA-C-O 121.47 0.652 . . . . 0.0 111.591 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.519 -0.222 0 CA-C-O 121.108 0.48 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.701 HD23 ' HE2' ' A' ' 150' ' ' MET . 0.6 OUTLIER -51.02 -32.14 20.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.913 177.256 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.732 HH11 ' HE2' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -58.22 -44.44 88.18 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.989 0.423 . . . . 0.0 111.618 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -71.67 -29.72 64.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.178 0.513 . . . . 0.0 110.241 176.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.419 ' HA ' HD11 ' A' ' 99' ' ' LEU . . . -75.56 -19.31 59.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.877 -175.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.732 ' HE2' HH11 ' A' ' 94' ' ' ARG . 22.6 m-85 -59.19 -48.99 79.55 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 120.844 0.354 . . . . 0.0 110.084 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -70.47 -12.9 61.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.527 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.419 HD11 ' HA ' ' A' ' 96' ' ' ALA . 85.5 mt -83.63 -27.37 29.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.832 176.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -105.14 -25.28 12.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.511 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -72.26 82.12 1.02 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.797 0.808 . . . . 0.0 111.099 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -72.39 -15.75 61.85 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.927 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -78.98 -35.99 42.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.339 -175.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.0 44.32 4.18 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.754 174.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -107.77 -18.44 13.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.064 0.459 . . . . 0.0 110.339 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.29 -24.44 27.18 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -172.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.56 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 6.3 m-85 -109.9 152.25 26.04 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.671 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 13.1 pt -92.44 124.66 44.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.6 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.58 ' HA ' HG22 ' A' ' 143' ' ' THR . 21.7 m -65.39 165.89 11.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.627 -175.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.8 p -62.33 -27.14 68.85 Favored 'General case' 0 C--N 1.318 -0.775 0 O-C-N 121.74 -0.6 . . . . 0.0 111.154 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.56 -49.79 76.13 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.667 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.671 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.6 p -70.73 -38.39 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.598 -178.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.515 ' HA ' ' HE3' ' A' ' 113' ' ' MET . 4.0 tpp -58.36 -43.12 88.24 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 174.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.53 ' O ' HD22 ' A' ' 129' ' ' LEU . 23.0 ttp180 -53.25 -40.36 64.53 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.669 177.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -74.37 -38.43 63.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.307 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 112' ' ' VAL . 59.3 mt -63.58 -52.67 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 120.945 0.402 . . . . 0.0 110.608 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.533 ' HB3' HD13 ' A' ' 129' ' ' LEU . 0.8 OUTLIER -54.02 -53.91 46.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.312 179.795 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.562 ' HB2' HD23 ' A' ' 129' ' ' LEU . . . -58.69 -27.52 64.92 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.257 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.22 -50.74 17.82 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.4 -48.96 71.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.802 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.621 ' HB3' HD21 ' A' ' 124' ' ' LEU . 4.8 m-20 -103.59 94.69 5.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.6 0.714 . . . . 0.0 110.189 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -73.92 -5.06 38.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.052 -0.977 . . . . 0.0 112.653 -171.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 66.9 p -94.85 -2.93 49.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.398 0.618 . . . . 0.0 111.359 -173.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.621 HD21 ' HB3' ' A' ' 121' ' ' ASP . 4.4 mm? -80.71 148.02 30.33 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.223 177.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 56.2 m -121.68 173.35 7.5 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.7 m -48.15 -47.53 34.79 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -174.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -68.81 -54.26 16.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.712 0.291 . . . . 0.0 111.227 -177.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -58.93 -44.89 91.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.725 0.774 . . . . 0.0 110.372 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.562 HD23 ' HB2' ' A' ' 118' ' ' ALA . 61.3 tp -60.57 -38.12 83.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.711 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.437 ' O ' ' HB ' ' A' ' 133' ' ' ILE . 5.6 t70 -69.35 -33.55 73.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.023 0.439 . . . . 0.0 110.251 -178.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.63 94.58 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.963 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.478 ' SD ' HD13 ' A' ' 117' ' ' LEU . 38.1 mtt -60.24 -36.34 77.51 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.262 175.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.528 HD13 ' HA ' ' A' ' 114' ' ' ARG . 17.0 mm -59.05 -47.2 90.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.835 0.35 . . . . 0.0 110.853 175.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -60.34 -39.79 88.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.229 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -70.03 -43.99 70.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.703 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.4 HG12 ' CG2' ' A' ' 152' ' ' VAL . 57.7 mt -57.98 -54.31 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.163 0.585 . . . . 0.0 112.519 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -73.65 91.59 1.89 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.587 0.708 . . . . 0.0 110.507 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.58 -41.97 36.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.521 -174.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -84.85 -13.47 50.9 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.934 -172.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 78.59 26.82 58.34 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.895 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.9 m -73.66 -18.03 61.08 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.363 0.601 . . . . 0.0 110.609 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.54 -13.6 51.05 Favored Glycine 0 CA--C 1.509 -0.307 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.096 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.58 HG22 ' HA ' ' A' ' 109' ' ' SER . 3.0 p -132.8 131.15 40.75 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.726 -0.737 . . . . 0.0 109.223 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 149' ' ' PHE . 52.8 t -84.73 111.81 20.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.938 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 11.0 t70 -139.46 -72.2 0.39 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.38 0.609 . . . . 0.0 110.913 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.56 ' O ' ' HG2' ' A' ' 150' ' ' MET . 0.7 OUTLIER -82.99 -98.46 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.517 -169.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.496 ' HG2' ' CD2' ' A' ' 146' ' ' PHE . 9.1 pt-20 -67.87 -29.49 68.63 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 122.259 -0.276 . . . . 0.0 111.118 -175.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -59.68 -51.05 71.45 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.4 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.587 ' HA ' HG11 ' A' ' 152' ' ' VAL . 9.4 t80 -79.66 -33.91 40.86 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.416 -174.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' MET . . . . . 0.701 ' HE2' HD23 ' A' ' 93' ' ' LEU . 10.3 mmt -62.53 -45.34 93.4 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.502 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.95 -33.32 83.55 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.251 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.587 HG11 ' HA ' ' A' ' 149' ' ' PHE . 8.1 p -81.71 -36.55 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 111.598 -176.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 52.1 tpp -96.85 -56.07 2.68 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -173.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 69.0 p . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 120.971 0.415 . . . . 0.0 111.551 -173.639 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.4 t . . . . . 0 N--CA 1.456 -0.174 0 CA-C-O 121.055 0.455 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.552 ' HD3' ' C ' ' A' ' 13' ' ' LYS . 5.5 tmtm? -66.01 -40.3 90.97 Favored 'General case' 0 N--CA 1.416 -2.143 0 C-N-CA 123.277 0.631 . . . . 0.0 110.043 177.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.53 -43.26 94.58 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.733 HD23 HD13 ' A' ' 80' ' ' LEU . 80.1 mt -55.99 -50.26 71.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.614 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.564 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 6.8 tp10 -54.13 -53.62 50.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.79 177.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 96.3 m -63.58 -39.42 94.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.477 ' HB3' HG23 ' A' ' 39' ' ' ILE . . . -77.66 -27.21 50.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.103 0.477 . . . . 0.0 110.564 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.748 ' HD1' ' HD2' ' A' ' 20' ' ' ARG . 45.4 t80 -62.63 -51.75 66.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.139 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.748 ' HD2' ' HD1' ' A' ' 19' ' ' PHE . 23.3 mmm-85 -70.34 -27.37 64.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.32 -172.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.76 -45.63 81.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.937 0.399 . . . . 0.0 110.715 -176.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.441 ' CD2' HG12 ' A' ' 39' ' ' ILE . 68.6 m-85 -103.45 14.19 31.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.129 0.49 . . . . 0.0 110.573 -178.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.559 ' HG2' ' N ' ' A' ' 24' ' ' THR . 16.9 tt0 -72.4 152.26 42.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.803 -176.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.559 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.4 OUTLIER 76.08 133.91 0.04 OUTLIER Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 114.752 -1.113 . . . . 0.0 113.266 163.574 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -83.22 -47.03 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.025 2.483 . . . . 0.0 110.727 171.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -163.84 46.5 0.12 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.455 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.26 59.99 0.92 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.259 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.7 t -106.83 -31.52 8.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.988 0.423 . . . . 0.0 110.608 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.01 -14.91 60.73 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.467 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.551 ' HG3' ' HA ' ' A' ' 68' ' ' ASP . 6.6 mpt_? -109.87 170.7 7.9 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.51 HG22 ' HA ' ' A' ' 23' ' ' GLU . 12.0 p -107.6 129.14 62.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 121.758 0.79 . . . . 0.0 109.918 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.431 ' HB3' ' HG2' ' A' ' 35' ' ' GLN . 15.8 t -59.45 143.67 49.2 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.377 -175.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.592 ' HB ' HG12 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -67.51 -19.45 65.31 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.838 -174.389 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -83.8 -22.26 31.87 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.308 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.431 ' HG2' ' HB3' ' A' ' 32' ' ' SER . 11.9 mm100 -83.24 -20.4 34.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.531 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.601 HG21 HD22 ' A' ' 40' ' ' LEU . 52.9 mt -53.96 -42.58 54.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.261 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.43 ' CA ' HG13 ' A' ' 52' ' ' ILE . . . -61.72 -39.28 97.22 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.157 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.642 ' O ' HG23 ' A' ' 42' ' ' VAL . 39.7 mt -63.36 -50.76 77.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.192 0.52 . . . . 0.0 109.872 178.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.483 HD11 HG23 ' A' ' 31' ' ' VAL . 64.5 mt -61.46 -45.67 98.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.583 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.601 HD22 HG21 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -58.42 -28.69 65.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.009 0.433 . . . . 0.0 110.64 177.066 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.499 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 38.4 tt0 -74.51 -41.38 60.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.428 174.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 38' ' ' ILE . 38.7 t -56.07 -51.7 58.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 121.84 0.829 . . . . 0.0 109.733 175.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.6 mt -74.75 -24.8 58.76 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.34 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.97 42.25 6.04 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.154 173.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 pt -119.06 -83.88 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.415 ' HG2' HD23 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -75.3 179.95 4.84 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.334 0.588 . . . . 0.0 112.26 -175.348 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -103.41 -170.35 1.77 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.862 -173.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.488 ' O ' HG12 ' A' ' 52' ' ' ILE . 15.0 t -60.01 177.27 0.25 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 66.4 mttm -52.32 -38.54 58.81 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.903 0.481 . . . . 0.0 112.108 -172.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.5 m -54.56 -34.04 61.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.102 0.477 . . . . 0.0 111.248 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.8 m -84.46 -31.52 24.52 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.51 0.671 . . . . 0.0 110.266 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.776 ' HA ' HD22 ' A' ' 55' ' ' LEU . 46.9 mm -68.84 -24.19 28.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.559 -177.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 29.4 mmt180 -57.91 -25.73 61.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.822 0.344 . . . . 0.0 110.598 176.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -66.18 -56.38 11.63 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 172.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.776 HD22 ' HA ' ' A' ' 52' ' ' ILE . 2.8 mm? -49.6 -48.4 48.89 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.119 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.592 HG12 ' HB ' ' A' ' 33' ' ' THR . 68.6 mt -63.37 -52.8 53.69 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.891 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -64.53 -23.0 67.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.255 0.55 . . . . 0.0 110.583 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -80.37 -54.35 5.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.697 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.511 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 72.0 m-85 -91.59 -22.38 20.35 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -173.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.427 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 44.6 t0 -125.8 63.62 47.62 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 121.075 0.464 . . . . 0.0 110.092 175.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.511 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 32.1 Cg_exo -61.65 -23.82 76.92 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.09 2.527 . . . . 0.0 112.382 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -76.08 -17.16 59.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.892 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.72 45.21 66.62 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.92 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -73.33 -46.09 51.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.656 0.265 . . . . 0.0 110.414 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.96 -18.82 5.87 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.668 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -147.87 164.36 33.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.703 0.287 . . . . 0.0 110.751 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.525 ' O ' ' HB3' ' A' ' 30' ' ' ARG . 35.1 pt -132.2 145.71 34.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.533 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.551 ' HA ' ' HG3' ' A' ' 30' ' ' ARG . 3.5 p-10 -76.75 171.07 15.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.142 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.557 ' HE1' ' HA ' ' A' ' 16' ' ' GLU . 21.3 t80 -55.21 -42.75 73.74 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.55 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 74' ' ' ILE . 15.3 t70 -59.11 -45.08 91.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.756 0.312 . . . . 0.0 110.829 -174.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.422 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 22.1 m -65.19 -31.83 73.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.629 177.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -80.21 -30.99 38.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.306 0.574 . . . . 0.0 109.77 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -66.39 -39.06 88.82 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.717 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 70' ' ' ASP . 61.7 mt -64.95 -43.5 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.056 0.455 . . . . 0.0 109.822 175.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.564 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 79.3 mt -55.87 -50.9 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.815 173.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.401 ' HA2' ' CD1' ' A' ' 80' ' ' LEU . . . -61.01 -43.33 99.58 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.585 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.92 -30.1 71.08 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.981 0.42 . . . . 0.0 111.452 -174.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.564 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 15.2 ptm180 -87.63 -11.02 49.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.781 -175.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.491 ' CE2' HD13 ' A' ' 55' ' ' LEU . 22.5 m-85 -120.29 -42.83 2.55 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.899 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.733 HD13 HD23 ' A' ' 15' ' ' LEU . 2.5 mp . . . . . 0 CA--C 1.511 -0.544 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 110.521 -0.178 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.573 HD12 ' HE1' ' A' ' 149' ' ' PHE . 0.4 OUTLIER -42.34 -41.37 2.81 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 123.721 0.638 . . . . 0.0 110.824 178.415 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.472 ' HA ' ' CE1' ' A' ' 97' ' ' PHE . 36.1 mmt180 -45.72 -42.0 11.3 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 124.038 0.837 . . . . 0.0 111.555 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.623 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 43.2 mt-10 -85.82 -32.71 21.61 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.668 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.606 ' O ' ' HB2' ' A' ' 99' ' ' LEU . . . -84.39 -39.85 18.54 Favored 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.475 -167.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.472 ' CE1' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -77.66 -19.71 54.96 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.895 178.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -76.74 -12.09 59.94 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.55 169.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 73.4 mt -84.43 -18.09 37.12 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.973 168.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' TYR . . . . . 0.59 ' HD1' ' O ' ' A' ' 96' ' ' ALA . 37.1 m-85 -105.29 -2.78 23.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.035 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -72.37 80.87 1.03 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.588 0.709 . . . . 0.0 111.135 -172.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -54.19 -46.32 72.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.937 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -84.07 -28.35 27.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.15 -168.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.08 63.8 1.43 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.404 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -114.7 -17.98 11.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.006 0.431 . . . . 0.0 110.536 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.85 -21.36 36.92 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -168.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.741 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 2.3 m-85 -116.53 164.85 13.96 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 172.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.65 HD12 ' CD2' ' A' ' 149' ' ' PHE . 3.3 pt -103.49 127.6 57.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.986 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.405 ' HA ' HG22 ' A' ' 143' ' ' THR . 45.9 m -66.56 168.82 8.55 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 -177.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.501 ' HB ' ' CG2' ' A' ' 133' ' ' ILE . 72.5 p -61.77 -31.75 71.97 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.544 0.687 . . . . 0.0 110.308 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.16 -34.29 77.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.107 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.601 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.2 p -87.15 -34.82 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.191 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' MET . . . . . 0.722 ' SD ' HG12 ' A' ' 144' ' ' VAL . 2.5 tpt -55.03 -38.81 68.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.036 0.446 . . . . 0.0 110.503 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.701 ' HB2' ' HB3' ' A' ' 129' ' ' LEU . 5.9 ptp180 -66.9 -49.63 64.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.545 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.505 ' HG2' ' HA ' ' A' ' 112' ' ' VAL . 15.3 pt-20 -63.4 -27.54 69.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.745 0.307 . . . . 0.0 111.071 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.501 HG12 ' CD2' ' A' ' 100' ' ' TYR . 19.9 mt -66.26 -48.24 81.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.174 0.511 . . . . 0.0 110.148 173.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.543 HD12 ' HG ' ' A' ' 124' ' ' LEU . 1.2 tm? -61.06 -51.52 68.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.718 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.531 ' HB3' HD11 ' A' ' 129' ' ' LEU . . . -60.13 -22.18 62.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.302 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -68.14 -45.92 72.27 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.5 mp -77.47 -53.62 7.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.353 0.597 . . . . 0.0 109.852 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.596 ' HB3' HD22 ' A' ' 124' ' ' LEU . 18.0 m-20 -96.47 90.12 5.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.931 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -76.89 15.35 0.68 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.06 -173.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 78.8 p -103.83 -13.7 16.31 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.503 0.668 . . . . 0.0 110.35 -177.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.596 HD22 ' HB3' ' A' ' 121' ' ' ASP . 4.1 mm? -75.32 119.18 19.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.64 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 21.9 t -89.94 177.84 6.37 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.1 t -57.1 -45.38 83.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.752 0.31 . . . . 0.0 110.863 -176.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 128' ' ' ASP . 3.0 pm0 -66.55 -38.36 86.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.054 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.479 ' HB3' HD13 ' A' ' 124' ' ' LEU . 40.9 m-20 -63.4 -49.74 72.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.157 0.503 . . . . 0.0 110.013 178.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.701 ' HB3' ' HB2' ' A' ' 114' ' ' ARG . 74.4 mt -56.74 -38.23 72.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.544 178.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -62.37 -39.74 94.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.861 0.363 . . . . 0.0 110.273 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.19 -43.35 70.94 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.552 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.4 ' HE1' HD11 ' A' ' 124' ' ' LEU . 27.2 mtt -61.13 -37.33 82.45 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.591 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.501 ' CG2' ' HB ' ' A' ' 110' ' ' THR . 10.1 mm -59.7 -47.32 91.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.078 0.466 . . . . 0.0 110.744 175.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.01 -39.04 68.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.791 0.805 . . . . 0.0 110.457 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.26 -44.99 23.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.407 -1.27 . . . . 0.0 111.831 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.409 HG22 ' HG2' ' A' ' 113' ' ' MET . 60.1 mt -59.76 -57.3 12.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 123.305 0.642 . . . . 0.0 112.21 -177.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.18 94.71 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.784 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.37 -53.92 7.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.421 -175.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -82.25 -12.99 57.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.352 0.596 . . . . 0.0 110.888 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 64.35 38.42 95.81 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.352 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.4 m -66.94 -14.81 63.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.343 0.592 . . . . 0.0 111.133 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.72 -16.81 58.28 Favored Glycine 0 CA--C 1.504 -0.595 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.507 ' HB ' ' HB2' ' A' ' 107' ' ' TYR . 2.3 p -140.99 135.45 31.16 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.491 -0.855 . . . . 0.0 109.27 175.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.722 HG12 ' SD ' ' A' ' 113' ' ' MET . 51.0 t -81.65 124.17 38.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.741 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 14.5 t70 -146.43 -64.21 0.3 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.777 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PHE . . . . . 0.534 ' HD2' ' H ' ' A' ' 147' ' ' GLU . 1.2 p90 -94.12 -97.98 0.15 Allowed 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.704 -166.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.534 ' H ' ' HD2' ' A' ' 146' ' ' PHE . 54.1 mt-10 -70.67 -22.05 62.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.002 0.43 . . . . 0.0 110.554 -177.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.422 ' CB ' HG11 ' A' ' 144' ' ' VAL . 5.9 mp0 -65.76 -53.77 36.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.172 0.51 . . . . 0.0 110.182 176.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.65 ' CD2' HD12 ' A' ' 108' ' ' ILE . 24.4 t80 -72.91 -39.2 66.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.379 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' MET . . . . . 0.455 ' HE1' ' HB2' ' A' ' 150' ' ' MET . 16.3 ttm -56.05 -51.69 66.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.191 177.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.68 -41.99 96.05 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.082 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 149' ' ' PHE . 14.7 p -77.27 -37.3 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 111.927 0.344 . . . . 0.0 111.927 -176.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 50.0 tpp -92.0 -49.72 6.07 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -173.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.4 p . . . . . 0 C--N 1.328 -0.348 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.113 -173.098 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 121.265 0.555 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.86 -83.96 0.58 Allowed Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -170.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 6' ' ' LYS . 7.8 m-20 64.17 -178.29 0.16 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.197 0.523 . . . . 0.0 111.924 173.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.6 m -128.55 -31.19 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.605 171.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.3 p -81.6 -8.64 59.74 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.854 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.508 ' HB2' ' HB2' ' A' ' 3' ' ' ASP . 1.5 mptm? -78.17 -13.32 59.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.893 175.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.491 ' HG ' ' CB ' ' A' ' 77' ' ' ALA . 10.1 mt -89.33 121.17 31.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.317 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.0 t -80.47 148.96 30.26 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 171.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.1 m -56.93 -26.54 59.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.003 -176.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -56.65 -44.48 81.36 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.249 0.547 . . . . 0.0 110.251 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.599 HE21 ' HG2' ' A' ' 82' ' ' GLU . 7.4 mt-30 -74.91 -36.11 62.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.987 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.5 t -64.24 -31.29 52.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.872 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -54.88 -53.63 52.96 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.694 0.283 . . . . 0.0 110.744 173.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.6 mp -59.09 -44.48 91.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.99 0.424 . . . . 0.0 110.325 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.448 HD22 HD22 ' A' ' 80' ' ' LEU . 82.1 mt -57.63 -57.66 11.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.189 178.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -58.9 -41.34 86.98 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.568 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.0 m -63.88 -41.13 97.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 0.0 111.289 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -82.11 -27.64 32.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.029 0.443 . . . . 0.0 110.469 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.499 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 71.8 t80 -57.31 -54.59 45.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.398 177.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.491 ' HA ' ' HB2' ' A' ' 23' ' ' GLU . 26.2 mmt180 -71.36 -21.65 62.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.117 -177.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.65 -44.21 74.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.915 -175.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.618 ' CD1' HG12 ' A' ' 39' ' ' ILE . 52.6 m-85 -106.44 17.16 23.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.473 0.654 . . . . 0.0 110.124 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.567 ' HG2' ' N ' ' A' ' 24' ' ' THR . 10.2 tt0 -71.43 152.84 42.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.334 -172.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.567 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.4 OUTLIER 75.05 138.1 0.06 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 158.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -88.74 -43.42 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.588 2.858 . . . . 0.0 111.652 172.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -156.02 25.08 0.37 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.671 0.748 . . . . 0.0 109.415 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.59 63.36 0.76 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.592 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.1 t -105.46 -30.1 9.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.921 0.391 . . . . 0.0 110.763 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.58 -11.36 66.71 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.873 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.728 ' HB2' ' OD2' ' A' ' 66' ' ' ASP . 3.3 mpt_? -110.95 172.22 7.0 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.455 HG23 HD11 ' A' ' 39' ' ' ILE . 12.8 p -108.03 129.59 61.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-O 121.941 0.877 . . . . 0.0 110.201 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.463 ' HA ' ' HB3' ' A' ' 66' ' ' ASP . 44.3 t -57.25 141.3 47.1 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 113.593 -1.64 . . . . 0.0 111.856 -175.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.554 ' HB ' HG12 ' A' ' 56' ' ' ILE . 28.4 p -67.74 -19.37 65.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.407 -178.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -76.2 -21.78 56.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.317 0.579 . . . . 0.0 109.758 175.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.492 ' O ' HG13 ' A' ' 39' ' ' ILE . 34.1 mm-40 -91.96 -21.65 20.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.939 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.61 HG22 HD23 ' A' ' 40' ' ' LEU . 71.3 mt -54.68 -46.67 73.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.673 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.98 -22.5 68.72 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.261 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.599 ' O ' HG12 ' A' ' 42' ' ' VAL . 25.8 mt -77.86 -54.85 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.708 ' HA ' HG12 ' A' ' 42' ' ' VAL . 36.5 mt -60.92 -37.89 77.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.203 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.61 HD23 HG22 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -60.49 -24.64 65.45 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.09 0.472 . . . . 0.0 110.181 176.191 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.509 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 39.2 tt0 -82.56 -39.73 21.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.819 172.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.708 HG12 ' HA ' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -62.03 -31.45 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 121.771 0.796 . . . . 0.0 110.865 177.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.46 HD12 ' HZ ' ' A' ' 72' ' ' PHE . 50.8 mt -92.79 -6.35 49.13 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.958 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.01 39.49 96.46 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.494 -0.775 . . . . 0.0 113.518 176.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pt -113.35 -83.41 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.34 179.67 3.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.558 0.694 . . . . 0.0 112.672 -174.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -102.05 -171.0 1.9 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.552 -175.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.427 ' O ' HG12 ' A' ' 52' ' ' ILE . 14.3 t -62.81 -179.46 0.27 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -52.28 -34.57 47.15 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -170.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.1 m -52.19 -40.2 61.18 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.152 0.501 . . . . 0.0 111.049 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 53.4 m -81.75 -34.59 30.36 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.659 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 48' ' ' THR . 42.0 mm -64.67 -27.38 42.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.283 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -57.5 -32.99 67.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.98 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.7 mm-40 -65.66 -49.44 68.6 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.651 HD13 ' CE2' ' A' ' 79' ' ' PHE . 3.0 mm? -53.67 -52.43 59.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.994 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.554 HG12 ' HB ' ' A' ' 33' ' ' THR . 60.2 mt -63.26 -44.84 99.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.409 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -59.59 -30.96 69.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.189 0.519 . . . . 0.0 110.757 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -84.21 -51.71 6.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.208 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.424 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 80.3 m-85 -90.59 -17.18 27.39 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -172.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.45 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 51.6 t0 -129.55 65.88 75.71 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 121.069 0.461 . . . . 0.0 110.88 175.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 22.9 Cg_exo -70.06 -17.25 36.32 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.913 2.409 . . . . 0.0 111.419 175.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -80.09 -17.86 51.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.116 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.97 40.73 73.3 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.778 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -76.0 -41.39 51.33 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.098 0.475 . . . . 0.0 110.423 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 117.83 -33.96 4.69 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.112 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.728 ' OD2' ' HB2' ' A' ' 30' ' ' ARG . 2.3 p-10 -139.47 148.43 42.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.151 0.501 . . . . 0.0 111.004 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.493 ' O ' ' HB3' ' A' ' 30' ' ' ARG . 44.1 pt -114.34 143.66 23.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.036 -174.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.458 ' HA ' ' HG3' ' A' ' 30' ' ' ARG . 1.9 p30 -74.36 174.08 9.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.826 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' A' ' 73' ' ' LYS . 5.0 t80 -63.55 -37.81 88.73 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.119 -175.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.497 ' O ' HG13 ' A' ' 74' ' ' ILE . 38.3 t70 -61.64 -42.68 99.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.925 0.393 . . . . 0.0 110.628 -176.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.7 m -65.53 -42.86 91.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.331 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.46 ' HZ ' HD12 ' A' ' 43' ' ' LEU . 75.8 t80 -69.11 -32.27 71.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.465 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 69' ' ' PHE . 40.8 ttmt -63.29 -44.04 96.18 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.61 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 70' ' ' ASP . 64.7 mt -62.29 -40.75 88.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.127 0.489 . . . . 0.0 110.05 176.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.578 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 78.6 mt -58.22 -51.09 75.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.128 175.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.491 ' CA ' HD21 ' A' ' 80' ' ' LEU . . . -62.52 -41.55 99.78 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.3 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.491 ' CB ' ' HG ' ' A' ' 7' ' ' LEU . . . -65.35 -25.72 67.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.953 0.406 . . . . 0.0 111.591 -174.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 11.8 ptm180 -93.08 -12.67 29.95 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.768 -176.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.651 ' CE2' HD13 ' A' ' 55' ' ' LEU . 23.9 m-85 -120.71 -37.35 3.01 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -174.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.491 HD21 ' CA ' ' A' ' 76' ' ' GLY . 3.2 mm? -48.65 -76.38 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -173.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 44.69 45.46 8.79 Favored Glycine 0 C--N 1.331 0.256 0 O-C-N 123.84 0.712 . . . . 0.0 112.471 -175.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.599 ' HG2' HE21 ' A' ' 11' ' ' GLN . 11.0 pt-20 -82.05 18.06 1.44 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.046 0.451 . . . . 0.0 111.023 -176.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -80.21 90.61 5.51 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.701 0.762 . . . . 0.0 110.864 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 t -128.98 77.92 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.371 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.501 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 4.6 t30 -85.89 138.95 34.96 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.771 -171.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 5.4 Cg_exo -75.27 -22.09 14.71 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.929 3.086 . . . . 0.0 111.808 -175.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.429 ' H ' ' ND2' ' A' ' 85' ' ' ASN . 13.3 mp0 -95.62 19.56 10.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.908 178.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -79.74 118.25 21.37 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 24.7 ptm 45.61 30.79 0.83 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.657 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -139.56 148.29 42.36 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 175.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.746 ' HG2' ' HE1' ' A' ' 150' ' ' MET . 40.1 mt-30 54.56 27.5 8.54 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.507 0.504 . . . . 0.0 111.045 -173.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.05 -18.67 59.11 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.534 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.719 HD23 ' HE3' ' A' ' 150' ' ' MET . 1.2 mm? -52.65 -28.11 20.07 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.126 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.644 ' HD3' ' HE2' ' A' ' 97' ' ' PHE . 30.7 mmt180 -57.0 -51.39 69.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.063 0.459 . . . . 0.0 111.361 177.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -77.74 -21.7 51.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.059 0.456 . . . . 0.0 110.327 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.453 ' HB2' ' HA ' ' A' ' 93' ' ' LEU . . . -77.51 -13.73 59.85 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.048 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.644 ' HE2' ' HD3' ' A' ' 94' ' ' ARG . 21.0 m-85 -61.4 -48.23 82.16 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.641 176.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.4 mtm-85 -67.17 -23.73 65.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.205 0.526 . . . . 0.0 110.386 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.9 tp -67.76 -37.31 81.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.753 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.668 ' O ' ' HD2' ' A' ' 102' ' ' LYS . 85.6 m-85 -104.12 -5.7 21.78 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.122 -176.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -78.27 80.32 4.68 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.461 0.648 . . . . 0.0 111.528 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.668 ' HD2' ' O ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -60.71 -39.75 89.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.002 173.27 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -72.27 -37.13 69.12 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.498 -169.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.18 48.46 2.23 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.91 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -113.18 -17.22 12.41 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.973 0.416 . . . . 0.0 110.526 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.12 -24.91 13.69 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -170.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.534 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 4.0 m-85 -109.37 150.9 27.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 173.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.679 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 14.8 pt -91.81 131.17 39.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.748 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.5 m -69.3 170.05 11.04 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.312 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.429 ' HB ' ' CG2' ' A' ' 133' ' ' ILE . 36.8 p -67.59 -23.72 65.42 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 121.846 -0.534 . . . . 0.0 110.724 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 114' ' ' ARG . 29.6 m-20 -62.43 -50.49 71.29 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 176.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.679 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.4 p -71.69 -35.0 54.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.719 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.65 ' SD ' HG11 ' A' ' 144' ' ' VAL . 2.9 tpt -57.37 -40.06 77.34 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.494 ' HB2' ' O ' ' A' ' 111' ' ' ASP . 76.0 mtt180 -53.04 -56.9 12.6 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.636 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 112' ' ' VAL . 13.3 pt-20 -65.23 -30.4 71.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.433 -175.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 112' ' ' VAL . 57.1 mt -63.43 -47.72 90.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.705 0.288 . . . . 0.0 110.798 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 113' ' ' MET . 9.6 mt -58.49 -55.63 32.55 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.168 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -49.19 -37.77 23.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.408 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -65.23 -56.57 12.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.909 0.385 . . . . 0.0 110.751 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -66.76 -44.53 81.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.079 0.466 . . . . 0.0 111.19 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.522 ' HB3' HD23 ' A' ' 124' ' ' LEU . 5.7 m-20 -119.46 88.01 2.85 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.531 -178.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -76.02 23.0 0.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.321 0.581 . . . . 0.0 111.589 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' ' 121' ' ' ASP . 39.6 p -102.77 -13.46 17.02 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.916 0.865 . . . . 0.0 109.227 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.522 HD23 ' HB3' ' A' ' 121' ' ' ASP . 4.0 mm? -85.06 115.63 22.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.373 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.446 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 42.7 m -77.08 172.19 13.62 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.9 p -56.75 -43.49 80.79 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.692 0.282 . . . . 0.0 111.581 -174.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -68.8 -40.08 79.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.0 110.751 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.428 ' HB3' ' CD1' ' A' ' 124' ' ' LEU . 5.6 m-20 -59.34 -42.36 91.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.465 176.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.606 ' O ' HG12 ' A' ' 133' ' ' ILE . 95.8 mt -54.63 -43.39 72.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.75 175.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.476 ' O ' ' HB ' ' A' ' 133' ' ' ILE . 31.5 t70 -63.2 -40.25 96.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.268 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.2 -40.58 82.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.164 177.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.408 ' O ' HG13 ' A' ' 136' ' ' ILE . 9.1 mtt -57.77 -43.51 85.54 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 173.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.606 HG12 ' O ' ' A' ' 129' ' ' LEU . 21.5 mm -51.69 -49.94 33.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.066 176.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -58.98 -43.32 91.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.733 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -72.11 -35.02 69.06 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.567 -176.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.589 HD13 HD23 ' A' ' 117' ' ' LEU . 67.6 mt -65.81 -58.79 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.983 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -68.22 93.78 0.48 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.581 0.705 . . . . 0.0 110.102 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.91 -29.51 50.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.961 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -88.19 -14.4 38.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.274 0.559 . . . . 0.0 110.862 -174.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 69.22 28.29 72.88 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.273 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 6.5 t -80.67 -18.28 48.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.083 0.468 . . . . 0.0 110.15 -175.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.71 -31.31 8.73 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.287 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 21.9 p -114.87 143.14 45.6 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.65 HG11 ' SD ' ' A' ' 113' ' ' MET . 61.0 t -89.04 118.3 34.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.534 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 28.5 t70 -144.17 -73.26 0.27 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.762 -178.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.623 ' O ' ' HG2' ' A' ' 150' ' ' MET . 0.1 OUTLIER -79.28 -97.17 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.122 -166.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -82.95 -11.78 57.87 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 121.583 -0.698 . . . . 0.0 110.94 -173.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' A' ' 148' ' ' GLU . 3.9 mp0 -61.81 -58.42 8.06 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.9 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.616 ' HA ' HG12 ' A' ' 152' ' ' VAL . 10.7 t80 -73.82 -46.73 43.37 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.677 -176.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' MET . . . . . 0.746 ' HE1' ' HG2' ' A' ' 91' ' ' GLN . 46.8 mmm -61.12 -18.41 57.84 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.742 0.306 . . . . 0.0 110.964 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -95.97 -20.3 26.41 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.066 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.616 HG12 ' HA ' ' A' ' 149' ' ' PHE . 9.1 p -95.72 -36.31 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 117.314 0.557 . . . . 0.0 111.067 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.457 ' SD ' HG22 ' A' ' 154' ' ' THR . 0.9 OUTLIER -90.74 -47.55 7.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.055 -177.307 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.457 HG22 ' SD ' ' A' ' 153' ' ' MET . 25.6 p -114.22 41.51 2.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.039 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -84.72 -35.84 12.76 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.84 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.41 76.54 1.3 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.511 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.16 -46.57 79.26 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.075 0.55 . . . . 0.0 111.87 -177.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.272 -173.179 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.0 ptp . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 121.434 0.635 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 147.3 62.13 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.175 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.777 ' HB3' ' HB3' ' A' ' 6' ' ' LYS . 11.7 m-20 -79.88 69.01 6.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.724 0.297 . . . . 0.0 110.231 177.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.8 t -57.8 -48.39 83.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -170.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.1 m -85.15 4.99 31.84 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.145 0.498 . . . . 0.0 111.235 -177.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.777 ' HB3' ' HB3' ' A' ' 3' ' ' ASP . 0.8 OUTLIER -96.25 -25.98 15.59 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.457 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.455 HD11 ' HB2' ' A' ' 11' ' ' GLN . 4.4 mm? -57.26 121.82 11.03 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.547 175.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.3 m -85.54 44.75 1.13 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -170.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.9 m 71.45 -41.83 0.52 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -56.42 -50.7 70.88 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -174.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.626 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 8.1 mm100 -60.46 -41.44 94.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.515 0.674 . . . . 0.0 109.754 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.427 ' HA ' HD11 ' A' ' 15' ' ' LEU . 26.8 t -62.01 -35.55 69.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.066 -178.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -62.16 -47.45 84.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.661 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.53 -45.21 92.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.904 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.646 HD21 ' CD1' ' A' ' 80' ' ' LEU . 84.5 mt -56.08 -52.7 63.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.773 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -62.52 -38.86 91.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.773 -178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 91.0 m -59.03 -52.21 66.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.735 0.302 . . . . 0.0 110.483 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.421 ' HB3' HG22 ' A' ' 39' ' ' ILE . . . -69.55 -33.77 73.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.139 0.495 . . . . 0.0 110.366 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.684 ' CE1' HG22 ' A' ' 31' ' ' VAL . 86.1 t80 -53.67 -58.78 5.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.584 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -61.27 -31.62 71.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.799 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -69.09 -43.91 73.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.834 0.35 . . . . 0.0 111.245 -175.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.468 ' CD2' HG12 ' A' ' 39' ' ' ILE . 56.0 m-85 -100.64 8.69 43.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.342 0.592 . . . . 0.0 110.132 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.559 ' HG2' ' N ' ' A' ' 24' ' ' THR . 3.9 tt0 -69.25 154.12 42.55 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.19 -177.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.775 HG23 ' H ' ' A' ' 27' ' ' GLY . 0.6 OUTLIER 79.75 131.78 0.04 OUTLIER Pre-proline 0 N--CA 1.437 -1.118 0 O-C-N 124.301 1.001 . . . . 0.0 112.863 161.582 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.86 -34.7 0.19 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.328 2.686 . . . . 0.0 111.163 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -165.52 32.1 0.05 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.041 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.775 ' H ' HG23 ' A' ' 24' ' ' THR . . . 98.32 66.41 0.88 Allowed Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.831 -175.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.7 t -111.68 -31.09 7.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.814 0.34 . . . . 0.0 111.002 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.02 -14.21 65.71 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.523 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.542 ' HG3' ' HA ' ' A' ' 68' ' ' ASP . 4.8 mpt_? -106.72 172.49 6.79 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.684 HG22 ' CE1' ' A' ' 19' ' ' PHE . 0.1 OUTLIER -105.19 129.93 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.568 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.272 172.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.6 t -54.0 138.88 36.05 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.994 -1.457 . . . . 0.0 108.723 171.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.58 ' HB ' HG12 ' A' ' 56' ' ' ILE . 2.9 p -67.03 -12.86 61.08 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.056 -174.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -72.05 -42.59 66.09 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.632 ' HA ' HD11 ' A' ' 38' ' ' ILE . 33.3 mm-40 -74.03 -16.22 61.06 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.438 -174.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.634 HG21 HD21 ' A' ' 40' ' ' LEU . 47.1 mt -59.01 -34.21 52.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.4 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -74.17 -36.98 49.77 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.328 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.641 ' O ' HG21 ' A' ' 42' ' ' VAL . 1.3 mp -58.79 -55.28 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-O 121.5 0.666 . . . . 0.0 109.762 174.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 35' ' ' GLN . 53.7 mt -63.14 -43.54 98.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.451 -176.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.634 HD21 HG21 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -61.91 -27.42 68.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.935 0.398 . . . . 0.0 110.713 177.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.66 -43.61 46.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.175 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.641 HG21 ' O ' ' A' ' 38' ' ' ILE . 64.0 t -54.78 -47.72 73.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.56 176.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.578 HD11 HD23 ' A' ' 15' ' ' LEU . 58.0 mt -86.58 4.3 40.73 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.358 -173.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.24 41.71 99.57 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.19 -0.914 . . . . 0.0 113.71 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -116.12 -77.3 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.559 ' HG2' HD21 ' A' ' 55' ' ' LEU . 0.7 OUTLIER -81.57 -176.49 6.07 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.418 0.627 . . . . 0.0 112.46 -176.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.411 ' HB2' ' CB ' ' A' ' 51' ' ' THR . 45.2 mt-30 -110.62 -170.38 1.63 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.505 -174.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.451 ' O ' HG12 ' A' ' 52' ' ' ILE . 13.5 t -56.89 176.97 0.09 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.49 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 63.0 mttm -52.24 -35.31 49.4 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.85 0.46 . . . . 0.0 112.155 -173.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.8 m -54.6 -34.31 61.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.251 0.548 . . . . 0.0 111.185 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.411 ' CB ' ' HB2' ' A' ' 47' ' ' GLN . 60.5 m -85.98 -34.23 20.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.483 0.658 . . . . 0.0 110.41 177.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.822 ' HA ' HD23 ' A' ' 55' ' ' LEU . 44.1 mm -63.4 -23.53 33.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.343 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 34.5 mmt180 -50.8 -38.69 49.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.558 173.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.461 ' HA ' ' OD2' ' A' ' 57' ' ' ASP . 7.3 mm-40 -60.54 -43.83 96.77 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.713 0.633 . . . . 0.0 110.653 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.822 HD23 ' HA ' ' A' ' 52' ' ' ILE . 3.1 mm? -62.21 -46.33 89.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.386 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.58 HG12 ' HB ' ' A' ' 33' ' ' THR . 64.1 mt -66.81 -47.66 82.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.304 -176.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.461 ' OD2' ' HA ' ' A' ' 54' ' ' GLN . 1.7 p30 -66.28 -19.75 65.91 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.059 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -85.11 -53.75 5.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.37 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -95.1 -17.0 22.22 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -171.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.406 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 21.0 t0 -128.22 68.25 76.35 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.09 0.471 . . . . 0.0 111.317 176.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 24.3 Cg_exo -69.75 -17.83 37.42 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.504 2.136 . . . . 0.0 110.492 171.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -69.88 -17.96 63.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.993 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.32 30.39 77.4 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -81.36 -27.31 34.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.273 -0.464 . . . . 0.0 110.868 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.5 -19.44 39.41 Favored Glycine 0 CA--C 1.509 -0.312 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.122 173.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -145.83 158.02 43.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.89 0.376 . . . . 0.0 110.933 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.431 ' O ' ' HB3' ' A' ' 30' ' ' ARG . 28.8 pt -126.92 142.54 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.556 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.542 ' HA ' ' HG3' ' A' ' 30' ' ' ARG . 0.5 OUTLIER -75.13 175.94 7.76 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.514 -176.877 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -60.66 -39.69 89.31 Favored 'General case' 0 C--O 1.213 -0.829 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.081 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.487 ' O ' HG13 ' A' ' 74' ' ' ILE . 19.7 t70 -60.75 -39.91 90.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.997 0.427 . . . . 0.0 109.964 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.425 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 17.0 m -67.61 -43.62 80.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.749 176.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -69.38 -32.46 71.5 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.259 0.552 . . . . 0.0 110.223 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -62.32 -42.4 99.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.099 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 70' ' ' ASP . 67.2 mt -65.41 -40.19 87.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.027 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.551 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 66.8 mt -56.38 -53.03 45.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.249 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.94 -41.05 99.62 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.151 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.04 -26.07 66.57 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 122.578 -0.366 . . . . 0.0 111.44 -174.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.551 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 15.8 ptm180 -89.92 -18.56 25.88 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.768 ' HE2' HD11 ' A' ' 55' ' ' LEU . 23.6 m-85 -108.52 -43.85 4.21 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.272 -174.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.646 ' CD1' HD21 ' A' ' 15' ' ' LEU . 2.4 mp -59.16 -67.97 0.32 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.459 0.171 . . . . 0.0 110.858 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 42.46 28.97 0.64 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 116.042 1.177 . . . . 0.0 116.042 169.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -97.09 22.49 8.43 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -58.22 105.85 0.32 Allowed 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.09 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 2.2 p -68.18 89.92 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 113.734 -1.576 . . . . 0.0 110.359 176.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.519 ' ND2' ' HD2' ' A' ' 86' ' ' PRO . 1.5 t30 -47.76 138.29 9.59 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.139 174.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.519 ' HD2' ' ND2' ' A' ' 85' ' ' ASN . 89.3 Cg_exo -50.98 -47.22 26.61 Favored 'Trans proline' 0 CA--C 1.528 0.214 0 C-N-CA 124.547 3.498 . . . . 0.0 115.077 -165.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.49 -12.94 16.23 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.588 0.233 . . . . 0.0 111.488 -172.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -60.65 -32.96 72.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.926 -173.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.5 ttt -125.92 46.3 2.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.33 0.585 . . . . 0.0 110.815 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.443 ' HB3' ' HG3' ' A' ' 92' ' ' GLU . 15.4 mm100 -95.07 -70.66 0.7 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.766 175.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 38.98 48.57 1.44 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.856 0.836 . . . . 0.0 111.325 -173.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.443 ' HG3' ' HB3' ' A' ' 90' ' ' GLN . 42.7 mt-10 -61.48 -18.88 61.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.262 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.911 HD21 ' HE1' ' A' ' 149' ' ' PHE . 44.7 mt -42.74 -41.59 3.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.62 -1.173 . . . . 0.0 112.269 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.755 ' HD2' ' HE2' ' A' ' 97' ' ' PHE . 18.5 mmm180 -59.53 -39.96 85.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -176.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -86.07 -18.28 32.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.125 0.488 . . . . 0.0 110.249 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.491 ' HA ' HD11 ' A' ' 99' ' ' LEU . . . -80.25 -19.9 45.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.678 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.755 ' HE2' ' HD2' ' A' ' 94' ' ' ARG . 23.0 m-85 -59.1 -44.45 91.96 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -70.96 -13.06 61.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.822 0.344 . . . . 0.0 111.358 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.491 HD11 ' HA ' ' A' ' 96' ' ' ALA . 97.0 mt -86.92 -27.55 23.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.89 0.376 . . . . 0.0 110.772 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.464 ' O ' HG23 ' A' ' 112' ' ' VAL . 76.2 m-85 -103.69 -14.63 16.03 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 97' ' ' PHE . 55.2 t0 -64.57 86.53 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.83 0.824 . . . . 0.0 111.197 -176.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -64.27 -18.33 64.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.655 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -96.18 -36.87 10.79 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.975 0.417 . . . . 0.0 112.119 -171.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.08 39.46 5.44 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.491 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -114.82 -15.33 11.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.871 0.367 . . . . 0.0 111.807 -176.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.83 -22.31 35.79 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.198 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -100.22 167.55 10.37 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 172.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.577 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 8.3 pt -111.03 118.85 58.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.291 166.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.2 m -62.73 166.53 5.37 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.952 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.7 p -57.29 -32.91 67.13 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.9 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.494 ' O ' ' HG3' ' A' ' 115' ' ' GLU . 28.0 m-20 -61.59 -50.19 73.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.046 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.577 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 1.8 p -68.65 -37.43 77.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.854 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.687 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 2.8 tpt -56.66 -43.29 80.21 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 174.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.427 ' HA ' HD12 ' A' ' 117' ' ' LEU . 15.9 ttt180 -55.22 -48.52 73.77 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.448 175.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 111' ' ' ASP . 47.3 mt-10 -60.33 -41.73 94.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.684 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 70.6 mt -59.17 -50.34 80.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.03 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.687 ' HG ' ' O ' ' A' ' 113' ' ' MET . 11.0 mt -56.58 -60.18 3.91 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.43 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.01 -22.01 47.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.746 -177.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -82.51 -41.08 20.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.676 0.274 . . . . 0.0 110.876 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.7 mp -79.52 -47.66 15.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.049 0.452 . . . . 0.0 110.762 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.621 ' HB3' HD21 ' A' ' 124' ' ' LEU . 3.1 m-20 -105.84 99.37 8.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.057 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -84.56 4.34 32.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.338 -173.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 71.0 p -90.38 -10.97 41.98 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.376 0.608 . . . . 0.0 110.203 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.754 ' HB3' HD21 ' A' ' 129' ' ' LEU . 3.7 mm? -77.14 146.33 37.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.071 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.472 ' HB2' ' OD1' ' A' ' 128' ' ' ASP . 21.4 m -115.68 171.7 7.58 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.254 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.8 m -47.31 -46.34 25.11 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -173.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -79.32 -32.43 43.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.814 0.34 . . . . 0.0 111.2 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.472 ' OD1' ' HB2' ' A' ' 125' ' ' SER . 2.7 m-20 -64.61 -40.32 95.29 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.754 HD21 ' HB3' ' A' ' 124' ' ' LEU . 2.7 mm? -51.66 -43.24 62.61 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.148 173.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -65.22 -42.48 93.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.612 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.42 -45.52 91.3 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.361 0.6 . . . . 0.0 110.032 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 58.0 mmm -54.9 -53.73 51.7 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.681 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 20.1 mm -55.02 -46.39 77.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.583 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -56.44 -41.2 76.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.774 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -79.49 -31.04 42.21 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.161 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.42 HG12 ' CG2' ' A' ' 152' ' ' VAL . 49.3 mt -67.74 -58.39 6.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.134 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.408 ' HA ' ' HB3' ' A' ' 148' ' ' GLU . 37.0 t0 -69.76 93.87 0.77 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.592 0.71 . . . . 0.0 110.288 -177.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.57 -40.26 42.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.807 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -82.85 -13.97 55.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.204 0.526 . . . . 0.0 111.065 -173.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 70.89 24.34 77.16 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.8 t -74.79 -18.26 60.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.387 0.613 . . . . 0.0 109.853 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.56 -26.97 9.25 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 25.3 p -114.59 128.92 56.58 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 175.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.673 HG11 ' SD ' ' A' ' 113' ' ' MET . 64.2 t -83.34 119.33 32.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.266 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.433 ' HB3' ' CD1' ' A' ' 146' ' ' PHE . 8.0 t70 -145.59 -55.58 0.3 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.128 0.489 . . . . 0.0 111.437 -175.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 145' ' ' ASP . 0.4 OUTLIER -105.55 -97.14 0.34 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.815 -168.653 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -38.33 90.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.794 0.331 . . . . 0.0 111.069 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.593 ' CD ' ' H ' ' A' ' 148' ' ' GLU . 3.4 mp0 -50.46 -53.09 32.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.222 177.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.911 ' HE1' HD21 ' A' ' 93' ' ' LEU . 31.8 t80 -76.93 -38.74 52.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.013 -175.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 42.2 tpp -62.68 -43.57 98.46 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.375 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -70.26 -16.11 73.0 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.496 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.42 ' CG2' HG12 ' A' ' 136' ' ' ILE . 12.1 p -101.41 -40.57 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 117.391 0.595 . . . . 0.0 111.805 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.423 ' HG2' ' CD2' ' A' ' 93' ' ' LEU . 15.4 tpt -81.18 -49.14 11.17 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -172.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 80.5 p -93.72 15.51 16.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.142 0.496 . . . . 0.0 110.843 -175.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -75.96 79.08 1.17 Allowed Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.152 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 156.5 148.4 5.06 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.291 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.02 -58.31 3.35 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 . . . . . 0 C--O 1.248 0.987 0 O-C-N 124.456 1.098 . . . . 0.0 112.16 172.966 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.2 ttt . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 121.473 0.654 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.594 ' N ' ' HA ' ' A' ' 78' ' ' ARG . . . 121.96 50.07 0.25 Allowed Glycine 0 CA--C 1.506 -0.472 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.71 ' HB3' ' HB2' ' A' ' 6' ' ' LYS . 5.8 m-20 -104.08 78.66 1.54 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.858 -0.671 . . . . 0.0 110.969 -170.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.3 t -65.85 127.51 27.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.469 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 72.1 m 64.76 14.1 8.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.936 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.71 ' HB2' ' HB3' ' A' ' 3' ' ' ASP . 13.8 mptt -93.84 -19.62 20.82 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 165.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 mp -72.32 117.07 13.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.999 174.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 t -75.0 167.16 22.47 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.91 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.0 p -51.79 -38.21 54.69 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -171.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -54.12 -48.89 70.29 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.082 0.239 . . . . 0.0 111.406 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.421 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 9.3 mm100 -62.36 -45.95 90.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.697 0.761 . . . . 0.0 109.989 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.3 t -68.66 -31.5 51.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.441 -174.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.501 ' HD2' ' HA ' ' A' ' 13' ' ' LYS . 27.1 tptt -61.14 -41.34 96.55 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-O 120.756 0.312 . . . . 0.0 111.543 176.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.41 -42.58 83.01 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.769 HD22 HD13 ' A' ' 80' ' ' LEU . 84.3 mt -58.3 -48.96 78.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.869 177.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -57.32 -54.98 40.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.326 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.564 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 27.8 m -59.83 -41.24 90.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.358 -175.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.633 ' HB3' HG23 ' A' ' 39' ' ' ILE . . . -74.83 -37.89 62.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.761 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.432 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 54.6 t80 -56.32 -59.19 5.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.979 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.11 -12.61 61.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.047 -174.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.564 ' HB2' ' O ' ' A' ' 17' ' ' THR . 2.1 t70 -80.29 -40.04 27.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.942 0.401 . . . . 0.0 110.531 -175.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.434 ' CD2' HG12 ' A' ' 39' ' ' ILE . 87.3 m-85 -105.99 6.9 31.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.408 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.462 ' HG2' ' N ' ' A' ' 24' ' ' THR . 3.8 tm-20 -62.82 152.49 35.92 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.262 -176.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.462 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER 86.24 130.86 0.03 OUTLIER Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 114.29 -1.323 . . . . 0.0 113.219 166.388 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -86.71 -40.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.441 2.761 . . . . 0.0 110.797 169.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -159.91 33.69 0.18 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.148 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.41 67.59 1.03 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.411 -176.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.5 t -112.22 -24.82 9.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.869 0.366 . . . . 0.0 111.328 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.09 -14.49 61.98 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -175.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.528 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 86.1 mtt180 -112.09 163.08 14.7 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.014 -0.593 . . . . 0.0 110.041 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.469 HG22 HD13 ' A' ' 39' ' ' ILE . 13.7 p -105.99 126.7 61.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 121.501 0.667 . . . . 0.0 110.093 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.2 t -53.6 139.51 31.6 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.029 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.559 ' HB ' HG12 ' A' ' 56' ' ' ILE . 1.7 p -63.05 -18.85 63.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.04 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.48 ' CG ' ' HZ1' ' A' ' 49' ' ' LYS . 21.4 t70 -73.8 -28.71 61.78 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.234 0.54 . . . . 0.0 110.375 177.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -86.98 -16.88 34.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.532 -177.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.662 HG21 HD21 ' A' ' 40' ' ' LEU . 52.6 mt -55.39 -41.4 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.817 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.432 ' CA ' HG13 ' A' ' 52' ' ' ILE . . . -61.97 -38.73 96.53 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.413 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.609 ' O ' HG23 ' A' ' 42' ' ' VAL . 31.5 mt -63.56 -52.18 61.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.302 0.572 . . . . 0.0 109.595 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.633 HG23 ' HB3' ' A' ' 18' ' ' ALA . 69.6 mt -60.09 -44.49 95.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.52 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.662 HD21 HG21 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -60.63 -25.41 66.27 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.808 178.55 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -80.02 -40.6 27.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.001 174.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 38' ' ' ILE . 43.1 t -53.88 -43.91 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.924 0.868 . . . . 0.0 109.79 174.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.7 mt -86.38 -4.02 59.1 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.939 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.9 39.48 89.48 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-N 115.444 -0.798 . . . . 0.0 113.705 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pt -116.17 -84.8 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.25 -171.42 2.38 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.248 0.547 . . . . 0.0 112.41 -177.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -123.33 -170.79 2.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.434 -172.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.1 t -54.94 170.87 0.16 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.835 0.826 . . . . 0.0 112.968 -176.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.48 ' HZ1' ' CG ' ' A' ' 34' ' ' ASP . 63.8 mttm -51.32 -34.52 33.89 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.344 -1.298 . . . . 0.0 113.204 -167.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 m -58.94 -32.39 69.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.084 0.468 . . . . 0.0 110.845 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -82.42 -32.76 28.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.392 0.615 . . . . 0.0 110.018 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.885 ' HA ' HD21 ' A' ' 55' ' ' LEU . 44.4 mm -68.7 -23.62 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.221 -177.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -50.17 -30.98 12.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.42 173.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -65.92 -55.19 18.18 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.306 0.574 . . . . 0.0 109.834 174.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.885 HD21 ' HA ' ' A' ' 52' ' ' ILE . 2.5 mm? -52.76 -50.06 64.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.435 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.559 HG12 ' HB ' ' A' ' 33' ' ' THR . 61.0 mt -63.52 -46.89 93.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.926 -177.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -61.39 -24.68 66.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.508 0.671 . . . . 0.0 110.727 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.465 ' CD ' HH12 ' A' ' 78' ' ' ARG . 29.6 tt0 -87.98 -51.28 5.91 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.226 -177.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.478 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 90.1 m-85 -94.53 -17.1 22.72 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -173.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.461 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 46.5 t0 -129.99 62.67 65.23 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-O 121.171 0.51 . . . . 0.0 110.181 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.478 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 31.3 Cg_exo -63.11 -24.86 73.14 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.032 2.488 . . . . 0.0 112.159 -178.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -76.68 -17.29 59.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.569 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.28 41.32 59.56 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.688 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -67.71 -39.89 84.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.673 0.273 . . . . 0.0 110.751 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.18 -22.31 9.04 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.672 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -139.79 178.49 7.21 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 27.2 pt -142.12 143.73 26.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.886 0.374 . . . . 0.0 110.331 177.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.528 ' HA ' ' HG2' ' A' ' 30' ' ' ARG . 25.6 t70 -83.39 166.9 18.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.807 176.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.47 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -56.09 -27.35 53.36 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 176.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -49.35 -51.44 34.54 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.87 0.367 . . . . 0.0 111.256 174.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.442 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 23.2 m -82.41 -36.88 26.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.924 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.47 ' HB3' ' HA ' ' A' ' 69' ' ' PHE . 89.8 t80 -64.83 -36.28 83.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.123 -178.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -62.32 -38.6 90.04 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.219 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.421 ' HB ' ' CE1' ' A' ' 59' ' ' PHE . 40.7 mt -69.48 -40.1 79.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.84 0.352 . . . . 0.0 110.105 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.584 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 78.1 mt -57.3 -48.48 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-O 121.41 0.624 . . . . 0.0 109.717 173.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.488 ' HA2' ' CD1' ' A' ' 80' ' ' LEU . . . -62.48 -45.19 96.39 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.065 177.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.97 -20.39 65.04 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -174.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.594 ' HA ' ' N ' ' A' ' 2' ' ' GLY . 9.9 ptm180 -91.28 -16.7 27.13 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.527 -177.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.499 ' CE2' HD13 ' A' ' 55' ' ' LEU . 21.1 m-85 -118.34 -46.49 2.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.754 0.311 . . . . 0.0 110.921 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.769 HD13 HD22 ' A' ' 15' ' ' LEU . 3.2 mp -73.76 -20.09 60.59 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.329 0.585 . . . . 0.0 111.199 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.83 9.29 77.09 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.453 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -91.49 21.74 4.41 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -88.52 100.04 12.76 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.846 -172.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.55 72.85 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.252 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.492 ' ND2' ' HD2' ' A' ' 86' ' ' PRO . 1.8 t30 -83.64 141.81 42.09 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.568 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.492 ' HD2' ' ND2' ' A' ' 85' ' ' ASN . 57.2 Cg_exo -53.53 -61.52 0.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.343 2.695 . . . . 0.0 112.354 -171.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -91.28 27.23 1.97 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.625 -174.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 85' ' ' ASN . 34.7 tt0 -124.49 -55.54 1.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.865 -177.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 14.3 tpt -102.57 -31.11 10.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.782 -172.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -127.0 -166.22 1.57 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.378 -175.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 38.68 48.95 1.39 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.557 1.143 . . . . 0.0 112.825 -176.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.49 -19.29 46.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.826 174.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.548 HD22 ' H ' ' A' ' 93' ' ' LEU . 0.9 OUTLIER -54.27 -26.93 31.77 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.302 -179.7 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.721 ' HD2' ' HE2' ' A' ' 97' ' ' PHE . 28.9 mmm180 -59.74 -35.63 74.95 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 120.807 0.337 . . . . 0.0 111.583 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -86.53 -26.93 24.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.253 0.549 . . . . 0.0 109.899 176.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 93' ' ' LEU . . . -72.73 -11.05 60.47 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.937 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.721 ' HE2' ' HD2' ' A' ' 94' ' ' ARG . 21.3 m-85 -61.72 -52.22 65.15 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.727 -0.389 . . . . 0.0 109.963 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 98' ' ' ARG . 42.2 mtm180 -65.66 -17.96 64.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.212 0.529 . . . . 0.0 110.88 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.4 tp -73.6 -38.63 65.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.826 177.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.643 ' O ' ' HD2' ' A' ' 102' ' ' LYS . 77.2 m-85 -100.16 -24.55 14.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.906 -176.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -69.3 82.68 0.37 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.413 0.625 . . . . 0.0 111.223 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.643 ' HD2' ' O ' ' A' ' 100' ' ' TYR . 9.8 mptt -56.53 -45.78 80.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.913 173.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.51 ' HB2' ' ND2' ' A' ' 105' ' ' ASN . 41.6 mt-10 -66.65 -37.23 84.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.432 -168.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.53 47.41 2.55 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.419 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.51 ' ND2' ' HB2' ' A' ' 103' ' ' GLU . 39.8 m-80 -100.1 -17.46 17.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.692 0.282 . . . . 0.0 110.68 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.9 -24.99 15.16 Favored Glycine 0 N--CA 1.453 -0.188 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -172.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -113.53 162.38 16.24 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 171.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.609 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 10.2 pt -97.22 128.16 48.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.298 173.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.463 ' HA ' HG23 ' A' ' 143' ' ' THR . 49.1 m -69.45 166.97 17.64 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.317 -177.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.2 p -62.95 -24.88 68.09 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.992 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -64.78 -51.8 60.33 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.258 176.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.609 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.0 p -68.72 -35.06 68.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.727 0.299 . . . . 0.0 110.36 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.65 ' HE1' ' HA ' ' A' ' 113' ' ' MET . 2.8 tpt -58.3 -40.18 81.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.099 0.476 . . . . 0.0 109.8 173.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.526 ' HA ' HD13 ' A' ' 133' ' ' ILE . 17.7 ttp180 -58.88 -46.03 88.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.162 176.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.459 ' OE1' ' HA ' ' A' ' 112' ' ' VAL . 34.6 mt-10 -60.68 -50.47 73.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.58 177.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 112' ' ' VAL . 63.6 mt -56.25 -53.6 37.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.43 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.611 HD11 ' SD ' ' A' ' 132' ' ' MET . 1.0 OUTLIER -57.33 -53.31 59.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.005 -178.316 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.481 ' HB2' HD23 ' A' ' 129' ' ' LEU . . . -64.33 -17.54 63.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.03 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -83.8 -53.26 5.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.682 0.277 . . . . 0.0 110.319 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.58 -44.04 79.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.991 0.424 . . . . 0.0 110.313 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.619 ' HB3' HD23 ' A' ' 124' ' ' LEU . 6.2 m-20 -112.19 84.85 2.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.254 0.549 . . . . 0.0 109.969 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -79.79 12.63 2.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.626 0.727 . . . . 0.0 110.908 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.403 ' H ' ' C ' ' A' ' 121' ' ' ASP . 69.8 p -95.44 -5.56 42.82 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.194 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.619 HD23 ' HB3' ' A' ' 121' ' ' ASP . 4.2 mm? -78.82 149.42 32.57 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.315 174.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.0 m -116.93 170.18 8.82 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.6 p -48.1 -48.43 33.75 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -73.45 -40.05 64.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.727 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -67.41 -43.42 81.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.649 0.738 . . . . 0.0 110.077 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.51 ' CD2' ' HG2' ' A' ' 114' ' ' ARG . 45.2 tp -63.33 -38.4 91.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.925 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.28 -41.46 99.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.897 0.379 . . . . 0.0 110.223 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.86 -45.69 92.66 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.331 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.611 ' SD ' HD11 ' A' ' 117' ' ' LEU . 33.5 mtt -60.38 -42.98 97.0 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.385 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.526 HD13 ' HA ' ' A' ' 114' ' ' ARG . 21.2 mm -54.44 -50.21 59.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.081 0.467 . . . . 0.0 110.647 174.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.15 -44.7 75.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.788 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -80.78 -26.42 37.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.83 -175.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.493 HG12 ' CG2' ' A' ' 152' ' ' VAL . 51.9 mt -64.38 -54.81 26.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.73 0.3 . . . . 0.0 110.589 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -76.63 85.12 3.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.966 0.888 . . . . 0.0 109.554 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.58 -35.0 53.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.465 -1.243 . . . . 0.0 112.319 -173.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -91.58 -10.59 40.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.042 0.449 . . . . 0.0 110.851 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.58 38.7 13.62 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.197 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.49 -18.75 56.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.263 0.554 . . . . 0.0 110.495 -177.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.29 -40.9 3.08 Favored Glycine 0 C--O 1.23 -0.106 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.216 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.463 HG23 ' HA ' ' A' ' 109' ' ' SER . 13.0 p -114.77 137.68 51.65 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 173.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.595 HG11 ' SD ' ' A' ' 113' ' ' MET . 57.8 t -82.06 124.98 39.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 O-C-N 123.611 0.57 . . . . 0.0 109.8 -176.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -145.53 -78.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.222 0.534 . . . . 0.0 112.206 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -76.74 -86.31 0.05 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -168.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -94.35 -14.39 25.4 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.983 -172.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.555 ' HB2' HG13 ' A' ' 144' ' ' VAL . 3.0 mp0 -64.24 -50.05 69.49 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.108 0.48 . . . . 0.0 109.945 174.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.543 ' HA ' HG11 ' A' ' 152' ' ' VAL . 19.1 t80 -75.43 -42.62 53.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.584 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' MET . . . . . 0.597 ' HA ' ' HE3' ' A' ' 150' ' ' MET . 0.0 OUTLIER -55.85 -46.17 78.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.935 0.398 . . . . 0.0 110.121 178.007 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 155' ' ' GLY . . . -69.64 -28.46 72.18 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.965 -0.561 . . . . 0.0 113.506 -177.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.543 HG11 ' HA ' ' A' ' 149' ' ' PHE . 14.6 p -87.62 -37.18 10.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 117.359 0.58 . . . . 0.0 111.495 -176.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -86.64 -53.92 4.68 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.006 -174.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 50.1 p -91.21 -34.11 15.12 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.148 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.461 ' O ' ' HA2' ' A' ' 151' ' ' GLY . . . 106.55 -122.23 6.93 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.018 177.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -118.94 32.71 5.03 Favored Glycine 0 C--N 1.318 -0.436 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.228 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.13 70.49 10.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.992 0.425 . . . . 0.0 111.049 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.246 0.913 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.05 177.716 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.417 ' HE3' ' O ' ' A' ' 78' ' ' ARG . 27.1 ttt . . . . . 0 N--CA 1.477 0.885 0 CA-C-O 120.979 0.418 . . . . 0.0 109.907 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 162.4 48.4 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.67 88.07 5.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.106 0.479 . . . . 0.0 111.589 -173.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.2 m -64.8 -19.31 25.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.468 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.7 p -92.48 -8.79 43.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.231 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.53 ' HD3' ' C ' ' A' ' 6' ' ' LYS . 12.8 tmtt? -93.24 -37.27 12.16 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.905 HD23 ' HG3' ' A' ' 11' ' ' GLN . 10.1 mt -70.25 102.79 2.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.215 173.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.446 ' C ' ' H ' ' A' ' 10' ' ' ASN . 0.9 OUTLIER -88.42 64.86 7.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.135 -167.391 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.4 m 69.09 -33.41 0.25 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.744 0.818 . . . . 0.0 113.024 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.446 ' H ' ' C ' ' A' ' 8' ' ' SER . 21.3 p-10 -58.3 -49.73 76.11 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -176.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.905 ' HG3' HD23 ' A' ' 7' ' ' LEU . 6.3 mm100 -75.33 -38.55 60.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.759 0.79 . . . . 0.0 109.769 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.685 ' HA ' HD23 ' A' ' 15' ' ' LEU . 39.6 t -63.09 -30.22 49.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.943 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.479 ' HD2' ' HA ' ' A' ' 13' ' ' LYS . 37.8 tptt -55.5 -52.34 63.99 Favored 'General case' 0 N--CA 1.425 -1.702 0 C-N-CA 123.106 0.562 . . . . 0.0 111.347 174.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.53 -37.66 88.15 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.685 HD23 ' HA ' ' A' ' 12' ' ' VAL . 3.0 mp -52.99 -59.36 4.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.487 173.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -58.38 -39.0 78.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.085 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.2 m -60.05 -46.08 90.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.941 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.527 ' HB2' HG22 ' A' ' 39' ' ' ILE . . . -80.05 -29.63 39.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.553 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.53 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 57.7 t80 -56.91 -56.01 27.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.192 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -71.7 -20.04 61.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.572 -175.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -72.33 -35.12 68.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.862 0.363 . . . . 0.0 110.864 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.486 ' CD2' HG12 ' A' ' 39' ' ' ILE . 71.9 m-85 -115.5 16.88 16.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.26 0.552 . . . . 0.0 110.574 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' ' 19' ' ' PHE . 2.9 tt0 -76.45 152.21 36.24 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.459 -172.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.529 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER 78.8 133.64 0.04 OUTLIER Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.642 159.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -87.07 -53.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.347 2.698 . . . . 0.0 111.127 172.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 15.6 tt0 -129.4 3.43 5.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.653 0.739 . . . . 0.0 109.592 176.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.79 67.73 0.51 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -169.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -109.15 -6.78 15.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.609 0.243 . . . . 0.0 111.028 -172.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.6 0.08 52.5 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.09 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.475 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 93.7 mtt180 -124.59 164.12 20.49 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.551 HG23 HD13 ' A' ' 39' ' ' ILE . 11.3 p -104.94 131.34 54.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.536 0.684 . . . . 0.0 109.495 177.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.0 t -59.39 140.17 56.38 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.851 -175.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.551 ' HA ' HG13 ' A' ' 36' ' ' ILE . 3.5 p -62.7 -19.87 64.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.024 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -75.94 -18.37 59.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.456 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.479 ' OE1' HD11 ' A' ' 38' ' ' ILE . 78.3 mm-40 -96.54 -15.8 21.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.585 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.664 HG23 HD23 ' A' ' 40' ' ' LEU . 55.8 mt -57.02 -41.87 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.61 -175.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.403 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -64.27 -38.38 95.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.022 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.614 ' O ' HG21 ' A' ' 42' ' ' VAL . 15.9 mt -61.47 -52.09 65.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.204 0.526 . . . . 0.0 109.648 176.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.551 HD13 HG23 ' A' ' 31' ' ' VAL . 66.8 mt -59.79 -42.62 89.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.5 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.664 HD23 HG23 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -65.5 -22.1 66.7 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.053 0.454 . . . . 0.0 110.763 -179.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 15.4 tp10 -78.49 -42.85 28.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.347 172.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.614 HG21 ' O ' ' A' ' 38' ' ' ILE . 47.0 t -53.08 -46.01 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.865 0.84 . . . . 0.0 110.161 175.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.5 mt -85.61 -6.51 59.15 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.637 -174.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.52 43.27 87.01 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.598 174.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.435 HD12 HD23 ' A' ' 80' ' ' LEU . 1.9 pt -119.6 -73.28 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -176.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.76 -175.05 5.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -173.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -107.08 -170.52 1.72 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.866 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.506 ' O ' HG12 ' A' ' 52' ' ' ILE . 14.8 t -60.47 177.45 0.28 Allowed 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -176.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.407 ' HA ' ' HB ' ' A' ' 52' ' ' ILE . 37.2 mtmm -55.11 -34.57 63.8 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -172.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.7 m -53.96 -37.78 64.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.871 0.367 . . . . 0.0 110.862 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.1 m -82.0 -34.18 29.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.374 176.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.513 ' HA ' HD23 ' A' ' 55' ' ' LEU . 49.3 mm -65.79 -24.31 34.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.873 -176.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.547 ' HA ' HD11 ' A' ' 56' ' ' ILE . 12.2 tpp180 -62.12 -28.51 69.68 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 177.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -68.0 -44.9 75.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.389 0.614 . . . . 0.0 109.685 173.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.631 HD12 ' CE2' ' A' ' 79' ' ' PHE . 3.1 mm? -54.66 -47.31 73.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.528 174.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.547 HD11 ' HA ' ' A' ' 53' ' ' ARG . 61.7 mt -62.2 -47.58 92.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.828 177.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -55.71 -32.56 63.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.149 0.5 . . . . 0.0 110.819 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -76.36 -54.33 6.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.832 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.508 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 98.4 m-85 -100.64 -11.4 20.04 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -169.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.422 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 48.2 t0 -125.54 66.81 56.23 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-O 121.335 0.588 . . . . 0.0 110.612 176.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.508 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 27.2 Cg_exo -67.9 -23.9 40.51 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.83 2.354 . . . . 0.0 111.755 177.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -78.74 -19.59 51.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.174 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.56 38.62 51.3 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -71.56 -33.94 69.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 122.469 0.308 . . . . 0.0 110.945 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.85 -21.02 39.57 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.003 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -139.85 167.11 22.87 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.1 pt -129.27 143.87 39.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.02 0.438 . . . . 0.0 110.108 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.475 ' HA ' ' HG2' ' A' ' 30' ' ' ARG . 18.1 t70 -78.1 165.94 23.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.522 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -58.64 -33.26 69.87 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 118.521 0.6 . . . . 0.0 109.759 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.484 ' O ' HG13 ' A' ' 74' ' ' ILE . 29.0 t70 -52.79 -43.5 65.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.728 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.506 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 28.6 m -79.08 -40.49 31.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.199 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -69.67 -32.33 70.9 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.947 0.403 . . . . 0.0 110.654 -177.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -62.35 -39.62 93.72 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.676 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 70' ' ' ASP . 44.3 mt -65.69 -38.7 82.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-O 121.132 0.491 . . . . 0.0 109.86 176.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.501 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 58.6 mt -57.11 -56.12 16.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.391 175.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.666 ' CA ' HD21 ' A' ' 80' ' ' LEU . . . -62.48 -35.19 91.39 Favored Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.016 177.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.698 ' HA ' ' CD1' ' A' ' 7' ' ' LEU . . . -69.61 -25.89 64.17 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 122.608 -0.349 . . . . 0.0 111.385 -176.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 15.0 ptm180 -91.93 -14.42 29.6 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.78 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.631 ' CE2' HD12 ' A' ' 55' ' ' LEU . 22.9 m-85 -117.76 -44.1 2.75 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.991 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.666 HD21 ' CA ' ' A' ' 76' ' ' GLY . 4.2 mm? -61.94 -26.89 68.46 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.01 0.433 . . . . 0.0 111.207 -178.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.28 -18.91 56.59 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.411 -0.813 . . . . 0.0 114.292 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 79' ' ' PHE . 12.4 pt-20 -62.77 -27.65 69.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.491 0.646 . . . . 0.0 109.764 176.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 23.96 99.06 0.0 OUTLIER 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.05 1.74 . . . . 0.0 115.145 172.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.9 t -140.78 79.97 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.494 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.528 ' HB3' ' HB3' ' A' ' 88' ' ' GLN . 4.7 t30 -79.31 136.65 56.56 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.491 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 52.3 Cg_exo -54.37 -54.35 4.78 Favored 'Trans proline' 0 C--N 1.331 -0.35 0 C-N-CA 123.581 2.854 . . . . 0.0 113.22 -167.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -99.03 10.79 40.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.773 0.32 . . . . 0.0 111.596 -175.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.528 ' HB3' ' HB3' ' A' ' 85' ' ' ASN . 51.9 tp60 -102.85 -35.17 8.71 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 40.7 tpp -87.49 -17.78 31.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.031 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -117.42 -163.69 0.94 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.512 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.451 ' HG3' ' HE3' ' A' ' 150' ' ' MET . 3.3 tt0 55.74 36.73 27.8 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.295 0.569 . . . . 0.0 111.208 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.44 -20.27 59.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.029 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.565 HD22 ' H ' ' A' ' 93' ' ' LEU . 0.5 OUTLIER -52.81 -36.44 58.44 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.655 -178.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.825 ' HD2' ' HE2' ' A' ' 97' ' ' PHE . 25.7 mmm180 -62.69 -32.55 73.65 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.874 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -86.09 -32.45 21.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.063 0.458 . . . . 0.0 109.912 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.655 ' HA ' HD23 ' A' ' 99' ' ' LEU . . . -66.59 -18.44 65.37 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.692 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.825 ' HE2' ' HD2' ' A' ' 94' ' ' ARG . 21.5 m-85 -58.55 -46.06 87.63 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.05 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 98' ' ' ARG . 33.7 mtp180 -70.85 -14.34 62.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.857 0.361 . . . . 0.0 110.908 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.655 HD23 ' HA ' ' A' ' 96' ' ' ALA . 0.5 OUTLIER -81.21 -37.21 29.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.806 176.249 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -95.82 -28.82 14.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.608 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.89 78.53 1.63 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.121 0.962 . . . . 0.0 110.929 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -76.97 -6.5 52.83 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.304 171.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -83.89 -37.37 22.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.983 -175.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.65 46.6 1.38 Allowed Glycine 0 C--O 1.228 -0.26 0 C-N-CA 121.098 -0.573 . . . . 0.0 113.259 171.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.443 ' C ' ' H ' ' A' ' 107' ' ' TYR . 21.3 m-80 -113.92 -17.92 11.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.777 0.323 . . . . 0.0 110.66 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.5 -20.78 12.65 Favored Glycine 0 C--O 1.228 -0.233 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -170.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.782 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 4.4 m-85 -116.71 147.54 41.9 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.683 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 9.3 pt -92.56 131.13 40.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.266 176.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.0 m -71.44 171.01 12.04 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.296 -176.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.483 ' HB ' HG21 ' A' ' 133' ' ' ILE . 16.4 p -61.78 -28.14 69.24 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.0 0.429 . . . . 0.0 110.721 178.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -60.36 -57.22 13.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.069 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.683 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.2 p -63.94 -35.45 73.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.815 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.589 ' SD ' HG12 ' A' ' 144' ' ' VAL . 0.7 OUTLIER -59.39 -40.08 85.44 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.754 176.639 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -51.98 -50.93 60.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.812 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.22 -42.94 96.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.094 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.2 mt -57.1 -48.99 80.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 121.071 0.462 . . . . 0.0 110.24 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.528 HD12 ' SD ' ' A' ' 132' ' ' MET . 0.8 OUTLIER -57.29 -54.17 49.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.438 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.57 -15.86 63.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.853 -176.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -78.63 -29.43 45.85 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.8 mp -80.63 -61.63 1.91 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.615 173.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.571 ' CG ' HD21 ' A' ' 124' ' ' LEU . 9.4 t70 -92.01 139.46 30.62 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.054 0.454 . . . . 0.0 110.498 -176.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -108.68 -2.54 18.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.683 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.4 p -104.08 -22.69 13.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.359 0.599 . . . . 0.0 109.516 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.571 HD21 ' CG ' ' A' ' 121' ' ' ASP . 4.1 mm? -62.81 100.86 0.22 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.609 169.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.413 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 15.5 t -71.69 171.89 10.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.56 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.8 p -53.51 -44.3 69.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.978 0.418 . . . . 0.0 110.884 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -66.3 -41.1 90.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.935 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.545 ' HB3' HD13 ' A' ' 124' ' ' LEU . 6.1 m-20 -66.29 -43.33 86.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.654 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.538 ' O ' HG12 ' A' ' 133' ' ' ILE . 95.7 mt -51.36 -44.4 62.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.961 172.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.404 ' O ' ' HB ' ' A' ' 133' ' ' ILE . 11.9 t70 -61.64 -41.26 97.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.892 0.377 . . . . 0.0 110.44 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.01 -37.04 78.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.382 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.528 ' SD ' HD12 ' A' ' 117' ' ' LEU . 7.1 mtt -65.82 -32.15 73.51 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.665 175.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.538 HG12 ' O ' ' A' ' 129' ' ' LEU . 19.4 mm -59.13 -45.87 92.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.954 0.407 . . . . 0.0 110.306 175.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -64.73 -35.53 81.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.891 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -72.23 -42.86 65.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.987 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.413 HG12 ' CG2' ' A' ' 152' ' ' VAL . 62.7 mt -65.36 -56.57 14.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.01 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.502 ' HA ' ' CG ' ' A' ' 148' ' ' GLU . 46.8 t0 -80.64 82.97 6.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 122.005 0.907 . . . . 0.0 109.374 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.27 -35.9 76.54 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.967 -1.469 . . . . 0.0 112.336 -173.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -87.07 -13.56 43.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.246 0.546 . . . . 0.0 110.99 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 72.07 42.83 50.4 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.0 t -83.14 -17.83 41.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.394 0.616 . . . . 0.0 109.966 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.15 -33.42 4.72 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.366 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 39.5 p -114.23 141.88 46.99 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.001 0.429 . . . . 0.0 110.096 176.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.589 HG12 ' SD ' ' A' ' 113' ' ' MET . 46.6 t -99.26 109.22 23.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.782 ' HB3' ' HB3' ' A' ' 107' ' ' TYR . 4.8 p-10 -153.91 -42.98 0.09 Allowed 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.404 -171.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.59 ' HD2' ' HG2' ' A' ' 147' ' ' GLU . 2.9 p90 -96.63 -93.07 0.22 Allowed 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.202 -0.999 . . . . 0.0 112.205 -176.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.59 ' HG2' ' HD2' ' A' ' 146' ' ' PHE . 22.0 mm-40 -81.19 -28.89 34.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.362 0.601 . . . . 0.0 109.947 -175.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.502 ' CG ' ' HA ' ' A' ' 137' ' ' ASP . 25.9 mp0 -60.14 -51.82 67.96 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.939 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.612 ' HA ' HG11 ' A' ' 152' ' ' VAL . 16.0 t80 -72.15 -38.12 69.25 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' MET . . . . . 0.451 ' HE3' ' HG3' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -54.07 -47.64 71.46 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.599 176.131 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -76.1 -22.07 74.65 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.893 -175.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.612 HG11 ' HA ' ' A' ' 149' ' ' PHE . 11.7 p -92.13 -37.34 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 117.545 0.672 . . . . 0.0 111.327 -176.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.87 ' HE2' ' HA ' ' A' ' 153' ' ' MET . 2.4 tpt -89.53 -56.81 3.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.827 0.346 . . . . 0.0 110.672 -176.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.8 p -94.41 41.42 1.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.31 0.576 . . . . 0.0 110.354 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -100.64 101.4 2.29 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.096 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.67 -27.05 21.99 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.74 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 61.97 49.16 4.78 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.505 0.669 . . . . 0.0 110.15 -176.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 C--O 1.248 0.994 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.79 179.986 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 121.025 0.441 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.14 54.01 29.91 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -175.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.688 ' HB3' ' HB2' ' A' ' 6' ' ' LYS . 3.0 m-20 -74.65 72.09 1.94 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.077 -0.562 . . . . 0.0 111.479 -173.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.8 -34.26 68.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.898 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.9 m -75.59 -22.56 56.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.015 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.688 ' HB2' ' HB3' ' A' ' 3' ' ' ASP . 2.6 mptm? -76.57 -21.49 55.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.717 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.447 ' HG ' ' CB ' ' A' ' 11' ' ' GLN . 3.3 mp -70.66 112.82 7.18 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.254 0.55 . . . . 0.0 110.786 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.4 p -85.51 -179.23 6.87 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.024 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.8 m -60.68 -33.98 73.65 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.547 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -57.59 -53.1 62.0 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.762 0.315 . . . . 0.0 110.954 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.531 HE22 ' HB2' ' A' ' 82' ' ' GLU . 5.4 mm100 -59.52 -46.48 88.72 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.636 0.732 . . . . 0.0 109.977 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.3 t -67.94 -28.52 41.6 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.754 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.695 -176.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HD2' ' HA ' ' A' ' 13' ' ' LYS . 8.3 mptt -67.57 -37.75 83.08 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 179.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.56 -44.27 96.74 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 172.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.42 ' HB3' ' HE2' ' A' ' 72' ' ' PHE . 85.5 mt -59.99 -45.63 92.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.671 175.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -64.94 -46.28 82.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.632 -175.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.9 m -61.31 -34.98 76.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.079 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.55 ' HB3' HG23 ' A' ' 39' ' ' ILE . . . -81.1 -38.5 27.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.331 177.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.539 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 51.7 t80 -54.8 -55.03 34.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.72 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -67.39 -21.89 65.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.131 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -77.31 -36.4 54.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.856 0.36 . . . . 0.0 111.098 -174.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.443 ' CD2' HG12 ' A' ' 39' ' ' ILE . 65.9 m-85 -110.74 16.2 21.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.283 0.563 . . . . 0.0 110.423 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.61 ' HG2' ' N ' ' A' ' 24' ' ' THR . 4.3 tt0 -78.67 156.44 29.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.22 -172.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.61 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER 80.25 127.15 0.03 OUTLIER Pre-proline 0 N--CA 1.444 -0.762 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.334 160.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -90.12 -45.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.79 2.993 . . . . 0.0 111.947 173.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -142.77 24.69 1.85 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.38 62.84 1.14 Allowed Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -174.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.0 t -100.35 -28.04 13.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.927 0.394 . . . . 0.0 111.109 -172.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.19 -16.16 56.45 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -172.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.488 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 92.8 mtt180 -103.43 164.23 11.78 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.896 -0.652 . . . . 0.0 109.874 175.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.557 HG23 ' HA ' ' A' ' 23' ' ' GLU . 13.6 p -108.05 131.77 57.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.384 0.612 . . . . 0.0 109.639 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.1 t -62.69 144.39 56.39 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.372 -175.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.56 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . 2.8 p -66.52 -18.35 65.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.851 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -70.73 -36.11 73.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.307 0.575 . . . . 0.0 109.934 176.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -89.23 -14.48 35.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.533 -175.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.651 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 71.3 mt -53.35 -47.75 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.764 0.316 . . . . 0.0 110.644 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.41 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -58.54 -38.49 91.33 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.756 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.652 ' O ' HG21 ' A' ' 42' ' ' VAL . 36.8 mt -61.25 -49.46 84.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.25 0.547 . . . . 0.0 109.604 176.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.55 HG23 ' HB3' ' A' ' 18' ' ' ALA . 65.5 mt -60.43 -45.41 96.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.578 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.788 HD11 HD11 ' A' ' 52' ' ' ILE . 46.2 mt -61.7 -25.09 67.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.364 0.602 . . . . 0.0 110.761 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.514 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 8.6 tp10 -76.49 -42.22 44.28 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.719 173.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.652 HG21 ' O ' ' A' ' 38' ' ' ILE . 39.4 t -54.22 -42.71 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.888 0.851 . . . . 0.0 109.878 174.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 29.1 mt -83.49 -11.46 57.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.153 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.57 32.22 67.69 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.578 -0.737 . . . . 0.0 113.362 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.408 ' HB ' ' HB3' ' A' ' 79' ' ' PHE . 1.9 pt -109.74 -61.36 2.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -177.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.7 -177.75 4.16 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -174.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -104.74 -170.61 1.79 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.004 -172.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.536 ' O ' HG12 ' A' ' 52' ' ' ILE . 15.2 t -62.04 179.06 0.31 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -57.74 -29.8 65.05 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -172.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.0 m -52.39 -45.55 65.88 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.297 0.57 . . . . 0.0 110.691 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.6 m -77.43 -34.3 54.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.474 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.788 HD11 HD11 ' A' ' 40' ' ' LEU . 42.1 mm -64.84 -24.49 35.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.31 -178.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -51.52 -38.09 52.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 172.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -75.16 -38.16 61.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.265 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.505 HD13 ' CE2' ' A' ' 79' ' ' PHE . 2.2 mm? -56.01 -48.42 75.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.226 174.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.546 HG12 ' HB ' ' A' ' 33' ' ' THR . 59.8 mt -62.96 -45.84 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.917 176.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -56.77 -29.81 62.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.273 0.559 . . . . 0.0 110.718 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -77.04 -54.51 6.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.55 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -101.24 -13.47 18.08 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -170.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.452 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 48.1 t0 -134.18 64.67 66.49 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.172 0.511 . . . . 0.0 111.194 176.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 24.6 Cg_exo -69.0 -18.42 40.6 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.769 2.313 . . . . 0.0 111.493 175.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -78.88 -17.51 55.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.244 -176.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.74 40.08 46.45 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.215 -177.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.4 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 1.2 t-20 -66.18 -43.97 85.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.917 0.487 . . . . 0.0 110.687 -176.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.91 -22.28 14.67 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.623 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -149.39 171.44 16.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.945 0.402 . . . . 0.0 110.377 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.408 ' C ' ' HD3' ' A' ' 30' ' ' ARG . 30.0 pt -135.27 145.42 31.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.555 ' HB3' ' HB3' ' A' ' 70' ' ' ASP . 15.2 t70 -83.01 171.55 13.69 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.474 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -62.18 -22.67 66.09 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 173.547 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.555 ' HB3' ' HB3' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -45.41 -53.23 8.97 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.597 170.617 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.7 m -87.38 -33.77 19.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.968 0.413 . . . . 0.0 111.249 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.474 ' HB3' ' HA ' ' A' ' 69' ' ' PHE . 73.4 t80 -65.29 -33.14 75.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.365 -176.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -65.28 -37.26 86.62 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.073 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.2 mt -68.1 -37.56 78.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.975 0.417 . . . . 0.0 109.928 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.532 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 61.2 mt -58.15 -53.62 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.004 174.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.511 ' O ' HD23 ' A' ' 80' ' ' LEU . . . -60.96 -39.64 97.3 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.207 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.92 -28.83 69.8 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.906 0.384 . . . . 0.0 111.68 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.532 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 16.3 ptm180 -90.68 -13.04 34.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.009 -175.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.505 ' CE2' HD13 ' A' ' 55' ' ' LEU . 23.8 m-85 -119.35 -37.01 3.24 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.131 -0.627 . . . . 0.0 112.547 -175.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.511 HD23 ' O ' ' A' ' 76' ' ' GLY . 4.1 mm? -53.67 -73.64 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.218 0.324 . . . . 0.0 111.101 -177.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.16 29.46 72.96 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.593 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.531 ' HB2' HE22 ' A' ' 11' ' ' GLN . 24.1 mm-40 -80.68 53.31 1.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 175.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -121.41 67.16 0.88 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.706 -170.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.5 t -143.4 80.52 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.209 0.528 . . . . 0.0 111.683 -172.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.509 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 0.7 OUTLIER -116.19 127.04 27.07 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-O 121.356 0.598 . . . . 0.0 110.054 173.192 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 13.4 Cg_exo -70.54 -47.12 0.74 Allowed 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 124.058 3.172 . . . . 0.0 113.551 -170.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -102.04 -43.87 5.64 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.877 0.37 . . . . 0.0 110.192 -173.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 85' ' ' ASN . 13.6 mm-40 -50.62 -36.8 36.92 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 26.0 mmt -111.19 -2.02 15.93 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -173.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -129.31 -78.39 0.55 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.112 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -85.17 57.33 4.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.358 0.599 . . . . 0.0 110.194 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -57.14 -21.57 33.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.545 177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.713 ' HB2' ' HE3' ' A' ' 150' ' ' MET . 0.9 OUTLIER -58.58 -34.4 71.03 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.985 -177.145 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.711 ' HA ' ' CE2' ' A' ' 97' ' ' PHE . 52.7 mmm-85 -62.72 -36.9 84.47 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.084 -177.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -84.55 -15.12 46.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.094 0.473 . . . . 0.0 110.86 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.479 ' HA ' HD12 ' A' ' 99' ' ' LEU . . . -82.55 -14.04 55.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.008 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.711 ' CE2' ' HA ' ' A' ' 94' ' ' ARG . 20.9 m-85 -62.46 -46.24 89.41 Favored 'General case' 0 C--O 1.215 -0.711 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 176.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -66.83 -12.41 58.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.82 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 96' ' ' ALA . 96.3 mt -83.66 -43.78 15.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.954 175.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -93.12 -24.01 18.42 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.417 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -71.89 80.19 0.9 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.922 0.868 . . . . 0.0 110.1 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -74.67 -16.93 60.75 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.476 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.471 ' HB2' ' ND2' ' A' ' 105' ' ' ASN . 22.7 mt-10 -83.61 -37.59 22.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.964 -173.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.25 34.83 3.29 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.763 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.471 ' ND2' ' HB2' ' A' ' 103' ' ' GLU . 21.1 m-80 -88.91 -18.74 26.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.895 0.378 . . . . 0.0 110.523 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.4 -25.79 4.83 Favored Glycine 0 N--CA 1.454 -0.147 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -171.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.482 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 1.7 m-85 -111.33 173.45 6.34 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 171.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.632 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 11.8 pt -109.39 126.64 66.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 119.364 -0.935 . . . . 0.0 109.611 171.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.423 ' HA ' HG22 ' A' ' 143' ' ' THR . 33.1 m -64.44 165.01 10.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.684 -177.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.1 p -59.65 -31.98 70.03 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.779 -0.576 . . . . 0.0 110.206 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -58.23 -51.62 69.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.699 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.632 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.3 p -69.73 -36.02 68.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.639 ' HE1' ' HA ' ' A' ' 113' ' ' MET . 1.3 tpt -58.27 -45.1 88.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.049 0.452 . . . . 0.0 110.243 176.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.558 ' HG2' HD12 ' A' ' 129' ' ' LEU . 33.2 ttp180 -51.56 -50.79 59.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.975 175.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -65.18 -39.37 92.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.084 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 112' ' ' VAL . 43.6 mt -58.99 -46.32 91.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 111.173 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.449 HD12 ' HG ' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -63.65 -54.0 42.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.162 0.506 . . . . 0.0 109.946 -178.411 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.425 ' HB1' HD22 ' A' ' 129' ' ' LEU . . . -63.92 -19.86 65.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.713 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -69.03 -40.56 78.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.94 0.4 . . . . 0.0 110.258 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -75.84 -51.32 12.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.01 174.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.566 ' HB3' HD23 ' A' ' 124' ' ' LEU . 2.1 m-20 -107.73 96.82 6.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.431 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -79.72 15.14 1.45 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.511 -171.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 41.7 p -112.34 -4.65 14.25 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.493 0.663 . . . . 0.0 110.882 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.566 HD23 ' HB3' ' A' ' 121' ' ' ASP . 3.7 mm? -70.09 114.27 8.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.65 174.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.3 m -90.3 176.5 6.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.002 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.7 p -52.49 -44.37 65.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.872 0.367 . . . . 0.0 111.691 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -65.14 -41.4 94.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.954 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.432 ' HB3' HD13 ' A' ' 124' ' ' LEU . 34.3 m-20 -69.85 -49.77 49.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.448 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.558 HD12 ' HG2' ' A' ' 114' ' ' ARG . 79.2 mt -56.28 -38.28 70.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.685 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -55.95 -46.28 78.58 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.988 0.423 . . . . 0.0 110.704 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.66 -41.44 98.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.101 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 48.8 mtt -68.88 -38.97 80.02 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.006 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 133' ' ' ILE . 13.6 mm -59.02 -45.89 92.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.133 0.492 . . . . 0.0 110.005 174.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -55.34 -43.61 75.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.744 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -73.08 -45.64 56.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.246 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.614 HG12 HG11 ' A' ' 152' ' ' VAL . 69.8 mt -59.53 -57.1 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.729 -178.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -76.71 82.57 3.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.033 0.921 . . . . 0.0 109.83 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.39 -35.39 54.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.663 -1.153 . . . . 0.0 112.238 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -90.31 -10.53 43.79 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.383 -175.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 72.79 37.49 57.21 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.742 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.3 m -83.3 -19.29 36.53 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.418 0.628 . . . . 0.0 110.733 -178.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 93.42 -29.99 7.75 Favored Glycine 0 CA--C 1.51 -0.257 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.494 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.423 HG22 ' HA ' ' A' ' 109' ' ' SER . 2.7 p -118.39 132.59 56.25 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 174.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.525 HG13 ' SD ' ' A' ' 113' ' ' MET . 96.5 t -82.76 115.89 26.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.767 -177.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.482 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 22.3 t70 -139.12 -61.53 0.56 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.028 0.442 . . . . 0.0 111.661 -174.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.58 ' O ' ' HG2' ' A' ' 150' ' ' MET . 2.3 p90 -94.84 -112.74 0.12 Allowed 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.519 -172.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.461 ' H ' ' HD1' ' A' ' 146' ' ' PHE . 6.3 mp0 -64.71 -11.22 33.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.904 0.383 . . . . 0.0 111.265 -176.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -66.84 -52.07 48.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.332 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.477 ' CG ' ' HE1' ' A' ' 97' ' ' PHE . 14.3 t80 -77.19 -33.8 56.33 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.009 0.433 . . . . 0.0 110.303 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' MET . . . . . 0.713 ' HE3' ' HB2' ' A' ' 93' ' ' LEU . 6.9 mmt -64.13 -23.44 67.32 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.25 -21.93 66.38 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.66 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.614 HG11 HG12 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -91.31 -71.82 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 CA-C-O 121.813 0.816 . . . . 0.0 110.727 -178.41 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 47.5 tpp -83.49 -37.45 23.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.8 -166.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.594 ' OG1' ' HA ' ' A' ' 150' ' ' MET . 0.2 OUTLIER -80.01 -23.15 41.72 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.219 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -81.03 51.57 4.36 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.961 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -90.56 -69.41 1.2 Allowed Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 175.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.2 t70 51.16 64.76 1.71 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.339 0.59 . . . . 0.0 110.493 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.686 -0.674 . . . . 0.0 109.993 -176.556 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.4 ttm . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 121.412 0.625 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -164.18 124.07 1.23 Allowed Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.37 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.686 ' HB3' ' HB2' ' A' ' 6' ' ' LYS . 29.8 m-20 -68.35 63.73 0.1 Allowed 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 122.755 0.422 . . . . 0.0 111.74 176.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.512 ' HB ' ' HE2' ' A' ' 73' ' ' LYS . 21.1 m -62.56 -31.3 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.449 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.9 m -78.5 -15.31 58.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.963 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.686 ' HB2' ' HB3' ' A' ' 3' ' ' ASP . 1.7 mptm? -90.19 -32.71 16.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.001 -176.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.681 HD12 ' HA ' ' A' ' 77' ' ' ALA . 14.7 mt -65.61 113.3 4.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.062 0.458 . . . . 0.0 109.862 175.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.418 ' C ' ' H ' ' A' ' 10' ' ' ASN . 10.2 m -83.07 47.67 1.26 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.615 -171.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.3 t 70.28 -35.64 0.33 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.85 0.86 . . . . 0.0 112.468 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.418 ' H ' ' C ' ' A' ' 8' ' ' SER . 22.3 p-10 -54.58 -56.86 14.54 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.619 ' HG3' HD23 ' A' ' 7' ' ' LEU . 6.5 mm100 -62.91 -30.77 71.8 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.58 0.705 . . . . 0.0 110.14 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.413 ' HA ' HD13 ' A' ' 15' ' ' LEU . 59.8 t -72.72 -30.03 32.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.871 -177.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -70.37 -37.48 74.58 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.009 173.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.0 mp -58.7 -48.92 79.47 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.468 HD12 ' HA3' ' A' ' 76' ' ' GLY . 84.8 mt -54.76 -47.85 73.39 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.758 175.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.71 -49.69 75.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.2 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.6 m -59.69 -41.3 90.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.968 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.609 ' HB2' HG22 ' A' ' 39' ' ' ILE . . . -76.27 -39.78 53.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.554 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -53.43 -56.14 19.31 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.643 175.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.432 ' HD2' ' OE1' ' A' ' 23' ' ' GLU . 28.1 mmm180 -66.96 -16.91 64.66 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.356 -174.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -87.6 -34.88 18.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.918 0.39 . . . . 0.0 111.354 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.445 ' HB2' HD12 ' A' ' 39' ' ' ILE . 78.8 m-85 -109.69 13.2 23.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.282 0.563 . . . . 0.0 110.227 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.684 ' HG2' ' HB ' ' A' ' 24' ' ' THR . 27.0 tt0 -71.21 148.28 47.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.811 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.684 ' HB ' ' HG2' ' A' ' 23' ' ' GLU . 0.4 OUTLIER 78.8 140.88 0.07 OUTLIER Pre-proline 0 N--CA 1.447 -0.623 0 O-C-N 124.664 1.227 . . . . 0.0 113.527 162.505 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -84.62 -36.69 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.265 2.643 . . . . 0.0 110.014 166.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -178.07 47.59 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.39 174.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.2 63.7 0.95 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.849 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.8 t -107.24 -18.29 13.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.005 0.431 . . . . 0.0 111.003 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.72 12.92 84.0 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -175.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.9 mtm-85 -140.54 168.46 19.75 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.567 -0.817 . . . . 0.0 109.597 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.525 HG21 ' HA ' ' A' ' 23' ' ' GLU . 12.3 p -107.7 127.66 63.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 173.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.8 m -55.45 138.5 46.04 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.852 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.555 ' HA ' HG13 ' A' ' 36' ' ' ILE . 1.5 p -64.53 -26.96 68.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.196 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -65.63 -27.85 68.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.109 0.48 . . . . 0.0 110.256 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -92.15 -13.52 30.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.47 -176.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.694 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 69.7 mt -53.86 -48.71 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 O-C-N 123.215 0.322 . . . . 0.0 110.773 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.73 -34.73 83.51 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.613 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.634 ' O ' HG22 ' A' ' 42' ' ' VAL . 50.3 mt -62.66 -49.71 82.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.4 0.619 . . . . 0.0 109.581 175.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.609 HG22 ' HB2' ' A' ' 18' ' ' ALA . 71.3 mt -61.64 -45.92 97.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.667 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.908 HD13 HD12 ' A' ' 52' ' ' ILE . 41.1 mt -61.91 -24.62 67.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.341 0.591 . . . . 0.0 110.423 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -75.97 -43.92 42.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.268 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 38' ' ' ILE . 47.8 t -53.85 -44.35 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.687 0.756 . . . . 0.0 110.264 175.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 22.2 mt -81.14 -12.1 59.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.275 -175.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.59 40.61 66.72 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.825 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 pt -118.76 -76.85 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.582 ' HG2' HD11 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -80.72 177.08 9.26 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -174.458 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.415 ' HB3' ' OE1' ' A' ' 158' ' ' GLU . 22.0 mm-40 -100.27 -171.18 1.99 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.126 -170.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.1 t -52.15 165.85 0.2 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.705 0.764 . . . . 0.0 111.762 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.523 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 59.4 mtpt -61.92 -20.56 63.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.349 -171.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.0 m -61.95 -31.21 71.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.208 0.528 . . . . 0.0 110.455 174.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.6 m -84.77 -31.48 23.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.334 176.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.908 HD12 HD13 ' A' ' 40' ' ' LEU . 28.3 mm -67.51 -25.3 32.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.009 -176.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -46.21 -45.28 16.82 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.922 173.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -62.29 -49.74 74.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.131 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.641 HD12 ' HA ' ' A' ' 52' ' ' ILE . 1.0 OUTLIER -58.14 -38.4 76.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.396 178.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.505 HG21 HG22 ' A' ' 33' ' ' THR . 75.2 mt -65.95 -46.67 87.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.044 177.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -62.42 -27.65 69.25 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.195 0.521 . . . . 0.0 110.289 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -76.0 -54.85 6.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.528 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.553 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 87.4 m-85 -97.57 -15.36 20.54 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -171.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.4 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 39.8 t0 -122.72 68.7 33.29 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 121.222 0.534 . . . . 0.0 110.358 174.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.553 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 20.7 Cg_exo -71.87 -18.12 28.39 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.032 2.488 . . . . 0.0 111.756 176.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -79.88 -17.62 52.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.712 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.38 37.46 53.98 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.781 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -72.59 -43.3 63.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.784 0.326 . . . . 0.0 111.237 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.97 -16.09 20.8 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.893 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -137.19 176.69 8.48 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.0 pt -136.9 152.64 28.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.894 0.378 . . . . 0.0 110.272 174.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -90.07 166.59 13.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.844 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.416 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -63.0 -21.69 66.32 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 178.916 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -57.61 -52.35 65.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.027 0.442 . . . . 0.0 109.986 174.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.484 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 3.4 m -70.72 -44.96 65.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.526 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.416 ' HB3' ' HA ' ' A' ' 69' ' ' PHE . 84.5 t80 -64.5 -34.77 79.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.651 -176.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.512 ' HE2' ' HB ' ' A' ' 4' ' ' VAL . 89.1 tttt -64.81 -35.84 82.39 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.6 mt -67.46 -43.9 87.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.555 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 88.8 mt -55.08 -47.55 77.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.275 175.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.781 ' HA2' HD23 ' A' ' 80' ' ' LEU . . . -67.52 -43.9 84.92 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.608 -0.805 . . . . 0.0 112.524 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.681 ' HA ' HD12 ' A' ' 7' ' ' LEU . . . -64.55 -24.33 67.57 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.894 0.378 . . . . 0.0 111.701 -174.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.555 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 10.7 ptm180 -89.1 -15.16 34.58 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.844 -175.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -124.34 -36.75 2.61 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.406 -0.518 . . . . 0.0 112.139 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.781 HD23 ' HA2' ' A' ' 76' ' ' GLY . 4.6 mm? -66.35 -27.24 67.73 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.99 -55.21 3.36 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.009 -1.091 . . . . 0.0 112.76 -175.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.19 50.41 1.64 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.511 0.672 . . . . 0.0 109.264 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.636 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -67.98 97.69 0.69 Allowed 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 123.379 1.561 . . . . 0.0 111.251 -173.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.3 96.06 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 113.738 -1.574 . . . . 0.0 109.475 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.491 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 4.9 t30 -45.9 135.61 6.47 Favored Pre-proline 0 N--CA 1.47 0.563 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.482 174.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 16.3 Cg_exo -67.87 -36.33 18.5 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 124.215 3.277 . . . . 0.0 113.042 -169.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -90.94 -84.04 0.25 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.65 176.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 55.01 26.16 7.71 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.152 0.501 . . . . 0.0 110.586 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 23.7 ttt 56.96 42.01 26.88 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.89 -176.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.462 ' HB3' ' HG2' ' A' ' 92' ' ' GLU . 14.3 mm100 -87.04 -70.42 0.62 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.228 174.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.433 ' HG3' ' HE3' ' A' ' 150' ' ' MET . 10.9 tt0 52.04 43.09 30.69 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.554 0.692 . . . . 0.0 110.683 -178.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.462 ' HG2' ' HB3' ' A' ' 90' ' ' GLN . 5.0 mm-40 -60.52 -20.6 60.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.113 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.657 HD11 ' HE1' ' A' ' 149' ' ' PHE . 0.9 OUTLIER -62.02 -35.58 78.99 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.894 -173.108 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.566 ' HD3' ' CE2' ' A' ' 97' ' ' PHE . 29.5 mmt180 -62.48 -41.69 98.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.086 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -74.62 -30.91 61.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.204 0.526 . . . . 0.0 110.818 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.501 ' HA ' HD12 ' A' ' 99' ' ' LEU . . . -74.95 -20.22 59.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.935 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.566 ' CE2' ' HD3' ' A' ' 94' ' ' ARG . 17.0 m-30 -56.57 -44.62 81.18 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.372 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.3 mtm-85 -72.02 -19.52 61.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.027 0.442 . . . . 0.0 110.906 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.501 HD12 ' HA ' ' A' ' 96' ' ' ALA . 94.2 mt -80.09 -43.87 21.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.654 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.632 ' O ' ' HD2' ' A' ' 102' ' ' LYS . 79.9 m-85 -89.59 -5.61 57.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.397 -177.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 97' ' ' PHE . 55.8 t0 -76.82 76.28 3.43 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.512 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.632 ' HD2' ' O ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -57.04 -42.33 80.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.601 174.548 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -67.75 -36.75 81.1 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.214 -171.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.96 37.15 7.97 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -171.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -96.06 -18.37 20.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.49 -0.855 . . . . 0.0 111.174 -168.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.9 -24.91 10.83 Favored Glycine 0 CA--C 1.517 0.194 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.436 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 4.2 m-85 -116.75 176.93 4.89 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 173.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.615 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 6.3 pt -117.84 121.94 68.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.239 169.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 66.3 m -65.91 174.75 2.28 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.149 0.5 . . . . 0.0 111.556 -175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.2 p -67.36 -26.76 66.64 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.953 0.406 . . . . 0.0 110.754 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -60.59 -58.09 9.95 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.851 176.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.615 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.4 p -63.26 -38.36 81.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.843 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.555 ' SD ' HG12 ' A' ' 144' ' ' VAL . 2.7 tpt -56.5 -40.89 75.73 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.827 0.346 . . . . 0.0 110.648 177.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -61.02 -45.19 95.79 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.991 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -58.99 -46.49 88.0 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.411 0.444 . . . . 0.0 110.215 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 63.7 mt -57.45 -53.83 38.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.567 177.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.4 tp -54.66 -60.29 3.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.36 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.08 -27.15 52.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.433 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -75.45 -44.15 45.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.616 0.246 . . . . 0.0 110.348 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.32 -55.7 7.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.141 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.627 ' HB3' HD22 ' A' ' 124' ' ' LEU . 5.3 m-20 -103.01 111.97 24.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.478 0.656 . . . . 0.0 110.649 -178.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 122' ' ' GLU . 0.3 OUTLIER -89.17 -5.41 57.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.717 -173.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.7 p -88.61 -2.98 58.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.339 0.59 . . . . 0.0 110.765 -174.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.627 HD22 ' HB3' ' A' ' 121' ' ' ASP . 4.2 mm? -84.87 129.03 34.87 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.854 176.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.479 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 92.0 p -89.69 -179.01 5.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 175.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.5 t -58.75 -48.49 81.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.692 0.282 . . . . 0.0 110.795 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -71.08 -35.86 72.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.828 0.347 . . . . 0.0 111.161 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -66.28 -38.14 87.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.45 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.499 ' O ' HG12 ' A' ' 133' ' ' ILE . 85.5 mt -58.65 -44.46 90.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.151 172.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -58.99 -46.24 88.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.616 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.45 -42.71 98.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.723 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.553 ' HE3' HD11 ' A' ' 124' ' ' LEU . 9.0 mtt -64.06 -37.26 86.8 Favored 'General case' 0 C--O 1.215 -0.731 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.923 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 129' ' ' LEU . 15.8 mm -57.41 -43.88 83.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.188 0.518 . . . . 0.0 110.419 174.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.4 -36.98 84.04 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.262 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -72.79 -39.5 66.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.517 -1.219 . . . . 0.0 111.242 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 132' ' ' MET . 66.8 mt -71.11 -57.11 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.993 -176.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -75.64 63.58 1.58 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 122.396 1.094 . . . . 0.0 108.621 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -78.37 -22.33 48.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.489 -1.232 . . . . 0.0 112.161 -174.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -88.23 -11.99 45.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.368 0.604 . . . . 0.0 110.202 -178.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 79.53 34.99 30.3 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.488 174.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.471 ' C ' ' H ' ' A' ' 143' ' ' THR . 46.9 t -78.74 -21.16 48.42 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.197 0.522 . . . . 0.0 110.406 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.67 -28.36 3.54 Favored Glycine 0 C--O 1.234 0.121 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.471 ' H ' ' C ' ' A' ' 141' ' ' SER . 19.5 p -124.3 128.27 48.87 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 172.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.555 HG12 ' SD ' ' A' ' 113' ' ' MET . 58.8 t -80.71 127.3 39.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -173.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 17.8 t70 -157.2 -77.63 0.08 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.872 0.844 . . . . 0.0 110.176 -175.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.402 ' HB3' HH22 ' A' ' 94' ' ' ARG . 20.7 p90 -92.65 136.42 33.24 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.072 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 146' ' ' PHE . 42.0 mm-40 64.86 -54.44 0.3 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.526 0.73 . . . . 0.0 112.204 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -54.66 -51.02 66.78 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.818 0.847 . . . . 0.0 112.144 -176.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.657 ' HE1' HD11 ' A' ' 93' ' ' LEU . 11.4 t80 -75.41 -37.0 60.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.125 0.488 . . . . 0.0 110.341 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' MET . . . . . 0.499 ' HE1' ' OG1' ' A' ' 154' ' ' THR . 0.0 OUTLIER -58.14 -43.15 87.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.347 178.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 155' ' ' GLY . . . -73.24 -35.62 56.73 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.455 -177.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.517 HG13 ' HA ' ' A' ' 149' ' ' PHE . 9.3 p -75.59 -38.9 39.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 117.112 0.456 . . . . 0.0 111.511 -175.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 16.0 tpt -93.88 -39.92 10.44 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.879 -174.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.499 ' OG1' ' HE1' ' A' ' 150' ' ' MET . 64.9 p -122.78 24.55 9.04 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -172.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.412 ' O ' ' HA2' ' A' ' 151' ' ' GLY . . . 77.43 -59.45 3.68 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.778 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 138.67 -160.16 25.56 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.141 -0.552 . . . . 0.0 111.985 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -99.11 81.06 2.53 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.415 ' OE1' ' HB3' ' A' ' 47' ' ' GLN . 24.6 tt0 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.503 -0.76 . . . . 0.0 109.994 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.2 mtt . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 121.571 0.701 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.435 ' O ' HG13 ' A' ' 4' ' ' VAL . . . -125.85 108.69 1.07 Allowed Glycine 0 N--CA 1.439 -1.163 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 170.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.461 ' HB3' ' HD3' ' A' ' 6' ' ' LYS . 6.0 m-20 -37.66 89.09 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -173.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.435 HG13 ' O ' ' A' ' 2' ' ' GLY . 14.9 m -80.96 -15.55 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.557 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.4 m -84.28 -16.23 43.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.283 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.461 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 5.0 mptp? -84.58 -32.51 23.75 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.963 175.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.495 HD22 ' HB1' ' A' ' 77' ' ' ALA . 8.2 mp -75.56 104.62 6.19 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.766 0.794 . . . . 0.0 110.373 177.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.1 t -125.33 68.16 1.14 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.518 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.0 t 71.54 -42.07 0.52 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.157 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -57.33 -58.84 6.49 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -174.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.49 ' CD ' ' HG2' ' A' ' 82' ' ' GLU . 3.4 mt-30 -72.55 -32.64 66.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.692 0.758 . . . . 0.0 109.212 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.431 HG11 ' CE2' ' A' ' 69' ' ' PHE . 89.2 t -63.88 -29.61 47.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.07 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.501 ' HD3' ' C ' ' A' ' 13' ' ' LYS . 1.1 tmtp? -62.82 -40.93 98.92 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 123.181 0.592 . . . . 0.0 110.854 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.424 ' N ' ' HD3' ' A' ' 13' ' ' LYS . 6.4 mp -69.92 -42.45 73.31 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.636 HD21 ' CD1' ' A' ' 80' ' ' LEU . 80.8 mt -59.97 -53.98 51.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.624 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.437 ' HA ' ' HE1' ' A' ' 69' ' ' PHE . 37.7 tt0 -64.65 -35.89 82.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.359 -175.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.1 m -59.82 -42.16 92.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 110.745 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.529 ' HB1' HG22 ' A' ' 39' ' ' ILE . . . -80.48 -33.12 36.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.146 0.498 . . . . 0.0 110.278 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.435 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 35.7 t80 -56.44 -55.04 38.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.35 177.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -69.08 -19.79 64.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.522 -174.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.61 -42.86 40.86 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.744 0.307 . . . . 0.0 110.908 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -103.77 14.01 31.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.137 0.494 . . . . 0.0 110.444 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.719 ' HG2' ' HB ' ' A' ' 24' ' ' THR . 10.3 tt0 -71.85 154.65 41.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.38 -176.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.719 ' HB ' ' HG2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER 76.01 137.77 0.05 OUTLIER Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-O 122.462 1.125 . . . . 0.0 113.812 158.637 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.32 -52.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.911 2.408 . . . . 0.0 109.835 168.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -138.83 -25.81 0.88 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.625 172.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.66 50.0 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -176.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 t -89.78 -29.77 18.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.807 0.337 . . . . 0.0 111.39 -174.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.88 -6.33 75.03 Favored Glycine 0 N--CA 1.453 -0.179 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 -175.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' A' ' 67' ' ' ILE . 61.0 mtt85 -115.25 163.7 15.29 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.207 -0.496 . . . . 0.0 109.745 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.519 HG23 HD12 ' A' ' 39' ' ' ILE . 13.3 p -106.18 126.61 61.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 121.86 0.838 . . . . 0.0 110.269 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 31.1 m -53.79 140.61 29.45 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.847 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.576 ' HB ' HG12 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -66.69 -25.31 66.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.85 -174.538 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -69.36 -26.08 64.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.589 0.709 . . . . 0.0 109.727 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -82.06 -22.4 36.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.661 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.477 HG13 ' HA ' ' A' ' 33' ' ' THR . 60.2 mt -55.61 -43.33 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 120.959 0.409 . . . . 0.0 110.143 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.417 ' CA ' HG13 ' A' ' 52' ' ' ILE . . . -65.24 -25.43 71.11 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.634 177.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.642 ' O ' HG21 ' A' ' 42' ' ' VAL . 39.3 mt -75.21 -51.97 19.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.529 HG22 ' HB1' ' A' ' 18' ' ' ALA . 63.5 mt -60.96 -44.83 98.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.839 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.423 HD22 HG21 ' A' ' 36' ' ' ILE . 1.6 mp -57.54 -39.26 76.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.352 0.596 . . . . 0.0 109.685 176.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -65.64 -38.44 89.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.769 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.642 HG21 ' O ' ' A' ' 38' ' ' ILE . 60.8 t -60.69 -50.38 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.622 0.725 . . . . 0.0 110.671 175.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.5 mt -83.35 -1.54 53.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.653 -171.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.55 35.19 42.12 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.403 172.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.5 pt -129.02 166.65 26.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.628 0.214 . . . . 0.0 110.468 176.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.29 -166.67 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -120.22 -171.88 2.25 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.975 -173.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.9 t -63.7 171.33 2.74 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.451 0.643 . . . . 0.0 111.437 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.446 ' HB3' ' HZ2' ' A' ' 49' ' ' LYS . 7.3 mtpm? -59.0 -24.6 62.92 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.317 -165.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.3 t -57.29 -44.8 84.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.931 0.396 . . . . 0.0 110.35 173.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.3 m -72.26 -34.42 68.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.433 0.635 . . . . 0.0 110.293 176.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.417 HG13 ' CA ' ' A' ' 37' ' ' GLY . 44.9 mm -63.41 -24.42 35.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.479 -176.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -50.83 -38.02 46.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.886 172.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.883 HE21 ' HA ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -74.44 -28.82 61.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.051 -179.051 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.401 HD11 ' CE2' ' A' ' 79' ' ' PHE . 2.3 mm? -65.35 -43.34 91.14 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.576 HG12 ' HB ' ' A' ' 33' ' ' THR . 71.8 mt -65.2 -45.42 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.96 177.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.03 -27.99 22.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.294 0.569 . . . . 0.0 111.076 176.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -83.31 -53.65 5.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.663 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.445 ' CE2' HG12 ' A' ' 75' ' ' ILE . 97.1 m-85 -100.87 -10.66 20.48 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -169.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.48 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 51.3 t0 -136.25 63.82 51.03 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 121.208 0.527 . . . . 0.0 110.458 174.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 24.6 Cg_exo -68.42 -20.56 41.87 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.841 2.361 . . . . 0.0 111.592 177.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -78.45 -17.48 56.28 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.757 -176.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.97 43.02 50.65 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.518 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -74.89 -38.04 61.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.216 0.532 . . . . 0.0 109.942 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 110.68 -5.37 29.43 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.961 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -161.32 175.77 11.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.405 ' O ' ' HB3' ' A' ' 30' ' ' ARG . 34.6 pt -143.19 146.71 21.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.371 -177.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -75.88 163.19 27.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.934 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.437 ' HE1' ' HA ' ' A' ' 16' ' ' GLU . 16.0 t80 -56.49 -35.65 68.23 Favored 'General case' 0 C--O 1.214 -0.772 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.075 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -62.18 -22.41 65.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.869 0.366 . . . . 0.0 111.029 -175.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 40.3 m -85.82 -41.26 15.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.905 0.383 . . . . 0.0 110.504 174.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.433 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 89.7 t80 -70.1 -30.56 67.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.467 0.651 . . . . 0.0 109.717 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -55.51 -50.53 69.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.871 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.0 -42.82 98.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.364 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.588 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 65.5 mt -54.34 -55.45 14.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.482 0.658 . . . . 0.0 110.068 176.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.69 -42.86 99.82 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.259 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.495 ' HB1' HD22 ' A' ' 7' ' ' LEU . . . -64.06 -28.03 69.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.854 0.359 . . . . 0.0 111.16 -174.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.588 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 13.8 ptm180 -89.64 -10.74 44.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.867 -176.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.504 ' CE1' ' HG3' ' A' ' 78' ' ' ARG . 22.6 m-85 -116.28 -40.14 3.3 Favored 'General case' 0 C--N 1.337 0.061 0 C-N-CA 120.66 -0.416 . . . . 0.0 112.105 -176.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.636 ' CD1' HD21 ' A' ' 15' ' ' LEU . 2.3 mp -69.37 -65.66 0.68 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.912 0.387 . . . . 0.0 110.828 176.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.85 11.99 26.52 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.785 -0.643 . . . . 0.0 114.312 175.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.49 ' HG2' ' CD ' ' A' ' 11' ' ' GLN . 29.4 mm-40 54.7 16.47 1.39 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 122.993 0.517 . . . . 0.0 111.767 -173.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -129.99 113.75 14.96 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.849 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.7 p -82.03 73.15 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 122.473 1.13 . . . . 0.0 110.993 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.43 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 0.7 OUTLIER -115.56 147.69 39.38 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 114.909 -1.042 . . . . 0.0 109.693 177.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 31.7 Cg_exo -62.11 -58.77 0.33 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.404 2.07 . . . . 0.0 111.625 -176.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.461 ' HB2' ' HG2' ' A' ' 90' ' ' GLN . 5.8 mm-40 -133.55 16.53 4.0 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.867 176.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 66.81 -50.14 0.46 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.946 -1.024 . . . . 0.0 112.166 -176.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 19.8 mmt -81.99 3.41 26.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.211 0.529 . . . . 0.0 110.516 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.461 ' HG2' ' HB2' ' A' ' 87' ' ' GLU . 13.9 mm100 -89.31 156.39 18.75 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.146 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 56.62 40.24 29.42 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 123.862 0.726 . . . . 0.0 111.868 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -56.16 -33.83 65.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.539 175.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.664 HD12 ' CD1' ' A' ' 149' ' ' PHE . 77.6 mt -57.83 -38.29 75.34 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.731 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.727 ' HA ' ' CD2' ' A' ' 97' ' ' PHE . 5.6 mpt_? -58.84 -46.27 88.09 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.755 0.312 . . . . 0.0 111.689 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -76.03 -17.08 59.82 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.13 0.49 . . . . 0.0 110.291 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.19 -18.04 33.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.182 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.727 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 22.4 m-85 -59.57 -45.5 91.66 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 98' ' ' ARG . 47.8 mtp180 -69.68 -13.86 62.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.156 0.503 . . . . 0.0 111.033 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.4 mt -84.35 -35.51 23.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.501 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -96.38 -11.55 25.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.182 0.515 . . . . 0.0 110.298 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -72.54 77.56 1.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.877 0.846 . . . . 0.0 110.337 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -75.65 -9.49 58.63 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.923 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -88.88 -37.11 15.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.654 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.95 30.55 7.05 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.676 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.412 ' C ' ' H ' ' A' ' 107' ' ' TYR . 92.2 m-20 -98.96 -17.48 18.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.848 0.356 . . . . 0.0 111.544 -175.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.57 -26.18 4.18 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.521 -0.631 . . . . 0.0 111.521 -174.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.529 ' HD2' ' CB ' ' A' ' 145' ' ' ASP . 30.5 m-85 -103.92 144.77 31.07 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 171.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.637 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 7.0 pt -93.11 120.8 43.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 118.591 -1.243 . . . . 0.0 108.977 174.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.5 m -67.76 172.12 5.7 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.96 -174.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.43 ' HB ' HG22 ' A' ' 133' ' ' ILE . 34.3 p -60.79 -29.06 69.21 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.211 0.529 . . . . 0.0 110.845 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.58 ' O ' ' HB2' ' A' ' 114' ' ' ARG . 2.0 t70 -62.97 -50.72 69.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.403 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.637 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.4 p -70.82 -35.28 59.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.933 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.717 ' SD ' HG11 ' A' ' 144' ' ' VAL . 1.4 tpt -59.66 -37.72 79.51 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.763 0.316 . . . . 0.0 110.205 176.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.58 ' HB2' ' O ' ' A' ' 111' ' ' ASP . 36.7 mtt180 -50.55 -59.55 3.93 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.407 172.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.0 -41.69 92.66 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.768 -176.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 53.6 mt -58.09 -46.89 88.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.148 0.499 . . . . 0.0 110.9 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.425 HD11 ' CD2' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -70.57 -47.39 60.5 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.128 -179.257 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.799 ' HB2' HD22 ' A' ' 129' ' ' LEU . . . -53.21 -25.81 15.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.753 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -68.34 -26.68 65.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.195 0.521 . . . . 0.0 110.247 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.401 HD12 ' N ' ' A' ' 120' ' ' LEU . 9.4 mp -89.55 -47.77 7.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.022 174.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.826 ' HB3' ' HB2' ' A' ' 124' ' ' LEU . 1.3 m-20 -90.57 93.57 9.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.3 0.572 . . . . 0.0 110.471 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -79.61 -13.84 59.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.728 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.5 p -96.79 -14.04 22.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 122.724 1.25 . . . . 0.0 108.607 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.884 ' HG ' HD23 ' A' ' 129' ' ' LEU . 36.9 tp -69.83 116.21 9.96 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 112.991 -1.913 . . . . 0.0 110.426 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 93.9 p -91.61 -179.71 5.43 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.622 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 24.9 m -58.73 -37.36 75.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.889 0.376 . . . . 0.0 110.911 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -74.58 -42.05 59.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.634 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.636 ' CB ' HD12 ' A' ' 124' ' ' LEU . 59.4 m-20 -64.35 -50.46 67.63 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.884 HD23 ' HG ' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -42.25 -48.41 4.93 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.835 169.646 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -62.19 -41.31 98.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.662 0.268 . . . . 0.0 111.219 -175.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.89 -41.6 97.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.101 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.418 ' O ' HG13 ' A' ' 136' ' ' ILE . 36.2 mtt -63.05 -39.21 94.05 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.624 176.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 129' ' ' LEU . 24.5 mm -57.91 -45.2 87.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.144 0.497 . . . . 0.0 110.382 175.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -61.02 -34.92 75.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.43 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -73.87 -38.52 64.4 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.849 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.524 HG12 ' HB ' ' A' ' 152' ' ' VAL . 59.8 mt -70.43 -49.41 53.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.385 -176.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.73 95.93 0.93 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 123.023 1.392 . . . . 0.0 110.713 -174.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.29 -54.95 5.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.208 -1.36 . . . . 0.0 112.337 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -84.23 -10.35 57.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.441 0.639 . . . . 0.0 110.979 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 61.55 40.95 99.41 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.621 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.1 t -89.89 5.04 48.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.079 0.466 . . . . 0.0 110.66 -176.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.56 -31.01 4.68 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.177 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 35.3 p -117.81 143.27 46.42 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.439 -0.381 . . . . 0.0 109.998 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.717 HG11 ' SD ' ' A' ' 113' ' ' MET . 71.7 t -91.88 111.41 24.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.529 ' CB ' ' HD2' ' A' ' 107' ' ' TYR . 22.6 t70 -146.37 -69.16 0.26 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.687 0.756 . . . . 0.0 111.574 -175.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.852 ' HD2' ' HG2' ' A' ' 147' ' ' GLU . 4.0 p90 -97.92 -53.44 3.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.02 -164.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.852 ' HG2' ' HD2' ' A' ' 146' ' ' PHE . 40.2 mm-40 -98.86 -36.17 9.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.496 0.665 . . . . 0.0 110.157 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 148' ' ' GLU . 40.9 mp0 -63.5 -54.95 28.37 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.038 -175.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.664 ' CD1' HD12 ' A' ' 93' ' ' LEU . 2.3 t80 -66.27 -45.98 78.6 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.793 -175.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' MET . . . . . 0.409 ' HG2' ' O ' ' A' ' 146' ' ' PHE . 52.4 mmm -61.47 -19.53 62.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.278 177.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -90.92 -17.54 51.11 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.878 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.524 ' HB ' HG12 ' A' ' 136' ' ' ILE . 6.6 p -98.31 -47.26 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 117.019 0.41 . . . . 0.0 111.393 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.409 ' N ' HG11 ' A' ' 152' ' ' VAL . 49.9 tpp -81.08 -56.46 4.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.881 0.372 . . . . 0.0 110.785 -176.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.1 p -97.2 26.63 4.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.78 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -122.25 54.1 0.7 Allowed Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.464 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -77.39 -2.52 79.87 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.972 -176.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 38.4 t70 58.2 68.99 0.77 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.589 0.709 . . . . 0.0 109.732 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.674 -173.758 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.5 ttp . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 121.262 0.553 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.87 -49.99 0.36 Allowed Glycine 0 CA--C 1.502 -0.74 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.811 ' HB3' ' HB2' ' A' ' 6' ' ' LYS . 3.7 m-20 59.37 41.73 19.17 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 124.474 0.749 . . . . 0.0 111.783 168.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.6 p -66.81 -23.81 31.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.324 0.583 . . . . 0.0 110.159 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.0 m -95.05 5.05 52.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.495 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.811 ' HB2' ' HB3' ' A' ' 3' ' ' ASP . 4.9 mptp? -97.23 -35.42 10.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.176 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.563 ' HA ' ' OE1' ' A' ' 11' ' ' GLN . 5.6 mp -59.14 113.46 2.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.578 0.704 . . . . 0.0 111.578 -176.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.4 t -81.44 56.34 2.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.764 -172.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.5 m 65.15 -54.19 0.32 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -54.73 -45.87 74.15 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.838 0.455 . . . . 0.0 111.183 -176.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.563 ' OE1' ' HA ' ' A' ' 7' ' ' LEU . 8.9 mt-30 -64.08 -31.46 72.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.764 0.793 . . . . 0.0 110.032 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.443 HG23 ' HB3' ' A' ' 7' ' ' LEU . 99.1 t -76.13 -33.79 25.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.462 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.473 ' HD2' ' HA ' ' A' ' 13' ' ' LYS . 12.0 tptt -61.64 -42.64 99.18 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 120.782 0.325 . . . . 0.0 110.642 173.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.9 mt -57.23 -48.7 78.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.426 0.631 . . . . 0.0 109.617 173.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 11' ' ' GLN . 67.9 mt -56.18 -51.34 68.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.261 176.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -61.08 -41.87 97.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.652 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.8 m -61.24 -39.28 89.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.063 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.437 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -84.2 -31.33 25.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.931 0.396 . . . . 0.0 110.616 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.584 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 65.3 t80 -57.95 -56.79 17.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.411 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -71.95 -0.96 12.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.468 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -93.79 -52.43 4.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.788 0.327 . . . . 0.0 110.746 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.601 ' CD1' HG12 ' A' ' 39' ' ' ILE . 64.5 m-85 -95.71 11.11 34.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.02 0.438 . . . . 0.0 110.455 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.61 ' HA ' HG23 ' A' ' 31' ' ' VAL . 11.1 tt0 -62.32 155.12 25.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.513 -174.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.581 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.4 OUTLIER 77.81 138.52 0.06 OUTLIER Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 114.128 -1.396 . . . . 0.0 113.737 161.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -88.32 -44.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.553 2.835 . . . . 0.0 110.799 170.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -164.3 47.03 0.11 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.494 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.78 66.67 1.27 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.808 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.0 t -113.14 -27.19 8.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -176.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.13 -4.76 82.45 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -171.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.446 ' HD2' ' OD2' ' A' ' 66' ' ' ASP . 25.5 mtt85 -115.25 160.22 20.03 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 114.068 -1.066 . . . . 0.0 109.565 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.61 HG23 ' HA ' ' A' ' 23' ' ' GLU . 10.2 p -106.8 126.98 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 121.697 0.76 . . . . 0.0 109.099 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.442 ' HA ' ' HB3' ' A' ' 66' ' ' ASP . 32.8 t -55.63 140.64 40.53 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.941 -1.481 . . . . 0.0 111.372 -177.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.596 ' HB ' HG12 ' A' ' 56' ' ' ILE . 7.0 p -66.5 -19.63 65.83 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.01 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.406 ' O ' ' HE2' ' A' ' 49' ' ' LYS . 32.9 t70 -70.9 -27.39 63.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.72 176.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.678 ' HA ' HD12 ' A' ' 38' ' ' ILE . 15.8 mm100 -95.06 -13.96 24.7 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.05 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.62 HG22 HD22 ' A' ' 40' ' ' LEU . 63.1 mt -56.93 -34.06 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.614 0.245 . . . . 0.0 110.665 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.425 ' CA ' HG13 ' A' ' 52' ' ' ILE . . . -73.12 -36.1 56.81 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.338 -177.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 35' ' ' GLN . 1.3 mp -59.81 -56.13 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 174.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.714 ' HA ' HG13 ' A' ' 42' ' ' VAL . 36.0 mt -64.08 -39.24 84.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.645 -176.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.62 HD22 HG22 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -60.83 -23.71 65.31 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.301 -0.56 . . . . 0.0 109.992 176.337 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 35.0 tt0 -81.74 -41.63 20.96 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.402 173.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.714 HG13 ' HA ' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -58.78 -38.74 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 121.572 0.701 . . . . 0.0 110.406 177.563 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.473 ' HG ' HG22 ' A' ' 42' ' ' VAL . 45.6 mt -83.52 -11.9 56.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.841 -178.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.91 32.52 56.76 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.269 175.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pt -110.96 -86.09 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -177.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -79.03 177.34 8.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.257 0.551 . . . . 0.0 112.362 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -100.79 -171.95 2.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.371 -174.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.2 t -64.38 175.81 1.24 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.444 0.64 . . . . 0.0 111.862 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 96.8 mttt -53.61 -30.42 42.48 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -165.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.4 m -55.7 -33.48 64.22 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.073 0.463 . . . . 0.0 111.058 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.7 m -84.25 -33.77 23.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.557 0.694 . . . . 0.0 110.3 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.454 HD13 HD22 ' A' ' 40' ' ' LEU . 36.9 mm -66.92 -23.98 31.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.497 -175.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 30.7 mmt180 -52.71 -33.1 46.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.923 0.392 . . . . 0.0 110.742 176.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -70.86 -51.05 28.84 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.164 0.507 . . . . 0.0 109.735 175.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.474 HD13 ' CE2' ' A' ' 79' ' ' PHE . 3.3 mm? -51.26 -45.92 62.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.249 177.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.596 HG12 ' HB ' ' A' ' 33' ' ' THR . 73.1 mt -62.97 -50.0 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.486 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -62.92 -25.39 68.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.197 0.523 . . . . 0.0 110.713 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -69.24 -55.02 11.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.236 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.531 ' HB3' ' HB3' ' A' ' 71' ' ' SER . 94.6 m-85 -100.92 -20.76 15.32 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -171.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -126.67 67.59 67.5 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-O 121.2 0.524 . . . . 0.0 110.615 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.438 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 31.3 Cg_exo -62.66 -17.16 57.34 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.862 2.374 . . . . 0.0 111.628 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -69.74 -18.34 63.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.279 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.9 32.44 84.19 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -173.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -75.41 -40.93 57.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.928 -0.636 . . . . 0.0 111.087 -170.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.01 -14.95 10.33 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.017 -1.087 . . . . 0.0 113.788 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.446 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 5.7 p-10 -154.75 157.9 38.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 117.171 0.486 . . . . 0.0 110.875 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.8 pt -133.59 149.11 30.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.255 -175.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -81.11 167.99 19.09 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.657 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -56.3 -26.63 52.79 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -42.89 -54.29 4.26 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.468 172.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.531 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 13.5 m -86.51 -37.17 18.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.819 -176.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -63.94 -35.26 80.1 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.129 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -63.87 -36.27 83.36 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.438 ' HB ' ' CE1' ' A' ' 59' ' ' PHE . 34.6 mt -72.44 -37.25 57.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 177.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.544 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 61.7 mt -57.78 -51.21 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.285 0.564 . . . . 0.0 109.654 173.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.483 ' O ' HD22 ' A' ' 80' ' ' LEU . . . -63.18 -42.78 99.32 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.893 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.467 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . . . -57.95 -37.58 74.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.385 0.612 . . . . 0.0 111.329 -175.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.544 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 15.0 ptm180 -81.83 -9.3 59.65 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.969 -173.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.474 ' CE2' HD13 ' A' ' 55' ' ' LEU . 22.2 m-85 -124.02 -31.56 3.36 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.72 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.483 HD22 ' O ' ' A' ' 76' ' ' GLY . 4.1 mm? -69.86 -26.08 64.03 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.155 0.503 . . . . 0.0 110.904 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.46 49.01 1.56 Allowed Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.481 -0.781 . . . . 0.0 113.657 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -94.8 27.82 2.94 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.398 0.618 . . . . 0.0 109.687 174.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -82.67 92.04 7.1 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.505 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.6 t -127.58 84.42 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.548 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.503 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 4.7 t30 -98.25 141.72 23.41 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.42 -175.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 23.5 Cg_exo -65.93 -52.09 1.05 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.597 2.865 . . . . 0.0 112.236 -176.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -89.1 25.64 1.8 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.019 -178.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -61.14 111.46 1.72 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.825 0.345 . . . . 0.0 111.015 -176.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 48.8 ttm 63.91 18.82 11.42 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.42 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -97.35 -25.02 15.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.981 0.42 . . . . 0.0 110.533 176.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -81.21 47.19 0.99 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.277 0.56 . . . . 0.0 110.555 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -62.8 -19.72 64.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.116 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.566 HD23 ' H ' ' A' ' 93' ' ' LEU . 0.6 OUTLIER -56.81 -38.18 72.23 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.037 -176.562 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.688 ' HA ' ' CE2' ' A' ' 97' ' ' PHE . 30.1 mmm180 -62.44 -34.85 77.59 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.485 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -86.96 -23.44 25.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.881 0.372 . . . . 0.0 110.652 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.0 -16.03 62.06 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.608 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.688 ' CE2' ' HA ' ' A' ' 94' ' ' ARG . 20.1 m-85 -61.71 -40.86 96.51 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -66.46 -17.74 64.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.323 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.2 mt -88.06 -30.72 19.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.321 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -104.28 -24.12 13.15 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -175.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -72.97 79.88 1.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.562 0.696 . . . . 0.0 109.982 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -69.72 -19.43 63.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.628 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.457 ' HB2' ' ND2' ' A' ' 105' ' ' ASN . 12.5 mt-10 -90.91 -37.01 13.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.279 -172.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.81 42.15 3.66 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.024 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' A' ' 103' ' ' GLU . 24.5 m-80 -87.53 -19.65 27.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 0.0 110.693 -176.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.54 1.9 82.86 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -169.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.54 ' HD2' ' CB ' ' A' ' 145' ' ' ASP . 4.7 m-85 -148.22 165.26 31.47 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.649 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 11.3 pt -102.46 120.48 52.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 C-N-CA 119.278 -0.969 . . . . 0.0 109.1 170.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.6 m -60.97 161.59 8.11 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.685 -176.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.0 p -58.34 -26.61 63.32 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.765 -0.584 . . . . 0.0 110.642 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -62.05 -51.03 69.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.78 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.649 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.1 p -70.37 -36.71 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.156 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.632 ' SD ' HG13 ' A' ' 144' ' ' VAL . 2.7 tpt -59.23 -38.34 79.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.103 0.477 . . . . 0.0 109.782 175.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -56.34 -53.48 56.83 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.125 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.62 -29.42 66.91 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.996 -178.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.601 HG13 ' O ' ' A' ' 112' ' ' VAL . 57.4 mt -63.52 -50.2 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 121.205 0.526 . . . . 0.0 110.021 174.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.682 HD12 ' SD ' ' A' ' 132' ' ' MET . 0.7 OUTLIER -58.7 -50.61 73.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.835 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.65 -27.82 68.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.775 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -69.97 -39.92 75.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.911 0.386 . . . . 0.0 110.14 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.44 -56.72 5.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.828 175.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.608 ' CG ' HD22 ' A' ' 124' ' ' LEU . 7.5 t70 -102.82 119.97 39.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.077 0.465 . . . . 0.0 110.881 -177.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -101.87 15.79 27.92 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.805 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 61.8 p -116.17 -17.0 10.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.477 0.656 . . . . 0.0 109.767 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.608 HD22 ' CG ' ' A' ' 121' ' ' ASP . 1.4 mm? -55.42 146.85 18.73 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.909 169.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.425 ' H ' ' HB2' ' A' ' 128' ' ' ASP . 27.3 t -107.85 162.46 13.98 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.601 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.1 m -51.76 -36.51 47.6 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 118.204 0.456 . . . . 0.0 111.396 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -76.38 -45.69 30.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.295 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.425 ' HB2' ' H ' ' A' ' 125' ' ' SER . 3.0 m-20 -63.35 -42.51 98.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.053 0.454 . . . . 0.0 110.487 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.6 HD12 ' HB3' ' A' ' 117' ' ' LEU . 26.6 tp -56.39 -39.5 73.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.528 176.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.449 ' O ' ' HB ' ' A' ' 133' ' ' ILE . 23.7 t70 -63.88 -41.7 97.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.234 177.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.48 -38.06 89.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.686 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.682 ' SD ' HD12 ' A' ' 117' ' ' LEU . 28.7 mtt -65.23 -34.04 77.43 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.59 175.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.449 ' HB ' ' O ' ' A' ' 130' ' ' ASP . 15.2 mm -58.54 -47.79 87.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.978 0.418 . . . . 0.0 110.312 173.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.66 -45.08 77.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.409 175.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -66.95 -37.12 83.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.253 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.451 HG23 ' SD ' ' A' ' 113' ' ' MET . 51.9 mt -69.41 -58.65 5.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.16 -178.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -71.29 96.26 1.41 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.7 0.762 . . . . 0.0 110.206 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -75.19 -42.97 54.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.736 -175.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -81.94 -15.14 54.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.491 0.662 . . . . 0.0 110.979 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 70.71 26.03 74.73 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.195 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.0 t -74.68 -18.25 60.55 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.428 0.633 . . . . 0.0 109.723 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.22 -23.94 24.64 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.534 ' HB ' ' HB2' ' A' ' 107' ' ' TYR . 24.6 p -116.93 128.92 55.69 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.632 HG13 ' SD ' ' A' ' 113' ' ' MET . 94.1 t -86.13 121.92 37.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.292 -176.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.54 ' CB ' ' HD2' ' A' ' 107' ' ' TYR . 22.7 t70 -150.43 -68.99 0.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.325 0.584 . . . . 0.0 111.867 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 146' ' ' PHE . 0.6 OUTLIER -85.23 -88.28 0.11 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.067 -167.185 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -78.31 -28.22 47.4 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.063 0.459 . . . . 0.0 110.823 -175.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.603 ' CD ' ' H ' ' A' ' 148' ' ' GLU . 3.0 mp0 -57.94 -64.11 1.02 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.588 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.522 ' CD2' HD11 ' A' ' 108' ' ' ILE . 19.8 t80 -66.97 -43.74 82.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.979 -174.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' MET . . . . . 0.563 ' HE1' HD21 ' A' ' 93' ' ' LEU . 40.7 tpp -62.43 -33.56 75.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.152 0.501 . . . . 0.0 109.797 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.55 -26.81 66.72 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 116.033 -0.53 . . . . 0.0 113.133 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.485 HG11 ' HA ' ' A' ' 149' ' ' PHE . 6.5 p -89.17 -42.51 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 117.238 0.519 . . . . 0.0 111.665 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -82.34 -57.89 3.17 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.543 -174.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 45.3 p -86.35 -39.4 16.48 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.585 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 123.17 -8.24 9.1 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 129.77 -110.45 1.05 Allowed Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -112.38 -73.98 0.65 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 175.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.16 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.7 mtp . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 121.114 0.483 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -163.44 44.77 0.33 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.482 ' HB3' ' HD3' ' A' ' 6' ' ' LYS . 1.4 m-20 -73.31 106.58 5.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.967 0.413 . . . . 0.0 111.721 -175.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.9 p -72.02 -18.61 19.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.006 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.6 t -89.67 -17.15 28.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.546 -176.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.482 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 14.5 mptt -91.27 -10.19 42.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.807 0.337 . . . . 0.0 111.284 -177.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.697 ' HG ' ' HA ' ' A' ' 77' ' ' ALA . 4.3 mm? -90.45 114.13 26.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.196 0.522 . . . . 0.0 110.282 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.0 t -85.05 173.38 10.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.803 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.3 m -54.9 -42.29 71.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -170.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -58.49 -43.11 88.88 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.782 0.325 . . . . 0.0 111.515 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.0 mm100 -64.34 -42.23 96.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.804 0.811 . . . . 0.0 109.86 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.418 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 93.3 t -72.17 -27.27 26.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 114.706 -1.133 . . . . 0.0 111.403 -177.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.488 ' HD2' ' HA ' ' A' ' 13' ' ' LYS . 11.9 tptt -62.08 -42.51 99.28 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-O 120.886 0.374 . . . . 0.0 111.223 177.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.6 mt -60.41 -41.61 94.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.407 0.622 . . . . 0.0 109.491 174.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.939 HD21 HD11 ' A' ' 80' ' ' LEU . 77.3 mt -61.16 -49.27 77.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.692 176.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -61.34 -43.47 98.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.461 -178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 57.9 m -58.6 -38.27 77.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.116 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.532 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -86.0 -35.67 20.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.042 0.449 . . . . 0.0 110.382 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.644 ' CE1' HG23 ' A' ' 31' ' ' VAL . 88.0 t80 -55.15 -49.58 71.46 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.096 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -81.35 -6.52 58.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.765 -175.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -87.58 -46.47 9.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.09 0.472 . . . . 0.0 110.318 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.56 ' HB3' ' HB3' ' A' ' 35' ' ' GLN . 68.4 m-85 -98.97 25.74 6.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.81 0.814 . . . . 0.0 109.461 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.965 ' HG2' ' HB ' ' A' ' 24' ' ' THR . 1.7 tt0 -78.42 139.48 38.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.249 -1.341 . . . . 0.0 112.8 -172.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.965 ' HB ' ' HG2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER 76.27 144.69 0.1 Allowed Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 155.515 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 24' ' ' THR . 7.1 Cg_exo -74.8 -53.71 0.1 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.531 2.821 . . . . 0.0 110.084 165.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -136.5 -39.61 0.65 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.69 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.3 38.55 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.9 t -76.37 -27.18 56.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.374 -0.413 . . . . 0.0 111.161 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.93 4.6 86.97 Favored Glycine 0 C--N 1.335 0.479 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.431 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 11.8 mtt180 -122.06 168.3 12.1 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.758 -0.721 . . . . 0.0 110.305 -175.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.644 HG23 ' CE1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -105.66 127.34 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.536 0 CA-C-O 121.446 0.641 . . . . 0.0 110.926 174.626 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.0 t -53.74 139.32 33.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.797 -1.547 . . . . 0.0 109.1 171.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.625 HG23 HG21 ' A' ' 56' ' ' ILE . 3.9 p -70.46 -13.04 61.96 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.869 0.366 . . . . 0.0 111.586 -176.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.71 -29.47 62.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.717 172.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.56 ' HB3' ' HB3' ' A' ' 22' ' ' PHE . 84.3 mm-40 -81.56 -23.54 37.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.977 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.479 HD12 HG22 ' A' ' 33' ' ' THR . 61.0 mt -57.18 -44.34 83.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.524 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.82 -20.73 70.7 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.366 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.609 ' O ' HG22 ' A' ' 42' ' ' VAL . 15.0 mt -81.9 -51.36 15.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.532 HG23 ' HB1' ' A' ' 18' ' ' ALA . 73.2 mt -57.66 -46.57 86.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.499 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.418 HD22 HG21 ' A' ' 36' ' ' ILE . 1.3 mp -56.81 -40.91 76.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.246 0.546 . . . . 0.0 109.928 177.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 32.8 tt0 -61.28 -43.96 98.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.566 175.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.609 HG22 ' O ' ' A' ' 38' ' ' ILE . 78.8 t -55.57 -48.03 77.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.814 0.816 . . . . 0.0 110.552 175.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.2 mt -83.14 -2.45 55.49 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.365 -172.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.8 26.84 59.84 Favored Glycine 0 N--CA 1.453 -0.188 0 CA-C-N 115.944 -0.571 . . . . 0.0 113.129 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.9 pt -122.45 167.74 15.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 O-C-N 122.708 -0.29 . . . . 0.0 111.066 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.62 -171.37 0.02 OUTLIER 'General case' 0 C--O 1.233 0.227 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -178.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -119.6 -170.88 2.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.938 -173.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.3 t -56.51 167.38 0.72 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.324 0.583 . . . . 0.0 111.149 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.484 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 55.9 mttp -57.36 -23.66 50.39 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -166.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.4 t -54.73 -47.84 73.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.093 0.473 . . . . 0.0 110.358 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.7 m -70.39 -35.27 73.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.63 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.484 ' CG1' ' HA ' ' A' ' 49' ' ' LYS . 44.4 mm -60.54 -29.2 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.359 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.522 ' HA ' HD11 ' A' ' 56' ' ' ILE . 34.5 mmt180 -56.5 -28.2 59.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.155 176.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -75.2 -35.22 61.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.884 0.373 . . . . 0.0 110.611 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -62.6 -43.82 97.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.416 0.627 . . . . 0.0 109.484 175.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.625 HG21 HG23 ' A' ' 33' ' ' THR . 52.6 mt -63.6 -43.64 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.839 176.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -55.75 -35.5 66.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.19 0.519 . . . . 0.0 110.897 176.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -71.68 -54.68 9.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.735 -178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.485 ' CE2' HG12 ' A' ' 75' ' ' ILE . 96.0 m-85 -100.62 -12.9 18.82 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -128.1 66.9 73.5 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-O 121.063 0.458 . . . . 0.0 110.606 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 33.1 Cg_exo -62.6 -29.75 78.37 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.795 2.33 . . . . 0.0 112.338 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -77.34 -17.62 58.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.387 -175.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.35 47.08 60.1 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -175.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -78.92 -26.98 43.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.111 0.482 . . . . 0.0 110.131 -174.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.3 -25.35 13.95 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.847 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' ' 30' ' ' ARG . 53.1 p-10 -146.06 168.48 20.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.918 0.39 . . . . 0.0 110.536 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.444 ' HB ' ' HB2' ' A' ' 71' ' ' SER . 36.6 pt -138.82 147.41 25.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.344 -178.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.431 ' HA ' ' HG2' ' A' ' 30' ' ' ARG . 28.7 t70 -80.8 170.27 16.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.316 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.26 -26.56 61.0 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 176.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -48.1 -52.89 18.47 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.822 173.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 2.2 m -78.3 -43.46 27.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.663 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -63.11 -36.76 84.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.599 -175.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -66.67 -35.45 80.17 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 56.2 mt -69.74 -39.2 77.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.603 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 62.6 mt -58.14 -52.57 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-O 121.373 0.606 . . . . 0.0 109.594 173.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.14 -38.89 96.88 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.237 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.697 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . . . -66.06 -30.18 70.65 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.82 0.343 . . . . 0.0 111.427 -174.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 16.4 ptm180 -85.14 -7.48 59.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.787 -175.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.444 ' CE1' ' HG3' ' A' ' 78' ' ' ARG . 19.9 m-85 -124.97 -48.58 1.75 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 120.874 -0.331 . . . . 0.0 111.047 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.939 HD11 HD21 ' A' ' 15' ' ' LEU . 3.3 mp -71.93 -25.06 61.74 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.47 0.652 . . . . 0.0 111.591 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.82 35.52 3.5 Favored Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.762 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -73.78 -8.66 56.89 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.367 -0.417 . . . . 0.0 110.731 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.0 -72.12 0.11 Allowed 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.1 p 37.41 58.7 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 124.631 1.207 . . . . 0.0 111.964 176.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.425 ' CG ' ' HD2' ' A' ' 86' ' ' PRO . 2.6 t30 -72.43 150.08 91.46 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.729 -176.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.454 ' HG3' HE21 ' A' ' 90' ' ' GLN . 10.1 Cg_endo -53.39 -60.19 0.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.045 2.496 . . . . 0.0 111.568 -177.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -126.75 7.23 6.78 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.363 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 59.53 19.46 7.95 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.616 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 52.2 ttp -172.25 80.84 0.06 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.454 HE21 ' HG3' ' A' ' 86' ' ' PRO . 96.2 mt-30 -77.62 -78.83 0.13 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.23 -172.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -138.14 25.63 2.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.423 0.63 . . . . 0.0 110.404 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.32 -19.44 35.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.227 175.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.701 HD23 ' HE2' ' A' ' 150' ' ' MET . 0.6 OUTLIER -51.02 -32.14 20.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.913 177.256 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.732 HH11 ' HE2' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -58.22 -44.44 88.18 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.989 0.423 . . . . 0.0 111.618 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -71.67 -29.72 64.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.178 0.513 . . . . 0.0 110.241 176.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.419 ' HA ' HD11 ' A' ' 99' ' ' LEU . . . -75.56 -19.31 59.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.877 -175.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.732 ' HE2' HH11 ' A' ' 94' ' ' ARG . 22.6 m-85 -59.19 -48.99 79.55 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 120.844 0.354 . . . . 0.0 110.084 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -70.47 -12.9 61.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.527 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.419 HD11 ' HA ' ' A' ' 96' ' ' ALA . 85.5 mt -83.63 -27.37 29.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.832 176.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -105.14 -25.28 12.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.511 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -72.26 82.12 1.02 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.797 0.808 . . . . 0.0 111.099 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -72.39 -15.75 61.85 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.927 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -78.98 -35.99 42.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.339 -175.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.0 44.32 4.18 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.754 174.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -107.77 -18.44 13.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.064 0.459 . . . . 0.0 110.339 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.29 -24.44 27.18 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -172.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.56 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 6.3 m-85 -109.9 152.25 26.04 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.671 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 13.1 pt -92.44 124.66 44.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.6 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.58 ' HA ' HG22 ' A' ' 143' ' ' THR . 21.7 m -65.39 165.89 11.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.627 -175.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.8 p -62.33 -27.14 68.85 Favored 'General case' 0 C--N 1.318 -0.775 0 O-C-N 121.74 -0.6 . . . . 0.0 111.154 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.56 -49.79 76.13 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.667 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.671 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.6 p -70.73 -38.39 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.598 -178.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.515 ' HA ' ' HE3' ' A' ' 113' ' ' MET . 4.0 tpp -58.36 -43.12 88.24 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 174.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.53 ' O ' HD22 ' A' ' 129' ' ' LEU . 23.0 ttp180 -53.25 -40.36 64.53 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.669 177.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -74.37 -38.43 63.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.307 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 112' ' ' VAL . 59.3 mt -63.58 -52.67 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 120.945 0.402 . . . . 0.0 110.608 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.533 ' HB3' HD13 ' A' ' 129' ' ' LEU . 0.8 OUTLIER -54.02 -53.91 46.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.312 179.795 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.562 ' HB2' HD23 ' A' ' 129' ' ' LEU . . . -58.69 -27.52 64.92 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.257 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.22 -50.74 17.82 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.4 -48.96 71.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.802 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.621 ' HB3' HD21 ' A' ' 124' ' ' LEU . 4.8 m-20 -103.59 94.69 5.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.6 0.714 . . . . 0.0 110.189 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -73.92 -5.06 38.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.052 -0.977 . . . . 0.0 112.653 -171.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 66.9 p -94.85 -2.93 49.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.398 0.618 . . . . 0.0 111.359 -173.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.621 HD21 ' HB3' ' A' ' 121' ' ' ASP . 4.4 mm? -80.71 148.02 30.33 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.223 177.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 56.2 m -121.68 173.35 7.5 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.7 m -48.15 -47.53 34.79 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -174.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -68.81 -54.26 16.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.712 0.291 . . . . 0.0 111.227 -177.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -58.93 -44.89 91.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.725 0.774 . . . . 0.0 110.372 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.562 HD23 ' HB2' ' A' ' 118' ' ' ALA . 61.3 tp -60.57 -38.12 83.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.711 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.437 ' O ' ' HB ' ' A' ' 133' ' ' ILE . 5.6 t70 -69.35 -33.55 73.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.023 0.439 . . . . 0.0 110.251 -178.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.63 94.58 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.963 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.478 ' SD ' HD13 ' A' ' 117' ' ' LEU . 38.1 mtt -60.24 -36.34 77.51 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.262 175.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.528 HD13 ' HA ' ' A' ' 114' ' ' ARG . 17.0 mm -59.05 -47.2 90.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.835 0.35 . . . . 0.0 110.853 175.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -60.34 -39.79 88.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.229 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -70.03 -43.99 70.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.703 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.4 HG12 ' CG2' ' A' ' 152' ' ' VAL . 57.7 mt -57.98 -54.31 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.163 0.585 . . . . 0.0 112.519 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -73.65 91.59 1.89 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.587 0.708 . . . . 0.0 110.507 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.58 -41.97 36.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.521 -174.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -84.85 -13.47 50.9 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.934 -172.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 78.59 26.82 58.34 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.895 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.9 m -73.66 -18.03 61.08 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.363 0.601 . . . . 0.0 110.609 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.54 -13.6 51.05 Favored Glycine 0 CA--C 1.509 -0.307 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.096 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.58 HG22 ' HA ' ' A' ' 109' ' ' SER . 3.0 p -132.8 131.15 40.75 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.726 -0.737 . . . . 0.0 109.223 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 149' ' ' PHE . 52.8 t -84.73 111.81 20.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.938 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 11.0 t70 -139.46 -72.2 0.39 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.38 0.609 . . . . 0.0 110.913 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.56 ' O ' ' HG2' ' A' ' 150' ' ' MET . 0.7 OUTLIER -82.99 -98.46 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.517 -169.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.496 ' HG2' ' CD2' ' A' ' 146' ' ' PHE . 9.1 pt-20 -67.87 -29.49 68.63 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 122.259 -0.276 . . . . 0.0 111.118 -175.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -59.68 -51.05 71.45 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.4 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.587 ' HA ' HG11 ' A' ' 152' ' ' VAL . 9.4 t80 -79.66 -33.91 40.86 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.416 -174.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' MET . . . . . 0.701 ' HE2' HD23 ' A' ' 93' ' ' LEU . 10.3 mmt -62.53 -45.34 93.4 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.502 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.95 -33.32 83.55 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.251 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.587 HG11 ' HA ' ' A' ' 149' ' ' PHE . 8.1 p -81.71 -36.55 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 111.598 -176.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 52.1 tpp -96.85 -56.07 2.68 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -173.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 69.0 p -97.49 -13.7 21.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.971 0.415 . . . . 0.0 111.551 -173.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 96.65 -24.04 32.57 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.879 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 72.04 -135.39 22.78 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.018 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -104.33 -38.32 6.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.252 0.549 . . . . 0.0 110.3 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 C--O 1.243 0.753 0 CA-C-O 118.386 -0.816 . . . . 0.0 110.389 -177.679 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.7 mtm . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 121.181 0.515 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -86.79 60.74 4.44 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 172.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.444 ' HB2' ' HB2' ' A' ' 6' ' ' LYS . 20.4 m-20 -61.13 110.11 1.29 Allowed 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.202 0.525 . . . . 0.0 111.924 -173.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.0 p -74.58 -9.69 13.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.505 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.2 p -91.44 -21.23 21.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.859 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.444 ' HB2' ' HB2' ' A' ' 3' ' ' ASP . 5.6 mptp? -76.39 -27.97 56.56 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.908 0.385 . . . . 0.0 110.088 177.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.763 ' HG ' ' HA ' ' A' ' 77' ' ' ALA . 5.1 mt -59.78 114.83 2.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.659 173.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.4 m -79.98 149.99 30.6 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -51.35 -41.17 60.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.7 0.286 . . . . 0.0 111.557 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -57.46 -39.74 77.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.32 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.535 ' HB2' HD21 ' A' ' 7' ' ' LEU . 8.2 mt-30 -70.26 -42.27 72.36 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.443 0.64 . . . . 0.0 109.357 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.586 HG23 HD12 ' A' ' 7' ' ' LEU . 57.4 t -63.22 -31.44 52.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.603 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.552 ' HD3' ' C ' ' A' ' 13' ' ' LYS . 5.5 tmtm? -66.01 -40.3 90.97 Favored 'General case' 0 N--CA 1.416 -2.143 0 C-N-CA 123.277 0.631 . . . . 0.0 110.043 177.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.53 -43.26 94.58 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.733 HD23 HD13 ' A' ' 80' ' ' LEU . 80.1 mt -55.99 -50.26 71.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.614 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.564 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 6.8 tp10 -54.13 -53.62 50.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.79 177.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 96.3 m -63.58 -39.42 94.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.477 ' HB3' HG23 ' A' ' 39' ' ' ILE . . . -77.66 -27.21 50.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.103 0.477 . . . . 0.0 110.564 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.748 ' HD1' ' HD2' ' A' ' 20' ' ' ARG . 45.4 t80 -62.63 -51.75 66.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.139 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.748 ' HD2' ' HD1' ' A' ' 19' ' ' PHE . 23.3 mmm-85 -70.34 -27.37 64.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.32 -172.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.76 -45.63 81.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.937 0.399 . . . . 0.0 110.715 -176.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.441 ' CD2' HG12 ' A' ' 39' ' ' ILE . 68.6 m-85 -103.45 14.19 31.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.129 0.49 . . . . 0.0 110.573 -178.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.559 ' HG2' ' N ' ' A' ' 24' ' ' THR . 16.9 tt0 -72.4 152.26 42.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.803 -176.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.559 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.4 OUTLIER 76.08 133.91 0.04 OUTLIER Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 114.752 -1.113 . . . . 0.0 113.266 163.574 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -83.22 -47.03 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.025 2.483 . . . . 0.0 110.727 171.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -163.84 46.5 0.12 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.455 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.26 59.99 0.92 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.259 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.7 t -106.83 -31.52 8.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.988 0.423 . . . . 0.0 110.608 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.01 -14.91 60.73 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.467 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.551 ' HG3' ' HA ' ' A' ' 68' ' ' ASP . 6.6 mpt_? -109.87 170.7 7.9 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.51 HG22 ' HA ' ' A' ' 23' ' ' GLU . 12.0 p -107.6 129.14 62.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 121.758 0.79 . . . . 0.0 109.918 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.431 ' HB3' ' HG2' ' A' ' 35' ' ' GLN . 15.8 t -59.45 143.67 49.2 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.377 -175.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.592 ' HB ' HG12 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -67.51 -19.45 65.31 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.838 -174.389 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -83.8 -22.26 31.87 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.308 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.431 ' HG2' ' HB3' ' A' ' 32' ' ' SER . 11.9 mm100 -83.24 -20.4 34.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.531 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.601 HG21 HD22 ' A' ' 40' ' ' LEU . 52.9 mt -53.96 -42.58 54.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.261 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.43 ' CA ' HG13 ' A' ' 52' ' ' ILE . . . -61.72 -39.28 97.22 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.157 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.642 ' O ' HG23 ' A' ' 42' ' ' VAL . 39.7 mt -63.36 -50.76 77.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.192 0.52 . . . . 0.0 109.872 178.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.483 HD11 HG23 ' A' ' 31' ' ' VAL . 64.5 mt -61.46 -45.67 98.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.583 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.601 HD22 HG21 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -58.42 -28.69 65.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.009 0.433 . . . . 0.0 110.64 177.066 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.499 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 38.4 tt0 -74.51 -41.38 60.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.428 174.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 38' ' ' ILE . 38.7 t -56.07 -51.7 58.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 121.84 0.829 . . . . 0.0 109.733 175.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.6 mt -74.75 -24.8 58.76 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.34 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.97 42.25 6.04 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.154 173.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 pt -119.06 -83.88 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.415 ' HG2' HD23 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -75.3 179.95 4.84 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.334 0.588 . . . . 0.0 112.26 -175.348 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -103.41 -170.35 1.77 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.862 -173.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.488 ' O ' HG12 ' A' ' 52' ' ' ILE . 15.0 t -60.01 177.27 0.25 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 66.4 mttm -52.32 -38.54 58.81 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.903 0.481 . . . . 0.0 112.108 -172.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.5 m -54.56 -34.04 61.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.102 0.477 . . . . 0.0 111.248 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.8 m -84.46 -31.52 24.52 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.51 0.671 . . . . 0.0 110.266 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.776 ' HA ' HD22 ' A' ' 55' ' ' LEU . 46.9 mm -68.84 -24.19 28.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.559 -177.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 29.4 mmt180 -57.91 -25.73 61.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.822 0.344 . . . . 0.0 110.598 176.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -66.18 -56.38 11.63 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 172.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.776 HD22 ' HA ' ' A' ' 52' ' ' ILE . 2.8 mm? -49.6 -48.4 48.89 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.119 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.592 HG12 ' HB ' ' A' ' 33' ' ' THR . 68.6 mt -63.37 -52.8 53.69 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.891 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -64.53 -23.0 67.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.255 0.55 . . . . 0.0 110.583 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -80.37 -54.35 5.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.697 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.511 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 72.0 m-85 -91.59 -22.38 20.35 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -173.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.427 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 44.6 t0 -125.8 63.62 47.62 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 121.075 0.464 . . . . 0.0 110.092 175.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.511 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 32.1 Cg_exo -61.65 -23.82 76.92 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.09 2.527 . . . . 0.0 112.382 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -76.08 -17.16 59.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.892 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.72 45.21 66.62 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.92 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -73.33 -46.09 51.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.656 0.265 . . . . 0.0 110.414 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.96 -18.82 5.87 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.668 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -147.87 164.36 33.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.703 0.287 . . . . 0.0 110.751 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.525 ' O ' ' HB3' ' A' ' 30' ' ' ARG . 35.1 pt -132.2 145.71 34.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.533 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.551 ' HA ' ' HG3' ' A' ' 30' ' ' ARG . 3.5 p-10 -76.75 171.07 15.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.142 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.557 ' HE1' ' HA ' ' A' ' 16' ' ' GLU . 21.3 t80 -55.21 -42.75 73.74 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.55 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 74' ' ' ILE . 15.3 t70 -59.11 -45.08 91.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.756 0.312 . . . . 0.0 110.829 -174.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.422 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 22.1 m -65.19 -31.83 73.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.629 177.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -80.21 -30.99 38.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.306 0.574 . . . . 0.0 109.77 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -66.39 -39.06 88.82 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.717 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 70' ' ' ASP . 61.7 mt -64.95 -43.5 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.056 0.455 . . . . 0.0 109.822 175.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.564 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 79.3 mt -55.87 -50.9 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.815 173.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.401 ' HA2' ' CD1' ' A' ' 80' ' ' LEU . . . -61.01 -43.33 99.58 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.585 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.763 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . . . -64.92 -30.1 71.08 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.981 0.42 . . . . 0.0 111.452 -174.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.564 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 15.2 ptm180 -87.63 -11.02 49.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.781 -175.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.491 ' CE2' HD13 ' A' ' 55' ' ' LEU . 22.5 m-85 -120.29 -42.83 2.55 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.899 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.733 HD13 HD23 ' A' ' 15' ' ' LEU . 2.5 mp -69.3 -10.56 58.39 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -62.14 98.36 0.19 Allowed Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.498 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.01 -24.02 41.09 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.443 0.64 . . . . 0.0 109.713 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.42 ' C ' HG21 ' A' ' 84' ' ' VAL . 10.4 tp10 -83.51 73.37 10.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.759 -178.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.42 HG21 ' C ' ' A' ' 83' ' ' GLU . 16.7 t -144.34 79.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.544 0.688 . . . . 0.0 111.682 -176.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.539 ' HB3' ' HB3' ' A' ' 88' ' ' GLN . 12.2 t30 -71.23 141.14 85.8 Favored Pre-proline 0 C--N 1.316 -0.881 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 166.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -51.3 -41.24 59.69 Favored 'Trans proline' 0 CA--C 1.52 -0.224 0 C-N-CA 123.164 2.576 . . . . 0.0 112.897 -167.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.434 ' HG2' ' HB2' ' A' ' 92' ' ' GLU . 23.7 mt-10 -125.58 50.82 1.78 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.052 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.539 ' HB3' ' HB3' ' A' ' 85' ' ' ASN . 28.7 pt20 -67.67 -42.26 82.44 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.327 -178.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 14.3 tpt -132.0 39.38 3.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.625 0.726 . . . . 0.0 109.667 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.594 ' HB3' ' HG2' ' A' ' 92' ' ' GLU . 50.9 mt-30 -127.4 133.62 49.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.138 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.542 ' HA ' HD23 ' A' ' 93' ' ' LEU . 44.8 mt-30 -81.63 29.99 0.37 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.383 0.611 . . . . 0.0 110.781 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.594 ' HG2' ' HB3' ' A' ' 90' ' ' GLN . 13.3 mm-40 -66.4 -16.52 64.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.521 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.573 HD12 ' HE1' ' A' ' 149' ' ' PHE . 0.4 OUTLIER -42.34 -41.37 2.81 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 123.721 0.638 . . . . 0.0 110.824 178.415 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.472 ' HA ' ' CE1' ' A' ' 97' ' ' PHE . 36.1 mmt180 -45.72 -42.0 11.3 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 124.038 0.837 . . . . 0.0 111.555 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.623 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 43.2 mt-10 -85.82 -32.71 21.61 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.668 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.606 ' O ' ' HB2' ' A' ' 99' ' ' LEU . . . -84.39 -39.85 18.54 Favored 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.475 -167.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.472 ' CE1' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -77.66 -19.71 54.96 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.895 178.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -76.74 -12.09 59.94 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.55 169.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.623 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 73.4 mt -84.43 -18.09 37.12 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.973 168.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TYR . . . . . 0.59 ' HD1' ' O ' ' A' ' 96' ' ' ALA . 37.1 m-85 -105.29 -2.78 23.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.035 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -72.37 80.87 1.03 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.588 0.709 . . . . 0.0 111.135 -172.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -54.19 -46.32 72.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.937 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -84.07 -28.35 27.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.15 -168.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.08 63.8 1.43 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.404 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -114.7 -17.98 11.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.006 0.431 . . . . 0.0 110.536 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.85 -21.36 36.92 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -168.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.741 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 2.3 m-85 -116.53 164.85 13.96 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 172.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.65 HD12 ' CD2' ' A' ' 149' ' ' PHE . 3.3 pt -103.49 127.6 57.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.986 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.405 ' HA ' HG22 ' A' ' 143' ' ' THR . 45.9 m -66.56 168.82 8.55 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 -177.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.501 ' HB ' ' CG2' ' A' ' 133' ' ' ILE . 72.5 p -61.77 -31.75 71.97 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.544 0.687 . . . . 0.0 110.308 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.16 -34.29 77.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.107 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.601 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.2 p -87.15 -34.82 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.191 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' MET . . . . . 0.722 ' SD ' HG12 ' A' ' 144' ' ' VAL . 2.5 tpt -55.03 -38.81 68.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.036 0.446 . . . . 0.0 110.503 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.701 ' HB2' ' HB3' ' A' ' 129' ' ' LEU . 5.9 ptp180 -66.9 -49.63 64.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.545 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.505 ' HG2' ' HA ' ' A' ' 112' ' ' VAL . 15.3 pt-20 -63.4 -27.54 69.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.745 0.307 . . . . 0.0 111.071 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.501 HG12 ' CD2' ' A' ' 100' ' ' TYR . 19.9 mt -66.26 -48.24 81.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.174 0.511 . . . . 0.0 110.148 173.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.543 HD12 ' HG ' ' A' ' 124' ' ' LEU . 1.2 tm? -61.06 -51.52 68.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.718 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.531 ' HB3' HD11 ' A' ' 129' ' ' LEU . . . -60.13 -22.18 62.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.302 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -68.14 -45.92 72.27 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.5 mp -77.47 -53.62 7.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.353 0.597 . . . . 0.0 109.852 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.596 ' HB3' HD22 ' A' ' 124' ' ' LEU . 18.0 m-20 -96.47 90.12 5.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.931 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -76.89 15.35 0.68 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.06 -173.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 78.8 p -103.83 -13.7 16.31 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.503 0.668 . . . . 0.0 110.35 -177.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.596 HD22 ' HB3' ' A' ' 121' ' ' ASP . 4.1 mm? -75.32 119.18 19.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.64 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 21.9 t -89.94 177.84 6.37 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.1 t -57.1 -45.38 83.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.752 0.31 . . . . 0.0 110.863 -176.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.418 ' HG2' ' N ' ' A' ' 128' ' ' ASP . 3.0 pm0 -66.55 -38.36 86.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.054 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.479 ' HB3' HD13 ' A' ' 124' ' ' LEU . 40.9 m-20 -63.4 -49.74 72.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.157 0.503 . . . . 0.0 110.013 178.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.701 ' HB3' ' HB2' ' A' ' 114' ' ' ARG . 74.4 mt -56.74 -38.23 72.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.544 178.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -62.37 -39.74 94.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.861 0.363 . . . . 0.0 110.273 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.19 -43.35 70.94 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.552 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.4 ' HE1' HD11 ' A' ' 124' ' ' LEU . 27.2 mtt -61.13 -37.33 82.45 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.591 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.501 ' CG2' ' HB ' ' A' ' 110' ' ' THR . 10.1 mm -59.7 -47.32 91.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.078 0.466 . . . . 0.0 110.744 175.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.01 -39.04 68.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.791 0.805 . . . . 0.0 110.457 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.26 -44.99 23.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.407 -1.27 . . . . 0.0 111.831 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.409 HG22 ' HG2' ' A' ' 113' ' ' MET . 60.1 mt -59.76 -57.3 12.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 123.305 0.642 . . . . 0.0 112.21 -177.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.18 94.71 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.784 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.37 -53.92 7.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.421 -175.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -82.25 -12.99 57.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.352 0.596 . . . . 0.0 110.888 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 64.35 38.42 95.81 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.352 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.4 m -66.94 -14.81 63.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.343 0.592 . . . . 0.0 111.133 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.72 -16.81 58.28 Favored Glycine 0 CA--C 1.504 -0.595 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.507 ' HB ' ' HB2' ' A' ' 107' ' ' TYR . 2.3 p -140.99 135.45 31.16 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.491 -0.855 . . . . 0.0 109.27 175.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.722 HG12 ' SD ' ' A' ' 113' ' ' MET . 51.0 t -81.65 124.17 38.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.741 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 14.5 t70 -146.43 -64.21 0.3 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.777 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.534 ' HD2' ' H ' ' A' ' 147' ' ' GLU . 1.2 p90 -94.12 -97.98 0.15 Allowed 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.704 -166.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.534 ' H ' ' HD2' ' A' ' 146' ' ' PHE . 54.1 mt-10 -70.67 -22.05 62.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.002 0.43 . . . . 0.0 110.554 -177.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.422 ' CB ' HG11 ' A' ' 144' ' ' VAL . 5.9 mp0 -65.76 -53.77 36.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.172 0.51 . . . . 0.0 110.182 176.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.65 ' CD2' HD12 ' A' ' 108' ' ' ILE . 24.4 t80 -72.91 -39.2 66.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.379 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' MET . . . . . 0.455 ' HE1' ' HB2' ' A' ' 150' ' ' MET . 16.3 ttm -56.05 -51.69 66.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.191 177.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.68 -41.99 96.05 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.082 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.417 HG12 ' HA ' ' A' ' 149' ' ' PHE . 14.7 p -77.27 -37.3 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 111.927 0.344 . . . . 0.0 111.927 -176.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 50.0 tpp -92.0 -49.72 6.07 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -173.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.4 p -79.92 -15.59 57.01 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.113 -173.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 78.0 -55.7 3.91 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.82 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.36 27.79 11.45 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.357 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -76.47 98.46 4.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.12 0.486 . . . . 0.0 110.618 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 . . . . . 0 C--O 1.248 0.978 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.403 -179.768 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.5 t . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 120.217 0.056 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -54.88 -53.63 52.96 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.694 0.283 . . . . 0.0 110.744 173.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.6 mp -59.09 -44.48 91.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.99 0.424 . . . . 0.0 110.325 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.442 HD21 HD21 ' A' ' 80' ' ' LEU . 82.1 mt -57.63 -57.66 11.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.189 178.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -58.9 -41.34 86.98 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.568 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.0 m -63.88 -41.13 97.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 0.0 111.289 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.463 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -82.11 -27.64 32.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.029 0.443 . . . . 0.0 110.469 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.513 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 71.8 t80 -57.31 -54.59 45.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.398 177.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.52 ' HA ' ' HB2' ' A' ' 23' ' ' GLU . 26.2 mmt180 -71.36 -21.65 62.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.117 -177.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.65 -44.21 74.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.915 -175.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.63 ' CD1' HG12 ' A' ' 39' ' ' ILE . 52.6 m-85 -106.44 17.16 23.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.473 0.654 . . . . 0.0 110.124 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.576 ' HG2' ' N ' ' A' ' 24' ' ' THR . 10.2 tt0 -71.43 152.84 42.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.334 -172.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.576 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.4 OUTLIER 75.05 138.1 0.06 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 158.798 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -88.74 -43.42 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.588 2.858 . . . . 0.0 111.652 172.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -156.02 25.08 0.37 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.671 0.748 . . . . 0.0 109.415 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.59 63.36 0.76 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.592 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.1 t -105.46 -30.1 9.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.921 0.391 . . . . 0.0 110.763 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.58 -11.36 66.71 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.873 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.734 ' HB2' ' OD2' ' A' ' 66' ' ' ASP . 3.3 mpt_? -110.95 172.22 7.0 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.476 HG23 ' HA ' ' A' ' 23' ' ' GLU . 12.8 p -108.03 129.59 61.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-O 121.941 0.877 . . . . 0.0 110.201 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.444 ' HA ' ' HB3' ' A' ' 66' ' ' ASP . 44.3 t -57.25 141.3 47.1 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 113.593 -1.64 . . . . 0.0 111.856 -175.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.544 ' HB ' HG12 ' A' ' 56' ' ' ILE . 28.4 p -67.74 -19.37 65.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.407 -178.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -76.2 -21.78 56.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.317 0.579 . . . . 0.0 109.758 175.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.506 ' HB3' ' HB3' ' A' ' 22' ' ' PHE . 34.1 mm-40 -91.96 -21.65 20.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.939 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.675 HG22 HD22 ' A' ' 40' ' ' LEU . 71.3 mt -54.68 -46.67 73.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.673 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.98 -22.5 68.72 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.261 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.607 ' O ' HG13 ' A' ' 42' ' ' VAL . 25.8 mt -77.86 -54.85 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.737 ' HA ' HG13 ' A' ' 42' ' ' VAL . 36.5 mt -60.92 -37.89 77.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.203 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.675 HD22 HG22 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -60.49 -24.64 65.45 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.09 0.472 . . . . 0.0 110.181 176.191 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.518 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 39.2 tt0 -82.56 -39.73 21.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.819 172.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.737 HG13 ' HA ' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -62.03 -31.45 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 121.771 0.796 . . . . 0.0 110.865 177.73 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.454 HD11 ' HZ ' ' A' ' 72' ' ' PHE . 50.8 mt -92.79 -6.35 49.13 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.958 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.01 39.49 96.46 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.494 -0.775 . . . . 0.0 113.518 176.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pt -113.35 -83.41 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -72.34 179.67 3.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.558 0.694 . . . . 0.0 112.672 -174.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -102.05 -171.0 1.9 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.552 -175.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.44 ' O ' HG12 ' A' ' 52' ' ' ILE . 14.3 t -62.81 -179.46 0.27 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -52.28 -34.57 47.15 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -170.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.1 m -52.19 -40.2 61.18 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.152 0.501 . . . . 0.0 111.049 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 53.4 m -81.75 -34.59 30.36 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.659 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 48' ' ' THR . 42.0 mm -64.67 -27.38 42.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.283 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -57.5 -32.99 67.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.98 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.7 mm-40 -65.66 -49.44 68.6 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.645 HD11 ' CE2' ' A' ' 79' ' ' PHE . 3.0 mm? -53.67 -52.43 59.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.994 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.544 HG12 ' HB ' ' A' ' 33' ' ' THR . 60.2 mt -63.26 -44.84 99.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.409 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -59.59 -30.96 69.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.189 0.519 . . . . 0.0 110.757 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -84.21 -51.71 6.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.208 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.447 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 80.3 m-85 -90.59 -17.18 27.39 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -172.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.45 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 51.6 t0 -129.55 65.88 75.71 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 121.069 0.461 . . . . 0.0 110.88 175.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 22.9 Cg_exo -70.06 -17.25 36.32 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.913 2.409 . . . . 0.0 111.419 175.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -80.09 -17.86 51.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.116 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.97 40.73 73.3 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.778 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -76.0 -41.39 51.33 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.098 0.475 . . . . 0.0 110.423 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 117.83 -33.96 4.69 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.112 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.734 ' OD2' ' HB2' ' A' ' 30' ' ' ARG . 2.3 p-10 -139.47 148.43 42.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.151 0.501 . . . . 0.0 111.004 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.493 ' O ' ' HB3' ' A' ' 30' ' ' ARG . 44.1 pt -114.34 143.66 23.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.036 -174.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.459 ' HA ' ' HG3' ' A' ' 30' ' ' ARG . 1.9 p30 -74.36 174.08 9.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.826 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' A' ' 73' ' ' LYS . 5.0 t80 -63.55 -37.81 88.73 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.119 -175.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.497 ' O ' HG13 ' A' ' 74' ' ' ILE . 38.3 t70 -61.64 -42.68 99.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.925 0.393 . . . . 0.0 110.628 -176.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.7 m -65.53 -42.86 91.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.331 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.454 ' HZ ' HD11 ' A' ' 43' ' ' LEU . 75.8 t80 -69.11 -32.27 71.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.465 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 69' ' ' PHE . 40.8 ttmt -63.29 -44.04 96.18 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.61 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 70' ' ' ASP . 64.7 mt -62.29 -40.75 88.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.127 0.489 . . . . 0.0 110.05 176.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.6 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 78.6 mt -58.22 -51.09 75.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.128 175.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.514 ' CA ' HD23 ' A' ' 80' ' ' LEU . . . -62.52 -41.55 99.78 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.3 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.35 -25.72 67.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.953 0.406 . . . . 0.0 111.591 -174.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 11.8 ptm180 -93.08 -12.67 29.95 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.768 -176.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.645 ' CE2' HD11 ' A' ' 55' ' ' LEU . 23.9 m-85 -120.71 -37.35 3.01 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -174.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.514 HD23 ' CA ' ' A' ' 76' ' ' GLY . 3.2 mm? . . . . . 0 N--CA 1.467 0.425 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -173.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 N--CA 1.465 0.289 0 CA-C-O 121.015 0.436 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.654 ' H ' HD22 ' A' ' 93' ' ' LEU . 1.2 mm? -52.65 -28.11 20.07 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.126 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.649 ' HD3' ' HE2' ' A' ' 97' ' ' PHE . 30.7 mmt180 -57.0 -51.39 69.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.063 0.459 . . . . 0.0 111.361 177.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -77.74 -21.7 51.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.059 0.456 . . . . 0.0 110.327 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.536 ' HB3' ' HA ' ' A' ' 93' ' ' LEU . . . -77.51 -13.73 59.85 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.048 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.649 ' HE2' ' HD3' ' A' ' 94' ' ' ARG . 21.0 m-85 -61.4 -48.23 82.16 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.641 176.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.4 mtm-85 -67.17 -23.73 65.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.205 0.526 . . . . 0.0 110.386 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.9 tp -67.76 -37.31 81.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.753 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.688 ' O ' ' HD2' ' A' ' 102' ' ' LYS . 85.6 m-85 -104.12 -5.7 21.78 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.122 -176.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -78.27 80.32 4.68 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.461 0.648 . . . . 0.0 111.528 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.688 ' HD2' ' O ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -60.71 -39.75 89.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.002 173.27 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -72.27 -37.13 69.12 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.498 -169.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.18 48.46 2.23 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.91 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -113.18 -17.22 12.41 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.973 0.416 . . . . 0.0 110.526 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.12 -24.91 13.69 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -170.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.535 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 4.0 m-85 -109.37 150.9 27.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 173.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.683 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 14.8 pt -91.81 131.17 39.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.748 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.5 m -69.3 170.05 11.04 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.312 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.435 ' HB ' ' CG2' ' A' ' 133' ' ' ILE . 36.8 p -67.59 -23.72 65.42 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 121.846 -0.534 . . . . 0.0 110.724 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 114' ' ' ARG . 29.6 m-20 -62.43 -50.49 71.29 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 176.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.683 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.4 p -71.69 -35.0 54.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.719 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.657 ' SD ' HG11 ' A' ' 144' ' ' VAL . 2.9 tpt -57.37 -40.06 77.34 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 111' ' ' ASP . 76.0 mtt180 -53.04 -56.9 12.6 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.636 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 112' ' ' VAL . 13.3 pt-20 -65.23 -30.4 71.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.433 -175.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 112' ' ' VAL . 57.1 mt -63.43 -47.72 90.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.705 0.288 . . . . 0.0 110.798 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 113' ' ' MET . 9.6 mt -58.49 -55.63 32.55 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.168 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.435 ' HB2' HD11 ' A' ' 129' ' ' LEU . . . -49.19 -37.77 23.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.408 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -65.23 -56.57 12.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.909 0.385 . . . . 0.0 110.751 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -66.76 -44.53 81.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.079 0.466 . . . . 0.0 111.19 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.556 ' HB3' HD23 ' A' ' 124' ' ' LEU . 5.7 m-20 -119.46 88.01 2.85 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.531 -178.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -76.02 23.0 0.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.321 0.581 . . . . 0.0 111.589 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.443 ' H ' ' C ' ' A' ' 121' ' ' ASP . 39.6 p -102.77 -13.46 17.02 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.916 0.865 . . . . 0.0 109.227 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' A' ' 121' ' ' ASP . 4.0 mm? -85.06 115.63 22.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.373 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.458 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 42.7 m -77.08 172.19 13.62 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.9 p -56.75 -43.49 80.79 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.692 0.282 . . . . 0.0 111.581 -174.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -68.8 -40.08 79.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.0 110.751 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.448 ' HB3' ' CD1' ' A' ' 124' ' ' LEU . 5.6 m-20 -59.34 -42.36 91.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.465 176.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.618 ' O ' HG12 ' A' ' 133' ' ' ILE . 95.8 mt -54.63 -43.39 72.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.75 175.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.482 ' O ' ' HB ' ' A' ' 133' ' ' ILE . 31.5 t70 -63.2 -40.25 96.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.268 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.2 -40.58 82.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.164 177.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 9.1 mtt -57.77 -43.51 85.54 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 173.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.618 HG12 ' O ' ' A' ' 129' ' ' LEU . 21.5 mm -51.69 -49.94 33.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.066 176.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -58.98 -43.32 91.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.733 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -72.11 -35.02 69.06 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.567 -176.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.612 HD11 HD21 ' A' ' 117' ' ' LEU . 67.6 mt -65.81 -58.79 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.983 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -68.22 93.78 0.48 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.581 0.705 . . . . 0.0 110.102 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.91 -29.51 50.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.961 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -88.19 -14.4 38.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.274 0.559 . . . . 0.0 110.862 -174.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 69.22 28.29 72.88 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.273 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 6.5 t -80.67 -18.28 48.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.083 0.468 . . . . 0.0 110.15 -175.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.71 -31.31 8.73 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.287 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 21.9 p -114.87 143.14 45.6 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.657 HG11 ' SD ' ' A' ' 113' ' ' MET . 61.0 t -89.04 118.3 34.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.535 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 28.5 t70 -144.17 -73.26 0.27 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.762 -178.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.633 ' O ' ' HG2' ' A' ' 150' ' ' MET . 0.1 OUTLIER -79.28 -97.17 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.122 -166.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -82.95 -11.78 57.87 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 121.583 -0.698 . . . . 0.0 110.94 -173.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.613 ' CD ' ' H ' ' A' ' 148' ' ' GLU . 3.9 mp0 -61.81 -58.42 8.06 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.9 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.629 ' HA ' HG12 ' A' ' 152' ' ' VAL . 10.7 t80 -73.82 -46.73 43.37 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.677 -176.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' MET . . . . . 0.633 ' HG2' ' O ' ' A' ' 146' ' ' PHE . 46.8 mmm -61.12 -18.41 57.84 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.742 0.306 . . . . 0.0 110.964 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -95.97 -20.3 26.41 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.066 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.629 HG12 ' HA ' ' A' ' 149' ' ' PHE . 9.1 p -95.72 -36.31 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 117.314 0.557 . . . . 0.0 111.067 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.468 ' SD ' HG23 ' A' ' 154' ' ' THR . 0.9 OUTLIER -90.74 -47.55 7.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.055 -177.307 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.468 HG23 ' SD ' ' A' ' 153' ' ' MET . 25.6 p . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.039 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.434 ' HA ' HD12 ' A' ' 15' ' ' LEU . 26.8 t . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.707 0.289 . . . . 0.0 111.066 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -62.16 -47.45 84.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.661 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.53 -45.21 92.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.904 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.665 HD21 ' CD1' ' A' ' 80' ' ' LEU . 84.5 mt -56.08 -52.7 63.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.773 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 27.4 tt0 -62.52 -38.86 91.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.773 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 91.0 m -59.03 -52.21 66.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.735 0.302 . . . . 0.0 110.483 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.499 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -69.55 -33.77 73.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.139 0.495 . . . . 0.0 110.366 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.742 ' CE1' HG22 ' A' ' 31' ' ' VAL . 86.1 t80 -53.67 -58.78 5.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.584 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -61.27 -31.62 71.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.799 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -69.09 -43.91 73.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.834 0.35 . . . . 0.0 111.245 -175.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.482 ' CD2' HG12 ' A' ' 39' ' ' ILE . 56.0 m-85 -100.64 8.69 43.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.342 0.592 . . . . 0.0 110.132 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.564 ' HA ' HG13 ' A' ' 31' ' ' VAL . 3.9 tt0 -69.25 154.12 42.55 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.19 -177.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.806 HG23 ' H ' ' A' ' 27' ' ' GLY . 0.6 OUTLIER 79.75 131.78 0.04 OUTLIER Pre-proline 0 N--CA 1.437 -1.118 0 O-C-N 124.301 1.001 . . . . 0.0 112.863 161.582 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.86 -34.7 0.19 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.328 2.686 . . . . 0.0 111.163 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -165.52 32.1 0.05 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.041 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.806 ' H ' HG23 ' A' ' 24' ' ' THR . . . 98.32 66.41 0.88 Allowed Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.831 -175.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.7 t -111.68 -31.09 7.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.814 0.34 . . . . 0.0 111.002 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.02 -14.21 65.71 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.523 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.558 ' HG3' ' HA ' ' A' ' 68' ' ' ASP . 4.8 mpt_? -106.72 172.49 6.79 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.742 HG22 ' CE1' ' A' ' 19' ' ' PHE . 0.1 OUTLIER -105.19 129.93 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.568 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.272 172.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.6 t -54.0 138.88 36.05 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.994 -1.457 . . . . 0.0 108.723 171.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.581 ' HB ' HG12 ' A' ' 56' ' ' ILE . 2.9 p -67.03 -12.86 61.08 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.056 -174.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -72.05 -42.59 66.09 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.663 ' HA ' HD13 ' A' ' 38' ' ' ILE . 33.3 mm-40 -74.03 -16.22 61.06 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.438 -174.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.736 HG22 HD22 ' A' ' 40' ' ' LEU . 47.1 mt -59.01 -34.21 52.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.429 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -74.17 -36.98 49.77 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.328 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.663 HD13 ' HA ' ' A' ' 35' ' ' GLN . 1.3 mp -58.79 -55.28 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-O 121.5 0.666 . . . . 0.0 109.762 174.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.499 HG23 ' HB1' ' A' ' 18' ' ' ALA . 53.7 mt -63.14 -43.54 98.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.451 -176.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.736 HD22 HG22 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -61.91 -27.42 68.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.935 0.398 . . . . 0.0 110.713 177.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.66 -43.61 46.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.175 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 38' ' ' ILE . 64.0 t -54.78 -47.72 73.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.56 176.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.596 HD13 HD23 ' A' ' 15' ' ' LEU . 58.0 mt -86.58 4.3 40.73 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.358 -173.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.24 41.71 99.57 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.19 -0.914 . . . . 0.0 113.71 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -116.12 -77.3 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.591 ' HG2' HD21 ' A' ' 55' ' ' LEU . 2.9 tp60 -81.57 -176.49 6.07 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.418 0.627 . . . . 0.0 112.46 -176.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.418 ' HB2' ' CB ' ' A' ' 51' ' ' THR . 45.2 mt-30 -110.62 -170.38 1.63 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.505 -174.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.465 ' O ' HG12 ' A' ' 52' ' ' ILE . 13.5 t -56.89 176.97 0.09 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.491 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 63.0 mttm -52.24 -35.31 49.4 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.85 0.46 . . . . 0.0 112.155 -173.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.8 m -54.6 -34.31 61.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.251 0.548 . . . . 0.0 111.185 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.418 ' CB ' ' HB2' ' A' ' 47' ' ' GLN . 60.5 m -85.98 -34.23 20.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.483 0.658 . . . . 0.0 110.41 177.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.847 ' HA ' HD23 ' A' ' 55' ' ' LEU . 44.1 mm -63.4 -23.53 33.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.343 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 34.5 mmt180 -50.8 -38.69 49.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.558 173.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.475 ' HA ' ' OD2' ' A' ' 57' ' ' ASP . 7.3 mm-40 -60.54 -43.83 96.77 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.713 0.633 . . . . 0.0 110.653 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.847 HD23 ' HA ' ' A' ' 52' ' ' ILE . 3.1 mm? -62.21 -46.33 89.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.386 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.581 HG12 ' HB ' ' A' ' 33' ' ' THR . 64.1 mt -66.81 -47.66 82.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.304 -176.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.475 ' OD2' ' HA ' ' A' ' 54' ' ' GLN . 1.7 p30 -66.28 -19.75 65.91 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.059 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -85.11 -53.75 5.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.37 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.414 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 89.1 m-85 -95.1 -17.0 22.22 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -171.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.409 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 21.0 t0 -128.22 68.25 76.35 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.09 0.471 . . . . 0.0 111.317 176.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.414 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 24.3 Cg_exo -69.75 -17.83 37.42 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.504 2.136 . . . . 0.0 110.492 171.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -69.88 -17.96 63.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.993 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.32 30.39 77.4 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -81.36 -27.31 34.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.273 -0.464 . . . . 0.0 110.868 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.5 -19.44 39.41 Favored Glycine 0 CA--C 1.509 -0.312 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.122 173.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -145.83 158.02 43.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.89 0.376 . . . . 0.0 110.933 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.457 ' HB ' ' HB2' ' A' ' 71' ' ' SER . 28.8 pt -126.92 142.54 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.556 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.558 ' HA ' ' HG3' ' A' ' 30' ' ' ARG . 0.5 OUTLIER -75.13 175.94 7.76 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.514 -176.877 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -60.66 -39.69 89.31 Favored 'General case' 0 C--O 1.213 -0.829 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.081 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.489 ' O ' HG13 ' A' ' 74' ' ' ILE . 19.7 t70 -60.75 -39.91 90.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.997 0.427 . . . . 0.0 109.964 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.457 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 17.0 m -67.61 -43.62 80.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.749 176.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -69.38 -32.46 71.5 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.259 0.552 . . . . 0.0 110.223 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.435 ' HB3' ' HE2' ' A' ' 73' ' ' LYS . 34.9 ttpt -62.32 -42.4 99.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.099 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 70' ' ' ASP . 67.2 mt -65.41 -40.19 87.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.027 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.578 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 66.8 mt -56.38 -53.03 45.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.249 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.94 -41.05 99.62 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.151 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.04 -26.07 66.57 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 122.578 -0.366 . . . . 0.0 111.44 -174.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 15.8 ptm180 -89.92 -18.56 25.88 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.758 ' HE2' HD11 ' A' ' 55' ' ' LEU . 23.6 m-85 -108.52 -43.85 4.21 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.272 -174.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.665 ' CD1' HD21 ' A' ' 15' ' ' LEU . 2.4 mp . . . . . 0 N--CA 1.448 -0.568 0 CA-C-O 120.459 0.171 . . . . 0.0 110.858 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 . . . . . 0 CA--C 1.521 -0.14 0 CA-C-O 121.216 0.532 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.916 HD22 ' HE1' ' A' ' 149' ' ' PHE . 44.7 mt -42.74 -41.59 3.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.62 -1.173 . . . . 0.0 112.269 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.769 ' HD2' ' HE2' ' A' ' 97' ' ' PHE . 18.5 mmm180 -59.53 -39.96 85.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -176.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -86.07 -18.28 32.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.125 0.488 . . . . 0.0 110.249 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.499 ' HA ' HD12 ' A' ' 99' ' ' LEU . . . -80.25 -19.9 45.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.678 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.769 ' HE2' ' HD2' ' A' ' 94' ' ' ARG . 23.0 m-85 -59.1 -44.45 91.96 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 98' ' ' ARG . 57.8 mtp180 -70.96 -13.06 61.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.822 0.344 . . . . 0.0 111.358 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 96' ' ' ALA . 97.0 mt -86.92 -27.55 23.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.89 0.376 . . . . 0.0 110.772 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.463 ' O ' HG21 ' A' ' 112' ' ' VAL . 76.2 m-85 -103.69 -14.63 16.03 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 97' ' ' PHE . 55.2 t0 -64.57 86.53 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.83 0.824 . . . . 0.0 111.197 -176.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -64.27 -18.33 64.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.655 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -96.18 -36.87 10.79 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.975 0.417 . . . . 0.0 112.119 -171.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.424 ' H ' ' CG ' ' A' ' 101' ' ' ASP . . . 92.08 39.46 5.44 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.491 175.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -114.82 -15.33 11.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.871 0.367 . . . . 0.0 111.807 -176.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.83 -22.31 35.79 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.198 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -100.22 167.55 10.37 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 172.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.61 ' HB ' HG13 ' A' ' 112' ' ' VAL . 8.3 pt -111.03 118.85 58.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.291 166.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.2 m -62.73 166.53 5.37 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.952 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.7 p -57.29 -32.91 67.13 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.9 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.507 ' O ' ' HG3' ' A' ' 115' ' ' GLU . 28.0 m-20 -61.59 -50.19 73.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.046 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.61 HG13 ' HB ' ' A' ' 108' ' ' ILE . 1.8 p -68.65 -37.43 77.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.854 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.691 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 2.8 tpt -56.66 -43.29 80.21 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 174.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.495 ' HA ' HD12 ' A' ' 117' ' ' LEU . 15.9 ttt180 -55.22 -48.52 73.77 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.448 175.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 111' ' ' ASP . 47.3 mt-10 -60.33 -41.73 94.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.684 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 70.6 mt -59.17 -50.34 80.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.03 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.691 ' HG ' ' O ' ' A' ' 113' ' ' MET . 11.0 mt -56.58 -60.18 3.91 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.43 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.01 -22.01 47.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.746 -177.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -82.51 -41.08 20.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.676 0.274 . . . . 0.0 110.876 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.7 mp -79.52 -47.66 15.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.049 0.452 . . . . 0.0 110.762 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.675 ' HB3' HD23 ' A' ' 124' ' ' LEU . 3.1 m-20 -105.84 99.37 8.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.057 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -84.56 4.34 32.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.338 -173.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 71.0 p -90.38 -10.97 41.98 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.376 0.608 . . . . 0.0 110.203 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.784 ' HB3' HD22 ' A' ' 129' ' ' LEU . 3.7 mm? -77.14 146.33 37.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.071 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.473 ' HB2' ' OD1' ' A' ' 128' ' ' ASP . 21.4 m -115.68 171.7 7.58 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.254 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.8 m -47.31 -46.34 25.11 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -173.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -79.32 -32.43 43.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.814 0.34 . . . . 0.0 111.2 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.473 ' OD1' ' HB2' ' A' ' 125' ' ' SER . 2.7 m-20 -64.61 -40.32 95.29 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.784 HD22 ' HB3' ' A' ' 124' ' ' LEU . 2.7 mm? -51.66 -43.24 62.61 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.148 173.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -65.22 -42.48 93.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.612 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.42 -45.52 91.3 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.361 0.6 . . . . 0.0 110.032 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 58.0 mmm -54.9 -53.73 51.7 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.681 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 20.1 mm -55.02 -46.39 77.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.583 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -56.44 -41.2 76.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.774 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -79.49 -31.04 42.21 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.161 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.423 HG12 ' CG2' ' A' ' 152' ' ' VAL . 49.3 mt -67.74 -58.39 6.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.134 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -69.76 93.87 0.77 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.592 0.71 . . . . 0.0 110.288 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.57 -40.26 42.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.807 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -82.85 -13.97 55.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.204 0.526 . . . . 0.0 111.065 -173.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 70.89 24.34 77.16 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.8 t -74.79 -18.26 60.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.387 0.613 . . . . 0.0 109.853 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.56 -26.97 9.25 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 25.3 p -114.59 128.92 56.58 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 175.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.675 HG11 ' SD ' ' A' ' 113' ' ' MET . 64.2 t -83.34 119.33 32.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.266 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.431 ' HB3' ' CD1' ' A' ' 146' ' ' PHE . 8.0 t70 -145.59 -55.58 0.3 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.128 0.489 . . . . 0.0 111.437 -175.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.431 ' CD1' ' HB3' ' A' ' 145' ' ' ASP . 0.4 OUTLIER -105.55 -97.14 0.34 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.815 -168.653 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -38.33 90.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.794 0.331 . . . . 0.0 111.069 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.663 ' CD ' ' H ' ' A' ' 148' ' ' GLU . 3.4 mp0 -50.46 -53.09 32.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.222 177.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.916 ' HE1' HD22 ' A' ' 93' ' ' LEU . 31.8 t80 -76.93 -38.74 52.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.013 -175.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 42.2 tpp -62.68 -43.57 98.46 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.375 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -70.26 -16.11 73.0 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.496 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.423 ' CG2' HG12 ' A' ' 136' ' ' ILE . 12.1 p -101.41 -40.57 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 117.391 0.595 . . . . 0.0 111.805 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.449 ' HG2' HD21 ' A' ' 93' ' ' LEU . 15.4 tpt -81.18 -49.14 11.17 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -172.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 80.5 p . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 121.142 0.496 . . . . 0.0 110.843 -175.674 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.3 t . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.51 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 27.1 tptt -61.14 -41.34 96.55 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-O 120.756 0.312 . . . . 0.0 111.543 176.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 14' ' ' LEU . 4.4 mm? -67.41 -42.58 83.01 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 174.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.749 HD21 HD13 ' A' ' 80' ' ' LEU . 84.3 mt -58.3 -48.96 78.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.869 177.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -57.32 -54.98 40.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.326 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.577 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 27.8 m -59.83 -41.24 90.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.358 -175.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.715 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -74.83 -37.89 62.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.761 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.447 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 54.6 t80 -56.32 -59.19 5.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.979 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.11 -12.61 61.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.047 -174.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 17' ' ' THR . 2.1 t70 -80.29 -40.04 27.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.942 0.401 . . . . 0.0 110.531 -175.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.451 ' CD2' HG12 ' A' ' 39' ' ' ILE . 87.3 m-85 -105.99 6.9 31.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.408 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.45 ' HA ' HG23 ' A' ' 31' ' ' VAL . 3.8 tm-20 -62.82 152.49 35.92 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.262 -176.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.44 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER 86.24 130.86 0.03 OUTLIER Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 114.29 -1.323 . . . . 0.0 113.219 166.388 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -86.71 -40.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.441 2.761 . . . . 0.0 110.797 169.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -159.91 33.69 0.18 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.148 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.417 ' H ' HG23 ' A' ' 24' ' ' THR . . . 94.41 67.59 1.03 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.411 -176.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.5 t -112.22 -24.82 9.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.869 0.366 . . . . 0.0 111.328 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.09 -14.49 61.98 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -175.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.53 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 86.1 mtt180 -112.09 163.08 14.7 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.014 -0.593 . . . . 0.0 110.041 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.522 HG21 HD11 ' A' ' 39' ' ' ILE . 13.7 p -105.99 126.7 61.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 121.501 0.667 . . . . 0.0 110.093 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 8.2 t -53.6 139.51 31.6 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.029 -177.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.562 ' HB ' HG12 ' A' ' 56' ' ' ILE . 1.7 p -63.05 -18.85 63.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.04 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -73.8 -28.71 61.78 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.234 0.54 . . . . 0.0 110.375 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -86.98 -16.88 34.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.532 -177.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.739 HG22 HD22 ' A' ' 40' ' ' LEU . 52.6 mt -55.39 -41.4 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.817 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.432 ' CA ' HG13 ' A' ' 52' ' ' ILE . . . -61.97 -38.73 96.53 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.413 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.639 ' O ' HG23 ' A' ' 42' ' ' VAL . 31.5 mt -63.56 -52.18 61.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.302 0.572 . . . . 0.0 109.595 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.715 HG23 ' HB1' ' A' ' 18' ' ' ALA . 69.6 mt -60.09 -44.49 95.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.52 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.739 HD22 HG22 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -60.63 -25.41 66.27 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.808 178.55 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -80.02 -40.6 27.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.001 174.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 38' ' ' ILE . 43.1 t -53.88 -43.91 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.924 0.868 . . . . 0.0 109.79 174.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.7 mt -86.38 -4.02 59.1 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.939 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.9 39.48 89.48 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-N 115.444 -0.798 . . . . 0.0 113.705 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pt -116.17 -84.8 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.443 ' HG2' HD21 ' A' ' 55' ' ' LEU . 3.1 tp60 -78.25 -171.42 2.38 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.248 0.547 . . . . 0.0 112.41 -177.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -123.33 -170.79 2.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.434 -172.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.1 t -54.94 170.87 0.16 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.835 0.826 . . . . 0.0 112.968 -176.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -51.32 -34.52 33.89 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.344 -1.298 . . . . 0.0 113.204 -167.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 m -58.94 -32.39 69.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.084 0.468 . . . . 0.0 110.845 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -82.42 -32.76 28.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.392 0.615 . . . . 0.0 110.018 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.906 ' HA ' HD23 ' A' ' 55' ' ' LEU . 44.4 mm -68.7 -23.62 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.221 -177.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -50.17 -30.98 12.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.42 173.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -65.92 -55.19 18.18 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.306 0.574 . . . . 0.0 109.834 174.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.906 HD23 ' HA ' ' A' ' 52' ' ' ILE . 2.5 mm? -52.76 -50.06 64.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.435 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.562 HG12 ' HB ' ' A' ' 33' ' ' THR . 61.0 mt -63.52 -46.89 93.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.926 -177.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -61.39 -24.68 66.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.508 0.671 . . . . 0.0 110.727 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.477 ' CD ' HH12 ' A' ' 78' ' ' ARG . 29.6 tt0 -87.98 -51.28 5.91 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.226 -177.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.498 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 90.1 m-85 -94.53 -17.1 22.72 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -173.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.463 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 46.5 t0 -129.99 62.67 65.23 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-O 121.171 0.51 . . . . 0.0 110.181 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.498 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 31.3 Cg_exo -63.11 -24.86 73.14 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.032 2.488 . . . . 0.0 112.159 -178.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -76.68 -17.29 59.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.569 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.28 41.32 59.56 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.688 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -67.71 -39.89 84.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.673 0.273 . . . . 0.0 110.751 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.18 -22.31 9.04 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.672 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 1.6 m-20 -139.79 178.49 7.21 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 27.2 pt -142.12 143.73 26.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.886 0.374 . . . . 0.0 110.331 177.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.53 ' HA ' ' HG2' ' A' ' 30' ' ' ARG . 25.6 t70 -83.39 166.9 18.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.807 176.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.481 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -56.09 -27.35 53.36 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 176.891 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -49.35 -51.44 34.54 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.87 0.367 . . . . 0.0 111.256 174.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 23.2 m -82.41 -36.88 26.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.924 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.481 ' HB3' ' HA ' ' A' ' 69' ' ' PHE . 89.8 t80 -64.83 -36.28 83.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.123 -178.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -62.32 -38.6 90.04 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.219 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.427 ' HB ' ' CE1' ' A' ' 59' ' ' PHE . 40.7 mt -69.48 -40.1 79.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.84 0.352 . . . . 0.0 110.105 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.605 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 78.1 mt -57.3 -48.48 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-O 121.41 0.624 . . . . 0.0 109.717 173.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.503 ' HA2' ' CD1' ' A' ' 80' ' ' LEU . . . -62.48 -45.19 96.39 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.065 177.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.97 -20.39 65.04 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -174.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 9.9 ptm180 -91.28 -16.7 27.13 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.527 -177.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.493 ' CE2' HD11 ' A' ' 55' ' ' LEU . 21.1 m-85 -118.34 -46.49 2.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.754 0.311 . . . . 0.0 110.921 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.749 HD13 HD21 ' A' ' 15' ' ' LEU . 3.2 mp . . . . . 0 CA--C 1.514 -0.426 0 CA-C-O 121.329 0.585 . . . . 0.0 111.199 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 CA--C 1.52 -0.193 0 CA-C-O 121.056 0.455 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.647 ' H ' HD22 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -54.27 -26.93 31.77 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.302 -179.7 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.733 ' HD2' ' HE2' ' A' ' 97' ' ' PHE . 28.9 mmm180 -59.74 -35.63 74.95 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 120.807 0.337 . . . . 0.0 111.583 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -86.53 -26.93 24.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.253 0.549 . . . . 0.0 109.899 176.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.485 ' HB3' ' HA ' ' A' ' 93' ' ' LEU . . . -72.73 -11.05 60.47 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.937 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.733 ' HE2' ' HD2' ' A' ' 94' ' ' ARG . 21.3 m-85 -61.72 -52.22 65.15 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.727 -0.389 . . . . 0.0 109.963 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 98' ' ' ARG . 42.2 mtm180 -65.66 -17.96 64.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.212 0.529 . . . . 0.0 110.88 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 99' ' ' LEU . 12.4 tp -73.6 -38.63 65.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.826 177.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.667 ' O ' ' HD2' ' A' ' 102' ' ' LYS . 77.2 m-85 -100.16 -24.55 14.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.906 -176.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -69.3 82.68 0.37 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.413 0.625 . . . . 0.0 111.223 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.667 ' HD2' ' O ' ' A' ' 100' ' ' TYR . 9.8 mptt -56.53 -45.78 80.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.913 173.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -66.65 -37.23 84.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.432 -168.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.53 47.41 2.55 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.419 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -100.1 -17.46 17.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.692 0.282 . . . . 0.0 110.68 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.9 -24.99 15.16 Favored Glycine 0 N--CA 1.453 -0.188 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -172.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -113.53 162.38 16.24 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 171.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.678 ' HB ' HG13 ' A' ' 112' ' ' VAL . 10.2 pt -97.22 128.16 48.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.298 173.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.466 ' HA ' HG22 ' A' ' 143' ' ' THR . 49.1 m -69.45 166.97 17.64 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.317 -177.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.2 p -62.95 -24.88 68.09 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.992 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -64.78 -51.8 60.33 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.258 176.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.678 HG13 ' HB ' ' A' ' 108' ' ' ILE . 2.0 p -68.72 -35.06 68.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.727 0.299 . . . . 0.0 110.36 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.591 ' SD ' HG11 ' A' ' 144' ' ' VAL . 2.8 tpt -58.3 -40.18 81.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.099 0.476 . . . . 0.0 109.8 173.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.531 ' HG2' ' CD2' ' A' ' 129' ' ' LEU . 17.7 ttp180 -58.88 -46.03 88.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.162 176.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.471 ' OE1' ' HA ' ' A' ' 112' ' ' VAL . 34.6 mt-10 -60.68 -50.47 73.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.58 177.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 112' ' ' VAL . 63.6 mt -56.25 -53.6 37.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.43 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.599 HD11 ' SD ' ' A' ' 132' ' ' MET . 1.0 OUTLIER -57.33 -53.31 59.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.005 -178.316 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.523 ' HB2' HD22 ' A' ' 129' ' ' LEU . . . -64.33 -17.54 63.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.03 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -83.8 -53.26 5.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.682 0.277 . . . . 0.0 110.319 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.58 -44.04 79.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.991 0.424 . . . . 0.0 110.313 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.67 ' HB3' HD23 ' A' ' 124' ' ' LEU . 6.2 m-20 -112.19 84.85 2.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.254 0.549 . . . . 0.0 109.969 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -79.79 12.63 2.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.626 0.727 . . . . 0.0 110.908 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 69.8 p -95.44 -5.56 42.82 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.194 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.67 HD23 ' HB3' ' A' ' 121' ' ' ASP . 4.2 mm? -78.82 149.42 32.57 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.315 174.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.423 ' H ' ' HB2' ' A' ' 128' ' ' ASP . 24.0 m -116.93 170.18 8.82 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.6 p -48.1 -48.43 33.75 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -73.45 -40.05 64.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.727 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 125' ' ' SER . 14.4 m-20 -67.41 -43.42 81.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.649 0.738 . . . . 0.0 110.077 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.531 ' CD2' ' HG2' ' A' ' 114' ' ' ARG . 45.2 tp -63.33 -38.4 91.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.925 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.28 -41.46 99.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.897 0.379 . . . . 0.0 110.223 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.86 -45.69 92.66 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.331 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.599 ' SD ' HD11 ' A' ' 117' ' ' LEU . 33.5 mtt -60.38 -42.98 97.0 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.385 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.515 HD11 ' HA ' ' A' ' 114' ' ' ARG . 21.2 mm -54.44 -50.21 59.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.081 0.467 . . . . 0.0 110.647 174.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.15 -44.7 75.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.788 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -80.78 -26.42 37.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.83 -175.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.494 HG12 ' CG2' ' A' ' 152' ' ' VAL . 51.9 mt -64.38 -54.81 26.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.73 0.3 . . . . 0.0 110.589 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -76.63 85.12 3.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.966 0.888 . . . . 0.0 109.554 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.58 -35.0 53.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.465 -1.243 . . . . 0.0 112.319 -173.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -91.58 -10.59 40.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.042 0.449 . . . . 0.0 110.851 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.58 38.7 13.62 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.197 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.49 -18.75 56.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.263 0.554 . . . . 0.0 110.495 -177.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.29 -40.9 3.08 Favored Glycine 0 C--O 1.23 -0.106 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.216 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.466 HG22 ' HA ' ' A' ' 109' ' ' SER . 13.0 p -114.77 137.68 51.65 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 173.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.623 HG13 ' HB2' ' A' ' 148' ' ' GLU . 57.8 t -82.06 124.98 39.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 O-C-N 123.611 0.57 . . . . 0.0 109.8 -176.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -145.53 -78.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.222 0.534 . . . . 0.0 112.206 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -76.74 -86.31 0.05 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -168.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -94.35 -14.39 25.4 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.983 -172.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.623 ' HB2' HG13 ' A' ' 144' ' ' VAL . 3.0 mp0 -64.24 -50.05 69.49 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.108 0.48 . . . . 0.0 109.945 174.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.564 ' HA ' HG12 ' A' ' 152' ' ' VAL . 19.1 t80 -75.43 -42.62 53.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.584 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' MET . . . . . 0.476 ' CE ' HD23 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -55.85 -46.17 78.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.935 0.398 . . . . 0.0 110.121 178.007 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -69.64 -28.46 72.18 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.965 -0.561 . . . . 0.0 113.506 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.564 HG12 ' HA ' ' A' ' 149' ' ' PHE . 14.6 p -87.62 -37.18 10.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 117.359 0.58 . . . . 0.0 111.495 -176.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -86.64 -53.92 4.68 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.006 -174.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 50.1 p . . . . . 0 C--N 1.327 -0.37 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.148 -179.002 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.674 ' HA ' HD22 ' A' ' 15' ' ' LEU . 39.6 t . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 120.902 0.382 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 37.8 tptt -55.5 -52.34 63.99 Favored 'General case' 0 N--CA 1.425 -1.702 0 C-N-CA 123.106 0.562 . . . . 0.0 111.347 174.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 14' ' ' LEU . 3.7 mm? -63.53 -37.66 88.15 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.674 HD22 ' HA ' ' A' ' 12' ' ' VAL . 3.0 mp -52.99 -59.36 4.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.487 173.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -58.38 -39.0 78.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.085 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.2 m -60.05 -46.08 90.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.941 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.557 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -80.05 -29.63 39.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.553 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.537 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 57.7 t80 -56.91 -56.01 27.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.192 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.423 ' HA ' ' HB2' ' A' ' 23' ' ' GLU . 23.2 mmt180 -71.7 -20.04 61.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.572 -175.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -72.33 -35.12 68.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.862 0.363 . . . . 0.0 110.864 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.502 ' CD2' HG12 ' A' ' 39' ' ' ILE . 71.9 m-85 -115.5 16.88 16.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.26 0.552 . . . . 0.0 110.574 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.548 ' HA ' HG23 ' A' ' 31' ' ' VAL . 2.9 tt0 -76.45 152.21 36.24 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.459 -172.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.522 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER 78.8 133.64 0.04 OUTLIER Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.642 159.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -87.07 -53.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.347 2.698 . . . . 0.0 111.127 172.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 15.6 tt0 -129.4 3.43 5.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.653 0.739 . . . . 0.0 109.592 176.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.79 67.73 0.51 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -169.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -109.15 -6.78 15.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.609 0.243 . . . . 0.0 111.028 -172.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.6 0.08 52.5 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.09 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.461 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 93.7 mtt180 -124.59 164.12 20.49 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.588 HG21 HD11 ' A' ' 39' ' ' ILE . 11.3 p -104.94 131.34 54.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.536 0.684 . . . . 0.0 109.495 177.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.0 t -59.39 140.17 56.38 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.851 -175.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.554 ' HA ' HG13 ' A' ' 36' ' ' ILE . 3.5 p -62.7 -19.87 64.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.024 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -75.94 -18.37 59.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.456 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.5 ' OE1' HD12 ' A' ' 38' ' ' ILE . 78.3 mm-40 -96.54 -15.8 21.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.585 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.755 HG22 HD22 ' A' ' 40' ' ' LEU . 55.8 mt -57.02 -41.87 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.61 -175.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.433 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -64.27 -38.38 95.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.022 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.627 ' O ' HG23 ' A' ' 42' ' ' VAL . 15.9 mt -61.47 -52.09 65.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.204 0.526 . . . . 0.0 109.648 176.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.588 HD11 HG21 ' A' ' 31' ' ' VAL . 66.8 mt -59.79 -42.62 89.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.5 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.755 HD22 HG22 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -65.5 -22.1 66.7 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.053 0.454 . . . . 0.0 110.763 -179.805 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 15.4 tp10 -78.49 -42.85 28.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.347 172.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 38' ' ' ILE . 47.0 t -53.08 -46.01 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.865 0.84 . . . . 0.0 110.161 175.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.5 mt -85.61 -6.51 59.15 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.637 -174.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.52 43.27 87.01 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.598 174.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.508 HD13 HD22 ' A' ' 80' ' ' LEU . 1.9 pt -119.6 -73.28 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -176.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.404 ' H ' HG13 ' A' ' 45' ' ' ILE . 2.5 tp60 -87.76 -175.05 5.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -173.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -107.08 -170.52 1.72 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.866 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.521 ' O ' HG12 ' A' ' 52' ' ' ILE . 14.8 t -60.47 177.45 0.28 Allowed 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -176.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.416 ' HA ' ' HB ' ' A' ' 52' ' ' ILE . 37.2 mtmm -55.11 -34.57 63.8 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -172.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.7 m -53.96 -37.78 64.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.871 0.367 . . . . 0.0 110.862 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.1 m -82.0 -34.18 29.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.374 176.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.54 ' HA ' HD23 ' A' ' 55' ' ' LEU . 49.3 mm -65.79 -24.31 34.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.873 -176.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.526 ' HA ' HD12 ' A' ' 56' ' ' ILE . 12.2 tpp180 -62.12 -28.51 69.68 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 177.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -68.0 -44.9 75.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.389 0.614 . . . . 0.0 109.685 173.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.616 HD11 ' CE2' ' A' ' 79' ' ' PHE . 3.1 mm? -54.66 -47.31 73.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.528 174.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.54 HG12 ' HB ' ' A' ' 33' ' ' THR . 61.7 mt -62.2 -47.58 92.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.828 177.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -55.71 -32.56 63.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.149 0.5 . . . . 0.0 110.819 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -76.36 -54.33 6.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.832 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.525 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 98.4 m-85 -100.64 -11.4 20.04 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -169.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.425 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 48.2 t0 -125.54 66.81 56.23 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-O 121.335 0.588 . . . . 0.0 110.612 176.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.525 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 27.2 Cg_exo -67.9 -23.9 40.51 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.83 2.354 . . . . 0.0 111.755 177.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -78.74 -19.59 51.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.174 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.56 38.62 51.3 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -71.56 -33.94 69.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 122.469 0.308 . . . . 0.0 110.945 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.85 -21.02 39.57 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.003 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -139.85 167.11 22.87 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.1 pt -129.27 143.87 39.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.02 0.438 . . . . 0.0 110.108 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.461 ' HA ' ' HG2' ' A' ' 30' ' ' ARG . 18.1 t70 -78.1 165.94 23.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.522 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -58.64 -33.26 69.87 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 118.521 0.6 . . . . 0.0 109.759 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.483 ' O ' HG13 ' A' ' 74' ' ' ILE . 29.0 t70 -52.79 -43.5 65.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.728 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.515 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 28.6 m -79.08 -40.49 31.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.199 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -69.67 -32.33 70.9 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.947 0.403 . . . . 0.0 110.654 -177.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -62.35 -39.62 93.72 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.676 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 70' ' ' ASP . 44.3 mt -65.69 -38.7 82.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-O 121.132 0.491 . . . . 0.0 109.86 176.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.524 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 58.6 mt -57.11 -56.12 16.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.391 175.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.701 ' HA2' HD23 ' A' ' 80' ' ' LEU . . . -62.48 -35.19 91.39 Favored Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.016 177.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.61 -25.89 64.17 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 122.608 -0.349 . . . . 0.0 111.385 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 15.0 ptm180 -91.93 -14.42 29.6 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.78 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.616 ' CE2' HD11 ' A' ' 55' ' ' LEU . 22.9 m-85 -117.76 -44.1 2.75 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.991 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.701 HD23 ' HA2' ' A' ' 76' ' ' GLY . 4.2 mm? . . . . . 0 N--CA 1.467 0.409 0 CA-C-O 121.01 0.433 . . . . 0.0 111.207 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 . . . . . 0 C--O 1.23 0.031 0 CA-C-O 120.69 0.281 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.706 ' H ' HD22 ' A' ' 93' ' ' LEU . 0.5 OUTLIER -52.81 -36.44 58.44 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.655 -178.551 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.836 ' HD2' ' HE2' ' A' ' 97' ' ' PHE . 25.7 mmm180 -62.69 -32.55 73.65 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.874 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -86.09 -32.45 21.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.063 0.458 . . . . 0.0 109.912 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.784 ' HA ' HD23 ' A' ' 99' ' ' LEU . . . -66.59 -18.44 65.37 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.692 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.836 ' HE2' ' HD2' ' A' ' 94' ' ' ARG . 21.5 m-85 -58.55 -46.06 87.63 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.05 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 98' ' ' ARG . 33.7 mtp180 -70.85 -14.34 62.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.857 0.361 . . . . 0.0 110.908 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.784 HD23 ' HA ' ' A' ' 96' ' ' ALA . 0.5 OUTLIER -81.21 -37.21 29.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.806 176.249 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -95.82 -28.82 14.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.608 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.89 78.53 1.63 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.121 0.962 . . . . 0.0 110.929 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -76.97 -6.5 52.83 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.304 171.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -83.89 -37.37 22.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.983 -175.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.65 46.6 1.38 Allowed Glycine 0 C--O 1.228 -0.26 0 C-N-CA 121.098 -0.573 . . . . 0.0 113.259 171.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.417 ' C ' ' H ' ' A' ' 107' ' ' TYR . 12.4 m120 -113.92 -17.92 11.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.777 0.323 . . . . 0.0 110.66 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.5 -20.78 12.65 Favored Glycine 0 C--O 1.228 -0.233 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -170.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.793 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 4.4 m-85 -116.71 147.54 41.9 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.688 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 9.3 pt -92.56 131.13 40.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.266 176.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.0 m -71.44 171.01 12.04 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.296 -176.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.517 ' HB ' HG23 ' A' ' 133' ' ' ILE . 16.4 p -61.78 -28.14 69.24 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.0 0.429 . . . . 0.0 110.721 178.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -60.36 -57.22 13.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.069 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.688 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.2 p -63.94 -35.45 73.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.815 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.61 ' SD ' HG11 ' A' ' 144' ' ' VAL . 0.7 OUTLIER -59.39 -40.08 85.44 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.754 176.639 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 114' ' ' ARG . 19.6 ttt180 -51.98 -50.93 60.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.812 176.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.22 -42.94 96.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.094 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.2 mt -57.1 -48.99 80.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 121.071 0.462 . . . . 0.0 110.24 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.503 HD11 ' SD ' ' A' ' 132' ' ' MET . 0.8 OUTLIER -57.29 -54.17 49.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.438 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.57 -15.86 63.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.853 -176.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -78.63 -29.43 45.85 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.8 mp -80.63 -61.63 1.91 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.615 173.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.582 ' CG ' HD23 ' A' ' 124' ' ' LEU . 9.4 t70 -92.01 139.46 30.62 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.054 0.454 . . . . 0.0 110.498 -176.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -108.68 -2.54 18.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.683 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.4 p -104.08 -22.69 13.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.359 0.599 . . . . 0.0 109.516 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.582 HD23 ' CG ' ' A' ' 121' ' ' ASP . 4.1 mm? -62.81 100.86 0.22 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.609 169.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.424 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 15.5 t -71.69 171.89 10.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.56 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.8 p -53.51 -44.3 69.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.978 0.418 . . . . 0.0 110.884 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -66.3 -41.1 90.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.935 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.527 ' HB3' HD13 ' A' ' 124' ' ' LEU . 6.1 m-20 -66.29 -43.33 86.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.654 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.546 ' O ' HG12 ' A' ' 133' ' ' ILE . 95.7 mt -51.36 -44.4 62.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.961 172.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.414 ' O ' ' HB ' ' A' ' 133' ' ' ILE . 11.9 t70 -61.64 -41.26 97.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.892 0.377 . . . . 0.0 110.44 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.01 -37.04 78.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.382 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.503 ' SD ' HD11 ' A' ' 117' ' ' LEU . 7.1 mtt -65.82 -32.15 73.51 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.665 175.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 129' ' ' LEU . 19.4 mm -59.13 -45.87 92.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.954 0.407 . . . . 0.0 110.306 175.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -64.73 -35.53 81.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.891 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -72.23 -42.86 65.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.987 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.412 HG12 ' CG2' ' A' ' 152' ' ' VAL . 62.7 mt -65.36 -56.57 14.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.01 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.515 ' HA ' ' CG ' ' A' ' 148' ' ' GLU . 46.8 t0 -80.64 82.97 6.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 122.005 0.907 . . . . 0.0 109.374 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.27 -35.9 76.54 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.967 -1.469 . . . . 0.0 112.336 -173.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -87.07 -13.56 43.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.246 0.546 . . . . 0.0 110.99 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 72.07 42.83 50.4 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.0 t -83.14 -17.83 41.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.394 0.616 . . . . 0.0 109.966 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.15 -33.42 4.72 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.366 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 39.5 p -114.23 141.88 46.99 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.001 0.429 . . . . 0.0 110.096 176.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.61 HG11 ' SD ' ' A' ' 113' ' ' MET . 46.6 t -99.26 109.22 23.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.793 ' HB3' ' HB3' ' A' ' 107' ' ' TYR . 4.8 p-10 -153.91 -42.98 0.09 Allowed 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.404 -171.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.603 ' HD2' ' HG2' ' A' ' 147' ' ' GLU . 2.9 p90 -96.63 -93.07 0.22 Allowed 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.202 -0.999 . . . . 0.0 112.205 -176.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.603 ' HG2' ' HD2' ' A' ' 146' ' ' PHE . 22.0 mm-40 -81.19 -28.89 34.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.362 0.601 . . . . 0.0 109.947 -175.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.515 ' CG ' ' HA ' ' A' ' 137' ' ' ASP . 25.9 mp0 -60.14 -51.82 67.96 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.939 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.621 ' HA ' HG12 ' A' ' 152' ' ' VAL . 16.0 t80 -72.15 -38.12 69.25 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.07 -47.64 71.46 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.599 176.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -76.1 -22.07 74.65 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.893 -175.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 149' ' ' PHE . 11.7 p -92.13 -37.34 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 117.545 0.672 . . . . 0.0 111.327 -176.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.505 ' HA ' ' CE ' ' A' ' 153' ' ' MET . 2.4 tpt -89.53 -56.81 3.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.827 0.346 . . . . 0.0 110.672 -176.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.8 p . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 121.31 0.576 . . . . 0.0 110.354 -179.708 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.3 t . . . . . 0 C--O 1.215 -0.754 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -67.57 -37.75 83.08 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 14' ' ' LEU . 4.4 mm? -62.56 -44.27 96.74 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 172.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.43 ' HB3' ' HE2' ' A' ' 72' ' ' PHE . 85.5 mt -59.99 -45.63 92.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.671 175.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -64.94 -46.28 82.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.632 -175.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.9 m -61.31 -34.98 76.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.079 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.591 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -81.1 -38.5 27.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.331 177.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.553 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 51.7 t80 -54.8 -55.03 34.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.72 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -67.39 -21.89 65.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.131 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -77.31 -36.4 54.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.856 0.36 . . . . 0.0 111.098 -174.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.459 ' CD2' HG12 ' A' ' 39' ' ' ILE . 65.9 m-85 -110.74 16.2 21.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.283 0.563 . . . . 0.0 110.423 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.607 ' HG2' ' N ' ' A' ' 24' ' ' THR . 4.3 tt0 -78.67 156.44 29.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.22 -172.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.607 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER 80.25 127.15 0.03 OUTLIER Pre-proline 0 N--CA 1.444 -0.762 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.334 160.826 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 24' ' ' THR . 66.4 Cg_endo -90.12 -45.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.79 2.993 . . . . 0.0 111.947 173.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -142.77 24.69 1.85 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.38 62.84 1.14 Allowed Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -174.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.0 t -100.35 -28.04 13.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.927 0.394 . . . . 0.0 111.109 -172.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.19 -16.16 56.45 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -172.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.473 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 92.8 mtt180 -103.43 164.23 11.78 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.896 -0.652 . . . . 0.0 109.874 175.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.589 HG23 ' HA ' ' A' ' 23' ' ' GLU . 13.6 p -108.05 131.77 57.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.384 0.612 . . . . 0.0 109.639 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.1 t -62.69 144.39 56.39 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.372 -175.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.567 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . 2.8 p -66.52 -18.35 65.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.851 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -70.73 -36.11 73.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.307 0.575 . . . . 0.0 109.934 176.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -89.23 -14.48 35.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.533 -175.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.658 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 71.3 mt -53.35 -47.75 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.764 0.316 . . . . 0.0 110.644 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.442 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -58.54 -38.49 91.33 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.756 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.667 ' O ' HG23 ' A' ' 42' ' ' VAL . 36.8 mt -61.25 -49.46 84.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.25 0.547 . . . . 0.0 109.604 176.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.591 HG23 ' HB1' ' A' ' 18' ' ' ALA . 65.5 mt -60.43 -45.41 96.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.578 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.784 HD12 HD12 ' A' ' 52' ' ' ILE . 46.2 mt -61.7 -25.09 67.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.364 0.602 . . . . 0.0 110.761 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.518 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 8.6 tp10 -76.49 -42.22 44.28 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.719 173.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 38' ' ' ILE . 39.4 t -54.22 -42.71 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.888 0.851 . . . . 0.0 109.878 174.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 29.1 mt -83.49 -11.46 57.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.153 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.57 32.22 67.69 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.578 -0.737 . . . . 0.0 113.362 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 pt -109.74 -61.36 2.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -177.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -95.7 -177.75 4.16 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -174.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.404 ' HB2' ' CB ' ' A' ' 51' ' ' THR . 12.5 mm100 -104.74 -170.61 1.79 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.004 -172.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.557 ' O ' HG12 ' A' ' 52' ' ' ILE . 15.2 t -62.04 179.06 0.31 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -57.74 -29.8 65.05 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -172.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.0 m -52.39 -45.55 65.88 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.297 0.57 . . . . 0.0 110.691 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.404 ' CB ' ' HB2' ' A' ' 47' ' ' GLN . 91.6 m -77.43 -34.3 54.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.474 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.784 HD12 HD12 ' A' ' 40' ' ' LEU . 42.1 mm -64.84 -24.49 35.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.31 -178.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -51.52 -38.09 52.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 172.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -75.16 -38.16 61.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.265 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.512 HD11 ' CE2' ' A' ' 79' ' ' PHE . 2.2 mm? -56.01 -48.42 75.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.226 174.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.545 HG12 ' HB ' ' A' ' 33' ' ' THR . 59.8 mt -62.96 -45.84 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.917 176.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -56.77 -29.81 62.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.273 0.559 . . . . 0.0 110.718 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -77.04 -54.51 6.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.55 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -101.24 -13.47 18.08 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -170.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.452 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 48.1 t0 -134.18 64.67 66.49 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.172 0.511 . . . . 0.0 111.194 176.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 24.6 Cg_exo -69.0 -18.42 40.6 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.769 2.313 . . . . 0.0 111.493 175.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -78.88 -17.51 55.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.244 -176.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.74 40.08 46.45 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.215 -177.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.412 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 1.2 t-20 -66.18 -43.97 85.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.917 0.487 . . . . 0.0 110.687 -176.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.91 -22.28 14.67 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.623 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -149.39 171.44 16.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.945 0.402 . . . . 0.0 110.377 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.405 ' C ' ' HD3' ' A' ' 30' ' ' ARG . 30.0 pt -135.27 145.42 31.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.56 ' HB3' ' HB3' ' A' ' 70' ' ' ASP . 15.2 t70 -83.01 171.55 13.69 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.487 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -62.18 -22.67 66.09 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 173.547 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.56 ' HB3' ' HB3' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -45.41 -53.23 8.97 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.597 170.617 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.7 m -87.38 -33.77 19.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.968 0.413 . . . . 0.0 111.249 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.487 ' HB3' ' HA ' ' A' ' 69' ' ' PHE . 73.4 t80 -65.29 -33.14 75.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.365 -176.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -65.28 -37.26 86.62 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.073 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.2 mt -68.1 -37.56 78.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.975 0.417 . . . . 0.0 109.928 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.56 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 61.2 mt -58.15 -53.62 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.004 174.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.516 ' CA ' HD23 ' A' ' 80' ' ' LEU . . . -60.96 -39.64 97.3 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.207 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.92 -28.83 69.8 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.906 0.384 . . . . 0.0 111.68 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 16.3 ptm180 -90.68 -13.04 34.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.009 -175.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.512 ' CE2' HD11 ' A' ' 55' ' ' LEU . 23.8 m-85 -119.35 -37.01 3.24 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.131 -0.627 . . . . 0.0 112.547 -175.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.516 HD23 ' CA ' ' A' ' 76' ' ' GLY . 4.1 mm? . . . . . 0 N--CA 1.466 0.327 0 O-C-N 123.218 0.324 . . . . 0.0 111.101 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 . . . . . 0 N--CA 1.464 0.225 0 CA-C-O 121.585 0.707 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.743 HD23 ' HE1' ' A' ' 150' ' ' MET . 0.9 OUTLIER -58.58 -34.4 71.03 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.985 -177.145 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.733 ' HA ' ' CE2' ' A' ' 97' ' ' PHE . 52.7 mmm-85 -62.72 -36.9 84.47 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.084 -177.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -84.55 -15.12 46.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.094 0.473 . . . . 0.0 110.86 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.479 ' HA ' HD12 ' A' ' 99' ' ' LEU . . . -82.55 -14.04 55.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.008 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.733 ' CE2' ' HA ' ' A' ' 94' ' ' ARG . 20.9 m-85 -62.46 -46.24 89.41 Favored 'General case' 0 C--O 1.215 -0.711 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 176.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -66.83 -12.41 58.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.82 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 96' ' ' ALA . 96.3 mt -83.66 -43.78 15.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.954 175.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -93.12 -24.01 18.42 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.417 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -71.89 80.19 0.9 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.922 0.868 . . . . 0.0 110.1 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -74.67 -16.93 60.75 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.476 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.486 ' HB2' ' ND2' ' A' ' 105' ' ' ASN . 22.7 mt-10 -83.61 -37.59 22.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.964 -173.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.25 34.83 3.29 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.763 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.486 ' ND2' ' HB2' ' A' ' 103' ' ' GLU . 21.1 m-80 -88.91 -18.74 26.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.895 0.378 . . . . 0.0 110.523 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.4 -25.79 4.83 Favored Glycine 0 N--CA 1.454 -0.147 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -171.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.488 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 1.7 m-85 -111.33 173.45 6.34 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 171.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.631 ' HB ' HG13 ' A' ' 112' ' ' VAL . 11.8 pt -109.39 126.64 66.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 119.364 -0.935 . . . . 0.0 109.611 171.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.438 ' HA ' HG22 ' A' ' 143' ' ' THR . 33.1 m -64.44 165.01 10.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.684 -177.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.1 p -59.65 -31.98 70.03 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.779 -0.576 . . . . 0.0 110.206 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -58.23 -51.62 69.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.699 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.631 HG13 ' HB ' ' A' ' 108' ' ' ILE . 2.3 p -69.73 -36.02 68.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.531 ' SD ' HG11 ' A' ' 144' ' ' VAL . 1.3 tpt -58.27 -45.1 88.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.049 0.452 . . . . 0.0 110.243 176.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.576 ' HG2' HD13 ' A' ' 129' ' ' LEU . 33.2 ttp180 -51.56 -50.79 59.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.975 175.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -65.18 -39.37 92.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.084 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 112' ' ' VAL . 43.6 mt -58.99 -46.32 91.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 111.173 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.477 HD12 ' HG ' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -63.65 -54.0 42.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.162 0.506 . . . . 0.0 109.946 -178.411 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.43 ' HB2' HD21 ' A' ' 129' ' ' LEU . . . -63.92 -19.86 65.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.713 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -69.03 -40.56 78.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.94 0.4 . . . . 0.0 110.258 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -75.84 -51.32 12.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.01 174.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.586 ' HB3' HD23 ' A' ' 124' ' ' LEU . 2.1 m-20 -107.73 96.82 6.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.431 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -79.72 15.14 1.45 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.511 -171.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 41.7 p -112.34 -4.65 14.25 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.493 0.663 . . . . 0.0 110.882 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.586 HD23 ' HB3' ' A' ' 121' ' ' ASP . 3.7 mm? -70.09 114.27 8.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.65 174.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.3 m -90.3 176.5 6.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.002 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.7 p -52.49 -44.37 65.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.872 0.367 . . . . 0.0 111.691 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -65.14 -41.4 94.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.954 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.46 ' HB3' HD13 ' A' ' 124' ' ' LEU . 34.3 m-20 -69.85 -49.77 49.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.448 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.576 HD13 ' HG2' ' A' ' 114' ' ' ARG . 79.2 mt -56.28 -38.28 70.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.685 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -55.95 -46.28 78.58 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.988 0.423 . . . . 0.0 110.704 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.66 -41.44 98.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.101 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 48.8 mtt -68.88 -38.97 80.02 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.006 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 133' ' ' ILE . 13.6 mm -59.02 -45.89 92.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.133 0.492 . . . . 0.0 110.005 174.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -55.34 -43.61 75.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.744 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -73.08 -45.64 56.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.246 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.621 HG12 HG13 ' A' ' 152' ' ' VAL . 69.8 mt -59.53 -57.1 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.729 -178.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -76.71 82.57 3.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.033 0.921 . . . . 0.0 109.83 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.39 -35.39 54.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.663 -1.153 . . . . 0.0 112.238 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -90.31 -10.53 43.79 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.383 -175.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 72.79 37.49 57.21 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.742 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.3 m -83.3 -19.29 36.53 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.418 0.628 . . . . 0.0 110.733 -178.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 93.42 -29.99 7.75 Favored Glycine 0 CA--C 1.51 -0.257 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.494 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.438 HG22 ' HA ' ' A' ' 109' ' ' SER . 2.7 p -118.39 132.59 56.25 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 174.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.531 HG11 ' SD ' ' A' ' 113' ' ' MET . 96.5 t -82.76 115.89 26.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.767 -177.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.488 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 22.3 t70 -139.12 -61.53 0.56 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.028 0.442 . . . . 0.0 111.661 -174.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.598 ' O ' ' HG2' ' A' ' 150' ' ' MET . 2.3 p90 -94.84 -112.74 0.12 Allowed 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.519 -172.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.5 ' H ' ' HD1' ' A' ' 146' ' ' PHE . 6.3 mp0 -64.71 -11.22 33.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.904 0.383 . . . . 0.0 111.265 -176.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -66.84 -52.07 48.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.332 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.49 ' O ' HG23 ' A' ' 152' ' ' VAL . 14.3 t80 -77.19 -33.8 56.33 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.009 0.433 . . . . 0.0 110.303 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' MET . . . . . 0.743 ' HE1' HD23 ' A' ' 93' ' ' LEU . 6.9 mmt -64.13 -23.44 67.32 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.25 -21.93 66.38 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.66 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.621 HG13 HG12 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -91.31 -71.82 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 CA-C-O 121.813 0.816 . . . . 0.0 110.727 -178.41 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 47.5 tpp -83.49 -37.45 23.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.8 -166.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.587 ' OG1' ' HA ' ' A' ' 150' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.442 -0.87 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.219 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.437 ' HA ' HD12 ' A' ' 15' ' ' LEU . 59.8 t . . . . . 0 N--CA 1.45 -0.441 0 CA-C-O 120.759 0.314 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -70.37 -37.48 74.58 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.009 173.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.0 mp -58.7 -48.92 79.47 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.529 HD11 ' HA3' ' A' ' 76' ' ' GLY . 84.8 mt -54.76 -47.85 73.39 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.758 175.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.71 -49.69 75.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.2 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.6 m -59.69 -41.3 90.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.968 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.667 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -76.27 -39.78 53.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.554 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.401 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 33.2 t80 -53.43 -56.14 19.31 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.643 175.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.448 ' HD2' ' OE1' ' A' ' 23' ' ' GLU . 28.1 mmm180 -66.96 -16.91 64.66 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.356 -174.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -87.6 -34.88 18.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.918 0.39 . . . . 0.0 111.354 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.457 ' HB2' HD11 ' A' ' 39' ' ' ILE . 78.8 m-85 -109.69 13.2 23.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.282 0.563 . . . . 0.0 110.227 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.708 ' HG2' ' HB ' ' A' ' 24' ' ' THR . 27.0 tt0 -71.21 148.28 47.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.811 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.708 ' HB ' ' HG2' ' A' ' 23' ' ' GLU . 0.4 OUTLIER 78.8 140.88 0.07 OUTLIER Pre-proline 0 N--CA 1.447 -0.623 0 O-C-N 124.664 1.227 . . . . 0.0 113.527 162.505 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -84.62 -36.69 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.265 2.643 . . . . 0.0 110.014 166.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -178.07 47.59 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.39 174.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.2 63.7 0.95 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.849 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.8 t -107.24 -18.29 13.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.005 0.431 . . . . 0.0 111.003 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.72 12.92 84.0 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -175.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.9 mtm-85 -140.54 168.46 19.75 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.567 -0.817 . . . . 0.0 109.597 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.547 HG23 ' HA ' ' A' ' 23' ' ' GLU . 12.3 p -107.7 127.66 63.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 173.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 13.8 m -55.45 138.5 46.04 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.852 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.564 ' HA ' HG13 ' A' ' 36' ' ' ILE . 1.5 p -64.53 -26.96 68.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.196 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -65.63 -27.85 68.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.109 0.48 . . . . 0.0 110.256 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -92.15 -13.52 30.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.47 -176.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.704 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 69.7 mt -53.86 -48.71 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 O-C-N 123.215 0.322 . . . . 0.0 110.773 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.416 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -59.73 -34.73 83.51 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.613 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.66 ' O ' HG23 ' A' ' 42' ' ' VAL . 50.3 mt -62.66 -49.71 82.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.4 0.619 . . . . 0.0 109.581 175.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.667 HG23 ' HB1' ' A' ' 18' ' ' ALA . 71.3 mt -61.64 -45.92 97.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.667 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.922 HD12 HD12 ' A' ' 52' ' ' ILE . 41.1 mt -61.91 -24.62 67.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.341 0.591 . . . . 0.0 110.423 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -75.97 -43.92 42.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.268 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 38' ' ' ILE . 47.8 t -53.85 -44.35 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.687 0.756 . . . . 0.0 110.264 175.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 22.2 mt -81.14 -12.1 59.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.275 -175.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.59 40.61 66.72 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.825 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.411 HG12 ' HB2' ' A' ' 43' ' ' LEU . 1.3 pt -118.76 -76.85 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.594 ' HG2' HD11 ' A' ' 55' ' ' LEU . 3.4 tp60 -80.72 177.08 9.26 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -174.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -100.27 -171.18 1.99 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.126 -170.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.1 t -52.15 165.85 0.2 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.705 0.764 . . . . 0.0 111.762 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.537 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 59.4 mtpt -61.92 -20.56 63.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.349 -171.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.0 m -61.95 -31.21 71.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.208 0.528 . . . . 0.0 110.455 174.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.6 m -84.77 -31.48 23.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.334 176.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.922 HD12 HD12 ' A' ' 40' ' ' LEU . 28.3 mm -67.51 -25.3 32.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.009 -176.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -46.21 -45.28 16.82 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.922 173.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -62.29 -49.74 74.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.131 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.686 HD12 ' HA ' ' A' ' 52' ' ' ILE . 1.0 OUTLIER -58.14 -38.4 76.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.396 178.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.532 HG23 HG21 ' A' ' 33' ' ' THR . 75.2 mt -65.95 -46.67 87.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.044 177.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -62.42 -27.65 69.25 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.195 0.521 . . . . 0.0 110.289 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -76.0 -54.85 6.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.528 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.568 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 87.4 m-85 -97.57 -15.36 20.54 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -171.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.401 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 39.8 t0 -122.72 68.7 33.29 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 121.222 0.534 . . . . 0.0 110.358 174.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.568 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 20.7 Cg_exo -71.87 -18.12 28.39 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.032 2.488 . . . . 0.0 111.756 176.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -79.88 -17.62 52.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.712 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.38 37.46 53.98 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.781 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -72.59 -43.3 63.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.784 0.326 . . . . 0.0 111.237 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.97 -16.09 20.8 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.893 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 5.5 m-20 -137.19 176.69 8.48 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.0 pt -136.9 152.64 28.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.894 0.378 . . . . 0.0 110.272 174.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -90.07 166.59 13.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.844 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.434 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -63.0 -21.69 66.32 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 178.916 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -57.61 -52.35 65.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.027 0.442 . . . . 0.0 109.986 174.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.492 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 3.4 m -70.72 -44.96 65.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.526 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.434 ' HB3' ' HA ' ' A' ' 69' ' ' PHE . 84.5 t80 -64.5 -34.77 79.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.651 -176.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -64.81 -35.84 82.39 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.6 mt -67.46 -43.9 87.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.58 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 88.8 mt -55.08 -47.55 77.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.275 175.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.801 ' HA2' HD23 ' A' ' 80' ' ' LEU . . . -67.52 -43.9 84.92 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.608 -0.805 . . . . 0.0 112.524 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.55 -24.33 67.57 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.894 0.378 . . . . 0.0 111.701 -174.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.58 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 10.7 ptm180 -89.1 -15.16 34.58 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.844 -175.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -124.34 -36.75 2.61 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.406 -0.518 . . . . 0.0 112.139 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.801 HD23 ' HA2' ' A' ' 76' ' ' GLY . 4.6 mm? . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 . . . . . 0 CA--C 1.52 -0.195 0 CA-C-O 121.308 0.575 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.763 ' H ' HD22 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -62.02 -35.58 78.99 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.894 -173.108 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.569 ' HD3' ' CE2' ' A' ' 97' ' ' PHE . 29.5 mmt180 -62.48 -41.69 98.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.086 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -74.62 -30.91 61.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.204 0.526 . . . . 0.0 110.818 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.509 ' HA ' HD12 ' A' ' 99' ' ' LEU . . . -74.95 -20.22 59.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.935 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.569 ' CE2' ' HD3' ' A' ' 94' ' ' ARG . 17.0 m-30 -56.57 -44.62 81.18 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.372 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.3 mtm-85 -72.02 -19.52 61.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.027 0.442 . . . . 0.0 110.906 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 96' ' ' ALA . 94.2 mt -80.09 -43.87 21.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.654 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.655 ' O ' ' HD2' ' A' ' 102' ' ' LYS . 79.9 m-85 -89.59 -5.61 57.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.397 -177.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 97' ' ' PHE . 55.8 t0 -76.82 76.28 3.43 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.512 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.655 ' HD2' ' O ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -57.04 -42.33 80.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.601 174.548 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -67.75 -36.75 81.1 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.214 -171.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.96 37.15 7.97 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -171.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.06 -18.37 20.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.49 -0.855 . . . . 0.0 111.174 -168.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.9 -24.91 10.83 Favored Glycine 0 CA--C 1.517 0.194 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.445 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 4.2 m-85 -116.75 176.93 4.89 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 173.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.617 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 6.3 pt -117.84 121.94 68.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.239 169.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 66.3 m -65.91 174.75 2.28 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.149 0.5 . . . . 0.0 111.556 -175.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.2 p -67.36 -26.76 66.64 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.953 0.406 . . . . 0.0 110.754 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -60.59 -58.09 9.95 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.851 176.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.617 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.4 p -63.26 -38.36 81.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.843 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.542 ' SD ' HG11 ' A' ' 144' ' ' VAL . 2.7 tpt -56.5 -40.89 75.73 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.827 0.346 . . . . 0.0 110.648 177.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -61.02 -45.19 95.79 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.991 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -58.99 -46.49 88.0 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.411 0.444 . . . . 0.0 110.215 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 63.7 mt -57.45 -53.83 38.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.567 177.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.4 tp -54.66 -60.29 3.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.36 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.08 -27.15 52.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.433 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -75.45 -44.15 45.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.616 0.246 . . . . 0.0 110.348 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.32 -55.7 7.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.141 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.663 ' HB3' HD23 ' A' ' 124' ' ' LEU . 5.3 m-20 -103.01 111.97 24.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.478 0.656 . . . . 0.0 110.649 -178.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' A' ' 122' ' ' GLU . 0.3 OUTLIER -89.17 -5.41 57.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.717 -173.787 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.7 p -88.61 -2.98 58.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.339 0.59 . . . . 0.0 110.765 -174.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.663 HD23 ' HB3' ' A' ' 121' ' ' ASP . 4.2 mm? -84.87 129.03 34.87 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.854 176.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.491 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 92.0 p -89.69 -179.01 5.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 175.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.5 t -58.75 -48.49 81.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.692 0.282 . . . . 0.0 110.795 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -71.08 -35.86 72.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.828 0.347 . . . . 0.0 111.161 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.424 ' HB2' ' H ' ' A' ' 125' ' ' SER . 68.4 m-20 -66.28 -38.14 87.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.45 178.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.509 ' O ' HG12 ' A' ' 133' ' ' ILE . 85.5 mt -58.65 -44.46 90.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.151 172.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -58.99 -46.24 88.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.616 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.45 -42.71 98.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.723 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.508 ' O ' HG13 ' A' ' 136' ' ' ILE . 9.0 mtt -64.06 -37.26 86.8 Favored 'General case' 0 C--O 1.215 -0.731 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.923 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 129' ' ' LEU . 15.8 mm -57.41 -43.88 83.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.188 0.518 . . . . 0.0 110.419 174.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.4 -36.98 84.04 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.262 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -72.79 -39.5 66.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.517 -1.219 . . . . 0.0 111.242 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 132' ' ' MET . 66.8 mt -71.11 -57.11 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.993 -176.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -75.64 63.58 1.58 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 122.396 1.094 . . . . 0.0 108.621 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -78.37 -22.33 48.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.489 -1.232 . . . . 0.0 112.161 -174.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -88.23 -11.99 45.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.368 0.604 . . . . 0.0 110.202 -178.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 79.53 34.99 30.3 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.488 174.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.431 ' C ' ' H ' ' A' ' 143' ' ' THR . 46.9 t -78.74 -21.16 48.42 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.197 0.522 . . . . 0.0 110.406 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.67 -28.36 3.54 Favored Glycine 0 C--O 1.234 0.121 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.431 ' H ' ' C ' ' A' ' 141' ' ' SER . 19.5 p -124.3 128.27 48.87 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 172.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.542 HG11 ' SD ' ' A' ' 113' ' ' MET . 58.8 t -80.71 127.3 39.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -173.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.445 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 17.8 t70 -157.2 -77.63 0.08 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.872 0.844 . . . . 0.0 110.176 -175.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.439 ' HB3' HH22 ' A' ' 94' ' ' ARG . 20.7 p90 -92.65 136.42 33.24 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.072 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 64.86 -54.44 0.3 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.526 0.73 . . . . 0.0 112.204 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -54.66 -51.02 66.78 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.818 0.847 . . . . 0.0 112.144 -176.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.662 ' HE1' HD12 ' A' ' 93' ' ' LEU . 11.4 t80 -75.41 -37.0 60.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.125 0.488 . . . . 0.0 110.341 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' MET . . . . . 0.573 ' CE ' HD23 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -58.14 -43.15 87.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.347 178.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.24 -35.62 56.73 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.455 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 149' ' ' PHE . 9.3 p -75.59 -38.9 39.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 117.112 0.456 . . . . 0.0 111.511 -175.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 16.0 tpt -93.88 -39.92 10.44 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.879 -174.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.446 HG21 HD21 ' A' ' 93' ' ' LEU . 64.9 p . . . . . 0 C--N 1.324 -0.5 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -172.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.436 HG13 ' CE2' ' A' ' 69' ' ' PHE . 89.2 t . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.833 0.349 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.486 ' C ' ' HD3' ' A' ' 13' ' ' LYS . 1.1 tmtp? -62.82 -40.93 98.92 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 123.181 0.592 . . . . 0.0 110.854 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.43 ' N ' ' HD3' ' A' ' 13' ' ' LYS . 6.4 mp -69.92 -42.45 73.31 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.65 HD21 ' CD1' ' A' ' 80' ' ' LEU . 80.8 mt -59.97 -53.98 51.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.624 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.428 ' HA ' ' HE1' ' A' ' 69' ' ' PHE . 37.7 tt0 -64.65 -35.89 82.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.359 -175.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.1 m -59.82 -42.16 92.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 110.745 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.558 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -80.48 -33.12 36.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.146 0.498 . . . . 0.0 110.278 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.452 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 35.7 t80 -56.44 -55.04 38.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.35 177.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -69.08 -19.79 64.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.522 -174.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.61 -42.86 40.86 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.744 0.307 . . . . 0.0 110.908 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -103.77 14.01 31.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.137 0.494 . . . . 0.0 110.444 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.709 ' HG2' ' HB ' ' A' ' 24' ' ' THR . 10.3 tt0 -71.85 154.65 41.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.38 -176.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.709 ' HB ' ' HG2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER 76.01 137.77 0.05 OUTLIER Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-O 122.462 1.125 . . . . 0.0 113.812 158.637 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.32 -52.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.911 2.408 . . . . 0.0 109.835 168.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -138.83 -25.81 0.88 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.625 172.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.66 50.0 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -176.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 t -89.78 -29.77 18.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.807 0.337 . . . . 0.0 111.39 -174.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.88 -6.33 75.03 Favored Glycine 0 N--CA 1.453 -0.179 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 -175.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 67' ' ' ILE . 61.0 mtt85 -115.25 163.7 15.29 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.207 -0.496 . . . . 0.0 109.745 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.572 HG21 HD11 ' A' ' 39' ' ' ILE . 13.3 p -106.18 126.61 61.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 121.86 0.838 . . . . 0.0 110.269 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 31.1 m -53.79 140.61 29.45 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.847 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.583 ' HB ' HG12 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -66.69 -25.31 66.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.85 -174.538 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -69.36 -26.08 64.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.589 0.709 . . . . 0.0 109.727 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -82.06 -22.4 36.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.661 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.545 HG22 HD22 ' A' ' 40' ' ' LEU . 60.2 mt -55.61 -43.33 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 120.959 0.409 . . . . 0.0 110.143 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.429 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -65.24 -25.43 71.11 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.634 177.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.649 ' O ' HG23 ' A' ' 42' ' ' VAL . 39.3 mt -75.21 -51.97 19.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.572 HD11 HG21 ' A' ' 31' ' ' VAL . 63.5 mt -60.96 -44.83 98.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.839 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.545 HD22 HG22 ' A' ' 36' ' ' ILE . 1.6 mp -57.54 -39.26 76.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.352 0.596 . . . . 0.0 109.685 176.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -65.64 -38.44 89.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.769 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 38' ' ' ILE . 60.8 t -60.69 -50.38 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.622 0.725 . . . . 0.0 110.671 175.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.5 mt -83.35 -1.54 53.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.653 -171.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.55 35.19 42.12 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.403 172.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.5 pt -129.02 166.65 26.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.628 0.214 . . . . 0.0 110.468 176.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 50.29 -166.67 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -120.22 -171.88 2.25 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.975 -173.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.9 t -63.7 171.33 2.74 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.451 0.643 . . . . 0.0 111.437 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.446 ' HA ' ' HB ' ' A' ' 52' ' ' ILE . 7.3 mtpm? -59.0 -24.6 62.92 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.317 -165.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.3 t -57.29 -44.8 84.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.931 0.396 . . . . 0.0 110.35 173.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.3 m -72.26 -34.42 68.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.433 0.635 . . . . 0.0 110.293 176.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.446 ' HB ' ' HA ' ' A' ' 49' ' ' LYS . 44.9 mm -63.41 -24.42 35.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.479 -176.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -50.83 -38.02 46.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.886 172.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -74.44 -28.82 61.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.051 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 52' ' ' ILE . 2.3 mm? -65.35 -43.34 91.14 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.583 HG12 ' HB ' ' A' ' 33' ' ' THR . 71.8 mt -65.2 -45.42 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.96 177.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.03 -27.99 22.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.294 0.569 . . . . 0.0 111.076 176.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -83.31 -53.65 5.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.663 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.459 ' CE2' HG12 ' A' ' 75' ' ' ILE . 97.1 m-85 -100.87 -10.66 20.48 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -169.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.482 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 51.3 t0 -136.25 63.82 51.03 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 121.208 0.527 . . . . 0.0 110.458 174.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.482 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 24.6 Cg_exo -68.42 -20.56 41.87 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.841 2.361 . . . . 0.0 111.592 177.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -78.45 -17.48 56.28 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.757 -176.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.97 43.02 50.65 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.518 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -74.89 -38.04 61.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.216 0.532 . . . . 0.0 109.942 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 110.68 -5.37 29.43 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.961 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -161.32 175.77 11.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 71' ' ' SER . 34.6 pt -143.19 146.71 21.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.371 -177.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -75.88 163.19 27.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.934 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.436 ' CE2' HG13 ' A' ' 12' ' ' VAL . 16.0 t80 -56.49 -35.65 68.23 Favored 'General case' 0 C--O 1.214 -0.772 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.075 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -62.18 -22.41 65.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.869 0.366 . . . . 0.0 111.029 -175.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.42 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 40.3 m -85.82 -41.26 15.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.905 0.383 . . . . 0.0 110.504 174.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.439 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 89.7 t80 -70.1 -30.56 67.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.467 0.651 . . . . 0.0 109.717 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -55.51 -50.53 69.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.871 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.0 -42.82 98.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.364 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.607 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 65.5 mt -54.34 -55.45 14.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.482 0.658 . . . . 0.0 110.068 176.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.69 -42.86 99.82 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.259 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.06 -28.03 69.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.854 0.359 . . . . 0.0 111.16 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 13.8 ptm180 -89.64 -10.74 44.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.867 -176.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.514 ' CE1' ' HG3' ' A' ' 78' ' ' ARG . 22.6 m-85 -116.28 -40.14 3.3 Favored 'General case' 0 C--N 1.337 0.061 0 C-N-CA 120.66 -0.416 . . . . 0.0 112.105 -176.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.65 ' CD1' HD21 ' A' ' 15' ' ' LEU . 2.3 mp . . . . . 0 C--N 1.326 -0.45 0 CA-C-O 120.912 0.387 . . . . 0.0 110.828 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 CA--C 1.52 -0.187 0 CA-C-O 120.932 0.396 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.671 HD13 ' CD1' ' A' ' 149' ' ' PHE . 77.6 mt -57.83 -38.29 75.34 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.731 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.737 ' HA ' ' CD2' ' A' ' 97' ' ' PHE . 5.6 mpt_? -58.84 -46.27 88.09 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.755 0.312 . . . . 0.0 111.689 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -76.03 -17.08 59.82 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.13 0.49 . . . . 0.0 110.291 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.19 -18.04 33.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.182 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.737 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 22.4 m-85 -59.57 -45.5 91.66 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 98' ' ' ARG . 47.8 mtp180 -69.68 -13.86 62.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.156 0.503 . . . . 0.0 111.033 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.4 mt -84.35 -35.51 23.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.501 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -96.38 -11.55 25.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.182 0.515 . . . . 0.0 110.298 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -72.54 77.56 1.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.877 0.846 . . . . 0.0 110.337 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -75.65 -9.49 58.63 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.923 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -88.88 -37.11 15.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.654 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.95 30.55 7.05 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.676 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -98.96 -17.48 18.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.848 0.356 . . . . 0.0 111.544 -175.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.57 -26.18 4.18 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.521 -0.631 . . . . 0.0 111.521 -174.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.526 ' HD2' ' CB ' ' A' ' 145' ' ' ASP . 30.5 m-85 -103.92 144.77 31.07 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 171.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.642 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 7.0 pt -93.11 120.8 43.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 118.591 -1.243 . . . . 0.0 108.977 174.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.5 m -67.76 172.12 5.7 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.96 -174.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 34.3 p -60.79 -29.06 69.21 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.211 0.529 . . . . 0.0 110.845 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.601 ' O ' ' HB2' ' A' ' 114' ' ' ARG . 2.0 t70 -62.97 -50.72 69.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.403 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.642 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.4 p -70.82 -35.28 59.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.933 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.728 ' SD ' HG11 ' A' ' 144' ' ' VAL . 1.4 tpt -59.66 -37.72 79.51 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.763 0.316 . . . . 0.0 110.205 176.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.601 ' HB2' ' O ' ' A' ' 111' ' ' ASP . 36.7 mtt180 -50.55 -59.55 3.93 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.407 172.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.0 -41.69 92.66 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.768 -176.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 53.6 mt -58.09 -46.89 88.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.148 0.499 . . . . 0.0 110.9 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.419 HD12 ' CD2' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -70.57 -47.39 60.5 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.128 -179.257 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.864 ' HB2' HD21 ' A' ' 129' ' ' LEU . . . -53.21 -25.81 15.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.753 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -68.34 -26.68 65.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.195 0.521 . . . . 0.0 110.247 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.4 mp -89.55 -47.77 7.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.022 174.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.897 ' HB3' ' HB2' ' A' ' 124' ' ' LEU . 1.3 m-20 -90.57 93.57 9.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.3 0.572 . . . . 0.0 110.471 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -79.61 -13.84 59.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.728 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.5 p -96.79 -14.04 22.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 122.724 1.25 . . . . 0.0 108.607 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.923 ' HG ' HD22 ' A' ' 129' ' ' LEU . 36.9 tp -69.83 116.21 9.96 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 112.991 -1.913 . . . . 0.0 110.426 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 93.9 p -91.61 -179.71 5.43 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.622 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 24.9 m -58.73 -37.36 75.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.889 0.376 . . . . 0.0 110.911 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -74.58 -42.05 59.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.634 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.65 ' CB ' HD12 ' A' ' 124' ' ' LEU . 59.4 m-20 -64.35 -50.46 67.63 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.923 HD22 ' HG ' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -42.25 -48.41 4.93 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.835 169.646 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -62.19 -41.31 98.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.662 0.268 . . . . 0.0 111.219 -175.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.89 -41.6 97.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.101 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.409 ' O ' HG13 ' A' ' 136' ' ' ILE . 36.2 mtt -63.05 -39.21 94.05 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.624 176.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 129' ' ' LEU . 24.5 mm -57.91 -45.2 87.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.144 0.497 . . . . 0.0 110.382 175.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -61.02 -34.92 75.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.43 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -73.87 -38.52 64.4 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.849 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.53 HG12 ' HB ' ' A' ' 152' ' ' VAL . 59.8 mt -70.43 -49.41 53.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.385 -176.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.73 95.93 0.93 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 123.023 1.392 . . . . 0.0 110.713 -174.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.29 -54.95 5.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.208 -1.36 . . . . 0.0 112.337 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -84.23 -10.35 57.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.441 0.639 . . . . 0.0 110.979 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 61.55 40.95 99.41 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.621 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.1 t -89.89 5.04 48.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.079 0.466 . . . . 0.0 110.66 -176.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.56 -31.01 4.68 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.177 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 35.3 p -117.81 143.27 46.42 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.439 -0.381 . . . . 0.0 109.998 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.728 HG11 ' SD ' ' A' ' 113' ' ' MET . 71.7 t -91.88 111.41 24.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.526 ' CB ' ' HD2' ' A' ' 107' ' ' TYR . 22.6 t70 -146.37 -69.16 0.26 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.687 0.756 . . . . 0.0 111.574 -175.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.858 ' HD2' ' HG2' ' A' ' 147' ' ' GLU . 4.0 p90 -97.92 -53.44 3.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.02 -164.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.858 ' HG2' ' HD2' ' A' ' 146' ' ' PHE . 40.2 mm-40 -98.86 -36.17 9.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.496 0.665 . . . . 0.0 110.157 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 148' ' ' GLU . 40.9 mp0 -63.5 -54.95 28.37 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.038 -175.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.671 ' CD1' HD13 ' A' ' 93' ' ' LEU . 2.3 t80 -66.27 -45.98 78.6 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.793 -175.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' A' ' 146' ' ' PHE . 52.4 mmm -61.47 -19.53 62.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.278 177.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -90.92 -17.54 51.11 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.878 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.53 ' HB ' HG12 ' A' ' 136' ' ' ILE . 6.6 p -98.31 -47.26 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 117.019 0.41 . . . . 0.0 111.393 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 49.9 tpp -81.08 -56.46 4.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.881 0.372 . . . . 0.0 110.785 -176.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.1 p . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.78 -178.556 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.1 t . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.614 0.245 . . . . 0.0 110.462 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.46 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 12.0 tptt -61.64 -42.64 99.18 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 120.782 0.325 . . . . 0.0 110.642 173.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.9 mt -57.23 -48.7 78.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.426 0.631 . . . . 0.0 109.617 173.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.9 mt -56.18 -51.34 68.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.261 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -61.08 -41.87 97.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.652 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.8 m -61.24 -39.28 89.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.063 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.538 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -84.2 -31.33 25.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.931 0.396 . . . . 0.0 110.616 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.591 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 65.3 t80 -57.95 -56.79 17.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.411 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -71.95 -0.96 12.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.468 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -93.79 -52.43 4.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.788 0.327 . . . . 0.0 110.746 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.611 ' CD1' HG12 ' A' ' 39' ' ' ILE . 64.5 m-85 -95.71 11.11 34.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.02 0.438 . . . . 0.0 110.455 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.615 ' HA ' HG23 ' A' ' 31' ' ' VAL . 11.1 tt0 -62.32 155.12 25.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.513 -174.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.579 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.4 OUTLIER 77.81 138.52 0.06 OUTLIER Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 114.128 -1.396 . . . . 0.0 113.737 161.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -88.32 -44.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.553 2.835 . . . . 0.0 110.799 170.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -164.3 47.03 0.11 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.494 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.78 66.67 1.27 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.808 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.0 t -113.14 -27.19 8.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -176.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.13 -4.76 82.45 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -171.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.448 ' HD2' ' OD2' ' A' ' 66' ' ' ASP . 25.5 mtt85 -115.25 160.22 20.03 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 114.068 -1.066 . . . . 0.0 109.565 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.615 HG23 ' HA ' ' A' ' 23' ' ' GLU . 10.2 p -106.8 126.98 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 121.697 0.76 . . . . 0.0 109.099 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 66' ' ' ASP . 32.8 t -55.63 140.64 40.53 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.941 -1.481 . . . . 0.0 111.372 -177.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.598 ' HB ' HG12 ' A' ' 56' ' ' ILE . 7.0 p -66.5 -19.63 65.83 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.01 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.416 ' O ' ' HE2' ' A' ' 49' ' ' LYS . 32.9 t70 -70.9 -27.39 63.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.72 176.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.682 ' HA ' HD13 ' A' ' 38' ' ' ILE . 87.4 mm-40 -95.06 -13.96 24.7 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.05 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.719 HG22 HD22 ' A' ' 40' ' ' LEU . 63.1 mt -56.93 -34.06 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.614 0.245 . . . . 0.0 110.665 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.437 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -73.12 -36.1 56.81 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.338 -177.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.682 HD13 ' HA ' ' A' ' 35' ' ' GLN . 1.3 mp -59.81 -56.13 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 174.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.78 ' HA ' HG13 ' A' ' 42' ' ' VAL . 36.0 mt -64.08 -39.24 84.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.645 -176.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.719 HD22 HG22 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -60.83 -23.71 65.31 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.301 -0.56 . . . . 0.0 109.992 176.337 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 35.0 tt0 -81.74 -41.63 20.96 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.402 173.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.78 HG13 ' HA ' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -58.78 -38.74 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 121.572 0.701 . . . . 0.0 110.406 177.563 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.479 ' HG ' HG22 ' A' ' 42' ' ' VAL . 45.6 mt -83.52 -11.9 56.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.841 -178.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.91 32.52 56.76 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.269 175.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pt -110.96 -86.09 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -177.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -79.03 177.34 8.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.257 0.551 . . . . 0.0 112.362 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -100.79 -171.95 2.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.371 -174.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.2 t -64.38 175.81 1.24 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.444 0.64 . . . . 0.0 111.862 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 96.8 mttt -53.61 -30.42 42.48 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -165.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.4 m -55.7 -33.48 64.22 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.073 0.463 . . . . 0.0 111.058 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.7 m -84.25 -33.77 23.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.557 0.694 . . . . 0.0 110.3 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.437 HG13 ' HA3' ' A' ' 37' ' ' GLY . 36.9 mm -66.92 -23.98 31.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.497 -175.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 30.7 mmt180 -52.71 -33.1 46.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.923 0.392 . . . . 0.0 110.742 176.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -70.86 -51.05 28.84 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.164 0.507 . . . . 0.0 109.735 175.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.473 HD11 ' CE2' ' A' ' 79' ' ' PHE . 3.3 mm? -51.26 -45.92 62.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.249 177.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.598 HG12 ' HB ' ' A' ' 33' ' ' THR . 73.1 mt -62.97 -50.0 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.486 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -62.92 -25.39 68.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.197 0.523 . . . . 0.0 110.713 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -69.24 -55.02 11.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.236 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.546 ' HB3' ' HB3' ' A' ' 71' ' ' SER . 94.6 m-85 -100.92 -20.76 15.32 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -171.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -126.67 67.59 67.5 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-O 121.2 0.524 . . . . 0.0 110.615 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.456 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 31.3 Cg_exo -62.66 -17.16 57.34 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.862 2.374 . . . . 0.0 111.628 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -69.74 -18.34 63.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.279 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.9 32.44 84.19 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -173.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -75.41 -40.93 57.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.928 -0.636 . . . . 0.0 111.087 -170.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.01 -14.95 10.33 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.017 -1.087 . . . . 0.0 113.788 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.448 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 5.7 p-10 -154.75 157.9 38.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 117.171 0.486 . . . . 0.0 110.875 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.8 pt -133.59 149.11 30.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.255 -175.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -81.11 167.99 19.09 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.657 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.416 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -56.3 -26.63 52.79 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.124 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -42.89 -54.29 4.26 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.468 172.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.546 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 13.5 m -86.51 -37.17 18.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.819 -176.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.416 ' HB3' ' HA ' ' A' ' 69' ' ' PHE . 92.3 t80 -63.94 -35.26 80.1 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.129 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -63.87 -36.27 83.36 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.443 ' HB ' ' CE1' ' A' ' 59' ' ' PHE . 34.6 mt -72.44 -37.25 57.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 177.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.565 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 61.7 mt -57.78 -51.21 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.285 0.564 . . . . 0.0 109.654 173.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.499 ' O ' HD23 ' A' ' 80' ' ' LEU . . . -63.18 -42.78 99.32 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.893 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.95 -37.58 74.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.385 0.612 . . . . 0.0 111.329 -175.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 15.0 ptm180 -81.83 -9.3 59.65 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.969 -173.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.473 ' CE2' HD11 ' A' ' 55' ' ' LEU . 22.2 m-85 -124.02 -31.56 3.36 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.72 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 76' ' ' GLY . 4.1 mm? . . . . . 0 CA--C 1.513 -0.448 0 CA-C-O 121.155 0.503 . . . . 0.0 110.904 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 121.075 0.464 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.65 ' H ' HD22 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -56.81 -38.18 72.23 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.037 -176.562 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.704 ' HA ' ' CE2' ' A' ' 97' ' ' PHE . 30.1 mmm180 -62.44 -34.85 77.59 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.485 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -86.96 -23.44 25.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.881 0.372 . . . . 0.0 110.652 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.0 -16.03 62.06 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.608 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.704 ' CE2' ' HA ' ' A' ' 94' ' ' ARG . 20.1 m-85 -61.71 -40.86 96.51 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -66.46 -17.74 64.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.323 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.2 mt -88.06 -30.72 19.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.321 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -104.28 -24.12 13.15 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -175.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -72.97 79.88 1.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.562 0.696 . . . . 0.0 109.982 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -69.72 -19.43 63.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.628 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.466 ' HB2' ' ND2' ' A' ' 105' ' ' ASN . 12.5 mt-10 -90.91 -37.01 13.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.279 -172.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.81 42.15 3.66 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.024 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.466 ' ND2' ' HB2' ' A' ' 103' ' ' GLU . 24.5 m-80 -87.53 -19.65 27.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 0.0 110.693 -176.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.54 1.9 82.86 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -169.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.552 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 4.7 m-85 -148.22 165.26 31.47 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.668 ' HB ' HG13 ' A' ' 112' ' ' VAL . 11.3 pt -102.46 120.48 52.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 C-N-CA 119.278 -0.969 . . . . 0.0 109.1 170.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.6 m -60.97 161.59 8.11 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.685 -176.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.0 p -58.34 -26.61 63.32 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.765 -0.584 . . . . 0.0 110.642 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -62.05 -51.03 69.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.78 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.668 HG13 ' HB ' ' A' ' 108' ' ' ILE . 2.1 p -70.37 -36.71 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.156 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.633 ' SD ' HG11 ' A' ' 144' ' ' VAL . 2.7 tpt -59.23 -38.34 79.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.103 0.477 . . . . 0.0 109.782 175.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -56.34 -53.48 56.83 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.125 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.62 -29.42 66.91 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.996 -178.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.6 HG13 ' O ' ' A' ' 112' ' ' VAL . 57.4 mt -63.52 -50.2 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 121.205 0.526 . . . . 0.0 110.021 174.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.62 HD11 ' SD ' ' A' ' 132' ' ' MET . 0.7 OUTLIER -58.7 -50.61 73.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.835 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.65 -27.82 68.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.775 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -69.97 -39.92 75.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.911 0.386 . . . . 0.0 110.14 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.44 -56.72 5.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.828 175.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.619 ' CG ' HD23 ' A' ' 124' ' ' LEU . 7.5 t70 -102.82 119.97 39.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.077 0.465 . . . . 0.0 110.881 -177.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -101.87 15.79 27.92 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.805 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 61.8 p -116.17 -17.0 10.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.477 0.656 . . . . 0.0 109.767 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.619 HD23 ' CG ' ' A' ' 121' ' ' ASP . 1.4 mm? -55.42 146.85 18.73 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.909 169.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.474 ' H ' ' HB2' ' A' ' 128' ' ' ASP . 27.3 t -107.85 162.46 13.98 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.601 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.1 m -51.76 -36.51 47.6 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 118.204 0.456 . . . . 0.0 111.396 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -76.38 -45.69 30.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.295 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.474 ' HB2' ' H ' ' A' ' 125' ' ' SER . 3.0 m-20 -63.35 -42.51 98.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.053 0.454 . . . . 0.0 110.487 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.616 HD11 ' HB3' ' A' ' 117' ' ' LEU . 26.6 tp -56.39 -39.5 73.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.528 176.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.455 ' O ' ' HB ' ' A' ' 133' ' ' ILE . 23.7 t70 -63.88 -41.7 97.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.234 177.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.48 -38.06 89.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.686 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.62 ' SD ' HD11 ' A' ' 117' ' ' LEU . 28.7 mtt -65.23 -34.04 77.43 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.59 175.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 133' ' ' ILE . 15.2 mm -58.54 -47.79 87.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.978 0.418 . . . . 0.0 110.312 173.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.66 -45.08 77.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.409 175.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -66.95 -37.12 83.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.253 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.452 HG21 ' SD ' ' A' ' 113' ' ' MET . 51.9 mt -69.41 -58.65 5.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.16 -178.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -71.29 96.26 1.41 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.7 0.762 . . . . 0.0 110.206 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -75.19 -42.97 54.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.736 -175.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -81.94 -15.14 54.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.491 0.662 . . . . 0.0 110.979 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 70.71 26.03 74.73 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.195 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.0 t -74.68 -18.25 60.55 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.428 0.633 . . . . 0.0 109.723 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.22 -23.94 24.64 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.552 ' HB ' ' HB2' ' A' ' 107' ' ' TYR . 24.6 p -116.93 128.92 55.69 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.633 HG11 ' SD ' ' A' ' 113' ' ' MET . 94.1 t -86.13 121.92 37.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.292 -176.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.535 ' CB ' ' HD2' ' A' ' 107' ' ' TYR . 22.7 t70 -150.43 -68.99 0.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.325 0.584 . . . . 0.0 111.867 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 146' ' ' PHE . 0.6 OUTLIER -85.23 -88.28 0.11 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.067 -167.185 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -78.31 -28.22 47.4 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.063 0.459 . . . . 0.0 110.823 -175.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.664 ' CD ' ' H ' ' A' ' 148' ' ' GLU . 3.0 mp0 -57.94 -64.11 1.02 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.588 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.546 ' CD2' HD11 ' A' ' 108' ' ' ILE . 19.8 t80 -66.97 -43.74 82.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.979 -174.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 40.7 tpp -62.43 -33.56 75.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.152 0.501 . . . . 0.0 109.797 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.55 -26.81 66.72 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 116.033 -0.53 . . . . 0.0 113.133 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.502 HG12 ' HA ' ' A' ' 149' ' ' PHE . 6.5 p -89.17 -42.51 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 117.238 0.519 . . . . 0.0 111.665 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -82.34 -57.89 3.17 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.543 -174.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 45.3 p . . . . . 0 C--N 1.331 -0.238 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.585 -178.938 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.42 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 93.3 t . . . . . 0 CA--C 1.531 0.233 0 CA-C-O 120.623 0.249 . . . . 0.0 111.403 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 11.9 tptt -62.08 -42.51 99.28 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-O 120.886 0.374 . . . . 0.0 111.223 177.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.6 mt -60.41 -41.61 94.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.407 0.622 . . . . 0.0 109.491 174.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.922 HD21 HD13 ' A' ' 80' ' ' LEU . 77.3 mt -61.16 -49.27 77.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.692 176.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -61.34 -43.47 98.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.461 -178.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 57.9 m -58.6 -38.27 77.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.116 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.566 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -86.0 -35.67 20.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.042 0.449 . . . . 0.0 110.382 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.693 ' CE1' HG22 ' A' ' 31' ' ' VAL . 88.0 t80 -55.15 -49.58 71.46 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.096 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.415 ' HA ' ' HB2' ' A' ' 23' ' ' GLU . 23.7 mmt180 -81.35 -6.52 58.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.765 -175.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -87.58 -46.47 9.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.09 0.472 . . . . 0.0 110.318 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.582 ' HB3' ' HB3' ' A' ' 35' ' ' GLN . 68.4 m-85 -98.97 25.74 6.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.81 0.814 . . . . 0.0 109.461 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.964 ' HG2' ' HB ' ' A' ' 24' ' ' THR . 1.7 tt0 -78.42 139.48 38.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.249 -1.341 . . . . 0.0 112.8 -172.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.964 ' HB ' ' HG2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER 76.27 144.69 0.1 Allowed Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 155.515 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 24' ' ' THR . 7.1 Cg_exo -74.8 -53.71 0.1 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.531 2.821 . . . . 0.0 110.084 165.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -136.5 -39.61 0.65 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.69 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.3 38.55 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.9 t -76.37 -27.18 56.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.374 -0.413 . . . . 0.0 111.161 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.93 4.6 86.97 Favored Glycine 0 C--N 1.335 0.479 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.457 ' HB2' ' OD2' ' A' ' 66' ' ' ASP . 11.8 mtt180 -122.06 168.3 12.1 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.758 -0.721 . . . . 0.0 110.305 -175.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.693 HG22 ' CE1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -105.66 127.34 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.536 0 CA-C-O 121.446 0.641 . . . . 0.0 110.926 174.626 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.418 ' HB3' ' HG2' ' A' ' 35' ' ' GLN . 6.0 t -53.74 139.32 33.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.797 -1.547 . . . . 0.0 109.1 171.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.628 HG21 HG23 ' A' ' 56' ' ' ILE . 3.9 p -70.46 -13.04 61.96 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.869 0.366 . . . . 0.0 111.586 -176.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.71 -29.47 62.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.717 172.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.582 ' HB3' ' HB3' ' A' ' 22' ' ' PHE . 84.3 mm-40 -81.56 -23.54 37.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.977 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.52 HG22 HD22 ' A' ' 40' ' ' LEU . 61.0 mt -57.18 -44.34 83.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.524 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.82 -20.73 70.7 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.366 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.618 ' O ' HG23 ' A' ' 42' ' ' VAL . 15.0 mt -81.9 -51.36 15.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.566 HG23 ' HB1' ' A' ' 18' ' ' ALA . 73.2 mt -57.66 -46.57 86.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.499 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.52 HD22 HG22 ' A' ' 36' ' ' ILE . 1.3 mp -56.81 -40.91 76.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.246 0.546 . . . . 0.0 109.928 177.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.5 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 32.8 tt0 -61.28 -43.96 98.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.566 175.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 38' ' ' ILE . 78.8 t -55.57 -48.03 77.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.814 0.816 . . . . 0.0 110.552 175.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.2 mt -83.14 -2.45 55.49 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.365 -172.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.8 26.84 59.84 Favored Glycine 0 N--CA 1.453 -0.188 0 CA-C-N 115.944 -0.571 . . . . 0.0 113.129 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.9 pt -122.45 167.74 15.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 O-C-N 122.708 -0.29 . . . . 0.0 111.066 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 50.62 -171.37 0.02 OUTLIER 'General case' 0 C--O 1.233 0.227 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -178.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -119.6 -170.88 2.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.938 -173.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.3 t -56.51 167.38 0.72 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.324 0.583 . . . . 0.0 111.149 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.507 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 55.9 mttp -57.36 -23.66 50.39 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -166.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.4 t -54.73 -47.84 73.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.093 0.473 . . . . 0.0 110.358 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.7 m -70.39 -35.27 73.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.63 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.507 ' CG1' ' HA ' ' A' ' 49' ' ' LYS . 44.4 mm -60.54 -29.2 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.359 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.528 ' HA ' HD12 ' A' ' 56' ' ' ILE . 34.5 mmt180 -56.5 -28.2 59.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.155 176.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -75.2 -35.22 61.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.884 0.373 . . . . 0.0 110.611 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 52' ' ' ILE . 2.7 mm? -62.6 -43.82 97.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.416 0.627 . . . . 0.0 109.484 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.628 HG23 HG21 ' A' ' 33' ' ' THR . 52.6 mt -63.6 -43.64 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.839 176.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -55.75 -35.5 66.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.19 0.519 . . . . 0.0 110.897 176.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.412 ' HG2' ' CE2' ' A' ' 59' ' ' PHE . 4.5 tp10 -71.68 -54.68 9.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.735 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.508 ' CE2' HG12 ' A' ' 75' ' ' ILE . 96.0 m-85 -100.62 -12.9 18.82 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -128.1 66.9 73.5 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-O 121.063 0.458 . . . . 0.0 110.606 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.458 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 33.1 Cg_exo -62.6 -29.75 78.37 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.795 2.33 . . . . 0.0 112.338 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -77.34 -17.62 58.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.387 -175.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.35 47.08 60.1 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -175.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -78.92 -26.98 43.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.111 0.482 . . . . 0.0 110.131 -174.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.3 -25.35 13.95 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.847 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.457 ' OD2' ' HB2' ' A' ' 30' ' ' ARG . 53.1 p-10 -146.06 168.48 20.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.918 0.39 . . . . 0.0 110.536 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.457 ' HB ' ' HB2' ' A' ' 71' ' ' SER . 36.6 pt -138.82 147.41 25.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.344 -178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.441 ' HA ' ' HG2' ' A' ' 30' ' ' ARG . 28.7 t70 -80.8 170.27 16.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.316 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.415 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -57.26 -26.56 61.0 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 176.086 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -48.1 -52.89 18.47 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.822 173.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.464 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 2.2 m -78.3 -43.46 27.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.663 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.415 ' HB3' ' HA ' ' A' ' 69' ' ' PHE . 87.0 t80 -63.11 -36.76 84.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.599 -175.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -66.67 -35.45 80.17 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 56.2 mt -69.74 -39.2 77.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.625 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 62.6 mt -58.14 -52.57 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-O 121.373 0.606 . . . . 0.0 109.594 173.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.404 ' HA2' ' CD1' ' A' ' 80' ' ' LEU . . . -62.14 -38.89 96.88 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.237 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.06 -30.18 70.65 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.82 0.343 . . . . 0.0 111.427 -174.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.625 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 16.4 ptm180 -85.14 -7.48 59.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.787 -175.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.449 ' CE1' ' HG3' ' A' ' 78' ' ' ARG . 19.9 m-85 -124.97 -48.58 1.75 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 120.874 -0.331 . . . . 0.0 111.047 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.922 HD13 HD21 ' A' ' 15' ' ' LEU . 3.3 mp . . . . . 0 CA--C 1.513 -0.444 0 CA-C-O 121.47 0.652 . . . . 0.0 111.591 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.519 -0.222 0 CA-C-O 121.108 0.48 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.606 ' H ' HD22 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -51.02 -32.14 20.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.913 177.256 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.743 HH11 ' HE2' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -58.22 -44.44 88.18 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.989 0.423 . . . . 0.0 111.618 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -71.67 -29.72 64.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.178 0.513 . . . . 0.0 110.241 176.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.412 ' HA ' HD12 ' A' ' 99' ' ' LEU . . . -75.56 -19.31 59.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.877 -175.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.743 ' HE2' HH11 ' A' ' 94' ' ' ARG . 22.6 m-85 -59.19 -48.99 79.55 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 120.844 0.354 . . . . 0.0 110.084 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -70.47 -12.9 61.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.527 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 96' ' ' ALA . 85.5 mt -83.63 -27.37 29.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.832 176.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -105.14 -25.28 12.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.511 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -72.26 82.12 1.02 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.797 0.808 . . . . 0.0 111.099 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -72.39 -15.75 61.85 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.927 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -78.98 -35.99 42.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.339 -175.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.0 44.32 4.18 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.754 174.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -107.77 -18.44 13.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.064 0.459 . . . . 0.0 110.339 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.29 -24.44 27.18 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -172.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.59 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 6.3 m-85 -109.9 152.25 26.04 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.677 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 13.1 pt -92.44 124.66 44.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.6 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.56 ' HA ' HG22 ' A' ' 143' ' ' THR . 21.7 m -65.39 165.89 11.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.627 -175.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.8 p -62.33 -27.14 68.85 Favored 'General case' 0 C--N 1.318 -0.775 0 O-C-N 121.74 -0.6 . . . . 0.0 111.154 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.56 -49.79 76.13 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.667 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.677 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.6 p -70.73 -38.39 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.598 -178.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.4 ' HA ' ' HE2' ' A' ' 113' ' ' MET . 4.0 tpp -58.36 -43.12 88.24 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 174.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.54 ' O ' HD21 ' A' ' 129' ' ' LEU . 23.0 ttp180 -53.25 -40.36 64.53 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.669 177.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -74.37 -38.43 63.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.307 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 112' ' ' VAL . 59.3 mt -63.58 -52.67 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 120.945 0.402 . . . . 0.0 110.608 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.552 ' HB3' HD11 ' A' ' 129' ' ' LEU . 0.8 OUTLIER -54.02 -53.91 46.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.312 179.795 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.599 ' HB2' HD22 ' A' ' 129' ' ' LEU . . . -58.69 -27.52 64.92 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.257 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.22 -50.74 17.82 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.4 -48.96 71.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.802 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.645 ' HB3' HD23 ' A' ' 124' ' ' LEU . 4.8 m-20 -103.59 94.69 5.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.6 0.714 . . . . 0.0 110.189 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -73.92 -5.06 38.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.052 -0.977 . . . . 0.0 112.653 -171.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 66.9 p -94.85 -2.93 49.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.398 0.618 . . . . 0.0 111.359 -173.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.645 HD23 ' HB3' ' A' ' 121' ' ' ASP . 4.4 mm? -80.71 148.02 30.33 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.223 177.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 56.2 m -121.68 173.35 7.5 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.7 m -48.15 -47.53 34.79 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -174.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -68.81 -54.26 16.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.712 0.291 . . . . 0.0 111.227 -177.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -58.93 -44.89 91.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.725 0.774 . . . . 0.0 110.372 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.599 HD22 ' HB2' ' A' ' 118' ' ' ALA . 61.3 tp -60.57 -38.12 83.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.711 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.443 ' O ' ' HB ' ' A' ' 133' ' ' ILE . 5.6 t70 -69.35 -33.55 73.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.023 0.439 . . . . 0.0 110.251 -178.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.63 94.58 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.963 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.471 ' SD ' HD11 ' A' ' 117' ' ' LEU . 38.1 mtt -60.24 -36.34 77.51 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.262 175.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.508 HD11 ' HA ' ' A' ' 114' ' ' ARG . 17.0 mm -59.05 -47.2 90.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.835 0.35 . . . . 0.0 110.853 175.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -60.34 -39.79 88.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.229 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -70.03 -43.99 70.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.703 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 57.7 mt -57.98 -54.31 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.163 0.585 . . . . 0.0 112.519 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -73.65 91.59 1.89 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.587 0.708 . . . . 0.0 110.507 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.58 -41.97 36.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.521 -174.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -84.85 -13.47 50.9 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.934 -172.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 78.59 26.82 58.34 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.895 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.9 m -73.66 -18.03 61.08 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.363 0.601 . . . . 0.0 110.609 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.54 -13.6 51.05 Favored Glycine 0 CA--C 1.509 -0.307 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.096 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.59 ' HB ' ' HB2' ' A' ' 107' ' ' TYR . 3.0 p -132.8 131.15 40.75 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.726 -0.737 . . . . 0.0 109.223 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.433 HG12 ' HB2' ' A' ' 149' ' ' PHE . 52.8 t -84.73 111.81 20.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.938 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.423 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 11.0 t70 -139.46 -72.2 0.39 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.38 0.609 . . . . 0.0 110.913 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.577 ' O ' ' HG2' ' A' ' 150' ' ' MET . 0.7 OUTLIER -82.99 -98.46 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.517 -169.615 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.503 ' HG2' ' CD2' ' A' ' 146' ' ' PHE . 9.1 pt-20 -67.87 -29.49 68.63 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 122.259 -0.276 . . . . 0.0 111.118 -175.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -59.68 -51.05 71.45 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.4 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.601 ' HA ' HG12 ' A' ' 152' ' ' VAL . 9.4 t80 -79.66 -33.91 40.86 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.416 -174.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' MET . . . . . 0.602 ' CE ' HD23 ' A' ' 93' ' ' LEU . 10.3 mmt -62.53 -45.34 93.4 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.502 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.95 -33.32 83.55 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.251 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.601 HG12 ' HA ' ' A' ' 149' ' ' PHE . 8.1 p -81.71 -36.55 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 111.598 -176.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 52.1 tpp -96.85 -56.07 2.68 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -173.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 69.0 p . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 120.971 0.415 . . . . 0.0 111.551 -173.639 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.4 t . . . . . 0 N--CA 1.456 -0.174 0 CA-C-O 121.055 0.455 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.538 ' C ' ' HD3' ' A' ' 13' ' ' LYS . 5.5 tmtm? -66.01 -40.3 90.97 Favored 'General case' 0 N--CA 1.416 -2.143 0 C-N-CA 123.277 0.631 . . . . 0.0 110.043 177.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.53 -43.26 94.58 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.66 HD21 HD13 ' A' ' 80' ' ' LEU . 80.1 mt -55.99 -50.26 71.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.614 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.574 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 6.8 tp10 -54.13 -53.62 50.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.79 177.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 96.3 m -63.58 -39.42 94.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.521 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -77.66 -27.21 50.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.103 0.477 . . . . 0.0 110.564 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.756 ' HD1' ' HD2' ' A' ' 20' ' ' ARG . 45.4 t80 -62.63 -51.75 66.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.139 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.756 ' HD2' ' HD1' ' A' ' 19' ' ' PHE . 23.3 mmm-85 -70.34 -27.37 64.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.32 -172.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.76 -45.63 81.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.937 0.399 . . . . 0.0 110.715 -176.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.457 ' CD2' HG12 ' A' ' 39' ' ' ILE . 68.6 m-85 -103.45 14.19 31.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.129 0.49 . . . . 0.0 110.573 -178.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.572 ' HG2' ' N ' ' A' ' 24' ' ' THR . 16.9 tt0 -72.4 152.26 42.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.803 -176.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.572 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.4 OUTLIER 76.08 133.91 0.04 OUTLIER Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 114.752 -1.113 . . . . 0.0 113.266 163.574 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -83.22 -47.03 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.025 2.483 . . . . 0.0 110.727 171.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -163.84 46.5 0.12 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.455 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.26 59.99 0.92 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.259 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.7 t -106.83 -31.52 8.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.988 0.423 . . . . 0.0 110.608 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.01 -14.91 60.73 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.467 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.58 ' HG3' ' HA ' ' A' ' 68' ' ' ASP . 6.6 mpt_? -109.87 170.7 7.9 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.538 HG23 ' HA ' ' A' ' 23' ' ' GLU . 12.0 p -107.6 129.14 62.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 121.758 0.79 . . . . 0.0 109.918 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.472 ' HB3' ' HG2' ' A' ' 35' ' ' GLN . 15.8 t -59.45 143.67 49.2 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.377 -175.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.587 ' HB ' HG12 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -67.51 -19.45 65.31 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.838 -174.389 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -83.8 -22.26 31.87 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.308 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.472 ' HG2' ' HB3' ' A' ' 32' ' ' SER . 11.9 mm100 -83.24 -20.4 34.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.531 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.678 HG22 HD22 ' A' ' 40' ' ' LEU . 52.9 mt -53.96 -42.58 54.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.261 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.439 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -61.72 -39.28 97.22 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.157 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.65 ' O ' HG23 ' A' ' 42' ' ' VAL . 39.7 mt -63.36 -50.76 77.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.192 0.52 . . . . 0.0 109.872 178.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.521 HG23 ' HB1' ' A' ' 18' ' ' ALA . 64.5 mt -61.46 -45.67 98.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.583 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.678 HD22 HG22 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -58.42 -28.69 65.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.009 0.433 . . . . 0.0 110.64 177.066 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.504 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 38.4 tt0 -74.51 -41.38 60.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.428 174.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 38' ' ' ILE . 38.7 t -56.07 -51.7 58.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 121.84 0.829 . . . . 0.0 109.733 175.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.6 mt -74.75 -24.8 58.76 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.34 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.97 42.25 6.04 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.154 173.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 pt -119.06 -83.88 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.466 ' HG2' HD21 ' A' ' 55' ' ' LEU . 3.4 tp60 -75.3 179.95 4.84 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.334 0.588 . . . . 0.0 112.26 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -103.41 -170.35 1.77 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.862 -173.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.507 ' O ' HG12 ' A' ' 52' ' ' ILE . 15.0 t -60.01 177.27 0.25 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 66.4 mttm -52.32 -38.54 58.81 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.903 0.481 . . . . 0.0 112.108 -172.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.5 m -54.56 -34.04 61.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.102 0.477 . . . . 0.0 111.248 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.8 m -84.46 -31.52 24.52 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.51 0.671 . . . . 0.0 110.266 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.799 ' HA ' HD23 ' A' ' 55' ' ' LEU . 46.9 mm -68.84 -24.19 28.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.559 -177.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 29.4 mmt180 -57.91 -25.73 61.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.822 0.344 . . . . 0.0 110.598 176.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -66.18 -56.38 11.63 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 172.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.799 HD23 ' HA ' ' A' ' 52' ' ' ILE . 2.8 mm? -49.6 -48.4 48.89 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.119 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.587 HG12 ' HB ' ' A' ' 33' ' ' THR . 68.6 mt -63.37 -52.8 53.69 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.891 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -64.53 -23.0 67.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.255 0.55 . . . . 0.0 110.583 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -80.37 -54.35 5.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.697 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.535 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 72.0 m-85 -91.59 -22.38 20.35 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -173.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.432 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 44.6 t0 -125.8 63.62 47.62 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 121.075 0.464 . . . . 0.0 110.092 175.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.535 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 32.1 Cg_exo -61.65 -23.82 76.92 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.09 2.527 . . . . 0.0 112.382 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -76.08 -17.16 59.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.892 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.72 45.21 66.62 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.92 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -73.33 -46.09 51.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.656 0.265 . . . . 0.0 110.414 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.96 -18.82 5.87 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.668 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 2.8 p30 -147.87 164.36 33.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.703 0.287 . . . . 0.0 110.751 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.525 ' O ' ' HB3' ' A' ' 30' ' ' ARG . 35.1 pt -132.2 145.71 34.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.533 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.58 ' HA ' ' HG3' ' A' ' 30' ' ' ARG . 3.5 p-10 -76.75 171.07 15.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.142 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.566 ' HE1' ' HA ' ' A' ' 16' ' ' GLU . 21.3 t80 -55.21 -42.75 73.74 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.55 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.462 ' O ' HG13 ' A' ' 74' ' ' ILE . 15.3 t70 -59.11 -45.08 91.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.756 0.312 . . . . 0.0 110.829 -174.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.449 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 22.1 m -65.19 -31.83 73.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.629 177.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -80.21 -30.99 38.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.306 0.574 . . . . 0.0 109.77 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -66.39 -39.06 88.82 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.717 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 70' ' ' ASP . 61.7 mt -64.95 -43.5 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.056 0.455 . . . . 0.0 109.822 175.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.586 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 79.3 mt -55.87 -50.9 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.815 173.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.413 ' HA2' ' CD1' ' A' ' 80' ' ' LEU . . . -61.01 -43.33 99.58 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.585 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.92 -30.1 71.08 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.981 0.42 . . . . 0.0 111.452 -174.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 15.2 ptm180 -87.63 -11.02 49.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.781 -175.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.493 ' CD1' ' HG3' ' A' ' 78' ' ' ARG . 22.5 m-85 -120.29 -42.83 2.55 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.899 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.66 HD13 HD21 ' A' ' 15' ' ' LEU . 2.5 mp . . . . . 0 CA--C 1.511 -0.544 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 110.521 -0.178 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.584 HD12 ' HE1' ' A' ' 149' ' ' PHE . 0.4 OUTLIER -42.34 -41.37 2.81 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 123.721 0.638 . . . . 0.0 110.824 178.415 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.494 ' HA ' ' CE1' ' A' ' 97' ' ' PHE . 36.1 mmt180 -45.72 -42.0 11.3 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 124.038 0.837 . . . . 0.0 111.555 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.634 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 43.2 mt-10 -85.82 -32.71 21.61 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.668 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.602 ' O ' ' HB2' ' A' ' 99' ' ' LEU . . . -84.39 -39.85 18.54 Favored 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.475 -167.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.494 ' CE1' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -77.66 -19.71 54.96 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.895 178.69 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -76.74 -12.09 59.94 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.55 169.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 73.4 mt -84.43 -18.09 37.12 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.973 168.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' TYR . . . . . 0.59 ' HD1' ' O ' ' A' ' 96' ' ' ALA . 37.1 m-85 -105.29 -2.78 23.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.035 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -72.37 80.87 1.03 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.588 0.709 . . . . 0.0 111.135 -172.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -54.19 -46.32 72.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.937 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -84.07 -28.35 27.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.15 -168.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.08 63.8 1.43 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.404 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -114.7 -17.98 11.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.006 0.431 . . . . 0.0 110.536 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.85 -21.36 36.92 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -168.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.754 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 2.3 m-85 -116.53 164.85 13.96 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 172.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.721 ' HB ' HG13 ' A' ' 112' ' ' VAL . 3.3 pt -103.49 127.6 57.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.986 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.4 ' HA ' HG22 ' A' ' 143' ' ' THR . 45.9 m -66.56 168.82 8.55 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 -177.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.509 ' HB ' ' CG2' ' A' ' 133' ' ' ILE . 72.5 p -61.77 -31.75 71.97 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.544 0.687 . . . . 0.0 110.308 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.16 -34.29 77.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.107 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.721 HG13 ' HB ' ' A' ' 108' ' ' ILE . 2.2 p -87.15 -34.82 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.191 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' MET . . . . . 0.718 ' SD ' HG11 ' A' ' 144' ' ' VAL . 2.5 tpt -55.03 -38.81 68.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.036 0.446 . . . . 0.0 110.503 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.731 ' HB2' ' HB3' ' A' ' 129' ' ' LEU . 5.9 ptp180 -66.9 -49.63 64.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.545 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.499 ' HG2' ' HA ' ' A' ' 112' ' ' VAL . 15.3 pt-20 -63.4 -27.54 69.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.745 0.307 . . . . 0.0 111.071 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.516 HD12 HD13 ' A' ' 108' ' ' ILE . 19.9 mt -66.26 -48.24 81.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.174 0.511 . . . . 0.0 110.148 173.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.569 HD12 ' HG ' ' A' ' 124' ' ' LEU . 1.2 tm? -61.06 -51.52 68.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.718 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.554 ' HB2' HD11 ' A' ' 129' ' ' LEU . . . -60.13 -22.18 62.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.302 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -68.14 -45.92 72.27 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.5 mp -77.47 -53.62 7.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.353 0.597 . . . . 0.0 109.852 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.619 ' HB3' HD23 ' A' ' 124' ' ' LEU . 18.0 m-20 -96.47 90.12 5.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.931 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -76.89 15.35 0.68 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.06 -173.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 78.8 p -103.83 -13.7 16.31 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.503 0.668 . . . . 0.0 110.35 -177.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.619 HD23 ' HB3' ' A' ' 121' ' ' ASP . 4.1 mm? -75.32 119.18 19.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.64 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 21.9 t -89.94 177.84 6.37 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.1 t -57.1 -45.38 83.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.752 0.31 . . . . 0.0 110.863 -176.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 128' ' ' ASP . 3.0 pm0 -66.55 -38.36 86.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.054 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.493 ' HB3' HD13 ' A' ' 124' ' ' LEU . 40.9 m-20 -63.4 -49.74 72.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.157 0.503 . . . . 0.0 110.013 178.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.731 ' HB3' ' HB2' ' A' ' 114' ' ' ARG . 74.4 mt -56.74 -38.23 72.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.544 178.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -62.37 -39.74 94.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.861 0.363 . . . . 0.0 110.273 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.19 -43.35 70.94 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.552 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 27.2 mtt -61.13 -37.33 82.45 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.591 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.509 ' CG2' ' HB ' ' A' ' 110' ' ' THR . 10.1 mm -59.7 -47.32 91.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.078 0.466 . . . . 0.0 110.744 175.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.01 -39.04 68.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.791 0.805 . . . . 0.0 110.457 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.26 -44.99 23.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.407 -1.27 . . . . 0.0 111.831 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.441 HG21 ' HG2' ' A' ' 113' ' ' MET . 60.1 mt -59.76 -57.3 12.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 123.305 0.642 . . . . 0.0 112.21 -177.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.18 94.71 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.784 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.37 -53.92 7.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.421 -175.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -82.25 -12.99 57.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.352 0.596 . . . . 0.0 110.888 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 64.35 38.42 95.81 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.352 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.4 m -66.94 -14.81 63.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.343 0.592 . . . . 0.0 111.133 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.72 -16.81 58.28 Favored Glycine 0 CA--C 1.504 -0.595 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.526 ' HB ' ' HB2' ' A' ' 107' ' ' TYR . 2.3 p -140.99 135.45 31.16 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.491 -0.855 . . . . 0.0 109.27 175.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.718 HG11 ' SD ' ' A' ' 113' ' ' MET . 51.0 t -81.65 124.17 38.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.754 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 14.5 t70 -146.43 -64.21 0.3 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.777 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PHE . . . . . 0.586 ' HD2' ' H ' ' A' ' 147' ' ' GLU . 1.2 p90 -94.12 -97.98 0.15 Allowed 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.704 -166.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.586 ' H ' ' HD2' ' A' ' 146' ' ' PHE . 54.1 mt-10 -70.67 -22.05 62.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.002 0.43 . . . . 0.0 110.554 -177.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.448 ' CB ' HG13 ' A' ' 144' ' ' VAL . 5.9 mp0 -65.76 -53.77 36.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.172 0.51 . . . . 0.0 110.182 176.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.635 ' CD2' HD11 ' A' ' 108' ' ' ILE . 24.4 t80 -72.91 -39.2 66.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.379 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 16.3 ttm -56.05 -51.69 66.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.191 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.68 -41.99 96.05 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.082 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 149' ' ' PHE . 14.7 p -77.27 -37.3 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 111.927 0.344 . . . . 0.0 111.927 -176.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 50.0 tpp -92.0 -49.72 6.07 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -173.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.4 p . . . . . 0 C--N 1.328 -0.348 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.113 -173.098 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 121.265 0.555 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.86 -83.96 0.58 Allowed Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -170.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.557 ' HB2' ' HB2' ' A' ' 6' ' ' LYS . 7.8 m-20 64.17 -178.29 0.16 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.197 0.523 . . . . 0.0 111.924 173.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.6 m -128.55 -31.19 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.605 171.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.3 p -81.6 -8.64 59.74 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.854 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.557 ' HB2' ' HB2' ' A' ' 3' ' ' ASP . 1.5 mptm? -78.17 -13.32 59.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.893 175.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.483 ' HG ' ' CB ' ' A' ' 77' ' ' ALA . 10.1 mt -89.33 121.17 31.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.317 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.0 t -80.47 148.96 30.26 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 171.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.1 m -56.93 -26.54 59.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.003 -176.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -56.65 -44.48 81.36 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.249 0.547 . . . . 0.0 110.251 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.66 HE21 ' HG2' ' A' ' 82' ' ' GLU . 7.4 mt-30 -74.91 -36.11 62.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.987 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.5 t -64.24 -31.29 52.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.872 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -54.88 -53.63 52.96 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.694 0.283 . . . . 0.0 110.744 173.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.6 mp -59.09 -44.48 91.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.99 0.424 . . . . 0.0 110.325 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.442 HD21 HD21 ' A' ' 80' ' ' LEU . 82.1 mt -57.63 -57.66 11.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.189 178.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -58.9 -41.34 86.98 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.568 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.0 m -63.88 -41.13 97.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 0.0 111.289 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.463 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -82.11 -27.64 32.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.029 0.443 . . . . 0.0 110.469 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.513 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 71.8 t80 -57.31 -54.59 45.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.398 177.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.52 ' HA ' ' HB2' ' A' ' 23' ' ' GLU . 26.2 mmt180 -71.36 -21.65 62.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.117 -177.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.65 -44.21 74.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.915 -175.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.63 ' CD1' HG12 ' A' ' 39' ' ' ILE . 52.6 m-85 -106.44 17.16 23.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.473 0.654 . . . . 0.0 110.124 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.576 ' HG2' ' N ' ' A' ' 24' ' ' THR . 10.2 tt0 -71.43 152.84 42.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.334 -172.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.576 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.4 OUTLIER 75.05 138.1 0.06 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 158.798 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -88.74 -43.42 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.588 2.858 . . . . 0.0 111.652 172.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -156.02 25.08 0.37 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.671 0.748 . . . . 0.0 109.415 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.59 63.36 0.76 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.592 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.1 t -105.46 -30.1 9.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.921 0.391 . . . . 0.0 110.763 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.58 -11.36 66.71 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.873 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.734 ' HB2' ' OD2' ' A' ' 66' ' ' ASP . 3.3 mpt_? -110.95 172.22 7.0 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.476 HG23 ' HA ' ' A' ' 23' ' ' GLU . 12.8 p -108.03 129.59 61.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-O 121.941 0.877 . . . . 0.0 110.201 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.444 ' HA ' ' HB3' ' A' ' 66' ' ' ASP . 44.3 t -57.25 141.3 47.1 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 113.593 -1.64 . . . . 0.0 111.856 -175.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.544 ' HB ' HG12 ' A' ' 56' ' ' ILE . 28.4 p -67.74 -19.37 65.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.407 -178.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -76.2 -21.78 56.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.317 0.579 . . . . 0.0 109.758 175.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.506 ' HB3' ' HB3' ' A' ' 22' ' ' PHE . 34.1 mm-40 -91.96 -21.65 20.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.939 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.675 HG22 HD22 ' A' ' 40' ' ' LEU . 71.3 mt -54.68 -46.67 73.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.673 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.98 -22.5 68.72 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.261 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.607 ' O ' HG13 ' A' ' 42' ' ' VAL . 25.8 mt -77.86 -54.85 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.737 ' HA ' HG13 ' A' ' 42' ' ' VAL . 36.5 mt -60.92 -37.89 77.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.203 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.675 HD22 HG22 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -60.49 -24.64 65.45 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.09 0.472 . . . . 0.0 110.181 176.191 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.518 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 39.2 tt0 -82.56 -39.73 21.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.819 172.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.737 HG13 ' HA ' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -62.03 -31.45 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 121.771 0.796 . . . . 0.0 110.865 177.73 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.454 HD11 ' HZ ' ' A' ' 72' ' ' PHE . 50.8 mt -92.79 -6.35 49.13 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.958 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.01 39.49 96.46 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.494 -0.775 . . . . 0.0 113.518 176.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pt -113.35 -83.41 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -72.34 179.67 3.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.558 0.694 . . . . 0.0 112.672 -174.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -102.05 -171.0 1.9 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.552 -175.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.44 ' O ' HG12 ' A' ' 52' ' ' ILE . 14.3 t -62.81 -179.46 0.27 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -52.28 -34.57 47.15 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -170.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.1 m -52.19 -40.2 61.18 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.152 0.501 . . . . 0.0 111.049 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 53.4 m -81.75 -34.59 30.36 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.659 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 48' ' ' THR . 42.0 mm -64.67 -27.38 42.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.283 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -57.5 -32.99 67.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.98 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.7 mm-40 -65.66 -49.44 68.6 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.645 HD11 ' CE2' ' A' ' 79' ' ' PHE . 3.0 mm? -53.67 -52.43 59.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.994 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.544 HG12 ' HB ' ' A' ' 33' ' ' THR . 60.2 mt -63.26 -44.84 99.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.409 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -59.59 -30.96 69.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.189 0.519 . . . . 0.0 110.757 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -84.21 -51.71 6.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.208 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.447 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 80.3 m-85 -90.59 -17.18 27.39 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -172.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.45 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 51.6 t0 -129.55 65.88 75.71 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 121.069 0.461 . . . . 0.0 110.88 175.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 22.9 Cg_exo -70.06 -17.25 36.32 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.913 2.409 . . . . 0.0 111.419 175.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -80.09 -17.86 51.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.116 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.97 40.73 73.3 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.778 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -76.0 -41.39 51.33 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.098 0.475 . . . . 0.0 110.423 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 117.83 -33.96 4.69 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.112 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.734 ' OD2' ' HB2' ' A' ' 30' ' ' ARG . 2.3 p-10 -139.47 148.43 42.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.151 0.501 . . . . 0.0 111.004 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.493 ' O ' ' HB3' ' A' ' 30' ' ' ARG . 44.1 pt -114.34 143.66 23.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.036 -174.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.459 ' HA ' ' HG3' ' A' ' 30' ' ' ARG . 1.9 p30 -74.36 174.08 9.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.826 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' A' ' 73' ' ' LYS . 5.0 t80 -63.55 -37.81 88.73 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.119 -175.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.497 ' O ' HG13 ' A' ' 74' ' ' ILE . 38.3 t70 -61.64 -42.68 99.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.925 0.393 . . . . 0.0 110.628 -176.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.7 m -65.53 -42.86 91.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.331 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.454 ' HZ ' HD11 ' A' ' 43' ' ' LEU . 75.8 t80 -69.11 -32.27 71.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.465 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 69' ' ' PHE . 40.8 ttmt -63.29 -44.04 96.18 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.61 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 70' ' ' ASP . 64.7 mt -62.29 -40.75 88.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.127 0.489 . . . . 0.0 110.05 176.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.6 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 78.6 mt -58.22 -51.09 75.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.128 175.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.514 ' CA ' HD23 ' A' ' 80' ' ' LEU . . . -62.52 -41.55 99.78 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.3 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.483 ' CB ' ' HG ' ' A' ' 7' ' ' LEU . . . -65.35 -25.72 67.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.953 0.406 . . . . 0.0 111.591 -174.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 11.8 ptm180 -93.08 -12.67 29.95 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.768 -176.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.645 ' CE2' HD11 ' A' ' 55' ' ' LEU . 23.9 m-85 -120.71 -37.35 3.01 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -174.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.514 HD23 ' CA ' ' A' ' 76' ' ' GLY . 3.2 mm? -48.65 -76.38 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -173.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 44.69 45.46 8.79 Favored Glycine 0 C--N 1.331 0.256 0 O-C-N 123.84 0.712 . . . . 0.0 112.471 -175.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.66 ' HG2' HE21 ' A' ' 11' ' ' GLN . 11.0 pt-20 -82.05 18.06 1.44 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.046 0.451 . . . . 0.0 111.023 -176.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -80.21 90.61 5.51 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.701 0.762 . . . . 0.0 110.864 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 t -128.98 77.92 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.371 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.497 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 5.7 t-20 -85.89 138.95 34.96 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.771 -171.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 5.4 Cg_exo -75.27 -22.09 14.71 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.929 3.086 . . . . 0.0 111.808 -175.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -95.62 19.56 10.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.908 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -79.74 118.25 21.37 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 24.7 ptm 45.61 30.79 0.83 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.657 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -139.56 148.29 42.36 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 175.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.504 ' HA ' ' HE1' ' A' ' 150' ' ' MET . 40.1 mt-30 54.56 27.5 8.54 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.507 0.504 . . . . 0.0 111.045 -173.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.05 -18.67 59.11 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.534 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.654 ' H ' HD22 ' A' ' 93' ' ' LEU . 1.2 mm? -52.65 -28.11 20.07 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.126 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.649 ' HD3' ' HE2' ' A' ' 97' ' ' PHE . 30.7 mmt180 -57.0 -51.39 69.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.063 0.459 . . . . 0.0 111.361 177.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -77.74 -21.7 51.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.059 0.456 . . . . 0.0 110.327 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.536 ' HB3' ' HA ' ' A' ' 93' ' ' LEU . . . -77.51 -13.73 59.85 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.048 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.649 ' HE2' ' HD3' ' A' ' 94' ' ' ARG . 21.0 m-85 -61.4 -48.23 82.16 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.641 176.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.4 mtm-85 -67.17 -23.73 65.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.205 0.526 . . . . 0.0 110.386 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.9 tp -67.76 -37.31 81.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.753 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.688 ' O ' ' HD2' ' A' ' 102' ' ' LYS . 85.6 m-85 -104.12 -5.7 21.78 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.122 -176.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -78.27 80.32 4.68 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.461 0.648 . . . . 0.0 111.528 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.688 ' HD2' ' O ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -60.71 -39.75 89.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.002 173.27 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -72.27 -37.13 69.12 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.498 -169.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.18 48.46 2.23 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.91 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -113.18 -17.22 12.41 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.973 0.416 . . . . 0.0 110.526 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.12 -24.91 13.69 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -170.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.535 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 4.0 m-85 -109.37 150.9 27.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 173.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.683 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 14.8 pt -91.81 131.17 39.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.748 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.5 m -69.3 170.05 11.04 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.312 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.435 ' HB ' ' CG2' ' A' ' 133' ' ' ILE . 36.8 p -67.59 -23.72 65.42 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 121.846 -0.534 . . . . 0.0 110.724 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 114' ' ' ARG . 29.6 m-20 -62.43 -50.49 71.29 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 176.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.683 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.4 p -71.69 -35.0 54.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.719 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.657 ' SD ' HG11 ' A' ' 144' ' ' VAL . 2.9 tpt -57.37 -40.06 77.34 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 111' ' ' ASP . 76.0 mtt180 -53.04 -56.9 12.6 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.636 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 112' ' ' VAL . 13.3 pt-20 -65.23 -30.4 71.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.433 -175.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 112' ' ' VAL . 57.1 mt -63.43 -47.72 90.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.705 0.288 . . . . 0.0 110.798 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 113' ' ' MET . 9.6 mt -58.49 -55.63 32.55 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.168 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.435 ' HB2' HD11 ' A' ' 129' ' ' LEU . . . -49.19 -37.77 23.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.408 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -65.23 -56.57 12.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.909 0.385 . . . . 0.0 110.751 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -66.76 -44.53 81.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.079 0.466 . . . . 0.0 111.19 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.556 ' HB3' HD23 ' A' ' 124' ' ' LEU . 5.7 m-20 -119.46 88.01 2.85 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.531 -178.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -76.02 23.0 0.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.321 0.581 . . . . 0.0 111.589 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.443 ' H ' ' C ' ' A' ' 121' ' ' ASP . 39.6 p -102.77 -13.46 17.02 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.916 0.865 . . . . 0.0 109.227 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' A' ' 121' ' ' ASP . 4.0 mm? -85.06 115.63 22.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.373 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.458 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 42.7 m -77.08 172.19 13.62 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.9 p -56.75 -43.49 80.79 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.692 0.282 . . . . 0.0 111.581 -174.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -68.8 -40.08 79.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.0 110.751 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.448 ' HB3' ' CD1' ' A' ' 124' ' ' LEU . 5.6 m-20 -59.34 -42.36 91.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.465 176.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.618 ' O ' HG12 ' A' ' 133' ' ' ILE . 95.8 mt -54.63 -43.39 72.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.75 175.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.482 ' O ' ' HB ' ' A' ' 133' ' ' ILE . 31.5 t70 -63.2 -40.25 96.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.268 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.2 -40.58 82.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.164 177.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 9.1 mtt -57.77 -43.51 85.54 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 173.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.618 HG12 ' O ' ' A' ' 129' ' ' LEU . 21.5 mm -51.69 -49.94 33.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.066 176.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -58.98 -43.32 91.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.733 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -72.11 -35.02 69.06 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.567 -176.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.612 HD11 HD21 ' A' ' 117' ' ' LEU . 67.6 mt -65.81 -58.79 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.983 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -68.22 93.78 0.48 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.581 0.705 . . . . 0.0 110.102 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.91 -29.51 50.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.961 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -88.19 -14.4 38.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.274 0.559 . . . . 0.0 110.862 -174.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 69.22 28.29 72.88 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.273 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 6.5 t -80.67 -18.28 48.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.083 0.468 . . . . 0.0 110.15 -175.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.71 -31.31 8.73 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.287 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 21.9 p -114.87 143.14 45.6 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.657 HG11 ' SD ' ' A' ' 113' ' ' MET . 61.0 t -89.04 118.3 34.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.535 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 28.5 t70 -144.17 -73.26 0.27 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.762 -178.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.633 ' O ' ' HG2' ' A' ' 150' ' ' MET . 0.1 OUTLIER -79.28 -97.17 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.122 -166.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -82.95 -11.78 57.87 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 121.583 -0.698 . . . . 0.0 110.94 -173.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.613 ' CD ' ' H ' ' A' ' 148' ' ' GLU . 3.9 mp0 -61.81 -58.42 8.06 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.9 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.629 ' HA ' HG12 ' A' ' 152' ' ' VAL . 10.7 t80 -73.82 -46.73 43.37 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.677 -176.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' MET . . . . . 0.633 ' HG2' ' O ' ' A' ' 146' ' ' PHE . 46.8 mmm -61.12 -18.41 57.84 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.742 0.306 . . . . 0.0 110.964 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -95.97 -20.3 26.41 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.066 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.629 HG12 ' HA ' ' A' ' 149' ' ' PHE . 9.1 p -95.72 -36.31 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 117.314 0.557 . . . . 0.0 111.067 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.468 ' SD ' HG23 ' A' ' 154' ' ' THR . 0.9 OUTLIER -90.74 -47.55 7.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.055 -177.307 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.468 HG23 ' SD ' ' A' ' 153' ' ' MET . 25.6 p -114.22 41.51 2.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.039 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -84.72 -35.84 12.76 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.84 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.41 76.54 1.3 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.511 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.16 -46.57 79.26 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.075 0.55 . . . . 0.0 111.87 -177.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.272 -173.179 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' A' ' 1' ' ' MET . 21.0 ptp . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 121.434 0.635 . . . . 0.0 110.466 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 147.3 62.13 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.175 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.808 ' HB3' ' HB3' ' A' ' 6' ' ' LYS . 11.7 m-20 -79.88 69.01 6.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.724 0.297 . . . . 0.0 110.231 177.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.8 t -57.8 -48.39 83.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -170.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.1 m -85.15 4.99 31.84 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.145 0.498 . . . . 0.0 111.235 -177.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.808 ' HB3' ' HB3' ' A' ' 3' ' ' ASP . 0.8 OUTLIER -96.25 -25.98 15.59 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.457 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.452 HD12 ' HB2' ' A' ' 11' ' ' GLN . 4.4 mm? -57.26 121.82 11.03 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.547 175.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.3 m -85.54 44.75 1.13 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -170.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.9 m 71.45 -41.83 0.52 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -56.42 -50.7 70.88 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -174.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.638 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 8.1 mm100 -60.46 -41.44 94.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.515 0.674 . . . . 0.0 109.754 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.434 ' HA ' HD12 ' A' ' 15' ' ' LEU . 26.8 t -62.01 -35.55 69.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.066 -178.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -62.16 -47.45 84.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.661 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.53 -45.21 92.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.904 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.665 HD21 ' CD1' ' A' ' 80' ' ' LEU . 84.5 mt -56.08 -52.7 63.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.773 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 27.4 tt0 -62.52 -38.86 91.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.773 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 91.0 m -59.03 -52.21 66.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.735 0.302 . . . . 0.0 110.483 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.499 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -69.55 -33.77 73.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.139 0.495 . . . . 0.0 110.366 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.742 ' CE1' HG22 ' A' ' 31' ' ' VAL . 86.1 t80 -53.67 -58.78 5.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.584 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -61.27 -31.62 71.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.799 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -69.09 -43.91 73.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.834 0.35 . . . . 0.0 111.245 -175.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.482 ' CD2' HG12 ' A' ' 39' ' ' ILE . 56.0 m-85 -100.64 8.69 43.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.342 0.592 . . . . 0.0 110.132 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.564 ' HA ' HG13 ' A' ' 31' ' ' VAL . 3.9 tt0 -69.25 154.12 42.55 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.19 -177.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.806 HG23 ' H ' ' A' ' 27' ' ' GLY . 0.6 OUTLIER 79.75 131.78 0.04 OUTLIER Pre-proline 0 N--CA 1.437 -1.118 0 O-C-N 124.301 1.001 . . . . 0.0 112.863 161.582 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.86 -34.7 0.19 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.328 2.686 . . . . 0.0 111.163 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -165.52 32.1 0.05 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.041 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.806 ' H ' HG23 ' A' ' 24' ' ' THR . . . 98.32 66.41 0.88 Allowed Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.831 -175.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.7 t -111.68 -31.09 7.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.814 0.34 . . . . 0.0 111.002 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.02 -14.21 65.71 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.523 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.558 ' HG3' ' HA ' ' A' ' 68' ' ' ASP . 4.8 mpt_? -106.72 172.49 6.79 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.742 HG22 ' CE1' ' A' ' 19' ' ' PHE . 0.1 OUTLIER -105.19 129.93 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.568 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.272 172.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.6 t -54.0 138.88 36.05 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.994 -1.457 . . . . 0.0 108.723 171.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.581 ' HB ' HG12 ' A' ' 56' ' ' ILE . 2.9 p -67.03 -12.86 61.08 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.056 -174.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -72.05 -42.59 66.09 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.663 ' HA ' HD13 ' A' ' 38' ' ' ILE . 33.3 mm-40 -74.03 -16.22 61.06 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.438 -174.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.736 HG22 HD22 ' A' ' 40' ' ' LEU . 47.1 mt -59.01 -34.21 52.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.429 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -74.17 -36.98 49.77 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.328 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.663 HD13 ' HA ' ' A' ' 35' ' ' GLN . 1.3 mp -58.79 -55.28 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-O 121.5 0.666 . . . . 0.0 109.762 174.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.499 HG23 ' HB1' ' A' ' 18' ' ' ALA . 53.7 mt -63.14 -43.54 98.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.451 -176.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.736 HD22 HG22 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -61.91 -27.42 68.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.935 0.398 . . . . 0.0 110.713 177.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.66 -43.61 46.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.175 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 38' ' ' ILE . 64.0 t -54.78 -47.72 73.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.56 176.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.596 HD13 HD23 ' A' ' 15' ' ' LEU . 58.0 mt -86.58 4.3 40.73 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.358 -173.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.24 41.71 99.57 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.19 -0.914 . . . . 0.0 113.71 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -116.12 -77.3 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.591 ' HG2' HD21 ' A' ' 55' ' ' LEU . 2.9 tp60 -81.57 -176.49 6.07 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.418 0.627 . . . . 0.0 112.46 -176.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.418 ' HB2' ' CB ' ' A' ' 51' ' ' THR . 45.2 mt-30 -110.62 -170.38 1.63 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.505 -174.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.465 ' O ' HG12 ' A' ' 52' ' ' ILE . 13.5 t -56.89 176.97 0.09 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.491 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 63.0 mttm -52.24 -35.31 49.4 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.85 0.46 . . . . 0.0 112.155 -173.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.8 m -54.6 -34.31 61.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.251 0.548 . . . . 0.0 111.185 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.418 ' CB ' ' HB2' ' A' ' 47' ' ' GLN . 60.5 m -85.98 -34.23 20.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.483 0.658 . . . . 0.0 110.41 177.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.847 ' HA ' HD23 ' A' ' 55' ' ' LEU . 44.1 mm -63.4 -23.53 33.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.343 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 34.5 mmt180 -50.8 -38.69 49.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.558 173.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.475 ' HA ' ' OD2' ' A' ' 57' ' ' ASP . 7.3 mm-40 -60.54 -43.83 96.77 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.713 0.633 . . . . 0.0 110.653 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.847 HD23 ' HA ' ' A' ' 52' ' ' ILE . 3.1 mm? -62.21 -46.33 89.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.386 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.581 HG12 ' HB ' ' A' ' 33' ' ' THR . 64.1 mt -66.81 -47.66 82.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.304 -176.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.475 ' OD2' ' HA ' ' A' ' 54' ' ' GLN . 1.7 p30 -66.28 -19.75 65.91 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.059 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -85.11 -53.75 5.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.37 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.414 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 89.1 m-85 -95.1 -17.0 22.22 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -171.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.409 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 21.0 t0 -128.22 68.25 76.35 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.09 0.471 . . . . 0.0 111.317 176.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.414 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 24.3 Cg_exo -69.75 -17.83 37.42 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.504 2.136 . . . . 0.0 110.492 171.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -69.88 -17.96 63.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.993 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.32 30.39 77.4 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -81.36 -27.31 34.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.273 -0.464 . . . . 0.0 110.868 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.5 -19.44 39.41 Favored Glycine 0 CA--C 1.509 -0.312 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.122 173.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -145.83 158.02 43.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.89 0.376 . . . . 0.0 110.933 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.457 ' HB ' ' HB2' ' A' ' 71' ' ' SER . 28.8 pt -126.92 142.54 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.556 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.558 ' HA ' ' HG3' ' A' ' 30' ' ' ARG . 0.5 OUTLIER -75.13 175.94 7.76 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.514 -176.877 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -60.66 -39.69 89.31 Favored 'General case' 0 C--O 1.213 -0.829 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.081 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.489 ' O ' HG13 ' A' ' 74' ' ' ILE . 19.7 t70 -60.75 -39.91 90.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.997 0.427 . . . . 0.0 109.964 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.457 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 17.0 m -67.61 -43.62 80.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.749 176.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -69.38 -32.46 71.5 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.259 0.552 . . . . 0.0 110.223 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.435 ' HB3' ' HE2' ' A' ' 73' ' ' LYS . 34.9 ttpt -62.32 -42.4 99.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.099 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 70' ' ' ASP . 67.2 mt -65.41 -40.19 87.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.027 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.578 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 66.8 mt -56.38 -53.03 45.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.249 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.94 -41.05 99.62 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.151 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.04 -26.07 66.57 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 122.578 -0.366 . . . . 0.0 111.44 -174.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 15.8 ptm180 -89.92 -18.56 25.88 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.758 ' HE2' HD11 ' A' ' 55' ' ' LEU . 23.6 m-85 -108.52 -43.85 4.21 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.272 -174.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.665 ' CD1' HD21 ' A' ' 15' ' ' LEU . 2.4 mp -59.16 -67.97 0.32 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.459 0.171 . . . . 0.0 110.858 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 42.46 28.97 0.64 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 116.042 1.177 . . . . 0.0 116.042 169.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -97.09 22.49 8.43 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -58.22 105.85 0.32 Allowed 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.09 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.434 HG12 ' H ' ' A' ' 84' ' ' VAL . 2.2 p -68.18 89.92 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 113.734 -1.576 . . . . 0.0 110.359 176.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.545 ' ND2' ' HD2' ' A' ' 86' ' ' PRO . 1.5 t30 -47.76 138.29 9.59 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.139 174.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.545 ' HD2' ' ND2' ' A' ' 85' ' ' ASN . 89.3 Cg_exo -50.98 -47.22 26.61 Favored 'Trans proline' 0 CA--C 1.528 0.214 0 C-N-CA 124.547 3.498 . . . . 0.0 115.077 -165.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.435 ' HA ' ' HG2' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -104.49 -12.94 16.23 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.588 0.233 . . . . 0.0 111.488 -172.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -60.65 -32.96 72.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.926 -173.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.5 ttt -125.92 46.3 2.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.33 0.585 . . . . 0.0 110.815 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.461 ' HB3' ' HG3' ' A' ' 92' ' ' GLU . 15.4 mm100 -95.07 -70.66 0.7 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.766 175.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 38.98 48.57 1.44 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.856 0.836 . . . . 0.0 111.325 -173.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.461 ' HG3' ' HB3' ' A' ' 90' ' ' GLN . 42.7 mt-10 -61.48 -18.88 61.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.262 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.916 HD22 ' HE1' ' A' ' 149' ' ' PHE . 44.7 mt -42.74 -41.59 3.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.62 -1.173 . . . . 0.0 112.269 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.769 ' HD2' ' HE2' ' A' ' 97' ' ' PHE . 18.5 mmm180 -59.53 -39.96 85.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -176.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -86.07 -18.28 32.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.125 0.488 . . . . 0.0 110.249 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.499 ' HA ' HD12 ' A' ' 99' ' ' LEU . . . -80.25 -19.9 45.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.678 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.769 ' HE2' ' HD2' ' A' ' 94' ' ' ARG . 23.0 m-85 -59.1 -44.45 91.96 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 98' ' ' ARG . 57.8 mtp180 -70.96 -13.06 61.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.822 0.344 . . . . 0.0 111.358 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 96' ' ' ALA . 97.0 mt -86.92 -27.55 23.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.89 0.376 . . . . 0.0 110.772 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.463 ' O ' HG21 ' A' ' 112' ' ' VAL . 76.2 m-85 -103.69 -14.63 16.03 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 97' ' ' PHE . 55.2 t0 -64.57 86.53 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.83 0.824 . . . . 0.0 111.197 -176.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -64.27 -18.33 64.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.655 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -96.18 -36.87 10.79 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.975 0.417 . . . . 0.0 112.119 -171.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.424 ' H ' ' CG ' ' A' ' 101' ' ' ASP . . . 92.08 39.46 5.44 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.491 175.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -114.82 -15.33 11.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.871 0.367 . . . . 0.0 111.807 -176.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.83 -22.31 35.79 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.198 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -100.22 167.55 10.37 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 172.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.61 ' HB ' HG13 ' A' ' 112' ' ' VAL . 8.3 pt -111.03 118.85 58.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.291 166.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.2 m -62.73 166.53 5.37 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.952 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.7 p -57.29 -32.91 67.13 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.9 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.507 ' O ' ' HG3' ' A' ' 115' ' ' GLU . 28.0 m-20 -61.59 -50.19 73.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.046 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.61 HG13 ' HB ' ' A' ' 108' ' ' ILE . 1.8 p -68.65 -37.43 77.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.854 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.691 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 2.8 tpt -56.66 -43.29 80.21 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 174.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.495 ' HA ' HD12 ' A' ' 117' ' ' LEU . 15.9 ttt180 -55.22 -48.52 73.77 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.448 175.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 111' ' ' ASP . 47.3 mt-10 -60.33 -41.73 94.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.684 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 70.6 mt -59.17 -50.34 80.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.03 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.691 ' HG ' ' O ' ' A' ' 113' ' ' MET . 11.0 mt -56.58 -60.18 3.91 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.43 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.01 -22.01 47.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.746 -177.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -82.51 -41.08 20.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.676 0.274 . . . . 0.0 110.876 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.7 mp -79.52 -47.66 15.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.049 0.452 . . . . 0.0 110.762 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.675 ' HB3' HD23 ' A' ' 124' ' ' LEU . 3.1 m-20 -105.84 99.37 8.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.057 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -84.56 4.34 32.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.338 -173.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 71.0 p -90.38 -10.97 41.98 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.376 0.608 . . . . 0.0 110.203 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.784 ' HB3' HD22 ' A' ' 129' ' ' LEU . 3.7 mm? -77.14 146.33 37.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.071 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.473 ' HB2' ' OD1' ' A' ' 128' ' ' ASP . 21.4 m -115.68 171.7 7.58 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.254 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.8 m -47.31 -46.34 25.11 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -173.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -79.32 -32.43 43.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.814 0.34 . . . . 0.0 111.2 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.473 ' OD1' ' HB2' ' A' ' 125' ' ' SER . 2.7 m-20 -64.61 -40.32 95.29 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.784 HD22 ' HB3' ' A' ' 124' ' ' LEU . 2.7 mm? -51.66 -43.24 62.61 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.148 173.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -65.22 -42.48 93.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.612 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.42 -45.52 91.3 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.361 0.6 . . . . 0.0 110.032 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 58.0 mmm -54.9 -53.73 51.7 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.681 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 20.1 mm -55.02 -46.39 77.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.583 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -56.44 -41.2 76.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.774 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -79.49 -31.04 42.21 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.161 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.423 HG12 ' CG2' ' A' ' 152' ' ' VAL . 49.3 mt -67.74 -58.39 6.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.134 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -69.76 93.87 0.77 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.592 0.71 . . . . 0.0 110.288 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.57 -40.26 42.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.807 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -82.85 -13.97 55.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.204 0.526 . . . . 0.0 111.065 -173.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 70.89 24.34 77.16 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.8 t -74.79 -18.26 60.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.387 0.613 . . . . 0.0 109.853 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.56 -26.97 9.25 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 25.3 p -114.59 128.92 56.58 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 175.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.675 HG11 ' SD ' ' A' ' 113' ' ' MET . 64.2 t -83.34 119.33 32.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.266 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.431 ' HB3' ' CD1' ' A' ' 146' ' ' PHE . 8.0 t70 -145.59 -55.58 0.3 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.128 0.489 . . . . 0.0 111.437 -175.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.431 ' CD1' ' HB3' ' A' ' 145' ' ' ASP . 0.4 OUTLIER -105.55 -97.14 0.34 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.815 -168.653 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -38.33 90.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.794 0.331 . . . . 0.0 111.069 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.663 ' CD ' ' H ' ' A' ' 148' ' ' GLU . 3.4 mp0 -50.46 -53.09 32.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.222 177.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.916 ' HE1' HD22 ' A' ' 93' ' ' LEU . 31.8 t80 -76.93 -38.74 52.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.013 -175.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 42.2 tpp -62.68 -43.57 98.46 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.375 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -70.26 -16.11 73.0 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.496 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.423 ' CG2' HG12 ' A' ' 136' ' ' ILE . 12.1 p -101.41 -40.57 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 117.391 0.595 . . . . 0.0 111.805 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.449 ' HG2' HD21 ' A' ' 93' ' ' LEU . 15.4 tpt -81.18 -49.14 11.17 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -172.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 80.5 p -93.72 15.51 16.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.142 0.496 . . . . 0.0 110.843 -175.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -75.96 79.08 1.17 Allowed Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.152 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 156.5 148.4 5.06 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.291 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.02 -58.31 3.35 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 . . . . . 0 C--O 1.248 0.987 0 O-C-N 124.456 1.098 . . . . 0.0 112.16 172.966 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.2 ttt . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 121.473 0.654 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.595 ' N ' ' HA ' ' A' ' 78' ' ' ARG . . . 121.96 50.07 0.25 Allowed Glycine 0 CA--C 1.506 -0.472 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.742 ' HB3' ' HB2' ' A' ' 6' ' ' LYS . 5.8 m-20 -104.08 78.66 1.54 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.858 -0.671 . . . . 0.0 110.969 -170.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.3 t -65.85 127.51 27.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.469 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 72.1 m 64.76 14.1 8.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.936 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.742 ' HB2' ' HB3' ' A' ' 3' ' ' ASP . 13.8 mptt -93.84 -19.62 20.82 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 165.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 mp -72.32 117.07 13.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.999 174.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 t -75.0 167.16 22.47 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.91 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.0 p -51.79 -38.21 54.69 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -171.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -54.12 -48.89 70.29 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.082 0.239 . . . . 0.0 111.406 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.435 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 9.3 mm100 -62.36 -45.95 90.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.697 0.761 . . . . 0.0 109.989 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.3 t -68.66 -31.5 51.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.441 -174.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.51 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 27.1 tptt -61.14 -41.34 96.55 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-O 120.756 0.312 . . . . 0.0 111.543 176.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 14' ' ' LEU . 4.4 mm? -67.41 -42.58 83.01 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 174.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.749 HD21 HD13 ' A' ' 80' ' ' LEU . 84.3 mt -58.3 -48.96 78.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.869 177.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -57.32 -54.98 40.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.326 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.577 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 27.8 m -59.83 -41.24 90.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.358 -175.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.715 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -74.83 -37.89 62.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.761 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.447 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 54.6 t80 -56.32 -59.19 5.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.979 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.11 -12.61 61.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.047 -174.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 17' ' ' THR . 2.1 t70 -80.29 -40.04 27.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.942 0.401 . . . . 0.0 110.531 -175.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.451 ' CD2' HG12 ' A' ' 39' ' ' ILE . 87.3 m-85 -105.99 6.9 31.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.408 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.45 ' HA ' HG23 ' A' ' 31' ' ' VAL . 3.8 tm-20 -62.82 152.49 35.92 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.262 -176.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.44 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER 86.24 130.86 0.03 OUTLIER Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 114.29 -1.323 . . . . 0.0 113.219 166.388 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -86.71 -40.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.441 2.761 . . . . 0.0 110.797 169.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -159.91 33.69 0.18 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.148 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.417 ' H ' HG23 ' A' ' 24' ' ' THR . . . 94.41 67.59 1.03 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.411 -176.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.5 t -112.22 -24.82 9.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.869 0.366 . . . . 0.0 111.328 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.09 -14.49 61.98 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -175.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.53 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 86.1 mtt180 -112.09 163.08 14.7 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.014 -0.593 . . . . 0.0 110.041 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.522 HG21 HD11 ' A' ' 39' ' ' ILE . 13.7 p -105.99 126.7 61.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 121.501 0.667 . . . . 0.0 110.093 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 8.2 t -53.6 139.51 31.6 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.029 -177.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.562 ' HB ' HG12 ' A' ' 56' ' ' ILE . 1.7 p -63.05 -18.85 63.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.04 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -73.8 -28.71 61.78 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.234 0.54 . . . . 0.0 110.375 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -86.98 -16.88 34.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.532 -177.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.739 HG22 HD22 ' A' ' 40' ' ' LEU . 52.6 mt -55.39 -41.4 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.817 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.432 ' CA ' HG13 ' A' ' 52' ' ' ILE . . . -61.97 -38.73 96.53 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.413 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.639 ' O ' HG23 ' A' ' 42' ' ' VAL . 31.5 mt -63.56 -52.18 61.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.302 0.572 . . . . 0.0 109.595 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.715 HG23 ' HB1' ' A' ' 18' ' ' ALA . 69.6 mt -60.09 -44.49 95.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.52 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.739 HD22 HG22 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -60.63 -25.41 66.27 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.808 178.55 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -80.02 -40.6 27.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.001 174.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 38' ' ' ILE . 43.1 t -53.88 -43.91 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.924 0.868 . . . . 0.0 109.79 174.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.7 mt -86.38 -4.02 59.1 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.939 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.9 39.48 89.48 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-N 115.444 -0.798 . . . . 0.0 113.705 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pt -116.17 -84.8 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.443 ' HG2' HD21 ' A' ' 55' ' ' LEU . 3.1 tp60 -78.25 -171.42 2.38 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.248 0.547 . . . . 0.0 112.41 -177.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -123.33 -170.79 2.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.434 -172.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.1 t -54.94 170.87 0.16 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.835 0.826 . . . . 0.0 112.968 -176.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -51.32 -34.52 33.89 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.344 -1.298 . . . . 0.0 113.204 -167.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 m -58.94 -32.39 69.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.084 0.468 . . . . 0.0 110.845 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -82.42 -32.76 28.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.392 0.615 . . . . 0.0 110.018 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.906 ' HA ' HD23 ' A' ' 55' ' ' LEU . 44.4 mm -68.7 -23.62 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.221 -177.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -50.17 -30.98 12.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.42 173.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -65.92 -55.19 18.18 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.306 0.574 . . . . 0.0 109.834 174.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.906 HD23 ' HA ' ' A' ' 52' ' ' ILE . 2.5 mm? -52.76 -50.06 64.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.435 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.562 HG12 ' HB ' ' A' ' 33' ' ' THR . 61.0 mt -63.52 -46.89 93.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.926 -177.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -61.39 -24.68 66.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.508 0.671 . . . . 0.0 110.727 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.477 ' CD ' HH12 ' A' ' 78' ' ' ARG . 29.6 tt0 -87.98 -51.28 5.91 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.226 -177.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.498 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 90.1 m-85 -94.53 -17.1 22.72 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -173.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.463 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 46.5 t0 -129.99 62.67 65.23 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-O 121.171 0.51 . . . . 0.0 110.181 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.498 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 31.3 Cg_exo -63.11 -24.86 73.14 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.032 2.488 . . . . 0.0 112.159 -178.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -76.68 -17.29 59.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.569 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.28 41.32 59.56 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.688 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -67.71 -39.89 84.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.673 0.273 . . . . 0.0 110.751 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.18 -22.31 9.04 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.672 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 1.6 m-20 -139.79 178.49 7.21 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 27.2 pt -142.12 143.73 26.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.886 0.374 . . . . 0.0 110.331 177.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.53 ' HA ' ' HG2' ' A' ' 30' ' ' ARG . 25.6 t70 -83.39 166.9 18.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.807 176.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.481 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -56.09 -27.35 53.36 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 176.891 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -49.35 -51.44 34.54 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.87 0.367 . . . . 0.0 111.256 174.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 23.2 m -82.41 -36.88 26.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.924 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.481 ' HB3' ' HA ' ' A' ' 69' ' ' PHE . 89.8 t80 -64.83 -36.28 83.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.123 -178.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -62.32 -38.6 90.04 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.219 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.427 ' HB ' ' CE1' ' A' ' 59' ' ' PHE . 40.7 mt -69.48 -40.1 79.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.84 0.352 . . . . 0.0 110.105 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.605 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 78.1 mt -57.3 -48.48 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-O 121.41 0.624 . . . . 0.0 109.717 173.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.503 ' HA2' ' CD1' ' A' ' 80' ' ' LEU . . . -62.48 -45.19 96.39 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.065 177.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.97 -20.39 65.04 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -174.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 9.9 ptm180 -91.28 -16.7 27.13 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.527 -177.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.493 ' CE2' HD11 ' A' ' 55' ' ' LEU . 21.1 m-85 -118.34 -46.49 2.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.754 0.311 . . . . 0.0 110.921 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.749 HD13 HD21 ' A' ' 15' ' ' LEU . 3.2 mp -73.76 -20.09 60.59 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.329 0.585 . . . . 0.0 111.199 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.83 9.29 77.09 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.453 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -91.49 21.74 4.41 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -88.52 100.04 12.76 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.846 -172.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.55 72.85 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.252 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.515 ' HB3' ' HB3' ' A' ' 88' ' ' GLN . 1.1 t-20 -83.64 141.81 42.09 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.568 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 57.2 Cg_exo -53.53 -61.52 0.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.343 2.695 . . . . 0.0 112.354 -171.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -91.28 27.23 1.97 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.625 -174.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.515 ' HB3' ' HB3' ' A' ' 85' ' ' ASN . 34.7 tt0 -124.49 -55.54 1.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.865 -177.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 14.3 tpt -102.57 -31.11 10.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.782 -172.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -127.0 -166.22 1.57 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.378 -175.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 38.68 48.95 1.39 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.557 1.143 . . . . 0.0 112.825 -176.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.49 -19.29 46.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.826 174.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.647 ' H ' HD22 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -54.27 -26.93 31.77 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.302 -179.7 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.733 ' HD2' ' HE2' ' A' ' 97' ' ' PHE . 28.9 mmm180 -59.74 -35.63 74.95 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 120.807 0.337 . . . . 0.0 111.583 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -86.53 -26.93 24.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.253 0.549 . . . . 0.0 109.899 176.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.485 ' HB3' ' HA ' ' A' ' 93' ' ' LEU . . . -72.73 -11.05 60.47 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.937 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.733 ' HE2' ' HD2' ' A' ' 94' ' ' ARG . 21.3 m-85 -61.72 -52.22 65.15 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.727 -0.389 . . . . 0.0 109.963 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 98' ' ' ARG . 42.2 mtm180 -65.66 -17.96 64.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.212 0.529 . . . . 0.0 110.88 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 99' ' ' LEU . 12.4 tp -73.6 -38.63 65.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.826 177.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.667 ' O ' ' HD2' ' A' ' 102' ' ' LYS . 77.2 m-85 -100.16 -24.55 14.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.906 -176.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -69.3 82.68 0.37 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.413 0.625 . . . . 0.0 111.223 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.667 ' HD2' ' O ' ' A' ' 100' ' ' TYR . 9.8 mptt -56.53 -45.78 80.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.913 173.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -66.65 -37.23 84.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.432 -168.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.53 47.41 2.55 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.419 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -100.1 -17.46 17.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.692 0.282 . . . . 0.0 110.68 -178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.9 -24.99 15.16 Favored Glycine 0 N--CA 1.453 -0.188 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -172.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -113.53 162.38 16.24 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 171.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.678 ' HB ' HG13 ' A' ' 112' ' ' VAL . 10.2 pt -97.22 128.16 48.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.298 173.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.466 ' HA ' HG22 ' A' ' 143' ' ' THR . 49.1 m -69.45 166.97 17.64 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.317 -177.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.2 p -62.95 -24.88 68.09 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.992 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -64.78 -51.8 60.33 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.258 176.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.678 HG13 ' HB ' ' A' ' 108' ' ' ILE . 2.0 p -68.72 -35.06 68.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.727 0.299 . . . . 0.0 110.36 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.591 ' SD ' HG11 ' A' ' 144' ' ' VAL . 2.8 tpt -58.3 -40.18 81.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.099 0.476 . . . . 0.0 109.8 173.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.531 ' HG2' ' CD2' ' A' ' 129' ' ' LEU . 17.7 ttp180 -58.88 -46.03 88.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.162 176.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.471 ' OE1' ' HA ' ' A' ' 112' ' ' VAL . 34.6 mt-10 -60.68 -50.47 73.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.58 177.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 112' ' ' VAL . 63.6 mt -56.25 -53.6 37.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.43 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.599 HD11 ' SD ' ' A' ' 132' ' ' MET . 1.0 OUTLIER -57.33 -53.31 59.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.005 -178.316 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.523 ' HB2' HD22 ' A' ' 129' ' ' LEU . . . -64.33 -17.54 63.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.03 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -83.8 -53.26 5.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.682 0.277 . . . . 0.0 110.319 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.58 -44.04 79.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.991 0.424 . . . . 0.0 110.313 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.67 ' HB3' HD23 ' A' ' 124' ' ' LEU . 6.2 m-20 -112.19 84.85 2.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.254 0.549 . . . . 0.0 109.969 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -79.79 12.63 2.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.626 0.727 . . . . 0.0 110.908 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 69.8 p -95.44 -5.56 42.82 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.194 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.67 HD23 ' HB3' ' A' ' 121' ' ' ASP . 4.2 mm? -78.82 149.42 32.57 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.315 174.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.423 ' H ' ' HB2' ' A' ' 128' ' ' ASP . 24.0 m -116.93 170.18 8.82 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.6 p -48.1 -48.43 33.75 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -73.45 -40.05 64.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.727 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 125' ' ' SER . 14.4 m-20 -67.41 -43.42 81.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.649 0.738 . . . . 0.0 110.077 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.531 ' CD2' ' HG2' ' A' ' 114' ' ' ARG . 45.2 tp -63.33 -38.4 91.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.925 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.28 -41.46 99.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.897 0.379 . . . . 0.0 110.223 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.86 -45.69 92.66 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.331 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.599 ' SD ' HD11 ' A' ' 117' ' ' LEU . 33.5 mtt -60.38 -42.98 97.0 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.385 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.515 HD11 ' HA ' ' A' ' 114' ' ' ARG . 21.2 mm -54.44 -50.21 59.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.081 0.467 . . . . 0.0 110.647 174.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.15 -44.7 75.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.788 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -80.78 -26.42 37.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.83 -175.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.494 HG12 ' CG2' ' A' ' 152' ' ' VAL . 51.9 mt -64.38 -54.81 26.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.73 0.3 . . . . 0.0 110.589 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -76.63 85.12 3.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.966 0.888 . . . . 0.0 109.554 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.58 -35.0 53.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.465 -1.243 . . . . 0.0 112.319 -173.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -91.58 -10.59 40.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.042 0.449 . . . . 0.0 110.851 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.58 38.7 13.62 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.197 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.49 -18.75 56.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.263 0.554 . . . . 0.0 110.495 -177.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.29 -40.9 3.08 Favored Glycine 0 C--O 1.23 -0.106 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.216 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.466 HG22 ' HA ' ' A' ' 109' ' ' SER . 13.0 p -114.77 137.68 51.65 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 173.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.623 HG13 ' HB2' ' A' ' 148' ' ' GLU . 57.8 t -82.06 124.98 39.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 O-C-N 123.611 0.57 . . . . 0.0 109.8 -176.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -145.53 -78.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.222 0.534 . . . . 0.0 112.206 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -76.74 -86.31 0.05 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -168.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -94.35 -14.39 25.4 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.983 -172.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.623 ' HB2' HG13 ' A' ' 144' ' ' VAL . 3.0 mp0 -64.24 -50.05 69.49 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.108 0.48 . . . . 0.0 109.945 174.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.564 ' HA ' HG12 ' A' ' 152' ' ' VAL . 19.1 t80 -75.43 -42.62 53.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.584 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' MET . . . . . 0.539 ' HA ' ' HE2' ' A' ' 150' ' ' MET . 0.0 OUTLIER -55.85 -46.17 78.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.935 0.398 . . . . 0.0 110.121 178.007 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 155' ' ' GLY . . . -69.64 -28.46 72.18 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.965 -0.561 . . . . 0.0 113.506 -177.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.564 HG12 ' HA ' ' A' ' 149' ' ' PHE . 14.6 p -87.62 -37.18 10.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 117.359 0.58 . . . . 0.0 111.495 -176.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -86.64 -53.92 4.68 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.006 -174.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 50.1 p -91.21 -34.11 15.12 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.148 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.471 ' O ' ' HA2' ' A' ' 151' ' ' GLY . . . 106.55 -122.23 6.93 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.018 177.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -118.94 32.71 5.03 Favored Glycine 0 C--N 1.318 -0.436 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.228 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.13 70.49 10.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.992 0.425 . . . . 0.0 111.049 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.246 0.913 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.05 177.716 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.477 0.885 0 CA-C-O 120.979 0.418 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 162.4 48.4 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.67 88.07 5.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.106 0.479 . . . . 0.0 111.589 -173.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.2 m -64.8 -19.31 25.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.468 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.7 p -92.48 -8.79 43.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.231 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.516 ' HD3' ' C ' ' A' ' 6' ' ' LYS . 12.8 tmtt? -93.24 -37.27 12.16 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.92 HD22 ' HG3' ' A' ' 11' ' ' GLN . 10.1 mt -70.25 102.79 2.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.215 173.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.405 ' C ' ' H ' ' A' ' 10' ' ' ASN . 0.9 OUTLIER -88.42 64.86 7.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.135 -167.391 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.4 m 69.09 -33.41 0.25 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.744 0.818 . . . . 0.0 113.024 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 8' ' ' SER . 21.3 p-10 -58.3 -49.73 76.11 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -176.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.92 ' HG3' HD22 ' A' ' 7' ' ' LEU . 6.3 mm100 -75.33 -38.55 60.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.759 0.79 . . . . 0.0 109.769 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.674 ' HA ' HD22 ' A' ' 15' ' ' LEU . 39.6 t -63.09 -30.22 49.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.943 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 37.8 tptt -55.5 -52.34 63.99 Favored 'General case' 0 N--CA 1.425 -1.702 0 C-N-CA 123.106 0.562 . . . . 0.0 111.347 174.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 14' ' ' LEU . 3.7 mm? -63.53 -37.66 88.15 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.674 HD22 ' HA ' ' A' ' 12' ' ' VAL . 3.0 mp -52.99 -59.36 4.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.487 173.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -58.38 -39.0 78.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.085 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.2 m -60.05 -46.08 90.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.941 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.557 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -80.05 -29.63 39.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.553 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.537 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 57.7 t80 -56.91 -56.01 27.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.192 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.423 ' HA ' ' HB2' ' A' ' 23' ' ' GLU . 23.2 mmt180 -71.7 -20.04 61.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.572 -175.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -72.33 -35.12 68.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.862 0.363 . . . . 0.0 110.864 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.502 ' CD2' HG12 ' A' ' 39' ' ' ILE . 71.9 m-85 -115.5 16.88 16.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.26 0.552 . . . . 0.0 110.574 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.548 ' HA ' HG23 ' A' ' 31' ' ' VAL . 2.9 tt0 -76.45 152.21 36.24 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.459 -172.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.522 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER 78.8 133.64 0.04 OUTLIER Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.642 159.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -87.07 -53.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.347 2.698 . . . . 0.0 111.127 172.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 15.6 tt0 -129.4 3.43 5.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.653 0.739 . . . . 0.0 109.592 176.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.79 67.73 0.51 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -169.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -109.15 -6.78 15.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.609 0.243 . . . . 0.0 111.028 -172.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.6 0.08 52.5 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.09 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.461 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 93.7 mtt180 -124.59 164.12 20.49 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.588 HG21 HD11 ' A' ' 39' ' ' ILE . 11.3 p -104.94 131.34 54.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.536 0.684 . . . . 0.0 109.495 177.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.0 t -59.39 140.17 56.38 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.851 -175.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.554 ' HA ' HG13 ' A' ' 36' ' ' ILE . 3.5 p -62.7 -19.87 64.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.024 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -75.94 -18.37 59.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.456 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.5 ' OE1' HD12 ' A' ' 38' ' ' ILE . 78.3 mm-40 -96.54 -15.8 21.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.585 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.755 HG22 HD22 ' A' ' 40' ' ' LEU . 55.8 mt -57.02 -41.87 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.61 -175.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.433 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -64.27 -38.38 95.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.022 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.627 ' O ' HG23 ' A' ' 42' ' ' VAL . 15.9 mt -61.47 -52.09 65.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.204 0.526 . . . . 0.0 109.648 176.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.588 HD11 HG21 ' A' ' 31' ' ' VAL . 66.8 mt -59.79 -42.62 89.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.5 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.755 HD22 HG22 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -65.5 -22.1 66.7 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.053 0.454 . . . . 0.0 110.763 -179.805 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 15.4 tp10 -78.49 -42.85 28.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.347 172.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 38' ' ' ILE . 47.0 t -53.08 -46.01 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.865 0.84 . . . . 0.0 110.161 175.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.5 mt -85.61 -6.51 59.15 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.637 -174.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.52 43.27 87.01 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.598 174.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.508 HD13 HD22 ' A' ' 80' ' ' LEU . 1.9 pt -119.6 -73.28 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -176.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.404 ' H ' HG13 ' A' ' 45' ' ' ILE . 2.5 tp60 -87.76 -175.05 5.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -173.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -107.08 -170.52 1.72 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.866 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.521 ' O ' HG12 ' A' ' 52' ' ' ILE . 14.8 t -60.47 177.45 0.28 Allowed 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -176.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.416 ' HA ' ' HB ' ' A' ' 52' ' ' ILE . 37.2 mtmm -55.11 -34.57 63.8 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -172.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.7 m -53.96 -37.78 64.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.871 0.367 . . . . 0.0 110.862 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.1 m -82.0 -34.18 29.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.374 176.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.54 ' HA ' HD23 ' A' ' 55' ' ' LEU . 49.3 mm -65.79 -24.31 34.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.873 -176.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.526 ' HA ' HD12 ' A' ' 56' ' ' ILE . 12.2 tpp180 -62.12 -28.51 69.68 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 177.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -68.0 -44.9 75.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.389 0.614 . . . . 0.0 109.685 173.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.616 HD11 ' CE2' ' A' ' 79' ' ' PHE . 3.1 mm? -54.66 -47.31 73.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.528 174.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.54 HG12 ' HB ' ' A' ' 33' ' ' THR . 61.7 mt -62.2 -47.58 92.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.828 177.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -55.71 -32.56 63.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.149 0.5 . . . . 0.0 110.819 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -76.36 -54.33 6.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.832 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.525 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 98.4 m-85 -100.64 -11.4 20.04 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -169.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.425 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 48.2 t0 -125.54 66.81 56.23 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-O 121.335 0.588 . . . . 0.0 110.612 176.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.525 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 27.2 Cg_exo -67.9 -23.9 40.51 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.83 2.354 . . . . 0.0 111.755 177.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -78.74 -19.59 51.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.174 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.56 38.62 51.3 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -71.56 -33.94 69.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 122.469 0.308 . . . . 0.0 110.945 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.85 -21.02 39.57 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.003 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -139.85 167.11 22.87 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.1 pt -129.27 143.87 39.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.02 0.438 . . . . 0.0 110.108 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.461 ' HA ' ' HG2' ' A' ' 30' ' ' ARG . 18.1 t70 -78.1 165.94 23.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.522 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -58.64 -33.26 69.87 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 118.521 0.6 . . . . 0.0 109.759 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.483 ' O ' HG13 ' A' ' 74' ' ' ILE . 29.0 t70 -52.79 -43.5 65.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.728 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.515 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 28.6 m -79.08 -40.49 31.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.199 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -69.67 -32.33 70.9 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.947 0.403 . . . . 0.0 110.654 -177.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -62.35 -39.62 93.72 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.676 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 70' ' ' ASP . 44.3 mt -65.69 -38.7 82.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-O 121.132 0.491 . . . . 0.0 109.86 176.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.524 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 58.6 mt -57.11 -56.12 16.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.391 175.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.701 ' HA2' HD23 ' A' ' 80' ' ' LEU . . . -62.48 -35.19 91.39 Favored Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.016 177.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.697 ' HA ' ' CD1' ' A' ' 7' ' ' LEU . . . -69.61 -25.89 64.17 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 122.608 -0.349 . . . . 0.0 111.385 -176.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 15.0 ptm180 -91.93 -14.42 29.6 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.78 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.616 ' CE2' HD11 ' A' ' 55' ' ' LEU . 22.9 m-85 -117.76 -44.1 2.75 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.991 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.701 HD23 ' HA2' ' A' ' 76' ' ' GLY . 4.2 mm? -61.94 -26.89 68.46 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.01 0.433 . . . . 0.0 111.207 -178.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.28 -18.91 56.59 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.411 -0.813 . . . . 0.0 114.292 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 79' ' ' PHE . 12.4 pt-20 -62.77 -27.65 69.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.491 0.646 . . . . 0.0 109.764 176.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 23.96 99.06 0.0 OUTLIER 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.05 1.74 . . . . 0.0 115.145 172.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.9 t -140.78 79.97 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.494 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.597 ' HB3' ' HB3' ' A' ' 88' ' ' GLN . 4.5 t-20 -79.31 136.65 56.56 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.491 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 52.3 Cg_exo -54.37 -54.35 4.78 Favored 'Trans proline' 0 C--N 1.331 -0.35 0 C-N-CA 123.581 2.854 . . . . 0.0 113.22 -167.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -99.03 10.79 40.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.773 0.32 . . . . 0.0 111.596 -175.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.597 ' HB3' ' HB3' ' A' ' 85' ' ' ASN . 51.9 tp60 -102.85 -35.17 8.71 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 40.7 tpp -87.49 -17.78 31.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.031 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -117.42 -163.69 0.94 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.512 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 55.74 36.73 27.8 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.295 0.569 . . . . 0.0 111.208 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.44 -20.27 59.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.029 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.706 ' H ' HD22 ' A' ' 93' ' ' LEU . 0.5 OUTLIER -52.81 -36.44 58.44 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.655 -178.551 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.836 ' HD2' ' HE2' ' A' ' 97' ' ' PHE . 25.7 mmm180 -62.69 -32.55 73.65 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.874 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -86.09 -32.45 21.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.063 0.458 . . . . 0.0 109.912 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.784 ' HA ' HD23 ' A' ' 99' ' ' LEU . . . -66.59 -18.44 65.37 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.692 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.836 ' HE2' ' HD2' ' A' ' 94' ' ' ARG . 21.5 m-85 -58.55 -46.06 87.63 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.05 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 98' ' ' ARG . 33.7 mtp180 -70.85 -14.34 62.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.857 0.361 . . . . 0.0 110.908 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.784 HD23 ' HA ' ' A' ' 96' ' ' ALA . 0.5 OUTLIER -81.21 -37.21 29.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.806 176.249 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -95.82 -28.82 14.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.608 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.89 78.53 1.63 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.121 0.962 . . . . 0.0 110.929 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -76.97 -6.5 52.83 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.304 171.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -83.89 -37.37 22.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.983 -175.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.65 46.6 1.38 Allowed Glycine 0 C--O 1.228 -0.26 0 C-N-CA 121.098 -0.573 . . . . 0.0 113.259 171.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.417 ' C ' ' H ' ' A' ' 107' ' ' TYR . 12.4 m120 -113.92 -17.92 11.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.777 0.323 . . . . 0.0 110.66 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.5 -20.78 12.65 Favored Glycine 0 C--O 1.228 -0.233 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -170.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.793 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 4.4 m-85 -116.71 147.54 41.9 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.688 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 9.3 pt -92.56 131.13 40.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.266 176.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.0 m -71.44 171.01 12.04 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.296 -176.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.517 ' HB ' HG23 ' A' ' 133' ' ' ILE . 16.4 p -61.78 -28.14 69.24 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.0 0.429 . . . . 0.0 110.721 178.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -60.36 -57.22 13.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.069 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.688 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.2 p -63.94 -35.45 73.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.815 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.61 ' SD ' HG11 ' A' ' 144' ' ' VAL . 0.7 OUTLIER -59.39 -40.08 85.44 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.754 176.639 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 114' ' ' ARG . 19.6 ttt180 -51.98 -50.93 60.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.812 176.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.22 -42.94 96.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.094 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.2 mt -57.1 -48.99 80.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 121.071 0.462 . . . . 0.0 110.24 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.503 HD11 ' SD ' ' A' ' 132' ' ' MET . 0.8 OUTLIER -57.29 -54.17 49.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.438 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.57 -15.86 63.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.853 -176.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -78.63 -29.43 45.85 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.8 mp -80.63 -61.63 1.91 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.615 173.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.582 ' CG ' HD23 ' A' ' 124' ' ' LEU . 9.4 t70 -92.01 139.46 30.62 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.054 0.454 . . . . 0.0 110.498 -176.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -108.68 -2.54 18.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.683 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.4 p -104.08 -22.69 13.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.359 0.599 . . . . 0.0 109.516 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.582 HD23 ' CG ' ' A' ' 121' ' ' ASP . 4.1 mm? -62.81 100.86 0.22 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.609 169.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.424 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 15.5 t -71.69 171.89 10.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.56 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.8 p -53.51 -44.3 69.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.978 0.418 . . . . 0.0 110.884 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -66.3 -41.1 90.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.935 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.527 ' HB3' HD13 ' A' ' 124' ' ' LEU . 6.1 m-20 -66.29 -43.33 86.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.654 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.546 ' O ' HG12 ' A' ' 133' ' ' ILE . 95.7 mt -51.36 -44.4 62.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.961 172.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.414 ' O ' ' HB ' ' A' ' 133' ' ' ILE . 11.9 t70 -61.64 -41.26 97.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.892 0.377 . . . . 0.0 110.44 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.01 -37.04 78.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.382 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.503 ' SD ' HD11 ' A' ' 117' ' ' LEU . 7.1 mtt -65.82 -32.15 73.51 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.665 175.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 129' ' ' LEU . 19.4 mm -59.13 -45.87 92.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.954 0.407 . . . . 0.0 110.306 175.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -64.73 -35.53 81.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.891 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -72.23 -42.86 65.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.987 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.412 HG12 ' CG2' ' A' ' 152' ' ' VAL . 62.7 mt -65.36 -56.57 14.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.01 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.515 ' HA ' ' CG ' ' A' ' 148' ' ' GLU . 46.8 t0 -80.64 82.97 6.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 122.005 0.907 . . . . 0.0 109.374 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.27 -35.9 76.54 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.967 -1.469 . . . . 0.0 112.336 -173.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -87.07 -13.56 43.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.246 0.546 . . . . 0.0 110.99 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 72.07 42.83 50.4 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.0 t -83.14 -17.83 41.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.394 0.616 . . . . 0.0 109.966 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.15 -33.42 4.72 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.366 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 39.5 p -114.23 141.88 46.99 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.001 0.429 . . . . 0.0 110.096 176.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.61 HG11 ' SD ' ' A' ' 113' ' ' MET . 46.6 t -99.26 109.22 23.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.793 ' HB3' ' HB3' ' A' ' 107' ' ' TYR . 4.8 p-10 -153.91 -42.98 0.09 Allowed 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.404 -171.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.603 ' HD2' ' HG2' ' A' ' 147' ' ' GLU . 2.9 p90 -96.63 -93.07 0.22 Allowed 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.202 -0.999 . . . . 0.0 112.205 -176.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.603 ' HG2' ' HD2' ' A' ' 146' ' ' PHE . 22.0 mm-40 -81.19 -28.89 34.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.362 0.601 . . . . 0.0 109.947 -175.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.515 ' CG ' ' HA ' ' A' ' 137' ' ' ASP . 25.9 mp0 -60.14 -51.82 67.96 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.939 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.621 ' HA ' HG12 ' A' ' 152' ' ' VAL . 16.0 t80 -72.15 -38.12 69.25 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.07 -47.64 71.46 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.599 176.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -76.1 -22.07 74.65 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.893 -175.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 149' ' ' PHE . 11.7 p -92.13 -37.34 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 117.545 0.672 . . . . 0.0 111.327 -176.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.505 ' HA ' ' CE ' ' A' ' 153' ' ' MET . 2.4 tpt -89.53 -56.81 3.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.827 0.346 . . . . 0.0 110.672 -176.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.8 p -94.41 41.42 1.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.31 0.576 . . . . 0.0 110.354 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -100.64 101.4 2.29 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.096 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.67 -27.05 21.99 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.74 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 61.97 49.16 4.78 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.505 0.669 . . . . 0.0 110.15 -176.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 C--O 1.248 0.994 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.79 179.986 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 121.025 0.441 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.14 54.01 29.91 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -175.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.71 ' HB3' ' HB2' ' A' ' 6' ' ' LYS . 3.0 m-20 -74.65 72.09 1.94 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.077 -0.562 . . . . 0.0 111.479 -173.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.8 -34.26 68.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.898 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.9 m -75.59 -22.56 56.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.015 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.71 ' HB2' ' HB3' ' A' ' 3' ' ' ASP . 2.6 mptm? -76.57 -21.49 55.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.717 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.465 ' HG ' ' CB ' ' A' ' 11' ' ' GLN . 3.3 mp -70.66 112.82 7.18 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.254 0.55 . . . . 0.0 110.786 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.4 p -85.51 -179.23 6.87 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.024 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.8 m -60.68 -33.98 73.65 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.547 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -57.59 -53.1 62.0 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.762 0.315 . . . . 0.0 110.954 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.465 ' CB ' ' HG ' ' A' ' 7' ' ' LEU . 10.1 mm-40 -59.52 -46.48 88.72 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.636 0.732 . . . . 0.0 109.977 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.3 t -67.94 -28.52 41.6 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.754 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.695 -176.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -67.57 -37.75 83.08 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 14' ' ' LEU . 4.4 mm? -62.56 -44.27 96.74 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 172.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.43 ' HB3' ' HE2' ' A' ' 72' ' ' PHE . 85.5 mt -59.99 -45.63 92.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.671 175.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -64.94 -46.28 82.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.632 -175.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.9 m -61.31 -34.98 76.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.079 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.591 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -81.1 -38.5 27.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.331 177.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.553 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 51.7 t80 -54.8 -55.03 34.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.72 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -67.39 -21.89 65.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.131 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -77.31 -36.4 54.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.856 0.36 . . . . 0.0 111.098 -174.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.459 ' CD2' HG12 ' A' ' 39' ' ' ILE . 65.9 m-85 -110.74 16.2 21.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.283 0.563 . . . . 0.0 110.423 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.607 ' HG2' ' N ' ' A' ' 24' ' ' THR . 4.3 tt0 -78.67 156.44 29.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.22 -172.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.607 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER 80.25 127.15 0.03 OUTLIER Pre-proline 0 N--CA 1.444 -0.762 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.334 160.826 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 24' ' ' THR . 66.4 Cg_endo -90.12 -45.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.79 2.993 . . . . 0.0 111.947 173.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -142.77 24.69 1.85 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.38 62.84 1.14 Allowed Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -174.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.0 t -100.35 -28.04 13.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.927 0.394 . . . . 0.0 111.109 -172.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.19 -16.16 56.45 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -172.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.473 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 92.8 mtt180 -103.43 164.23 11.78 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.896 -0.652 . . . . 0.0 109.874 175.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.589 HG23 ' HA ' ' A' ' 23' ' ' GLU . 13.6 p -108.05 131.77 57.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.384 0.612 . . . . 0.0 109.639 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.1 t -62.69 144.39 56.39 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.372 -175.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.567 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . 2.8 p -66.52 -18.35 65.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.851 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -70.73 -36.11 73.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.307 0.575 . . . . 0.0 109.934 176.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -89.23 -14.48 35.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.533 -175.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.658 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 71.3 mt -53.35 -47.75 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.764 0.316 . . . . 0.0 110.644 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.442 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -58.54 -38.49 91.33 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.756 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.667 ' O ' HG23 ' A' ' 42' ' ' VAL . 36.8 mt -61.25 -49.46 84.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.25 0.547 . . . . 0.0 109.604 176.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.591 HG23 ' HB1' ' A' ' 18' ' ' ALA . 65.5 mt -60.43 -45.41 96.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.578 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.784 HD12 HD12 ' A' ' 52' ' ' ILE . 46.2 mt -61.7 -25.09 67.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.364 0.602 . . . . 0.0 110.761 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.518 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 8.6 tp10 -76.49 -42.22 44.28 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.719 173.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 38' ' ' ILE . 39.4 t -54.22 -42.71 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.888 0.851 . . . . 0.0 109.878 174.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 29.1 mt -83.49 -11.46 57.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.153 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.57 32.22 67.69 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.578 -0.737 . . . . 0.0 113.362 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 pt -109.74 -61.36 2.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -177.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -95.7 -177.75 4.16 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -174.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.404 ' HB2' ' CB ' ' A' ' 51' ' ' THR . 12.5 mm100 -104.74 -170.61 1.79 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.004 -172.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.557 ' O ' HG12 ' A' ' 52' ' ' ILE . 15.2 t -62.04 179.06 0.31 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -57.74 -29.8 65.05 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -172.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.0 m -52.39 -45.55 65.88 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.297 0.57 . . . . 0.0 110.691 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.404 ' CB ' ' HB2' ' A' ' 47' ' ' GLN . 91.6 m -77.43 -34.3 54.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.474 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.784 HD12 HD12 ' A' ' 40' ' ' LEU . 42.1 mm -64.84 -24.49 35.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.31 -178.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -51.52 -38.09 52.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 172.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -75.16 -38.16 61.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.265 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.512 HD11 ' CE2' ' A' ' 79' ' ' PHE . 2.2 mm? -56.01 -48.42 75.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.226 174.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.545 HG12 ' HB ' ' A' ' 33' ' ' THR . 59.8 mt -62.96 -45.84 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.917 176.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -56.77 -29.81 62.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.273 0.559 . . . . 0.0 110.718 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -77.04 -54.51 6.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.55 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -101.24 -13.47 18.08 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -170.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.452 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 48.1 t0 -134.18 64.67 66.49 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.172 0.511 . . . . 0.0 111.194 176.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 24.6 Cg_exo -69.0 -18.42 40.6 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.769 2.313 . . . . 0.0 111.493 175.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -78.88 -17.51 55.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.244 -176.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.74 40.08 46.45 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.215 -177.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.412 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 1.2 t-20 -66.18 -43.97 85.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.917 0.487 . . . . 0.0 110.687 -176.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.91 -22.28 14.67 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.623 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -149.39 171.44 16.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.945 0.402 . . . . 0.0 110.377 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.405 ' C ' ' HD3' ' A' ' 30' ' ' ARG . 30.0 pt -135.27 145.42 31.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.56 ' HB3' ' HB3' ' A' ' 70' ' ' ASP . 15.2 t70 -83.01 171.55 13.69 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.487 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -62.18 -22.67 66.09 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 173.547 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.56 ' HB3' ' HB3' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -45.41 -53.23 8.97 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.597 170.617 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.7 m -87.38 -33.77 19.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.968 0.413 . . . . 0.0 111.249 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.487 ' HB3' ' HA ' ' A' ' 69' ' ' PHE . 73.4 t80 -65.29 -33.14 75.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.365 -176.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -65.28 -37.26 86.62 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.073 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.2 mt -68.1 -37.56 78.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.975 0.417 . . . . 0.0 109.928 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.56 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 61.2 mt -58.15 -53.62 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.004 174.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.516 ' CA ' HD23 ' A' ' 80' ' ' LEU . . . -60.96 -39.64 97.3 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.207 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.92 -28.83 69.8 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.906 0.384 . . . . 0.0 111.68 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 16.3 ptm180 -90.68 -13.04 34.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.009 -175.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.512 ' CE2' HD11 ' A' ' 55' ' ' LEU . 23.8 m-85 -119.35 -37.01 3.24 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.131 -0.627 . . . . 0.0 112.547 -175.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.516 HD23 ' CA ' ' A' ' 76' ' ' GLY . 4.1 mm? -53.67 -73.64 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.218 0.324 . . . . 0.0 111.101 -177.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.16 29.46 72.96 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.593 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -80.68 53.31 1.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 175.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -121.41 67.16 0.88 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.706 -170.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.5 t -143.4 80.52 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.209 0.528 . . . . 0.0 111.683 -172.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.497 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 0.7 OUTLIER -116.19 127.04 27.07 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-O 121.356 0.598 . . . . 0.0 110.054 173.192 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 13.4 Cg_exo -70.54 -47.12 0.74 Allowed 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 124.058 3.172 . . . . 0.0 113.551 -170.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -102.04 -43.87 5.64 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.877 0.37 . . . . 0.0 110.192 -173.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.476 ' HB2' ' HB3' ' A' ' 85' ' ' ASN . 13.6 mm-40 -50.62 -36.8 36.92 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 26.0 mmt -111.19 -2.02 15.93 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -173.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -129.31 -78.39 0.55 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.112 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -85.17 57.33 4.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.358 0.599 . . . . 0.0 110.194 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -57.14 -21.57 33.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.545 177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.743 HD23 ' HE1' ' A' ' 150' ' ' MET . 0.9 OUTLIER -58.58 -34.4 71.03 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.985 -177.145 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.733 ' HA ' ' CE2' ' A' ' 97' ' ' PHE . 52.7 mmm-85 -62.72 -36.9 84.47 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.084 -177.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -84.55 -15.12 46.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.094 0.473 . . . . 0.0 110.86 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.479 ' HA ' HD12 ' A' ' 99' ' ' LEU . . . -82.55 -14.04 55.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.008 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.733 ' CE2' ' HA ' ' A' ' 94' ' ' ARG . 20.9 m-85 -62.46 -46.24 89.41 Favored 'General case' 0 C--O 1.215 -0.711 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 176.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -66.83 -12.41 58.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.82 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 96' ' ' ALA . 96.3 mt -83.66 -43.78 15.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.954 175.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -93.12 -24.01 18.42 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.417 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -71.89 80.19 0.9 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.922 0.868 . . . . 0.0 110.1 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -74.67 -16.93 60.75 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.476 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.486 ' HB2' ' ND2' ' A' ' 105' ' ' ASN . 22.7 mt-10 -83.61 -37.59 22.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.964 -173.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.25 34.83 3.29 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.763 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.486 ' ND2' ' HB2' ' A' ' 103' ' ' GLU . 21.1 m-80 -88.91 -18.74 26.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.895 0.378 . . . . 0.0 110.523 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.4 -25.79 4.83 Favored Glycine 0 N--CA 1.454 -0.147 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -171.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.488 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 1.7 m-85 -111.33 173.45 6.34 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 171.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.631 ' HB ' HG13 ' A' ' 112' ' ' VAL . 11.8 pt -109.39 126.64 66.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 119.364 -0.935 . . . . 0.0 109.611 171.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.438 ' HA ' HG22 ' A' ' 143' ' ' THR . 33.1 m -64.44 165.01 10.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.684 -177.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.1 p -59.65 -31.98 70.03 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.779 -0.576 . . . . 0.0 110.206 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -58.23 -51.62 69.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.699 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.631 HG13 ' HB ' ' A' ' 108' ' ' ILE . 2.3 p -69.73 -36.02 68.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.531 ' SD ' HG11 ' A' ' 144' ' ' VAL . 1.3 tpt -58.27 -45.1 88.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.049 0.452 . . . . 0.0 110.243 176.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.576 ' HG2' HD13 ' A' ' 129' ' ' LEU . 33.2 ttp180 -51.56 -50.79 59.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.975 175.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -65.18 -39.37 92.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.084 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 112' ' ' VAL . 43.6 mt -58.99 -46.32 91.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 111.173 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.477 HD12 ' HG ' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -63.65 -54.0 42.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.162 0.506 . . . . 0.0 109.946 -178.411 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.43 ' HB2' HD21 ' A' ' 129' ' ' LEU . . . -63.92 -19.86 65.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.713 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -69.03 -40.56 78.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.94 0.4 . . . . 0.0 110.258 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -75.84 -51.32 12.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.01 174.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.586 ' HB3' HD23 ' A' ' 124' ' ' LEU . 2.1 m-20 -107.73 96.82 6.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.431 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -79.72 15.14 1.45 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.511 -171.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 41.7 p -112.34 -4.65 14.25 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.493 0.663 . . . . 0.0 110.882 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.586 HD23 ' HB3' ' A' ' 121' ' ' ASP . 3.7 mm? -70.09 114.27 8.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.65 174.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.3 m -90.3 176.5 6.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.002 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.7 p -52.49 -44.37 65.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.872 0.367 . . . . 0.0 111.691 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -65.14 -41.4 94.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.954 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.46 ' HB3' HD13 ' A' ' 124' ' ' LEU . 34.3 m-20 -69.85 -49.77 49.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.448 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.576 HD13 ' HG2' ' A' ' 114' ' ' ARG . 79.2 mt -56.28 -38.28 70.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.685 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -55.95 -46.28 78.58 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.988 0.423 . . . . 0.0 110.704 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.66 -41.44 98.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.101 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 48.8 mtt -68.88 -38.97 80.02 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.006 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 133' ' ' ILE . 13.6 mm -59.02 -45.89 92.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.133 0.492 . . . . 0.0 110.005 174.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -55.34 -43.61 75.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.744 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -73.08 -45.64 56.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.246 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.621 HG12 HG13 ' A' ' 152' ' ' VAL . 69.8 mt -59.53 -57.1 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.729 -178.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -76.71 82.57 3.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.033 0.921 . . . . 0.0 109.83 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.39 -35.39 54.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.663 -1.153 . . . . 0.0 112.238 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -90.31 -10.53 43.79 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.383 -175.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 72.79 37.49 57.21 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.742 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.3 m -83.3 -19.29 36.53 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.418 0.628 . . . . 0.0 110.733 -178.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 93.42 -29.99 7.75 Favored Glycine 0 CA--C 1.51 -0.257 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.494 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.438 HG22 ' HA ' ' A' ' 109' ' ' SER . 2.7 p -118.39 132.59 56.25 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 174.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.531 HG11 ' SD ' ' A' ' 113' ' ' MET . 96.5 t -82.76 115.89 26.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.767 -177.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.488 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 22.3 t70 -139.12 -61.53 0.56 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.028 0.442 . . . . 0.0 111.661 -174.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.598 ' O ' ' HG2' ' A' ' 150' ' ' MET . 2.3 p90 -94.84 -112.74 0.12 Allowed 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.519 -172.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.5 ' H ' ' HD1' ' A' ' 146' ' ' PHE . 6.3 mp0 -64.71 -11.22 33.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.904 0.383 . . . . 0.0 111.265 -176.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -66.84 -52.07 48.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.332 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.49 ' O ' HG23 ' A' ' 152' ' ' VAL . 14.3 t80 -77.19 -33.8 56.33 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.009 0.433 . . . . 0.0 110.303 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' MET . . . . . 0.743 ' HE1' HD23 ' A' ' 93' ' ' LEU . 6.9 mmt -64.13 -23.44 67.32 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.25 -21.93 66.38 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.66 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.621 HG13 HG12 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -91.31 -71.82 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 CA-C-O 121.813 0.816 . . . . 0.0 110.727 -178.41 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 47.5 tpp -83.49 -37.45 23.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.8 -166.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.587 ' OG1' ' HA ' ' A' ' 150' ' ' MET . 0.2 OUTLIER -80.01 -23.15 41.72 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.219 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -81.03 51.57 4.36 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.961 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -90.56 -69.41 1.2 Allowed Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 175.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.2 t70 51.16 64.76 1.71 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.339 0.59 . . . . 0.0 110.493 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.686 -0.674 . . . . 0.0 109.993 -176.556 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.4 ttm . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 121.412 0.625 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -164.18 124.07 1.23 Allowed Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.37 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.702 ' HB3' ' HB2' ' A' ' 6' ' ' LYS . 29.8 m-20 -68.35 63.73 0.1 Allowed 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 122.755 0.422 . . . . 0.0 111.74 176.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.529 ' HB ' ' HE2' ' A' ' 73' ' ' LYS . 21.1 m -62.56 -31.3 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.449 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.9 m -78.5 -15.31 58.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.963 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.702 ' HB2' ' HB3' ' A' ' 3' ' ' ASP . 1.7 mptm? -90.19 -32.71 16.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.001 -176.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.672 HD11 ' HA ' ' A' ' 77' ' ' ALA . 14.7 mt -65.61 113.3 4.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.062 0.458 . . . . 0.0 109.862 175.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.2 m -83.07 47.67 1.26 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.615 -171.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.3 t 70.28 -35.64 0.33 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.85 0.86 . . . . 0.0 112.468 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -54.58 -56.86 14.54 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.635 ' HG3' HD22 ' A' ' 7' ' ' LEU . 6.5 mm100 -62.91 -30.77 71.8 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.58 0.705 . . . . 0.0 110.14 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.437 ' HA ' HD12 ' A' ' 15' ' ' LEU . 59.8 t -72.72 -30.03 32.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.871 -177.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -70.37 -37.48 74.58 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.009 173.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.0 mp -58.7 -48.92 79.47 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.529 HD11 ' HA3' ' A' ' 76' ' ' GLY . 84.8 mt -54.76 -47.85 73.39 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.758 175.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.71 -49.69 75.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.2 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.6 m -59.69 -41.3 90.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.968 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.667 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -76.27 -39.78 53.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.554 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.401 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 33.2 t80 -53.43 -56.14 19.31 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.643 175.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.448 ' HD2' ' OE1' ' A' ' 23' ' ' GLU . 28.1 mmm180 -66.96 -16.91 64.66 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.356 -174.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -87.6 -34.88 18.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.918 0.39 . . . . 0.0 111.354 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.457 ' HB2' HD11 ' A' ' 39' ' ' ILE . 78.8 m-85 -109.69 13.2 23.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.282 0.563 . . . . 0.0 110.227 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.708 ' HG2' ' HB ' ' A' ' 24' ' ' THR . 27.0 tt0 -71.21 148.28 47.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.811 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.708 ' HB ' ' HG2' ' A' ' 23' ' ' GLU . 0.4 OUTLIER 78.8 140.88 0.07 OUTLIER Pre-proline 0 N--CA 1.447 -0.623 0 O-C-N 124.664 1.227 . . . . 0.0 113.527 162.505 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -84.62 -36.69 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.265 2.643 . . . . 0.0 110.014 166.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -178.07 47.59 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.39 174.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.2 63.7 0.95 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.849 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.8 t -107.24 -18.29 13.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.005 0.431 . . . . 0.0 111.003 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.72 12.92 84.0 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -175.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.9 mtm-85 -140.54 168.46 19.75 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.567 -0.817 . . . . 0.0 109.597 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.547 HG23 ' HA ' ' A' ' 23' ' ' GLU . 12.3 p -107.7 127.66 63.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 173.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 13.8 m -55.45 138.5 46.04 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.852 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.564 ' HA ' HG13 ' A' ' 36' ' ' ILE . 1.5 p -64.53 -26.96 68.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.196 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -65.63 -27.85 68.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.109 0.48 . . . . 0.0 110.256 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -92.15 -13.52 30.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.47 -176.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.704 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 69.7 mt -53.86 -48.71 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 O-C-N 123.215 0.322 . . . . 0.0 110.773 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.416 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -59.73 -34.73 83.51 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.613 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.66 ' O ' HG23 ' A' ' 42' ' ' VAL . 50.3 mt -62.66 -49.71 82.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.4 0.619 . . . . 0.0 109.581 175.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.667 HG23 ' HB1' ' A' ' 18' ' ' ALA . 71.3 mt -61.64 -45.92 97.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.667 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.922 HD12 HD12 ' A' ' 52' ' ' ILE . 41.1 mt -61.91 -24.62 67.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.341 0.591 . . . . 0.0 110.423 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -75.97 -43.92 42.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.268 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 38' ' ' ILE . 47.8 t -53.85 -44.35 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.687 0.756 . . . . 0.0 110.264 175.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 22.2 mt -81.14 -12.1 59.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.275 -175.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.59 40.61 66.72 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.825 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.411 HG12 ' HB2' ' A' ' 43' ' ' LEU . 1.3 pt -118.76 -76.85 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.594 ' HG2' HD11 ' A' ' 55' ' ' LEU . 3.4 tp60 -80.72 177.08 9.26 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -174.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.423 ' HB3' ' OE1' ' A' ' 158' ' ' GLU . 10.5 mm100 -100.27 -171.18 1.99 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.126 -170.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.1 t -52.15 165.85 0.2 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.705 0.764 . . . . 0.0 111.762 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.537 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 59.4 mtpt -61.92 -20.56 63.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.349 -171.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.0 m -61.95 -31.21 71.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.208 0.528 . . . . 0.0 110.455 174.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.6 m -84.77 -31.48 23.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.334 176.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.922 HD12 HD12 ' A' ' 40' ' ' LEU . 28.3 mm -67.51 -25.3 32.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.009 -176.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -46.21 -45.28 16.82 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.922 173.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -62.29 -49.74 74.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.131 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.686 HD12 ' HA ' ' A' ' 52' ' ' ILE . 1.0 OUTLIER -58.14 -38.4 76.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.396 178.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.532 HG23 HG21 ' A' ' 33' ' ' THR . 75.2 mt -65.95 -46.67 87.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.044 177.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -62.42 -27.65 69.25 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.195 0.521 . . . . 0.0 110.289 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -76.0 -54.85 6.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.528 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.568 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 87.4 m-85 -97.57 -15.36 20.54 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -171.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.401 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 39.8 t0 -122.72 68.7 33.29 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 121.222 0.534 . . . . 0.0 110.358 174.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.568 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 20.7 Cg_exo -71.87 -18.12 28.39 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.032 2.488 . . . . 0.0 111.756 176.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -79.88 -17.62 52.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.712 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.38 37.46 53.98 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.781 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -72.59 -43.3 63.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.784 0.326 . . . . 0.0 111.237 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.97 -16.09 20.8 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.893 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 5.5 m-20 -137.19 176.69 8.48 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.0 pt -136.9 152.64 28.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.894 0.378 . . . . 0.0 110.272 174.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -90.07 166.59 13.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.844 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.434 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -63.0 -21.69 66.32 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 178.916 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -57.61 -52.35 65.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.027 0.442 . . . . 0.0 109.986 174.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.492 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 3.4 m -70.72 -44.96 65.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.526 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.434 ' HB3' ' HA ' ' A' ' 69' ' ' PHE . 84.5 t80 -64.5 -34.77 79.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.651 -176.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.529 ' HE2' ' HB ' ' A' ' 4' ' ' VAL . 89.1 tttt -64.81 -35.84 82.39 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.6 mt -67.46 -43.9 87.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.58 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 88.8 mt -55.08 -47.55 77.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.275 175.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.801 ' HA2' HD23 ' A' ' 80' ' ' LEU . . . -67.52 -43.9 84.92 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.608 -0.805 . . . . 0.0 112.524 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.672 ' HA ' HD11 ' A' ' 7' ' ' LEU . . . -64.55 -24.33 67.57 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.894 0.378 . . . . 0.0 111.701 -174.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.58 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 10.7 ptm180 -89.1 -15.16 34.58 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.844 -175.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -124.34 -36.75 2.61 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.406 -0.518 . . . . 0.0 112.139 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.801 HD23 ' HA2' ' A' ' 76' ' ' GLY . 4.6 mm? -66.35 -27.24 67.73 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.99 -55.21 3.36 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.009 -1.091 . . . . 0.0 112.76 -175.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.19 50.41 1.64 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.511 0.672 . . . . 0.0 109.264 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -67.98 97.69 0.69 Allowed 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 123.379 1.561 . . . . 0.0 111.251 -173.278 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.3 96.06 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 113.738 -1.574 . . . . 0.0 109.475 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.48 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 11.3 t-20 -45.9 135.61 6.47 Favored Pre-proline 0 N--CA 1.47 0.563 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.482 174.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 16.3 Cg_exo -67.87 -36.33 18.5 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 124.215 3.277 . . . . 0.0 113.042 -169.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -90.94 -84.04 0.25 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.65 176.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 55.01 26.16 7.71 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.152 0.501 . . . . 0.0 110.586 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 23.7 ttt 56.96 42.01 26.88 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.89 -176.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.492 ' HB3' ' HG2' ' A' ' 92' ' ' GLU . 14.3 mm100 -87.04 -70.42 0.62 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.228 174.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 52.04 43.09 30.69 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.554 0.692 . . . . 0.0 110.683 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.492 ' HG2' ' HB3' ' A' ' 90' ' ' GLN . 5.0 mm-40 -60.52 -20.6 60.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.113 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.763 ' H ' HD22 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -62.02 -35.58 78.99 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.894 -173.108 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.569 ' HD3' ' CE2' ' A' ' 97' ' ' PHE . 29.5 mmt180 -62.48 -41.69 98.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.086 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -74.62 -30.91 61.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.204 0.526 . . . . 0.0 110.818 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.509 ' HA ' HD12 ' A' ' 99' ' ' LEU . . . -74.95 -20.22 59.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.935 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.569 ' CE2' ' HD3' ' A' ' 94' ' ' ARG . 17.0 m-30 -56.57 -44.62 81.18 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.372 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.3 mtm-85 -72.02 -19.52 61.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.027 0.442 . . . . 0.0 110.906 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 96' ' ' ALA . 94.2 mt -80.09 -43.87 21.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.654 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.655 ' O ' ' HD2' ' A' ' 102' ' ' LYS . 79.9 m-85 -89.59 -5.61 57.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.397 -177.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 97' ' ' PHE . 55.8 t0 -76.82 76.28 3.43 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.512 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.655 ' HD2' ' O ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -57.04 -42.33 80.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.601 174.548 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -67.75 -36.75 81.1 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.214 -171.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.96 37.15 7.97 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -171.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.06 -18.37 20.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.49 -0.855 . . . . 0.0 111.174 -168.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.9 -24.91 10.83 Favored Glycine 0 CA--C 1.517 0.194 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.445 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 4.2 m-85 -116.75 176.93 4.89 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 173.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.617 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 6.3 pt -117.84 121.94 68.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.239 169.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 66.3 m -65.91 174.75 2.28 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.149 0.5 . . . . 0.0 111.556 -175.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.2 p -67.36 -26.76 66.64 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.953 0.406 . . . . 0.0 110.754 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -60.59 -58.09 9.95 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.851 176.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.617 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.4 p -63.26 -38.36 81.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.843 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.542 ' SD ' HG11 ' A' ' 144' ' ' VAL . 2.7 tpt -56.5 -40.89 75.73 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.827 0.346 . . . . 0.0 110.648 177.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -61.02 -45.19 95.79 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.991 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -58.99 -46.49 88.0 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.411 0.444 . . . . 0.0 110.215 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 63.7 mt -57.45 -53.83 38.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.567 177.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.4 tp -54.66 -60.29 3.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.36 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.08 -27.15 52.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.433 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -75.45 -44.15 45.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.616 0.246 . . . . 0.0 110.348 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.32 -55.7 7.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.141 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.663 ' HB3' HD23 ' A' ' 124' ' ' LEU . 5.3 m-20 -103.01 111.97 24.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.478 0.656 . . . . 0.0 110.649 -178.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' A' ' 122' ' ' GLU . 0.3 OUTLIER -89.17 -5.41 57.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.717 -173.787 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.7 p -88.61 -2.98 58.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.339 0.59 . . . . 0.0 110.765 -174.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.663 HD23 ' HB3' ' A' ' 121' ' ' ASP . 4.2 mm? -84.87 129.03 34.87 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.854 176.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.491 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 92.0 p -89.69 -179.01 5.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 175.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.5 t -58.75 -48.49 81.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.692 0.282 . . . . 0.0 110.795 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -71.08 -35.86 72.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.828 0.347 . . . . 0.0 111.161 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.424 ' HB2' ' H ' ' A' ' 125' ' ' SER . 68.4 m-20 -66.28 -38.14 87.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.45 178.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.509 ' O ' HG12 ' A' ' 133' ' ' ILE . 85.5 mt -58.65 -44.46 90.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.151 172.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -58.99 -46.24 88.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.616 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.45 -42.71 98.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.723 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.508 ' O ' HG13 ' A' ' 136' ' ' ILE . 9.0 mtt -64.06 -37.26 86.8 Favored 'General case' 0 C--O 1.215 -0.731 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.923 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 129' ' ' LEU . 15.8 mm -57.41 -43.88 83.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.188 0.518 . . . . 0.0 110.419 174.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.4 -36.98 84.04 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.262 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -72.79 -39.5 66.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.517 -1.219 . . . . 0.0 111.242 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 132' ' ' MET . 66.8 mt -71.11 -57.11 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.993 -176.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -75.64 63.58 1.58 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 122.396 1.094 . . . . 0.0 108.621 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -78.37 -22.33 48.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.489 -1.232 . . . . 0.0 112.161 -174.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -88.23 -11.99 45.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.368 0.604 . . . . 0.0 110.202 -178.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 79.53 34.99 30.3 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.488 174.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.431 ' C ' ' H ' ' A' ' 143' ' ' THR . 46.9 t -78.74 -21.16 48.42 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.197 0.522 . . . . 0.0 110.406 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.67 -28.36 3.54 Favored Glycine 0 C--O 1.234 0.121 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.431 ' H ' ' C ' ' A' ' 141' ' ' SER . 19.5 p -124.3 128.27 48.87 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 172.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.542 HG11 ' SD ' ' A' ' 113' ' ' MET . 58.8 t -80.71 127.3 39.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -173.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.445 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 17.8 t70 -157.2 -77.63 0.08 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.872 0.844 . . . . 0.0 110.176 -175.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.439 ' HB3' HH22 ' A' ' 94' ' ' ARG . 20.7 p90 -92.65 136.42 33.24 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.072 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 64.86 -54.44 0.3 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.526 0.73 . . . . 0.0 112.204 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -54.66 -51.02 66.78 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.818 0.847 . . . . 0.0 112.144 -176.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.662 ' HE1' HD12 ' A' ' 93' ' ' LEU . 11.4 t80 -75.41 -37.0 60.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.125 0.488 . . . . 0.0 110.341 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' MET . . . . . 0.573 ' CE ' HD23 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -58.14 -43.15 87.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.347 178.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 155' ' ' GLY . . . -73.24 -35.62 56.73 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.455 -177.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 149' ' ' PHE . 9.3 p -75.59 -38.9 39.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 117.112 0.456 . . . . 0.0 111.511 -175.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 16.0 tpt -93.88 -39.92 10.44 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.879 -174.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.446 HG21 HD21 ' A' ' 93' ' ' LEU . 64.9 p -122.78 24.55 9.04 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -172.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.425 ' O ' ' HA2' ' A' ' 151' ' ' GLY . . . 77.43 -59.45 3.68 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.778 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 138.67 -160.16 25.56 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.141 -0.552 . . . . 0.0 111.985 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -99.11 81.06 2.53 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.423 ' OE1' ' HB3' ' A' ' 47' ' ' GLN . 24.6 tt0 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.503 -0.76 . . . . 0.0 109.994 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.2 mtt . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 121.571 0.701 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.429 ' O ' HG13 ' A' ' 4' ' ' VAL . . . -125.85 108.69 1.07 Allowed Glycine 0 N--CA 1.439 -1.163 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 170.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.468 ' HB3' ' HD3' ' A' ' 6' ' ' LYS . 6.0 m-20 -37.66 89.09 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -173.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 2' ' ' GLY . 14.9 m -80.96 -15.55 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.557 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.4 m -84.28 -16.23 43.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.283 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.468 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 5.0 mptp? -84.58 -32.51 23.75 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.963 175.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.531 HD22 ' HB2' ' A' ' 77' ' ' ALA . 8.2 mp -75.56 104.62 6.19 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.766 0.794 . . . . 0.0 110.373 177.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.1 t -125.33 68.16 1.14 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.518 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.0 t 71.54 -42.07 0.52 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.157 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -57.33 -58.84 6.49 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -174.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.506 ' CD ' ' HG2' ' A' ' 82' ' ' GLU . 16.0 mt-30 -72.55 -32.64 66.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.692 0.758 . . . . 0.0 109.212 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.436 HG13 ' CE2' ' A' ' 69' ' ' PHE . 89.2 t -63.88 -29.61 47.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.07 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.486 ' C ' ' HD3' ' A' ' 13' ' ' LYS . 1.1 tmtp? -62.82 -40.93 98.92 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 123.181 0.592 . . . . 0.0 110.854 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.43 ' N ' ' HD3' ' A' ' 13' ' ' LYS . 6.4 mp -69.92 -42.45 73.31 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.65 HD21 ' CD1' ' A' ' 80' ' ' LEU . 80.8 mt -59.97 -53.98 51.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.624 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.428 ' HA ' ' HE1' ' A' ' 69' ' ' PHE . 37.7 tt0 -64.65 -35.89 82.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.359 -175.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.1 m -59.82 -42.16 92.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 110.745 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.558 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -80.48 -33.12 36.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.146 0.498 . . . . 0.0 110.278 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.452 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 35.7 t80 -56.44 -55.04 38.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.35 177.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -69.08 -19.79 64.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.522 -174.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.61 -42.86 40.86 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.744 0.307 . . . . 0.0 110.908 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -103.77 14.01 31.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.137 0.494 . . . . 0.0 110.444 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.709 ' HG2' ' HB ' ' A' ' 24' ' ' THR . 10.3 tt0 -71.85 154.65 41.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.38 -176.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.709 ' HB ' ' HG2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER 76.01 137.77 0.05 OUTLIER Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-O 122.462 1.125 . . . . 0.0 113.812 158.637 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.32 -52.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.911 2.408 . . . . 0.0 109.835 168.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -138.83 -25.81 0.88 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.625 172.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.66 50.0 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -176.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 t -89.78 -29.77 18.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.807 0.337 . . . . 0.0 111.39 -174.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.88 -6.33 75.03 Favored Glycine 0 N--CA 1.453 -0.179 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 -175.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 67' ' ' ILE . 61.0 mtt85 -115.25 163.7 15.29 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.207 -0.496 . . . . 0.0 109.745 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.572 HG21 HD11 ' A' ' 39' ' ' ILE . 13.3 p -106.18 126.61 61.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 121.86 0.838 . . . . 0.0 110.269 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 31.1 m -53.79 140.61 29.45 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.847 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.583 ' HB ' HG12 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -66.69 -25.31 66.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.85 -174.538 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -69.36 -26.08 64.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.589 0.709 . . . . 0.0 109.727 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -82.06 -22.4 36.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.661 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.545 HG22 HD22 ' A' ' 40' ' ' LEU . 60.2 mt -55.61 -43.33 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 120.959 0.409 . . . . 0.0 110.143 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.429 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -65.24 -25.43 71.11 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.634 177.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.649 ' O ' HG23 ' A' ' 42' ' ' VAL . 39.3 mt -75.21 -51.97 19.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.572 HD11 HG21 ' A' ' 31' ' ' VAL . 63.5 mt -60.96 -44.83 98.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.839 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.545 HD22 HG22 ' A' ' 36' ' ' ILE . 1.6 mp -57.54 -39.26 76.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.352 0.596 . . . . 0.0 109.685 176.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -65.64 -38.44 89.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.769 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 38' ' ' ILE . 60.8 t -60.69 -50.38 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.622 0.725 . . . . 0.0 110.671 175.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.5 mt -83.35 -1.54 53.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.653 -171.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.55 35.19 42.12 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.403 172.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.5 pt -129.02 166.65 26.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.628 0.214 . . . . 0.0 110.468 176.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 50.29 -166.67 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -120.22 -171.88 2.25 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.975 -173.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.9 t -63.7 171.33 2.74 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.451 0.643 . . . . 0.0 111.437 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.446 ' HA ' ' HB ' ' A' ' 52' ' ' ILE . 7.3 mtpm? -59.0 -24.6 62.92 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.317 -165.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.3 t -57.29 -44.8 84.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.931 0.396 . . . . 0.0 110.35 173.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.3 m -72.26 -34.42 68.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.433 0.635 . . . . 0.0 110.293 176.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.446 ' HB ' ' HA ' ' A' ' 49' ' ' LYS . 44.9 mm -63.41 -24.42 35.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.479 -176.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -50.83 -38.02 46.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.886 172.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -74.44 -28.82 61.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.051 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 52' ' ' ILE . 2.3 mm? -65.35 -43.34 91.14 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.583 HG12 ' HB ' ' A' ' 33' ' ' THR . 71.8 mt -65.2 -45.42 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.96 177.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.03 -27.99 22.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.294 0.569 . . . . 0.0 111.076 176.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -83.31 -53.65 5.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.663 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.459 ' CE2' HG12 ' A' ' 75' ' ' ILE . 97.1 m-85 -100.87 -10.66 20.48 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -169.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.482 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 51.3 t0 -136.25 63.82 51.03 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 121.208 0.527 . . . . 0.0 110.458 174.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.482 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 24.6 Cg_exo -68.42 -20.56 41.87 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.841 2.361 . . . . 0.0 111.592 177.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -78.45 -17.48 56.28 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.757 -176.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.97 43.02 50.65 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.518 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -74.89 -38.04 61.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.216 0.532 . . . . 0.0 109.942 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 110.68 -5.37 29.43 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.961 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -161.32 175.77 11.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 71' ' ' SER . 34.6 pt -143.19 146.71 21.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.371 -177.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -75.88 163.19 27.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.934 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.436 ' CE2' HG13 ' A' ' 12' ' ' VAL . 16.0 t80 -56.49 -35.65 68.23 Favored 'General case' 0 C--O 1.214 -0.772 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.075 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -62.18 -22.41 65.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.869 0.366 . . . . 0.0 111.029 -175.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.42 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 40.3 m -85.82 -41.26 15.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.905 0.383 . . . . 0.0 110.504 174.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.439 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 89.7 t80 -70.1 -30.56 67.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.467 0.651 . . . . 0.0 109.717 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -55.51 -50.53 69.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.871 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.0 -42.82 98.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.364 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.607 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 65.5 mt -54.34 -55.45 14.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.482 0.658 . . . . 0.0 110.068 176.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.69 -42.86 99.82 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.259 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.531 ' HB2' HD22 ' A' ' 7' ' ' LEU . . . -64.06 -28.03 69.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.854 0.359 . . . . 0.0 111.16 -174.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 13.8 ptm180 -89.64 -10.74 44.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.867 -176.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.514 ' CE1' ' HG3' ' A' ' 78' ' ' ARG . 22.6 m-85 -116.28 -40.14 3.3 Favored 'General case' 0 C--N 1.337 0.061 0 C-N-CA 120.66 -0.416 . . . . 0.0 112.105 -176.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.65 ' CD1' HD21 ' A' ' 15' ' ' LEU . 2.3 mp -69.37 -65.66 0.68 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.912 0.387 . . . . 0.0 110.828 176.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.85 11.99 26.52 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.785 -0.643 . . . . 0.0 114.312 175.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.506 ' HG2' ' CD ' ' A' ' 11' ' ' GLN . 29.4 mm-40 54.7 16.47 1.39 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 122.993 0.517 . . . . 0.0 111.767 -173.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -129.99 113.75 14.96 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.849 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.7 p -82.03 73.15 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 122.473 1.13 . . . . 0.0 110.993 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.432 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 0.3 OUTLIER -115.56 147.69 39.38 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 114.909 -1.042 . . . . 0.0 109.693 177.921 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 31.7 Cg_exo -62.11 -58.77 0.33 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.404 2.07 . . . . 0.0 111.625 -176.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.493 ' HB2' ' HG2' ' A' ' 90' ' ' GLN . 5.8 mm-40 -133.55 16.53 4.0 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.867 176.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 66.81 -50.14 0.46 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.946 -1.024 . . . . 0.0 112.166 -176.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 19.8 mmt -81.99 3.41 26.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.211 0.529 . . . . 0.0 110.516 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.493 ' HG2' ' HB2' ' A' ' 87' ' ' GLU . 13.9 mm100 -89.31 156.39 18.75 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.146 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.409 ' OE1' ' HB3' ' A' ' 90' ' ' GLN . 10.1 mp0 56.62 40.24 29.42 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 123.862 0.726 . . . . 0.0 111.868 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -56.16 -33.83 65.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.539 175.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.671 HD13 ' CD1' ' A' ' 149' ' ' PHE . 77.6 mt -57.83 -38.29 75.34 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.731 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.737 ' HA ' ' CD2' ' A' ' 97' ' ' PHE . 5.6 mpt_? -58.84 -46.27 88.09 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.755 0.312 . . . . 0.0 111.689 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -76.03 -17.08 59.82 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.13 0.49 . . . . 0.0 110.291 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.19 -18.04 33.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.182 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.737 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 22.4 m-85 -59.57 -45.5 91.66 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 98' ' ' ARG . 47.8 mtp180 -69.68 -13.86 62.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.156 0.503 . . . . 0.0 111.033 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.4 mt -84.35 -35.51 23.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.501 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -96.38 -11.55 25.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.182 0.515 . . . . 0.0 110.298 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -72.54 77.56 1.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.877 0.846 . . . . 0.0 110.337 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -75.65 -9.49 58.63 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.923 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -88.88 -37.11 15.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.654 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.95 30.55 7.05 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.676 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -98.96 -17.48 18.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.848 0.356 . . . . 0.0 111.544 -175.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.57 -26.18 4.18 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.521 -0.631 . . . . 0.0 111.521 -174.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.526 ' HD2' ' CB ' ' A' ' 145' ' ' ASP . 30.5 m-85 -103.92 144.77 31.07 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 171.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.642 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 7.0 pt -93.11 120.8 43.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 118.591 -1.243 . . . . 0.0 108.977 174.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.5 m -67.76 172.12 5.7 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.96 -174.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 34.3 p -60.79 -29.06 69.21 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.211 0.529 . . . . 0.0 110.845 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.601 ' O ' ' HB2' ' A' ' 114' ' ' ARG . 2.0 t70 -62.97 -50.72 69.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.403 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.642 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.4 p -70.82 -35.28 59.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.933 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.728 ' SD ' HG11 ' A' ' 144' ' ' VAL . 1.4 tpt -59.66 -37.72 79.51 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.763 0.316 . . . . 0.0 110.205 176.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.601 ' HB2' ' O ' ' A' ' 111' ' ' ASP . 36.7 mtt180 -50.55 -59.55 3.93 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.407 172.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.0 -41.69 92.66 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.768 -176.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 53.6 mt -58.09 -46.89 88.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.148 0.499 . . . . 0.0 110.9 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.419 HD12 ' CD2' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -70.57 -47.39 60.5 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.128 -179.257 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.864 ' HB2' HD21 ' A' ' 129' ' ' LEU . . . -53.21 -25.81 15.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.753 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -68.34 -26.68 65.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.195 0.521 . . . . 0.0 110.247 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.4 mp -89.55 -47.77 7.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.022 174.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.897 ' HB3' ' HB2' ' A' ' 124' ' ' LEU . 1.3 m-20 -90.57 93.57 9.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.3 0.572 . . . . 0.0 110.471 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -79.61 -13.84 59.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.728 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.5 p -96.79 -14.04 22.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 122.724 1.25 . . . . 0.0 108.607 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.923 ' HG ' HD22 ' A' ' 129' ' ' LEU . 36.9 tp -69.83 116.21 9.96 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 112.991 -1.913 . . . . 0.0 110.426 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 93.9 p -91.61 -179.71 5.43 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.622 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 24.9 m -58.73 -37.36 75.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.889 0.376 . . . . 0.0 110.911 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -74.58 -42.05 59.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.634 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.65 ' CB ' HD12 ' A' ' 124' ' ' LEU . 59.4 m-20 -64.35 -50.46 67.63 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.923 HD22 ' HG ' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -42.25 -48.41 4.93 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.835 169.646 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -62.19 -41.31 98.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.662 0.268 . . . . 0.0 111.219 -175.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.89 -41.6 97.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.101 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.409 ' O ' HG13 ' A' ' 136' ' ' ILE . 36.2 mtt -63.05 -39.21 94.05 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.624 176.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 129' ' ' LEU . 24.5 mm -57.91 -45.2 87.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.144 0.497 . . . . 0.0 110.382 175.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -61.02 -34.92 75.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.43 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -73.87 -38.52 64.4 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.849 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.53 HG12 ' HB ' ' A' ' 152' ' ' VAL . 59.8 mt -70.43 -49.41 53.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.385 -176.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.73 95.93 0.93 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 123.023 1.392 . . . . 0.0 110.713 -174.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.29 -54.95 5.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.208 -1.36 . . . . 0.0 112.337 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -84.23 -10.35 57.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.441 0.639 . . . . 0.0 110.979 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 61.55 40.95 99.41 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.621 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.1 t -89.89 5.04 48.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.079 0.466 . . . . 0.0 110.66 -176.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.56 -31.01 4.68 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.177 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 35.3 p -117.81 143.27 46.42 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.439 -0.381 . . . . 0.0 109.998 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.728 HG11 ' SD ' ' A' ' 113' ' ' MET . 71.7 t -91.88 111.41 24.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.526 ' CB ' ' HD2' ' A' ' 107' ' ' TYR . 22.6 t70 -146.37 -69.16 0.26 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.687 0.756 . . . . 0.0 111.574 -175.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.858 ' HD2' ' HG2' ' A' ' 147' ' ' GLU . 4.0 p90 -97.92 -53.44 3.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.02 -164.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.858 ' HG2' ' HD2' ' A' ' 146' ' ' PHE . 40.2 mm-40 -98.86 -36.17 9.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.496 0.665 . . . . 0.0 110.157 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 148' ' ' GLU . 40.9 mp0 -63.5 -54.95 28.37 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.038 -175.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.671 ' CD1' HD13 ' A' ' 93' ' ' LEU . 2.3 t80 -66.27 -45.98 78.6 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.793 -175.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' A' ' 146' ' ' PHE . 52.4 mmm -61.47 -19.53 62.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.278 177.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -90.92 -17.54 51.11 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.878 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.53 ' HB ' HG12 ' A' ' 136' ' ' ILE . 6.6 p -98.31 -47.26 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 117.019 0.41 . . . . 0.0 111.393 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 49.9 tpp -81.08 -56.46 4.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.881 0.372 . . . . 0.0 110.785 -176.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.1 p -97.2 26.63 4.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.78 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -122.25 54.1 0.7 Allowed Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.464 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -77.39 -2.52 79.87 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.972 -176.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 38.4 t70 58.2 68.99 0.77 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.589 0.709 . . . . 0.0 109.732 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.674 -173.758 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.5 ttp . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 121.262 0.553 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.87 -49.99 0.36 Allowed Glycine 0 CA--C 1.502 -0.74 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.826 ' HB3' ' HB2' ' A' ' 6' ' ' LYS . 3.7 m-20 59.37 41.73 19.17 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 124.474 0.749 . . . . 0.0 111.783 168.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.6 p -66.81 -23.81 31.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.324 0.583 . . . . 0.0 110.159 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.0 m -95.05 5.05 52.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.495 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.826 ' HB2' ' HB3' ' A' ' 3' ' ' ASP . 4.9 mptp? -97.23 -35.42 10.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.176 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.576 ' HA ' ' OE1' ' A' ' 11' ' ' GLN . 5.6 mp -59.14 113.46 2.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.578 0.704 . . . . 0.0 111.578 -176.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.4 t -81.44 56.34 2.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.764 -172.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.5 m 65.15 -54.19 0.32 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -54.73 -45.87 74.15 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.838 0.455 . . . . 0.0 111.183 -176.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.576 ' OE1' ' HA ' ' A' ' 7' ' ' LEU . 8.9 mt-30 -64.08 -31.46 72.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.764 0.793 . . . . 0.0 110.032 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.463 HG23 ' HB3' ' A' ' 7' ' ' LEU . 99.1 t -76.13 -33.79 25.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.462 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.46 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 12.0 tptt -61.64 -42.64 99.18 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 120.782 0.325 . . . . 0.0 110.642 173.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.9 mt -57.23 -48.7 78.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.426 0.631 . . . . 0.0 109.617 173.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 11' ' ' GLN . 67.9 mt -56.18 -51.34 68.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.261 176.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -61.08 -41.87 97.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.652 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.8 m -61.24 -39.28 89.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.063 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.538 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -84.2 -31.33 25.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.931 0.396 . . . . 0.0 110.616 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.591 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 65.3 t80 -57.95 -56.79 17.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.411 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -71.95 -0.96 12.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.468 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -93.79 -52.43 4.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.788 0.327 . . . . 0.0 110.746 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.611 ' CD1' HG12 ' A' ' 39' ' ' ILE . 64.5 m-85 -95.71 11.11 34.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.02 0.438 . . . . 0.0 110.455 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.615 ' HA ' HG23 ' A' ' 31' ' ' VAL . 11.1 tt0 -62.32 155.12 25.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.513 -174.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.579 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.4 OUTLIER 77.81 138.52 0.06 OUTLIER Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 114.128 -1.396 . . . . 0.0 113.737 161.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -88.32 -44.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.553 2.835 . . . . 0.0 110.799 170.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -164.3 47.03 0.11 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.494 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.78 66.67 1.27 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.808 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.0 t -113.14 -27.19 8.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -176.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.13 -4.76 82.45 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -171.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.448 ' HD2' ' OD2' ' A' ' 66' ' ' ASP . 25.5 mtt85 -115.25 160.22 20.03 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 114.068 -1.066 . . . . 0.0 109.565 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.615 HG23 ' HA ' ' A' ' 23' ' ' GLU . 10.2 p -106.8 126.98 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 121.697 0.76 . . . . 0.0 109.099 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 66' ' ' ASP . 32.8 t -55.63 140.64 40.53 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.941 -1.481 . . . . 0.0 111.372 -177.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.598 ' HB ' HG12 ' A' ' 56' ' ' ILE . 7.0 p -66.5 -19.63 65.83 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.01 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.416 ' O ' ' HE2' ' A' ' 49' ' ' LYS . 32.9 t70 -70.9 -27.39 63.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.72 176.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.682 ' HA ' HD13 ' A' ' 38' ' ' ILE . 87.4 mm-40 -95.06 -13.96 24.7 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.05 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.719 HG22 HD22 ' A' ' 40' ' ' LEU . 63.1 mt -56.93 -34.06 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.614 0.245 . . . . 0.0 110.665 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.437 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -73.12 -36.1 56.81 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.338 -177.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.682 HD13 ' HA ' ' A' ' 35' ' ' GLN . 1.3 mp -59.81 -56.13 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 174.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.78 ' HA ' HG13 ' A' ' 42' ' ' VAL . 36.0 mt -64.08 -39.24 84.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.645 -176.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.719 HD22 HG22 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -60.83 -23.71 65.31 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.301 -0.56 . . . . 0.0 109.992 176.337 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 35.0 tt0 -81.74 -41.63 20.96 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.402 173.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.78 HG13 ' HA ' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -58.78 -38.74 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 121.572 0.701 . . . . 0.0 110.406 177.563 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.479 ' HG ' HG22 ' A' ' 42' ' ' VAL . 45.6 mt -83.52 -11.9 56.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.841 -178.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.91 32.52 56.76 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.269 175.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pt -110.96 -86.09 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -177.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -79.03 177.34 8.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.257 0.551 . . . . 0.0 112.362 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -100.79 -171.95 2.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.371 -174.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.2 t -64.38 175.81 1.24 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.444 0.64 . . . . 0.0 111.862 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 96.8 mttt -53.61 -30.42 42.48 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -165.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.4 m -55.7 -33.48 64.22 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.073 0.463 . . . . 0.0 111.058 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.7 m -84.25 -33.77 23.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.557 0.694 . . . . 0.0 110.3 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.437 HG13 ' HA3' ' A' ' 37' ' ' GLY . 36.9 mm -66.92 -23.98 31.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.497 -175.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 30.7 mmt180 -52.71 -33.1 46.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.923 0.392 . . . . 0.0 110.742 176.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -70.86 -51.05 28.84 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.164 0.507 . . . . 0.0 109.735 175.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.473 HD11 ' CE2' ' A' ' 79' ' ' PHE . 3.3 mm? -51.26 -45.92 62.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.249 177.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.598 HG12 ' HB ' ' A' ' 33' ' ' THR . 73.1 mt -62.97 -50.0 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.486 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -62.92 -25.39 68.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.197 0.523 . . . . 0.0 110.713 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -69.24 -55.02 11.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.236 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.546 ' HB3' ' HB3' ' A' ' 71' ' ' SER . 94.6 m-85 -100.92 -20.76 15.32 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -171.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -126.67 67.59 67.5 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-O 121.2 0.524 . . . . 0.0 110.615 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.456 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 31.3 Cg_exo -62.66 -17.16 57.34 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.862 2.374 . . . . 0.0 111.628 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -69.74 -18.34 63.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.279 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.9 32.44 84.19 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -173.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -75.41 -40.93 57.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.928 -0.636 . . . . 0.0 111.087 -170.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.01 -14.95 10.33 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.017 -1.087 . . . . 0.0 113.788 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.448 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 5.7 p-10 -154.75 157.9 38.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 117.171 0.486 . . . . 0.0 110.875 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.8 pt -133.59 149.11 30.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.255 -175.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -81.11 167.99 19.09 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.657 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.416 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -56.3 -26.63 52.79 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.124 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -42.89 -54.29 4.26 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.468 172.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.546 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 13.5 m -86.51 -37.17 18.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.819 -176.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.416 ' HB3' ' HA ' ' A' ' 69' ' ' PHE . 92.3 t80 -63.94 -35.26 80.1 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.129 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -63.87 -36.27 83.36 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.443 ' HB ' ' CE1' ' A' ' 59' ' ' PHE . 34.6 mt -72.44 -37.25 57.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 177.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.565 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 61.7 mt -57.78 -51.21 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.285 0.564 . . . . 0.0 109.654 173.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.499 ' O ' HD23 ' A' ' 80' ' ' LEU . . . -63.18 -42.78 99.32 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.893 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.464 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . . . -57.95 -37.58 74.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.385 0.612 . . . . 0.0 111.329 -175.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 15.0 ptm180 -81.83 -9.3 59.65 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.969 -173.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.473 ' CE2' HD11 ' A' ' 55' ' ' LEU . 22.2 m-85 -124.02 -31.56 3.36 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.72 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 76' ' ' GLY . 4.1 mm? -69.86 -26.08 64.03 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.155 0.503 . . . . 0.0 110.904 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.46 49.01 1.56 Allowed Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.481 -0.781 . . . . 0.0 113.657 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -94.8 27.82 2.94 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.398 0.618 . . . . 0.0 109.687 174.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -82.67 92.04 7.1 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.505 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.6 t -127.58 84.42 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.548 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.503 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 4.7 t30 -98.25 141.72 23.41 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.42 -175.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 23.5 Cg_exo -65.93 -52.09 1.05 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.597 2.865 . . . . 0.0 112.236 -176.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -89.1 25.64 1.8 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.019 -178.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 85' ' ' ASN . 35.0 tt0 -61.14 111.46 1.72 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.825 0.345 . . . . 0.0 111.015 -176.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.403 ' O ' ' HG2' ' A' ' 89' ' ' MET . 48.8 ttm 63.91 18.82 11.42 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.42 178.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -97.35 -25.02 15.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.981 0.42 . . . . 0.0 110.533 176.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -81.21 47.19 0.99 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.277 0.56 . . . . 0.0 110.555 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -62.8 -19.72 64.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.116 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.65 ' H ' HD22 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -56.81 -38.18 72.23 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.037 -176.562 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.704 ' HA ' ' CE2' ' A' ' 97' ' ' PHE . 30.1 mmm180 -62.44 -34.85 77.59 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.485 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -86.96 -23.44 25.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.881 0.372 . . . . 0.0 110.652 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.0 -16.03 62.06 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.608 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.704 ' CE2' ' HA ' ' A' ' 94' ' ' ARG . 20.1 m-85 -61.71 -40.86 96.51 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -66.46 -17.74 64.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.323 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.2 mt -88.06 -30.72 19.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.321 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -104.28 -24.12 13.15 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -175.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -72.97 79.88 1.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.562 0.696 . . . . 0.0 109.982 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -69.72 -19.43 63.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.628 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.466 ' HB2' ' ND2' ' A' ' 105' ' ' ASN . 12.5 mt-10 -90.91 -37.01 13.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.279 -172.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.81 42.15 3.66 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.024 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.466 ' ND2' ' HB2' ' A' ' 103' ' ' GLU . 24.5 m-80 -87.53 -19.65 27.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 0.0 110.693 -176.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.54 1.9 82.86 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -169.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.552 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 4.7 m-85 -148.22 165.26 31.47 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.668 ' HB ' HG13 ' A' ' 112' ' ' VAL . 11.3 pt -102.46 120.48 52.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 C-N-CA 119.278 -0.969 . . . . 0.0 109.1 170.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.6 m -60.97 161.59 8.11 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.685 -176.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.0 p -58.34 -26.61 63.32 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.765 -0.584 . . . . 0.0 110.642 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -62.05 -51.03 69.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.78 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.668 HG13 ' HB ' ' A' ' 108' ' ' ILE . 2.1 p -70.37 -36.71 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.156 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.633 ' SD ' HG11 ' A' ' 144' ' ' VAL . 2.7 tpt -59.23 -38.34 79.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.103 0.477 . . . . 0.0 109.782 175.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -56.34 -53.48 56.83 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.125 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.62 -29.42 66.91 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.996 -178.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.6 HG13 ' O ' ' A' ' 112' ' ' VAL . 57.4 mt -63.52 -50.2 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 121.205 0.526 . . . . 0.0 110.021 174.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.62 HD11 ' SD ' ' A' ' 132' ' ' MET . 0.7 OUTLIER -58.7 -50.61 73.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.835 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.65 -27.82 68.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.775 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -69.97 -39.92 75.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.911 0.386 . . . . 0.0 110.14 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.44 -56.72 5.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.828 175.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.619 ' CG ' HD23 ' A' ' 124' ' ' LEU . 7.5 t70 -102.82 119.97 39.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.077 0.465 . . . . 0.0 110.881 -177.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -101.87 15.79 27.92 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.805 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 61.8 p -116.17 -17.0 10.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.477 0.656 . . . . 0.0 109.767 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.619 HD23 ' CG ' ' A' ' 121' ' ' ASP . 1.4 mm? -55.42 146.85 18.73 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.909 169.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.474 ' H ' ' HB2' ' A' ' 128' ' ' ASP . 27.3 t -107.85 162.46 13.98 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.601 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.1 m -51.76 -36.51 47.6 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 118.204 0.456 . . . . 0.0 111.396 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -76.38 -45.69 30.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.295 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.474 ' HB2' ' H ' ' A' ' 125' ' ' SER . 3.0 m-20 -63.35 -42.51 98.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.053 0.454 . . . . 0.0 110.487 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.616 HD11 ' HB3' ' A' ' 117' ' ' LEU . 26.6 tp -56.39 -39.5 73.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.528 176.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.455 ' O ' ' HB ' ' A' ' 133' ' ' ILE . 23.7 t70 -63.88 -41.7 97.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.234 177.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.48 -38.06 89.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.686 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.62 ' SD ' HD11 ' A' ' 117' ' ' LEU . 28.7 mtt -65.23 -34.04 77.43 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.59 175.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 133' ' ' ILE . 15.2 mm -58.54 -47.79 87.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.978 0.418 . . . . 0.0 110.312 173.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.66 -45.08 77.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.409 175.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -66.95 -37.12 83.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.253 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.452 HG21 ' SD ' ' A' ' 113' ' ' MET . 51.9 mt -69.41 -58.65 5.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.16 -178.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -71.29 96.26 1.41 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.7 0.762 . . . . 0.0 110.206 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -75.19 -42.97 54.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.736 -175.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -81.94 -15.14 54.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.491 0.662 . . . . 0.0 110.979 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 70.71 26.03 74.73 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.195 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.0 t -74.68 -18.25 60.55 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.428 0.633 . . . . 0.0 109.723 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.22 -23.94 24.64 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.552 ' HB ' ' HB2' ' A' ' 107' ' ' TYR . 24.6 p -116.93 128.92 55.69 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.633 HG11 ' SD ' ' A' ' 113' ' ' MET . 94.1 t -86.13 121.92 37.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.292 -176.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.535 ' CB ' ' HD2' ' A' ' 107' ' ' TYR . 22.7 t70 -150.43 -68.99 0.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.325 0.584 . . . . 0.0 111.867 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 146' ' ' PHE . 0.6 OUTLIER -85.23 -88.28 0.11 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.067 -167.185 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -78.31 -28.22 47.4 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.063 0.459 . . . . 0.0 110.823 -175.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.664 ' CD ' ' H ' ' A' ' 148' ' ' GLU . 3.0 mp0 -57.94 -64.11 1.02 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.588 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.546 ' CD2' HD11 ' A' ' 108' ' ' ILE . 19.8 t80 -66.97 -43.74 82.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.979 -174.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 40.7 tpp -62.43 -33.56 75.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.152 0.501 . . . . 0.0 109.797 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.55 -26.81 66.72 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 116.033 -0.53 . . . . 0.0 113.133 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.502 HG12 ' HA ' ' A' ' 149' ' ' PHE . 6.5 p -89.17 -42.51 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 117.238 0.519 . . . . 0.0 111.665 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -82.34 -57.89 3.17 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.543 -174.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 45.3 p -86.35 -39.4 16.48 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.585 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 123.17 -8.24 9.1 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 129.77 -110.45 1.05 Allowed Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -112.38 -73.98 0.65 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 175.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.16 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.7 mtp . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 121.114 0.483 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -163.44 44.77 0.33 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.506 ' HB3' ' HD3' ' A' ' 6' ' ' LYS . 1.4 m-20 -73.31 106.58 5.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.967 0.413 . . . . 0.0 111.721 -175.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.9 p -72.02 -18.61 19.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.006 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.6 t -89.67 -17.15 28.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.546 -176.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.506 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 14.5 mptt -91.27 -10.19 42.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.807 0.337 . . . . 0.0 111.284 -177.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.675 ' HG ' ' HA ' ' A' ' 77' ' ' ALA . 4.3 mm? -90.45 114.13 26.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.196 0.522 . . . . 0.0 110.282 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.0 t -85.05 173.38 10.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.803 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.3 m -54.9 -42.29 71.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -170.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -58.49 -43.11 88.88 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.782 0.325 . . . . 0.0 111.515 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.422 ' H ' ' HG2' ' A' ' 11' ' ' GLN . 37.8 mm-40 -64.34 -42.23 96.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.804 0.811 . . . . 0.0 109.86 177.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.42 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 93.3 t -72.17 -27.27 26.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 114.706 -1.133 . . . . 0.0 111.403 -177.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 11.9 tptt -62.08 -42.51 99.28 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-O 120.886 0.374 . . . . 0.0 111.223 177.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.6 mt -60.41 -41.61 94.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.407 0.622 . . . . 0.0 109.491 174.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.922 HD21 HD13 ' A' ' 80' ' ' LEU . 77.3 mt -61.16 -49.27 77.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.692 176.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -61.34 -43.47 98.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.461 -178.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 57.9 m -58.6 -38.27 77.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.116 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.566 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -86.0 -35.67 20.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.042 0.449 . . . . 0.0 110.382 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.693 ' CE1' HG22 ' A' ' 31' ' ' VAL . 88.0 t80 -55.15 -49.58 71.46 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.096 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.415 ' HA ' ' HB2' ' A' ' 23' ' ' GLU . 23.7 mmt180 -81.35 -6.52 58.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.765 -175.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -87.58 -46.47 9.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.09 0.472 . . . . 0.0 110.318 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.582 ' HB3' ' HB3' ' A' ' 35' ' ' GLN . 68.4 m-85 -98.97 25.74 6.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.81 0.814 . . . . 0.0 109.461 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.964 ' HG2' ' HB ' ' A' ' 24' ' ' THR . 1.7 tt0 -78.42 139.48 38.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.249 -1.341 . . . . 0.0 112.8 -172.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.964 ' HB ' ' HG2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER 76.27 144.69 0.1 Allowed Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 155.515 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 24' ' ' THR . 7.1 Cg_exo -74.8 -53.71 0.1 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.531 2.821 . . . . 0.0 110.084 165.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -136.5 -39.61 0.65 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.69 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.3 38.55 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.9 t -76.37 -27.18 56.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.374 -0.413 . . . . 0.0 111.161 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.93 4.6 86.97 Favored Glycine 0 C--N 1.335 0.479 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.457 ' HB2' ' OD2' ' A' ' 66' ' ' ASP . 11.8 mtt180 -122.06 168.3 12.1 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.758 -0.721 . . . . 0.0 110.305 -175.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.693 HG22 ' CE1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -105.66 127.34 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.536 0 CA-C-O 121.446 0.641 . . . . 0.0 110.926 174.626 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.418 ' HB3' ' HG2' ' A' ' 35' ' ' GLN . 6.0 t -53.74 139.32 33.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.797 -1.547 . . . . 0.0 109.1 171.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.628 HG21 HG23 ' A' ' 56' ' ' ILE . 3.9 p -70.46 -13.04 61.96 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.869 0.366 . . . . 0.0 111.586 -176.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.71 -29.47 62.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.717 172.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.582 ' HB3' ' HB3' ' A' ' 22' ' ' PHE . 84.3 mm-40 -81.56 -23.54 37.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.977 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.52 HG22 HD22 ' A' ' 40' ' ' LEU . 61.0 mt -57.18 -44.34 83.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.524 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.82 -20.73 70.7 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.366 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.618 ' O ' HG23 ' A' ' 42' ' ' VAL . 15.0 mt -81.9 -51.36 15.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.566 HG23 ' HB1' ' A' ' 18' ' ' ALA . 73.2 mt -57.66 -46.57 86.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.499 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.52 HD22 HG22 ' A' ' 36' ' ' ILE . 1.3 mp -56.81 -40.91 76.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.246 0.546 . . . . 0.0 109.928 177.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.5 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 32.8 tt0 -61.28 -43.96 98.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.566 175.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 38' ' ' ILE . 78.8 t -55.57 -48.03 77.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.814 0.816 . . . . 0.0 110.552 175.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.2 mt -83.14 -2.45 55.49 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.365 -172.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.8 26.84 59.84 Favored Glycine 0 N--CA 1.453 -0.188 0 CA-C-N 115.944 -0.571 . . . . 0.0 113.129 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.9 pt -122.45 167.74 15.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 O-C-N 122.708 -0.29 . . . . 0.0 111.066 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 50.62 -171.37 0.02 OUTLIER 'General case' 0 C--O 1.233 0.227 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -178.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -119.6 -170.88 2.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.938 -173.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.3 t -56.51 167.38 0.72 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.324 0.583 . . . . 0.0 111.149 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.507 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 55.9 mttp -57.36 -23.66 50.39 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -166.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.4 t -54.73 -47.84 73.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.093 0.473 . . . . 0.0 110.358 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.7 m -70.39 -35.27 73.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.63 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.507 ' CG1' ' HA ' ' A' ' 49' ' ' LYS . 44.4 mm -60.54 -29.2 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.359 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.528 ' HA ' HD12 ' A' ' 56' ' ' ILE . 34.5 mmt180 -56.5 -28.2 59.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.155 176.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -75.2 -35.22 61.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.884 0.373 . . . . 0.0 110.611 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 52' ' ' ILE . 2.7 mm? -62.6 -43.82 97.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.416 0.627 . . . . 0.0 109.484 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.628 HG23 HG21 ' A' ' 33' ' ' THR . 52.6 mt -63.6 -43.64 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.839 176.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -55.75 -35.5 66.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.19 0.519 . . . . 0.0 110.897 176.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.412 ' HG2' ' CE2' ' A' ' 59' ' ' PHE . 4.5 tp10 -71.68 -54.68 9.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.735 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.508 ' CE2' HG12 ' A' ' 75' ' ' ILE . 96.0 m-85 -100.62 -12.9 18.82 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -128.1 66.9 73.5 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-O 121.063 0.458 . . . . 0.0 110.606 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.458 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 33.1 Cg_exo -62.6 -29.75 78.37 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.795 2.33 . . . . 0.0 112.338 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -77.34 -17.62 58.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.387 -175.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.35 47.08 60.1 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -175.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -78.92 -26.98 43.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.111 0.482 . . . . 0.0 110.131 -174.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.3 -25.35 13.95 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.847 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.457 ' OD2' ' HB2' ' A' ' 30' ' ' ARG . 53.1 p-10 -146.06 168.48 20.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.918 0.39 . . . . 0.0 110.536 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.457 ' HB ' ' HB2' ' A' ' 71' ' ' SER . 36.6 pt -138.82 147.41 25.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.344 -178.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.441 ' HA ' ' HG2' ' A' ' 30' ' ' ARG . 28.7 t70 -80.8 170.27 16.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.316 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.415 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -57.26 -26.56 61.0 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 176.086 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -48.1 -52.89 18.47 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.822 173.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.464 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 2.2 m -78.3 -43.46 27.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.663 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.415 ' HB3' ' HA ' ' A' ' 69' ' ' PHE . 87.0 t80 -63.11 -36.76 84.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.599 -175.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -66.67 -35.45 80.17 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 56.2 mt -69.74 -39.2 77.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.625 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 62.6 mt -58.14 -52.57 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-O 121.373 0.606 . . . . 0.0 109.594 173.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.404 ' HA2' ' CD1' ' A' ' 80' ' ' LEU . . . -62.14 -38.89 96.88 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.237 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.675 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . . . -66.06 -30.18 70.65 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.82 0.343 . . . . 0.0 111.427 -174.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.625 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 16.4 ptm180 -85.14 -7.48 59.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.787 -175.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.449 ' CE1' ' HG3' ' A' ' 78' ' ' ARG . 19.9 m-85 -124.97 -48.58 1.75 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 120.874 -0.331 . . . . 0.0 111.047 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.922 HD13 HD21 ' A' ' 15' ' ' LEU . 3.3 mp -71.93 -25.06 61.74 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.47 0.652 . . . . 0.0 111.591 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.82 35.52 3.5 Favored Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.762 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -73.78 -8.66 56.89 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.367 -0.417 . . . . 0.0 110.731 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.0 -72.12 0.11 Allowed 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.1 p 37.41 58.7 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 124.631 1.207 . . . . 0.0 111.964 176.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.437 ' CG ' ' HD2' ' A' ' 86' ' ' PRO . 2.6 t30 -72.43 150.08 91.46 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.729 -176.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.437 ' HD2' ' CG ' ' A' ' 85' ' ' ASN . 10.1 Cg_endo -53.39 -60.19 0.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.045 2.496 . . . . 0.0 111.568 -177.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -126.75 7.23 6.78 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.363 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 59.53 19.46 7.95 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.616 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 52.2 ttp -172.25 80.84 0.06 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -77.62 -78.83 0.13 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.23 -172.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -138.14 25.63 2.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.423 0.63 . . . . 0.0 110.404 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.32 -19.44 35.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.227 175.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.606 ' H ' HD22 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -51.02 -32.14 20.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.913 177.256 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.743 HH11 ' HE2' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -58.22 -44.44 88.18 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.989 0.423 . . . . 0.0 111.618 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -71.67 -29.72 64.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.178 0.513 . . . . 0.0 110.241 176.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.412 ' HA ' HD12 ' A' ' 99' ' ' LEU . . . -75.56 -19.31 59.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.877 -175.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.743 ' HE2' HH11 ' A' ' 94' ' ' ARG . 22.6 m-85 -59.19 -48.99 79.55 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 120.844 0.354 . . . . 0.0 110.084 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -70.47 -12.9 61.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.527 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 96' ' ' ALA . 85.5 mt -83.63 -27.37 29.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.832 176.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -105.14 -25.28 12.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.511 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -72.26 82.12 1.02 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.797 0.808 . . . . 0.0 111.099 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -72.39 -15.75 61.85 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.927 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -78.98 -35.99 42.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.339 -175.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.0 44.32 4.18 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.754 174.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -107.77 -18.44 13.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.064 0.459 . . . . 0.0 110.339 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.29 -24.44 27.18 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -172.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.59 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 6.3 m-85 -109.9 152.25 26.04 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.677 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 13.1 pt -92.44 124.66 44.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.6 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.56 ' HA ' HG22 ' A' ' 143' ' ' THR . 21.7 m -65.39 165.89 11.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.627 -175.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.8 p -62.33 -27.14 68.85 Favored 'General case' 0 C--N 1.318 -0.775 0 O-C-N 121.74 -0.6 . . . . 0.0 111.154 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.56 -49.79 76.13 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.667 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.677 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.6 p -70.73 -38.39 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.598 -178.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.4 ' HA ' ' HE2' ' A' ' 113' ' ' MET . 4.0 tpp -58.36 -43.12 88.24 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 174.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.54 ' O ' HD21 ' A' ' 129' ' ' LEU . 23.0 ttp180 -53.25 -40.36 64.53 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.669 177.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -74.37 -38.43 63.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.307 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 112' ' ' VAL . 59.3 mt -63.58 -52.67 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 120.945 0.402 . . . . 0.0 110.608 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.552 ' HB3' HD11 ' A' ' 129' ' ' LEU . 0.8 OUTLIER -54.02 -53.91 46.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.312 179.795 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.599 ' HB2' HD22 ' A' ' 129' ' ' LEU . . . -58.69 -27.52 64.92 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.257 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.22 -50.74 17.82 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.4 -48.96 71.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.802 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.645 ' HB3' HD23 ' A' ' 124' ' ' LEU . 4.8 m-20 -103.59 94.69 5.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.6 0.714 . . . . 0.0 110.189 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -73.92 -5.06 38.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.052 -0.977 . . . . 0.0 112.653 -171.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 66.9 p -94.85 -2.93 49.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.398 0.618 . . . . 0.0 111.359 -173.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.645 HD23 ' HB3' ' A' ' 121' ' ' ASP . 4.4 mm? -80.71 148.02 30.33 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.223 177.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 56.2 m -121.68 173.35 7.5 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.7 m -48.15 -47.53 34.79 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -174.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -68.81 -54.26 16.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.712 0.291 . . . . 0.0 111.227 -177.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -58.93 -44.89 91.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.725 0.774 . . . . 0.0 110.372 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.599 HD22 ' HB2' ' A' ' 118' ' ' ALA . 61.3 tp -60.57 -38.12 83.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.711 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.443 ' O ' ' HB ' ' A' ' 133' ' ' ILE . 5.6 t70 -69.35 -33.55 73.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.023 0.439 . . . . 0.0 110.251 -178.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.63 94.58 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.963 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.471 ' SD ' HD11 ' A' ' 117' ' ' LEU . 38.1 mtt -60.24 -36.34 77.51 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.262 175.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.508 HD11 ' HA ' ' A' ' 114' ' ' ARG . 17.0 mm -59.05 -47.2 90.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.835 0.35 . . . . 0.0 110.853 175.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -60.34 -39.79 88.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.229 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -70.03 -43.99 70.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.703 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 57.7 mt -57.98 -54.31 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.163 0.585 . . . . 0.0 112.519 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -73.65 91.59 1.89 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.587 0.708 . . . . 0.0 110.507 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.58 -41.97 36.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.521 -174.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -84.85 -13.47 50.9 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.934 -172.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 78.59 26.82 58.34 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.895 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.9 m -73.66 -18.03 61.08 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.363 0.601 . . . . 0.0 110.609 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.54 -13.6 51.05 Favored Glycine 0 CA--C 1.509 -0.307 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.096 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.59 ' HB ' ' HB2' ' A' ' 107' ' ' TYR . 3.0 p -132.8 131.15 40.75 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.726 -0.737 . . . . 0.0 109.223 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.433 HG12 ' HB2' ' A' ' 149' ' ' PHE . 52.8 t -84.73 111.81 20.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.938 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.423 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 11.0 t70 -139.46 -72.2 0.39 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.38 0.609 . . . . 0.0 110.913 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.577 ' O ' ' HG2' ' A' ' 150' ' ' MET . 0.7 OUTLIER -82.99 -98.46 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.517 -169.615 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.503 ' HG2' ' CD2' ' A' ' 146' ' ' PHE . 9.1 pt-20 -67.87 -29.49 68.63 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 122.259 -0.276 . . . . 0.0 111.118 -175.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -59.68 -51.05 71.45 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.4 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.601 ' HA ' HG12 ' A' ' 152' ' ' VAL . 9.4 t80 -79.66 -33.91 40.86 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.416 -174.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' MET . . . . . 0.602 ' CE ' HD23 ' A' ' 93' ' ' LEU . 10.3 mmt -62.53 -45.34 93.4 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.502 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.95 -33.32 83.55 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.251 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.601 HG12 ' HA ' ' A' ' 149' ' ' PHE . 8.1 p -81.71 -36.55 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 111.598 -176.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 52.1 tpp -96.85 -56.07 2.68 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -173.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 69.0 p -97.49 -13.7 21.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.971 0.415 . . . . 0.0 111.551 -173.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 96.65 -24.04 32.57 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.879 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 72.04 -135.39 22.78 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.018 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -104.33 -38.32 6.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.252 0.549 . . . . 0.0 110.3 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 C--O 1.243 0.753 0 CA-C-O 118.386 -0.816 . . . . 0.0 110.389 -177.679 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.7 mtm . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 121.181 0.515 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -86.79 60.74 4.44 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 172.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.461 ' HB2' ' HB2' ' A' ' 6' ' ' LYS . 20.4 m-20 -61.13 110.11 1.29 Allowed 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.202 0.525 . . . . 0.0 111.924 -173.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.0 p -74.58 -9.69 13.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.505 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.2 p -91.44 -21.23 21.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.859 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 3' ' ' ASP . 5.6 mptp? -76.39 -27.97 56.56 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.908 0.385 . . . . 0.0 110.088 177.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.749 ' HG ' ' HA ' ' A' ' 77' ' ' ALA . 5.1 mt -59.78 114.83 2.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.659 173.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.406 ' HB2' ' HG3' ' A' ' 11' ' ' GLN . 20.4 m -79.98 149.99 30.6 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -51.35 -41.17 60.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.7 0.286 . . . . 0.0 111.557 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -57.46 -39.74 77.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.32 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.551 ' HB2' HD22 ' A' ' 7' ' ' LEU . 8.2 mt-30 -70.26 -42.27 72.36 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.443 0.64 . . . . 0.0 109.357 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.609 HG22 HD13 ' A' ' 7' ' ' LEU . 57.4 t -63.22 -31.44 52.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.603 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.538 ' C ' ' HD3' ' A' ' 13' ' ' LYS . 5.5 tmtm? -66.01 -40.3 90.97 Favored 'General case' 0 N--CA 1.416 -2.143 0 C-N-CA 123.277 0.631 . . . . 0.0 110.043 177.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.53 -43.26 94.58 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.66 HD21 HD13 ' A' ' 80' ' ' LEU . 80.1 mt -55.99 -50.26 71.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.614 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.574 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 6.8 tp10 -54.13 -53.62 50.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.79 177.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 96.3 m -63.58 -39.42 94.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.521 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -77.66 -27.21 50.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.103 0.477 . . . . 0.0 110.564 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.756 ' HD1' ' HD2' ' A' ' 20' ' ' ARG . 45.4 t80 -62.63 -51.75 66.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.139 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.756 ' HD2' ' HD1' ' A' ' 19' ' ' PHE . 23.3 mmm-85 -70.34 -27.37 64.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.32 -172.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.76 -45.63 81.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.937 0.399 . . . . 0.0 110.715 -176.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.457 ' CD2' HG12 ' A' ' 39' ' ' ILE . 68.6 m-85 -103.45 14.19 31.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.129 0.49 . . . . 0.0 110.573 -178.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.572 ' HG2' ' N ' ' A' ' 24' ' ' THR . 16.9 tt0 -72.4 152.26 42.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.803 -176.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.572 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.4 OUTLIER 76.08 133.91 0.04 OUTLIER Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 114.752 -1.113 . . . . 0.0 113.266 163.574 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -83.22 -47.03 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.025 2.483 . . . . 0.0 110.727 171.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -163.84 46.5 0.12 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.455 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.26 59.99 0.92 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.259 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.7 t -106.83 -31.52 8.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.988 0.423 . . . . 0.0 110.608 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.01 -14.91 60.73 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.467 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.58 ' HG3' ' HA ' ' A' ' 68' ' ' ASP . 6.6 mpt_? -109.87 170.7 7.9 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.538 HG23 ' HA ' ' A' ' 23' ' ' GLU . 12.0 p -107.6 129.14 62.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 121.758 0.79 . . . . 0.0 109.918 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.472 ' HB3' ' HG2' ' A' ' 35' ' ' GLN . 15.8 t -59.45 143.67 49.2 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.377 -175.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.587 ' HB ' HG12 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -67.51 -19.45 65.31 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.838 -174.389 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -83.8 -22.26 31.87 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.308 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.472 ' HG2' ' HB3' ' A' ' 32' ' ' SER . 11.9 mm100 -83.24 -20.4 34.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.531 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.678 HG22 HD22 ' A' ' 40' ' ' LEU . 52.9 mt -53.96 -42.58 54.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.261 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.439 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -61.72 -39.28 97.22 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.157 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.65 ' O ' HG23 ' A' ' 42' ' ' VAL . 39.7 mt -63.36 -50.76 77.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.192 0.52 . . . . 0.0 109.872 178.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.521 HG23 ' HB1' ' A' ' 18' ' ' ALA . 64.5 mt -61.46 -45.67 98.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.583 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.678 HD22 HG22 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -58.42 -28.69 65.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.009 0.433 . . . . 0.0 110.64 177.066 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.504 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 38.4 tt0 -74.51 -41.38 60.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.428 174.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 38' ' ' ILE . 38.7 t -56.07 -51.7 58.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 121.84 0.829 . . . . 0.0 109.733 175.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.6 mt -74.75 -24.8 58.76 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.34 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.97 42.25 6.04 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.154 173.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 pt -119.06 -83.88 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.466 ' HG2' HD21 ' A' ' 55' ' ' LEU . 3.4 tp60 -75.3 179.95 4.84 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.334 0.588 . . . . 0.0 112.26 -175.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -103.41 -170.35 1.77 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.862 -173.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.507 ' O ' HG12 ' A' ' 52' ' ' ILE . 15.0 t -60.01 177.27 0.25 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 66.4 mttm -52.32 -38.54 58.81 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.903 0.481 . . . . 0.0 112.108 -172.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.5 m -54.56 -34.04 61.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.102 0.477 . . . . 0.0 111.248 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.8 m -84.46 -31.52 24.52 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.51 0.671 . . . . 0.0 110.266 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.799 ' HA ' HD23 ' A' ' 55' ' ' LEU . 46.9 mm -68.84 -24.19 28.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.559 -177.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 29.4 mmt180 -57.91 -25.73 61.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.822 0.344 . . . . 0.0 110.598 176.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -66.18 -56.38 11.63 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 172.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.799 HD23 ' HA ' ' A' ' 52' ' ' ILE . 2.8 mm? -49.6 -48.4 48.89 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.119 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.587 HG12 ' HB ' ' A' ' 33' ' ' THR . 68.6 mt -63.37 -52.8 53.69 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.891 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -64.53 -23.0 67.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.255 0.55 . . . . 0.0 110.583 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -80.37 -54.35 5.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.697 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.535 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 72.0 m-85 -91.59 -22.38 20.35 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -173.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.432 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 44.6 t0 -125.8 63.62 47.62 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 121.075 0.464 . . . . 0.0 110.092 175.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.535 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 32.1 Cg_exo -61.65 -23.82 76.92 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.09 2.527 . . . . 0.0 112.382 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -76.08 -17.16 59.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.892 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.72 45.21 66.62 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.92 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -73.33 -46.09 51.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.656 0.265 . . . . 0.0 110.414 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.96 -18.82 5.87 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.668 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 2.8 p30 -147.87 164.36 33.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.703 0.287 . . . . 0.0 110.751 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.525 ' O ' ' HB3' ' A' ' 30' ' ' ARG . 35.1 pt -132.2 145.71 34.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.533 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.58 ' HA ' ' HG3' ' A' ' 30' ' ' ARG . 3.5 p-10 -76.75 171.07 15.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.142 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.566 ' HE1' ' HA ' ' A' ' 16' ' ' GLU . 21.3 t80 -55.21 -42.75 73.74 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.55 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.462 ' O ' HG13 ' A' ' 74' ' ' ILE . 15.3 t70 -59.11 -45.08 91.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.756 0.312 . . . . 0.0 110.829 -174.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.449 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 22.1 m -65.19 -31.83 73.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.629 177.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -80.21 -30.99 38.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.306 0.574 . . . . 0.0 109.77 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -66.39 -39.06 88.82 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.717 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 70' ' ' ASP . 61.7 mt -64.95 -43.5 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.056 0.455 . . . . 0.0 109.822 175.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.586 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 79.3 mt -55.87 -50.9 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.815 173.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.413 ' HA2' ' CD1' ' A' ' 80' ' ' LEU . . . -61.01 -43.33 99.58 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.585 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.749 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . . . -64.92 -30.1 71.08 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.981 0.42 . . . . 0.0 111.452 -174.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 15.2 ptm180 -87.63 -11.02 49.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.781 -175.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.493 ' CD1' ' HG3' ' A' ' 78' ' ' ARG . 22.5 m-85 -120.29 -42.83 2.55 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.899 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.66 HD13 HD21 ' A' ' 15' ' ' LEU . 2.5 mp -69.3 -10.56 58.39 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -62.14 98.36 0.19 Allowed Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.498 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.01 -24.02 41.09 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.443 0.64 . . . . 0.0 109.713 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -83.51 73.37 10.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.759 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.7 t -144.34 79.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.544 0.688 . . . . 0.0 111.682 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.566 ' HB3' ' HB3' ' A' ' 88' ' ' GLN . 12.2 t30 -71.23 141.14 85.8 Favored Pre-proline 0 C--N 1.316 -0.881 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 166.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -51.3 -41.24 59.69 Favored 'Trans proline' 0 CA--C 1.52 -0.224 0 C-N-CA 123.164 2.576 . . . . 0.0 112.897 -167.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.427 ' HG2' ' HB2' ' A' ' 92' ' ' GLU . 23.7 mt-10 -125.58 50.82 1.78 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.052 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.566 ' HB3' ' HB3' ' A' ' 85' ' ' ASN . 28.7 pt20 -67.67 -42.26 82.44 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.327 -178.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 14.3 tpt -132.0 39.38 3.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.625 0.726 . . . . 0.0 109.667 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.631 ' HB3' ' HG2' ' A' ' 92' ' ' GLU . 50.9 mt-30 -127.4 133.62 49.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.138 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.552 ' HA ' HD22 ' A' ' 93' ' ' LEU . 44.8 mt-30 -81.63 29.99 0.37 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.383 0.611 . . . . 0.0 110.781 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.631 ' HG2' ' HB3' ' A' ' 90' ' ' GLN . 13.3 mm-40 -66.4 -16.52 64.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.521 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.584 HD12 ' HE1' ' A' ' 149' ' ' PHE . 0.4 OUTLIER -42.34 -41.37 2.81 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 123.721 0.638 . . . . 0.0 110.824 178.415 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.494 ' HA ' ' CE1' ' A' ' 97' ' ' PHE . 36.1 mmt180 -45.72 -42.0 11.3 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 124.038 0.837 . . . . 0.0 111.555 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.634 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 43.2 mt-10 -85.82 -32.71 21.61 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.668 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.602 ' O ' ' HB2' ' A' ' 99' ' ' LEU . . . -84.39 -39.85 18.54 Favored 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.475 -167.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.494 ' CE1' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -77.66 -19.71 54.96 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.895 178.69 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -76.74 -12.09 59.94 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.55 169.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 73.4 mt -84.43 -18.09 37.12 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.973 168.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TYR . . . . . 0.59 ' HD1' ' O ' ' A' ' 96' ' ' ALA . 37.1 m-85 -105.29 -2.78 23.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.035 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -72.37 80.87 1.03 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.588 0.709 . . . . 0.0 111.135 -172.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -54.19 -46.32 72.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.937 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -84.07 -28.35 27.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.15 -168.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.08 63.8 1.43 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.404 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -114.7 -17.98 11.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.006 0.431 . . . . 0.0 110.536 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.85 -21.36 36.92 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -168.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.754 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 2.3 m-85 -116.53 164.85 13.96 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 172.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.721 ' HB ' HG13 ' A' ' 112' ' ' VAL . 3.3 pt -103.49 127.6 57.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.986 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.4 ' HA ' HG22 ' A' ' 143' ' ' THR . 45.9 m -66.56 168.82 8.55 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 -177.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.509 ' HB ' ' CG2' ' A' ' 133' ' ' ILE . 72.5 p -61.77 -31.75 71.97 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.544 0.687 . . . . 0.0 110.308 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.16 -34.29 77.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.107 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.721 HG13 ' HB ' ' A' ' 108' ' ' ILE . 2.2 p -87.15 -34.82 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.191 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' MET . . . . . 0.718 ' SD ' HG11 ' A' ' 144' ' ' VAL . 2.5 tpt -55.03 -38.81 68.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.036 0.446 . . . . 0.0 110.503 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.731 ' HB2' ' HB3' ' A' ' 129' ' ' LEU . 5.9 ptp180 -66.9 -49.63 64.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.545 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.499 ' HG2' ' HA ' ' A' ' 112' ' ' VAL . 15.3 pt-20 -63.4 -27.54 69.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.745 0.307 . . . . 0.0 111.071 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.516 HD12 HD13 ' A' ' 108' ' ' ILE . 19.9 mt -66.26 -48.24 81.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.174 0.511 . . . . 0.0 110.148 173.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.569 HD12 ' HG ' ' A' ' 124' ' ' LEU . 1.2 tm? -61.06 -51.52 68.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.718 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.554 ' HB2' HD11 ' A' ' 129' ' ' LEU . . . -60.13 -22.18 62.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.302 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -68.14 -45.92 72.27 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.5 mp -77.47 -53.62 7.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.353 0.597 . . . . 0.0 109.852 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.619 ' HB3' HD23 ' A' ' 124' ' ' LEU . 18.0 m-20 -96.47 90.12 5.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.931 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -76.89 15.35 0.68 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.06 -173.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 78.8 p -103.83 -13.7 16.31 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.503 0.668 . . . . 0.0 110.35 -177.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.619 HD23 ' HB3' ' A' ' 121' ' ' ASP . 4.1 mm? -75.32 119.18 19.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.64 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 21.9 t -89.94 177.84 6.37 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.1 t -57.1 -45.38 83.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.752 0.31 . . . . 0.0 110.863 -176.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 128' ' ' ASP . 3.0 pm0 -66.55 -38.36 86.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.054 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.493 ' HB3' HD13 ' A' ' 124' ' ' LEU . 40.9 m-20 -63.4 -49.74 72.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.157 0.503 . . . . 0.0 110.013 178.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.731 ' HB3' ' HB2' ' A' ' 114' ' ' ARG . 74.4 mt -56.74 -38.23 72.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.544 178.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -62.37 -39.74 94.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.861 0.363 . . . . 0.0 110.273 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.19 -43.35 70.94 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.552 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 27.2 mtt -61.13 -37.33 82.45 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.591 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.509 ' CG2' ' HB ' ' A' ' 110' ' ' THR . 10.1 mm -59.7 -47.32 91.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.078 0.466 . . . . 0.0 110.744 175.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.01 -39.04 68.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.791 0.805 . . . . 0.0 110.457 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.26 -44.99 23.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.407 -1.27 . . . . 0.0 111.831 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.441 HG21 ' HG2' ' A' ' 113' ' ' MET . 60.1 mt -59.76 -57.3 12.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 123.305 0.642 . . . . 0.0 112.21 -177.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.18 94.71 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.784 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.37 -53.92 7.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.421 -175.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -82.25 -12.99 57.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.352 0.596 . . . . 0.0 110.888 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 64.35 38.42 95.81 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.352 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.4 m -66.94 -14.81 63.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.343 0.592 . . . . 0.0 111.133 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.72 -16.81 58.28 Favored Glycine 0 CA--C 1.504 -0.595 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.526 ' HB ' ' HB2' ' A' ' 107' ' ' TYR . 2.3 p -140.99 135.45 31.16 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.491 -0.855 . . . . 0.0 109.27 175.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.718 HG11 ' SD ' ' A' ' 113' ' ' MET . 51.0 t -81.65 124.17 38.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.754 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 14.5 t70 -146.43 -64.21 0.3 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.777 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.586 ' HD2' ' H ' ' A' ' 147' ' ' GLU . 1.2 p90 -94.12 -97.98 0.15 Allowed 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.704 -166.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.586 ' H ' ' HD2' ' A' ' 146' ' ' PHE . 54.1 mt-10 -70.67 -22.05 62.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.002 0.43 . . . . 0.0 110.554 -177.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.448 ' CB ' HG13 ' A' ' 144' ' ' VAL . 5.9 mp0 -65.76 -53.77 36.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.172 0.51 . . . . 0.0 110.182 176.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.635 ' CD2' HD11 ' A' ' 108' ' ' ILE . 24.4 t80 -72.91 -39.2 66.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.379 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 16.3 ttm -56.05 -51.69 66.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.191 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.68 -41.99 96.05 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.082 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 149' ' ' PHE . 14.7 p -77.27 -37.3 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 111.927 0.344 . . . . 0.0 111.927 -176.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 50.0 tpp -92.0 -49.72 6.07 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -173.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 29.4 p -79.92 -15.59 57.01 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.113 -173.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 78.0 -55.7 3.91 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.82 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.36 27.79 11.45 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.357 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -76.47 98.46 4.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.12 0.486 . . . . 0.0 110.618 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 . . . . . 0 C--O 1.248 0.978 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.403 -179.768 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.5 t . . . . . 0 N--CA 1.454 -0.234 0 CA-C-O 120.217 0.056 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -54.88 -53.63 52.96 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.694 0.283 . . . . 0.0 110.744 173.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.6 mp -59.09 -44.48 91.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.99 0.424 . . . . 0.0 110.325 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.442 HD21 HD21 ' A' ' 80' ' ' LEU . 82.1 mt -57.63 -57.66 11.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.189 178.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -58.9 -41.34 86.98 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.568 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.0 m -63.88 -41.13 97.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 0.0 111.289 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.463 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -82.11 -27.64 32.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.029 0.443 . . . . 0.0 110.469 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.513 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 71.8 t80 -57.31 -54.59 45.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.398 177.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.52 ' HA ' ' HB2' ' A' ' 23' ' ' GLU . 26.2 mmt180 -71.36 -21.65 62.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.117 -177.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.65 -44.21 74.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.915 -175.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.63 ' CD1' HG12 ' A' ' 39' ' ' ILE . 52.6 m-85 -106.44 17.16 23.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.473 0.654 . . . . 0.0 110.124 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.576 ' HG2' ' N ' ' A' ' 24' ' ' THR . 10.2 tt0 -71.43 152.84 42.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.334 -172.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.576 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.4 OUTLIER 75.05 138.1 0.06 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 158.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -88.74 -43.42 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.588 2.858 . . . . 0.0 111.652 172.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -156.02 25.08 0.37 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.671 0.748 . . . . 0.0 109.415 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.59 63.36 0.76 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.592 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.1 t -105.46 -30.1 9.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.921 0.391 . . . . 0.0 110.763 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.58 -11.36 66.71 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.873 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.734 ' HB2' ' OD2' ' A' ' 66' ' ' ASP . 3.3 mpt_? -110.95 172.22 7.0 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.476 HG23 ' HA ' ' A' ' 23' ' ' GLU . 12.8 p -108.03 129.59 61.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-O 121.941 0.877 . . . . 0.0 110.201 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.444 ' HA ' ' HB3' ' A' ' 66' ' ' ASP . 44.3 t -57.25 141.3 47.1 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 113.593 -1.64 . . . . 0.0 111.856 -175.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.544 ' HB ' HG12 ' A' ' 56' ' ' ILE . 28.4 p -67.74 -19.37 65.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.407 -178.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -76.2 -21.78 56.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.317 0.579 . . . . 0.0 109.758 175.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.506 ' HB3' ' HB3' ' A' ' 22' ' ' PHE . 34.1 mm-40 -91.96 -21.65 20.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.939 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.675 HG22 HD22 ' A' ' 40' ' ' LEU . 71.3 mt -54.68 -46.67 73.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.673 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.98 -22.5 68.72 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.261 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.607 ' O ' HG13 ' A' ' 42' ' ' VAL . 25.8 mt -77.86 -54.85 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.737 ' HA ' HG13 ' A' ' 42' ' ' VAL . 36.5 mt -60.92 -37.89 77.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.203 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.675 HD22 HG22 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -60.49 -24.64 65.45 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.09 0.472 . . . . 0.0 110.181 176.191 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.518 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 39.2 tt0 -82.56 -39.73 21.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.819 172.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.737 HG13 ' HA ' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -62.03 -31.45 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 121.771 0.796 . . . . 0.0 110.865 177.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.454 HD11 ' HZ ' ' A' ' 72' ' ' PHE . 50.8 mt -92.79 -6.35 49.13 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.958 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.01 39.49 96.46 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.494 -0.775 . . . . 0.0 113.518 176.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pt -113.35 -83.41 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.34 179.67 3.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.558 0.694 . . . . 0.0 112.672 -174.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -102.05 -171.0 1.9 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.552 -175.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.44 ' O ' HG12 ' A' ' 52' ' ' ILE . 14.3 t -62.81 -179.46 0.27 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -52.28 -34.57 47.15 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -170.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.1 m -52.19 -40.2 61.18 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.152 0.501 . . . . 0.0 111.049 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 53.4 m -81.75 -34.59 30.36 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.659 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 48' ' ' THR . 42.0 mm -64.67 -27.38 42.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.283 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -57.5 -32.99 67.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.98 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.7 mm-40 -65.66 -49.44 68.6 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.645 HD11 ' CE2' ' A' ' 79' ' ' PHE . 3.0 mm? -53.67 -52.43 59.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.994 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.544 HG12 ' HB ' ' A' ' 33' ' ' THR . 60.2 mt -63.26 -44.84 99.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.409 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -59.59 -30.96 69.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.189 0.519 . . . . 0.0 110.757 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -84.21 -51.71 6.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.208 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.447 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 80.3 m-85 -90.59 -17.18 27.39 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -172.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.45 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 51.6 t0 -129.55 65.88 75.71 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 121.069 0.461 . . . . 0.0 110.88 175.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 22.9 Cg_exo -70.06 -17.25 36.32 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.913 2.409 . . . . 0.0 111.419 175.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -80.09 -17.86 51.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.116 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.97 40.73 73.3 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.778 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -76.0 -41.39 51.33 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.098 0.475 . . . . 0.0 110.423 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 117.83 -33.96 4.69 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.112 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.734 ' OD2' ' HB2' ' A' ' 30' ' ' ARG . 2.3 p-10 -139.47 148.43 42.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.151 0.501 . . . . 0.0 111.004 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.493 ' O ' ' HB3' ' A' ' 30' ' ' ARG . 44.1 pt -114.34 143.66 23.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.036 -174.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.459 ' HA ' ' HG3' ' A' ' 30' ' ' ARG . 1.9 p30 -74.36 174.08 9.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.826 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' A' ' 73' ' ' LYS . 5.0 t80 -63.55 -37.81 88.73 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.119 -175.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.497 ' O ' HG13 ' A' ' 74' ' ' ILE . 38.3 t70 -61.64 -42.68 99.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.925 0.393 . . . . 0.0 110.628 -176.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.7 m -65.53 -42.86 91.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.331 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.454 ' HZ ' HD11 ' A' ' 43' ' ' LEU . 75.8 t80 -69.11 -32.27 71.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.465 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 69' ' ' PHE . 40.8 ttmt -63.29 -44.04 96.18 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.61 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 70' ' ' ASP . 64.7 mt -62.29 -40.75 88.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.127 0.489 . . . . 0.0 110.05 176.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.6 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 78.6 mt -58.22 -51.09 75.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.128 175.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.514 ' CA ' HD23 ' A' ' 80' ' ' LEU . . . -62.52 -41.55 99.78 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.3 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.35 -25.72 67.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.953 0.406 . . . . 0.0 111.591 -174.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 11.8 ptm180 -93.08 -12.67 29.95 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.768 -176.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.645 ' CE2' HD11 ' A' ' 55' ' ' LEU . 23.9 m-85 -120.71 -37.35 3.01 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -174.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.514 HD23 ' CA ' ' A' ' 76' ' ' GLY . 3.2 mm? . . . . . 0 N--CA 1.467 0.425 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -173.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 N--CA 1.465 0.289 0 CA-C-O 121.015 0.436 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.654 HD22 ' H ' ' A' ' 93' ' ' LEU . 1.2 mm? -52.65 -28.11 20.07 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.126 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.649 ' HD3' ' HE2' ' A' ' 97' ' ' PHE . 30.7 mmt180 -57.0 -51.39 69.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.063 0.459 . . . . 0.0 111.361 177.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -77.74 -21.7 51.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.059 0.456 . . . . 0.0 110.327 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.536 ' HB3' ' HA ' ' A' ' 93' ' ' LEU . . . -77.51 -13.73 59.85 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.048 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.649 ' HE2' ' HD3' ' A' ' 94' ' ' ARG . 21.0 m-85 -61.4 -48.23 82.16 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.641 176.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.4 mtm-85 -67.17 -23.73 65.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.205 0.526 . . . . 0.0 110.386 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.9 tp -67.76 -37.31 81.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.753 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.688 ' O ' ' HD2' ' A' ' 102' ' ' LYS . 85.6 m-85 -104.12 -5.7 21.78 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.122 -176.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -78.27 80.32 4.68 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.461 0.648 . . . . 0.0 111.528 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.688 ' HD2' ' O ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -60.71 -39.75 89.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.002 173.27 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -72.27 -37.13 69.12 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.498 -169.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.18 48.46 2.23 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.91 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -113.18 -17.22 12.41 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.973 0.416 . . . . 0.0 110.526 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.12 -24.91 13.69 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -170.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.535 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 4.0 m-85 -109.37 150.9 27.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 173.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.683 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 14.8 pt -91.81 131.17 39.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.748 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.5 m -69.3 170.05 11.04 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.312 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.435 ' HB ' ' CG2' ' A' ' 133' ' ' ILE . 36.8 p -67.59 -23.72 65.42 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 121.846 -0.534 . . . . 0.0 110.724 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 114' ' ' ARG . 29.6 m-20 -62.43 -50.49 71.29 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 176.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.683 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.4 p -71.69 -35.0 54.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.719 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.657 ' SD ' HG11 ' A' ' 144' ' ' VAL . 2.9 tpt -57.37 -40.06 77.34 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 111' ' ' ASP . 76.0 mtt180 -53.04 -56.9 12.6 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.636 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 112' ' ' VAL . 13.3 pt-20 -65.23 -30.4 71.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.433 -175.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 112' ' ' VAL . 57.1 mt -63.43 -47.72 90.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.705 0.288 . . . . 0.0 110.798 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 113' ' ' MET . 9.6 mt -58.49 -55.63 32.55 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.168 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.435 ' HB2' HD11 ' A' ' 129' ' ' LEU . . . -49.19 -37.77 23.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.408 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -65.23 -56.57 12.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.909 0.385 . . . . 0.0 110.751 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -66.76 -44.53 81.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.079 0.466 . . . . 0.0 111.19 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.556 ' HB3' HD23 ' A' ' 124' ' ' LEU . 5.7 m-20 -119.46 88.01 2.85 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.531 -178.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -76.02 23.0 0.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.321 0.581 . . . . 0.0 111.589 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.443 ' H ' ' C ' ' A' ' 121' ' ' ASP . 39.6 p -102.77 -13.46 17.02 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.916 0.865 . . . . 0.0 109.227 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' A' ' 121' ' ' ASP . 4.0 mm? -85.06 115.63 22.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.373 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.458 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 42.7 m -77.08 172.19 13.62 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.9 p -56.75 -43.49 80.79 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.692 0.282 . . . . 0.0 111.581 -174.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -68.8 -40.08 79.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.0 110.751 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.448 ' HB3' ' CD1' ' A' ' 124' ' ' LEU . 5.6 m-20 -59.34 -42.36 91.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.465 176.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.618 ' O ' HG12 ' A' ' 133' ' ' ILE . 95.8 mt -54.63 -43.39 72.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.75 175.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.482 ' O ' ' HB ' ' A' ' 133' ' ' ILE . 31.5 t70 -63.2 -40.25 96.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.268 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.2 -40.58 82.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.164 177.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 9.1 mtt -57.77 -43.51 85.54 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 173.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.618 HG12 ' O ' ' A' ' 129' ' ' LEU . 21.5 mm -51.69 -49.94 33.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.066 176.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -58.98 -43.32 91.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.733 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -72.11 -35.02 69.06 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.567 -176.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.612 HD11 HD21 ' A' ' 117' ' ' LEU . 67.6 mt -65.81 -58.79 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.983 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -68.22 93.78 0.48 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.581 0.705 . . . . 0.0 110.102 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.91 -29.51 50.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.961 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -88.19 -14.4 38.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.274 0.559 . . . . 0.0 110.862 -174.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 69.22 28.29 72.88 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.273 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 6.5 t -80.67 -18.28 48.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.083 0.468 . . . . 0.0 110.15 -175.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.71 -31.31 8.73 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.287 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 21.9 p -114.87 143.14 45.6 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.657 HG11 ' SD ' ' A' ' 113' ' ' MET . 61.0 t -89.04 118.3 34.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.535 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 28.5 t70 -144.17 -73.26 0.27 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.762 -178.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.633 ' O ' ' HG2' ' A' ' 150' ' ' MET . 0.1 OUTLIER -79.28 -97.17 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.122 -166.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -82.95 -11.78 57.87 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 121.583 -0.698 . . . . 0.0 110.94 -173.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.613 ' CD ' ' H ' ' A' ' 148' ' ' GLU . 3.9 mp0 -61.81 -58.42 8.06 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.9 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.629 ' HA ' HG12 ' A' ' 152' ' ' VAL . 10.7 t80 -73.82 -46.73 43.37 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.677 -176.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . 0.633 ' HG2' ' O ' ' A' ' 146' ' ' PHE . 46.8 mmm -61.12 -18.41 57.84 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.742 0.306 . . . . 0.0 110.964 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -95.97 -20.3 26.41 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.066 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.629 HG12 ' HA ' ' A' ' 149' ' ' PHE . 9.1 p -95.72 -36.31 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 117.314 0.557 . . . . 0.0 111.067 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.468 ' SD ' HG23 ' A' ' 154' ' ' THR . 0.9 OUTLIER -90.74 -47.55 7.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.055 -177.307 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.468 HG23 ' SD ' ' A' ' 153' ' ' MET . 25.6 p . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.039 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.434 ' HA ' HD12 ' A' ' 15' ' ' LEU . 26.8 t . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.707 0.289 . . . . 0.0 111.066 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -62.16 -47.45 84.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.661 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.53 -45.21 92.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.904 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.665 HD21 ' CD1' ' A' ' 80' ' ' LEU . 84.5 mt -56.08 -52.7 63.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.773 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 27.4 tt0 -62.52 -38.86 91.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.773 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 91.0 m -59.03 -52.21 66.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.735 0.302 . . . . 0.0 110.483 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.499 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -69.55 -33.77 73.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.139 0.495 . . . . 0.0 110.366 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.742 ' CE1' HG22 ' A' ' 31' ' ' VAL . 86.1 t80 -53.67 -58.78 5.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.584 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -61.27 -31.62 71.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.799 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -69.09 -43.91 73.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.834 0.35 . . . . 0.0 111.245 -175.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.482 ' CD2' HG12 ' A' ' 39' ' ' ILE . 56.0 m-85 -100.64 8.69 43.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.342 0.592 . . . . 0.0 110.132 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.564 ' HA ' HG13 ' A' ' 31' ' ' VAL . 3.9 tt0 -69.25 154.12 42.55 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.19 -177.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.806 HG23 ' H ' ' A' ' 27' ' ' GLY . 0.6 OUTLIER 79.75 131.78 0.04 OUTLIER Pre-proline 0 N--CA 1.437 -1.118 0 O-C-N 124.301 1.001 . . . . 0.0 112.863 161.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.86 -34.7 0.19 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.328 2.686 . . . . 0.0 111.163 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -165.52 32.1 0.05 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.041 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.806 ' H ' HG23 ' A' ' 24' ' ' THR . . . 98.32 66.41 0.88 Allowed Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.831 -175.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.7 t -111.68 -31.09 7.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.814 0.34 . . . . 0.0 111.002 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.02 -14.21 65.71 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.523 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.558 ' HG3' ' HA ' ' A' ' 68' ' ' ASP . 4.8 mpt_? -106.72 172.49 6.79 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.742 HG22 ' CE1' ' A' ' 19' ' ' PHE . 0.1 OUTLIER -105.19 129.93 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.568 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.272 172.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.6 t -54.0 138.88 36.05 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.994 -1.457 . . . . 0.0 108.723 171.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.581 ' HB ' HG12 ' A' ' 56' ' ' ILE . 2.9 p -67.03 -12.86 61.08 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.056 -174.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -72.05 -42.59 66.09 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.663 ' HA ' HD13 ' A' ' 38' ' ' ILE . 33.3 mm-40 -74.03 -16.22 61.06 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.438 -174.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.736 HG22 HD22 ' A' ' 40' ' ' LEU . 47.1 mt -59.01 -34.21 52.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.429 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -74.17 -36.98 49.77 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.328 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.663 HD13 ' HA ' ' A' ' 35' ' ' GLN . 1.3 mp -58.79 -55.28 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-O 121.5 0.666 . . . . 0.0 109.762 174.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.499 HG23 ' HB1' ' A' ' 18' ' ' ALA . 53.7 mt -63.14 -43.54 98.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.451 -176.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.736 HD22 HG22 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -61.91 -27.42 68.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.935 0.398 . . . . 0.0 110.713 177.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.66 -43.61 46.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.175 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 38' ' ' ILE . 64.0 t -54.78 -47.72 73.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.56 176.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.596 HD13 HD23 ' A' ' 15' ' ' LEU . 58.0 mt -86.58 4.3 40.73 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.358 -173.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.24 41.71 99.57 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.19 -0.914 . . . . 0.0 113.71 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -116.12 -77.3 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.591 ' HG2' HD21 ' A' ' 55' ' ' LEU . 0.7 OUTLIER -81.57 -176.49 6.07 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.418 0.627 . . . . 0.0 112.46 -176.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.418 ' HB2' ' CB ' ' A' ' 51' ' ' THR . 45.2 mt-30 -110.62 -170.38 1.63 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.505 -174.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.465 ' O ' HG12 ' A' ' 52' ' ' ILE . 13.5 t -56.89 176.97 0.09 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.491 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 63.0 mttm -52.24 -35.31 49.4 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.85 0.46 . . . . 0.0 112.155 -173.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.8 m -54.6 -34.31 61.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.251 0.548 . . . . 0.0 111.185 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.418 ' CB ' ' HB2' ' A' ' 47' ' ' GLN . 60.5 m -85.98 -34.23 20.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.483 0.658 . . . . 0.0 110.41 177.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.847 ' HA ' HD23 ' A' ' 55' ' ' LEU . 44.1 mm -63.4 -23.53 33.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.343 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 34.5 mmt180 -50.8 -38.69 49.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.558 173.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.475 ' HA ' ' OD2' ' A' ' 57' ' ' ASP . 7.3 mm-40 -60.54 -43.83 96.77 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.713 0.633 . . . . 0.0 110.653 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.847 HD23 ' HA ' ' A' ' 52' ' ' ILE . 3.1 mm? -62.21 -46.33 89.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.386 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.581 HG12 ' HB ' ' A' ' 33' ' ' THR . 64.1 mt -66.81 -47.66 82.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.304 -176.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.475 ' OD2' ' HA ' ' A' ' 54' ' ' GLN . 1.7 p30 -66.28 -19.75 65.91 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.059 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -85.11 -53.75 5.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.37 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.414 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 89.1 m-85 -95.1 -17.0 22.22 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -171.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.409 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 21.0 t0 -128.22 68.25 76.35 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.09 0.471 . . . . 0.0 111.317 176.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.414 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 24.3 Cg_exo -69.75 -17.83 37.42 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.504 2.136 . . . . 0.0 110.492 171.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -69.88 -17.96 63.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.993 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.32 30.39 77.4 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -81.36 -27.31 34.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.273 -0.464 . . . . 0.0 110.868 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.5 -19.44 39.41 Favored Glycine 0 CA--C 1.509 -0.312 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.122 173.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -145.83 158.02 43.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.89 0.376 . . . . 0.0 110.933 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.457 ' HB ' ' HB2' ' A' ' 71' ' ' SER . 28.8 pt -126.92 142.54 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.556 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.558 ' HA ' ' HG3' ' A' ' 30' ' ' ARG . 0.5 OUTLIER -75.13 175.94 7.76 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.514 -176.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -60.66 -39.69 89.31 Favored 'General case' 0 C--O 1.213 -0.829 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.081 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.489 ' O ' HG13 ' A' ' 74' ' ' ILE . 19.7 t70 -60.75 -39.91 90.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.997 0.427 . . . . 0.0 109.964 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.457 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 17.0 m -67.61 -43.62 80.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.749 176.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -69.38 -32.46 71.5 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.259 0.552 . . . . 0.0 110.223 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.435 ' HB3' ' HE2' ' A' ' 73' ' ' LYS . 34.9 ttpt -62.32 -42.4 99.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.099 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 70' ' ' ASP . 67.2 mt -65.41 -40.19 87.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.027 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.578 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 66.8 mt -56.38 -53.03 45.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.249 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.94 -41.05 99.62 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.151 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.04 -26.07 66.57 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 122.578 -0.366 . . . . 0.0 111.44 -174.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 15.8 ptm180 -89.92 -18.56 25.88 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.758 ' HE2' HD11 ' A' ' 55' ' ' LEU . 23.6 m-85 -108.52 -43.85 4.21 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.272 -174.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.665 ' CD1' HD21 ' A' ' 15' ' ' LEU . 2.4 mp . . . . . 0 N--CA 1.448 -0.568 0 CA-C-O 120.459 0.171 . . . . 0.0 110.858 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 . . . . . 0 CA--C 1.521 -0.14 0 CA-C-O 121.216 0.532 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.916 HD22 ' HE1' ' A' ' 149' ' ' PHE . 44.7 mt -42.74 -41.59 3.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.62 -1.173 . . . . 0.0 112.269 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.769 ' HD2' ' HE2' ' A' ' 97' ' ' PHE . 18.5 mmm180 -59.53 -39.96 85.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -176.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -86.07 -18.28 32.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.125 0.488 . . . . 0.0 110.249 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.499 ' HA ' HD12 ' A' ' 99' ' ' LEU . . . -80.25 -19.9 45.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.678 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.769 ' HE2' ' HD2' ' A' ' 94' ' ' ARG . 23.0 m-85 -59.1 -44.45 91.96 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 98' ' ' ARG . 57.8 mtp180 -70.96 -13.06 61.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.822 0.344 . . . . 0.0 111.358 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 96' ' ' ALA . 97.0 mt -86.92 -27.55 23.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.89 0.376 . . . . 0.0 110.772 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.463 ' O ' HG21 ' A' ' 112' ' ' VAL . 76.2 m-85 -103.69 -14.63 16.03 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 97' ' ' PHE . 55.2 t0 -64.57 86.53 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.83 0.824 . . . . 0.0 111.197 -176.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -64.27 -18.33 64.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.655 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -96.18 -36.87 10.79 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.975 0.417 . . . . 0.0 112.119 -171.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.424 ' H ' ' CG ' ' A' ' 101' ' ' ASP . . . 92.08 39.46 5.44 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.491 175.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -114.82 -15.33 11.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.871 0.367 . . . . 0.0 111.807 -176.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.83 -22.31 35.79 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.198 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -100.22 167.55 10.37 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 172.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.61 ' HB ' HG13 ' A' ' 112' ' ' VAL . 8.3 pt -111.03 118.85 58.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.291 166.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.2 m -62.73 166.53 5.37 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.952 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.7 p -57.29 -32.91 67.13 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.9 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.507 ' O ' ' HG3' ' A' ' 115' ' ' GLU . 28.0 m-20 -61.59 -50.19 73.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.046 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.61 HG13 ' HB ' ' A' ' 108' ' ' ILE . 1.8 p -68.65 -37.43 77.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.854 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.691 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 2.8 tpt -56.66 -43.29 80.21 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 174.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.495 ' HA ' HD12 ' A' ' 117' ' ' LEU . 15.9 ttt180 -55.22 -48.52 73.77 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.448 175.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 111' ' ' ASP . 47.3 mt-10 -60.33 -41.73 94.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.684 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 70.6 mt -59.17 -50.34 80.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.03 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.691 ' HG ' ' O ' ' A' ' 113' ' ' MET . 11.0 mt -56.58 -60.18 3.91 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.43 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.01 -22.01 47.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.746 -177.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -82.51 -41.08 20.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.676 0.274 . . . . 0.0 110.876 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.7 mp -79.52 -47.66 15.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.049 0.452 . . . . 0.0 110.762 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.675 ' HB3' HD23 ' A' ' 124' ' ' LEU . 3.1 m-20 -105.84 99.37 8.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.057 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -84.56 4.34 32.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.338 -173.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 71.0 p -90.38 -10.97 41.98 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.376 0.608 . . . . 0.0 110.203 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.784 ' HB3' HD22 ' A' ' 129' ' ' LEU . 3.7 mm? -77.14 146.33 37.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.071 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.473 ' HB2' ' OD1' ' A' ' 128' ' ' ASP . 21.4 m -115.68 171.7 7.58 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.254 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.8 m -47.31 -46.34 25.11 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -173.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -79.32 -32.43 43.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.814 0.34 . . . . 0.0 111.2 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.473 ' OD1' ' HB2' ' A' ' 125' ' ' SER . 2.7 m-20 -64.61 -40.32 95.29 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.784 HD22 ' HB3' ' A' ' 124' ' ' LEU . 2.7 mm? -51.66 -43.24 62.61 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.148 173.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -65.22 -42.48 93.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.612 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.42 -45.52 91.3 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.361 0.6 . . . . 0.0 110.032 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 58.0 mmm -54.9 -53.73 51.7 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.681 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 20.1 mm -55.02 -46.39 77.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.583 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -56.44 -41.2 76.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.774 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -79.49 -31.04 42.21 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.161 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.423 HG12 ' CG2' ' A' ' 152' ' ' VAL . 49.3 mt -67.74 -58.39 6.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.134 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -69.76 93.87 0.77 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.592 0.71 . . . . 0.0 110.288 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.57 -40.26 42.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.807 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -82.85 -13.97 55.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.204 0.526 . . . . 0.0 111.065 -173.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 70.89 24.34 77.16 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.8 t -74.79 -18.26 60.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.387 0.613 . . . . 0.0 109.853 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.56 -26.97 9.25 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 25.3 p -114.59 128.92 56.58 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 175.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.675 HG11 ' SD ' ' A' ' 113' ' ' MET . 64.2 t -83.34 119.33 32.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.266 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.431 ' HB3' ' CD1' ' A' ' 146' ' ' PHE . 8.0 t70 -145.59 -55.58 0.3 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.128 0.489 . . . . 0.0 111.437 -175.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.431 ' CD1' ' HB3' ' A' ' 145' ' ' ASP . 0.4 OUTLIER -105.55 -97.14 0.34 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.815 -168.653 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -38.33 90.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.794 0.331 . . . . 0.0 111.069 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.663 ' CD ' ' H ' ' A' ' 148' ' ' GLU . 3.4 mp0 -50.46 -53.09 32.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.222 177.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.916 ' HE1' HD22 ' A' ' 93' ' ' LEU . 31.8 t80 -76.93 -38.74 52.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.013 -175.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 42.2 tpp -62.68 -43.57 98.46 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.375 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -70.26 -16.11 73.0 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.496 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.423 ' CG2' HG12 ' A' ' 136' ' ' ILE . 12.1 p -101.41 -40.57 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 117.391 0.595 . . . . 0.0 111.805 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.449 ' HG2' HD21 ' A' ' 93' ' ' LEU . 15.4 tpt -81.18 -49.14 11.17 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -172.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 80.5 p . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 121.142 0.496 . . . . 0.0 110.843 -175.674 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.3 t . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.51 ' HD2' ' HA ' ' A' ' 13' ' ' LYS . 27.1 tptt -61.14 -41.34 96.55 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-O 120.756 0.312 . . . . 0.0 111.543 176.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 14' ' ' LEU . 4.4 mm? -67.41 -42.58 83.01 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 174.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.749 HD21 HD13 ' A' ' 80' ' ' LEU . 84.3 mt -58.3 -48.96 78.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.869 177.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -57.32 -54.98 40.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.326 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.577 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 27.8 m -59.83 -41.24 90.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.358 -175.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.715 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -74.83 -37.89 62.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.761 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.447 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 54.6 t80 -56.32 -59.19 5.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.979 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.11 -12.61 61.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.047 -174.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 17' ' ' THR . 2.1 t70 -80.29 -40.04 27.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.942 0.401 . . . . 0.0 110.531 -175.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.451 ' CD2' HG12 ' A' ' 39' ' ' ILE . 87.3 m-85 -105.99 6.9 31.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.408 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.45 ' HA ' HG23 ' A' ' 31' ' ' VAL . 3.8 tm-20 -62.82 152.49 35.92 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.262 -176.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.44 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER 86.24 130.86 0.03 OUTLIER Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 114.29 -1.323 . . . . 0.0 113.219 166.388 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -86.71 -40.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.441 2.761 . . . . 0.0 110.797 169.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -159.91 33.69 0.18 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.148 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.417 ' H ' HG23 ' A' ' 24' ' ' THR . . . 94.41 67.59 1.03 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.411 -176.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.5 t -112.22 -24.82 9.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.869 0.366 . . . . 0.0 111.328 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.09 -14.49 61.98 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -175.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.53 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 86.1 mtt180 -112.09 163.08 14.7 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.014 -0.593 . . . . 0.0 110.041 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.522 HG21 HD11 ' A' ' 39' ' ' ILE . 13.7 p -105.99 126.7 61.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 121.501 0.667 . . . . 0.0 110.093 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 8.2 t -53.6 139.51 31.6 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.029 -177.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.562 ' HB ' HG12 ' A' ' 56' ' ' ILE . 1.7 p -63.05 -18.85 63.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.04 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -73.8 -28.71 61.78 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.234 0.54 . . . . 0.0 110.375 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -86.98 -16.88 34.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.532 -177.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.739 HG22 HD22 ' A' ' 40' ' ' LEU . 52.6 mt -55.39 -41.4 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.817 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.432 ' CA ' HG13 ' A' ' 52' ' ' ILE . . . -61.97 -38.73 96.53 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.413 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.639 ' O ' HG23 ' A' ' 42' ' ' VAL . 31.5 mt -63.56 -52.18 61.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.302 0.572 . . . . 0.0 109.595 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.715 HG23 ' HB1' ' A' ' 18' ' ' ALA . 69.6 mt -60.09 -44.49 95.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.52 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.739 HD22 HG22 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -60.63 -25.41 66.27 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.808 178.55 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -80.02 -40.6 27.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.001 174.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 38' ' ' ILE . 43.1 t -53.88 -43.91 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.924 0.868 . . . . 0.0 109.79 174.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.7 mt -86.38 -4.02 59.1 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.939 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.9 39.48 89.48 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-N 115.444 -0.798 . . . . 0.0 113.705 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pt -116.17 -84.8 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.443 ' HG2' HD21 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -78.25 -171.42 2.38 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.248 0.547 . . . . 0.0 112.41 -177.341 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -123.33 -170.79 2.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.434 -172.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.1 t -54.94 170.87 0.16 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.835 0.826 . . . . 0.0 112.968 -176.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -51.32 -34.52 33.89 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.344 -1.298 . . . . 0.0 113.204 -167.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 m -58.94 -32.39 69.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.084 0.468 . . . . 0.0 110.845 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -82.42 -32.76 28.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.392 0.615 . . . . 0.0 110.018 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.906 ' HA ' HD23 ' A' ' 55' ' ' LEU . 44.4 mm -68.7 -23.62 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.221 -177.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -50.17 -30.98 12.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.42 173.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -65.92 -55.19 18.18 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.306 0.574 . . . . 0.0 109.834 174.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.906 HD23 ' HA ' ' A' ' 52' ' ' ILE . 2.5 mm? -52.76 -50.06 64.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.435 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.562 HG12 ' HB ' ' A' ' 33' ' ' THR . 61.0 mt -63.52 -46.89 93.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.926 -177.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -61.39 -24.68 66.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.508 0.671 . . . . 0.0 110.727 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.477 ' CD ' HH12 ' A' ' 78' ' ' ARG . 29.6 tt0 -87.98 -51.28 5.91 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.226 -177.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.498 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 90.1 m-85 -94.53 -17.1 22.72 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -173.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.463 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 46.5 t0 -129.99 62.67 65.23 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-O 121.171 0.51 . . . . 0.0 110.181 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.498 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 31.3 Cg_exo -63.11 -24.86 73.14 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.032 2.488 . . . . 0.0 112.159 -178.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -76.68 -17.29 59.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.569 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.28 41.32 59.56 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.688 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -67.71 -39.89 84.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.673 0.273 . . . . 0.0 110.751 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.18 -22.31 9.04 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.672 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 1.6 m-20 -139.79 178.49 7.21 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 27.2 pt -142.12 143.73 26.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.886 0.374 . . . . 0.0 110.331 177.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.53 ' HA ' ' HG2' ' A' ' 30' ' ' ARG . 25.6 t70 -83.39 166.9 18.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.807 176.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.481 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -56.09 -27.35 53.36 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 176.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -49.35 -51.44 34.54 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.87 0.367 . . . . 0.0 111.256 174.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 23.2 m -82.41 -36.88 26.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.924 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.481 ' HB3' ' HA ' ' A' ' 69' ' ' PHE . 89.8 t80 -64.83 -36.28 83.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.123 -178.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -62.32 -38.6 90.04 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.219 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.427 ' HB ' ' CE1' ' A' ' 59' ' ' PHE . 40.7 mt -69.48 -40.1 79.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.84 0.352 . . . . 0.0 110.105 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.605 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 78.1 mt -57.3 -48.48 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-O 121.41 0.624 . . . . 0.0 109.717 173.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.503 ' HA2' ' CD1' ' A' ' 80' ' ' LEU . . . -62.48 -45.19 96.39 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.065 177.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.97 -20.39 65.04 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -174.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 9.9 ptm180 -91.28 -16.7 27.13 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.527 -177.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.493 ' CE2' HD11 ' A' ' 55' ' ' LEU . 21.1 m-85 -118.34 -46.49 2.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.754 0.311 . . . . 0.0 110.921 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.749 HD13 HD21 ' A' ' 15' ' ' LEU . 3.2 mp . . . . . 0 CA--C 1.514 -0.426 0 CA-C-O 121.329 0.585 . . . . 0.0 111.199 178.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 CA--C 1.52 -0.193 0 CA-C-O 121.056 0.455 . . . . 0.0 109.826 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.647 HD22 ' H ' ' A' ' 93' ' ' LEU . 0.9 OUTLIER -54.27 -26.93 31.77 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.302 -179.7 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.733 ' HD2' ' HE2' ' A' ' 97' ' ' PHE . 28.9 mmm180 -59.74 -35.63 74.95 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 120.807 0.337 . . . . 0.0 111.583 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -86.53 -26.93 24.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.253 0.549 . . . . 0.0 109.899 176.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.485 ' HB3' ' HA ' ' A' ' 93' ' ' LEU . . . -72.73 -11.05 60.47 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.937 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.733 ' HE2' ' HD2' ' A' ' 94' ' ' ARG . 21.3 m-85 -61.72 -52.22 65.15 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.727 -0.389 . . . . 0.0 109.963 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 98' ' ' ARG . 42.2 mtm180 -65.66 -17.96 64.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.212 0.529 . . . . 0.0 110.88 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 99' ' ' LEU . 12.4 tp -73.6 -38.63 65.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.826 177.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.667 ' O ' ' HD2' ' A' ' 102' ' ' LYS . 77.2 m-85 -100.16 -24.55 14.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.906 -176.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -69.3 82.68 0.37 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.413 0.625 . . . . 0.0 111.223 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.667 ' HD2' ' O ' ' A' ' 100' ' ' TYR . 9.8 mptt -56.53 -45.78 80.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.913 173.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.53 ' HB2' ' ND2' ' A' ' 105' ' ' ASN . 41.6 mt-10 -66.65 -37.23 84.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.432 -168.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.53 47.41 2.55 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.419 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.53 ' ND2' ' HB2' ' A' ' 103' ' ' GLU . 39.8 m-80 -100.1 -17.46 17.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.692 0.282 . . . . 0.0 110.68 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.9 -24.99 15.16 Favored Glycine 0 N--CA 1.453 -0.188 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -172.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -113.53 162.38 16.24 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 171.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.678 ' HB ' HG13 ' A' ' 112' ' ' VAL . 10.2 pt -97.22 128.16 48.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.298 173.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.466 ' HA ' HG22 ' A' ' 143' ' ' THR . 49.1 m -69.45 166.97 17.64 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.317 -177.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.2 p -62.95 -24.88 68.09 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.992 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -64.78 -51.8 60.33 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.258 176.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.678 HG13 ' HB ' ' A' ' 108' ' ' ILE . 2.0 p -68.72 -35.06 68.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.727 0.299 . . . . 0.0 110.36 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.591 ' SD ' HG11 ' A' ' 144' ' ' VAL . 2.8 tpt -58.3 -40.18 81.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.099 0.476 . . . . 0.0 109.8 173.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.531 ' HG2' ' CD2' ' A' ' 129' ' ' LEU . 17.7 ttp180 -58.88 -46.03 88.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.162 176.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.471 ' OE1' ' HA ' ' A' ' 112' ' ' VAL . 34.6 mt-10 -60.68 -50.47 73.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.58 177.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 112' ' ' VAL . 63.6 mt -56.25 -53.6 37.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.43 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.599 HD11 ' SD ' ' A' ' 132' ' ' MET . 1.0 OUTLIER -57.33 -53.31 59.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.005 -178.316 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.523 ' HB2' HD22 ' A' ' 129' ' ' LEU . . . -64.33 -17.54 63.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.03 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -83.8 -53.26 5.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.682 0.277 . . . . 0.0 110.319 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.58 -44.04 79.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.991 0.424 . . . . 0.0 110.313 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.67 ' HB3' HD23 ' A' ' 124' ' ' LEU . 6.2 m-20 -112.19 84.85 2.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.254 0.549 . . . . 0.0 109.969 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -79.79 12.63 2.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.626 0.727 . . . . 0.0 110.908 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 69.8 p -95.44 -5.56 42.82 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.194 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.67 HD23 ' HB3' ' A' ' 121' ' ' ASP . 4.2 mm? -78.82 149.42 32.57 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.315 174.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.423 ' H ' ' HB2' ' A' ' 128' ' ' ASP . 24.0 m -116.93 170.18 8.82 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.6 p -48.1 -48.43 33.75 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -73.45 -40.05 64.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.727 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 125' ' ' SER . 14.4 m-20 -67.41 -43.42 81.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.649 0.738 . . . . 0.0 110.077 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.531 ' CD2' ' HG2' ' A' ' 114' ' ' ARG . 45.2 tp -63.33 -38.4 91.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.925 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.28 -41.46 99.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.897 0.379 . . . . 0.0 110.223 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.86 -45.69 92.66 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.331 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.599 ' SD ' HD11 ' A' ' 117' ' ' LEU . 33.5 mtt -60.38 -42.98 97.0 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.385 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.515 HD11 ' HA ' ' A' ' 114' ' ' ARG . 21.2 mm -54.44 -50.21 59.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.081 0.467 . . . . 0.0 110.647 174.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.15 -44.7 75.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.788 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -80.78 -26.42 37.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.83 -175.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.494 HG12 ' CG2' ' A' ' 152' ' ' VAL . 51.9 mt -64.38 -54.81 26.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.73 0.3 . . . . 0.0 110.589 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -76.63 85.12 3.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.966 0.888 . . . . 0.0 109.554 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.58 -35.0 53.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.465 -1.243 . . . . 0.0 112.319 -173.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -91.58 -10.59 40.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.042 0.449 . . . . 0.0 110.851 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.58 38.7 13.62 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.197 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.49 -18.75 56.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.263 0.554 . . . . 0.0 110.495 -177.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.29 -40.9 3.08 Favored Glycine 0 C--O 1.23 -0.106 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.216 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.466 HG22 ' HA ' ' A' ' 109' ' ' SER . 13.0 p -114.77 137.68 51.65 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 173.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.623 HG13 ' HB2' ' A' ' 148' ' ' GLU . 57.8 t -82.06 124.98 39.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 O-C-N 123.611 0.57 . . . . 0.0 109.8 -176.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -145.53 -78.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.222 0.534 . . . . 0.0 112.206 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -76.74 -86.31 0.05 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -168.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -94.35 -14.39 25.4 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.983 -172.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.623 ' HB2' HG13 ' A' ' 144' ' ' VAL . 3.0 mp0 -64.24 -50.05 69.49 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.108 0.48 . . . . 0.0 109.945 174.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.564 ' HA ' HG12 ' A' ' 152' ' ' VAL . 19.1 t80 -75.43 -42.62 53.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.584 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . 0.476 ' CE ' HD23 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -55.85 -46.17 78.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.935 0.398 . . . . 0.0 110.121 178.007 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -69.64 -28.46 72.18 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.965 -0.561 . . . . 0.0 113.506 -177.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.564 HG12 ' HA ' ' A' ' 149' ' ' PHE . 14.6 p -87.62 -37.18 10.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 117.359 0.58 . . . . 0.0 111.495 -176.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -86.64 -53.92 4.68 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.006 -174.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 50.1 p . . . . . 0 C--N 1.327 -0.37 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.148 -179.002 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.674 ' HA ' HD22 ' A' ' 15' ' ' LEU . 39.6 t . . . . . 0 CA--C 1.532 0.265 0 CA-C-O 120.902 0.382 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HD2' ' HA ' ' A' ' 13' ' ' LYS . 37.8 tptt -55.5 -52.34 63.99 Favored 'General case' 0 N--CA 1.425 -1.702 0 C-N-CA 123.106 0.562 . . . . 0.0 111.347 174.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 14' ' ' LEU . 3.7 mm? -63.53 -37.66 88.15 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.674 HD22 ' HA ' ' A' ' 12' ' ' VAL . 3.0 mp -52.99 -59.36 4.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.487 173.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -58.38 -39.0 78.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.085 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.2 m -60.05 -46.08 90.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.941 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.557 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -80.05 -29.63 39.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.553 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.537 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 57.7 t80 -56.91 -56.01 27.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.192 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.423 ' HA ' ' HB2' ' A' ' 23' ' ' GLU . 23.2 mmt180 -71.7 -20.04 61.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.572 -175.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -72.33 -35.12 68.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.862 0.363 . . . . 0.0 110.864 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.502 ' CD2' HG12 ' A' ' 39' ' ' ILE . 71.9 m-85 -115.5 16.88 16.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.26 0.552 . . . . 0.0 110.574 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.548 ' HA ' HG23 ' A' ' 31' ' ' VAL . 2.9 tt0 -76.45 152.21 36.24 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.459 -172.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.522 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER 78.8 133.64 0.04 OUTLIER Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.642 159.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -87.07 -53.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.347 2.698 . . . . 0.0 111.127 172.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 15.6 tt0 -129.4 3.43 5.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.653 0.739 . . . . 0.0 109.592 176.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.79 67.73 0.51 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -169.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -109.15 -6.78 15.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.609 0.243 . . . . 0.0 111.028 -172.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.6 0.08 52.5 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.09 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.461 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 93.7 mtt180 -124.59 164.12 20.49 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.588 HG21 HD11 ' A' ' 39' ' ' ILE . 11.3 p -104.94 131.34 54.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.536 0.684 . . . . 0.0 109.495 177.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.0 t -59.39 140.17 56.38 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.851 -175.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.554 ' HA ' HG13 ' A' ' 36' ' ' ILE . 3.5 p -62.7 -19.87 64.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.024 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -75.94 -18.37 59.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.456 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.5 ' OE1' HD12 ' A' ' 38' ' ' ILE . 78.3 mm-40 -96.54 -15.8 21.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.585 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.755 HG22 HD22 ' A' ' 40' ' ' LEU . 55.8 mt -57.02 -41.87 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.61 -175.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.433 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -64.27 -38.38 95.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.022 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.627 ' O ' HG23 ' A' ' 42' ' ' VAL . 15.9 mt -61.47 -52.09 65.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.204 0.526 . . . . 0.0 109.648 176.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.588 HD11 HG21 ' A' ' 31' ' ' VAL . 66.8 mt -59.79 -42.62 89.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.5 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.755 HD22 HG22 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -65.5 -22.1 66.7 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.053 0.454 . . . . 0.0 110.763 -179.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 15.4 tp10 -78.49 -42.85 28.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.347 172.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 38' ' ' ILE . 47.0 t -53.08 -46.01 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.865 0.84 . . . . 0.0 110.161 175.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.5 mt -85.61 -6.51 59.15 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.637 -174.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.52 43.27 87.01 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.598 174.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.508 HD13 HD22 ' A' ' 80' ' ' LEU . 1.9 pt -119.6 -73.28 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -176.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.404 ' H ' HG13 ' A' ' 45' ' ' ILE . 0.6 OUTLIER -87.76 -175.05 5.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -173.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -107.08 -170.52 1.72 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.866 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.521 ' O ' HG12 ' A' ' 52' ' ' ILE . 14.8 t -60.47 177.45 0.28 Allowed 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -176.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.416 ' HA ' ' HB ' ' A' ' 52' ' ' ILE . 37.2 mtmm -55.11 -34.57 63.8 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -172.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.7 m -53.96 -37.78 64.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.871 0.367 . . . . 0.0 110.862 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.1 m -82.0 -34.18 29.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.374 176.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.54 ' HA ' HD23 ' A' ' 55' ' ' LEU . 49.3 mm -65.79 -24.31 34.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.873 -176.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.526 ' HA ' HD12 ' A' ' 56' ' ' ILE . 12.2 tpp180 -62.12 -28.51 69.68 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 177.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -68.0 -44.9 75.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.389 0.614 . . . . 0.0 109.685 173.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.616 HD11 ' CE2' ' A' ' 79' ' ' PHE . 3.1 mm? -54.66 -47.31 73.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.528 174.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.54 HG12 ' HB ' ' A' ' 33' ' ' THR . 61.7 mt -62.2 -47.58 92.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.828 177.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -55.71 -32.56 63.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.149 0.5 . . . . 0.0 110.819 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -76.36 -54.33 6.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.832 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.525 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 98.4 m-85 -100.64 -11.4 20.04 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -169.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.425 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 48.2 t0 -125.54 66.81 56.23 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-O 121.335 0.588 . . . . 0.0 110.612 176.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.525 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 27.2 Cg_exo -67.9 -23.9 40.51 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.83 2.354 . . . . 0.0 111.755 177.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -78.74 -19.59 51.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.174 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.56 38.62 51.3 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -71.56 -33.94 69.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 122.469 0.308 . . . . 0.0 110.945 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.85 -21.02 39.57 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.003 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -139.85 167.11 22.87 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.1 pt -129.27 143.87 39.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.02 0.438 . . . . 0.0 110.108 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.461 ' HA ' ' HG2' ' A' ' 30' ' ' ARG . 18.1 t70 -78.1 165.94 23.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.522 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -58.64 -33.26 69.87 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 118.521 0.6 . . . . 0.0 109.759 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.483 ' O ' HG13 ' A' ' 74' ' ' ILE . 29.0 t70 -52.79 -43.5 65.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.728 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.515 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 28.6 m -79.08 -40.49 31.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.199 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -69.67 -32.33 70.9 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.947 0.403 . . . . 0.0 110.654 -177.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -62.35 -39.62 93.72 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.676 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 70' ' ' ASP . 44.3 mt -65.69 -38.7 82.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-O 121.132 0.491 . . . . 0.0 109.86 176.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.524 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 58.6 mt -57.11 -56.12 16.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.391 175.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.701 ' HA2' HD23 ' A' ' 80' ' ' LEU . . . -62.48 -35.19 91.39 Favored Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.016 177.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.61 -25.89 64.17 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 122.608 -0.349 . . . . 0.0 111.385 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 15.0 ptm180 -91.93 -14.42 29.6 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.78 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.616 ' CE2' HD11 ' A' ' 55' ' ' LEU . 22.9 m-85 -117.76 -44.1 2.75 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.991 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.701 HD23 ' HA2' ' A' ' 76' ' ' GLY . 4.2 mm? . . . . . 0 N--CA 1.467 0.409 0 CA-C-O 121.01 0.433 . . . . 0.0 111.207 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 . . . . . 0 C--O 1.23 0.031 0 CA-C-O 120.69 0.281 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.706 HD22 ' H ' ' A' ' 93' ' ' LEU . 0.5 OUTLIER -52.81 -36.44 58.44 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.655 -178.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.836 ' HD2' ' HE2' ' A' ' 97' ' ' PHE . 25.7 mmm180 -62.69 -32.55 73.65 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.874 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -86.09 -32.45 21.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.063 0.458 . . . . 0.0 109.912 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.784 ' HA ' HD23 ' A' ' 99' ' ' LEU . . . -66.59 -18.44 65.37 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.692 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.836 ' HE2' ' HD2' ' A' ' 94' ' ' ARG . 21.5 m-85 -58.55 -46.06 87.63 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.05 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 98' ' ' ARG . 33.7 mtp180 -70.85 -14.34 62.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.857 0.361 . . . . 0.0 110.908 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.784 HD23 ' HA ' ' A' ' 96' ' ' ALA . 0.5 OUTLIER -81.21 -37.21 29.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.806 176.249 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -95.82 -28.82 14.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.608 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.89 78.53 1.63 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.121 0.962 . . . . 0.0 110.929 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -76.97 -6.5 52.83 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.304 171.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -83.89 -37.37 22.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.983 -175.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.65 46.6 1.38 Allowed Glycine 0 C--O 1.228 -0.26 0 C-N-CA 121.098 -0.573 . . . . 0.0 113.259 171.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.417 ' C ' ' H ' ' A' ' 107' ' ' TYR . 21.3 m-80 -113.92 -17.92 11.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.777 0.323 . . . . 0.0 110.66 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.5 -20.78 12.65 Favored Glycine 0 C--O 1.228 -0.233 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -170.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.793 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 4.4 m-85 -116.71 147.54 41.9 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.688 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 9.3 pt -92.56 131.13 40.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.266 176.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.0 m -71.44 171.01 12.04 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.296 -176.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.517 ' HB ' HG23 ' A' ' 133' ' ' ILE . 16.4 p -61.78 -28.14 69.24 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.0 0.429 . . . . 0.0 110.721 178.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -60.36 -57.22 13.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.069 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.688 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.2 p -63.94 -35.45 73.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.815 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.61 ' SD ' HG11 ' A' ' 144' ' ' VAL . 0.7 OUTLIER -59.39 -40.08 85.44 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.754 176.639 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 114' ' ' ARG . 19.6 ttt180 -51.98 -50.93 60.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.812 176.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.22 -42.94 96.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.094 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.2 mt -57.1 -48.99 80.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 121.071 0.462 . . . . 0.0 110.24 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.503 HD11 ' SD ' ' A' ' 132' ' ' MET . 0.8 OUTLIER -57.29 -54.17 49.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.438 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.57 -15.86 63.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.853 -176.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -78.63 -29.43 45.85 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.8 mp -80.63 -61.63 1.91 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.615 173.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.582 ' CG ' HD23 ' A' ' 124' ' ' LEU . 9.4 t70 -92.01 139.46 30.62 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.054 0.454 . . . . 0.0 110.498 -176.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -108.68 -2.54 18.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.683 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.4 p -104.08 -22.69 13.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.359 0.599 . . . . 0.0 109.516 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.582 HD23 ' CG ' ' A' ' 121' ' ' ASP . 4.1 mm? -62.81 100.86 0.22 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.609 169.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.424 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 15.5 t -71.69 171.89 10.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.56 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.8 p -53.51 -44.3 69.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.978 0.418 . . . . 0.0 110.884 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -66.3 -41.1 90.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.935 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.527 ' HB3' HD13 ' A' ' 124' ' ' LEU . 6.1 m-20 -66.29 -43.33 86.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.654 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.546 ' O ' HG12 ' A' ' 133' ' ' ILE . 95.7 mt -51.36 -44.4 62.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.961 172.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.414 ' O ' ' HB ' ' A' ' 133' ' ' ILE . 11.9 t70 -61.64 -41.26 97.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.892 0.377 . . . . 0.0 110.44 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.01 -37.04 78.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.382 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.503 ' SD ' HD11 ' A' ' 117' ' ' LEU . 7.1 mtt -65.82 -32.15 73.51 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.665 175.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 129' ' ' LEU . 19.4 mm -59.13 -45.87 92.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.954 0.407 . . . . 0.0 110.306 175.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -64.73 -35.53 81.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.891 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -72.23 -42.86 65.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.987 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.412 HG12 ' CG2' ' A' ' 152' ' ' VAL . 62.7 mt -65.36 -56.57 14.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.01 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.515 ' HA ' ' CG ' ' A' ' 148' ' ' GLU . 46.8 t0 -80.64 82.97 6.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 122.005 0.907 . . . . 0.0 109.374 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.27 -35.9 76.54 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.967 -1.469 . . . . 0.0 112.336 -173.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -87.07 -13.56 43.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.246 0.546 . . . . 0.0 110.99 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 72.07 42.83 50.4 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.0 t -83.14 -17.83 41.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.394 0.616 . . . . 0.0 109.966 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.15 -33.42 4.72 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.366 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 39.5 p -114.23 141.88 46.99 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.001 0.429 . . . . 0.0 110.096 176.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.61 HG11 ' SD ' ' A' ' 113' ' ' MET . 46.6 t -99.26 109.22 23.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.793 ' HB3' ' HB3' ' A' ' 107' ' ' TYR . 4.8 p-10 -153.91 -42.98 0.09 Allowed 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.404 -171.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.603 ' HD2' ' HG2' ' A' ' 147' ' ' GLU . 2.9 p90 -96.63 -93.07 0.22 Allowed 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.202 -0.999 . . . . 0.0 112.205 -176.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.603 ' HG2' ' HD2' ' A' ' 146' ' ' PHE . 22.0 mm-40 -81.19 -28.89 34.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.362 0.601 . . . . 0.0 109.947 -175.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.515 ' CG ' ' HA ' ' A' ' 137' ' ' ASP . 25.9 mp0 -60.14 -51.82 67.96 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.939 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.621 ' HA ' HG12 ' A' ' 152' ' ' VAL . 16.0 t80 -72.15 -38.12 69.25 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.07 -47.64 71.46 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.599 176.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -76.1 -22.07 74.65 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.893 -175.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 149' ' ' PHE . 11.7 p -92.13 -37.34 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 117.545 0.672 . . . . 0.0 111.327 -176.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.505 ' CE ' ' HA ' ' A' ' 153' ' ' MET . 2.4 tpt -89.53 -56.81 3.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.827 0.346 . . . . 0.0 110.672 -176.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.8 p . . . . . 0 C--N 1.325 -0.483 0 CA-C-O 121.31 0.576 . . . . 0.0 110.354 -179.708 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.3 t . . . . . 0 C--O 1.215 -0.754 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -67.57 -37.75 83.08 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 14' ' ' LEU . 4.4 mm? -62.56 -44.27 96.74 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 172.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.43 ' HB3' ' HE2' ' A' ' 72' ' ' PHE . 85.5 mt -59.99 -45.63 92.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.671 175.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -64.94 -46.28 82.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.632 -175.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.9 m -61.31 -34.98 76.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.079 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.591 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -81.1 -38.5 27.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.331 177.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.553 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 51.7 t80 -54.8 -55.03 34.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.72 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -67.39 -21.89 65.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.131 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -77.31 -36.4 54.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.856 0.36 . . . . 0.0 111.098 -174.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.459 ' CD2' HG12 ' A' ' 39' ' ' ILE . 65.9 m-85 -110.74 16.2 21.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.283 0.563 . . . . 0.0 110.423 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.607 ' HG2' ' N ' ' A' ' 24' ' ' THR . 4.3 tt0 -78.67 156.44 29.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.22 -172.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.607 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER 80.25 127.15 0.03 OUTLIER Pre-proline 0 N--CA 1.444 -0.762 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.334 160.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 24' ' ' THR . 66.4 Cg_endo -90.12 -45.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.79 2.993 . . . . 0.0 111.947 173.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -142.77 24.69 1.85 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.38 62.84 1.14 Allowed Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -174.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.0 t -100.35 -28.04 13.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.927 0.394 . . . . 0.0 111.109 -172.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.19 -16.16 56.45 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -172.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.473 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 92.8 mtt180 -103.43 164.23 11.78 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.896 -0.652 . . . . 0.0 109.874 175.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.589 HG23 ' HA ' ' A' ' 23' ' ' GLU . 13.6 p -108.05 131.77 57.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.384 0.612 . . . . 0.0 109.639 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.1 t -62.69 144.39 56.39 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.372 -175.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.567 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . 2.8 p -66.52 -18.35 65.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.851 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -70.73 -36.11 73.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.307 0.575 . . . . 0.0 109.934 176.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -89.23 -14.48 35.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.533 -175.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.658 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 71.3 mt -53.35 -47.75 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.764 0.316 . . . . 0.0 110.644 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.442 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -58.54 -38.49 91.33 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.756 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.667 ' O ' HG23 ' A' ' 42' ' ' VAL . 36.8 mt -61.25 -49.46 84.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.25 0.547 . . . . 0.0 109.604 176.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.591 HG23 ' HB1' ' A' ' 18' ' ' ALA . 65.5 mt -60.43 -45.41 96.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.578 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.784 HD12 HD12 ' A' ' 52' ' ' ILE . 46.2 mt -61.7 -25.09 67.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.364 0.602 . . . . 0.0 110.761 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.518 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 8.6 tp10 -76.49 -42.22 44.28 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.719 173.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 38' ' ' ILE . 39.4 t -54.22 -42.71 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.888 0.851 . . . . 0.0 109.878 174.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 29.1 mt -83.49 -11.46 57.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.153 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.57 32.22 67.69 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.578 -0.737 . . . . 0.0 113.362 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 pt -109.74 -61.36 2.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -177.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.7 -177.75 4.16 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -174.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.404 ' HB2' ' CB ' ' A' ' 51' ' ' THR . 27.9 mm-40 -104.74 -170.61 1.79 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.004 -172.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.557 ' O ' HG12 ' A' ' 52' ' ' ILE . 15.2 t -62.04 179.06 0.31 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -57.74 -29.8 65.05 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -172.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.0 m -52.39 -45.55 65.88 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.297 0.57 . . . . 0.0 110.691 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.404 ' CB ' ' HB2' ' A' ' 47' ' ' GLN . 91.6 m -77.43 -34.3 54.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.474 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.784 HD12 HD12 ' A' ' 40' ' ' LEU . 42.1 mm -64.84 -24.49 35.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.31 -178.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -51.52 -38.09 52.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 172.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -75.16 -38.16 61.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.265 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.512 HD11 ' CE2' ' A' ' 79' ' ' PHE . 2.2 mm? -56.01 -48.42 75.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.226 174.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.545 HG12 ' HB ' ' A' ' 33' ' ' THR . 59.8 mt -62.96 -45.84 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.917 176.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -56.77 -29.81 62.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.273 0.559 . . . . 0.0 110.718 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -77.04 -54.51 6.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.55 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -101.24 -13.47 18.08 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -170.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.452 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 48.1 t0 -134.18 64.67 66.49 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.172 0.511 . . . . 0.0 111.194 176.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 24.6 Cg_exo -69.0 -18.42 40.6 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.769 2.313 . . . . 0.0 111.493 175.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -78.88 -17.51 55.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.244 -176.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.74 40.08 46.45 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.215 -177.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.412 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 1.2 t-20 -66.18 -43.97 85.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.917 0.487 . . . . 0.0 110.687 -176.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.91 -22.28 14.67 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.623 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -149.39 171.44 16.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.945 0.402 . . . . 0.0 110.377 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.405 ' C ' ' HD3' ' A' ' 30' ' ' ARG . 30.0 pt -135.27 145.42 31.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.56 ' HB3' ' HB3' ' A' ' 70' ' ' ASP . 15.2 t70 -83.01 171.55 13.69 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.487 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -62.18 -22.67 66.09 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 173.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.56 ' HB3' ' HB3' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -45.41 -53.23 8.97 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.597 170.617 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.7 m -87.38 -33.77 19.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.968 0.413 . . . . 0.0 111.249 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.487 ' HB3' ' HA ' ' A' ' 69' ' ' PHE . 73.4 t80 -65.29 -33.14 75.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.365 -176.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -65.28 -37.26 86.62 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.073 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.2 mt -68.1 -37.56 78.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.975 0.417 . . . . 0.0 109.928 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.56 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 61.2 mt -58.15 -53.62 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.004 174.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.516 ' CA ' HD23 ' A' ' 80' ' ' LEU . . . -60.96 -39.64 97.3 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.207 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.92 -28.83 69.8 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.906 0.384 . . . . 0.0 111.68 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 16.3 ptm180 -90.68 -13.04 34.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.009 -175.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.512 ' CE2' HD11 ' A' ' 55' ' ' LEU . 23.8 m-85 -119.35 -37.01 3.24 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.131 -0.627 . . . . 0.0 112.547 -175.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.516 HD23 ' CA ' ' A' ' 76' ' ' GLY . 4.1 mm? . . . . . 0 N--CA 1.466 0.327 0 O-C-N 123.218 0.324 . . . . 0.0 111.101 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 . . . . . 0 N--CA 1.464 0.225 0 CA-C-O 121.585 0.707 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.743 HD23 ' HE1' ' A' ' 150' ' ' MET . 0.9 OUTLIER -58.58 -34.4 71.03 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.985 -177.145 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.733 ' HA ' ' CE2' ' A' ' 97' ' ' PHE . 52.7 mmm-85 -62.72 -36.9 84.47 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.084 -177.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -84.55 -15.12 46.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.094 0.473 . . . . 0.0 110.86 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.479 ' HA ' HD12 ' A' ' 99' ' ' LEU . . . -82.55 -14.04 55.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.008 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.733 ' CE2' ' HA ' ' A' ' 94' ' ' ARG . 20.9 m-85 -62.46 -46.24 89.41 Favored 'General case' 0 C--O 1.215 -0.711 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 176.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -66.83 -12.41 58.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.82 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 96' ' ' ALA . 96.3 mt -83.66 -43.78 15.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.954 175.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -93.12 -24.01 18.42 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.417 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -71.89 80.19 0.9 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.922 0.868 . . . . 0.0 110.1 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -74.67 -16.93 60.75 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.476 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.486 ' HB2' ' ND2' ' A' ' 105' ' ' ASN . 22.7 mt-10 -83.61 -37.59 22.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.964 -173.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.25 34.83 3.29 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.763 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.486 ' ND2' ' HB2' ' A' ' 103' ' ' GLU . 21.1 m-80 -88.91 -18.74 26.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.895 0.378 . . . . 0.0 110.523 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.4 -25.79 4.83 Favored Glycine 0 N--CA 1.454 -0.147 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -171.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.488 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 1.7 m-85 -111.33 173.45 6.34 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 171.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.631 ' HB ' HG13 ' A' ' 112' ' ' VAL . 11.8 pt -109.39 126.64 66.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 119.364 -0.935 . . . . 0.0 109.611 171.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.438 ' HA ' HG22 ' A' ' 143' ' ' THR . 33.1 m -64.44 165.01 10.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.684 -177.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.1 p -59.65 -31.98 70.03 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.779 -0.576 . . . . 0.0 110.206 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -58.23 -51.62 69.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.699 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.631 HG13 ' HB ' ' A' ' 108' ' ' ILE . 2.3 p -69.73 -36.02 68.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.531 ' SD ' HG11 ' A' ' 144' ' ' VAL . 1.3 tpt -58.27 -45.1 88.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.049 0.452 . . . . 0.0 110.243 176.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.576 ' HG2' HD13 ' A' ' 129' ' ' LEU . 33.2 ttp180 -51.56 -50.79 59.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.975 175.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -65.18 -39.37 92.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.084 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 112' ' ' VAL . 43.6 mt -58.99 -46.32 91.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 111.173 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.477 HD12 ' HG ' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -63.65 -54.0 42.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.162 0.506 . . . . 0.0 109.946 -178.411 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.43 ' HB2' HD21 ' A' ' 129' ' ' LEU . . . -63.92 -19.86 65.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.713 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -69.03 -40.56 78.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.94 0.4 . . . . 0.0 110.258 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -75.84 -51.32 12.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.01 174.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.586 ' HB3' HD23 ' A' ' 124' ' ' LEU . 2.1 m-20 -107.73 96.82 6.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.431 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -79.72 15.14 1.45 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.511 -171.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 41.7 p -112.34 -4.65 14.25 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.493 0.663 . . . . 0.0 110.882 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.586 HD23 ' HB3' ' A' ' 121' ' ' ASP . 3.7 mm? -70.09 114.27 8.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.65 174.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.3 m -90.3 176.5 6.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.002 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.7 p -52.49 -44.37 65.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.872 0.367 . . . . 0.0 111.691 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -65.14 -41.4 94.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.954 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.46 ' HB3' HD13 ' A' ' 124' ' ' LEU . 34.3 m-20 -69.85 -49.77 49.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.448 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.576 HD13 ' HG2' ' A' ' 114' ' ' ARG . 79.2 mt -56.28 -38.28 70.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.685 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -55.95 -46.28 78.58 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.988 0.423 . . . . 0.0 110.704 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.66 -41.44 98.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.101 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 48.8 mtt -68.88 -38.97 80.02 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.006 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 133' ' ' ILE . 13.6 mm -59.02 -45.89 92.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.133 0.492 . . . . 0.0 110.005 174.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -55.34 -43.61 75.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.744 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -73.08 -45.64 56.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.246 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.621 HG12 HG13 ' A' ' 152' ' ' VAL . 69.8 mt -59.53 -57.1 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.729 -178.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -76.71 82.57 3.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.033 0.921 . . . . 0.0 109.83 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.39 -35.39 54.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.663 -1.153 . . . . 0.0 112.238 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -90.31 -10.53 43.79 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.383 -175.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 72.79 37.49 57.21 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.742 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.3 m -83.3 -19.29 36.53 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.418 0.628 . . . . 0.0 110.733 -178.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 93.42 -29.99 7.75 Favored Glycine 0 CA--C 1.51 -0.257 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.494 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.438 HG22 ' HA ' ' A' ' 109' ' ' SER . 2.7 p -118.39 132.59 56.25 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 174.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.531 HG11 ' SD ' ' A' ' 113' ' ' MET . 96.5 t -82.76 115.89 26.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.767 -177.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.488 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 22.3 t70 -139.12 -61.53 0.56 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.028 0.442 . . . . 0.0 111.661 -174.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.598 ' O ' ' HG2' ' A' ' 150' ' ' MET . 2.3 p90 -94.84 -112.74 0.12 Allowed 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.519 -172.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.5 ' H ' ' HD1' ' A' ' 146' ' ' PHE . 6.3 mp0 -64.71 -11.22 33.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.904 0.383 . . . . 0.0 111.265 -176.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -66.84 -52.07 48.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.332 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.49 ' O ' HG23 ' A' ' 152' ' ' VAL . 14.3 t80 -77.19 -33.8 56.33 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.009 0.433 . . . . 0.0 110.303 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . 0.743 ' HE1' HD23 ' A' ' 93' ' ' LEU . 6.9 mmt -64.13 -23.44 67.32 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.25 -21.93 66.38 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.66 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.621 HG13 HG12 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -91.31 -71.82 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 CA-C-O 121.813 0.816 . . . . 0.0 110.727 -178.41 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 47.5 tpp -83.49 -37.45 23.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.8 -166.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.587 ' OG1' ' HA ' ' A' ' 150' ' ' MET . 0.2 OUTLIER . . . . . 0 N--CA 1.442 -0.87 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.219 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.437 ' HA ' HD12 ' A' ' 15' ' ' LEU . 59.8 t . . . . . 0 N--CA 1.45 -0.441 0 CA-C-O 120.759 0.314 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -70.37 -37.48 74.58 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.009 173.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.0 mp -58.7 -48.92 79.47 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.529 HD11 ' HA3' ' A' ' 76' ' ' GLY . 84.8 mt -54.76 -47.85 73.39 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.758 175.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.71 -49.69 75.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.2 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.6 m -59.69 -41.3 90.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.968 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.667 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -76.27 -39.78 53.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.554 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.401 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 33.2 t80 -53.43 -56.14 19.31 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.643 175.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.448 ' HD2' ' OE1' ' A' ' 23' ' ' GLU . 28.1 mmm180 -66.96 -16.91 64.66 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.356 -174.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -87.6 -34.88 18.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.918 0.39 . . . . 0.0 111.354 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.457 ' HB2' HD11 ' A' ' 39' ' ' ILE . 78.8 m-85 -109.69 13.2 23.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.282 0.563 . . . . 0.0 110.227 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.708 ' HG2' ' HB ' ' A' ' 24' ' ' THR . 27.0 tt0 -71.21 148.28 47.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.811 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.708 ' HB ' ' HG2' ' A' ' 23' ' ' GLU . 0.4 OUTLIER 78.8 140.88 0.07 OUTLIER Pre-proline 0 N--CA 1.447 -0.623 0 O-C-N 124.664 1.227 . . . . 0.0 113.527 162.505 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -84.62 -36.69 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.265 2.643 . . . . 0.0 110.014 166.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -178.07 47.59 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.39 174.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.2 63.7 0.95 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.849 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.8 t -107.24 -18.29 13.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.005 0.431 . . . . 0.0 111.003 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.72 12.92 84.0 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -175.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.9 mtm-85 -140.54 168.46 19.75 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.567 -0.817 . . . . 0.0 109.597 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.547 HG23 ' HA ' ' A' ' 23' ' ' GLU . 12.3 p -107.7 127.66 63.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 173.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 13.8 m -55.45 138.5 46.04 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.852 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.564 ' HA ' HG13 ' A' ' 36' ' ' ILE . 1.5 p -64.53 -26.96 68.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.196 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -65.63 -27.85 68.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.109 0.48 . . . . 0.0 110.256 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -92.15 -13.52 30.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.47 -176.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.704 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 69.7 mt -53.86 -48.71 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 O-C-N 123.215 0.322 . . . . 0.0 110.773 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.416 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -59.73 -34.73 83.51 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.613 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.66 ' O ' HG23 ' A' ' 42' ' ' VAL . 50.3 mt -62.66 -49.71 82.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.4 0.619 . . . . 0.0 109.581 175.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.667 HG23 ' HB1' ' A' ' 18' ' ' ALA . 71.3 mt -61.64 -45.92 97.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.667 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.922 HD12 HD12 ' A' ' 52' ' ' ILE . 41.1 mt -61.91 -24.62 67.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.341 0.591 . . . . 0.0 110.423 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -75.97 -43.92 42.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.268 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 38' ' ' ILE . 47.8 t -53.85 -44.35 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.687 0.756 . . . . 0.0 110.264 175.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 22.2 mt -81.14 -12.1 59.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.275 -175.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.59 40.61 66.72 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.825 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.411 HG12 ' HB2' ' A' ' 43' ' ' LEU . 1.3 pt -118.76 -76.85 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.594 ' HG2' HD11 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -80.72 177.08 9.26 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -174.458 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 22.0 mm-40 -100.27 -171.18 1.99 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.126 -170.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.1 t -52.15 165.85 0.2 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.705 0.764 . . . . 0.0 111.762 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.537 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 59.4 mtpt -61.92 -20.56 63.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.349 -171.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.0 m -61.95 -31.21 71.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.208 0.528 . . . . 0.0 110.455 174.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.6 m -84.77 -31.48 23.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.334 176.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.922 HD12 HD12 ' A' ' 40' ' ' LEU . 28.3 mm -67.51 -25.3 32.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.009 -176.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -46.21 -45.28 16.82 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.922 173.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -62.29 -49.74 74.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.131 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.686 HD12 ' HA ' ' A' ' 52' ' ' ILE . 1.0 OUTLIER -58.14 -38.4 76.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.396 178.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.532 HG23 HG21 ' A' ' 33' ' ' THR . 75.2 mt -65.95 -46.67 87.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.044 177.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -62.42 -27.65 69.25 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.195 0.521 . . . . 0.0 110.289 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -76.0 -54.85 6.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.528 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.568 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 87.4 m-85 -97.57 -15.36 20.54 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -171.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.401 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 39.8 t0 -122.72 68.7 33.29 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 121.222 0.534 . . . . 0.0 110.358 174.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.568 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 20.7 Cg_exo -71.87 -18.12 28.39 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.032 2.488 . . . . 0.0 111.756 176.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -79.88 -17.62 52.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.712 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.38 37.46 53.98 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.781 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -72.59 -43.3 63.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.784 0.326 . . . . 0.0 111.237 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.97 -16.09 20.8 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.893 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 5.5 m-20 -137.19 176.69 8.48 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.0 pt -136.9 152.64 28.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.894 0.378 . . . . 0.0 110.272 174.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -90.07 166.59 13.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.844 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.434 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -63.0 -21.69 66.32 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 178.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -57.61 -52.35 65.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.027 0.442 . . . . 0.0 109.986 174.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.492 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 3.4 m -70.72 -44.96 65.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.526 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.434 ' HB3' ' HA ' ' A' ' 69' ' ' PHE . 84.5 t80 -64.5 -34.77 79.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.651 -176.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -64.81 -35.84 82.39 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.6 mt -67.46 -43.9 87.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.58 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 88.8 mt -55.08 -47.55 77.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.275 175.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.801 ' HA2' HD23 ' A' ' 80' ' ' LEU . . . -67.52 -43.9 84.92 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.608 -0.805 . . . . 0.0 112.524 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.55 -24.33 67.57 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.894 0.378 . . . . 0.0 111.701 -174.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.58 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 10.7 ptm180 -89.1 -15.16 34.58 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.844 -175.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -124.34 -36.75 2.61 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.406 -0.518 . . . . 0.0 112.139 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.801 HD23 ' HA2' ' A' ' 76' ' ' GLY . 4.6 mm? . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 . . . . . 0 CA--C 1.52 -0.195 0 CA-C-O 121.308 0.575 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.763 HD22 ' H ' ' A' ' 93' ' ' LEU . 0.9 OUTLIER -62.02 -35.58 78.99 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.894 -173.108 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.569 ' HD3' ' CE2' ' A' ' 97' ' ' PHE . 29.5 mmt180 -62.48 -41.69 98.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.086 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -74.62 -30.91 61.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.204 0.526 . . . . 0.0 110.818 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.509 ' HA ' HD12 ' A' ' 99' ' ' LEU . . . -74.95 -20.22 59.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.935 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.569 ' CE2' ' HD3' ' A' ' 94' ' ' ARG . 17.0 m-30 -56.57 -44.62 81.18 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.372 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.3 mtm-85 -72.02 -19.52 61.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.027 0.442 . . . . 0.0 110.906 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 96' ' ' ALA . 94.2 mt -80.09 -43.87 21.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.654 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.655 ' O ' ' HD2' ' A' ' 102' ' ' LYS . 79.9 m-85 -89.59 -5.61 57.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.397 -177.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 97' ' ' PHE . 55.8 t0 -76.82 76.28 3.43 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.512 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.655 ' HD2' ' O ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -57.04 -42.33 80.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.601 174.548 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -67.75 -36.75 81.1 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.214 -171.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.96 37.15 7.97 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -171.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -96.06 -18.37 20.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.49 -0.855 . . . . 0.0 111.174 -168.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.9 -24.91 10.83 Favored Glycine 0 CA--C 1.517 0.194 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.445 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 4.2 m-85 -116.75 176.93 4.89 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 173.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.617 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 6.3 pt -117.84 121.94 68.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.239 169.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 66.3 m -65.91 174.75 2.28 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.149 0.5 . . . . 0.0 111.556 -175.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.2 p -67.36 -26.76 66.64 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.953 0.406 . . . . 0.0 110.754 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -60.59 -58.09 9.95 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.851 176.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.617 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.4 p -63.26 -38.36 81.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.843 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.542 ' SD ' HG11 ' A' ' 144' ' ' VAL . 2.7 tpt -56.5 -40.89 75.73 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.827 0.346 . . . . 0.0 110.648 177.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -61.02 -45.19 95.79 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.991 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -58.99 -46.49 88.0 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.411 0.444 . . . . 0.0 110.215 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 63.7 mt -57.45 -53.83 38.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.567 177.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.4 tp -54.66 -60.29 3.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.36 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.08 -27.15 52.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.433 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -75.45 -44.15 45.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.616 0.246 . . . . 0.0 110.348 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.32 -55.7 7.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.141 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.663 ' HB3' HD23 ' A' ' 124' ' ' LEU . 5.3 m-20 -103.01 111.97 24.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.478 0.656 . . . . 0.0 110.649 -178.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.502 ' H ' ' CD ' ' A' ' 122' ' ' GLU . 0.3 OUTLIER -89.17 -5.41 57.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.717 -173.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.7 p -88.61 -2.98 58.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.339 0.59 . . . . 0.0 110.765 -174.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.663 HD23 ' HB3' ' A' ' 121' ' ' ASP . 4.2 mm? -84.87 129.03 34.87 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.854 176.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.491 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 92.0 p -89.69 -179.01 5.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 175.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.5 t -58.75 -48.49 81.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.692 0.282 . . . . 0.0 110.795 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -71.08 -35.86 72.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.828 0.347 . . . . 0.0 111.161 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.424 ' HB2' ' H ' ' A' ' 125' ' ' SER . 68.4 m-20 -66.28 -38.14 87.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.45 178.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.509 ' O ' HG12 ' A' ' 133' ' ' ILE . 85.5 mt -58.65 -44.46 90.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.151 172.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -58.99 -46.24 88.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.616 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.45 -42.71 98.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.723 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.508 ' O ' HG13 ' A' ' 136' ' ' ILE . 9.0 mtt -64.06 -37.26 86.8 Favored 'General case' 0 C--O 1.215 -0.731 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.923 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 129' ' ' LEU . 15.8 mm -57.41 -43.88 83.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.188 0.518 . . . . 0.0 110.419 174.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.4 -36.98 84.04 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.262 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -72.79 -39.5 66.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.517 -1.219 . . . . 0.0 111.242 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 132' ' ' MET . 66.8 mt -71.11 -57.11 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.993 -176.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -75.64 63.58 1.58 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 122.396 1.094 . . . . 0.0 108.621 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -78.37 -22.33 48.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.489 -1.232 . . . . 0.0 112.161 -174.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -88.23 -11.99 45.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.368 0.604 . . . . 0.0 110.202 -178.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 79.53 34.99 30.3 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.488 174.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.431 ' C ' ' H ' ' A' ' 143' ' ' THR . 46.9 t -78.74 -21.16 48.42 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.197 0.522 . . . . 0.0 110.406 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.67 -28.36 3.54 Favored Glycine 0 C--O 1.234 0.121 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.431 ' H ' ' C ' ' A' ' 141' ' ' SER . 19.5 p -124.3 128.27 48.87 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 172.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.542 HG11 ' SD ' ' A' ' 113' ' ' MET . 58.8 t -80.71 127.3 39.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -173.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.445 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 17.8 t70 -157.2 -77.63 0.08 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.872 0.844 . . . . 0.0 110.176 -175.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.439 ' HB3' HH22 ' A' ' 94' ' ' ARG . 20.7 p90 -92.65 136.42 33.24 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.072 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 64.86 -54.44 0.3 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.526 0.73 . . . . 0.0 112.204 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -54.66 -51.02 66.78 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.818 0.847 . . . . 0.0 112.144 -176.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.662 ' HE1' HD12 ' A' ' 93' ' ' LEU . 11.4 t80 -75.41 -37.0 60.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.125 0.488 . . . . 0.0 110.341 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . 0.573 ' CE ' HD23 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -58.14 -43.15 87.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.347 178.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -73.24 -35.62 56.73 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.455 -177.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 149' ' ' PHE . 9.3 p -75.59 -38.9 39.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 117.112 0.456 . . . . 0.0 111.511 -175.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 16.0 tpt -93.88 -39.92 10.44 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.879 -174.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.446 HG21 HD21 ' A' ' 93' ' ' LEU . 64.9 p . . . . . 0 C--N 1.324 -0.5 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -172.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.436 HG13 ' CE2' ' A' ' 69' ' ' PHE . 89.2 t . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.833 0.349 . . . . 0.0 111.07 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.486 ' HD3' ' C ' ' A' ' 13' ' ' LYS . 1.1 tmtp? -62.82 -40.93 98.92 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 123.181 0.592 . . . . 0.0 110.854 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.43 ' N ' ' HD3' ' A' ' 13' ' ' LYS . 6.4 mp -69.92 -42.45 73.31 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.65 HD21 ' CD1' ' A' ' 80' ' ' LEU . 80.8 mt -59.97 -53.98 51.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.624 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.428 ' HA ' ' HE1' ' A' ' 69' ' ' PHE . 37.7 tt0 -64.65 -35.89 82.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.359 -175.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.1 m -59.82 -42.16 92.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 110.745 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.558 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -80.48 -33.12 36.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.146 0.498 . . . . 0.0 110.278 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.452 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 35.7 t80 -56.44 -55.04 38.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.35 177.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -69.08 -19.79 64.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.522 -174.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.61 -42.86 40.86 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.744 0.307 . . . . 0.0 110.908 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -103.77 14.01 31.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.137 0.494 . . . . 0.0 110.444 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.709 ' HG2' ' HB ' ' A' ' 24' ' ' THR . 10.3 tt0 -71.85 154.65 41.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.38 -176.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.709 ' HB ' ' HG2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER 76.01 137.77 0.05 OUTLIER Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-O 122.462 1.125 . . . . 0.0 113.812 158.637 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.32 -52.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.911 2.408 . . . . 0.0 109.835 168.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -138.83 -25.81 0.88 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.625 172.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.66 50.0 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -176.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 t -89.78 -29.77 18.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.807 0.337 . . . . 0.0 111.39 -174.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.88 -6.33 75.03 Favored Glycine 0 N--CA 1.453 -0.179 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 -175.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 67' ' ' ILE . 61.0 mtt85 -115.25 163.7 15.29 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.207 -0.496 . . . . 0.0 109.745 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.572 HG21 HD11 ' A' ' 39' ' ' ILE . 13.3 p -106.18 126.61 61.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 121.86 0.838 . . . . 0.0 110.269 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 31.1 m -53.79 140.61 29.45 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.847 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.583 ' HB ' HG12 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -66.69 -25.31 66.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.85 -174.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -69.36 -26.08 64.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.589 0.709 . . . . 0.0 109.727 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -82.06 -22.4 36.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.661 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.545 HG22 HD22 ' A' ' 40' ' ' LEU . 60.2 mt -55.61 -43.33 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 120.959 0.409 . . . . 0.0 110.143 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.429 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -65.24 -25.43 71.11 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.634 177.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.649 ' O ' HG23 ' A' ' 42' ' ' VAL . 39.3 mt -75.21 -51.97 19.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.572 HD11 HG21 ' A' ' 31' ' ' VAL . 63.5 mt -60.96 -44.83 98.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.839 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.545 HD22 HG22 ' A' ' 36' ' ' ILE . 1.6 mp -57.54 -39.26 76.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.352 0.596 . . . . 0.0 109.685 176.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -65.64 -38.44 89.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.769 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 38' ' ' ILE . 60.8 t -60.69 -50.38 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.622 0.725 . . . . 0.0 110.671 175.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.5 mt -83.35 -1.54 53.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.653 -171.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.55 35.19 42.12 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.403 172.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.5 pt -129.02 166.65 26.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.628 0.214 . . . . 0.0 110.468 176.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.29 -166.67 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -120.22 -171.88 2.25 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.975 -173.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.9 t -63.7 171.33 2.74 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.451 0.643 . . . . 0.0 111.437 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.446 ' HA ' ' HB ' ' A' ' 52' ' ' ILE . 7.3 mtpm? -59.0 -24.6 62.92 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.317 -165.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.3 t -57.29 -44.8 84.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.931 0.396 . . . . 0.0 110.35 173.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.3 m -72.26 -34.42 68.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.433 0.635 . . . . 0.0 110.293 176.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.446 ' HB ' ' HA ' ' A' ' 49' ' ' LYS . 44.9 mm -63.41 -24.42 35.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.479 -176.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -50.83 -38.02 46.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.886 172.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.917 HE21 ' HA ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -74.44 -28.82 61.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.051 -179.051 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 52' ' ' ILE . 2.3 mm? -65.35 -43.34 91.14 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.583 HG12 ' HB ' ' A' ' 33' ' ' THR . 71.8 mt -65.2 -45.42 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.96 177.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.03 -27.99 22.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.294 0.569 . . . . 0.0 111.076 176.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -83.31 -53.65 5.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.663 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.459 ' CE2' HG12 ' A' ' 75' ' ' ILE . 97.1 m-85 -100.87 -10.66 20.48 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -169.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.482 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 51.3 t0 -136.25 63.82 51.03 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 121.208 0.527 . . . . 0.0 110.458 174.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.482 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 24.6 Cg_exo -68.42 -20.56 41.87 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.841 2.361 . . . . 0.0 111.592 177.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -78.45 -17.48 56.28 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.757 -176.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.97 43.02 50.65 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.518 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -74.89 -38.04 61.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.216 0.532 . . . . 0.0 109.942 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 110.68 -5.37 29.43 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.961 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -161.32 175.77 11.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 71' ' ' SER . 34.6 pt -143.19 146.71 21.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.371 -177.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -75.88 163.19 27.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.934 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.436 ' CE2' HG13 ' A' ' 12' ' ' VAL . 16.0 t80 -56.49 -35.65 68.23 Favored 'General case' 0 C--O 1.214 -0.772 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.075 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -62.18 -22.41 65.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.869 0.366 . . . . 0.0 111.029 -175.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.42 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 40.3 m -85.82 -41.26 15.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.905 0.383 . . . . 0.0 110.504 174.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.439 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 89.7 t80 -70.1 -30.56 67.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.467 0.651 . . . . 0.0 109.717 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -55.51 -50.53 69.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.871 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.0 -42.82 98.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.364 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.607 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 65.5 mt -54.34 -55.45 14.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.482 0.658 . . . . 0.0 110.068 176.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.69 -42.86 99.82 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.259 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.06 -28.03 69.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.854 0.359 . . . . 0.0 111.16 -174.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 13.8 ptm180 -89.64 -10.74 44.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.867 -176.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.514 ' CD1' ' HG3' ' A' ' 78' ' ' ARG . 22.6 m-85 -116.28 -40.14 3.3 Favored 'General case' 0 C--N 1.337 0.061 0 C-N-CA 120.66 -0.416 . . . . 0.0 112.105 -176.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.65 ' CD1' HD21 ' A' ' 15' ' ' LEU . 2.3 mp . . . . . 0 C--N 1.326 -0.45 0 CA-C-O 120.912 0.387 . . . . 0.0 110.828 176.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 . . . . . 0 CA--C 1.52 -0.187 0 CA-C-O 120.932 0.396 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.671 HD13 ' CD1' ' A' ' 149' ' ' PHE . 77.6 mt -57.83 -38.29 75.34 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.731 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.737 ' HA ' ' CD2' ' A' ' 97' ' ' PHE . 5.6 mpt_? -58.84 -46.27 88.09 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.755 0.312 . . . . 0.0 111.689 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -76.03 -17.08 59.82 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.13 0.49 . . . . 0.0 110.291 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.19 -18.04 33.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.182 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.737 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 22.4 m-85 -59.57 -45.5 91.66 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 98' ' ' ARG . 47.8 mtp180 -69.68 -13.86 62.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.156 0.503 . . . . 0.0 111.033 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.4 mt -84.35 -35.51 23.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.501 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -96.38 -11.55 25.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.182 0.515 . . . . 0.0 110.298 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -72.54 77.56 1.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.877 0.846 . . . . 0.0 110.337 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -75.65 -9.49 58.63 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.923 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -88.88 -37.11 15.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.654 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.95 30.55 7.05 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.676 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -98.96 -17.48 18.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.848 0.356 . . . . 0.0 111.544 -175.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.57 -26.18 4.18 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.521 -0.631 . . . . 0.0 111.521 -174.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.526 ' HD2' ' CB ' ' A' ' 145' ' ' ASP . 30.5 m-85 -103.92 144.77 31.07 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 171.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.642 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 7.0 pt -93.11 120.8 43.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 118.591 -1.243 . . . . 0.0 108.977 174.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.5 m -67.76 172.12 5.7 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.96 -174.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 34.3 p -60.79 -29.06 69.21 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.211 0.529 . . . . 0.0 110.845 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.601 ' O ' ' HB2' ' A' ' 114' ' ' ARG . 2.0 t70 -62.97 -50.72 69.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.403 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.642 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.4 p -70.82 -35.28 59.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.933 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.728 ' SD ' HG11 ' A' ' 144' ' ' VAL . 1.4 tpt -59.66 -37.72 79.51 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.763 0.316 . . . . 0.0 110.205 176.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.601 ' HB2' ' O ' ' A' ' 111' ' ' ASP . 36.7 mtt180 -50.55 -59.55 3.93 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.407 172.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.0 -41.69 92.66 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.768 -176.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 53.6 mt -58.09 -46.89 88.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.148 0.499 . . . . 0.0 110.9 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.419 HD12 ' CD2' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -70.57 -47.39 60.5 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.128 -179.257 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.864 ' HB2' HD21 ' A' ' 129' ' ' LEU . . . -53.21 -25.81 15.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.753 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -68.34 -26.68 65.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.195 0.521 . . . . 0.0 110.247 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.4 mp -89.55 -47.77 7.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.022 174.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.897 ' HB3' ' HB2' ' A' ' 124' ' ' LEU . 1.3 m-20 -90.57 93.57 9.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.3 0.572 . . . . 0.0 110.471 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -79.61 -13.84 59.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.728 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.5 p -96.79 -14.04 22.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 122.724 1.25 . . . . 0.0 108.607 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.923 ' HG ' HD22 ' A' ' 129' ' ' LEU . 36.9 tp -69.83 116.21 9.96 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 112.991 -1.913 . . . . 0.0 110.426 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 93.9 p -91.61 -179.71 5.43 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.622 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 24.9 m -58.73 -37.36 75.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.889 0.376 . . . . 0.0 110.911 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -74.58 -42.05 59.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.634 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.65 ' CB ' HD12 ' A' ' 124' ' ' LEU . 59.4 m-20 -64.35 -50.46 67.63 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.923 HD22 ' HG ' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -42.25 -48.41 4.93 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.835 169.646 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -62.19 -41.31 98.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.662 0.268 . . . . 0.0 111.219 -175.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.89 -41.6 97.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.101 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.409 ' O ' HG13 ' A' ' 136' ' ' ILE . 36.2 mtt -63.05 -39.21 94.05 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.624 176.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 129' ' ' LEU . 24.5 mm -57.91 -45.2 87.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.144 0.497 . . . . 0.0 110.382 175.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -61.02 -34.92 75.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.43 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -73.87 -38.52 64.4 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.849 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.53 HG12 ' HB ' ' A' ' 152' ' ' VAL . 59.8 mt -70.43 -49.41 53.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.385 -176.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.73 95.93 0.93 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 123.023 1.392 . . . . 0.0 110.713 -174.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.29 -54.95 5.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.208 -1.36 . . . . 0.0 112.337 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -84.23 -10.35 57.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.441 0.639 . . . . 0.0 110.979 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 61.55 40.95 99.41 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.621 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.1 t -89.89 5.04 48.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.079 0.466 . . . . 0.0 110.66 -176.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.56 -31.01 4.68 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.177 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 35.3 p -117.81 143.27 46.42 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.439 -0.381 . . . . 0.0 109.998 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.728 HG11 ' SD ' ' A' ' 113' ' ' MET . 71.7 t -91.88 111.41 24.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.526 ' CB ' ' HD2' ' A' ' 107' ' ' TYR . 22.6 t70 -146.37 -69.16 0.26 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.687 0.756 . . . . 0.0 111.574 -175.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.858 ' HD2' ' HG2' ' A' ' 147' ' ' GLU . 4.0 p90 -97.92 -53.44 3.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.02 -164.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.858 ' HG2' ' HD2' ' A' ' 146' ' ' PHE . 40.2 mm-40 -98.86 -36.17 9.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.496 0.665 . . . . 0.0 110.157 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 148' ' ' GLU . 40.9 mp0 -63.5 -54.95 28.37 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.038 -175.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.671 ' CD1' HD13 ' A' ' 93' ' ' LEU . 2.3 t80 -66.27 -45.98 78.6 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.793 -175.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' A' ' 146' ' ' PHE . 52.4 mmm -61.47 -19.53 62.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.278 177.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -90.92 -17.54 51.11 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.878 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.53 ' HB ' HG12 ' A' ' 136' ' ' ILE . 6.6 p -98.31 -47.26 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 117.019 0.41 . . . . 0.0 111.393 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 49.9 tpp -81.08 -56.46 4.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.881 0.372 . . . . 0.0 110.785 -176.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.1 p . . . . . 0 C--N 1.322 -0.592 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.78 -178.556 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.1 t . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 120.614 0.245 . . . . 0.0 110.462 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.46 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 12.0 tptt -61.64 -42.64 99.18 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 120.782 0.325 . . . . 0.0 110.642 173.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.9 mt -57.23 -48.7 78.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.426 0.631 . . . . 0.0 109.617 173.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.9 mt -56.18 -51.34 68.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.261 176.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -61.08 -41.87 97.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.652 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.8 m -61.24 -39.28 89.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.063 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.538 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -84.2 -31.33 25.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.931 0.396 . . . . 0.0 110.616 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.591 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 65.3 t80 -57.95 -56.79 17.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.411 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -71.95 -0.96 12.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.468 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -93.79 -52.43 4.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.788 0.327 . . . . 0.0 110.746 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.611 ' CD1' HG12 ' A' ' 39' ' ' ILE . 64.5 m-85 -95.71 11.11 34.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.02 0.438 . . . . 0.0 110.455 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.615 ' HA ' HG23 ' A' ' 31' ' ' VAL . 11.1 tt0 -62.32 155.12 25.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.513 -174.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.579 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.4 OUTLIER 77.81 138.52 0.06 OUTLIER Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 114.128 -1.396 . . . . 0.0 113.737 161.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -88.32 -44.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.553 2.835 . . . . 0.0 110.799 170.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -164.3 47.03 0.11 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.494 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.78 66.67 1.27 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.808 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.0 t -113.14 -27.19 8.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -176.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.13 -4.76 82.45 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -171.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.448 ' HD2' ' OD2' ' A' ' 66' ' ' ASP . 25.5 mtt85 -115.25 160.22 20.03 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 114.068 -1.066 . . . . 0.0 109.565 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.615 HG23 ' HA ' ' A' ' 23' ' ' GLU . 10.2 p -106.8 126.98 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 121.697 0.76 . . . . 0.0 109.099 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 66' ' ' ASP . 32.8 t -55.63 140.64 40.53 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.941 -1.481 . . . . 0.0 111.372 -177.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.598 ' HB ' HG12 ' A' ' 56' ' ' ILE . 7.0 p -66.5 -19.63 65.83 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.01 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.416 ' O ' ' HE2' ' A' ' 49' ' ' LYS . 32.9 t70 -70.9 -27.39 63.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.72 176.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.682 ' HA ' HD13 ' A' ' 38' ' ' ILE . 15.8 mm100 -95.06 -13.96 24.7 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.05 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.719 HG22 HD22 ' A' ' 40' ' ' LEU . 63.1 mt -56.93 -34.06 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.614 0.245 . . . . 0.0 110.665 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.437 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -73.12 -36.1 56.81 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.338 -177.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.682 HD13 ' HA ' ' A' ' 35' ' ' GLN . 1.3 mp -59.81 -56.13 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 174.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.78 ' HA ' HG13 ' A' ' 42' ' ' VAL . 36.0 mt -64.08 -39.24 84.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.645 -176.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.719 HD22 HG22 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -60.83 -23.71 65.31 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.301 -0.56 . . . . 0.0 109.992 176.337 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 35.0 tt0 -81.74 -41.63 20.96 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.402 173.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.78 HG13 ' HA ' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -58.78 -38.74 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 121.572 0.701 . . . . 0.0 110.406 177.563 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.479 ' HG ' HG22 ' A' ' 42' ' ' VAL . 45.6 mt -83.52 -11.9 56.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.841 -178.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.91 32.52 56.76 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.269 175.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pt -110.96 -86.09 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -177.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -79.03 177.34 8.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.257 0.551 . . . . 0.0 112.362 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -100.79 -171.95 2.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.371 -174.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.2 t -64.38 175.81 1.24 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.444 0.64 . . . . 0.0 111.862 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 96.8 mttt -53.61 -30.42 42.48 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -165.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.4 m -55.7 -33.48 64.22 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.073 0.463 . . . . 0.0 111.058 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.7 m -84.25 -33.77 23.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.557 0.694 . . . . 0.0 110.3 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.437 HG13 ' HA3' ' A' ' 37' ' ' GLY . 36.9 mm -66.92 -23.98 31.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.497 -175.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 30.7 mmt180 -52.71 -33.1 46.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.923 0.392 . . . . 0.0 110.742 176.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -70.86 -51.05 28.84 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.164 0.507 . . . . 0.0 109.735 175.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.473 HD11 ' CE2' ' A' ' 79' ' ' PHE . 3.3 mm? -51.26 -45.92 62.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.249 177.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.598 HG12 ' HB ' ' A' ' 33' ' ' THR . 73.1 mt -62.97 -50.0 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.486 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -62.92 -25.39 68.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.197 0.523 . . . . 0.0 110.713 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -69.24 -55.02 11.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.236 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.546 ' HB3' ' HB3' ' A' ' 71' ' ' SER . 94.6 m-85 -100.92 -20.76 15.32 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -171.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -126.67 67.59 67.5 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-O 121.2 0.524 . . . . 0.0 110.615 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.456 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 31.3 Cg_exo -62.66 -17.16 57.34 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.862 2.374 . . . . 0.0 111.628 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -69.74 -18.34 63.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.279 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.9 32.44 84.19 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -173.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -75.41 -40.93 57.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.928 -0.636 . . . . 0.0 111.087 -170.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.01 -14.95 10.33 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.017 -1.087 . . . . 0.0 113.788 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.448 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 5.7 p-10 -154.75 157.9 38.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 117.171 0.486 . . . . 0.0 110.875 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.8 pt -133.59 149.11 30.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.255 -175.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -81.11 167.99 19.09 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.657 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.416 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -56.3 -26.63 52.79 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.124 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -42.89 -54.29 4.26 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.468 172.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.546 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 13.5 m -86.51 -37.17 18.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.819 -176.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.416 ' HB3' ' HA ' ' A' ' 69' ' ' PHE . 92.3 t80 -63.94 -35.26 80.1 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.129 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -63.87 -36.27 83.36 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.443 ' HB ' ' CE1' ' A' ' 59' ' ' PHE . 34.6 mt -72.44 -37.25 57.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 177.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.565 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 61.7 mt -57.78 -51.21 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.285 0.564 . . . . 0.0 109.654 173.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.499 ' O ' HD23 ' A' ' 80' ' ' LEU . . . -63.18 -42.78 99.32 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.893 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.95 -37.58 74.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.385 0.612 . . . . 0.0 111.329 -175.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 15.0 ptm180 -81.83 -9.3 59.65 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.969 -173.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.473 ' CE2' HD11 ' A' ' 55' ' ' LEU . 22.2 m-85 -124.02 -31.56 3.36 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.72 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 76' ' ' GLY . 4.1 mm? . . . . . 0 CA--C 1.513 -0.448 0 CA-C-O 121.155 0.503 . . . . 0.0 110.904 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 121.075 0.464 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.65 HD22 ' H ' ' A' ' 93' ' ' LEU . 0.6 OUTLIER -56.81 -38.18 72.23 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.037 -176.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.704 ' HA ' ' CE2' ' A' ' 97' ' ' PHE . 30.1 mmm180 -62.44 -34.85 77.59 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.485 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -86.96 -23.44 25.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.881 0.372 . . . . 0.0 110.652 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.0 -16.03 62.06 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.608 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.704 ' CE2' ' HA ' ' A' ' 94' ' ' ARG . 20.1 m-85 -61.71 -40.86 96.51 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -66.46 -17.74 64.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.323 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.2 mt -88.06 -30.72 19.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.321 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -104.28 -24.12 13.15 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -175.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -72.97 79.88 1.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.562 0.696 . . . . 0.0 109.982 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -69.72 -19.43 63.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.628 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.466 ' HB2' ' ND2' ' A' ' 105' ' ' ASN . 12.5 mt-10 -90.91 -37.01 13.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.279 -172.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.81 42.15 3.66 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.024 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.466 ' ND2' ' HB2' ' A' ' 103' ' ' GLU . 24.5 m-80 -87.53 -19.65 27.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 0.0 110.693 -176.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.54 1.9 82.86 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -169.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.552 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 4.7 m-85 -148.22 165.26 31.47 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.668 ' HB ' HG13 ' A' ' 112' ' ' VAL . 11.3 pt -102.46 120.48 52.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 C-N-CA 119.278 -0.969 . . . . 0.0 109.1 170.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.6 m -60.97 161.59 8.11 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.685 -176.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.0 p -58.34 -26.61 63.32 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.765 -0.584 . . . . 0.0 110.642 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -62.05 -51.03 69.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.78 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.668 HG13 ' HB ' ' A' ' 108' ' ' ILE . 2.1 p -70.37 -36.71 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.156 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.633 ' SD ' HG11 ' A' ' 144' ' ' VAL . 2.7 tpt -59.23 -38.34 79.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.103 0.477 . . . . 0.0 109.782 175.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -56.34 -53.48 56.83 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.125 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.62 -29.42 66.91 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.996 -178.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.6 HG13 ' O ' ' A' ' 112' ' ' VAL . 57.4 mt -63.52 -50.2 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 121.205 0.526 . . . . 0.0 110.021 174.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.62 HD11 ' SD ' ' A' ' 132' ' ' MET . 0.7 OUTLIER -58.7 -50.61 73.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.835 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.65 -27.82 68.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.775 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -69.97 -39.92 75.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.911 0.386 . . . . 0.0 110.14 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.44 -56.72 5.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.828 175.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.619 ' CG ' HD23 ' A' ' 124' ' ' LEU . 7.5 t70 -102.82 119.97 39.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.077 0.465 . . . . 0.0 110.881 -177.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -101.87 15.79 27.92 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.805 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 61.8 p -116.17 -17.0 10.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.477 0.656 . . . . 0.0 109.767 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.619 HD23 ' CG ' ' A' ' 121' ' ' ASP . 1.4 mm? -55.42 146.85 18.73 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.909 169.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.474 ' H ' ' HB2' ' A' ' 128' ' ' ASP . 27.3 t -107.85 162.46 13.98 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.601 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.1 m -51.76 -36.51 47.6 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 118.204 0.456 . . . . 0.0 111.396 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -76.38 -45.69 30.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.295 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.474 ' HB2' ' H ' ' A' ' 125' ' ' SER . 3.0 m-20 -63.35 -42.51 98.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.053 0.454 . . . . 0.0 110.487 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.616 HD11 ' HB3' ' A' ' 117' ' ' LEU . 26.6 tp -56.39 -39.5 73.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.528 176.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.455 ' O ' ' HB ' ' A' ' 133' ' ' ILE . 23.7 t70 -63.88 -41.7 97.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.234 177.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.48 -38.06 89.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.686 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.62 ' SD ' HD11 ' A' ' 117' ' ' LEU . 28.7 mtt -65.23 -34.04 77.43 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.59 175.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 133' ' ' ILE . 15.2 mm -58.54 -47.79 87.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.978 0.418 . . . . 0.0 110.312 173.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.66 -45.08 77.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.409 175.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -66.95 -37.12 83.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.253 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.452 HG21 ' SD ' ' A' ' 113' ' ' MET . 51.9 mt -69.41 -58.65 5.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.16 -178.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -71.29 96.26 1.41 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.7 0.762 . . . . 0.0 110.206 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -75.19 -42.97 54.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.736 -175.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -81.94 -15.14 54.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.491 0.662 . . . . 0.0 110.979 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 70.71 26.03 74.73 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.195 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.0 t -74.68 -18.25 60.55 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.428 0.633 . . . . 0.0 109.723 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.22 -23.94 24.64 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.552 ' HB ' ' HB2' ' A' ' 107' ' ' TYR . 24.6 p -116.93 128.92 55.69 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.633 HG11 ' SD ' ' A' ' 113' ' ' MET . 94.1 t -86.13 121.92 37.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.292 -176.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.535 ' CB ' ' HD2' ' A' ' 107' ' ' TYR . 22.7 t70 -150.43 -68.99 0.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.325 0.584 . . . . 0.0 111.867 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 146' ' ' PHE . 0.6 OUTLIER -85.23 -88.28 0.11 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.067 -167.185 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -78.31 -28.22 47.4 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.063 0.459 . . . . 0.0 110.823 -175.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.664 ' CD ' ' H ' ' A' ' 148' ' ' GLU . 3.0 mp0 -57.94 -64.11 1.02 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.588 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.546 ' CD2' HD11 ' A' ' 108' ' ' ILE . 19.8 t80 -66.97 -43.74 82.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.979 -174.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 40.7 tpp -62.43 -33.56 75.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.152 0.501 . . . . 0.0 109.797 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.55 -26.81 66.72 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 116.033 -0.53 . . . . 0.0 113.133 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.502 HG12 ' HA ' ' A' ' 149' ' ' PHE . 6.5 p -89.17 -42.51 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 117.238 0.519 . . . . 0.0 111.665 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -82.34 -57.89 3.17 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.543 -174.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 45.3 p . . . . . 0 C--N 1.331 -0.238 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.585 -178.938 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.42 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 93.3 t . . . . . 0 CA--C 1.531 0.233 0 CA-C-O 120.623 0.249 . . . . 0.0 111.403 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HD2' ' HA ' ' A' ' 13' ' ' LYS . 11.9 tptt -62.08 -42.51 99.28 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-O 120.886 0.374 . . . . 0.0 111.223 177.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.6 mt -60.41 -41.61 94.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.407 0.622 . . . . 0.0 109.491 174.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.922 HD21 HD13 ' A' ' 80' ' ' LEU . 77.3 mt -61.16 -49.27 77.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.692 176.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -61.34 -43.47 98.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.461 -178.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 57.9 m -58.6 -38.27 77.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.116 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.566 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -86.0 -35.67 20.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.042 0.449 . . . . 0.0 110.382 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.693 ' CE1' HG22 ' A' ' 31' ' ' VAL . 88.0 t80 -55.15 -49.58 71.46 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.096 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.415 ' HA ' ' HB2' ' A' ' 23' ' ' GLU . 23.7 mmt180 -81.35 -6.52 58.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.765 -175.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -87.58 -46.47 9.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.09 0.472 . . . . 0.0 110.318 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.582 ' HB3' ' HB3' ' A' ' 35' ' ' GLN . 68.4 m-85 -98.97 25.74 6.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.81 0.814 . . . . 0.0 109.461 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.964 ' HG2' ' HB ' ' A' ' 24' ' ' THR . 1.7 tt0 -78.42 139.48 38.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.249 -1.341 . . . . 0.0 112.8 -172.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.964 ' HB ' ' HG2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER 76.27 144.69 0.1 Allowed Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 155.515 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 24' ' ' THR . 7.1 Cg_exo -74.8 -53.71 0.1 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.531 2.821 . . . . 0.0 110.084 165.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -136.5 -39.61 0.65 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.69 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.3 38.55 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.9 t -76.37 -27.18 56.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.374 -0.413 . . . . 0.0 111.161 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.93 4.6 86.97 Favored Glycine 0 C--N 1.335 0.479 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.457 ' HB2' ' OD2' ' A' ' 66' ' ' ASP . 11.8 mtt180 -122.06 168.3 12.1 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.758 -0.721 . . . . 0.0 110.305 -175.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.693 HG22 ' CE1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -105.66 127.34 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.536 0 CA-C-O 121.446 0.641 . . . . 0.0 110.926 174.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.418 ' HB3' ' HG2' ' A' ' 35' ' ' GLN . 6.0 t -53.74 139.32 33.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.797 -1.547 . . . . 0.0 109.1 171.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.628 HG21 HG23 ' A' ' 56' ' ' ILE . 3.9 p -70.46 -13.04 61.96 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.869 0.366 . . . . 0.0 111.586 -176.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.71 -29.47 62.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.717 172.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.582 ' HB3' ' HB3' ' A' ' 22' ' ' PHE . 84.3 mm-40 -81.56 -23.54 37.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.977 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.52 HG22 HD22 ' A' ' 40' ' ' LEU . 61.0 mt -57.18 -44.34 83.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.524 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.82 -20.73 70.7 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.366 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.618 ' O ' HG23 ' A' ' 42' ' ' VAL . 15.0 mt -81.9 -51.36 15.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.566 HG23 ' HB1' ' A' ' 18' ' ' ALA . 73.2 mt -57.66 -46.57 86.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.499 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.52 HD22 HG22 ' A' ' 36' ' ' ILE . 1.3 mp -56.81 -40.91 76.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.246 0.546 . . . . 0.0 109.928 177.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.5 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 32.8 tt0 -61.28 -43.96 98.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.566 175.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 38' ' ' ILE . 78.8 t -55.57 -48.03 77.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.814 0.816 . . . . 0.0 110.552 175.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.2 mt -83.14 -2.45 55.49 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.365 -172.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.8 26.84 59.84 Favored Glycine 0 N--CA 1.453 -0.188 0 CA-C-N 115.944 -0.571 . . . . 0.0 113.129 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.9 pt -122.45 167.74 15.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 O-C-N 122.708 -0.29 . . . . 0.0 111.066 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.62 -171.37 0.02 OUTLIER 'General case' 0 C--O 1.233 0.227 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -178.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -119.6 -170.88 2.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.938 -173.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.3 t -56.51 167.38 0.72 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.324 0.583 . . . . 0.0 111.149 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.507 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 55.9 mttp -57.36 -23.66 50.39 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -166.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.4 t -54.73 -47.84 73.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.093 0.473 . . . . 0.0 110.358 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.7 m -70.39 -35.27 73.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.63 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.507 ' CG1' ' HA ' ' A' ' 49' ' ' LYS . 44.4 mm -60.54 -29.2 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.359 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.528 ' HA ' HD12 ' A' ' 56' ' ' ILE . 34.5 mmt180 -56.5 -28.2 59.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.155 176.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -75.2 -35.22 61.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.884 0.373 . . . . 0.0 110.611 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 52' ' ' ILE . 2.7 mm? -62.6 -43.82 97.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.416 0.627 . . . . 0.0 109.484 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.628 HG23 HG21 ' A' ' 33' ' ' THR . 52.6 mt -63.6 -43.64 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.839 176.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -55.75 -35.5 66.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.19 0.519 . . . . 0.0 110.897 176.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.412 ' HG2' ' CE2' ' A' ' 59' ' ' PHE . 4.5 tp10 -71.68 -54.68 9.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.735 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.508 ' CE2' HG12 ' A' ' 75' ' ' ILE . 96.0 m-85 -100.62 -12.9 18.82 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -128.1 66.9 73.5 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-O 121.063 0.458 . . . . 0.0 110.606 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.458 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 33.1 Cg_exo -62.6 -29.75 78.37 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.795 2.33 . . . . 0.0 112.338 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -77.34 -17.62 58.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.387 -175.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.35 47.08 60.1 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -175.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -78.92 -26.98 43.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.111 0.482 . . . . 0.0 110.131 -174.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.3 -25.35 13.95 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.847 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.457 ' OD2' ' HB2' ' A' ' 30' ' ' ARG . 53.1 p-10 -146.06 168.48 20.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.918 0.39 . . . . 0.0 110.536 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.457 ' HB ' ' HB2' ' A' ' 71' ' ' SER . 36.6 pt -138.82 147.41 25.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.344 -178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.441 ' HA ' ' HG2' ' A' ' 30' ' ' ARG . 28.7 t70 -80.8 170.27 16.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.316 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.415 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -57.26 -26.56 61.0 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 176.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -48.1 -52.89 18.47 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.822 173.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.464 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 2.2 m -78.3 -43.46 27.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.663 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.415 ' HB3' ' HA ' ' A' ' 69' ' ' PHE . 87.0 t80 -63.11 -36.76 84.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.599 -175.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -66.67 -35.45 80.17 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 56.2 mt -69.74 -39.2 77.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.625 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 62.6 mt -58.14 -52.57 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-O 121.373 0.606 . . . . 0.0 109.594 173.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.404 ' HA2' ' CD1' ' A' ' 80' ' ' LEU . . . -62.14 -38.89 96.88 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.237 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.06 -30.18 70.65 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.82 0.343 . . . . 0.0 111.427 -174.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.625 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 16.4 ptm180 -85.14 -7.48 59.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.787 -175.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.449 ' CE1' ' HG3' ' A' ' 78' ' ' ARG . 19.9 m-85 -124.97 -48.58 1.75 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 120.874 -0.331 . . . . 0.0 111.047 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.922 HD13 HD21 ' A' ' 15' ' ' LEU . 3.3 mp . . . . . 0 CA--C 1.513 -0.444 0 CA-C-O 121.47 0.652 . . . . 0.0 111.591 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.519 -0.222 0 CA-C-O 121.108 0.48 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.606 HD22 ' H ' ' A' ' 93' ' ' LEU . 0.6 OUTLIER -51.02 -32.14 20.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.913 177.256 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.743 HH11 ' HE2' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -58.22 -44.44 88.18 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.989 0.423 . . . . 0.0 111.618 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -71.67 -29.72 64.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.178 0.513 . . . . 0.0 110.241 176.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.412 ' HA ' HD12 ' A' ' 99' ' ' LEU . . . -75.56 -19.31 59.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.877 -175.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.743 ' HE2' HH11 ' A' ' 94' ' ' ARG . 22.6 m-85 -59.19 -48.99 79.55 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 120.844 0.354 . . . . 0.0 110.084 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -70.47 -12.9 61.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.527 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 96' ' ' ALA . 85.5 mt -83.63 -27.37 29.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.832 176.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -105.14 -25.28 12.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.511 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -72.26 82.12 1.02 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.797 0.808 . . . . 0.0 111.099 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -72.39 -15.75 61.85 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.927 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -78.98 -35.99 42.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.339 -175.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.0 44.32 4.18 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.754 174.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -107.77 -18.44 13.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.064 0.459 . . . . 0.0 110.339 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.29 -24.44 27.18 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -172.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.59 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 6.3 m-85 -109.9 152.25 26.04 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.677 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 13.1 pt -92.44 124.66 44.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.6 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.56 ' HA ' HG22 ' A' ' 143' ' ' THR . 21.7 m -65.39 165.89 11.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.627 -175.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.8 p -62.33 -27.14 68.85 Favored 'General case' 0 C--N 1.318 -0.775 0 O-C-N 121.74 -0.6 . . . . 0.0 111.154 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.56 -49.79 76.13 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.667 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.677 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.6 p -70.73 -38.39 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.598 -178.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.4 ' HE2' ' HA ' ' A' ' 113' ' ' MET . 4.0 tpp -58.36 -43.12 88.24 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 174.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.54 ' O ' HD21 ' A' ' 129' ' ' LEU . 23.0 ttp180 -53.25 -40.36 64.53 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.669 177.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -74.37 -38.43 63.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.307 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 112' ' ' VAL . 59.3 mt -63.58 -52.67 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 120.945 0.402 . . . . 0.0 110.608 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.552 ' HB3' HD11 ' A' ' 129' ' ' LEU . 0.8 OUTLIER -54.02 -53.91 46.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.312 179.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.599 ' HB2' HD22 ' A' ' 129' ' ' LEU . . . -58.69 -27.52 64.92 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.257 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.22 -50.74 17.82 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.4 -48.96 71.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.802 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.645 ' HB3' HD23 ' A' ' 124' ' ' LEU . 4.8 m-20 -103.59 94.69 5.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.6 0.714 . . . . 0.0 110.189 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -73.92 -5.06 38.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.052 -0.977 . . . . 0.0 112.653 -171.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 66.9 p -94.85 -2.93 49.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.398 0.618 . . . . 0.0 111.359 -173.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.645 HD23 ' HB3' ' A' ' 121' ' ' ASP . 4.4 mm? -80.71 148.02 30.33 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.223 177.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 56.2 m -121.68 173.35 7.5 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.7 m -48.15 -47.53 34.79 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -174.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -68.81 -54.26 16.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.712 0.291 . . . . 0.0 111.227 -177.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -58.93 -44.89 91.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.725 0.774 . . . . 0.0 110.372 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.599 HD22 ' HB2' ' A' ' 118' ' ' ALA . 61.3 tp -60.57 -38.12 83.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.711 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.443 ' O ' ' HB ' ' A' ' 133' ' ' ILE . 5.6 t70 -69.35 -33.55 73.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.023 0.439 . . . . 0.0 110.251 -178.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.63 94.58 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.963 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.471 ' SD ' HD11 ' A' ' 117' ' ' LEU . 38.1 mtt -60.24 -36.34 77.51 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.262 175.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.508 HD11 ' HA ' ' A' ' 114' ' ' ARG . 17.0 mm -59.05 -47.2 90.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.835 0.35 . . . . 0.0 110.853 175.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -60.34 -39.79 88.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.229 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -70.03 -43.99 70.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.703 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 57.7 mt -57.98 -54.31 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.163 0.585 . . . . 0.0 112.519 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -73.65 91.59 1.89 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.587 0.708 . . . . 0.0 110.507 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.58 -41.97 36.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.521 -174.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -84.85 -13.47 50.9 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.934 -172.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 78.59 26.82 58.34 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.895 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.9 m -73.66 -18.03 61.08 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.363 0.601 . . . . 0.0 110.609 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.54 -13.6 51.05 Favored Glycine 0 CA--C 1.509 -0.307 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.096 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.59 ' HB ' ' HB2' ' A' ' 107' ' ' TYR . 3.0 p -132.8 131.15 40.75 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.726 -0.737 . . . . 0.0 109.223 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.433 HG12 ' HB2' ' A' ' 149' ' ' PHE . 52.8 t -84.73 111.81 20.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.938 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.423 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 11.0 t70 -139.46 -72.2 0.39 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.38 0.609 . . . . 0.0 110.913 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.577 ' O ' ' HG2' ' A' ' 150' ' ' MET . 0.7 OUTLIER -82.99 -98.46 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.517 -169.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.503 ' HG2' ' CD2' ' A' ' 146' ' ' PHE . 9.1 pt-20 -67.87 -29.49 68.63 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 122.259 -0.276 . . . . 0.0 111.118 -175.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -59.68 -51.05 71.45 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.4 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.601 ' HA ' HG12 ' A' ' 152' ' ' VAL . 9.4 t80 -79.66 -33.91 40.86 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.416 -174.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . 0.602 ' CE ' HD23 ' A' ' 93' ' ' LEU . 10.3 mmt -62.53 -45.34 93.4 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.502 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.95 -33.32 83.55 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.251 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.601 HG12 ' HA ' ' A' ' 149' ' ' PHE . 8.1 p -81.71 -36.55 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 111.598 -176.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 52.1 tpp -96.85 -56.07 2.68 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -173.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 69.0 p . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 120.971 0.415 . . . . 0.0 111.551 -173.639 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.4 t . . . . . 0 N--CA 1.456 -0.174 0 CA-C-O 121.055 0.455 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.538 ' HD3' ' C ' ' A' ' 13' ' ' LYS . 5.5 tmtm? -66.01 -40.3 90.97 Favored 'General case' 0 N--CA 1.416 -2.143 0 C-N-CA 123.277 0.631 . . . . 0.0 110.043 177.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.53 -43.26 94.58 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.66 HD21 HD13 ' A' ' 80' ' ' LEU . 80.1 mt -55.99 -50.26 71.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.614 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.574 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 6.8 tp10 -54.13 -53.62 50.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.79 177.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 96.3 m -63.58 -39.42 94.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.521 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -77.66 -27.21 50.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.103 0.477 . . . . 0.0 110.564 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.756 ' HD1' ' HD2' ' A' ' 20' ' ' ARG . 45.4 t80 -62.63 -51.75 66.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.139 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.756 ' HD2' ' HD1' ' A' ' 19' ' ' PHE . 23.3 mmm-85 -70.34 -27.37 64.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.32 -172.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.76 -45.63 81.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.937 0.399 . . . . 0.0 110.715 -176.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.457 ' CD2' HG12 ' A' ' 39' ' ' ILE . 68.6 m-85 -103.45 14.19 31.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.129 0.49 . . . . 0.0 110.573 -178.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.572 ' HG2' ' N ' ' A' ' 24' ' ' THR . 16.9 tt0 -72.4 152.26 42.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.803 -176.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.572 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.4 OUTLIER 76.08 133.91 0.04 OUTLIER Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 114.752 -1.113 . . . . 0.0 113.266 163.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -83.22 -47.03 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.025 2.483 . . . . 0.0 110.727 171.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -163.84 46.5 0.12 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.455 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.26 59.99 0.92 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.259 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.7 t -106.83 -31.52 8.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.988 0.423 . . . . 0.0 110.608 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.01 -14.91 60.73 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.467 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.58 ' HG3' ' HA ' ' A' ' 68' ' ' ASP . 6.6 mpt_? -109.87 170.7 7.9 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.538 HG23 ' HA ' ' A' ' 23' ' ' GLU . 12.0 p -107.6 129.14 62.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 121.758 0.79 . . . . 0.0 109.918 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.472 ' HB3' ' HG2' ' A' ' 35' ' ' GLN . 15.8 t -59.45 143.67 49.2 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.377 -175.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.587 ' HB ' HG12 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -67.51 -19.45 65.31 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.838 -174.389 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -83.8 -22.26 31.87 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.308 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.472 ' HG2' ' HB3' ' A' ' 32' ' ' SER . 11.9 mm100 -83.24 -20.4 34.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.531 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.678 HG22 HD22 ' A' ' 40' ' ' LEU . 52.9 mt -53.96 -42.58 54.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.261 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.439 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -61.72 -39.28 97.22 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.157 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.65 ' O ' HG23 ' A' ' 42' ' ' VAL . 39.7 mt -63.36 -50.76 77.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.192 0.52 . . . . 0.0 109.872 178.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.521 HG23 ' HB1' ' A' ' 18' ' ' ALA . 64.5 mt -61.46 -45.67 98.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.583 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.678 HD22 HG22 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -58.42 -28.69 65.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.009 0.433 . . . . 0.0 110.64 177.066 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.504 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 38.4 tt0 -74.51 -41.38 60.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.428 174.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 38' ' ' ILE . 38.7 t -56.07 -51.7 58.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 121.84 0.829 . . . . 0.0 109.733 175.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.6 mt -74.75 -24.8 58.76 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.34 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.97 42.25 6.04 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.154 173.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 pt -119.06 -83.88 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.466 ' HG2' HD21 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -75.3 179.95 4.84 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.334 0.588 . . . . 0.0 112.26 -175.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -103.41 -170.35 1.77 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.862 -173.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.507 ' O ' HG12 ' A' ' 52' ' ' ILE . 15.0 t -60.01 177.27 0.25 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 66.4 mttm -52.32 -38.54 58.81 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.903 0.481 . . . . 0.0 112.108 -172.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.5 m -54.56 -34.04 61.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.102 0.477 . . . . 0.0 111.248 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.8 m -84.46 -31.52 24.52 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.51 0.671 . . . . 0.0 110.266 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.799 ' HA ' HD23 ' A' ' 55' ' ' LEU . 46.9 mm -68.84 -24.19 28.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.559 -177.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 29.4 mmt180 -57.91 -25.73 61.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.822 0.344 . . . . 0.0 110.598 176.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -66.18 -56.38 11.63 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 172.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.799 HD23 ' HA ' ' A' ' 52' ' ' ILE . 2.8 mm? -49.6 -48.4 48.89 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.119 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.587 HG12 ' HB ' ' A' ' 33' ' ' THR . 68.6 mt -63.37 -52.8 53.69 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.891 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -64.53 -23.0 67.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.255 0.55 . . . . 0.0 110.583 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -80.37 -54.35 5.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.697 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.535 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 72.0 m-85 -91.59 -22.38 20.35 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -173.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.432 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 44.6 t0 -125.8 63.62 47.62 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 121.075 0.464 . . . . 0.0 110.092 175.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.535 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 32.1 Cg_exo -61.65 -23.82 76.92 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.09 2.527 . . . . 0.0 112.382 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -76.08 -17.16 59.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.892 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.72 45.21 66.62 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.92 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -73.33 -46.09 51.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.656 0.265 . . . . 0.0 110.414 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.96 -18.82 5.87 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.668 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 2.8 p30 -147.87 164.36 33.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.703 0.287 . . . . 0.0 110.751 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.525 ' O ' ' HB3' ' A' ' 30' ' ' ARG . 35.1 pt -132.2 145.71 34.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.533 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.58 ' HA ' ' HG3' ' A' ' 30' ' ' ARG . 3.5 p-10 -76.75 171.07 15.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.142 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.566 ' HE1' ' HA ' ' A' ' 16' ' ' GLU . 21.3 t80 -55.21 -42.75 73.74 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.55 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.462 ' O ' HG13 ' A' ' 74' ' ' ILE . 15.3 t70 -59.11 -45.08 91.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.756 0.312 . . . . 0.0 110.829 -174.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.449 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 22.1 m -65.19 -31.83 73.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.629 177.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -80.21 -30.99 38.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.306 0.574 . . . . 0.0 109.77 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -66.39 -39.06 88.82 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.717 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 70' ' ' ASP . 61.7 mt -64.95 -43.5 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.056 0.455 . . . . 0.0 109.822 175.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.586 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 79.3 mt -55.87 -50.9 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.815 173.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.413 ' HA2' ' CD1' ' A' ' 80' ' ' LEU . . . -61.01 -43.33 99.58 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.585 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.92 -30.1 71.08 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.981 0.42 . . . . 0.0 111.452 -174.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 15.2 ptm180 -87.63 -11.02 49.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.781 -175.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.493 ' CD1' ' HG3' ' A' ' 78' ' ' ARG . 22.5 m-85 -120.29 -42.83 2.55 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.899 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.66 HD13 HD21 ' A' ' 15' ' ' LEU . 2.5 mp . . . . . 0 CA--C 1.511 -0.544 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 110.521 -0.178 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.584 HD12 ' HE1' ' A' ' 149' ' ' PHE . 0.4 OUTLIER -42.34 -41.37 2.81 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 123.721 0.638 . . . . 0.0 110.824 178.415 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.494 ' HA ' ' CE1' ' A' ' 97' ' ' PHE . 36.1 mmt180 -45.72 -42.0 11.3 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 124.038 0.837 . . . . 0.0 111.555 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.634 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 43.2 mt-10 -85.82 -32.71 21.61 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.668 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.602 ' O ' ' HB2' ' A' ' 99' ' ' LEU . . . -84.39 -39.85 18.54 Favored 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.475 -167.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.494 ' CE1' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -77.66 -19.71 54.96 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.895 178.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -76.74 -12.09 59.94 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.55 169.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 73.4 mt -84.43 -18.09 37.12 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.973 168.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' TYR . . . . . 0.59 ' HD1' ' O ' ' A' ' 96' ' ' ALA . 37.1 m-85 -105.29 -2.78 23.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.035 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -72.37 80.87 1.03 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.588 0.709 . . . . 0.0 111.135 -172.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -54.19 -46.32 72.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.937 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -84.07 -28.35 27.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.15 -168.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.08 63.8 1.43 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.404 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -114.7 -17.98 11.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.006 0.431 . . . . 0.0 110.536 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.85 -21.36 36.92 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -168.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.754 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 2.3 m-85 -116.53 164.85 13.96 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 172.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.721 ' HB ' HG13 ' A' ' 112' ' ' VAL . 3.3 pt -103.49 127.6 57.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.986 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.4 ' HA ' HG22 ' A' ' 143' ' ' THR . 45.9 m -66.56 168.82 8.55 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 -177.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.509 ' HB ' ' CG2' ' A' ' 133' ' ' ILE . 72.5 p -61.77 -31.75 71.97 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.544 0.687 . . . . 0.0 110.308 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.16 -34.29 77.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.107 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.721 HG13 ' HB ' ' A' ' 108' ' ' ILE . 2.2 p -87.15 -34.82 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.191 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . 0.718 ' SD ' HG11 ' A' ' 144' ' ' VAL . 2.5 tpt -55.03 -38.81 68.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.036 0.446 . . . . 0.0 110.503 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.731 ' HB2' ' HB3' ' A' ' 129' ' ' LEU . 5.9 ptp180 -66.9 -49.63 64.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.545 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.499 ' HG2' ' HA ' ' A' ' 112' ' ' VAL . 15.3 pt-20 -63.4 -27.54 69.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.745 0.307 . . . . 0.0 111.071 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.516 HD12 HD13 ' A' ' 108' ' ' ILE . 19.9 mt -66.26 -48.24 81.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.174 0.511 . . . . 0.0 110.148 173.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.569 HD12 ' HG ' ' A' ' 124' ' ' LEU . 1.2 tm? -61.06 -51.52 68.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.718 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.554 ' HB2' HD11 ' A' ' 129' ' ' LEU . . . -60.13 -22.18 62.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.302 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -68.14 -45.92 72.27 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.5 mp -77.47 -53.62 7.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.353 0.597 . . . . 0.0 109.852 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.619 ' HB3' HD23 ' A' ' 124' ' ' LEU . 18.0 m-20 -96.47 90.12 5.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.931 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -76.89 15.35 0.68 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.06 -173.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 78.8 p -103.83 -13.7 16.31 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.503 0.668 . . . . 0.0 110.35 -177.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.619 HD23 ' HB3' ' A' ' 121' ' ' ASP . 4.1 mm? -75.32 119.18 19.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.64 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 21.9 t -89.94 177.84 6.37 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.1 t -57.1 -45.38 83.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.752 0.31 . . . . 0.0 110.863 -176.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 128' ' ' ASP . 3.0 pm0 -66.55 -38.36 86.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.054 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.493 ' HB3' HD13 ' A' ' 124' ' ' LEU . 40.9 m-20 -63.4 -49.74 72.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.157 0.503 . . . . 0.0 110.013 178.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.731 ' HB3' ' HB2' ' A' ' 114' ' ' ARG . 74.4 mt -56.74 -38.23 72.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.544 178.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -62.37 -39.74 94.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.861 0.363 . . . . 0.0 110.273 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.19 -43.35 70.94 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.552 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 27.2 mtt -61.13 -37.33 82.45 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.591 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.509 ' CG2' ' HB ' ' A' ' 110' ' ' THR . 10.1 mm -59.7 -47.32 91.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.078 0.466 . . . . 0.0 110.744 175.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.01 -39.04 68.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.791 0.805 . . . . 0.0 110.457 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.26 -44.99 23.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.407 -1.27 . . . . 0.0 111.831 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.441 HG21 ' HG2' ' A' ' 113' ' ' MET . 60.1 mt -59.76 -57.3 12.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 123.305 0.642 . . . . 0.0 112.21 -177.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.18 94.71 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.784 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.37 -53.92 7.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.421 -175.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -82.25 -12.99 57.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.352 0.596 . . . . 0.0 110.888 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 64.35 38.42 95.81 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.352 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.4 m -66.94 -14.81 63.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.343 0.592 . . . . 0.0 111.133 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.72 -16.81 58.28 Favored Glycine 0 CA--C 1.504 -0.595 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.526 ' HB ' ' HB2' ' A' ' 107' ' ' TYR . 2.3 p -140.99 135.45 31.16 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.491 -0.855 . . . . 0.0 109.27 175.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.718 HG11 ' SD ' ' A' ' 113' ' ' MET . 51.0 t -81.65 124.17 38.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.754 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 14.5 t70 -146.43 -64.21 0.3 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.777 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PHE . . . . . 0.586 ' HD2' ' H ' ' A' ' 147' ' ' GLU . 1.2 p90 -94.12 -97.98 0.15 Allowed 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.704 -166.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.586 ' H ' ' HD2' ' A' ' 146' ' ' PHE . 54.1 mt-10 -70.67 -22.05 62.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.002 0.43 . . . . 0.0 110.554 -177.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.448 ' CB ' HG13 ' A' ' 144' ' ' VAL . 5.9 mp0 -65.76 -53.77 36.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.172 0.51 . . . . 0.0 110.182 176.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.635 ' CD2' HD11 ' A' ' 108' ' ' ILE . 24.4 t80 -72.91 -39.2 66.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.379 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 16.3 ttm -56.05 -51.69 66.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.191 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.68 -41.99 96.05 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.082 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 149' ' ' PHE . 14.7 p -77.27 -37.3 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 111.927 0.344 . . . . 0.0 111.927 -176.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 50.0 tpp -92.0 -49.72 6.07 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -173.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 29.4 p . . . . . 0 C--N 1.328 -0.348 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.113 -173.098 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 121.265 0.555 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.86 -83.96 0.58 Allowed Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 -170.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.557 ' HB2' ' HB2' ' A' ' 6' ' ' LYS . 7.8 m-20 64.17 -178.29 0.16 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.197 0.523 . . . . 0.0 111.924 173.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.6 m -128.55 -31.19 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.605 171.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.3 p -81.6 -8.64 59.74 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.854 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.557 ' HB2' ' HB2' ' A' ' 3' ' ' ASP . 1.5 mptm? -78.17 -13.32 59.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.893 175.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.483 ' HG ' ' CB ' ' A' ' 77' ' ' ALA . 10.1 mt -89.33 121.17 31.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.317 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.0 t -80.47 148.96 30.26 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 171.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.1 m -56.93 -26.54 59.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.003 -176.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -56.65 -44.48 81.36 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.249 0.547 . . . . 0.0 110.251 176.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.66 HE21 ' HG2' ' A' ' 82' ' ' GLU . 7.4 mt-30 -74.91 -36.11 62.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.987 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.5 t -64.24 -31.29 52.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.872 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -54.88 -53.63 52.96 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.694 0.283 . . . . 0.0 110.744 173.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.6 mp -59.09 -44.48 91.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.99 0.424 . . . . 0.0 110.325 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.442 HD21 HD21 ' A' ' 80' ' ' LEU . 82.1 mt -57.63 -57.66 11.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.189 178.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -58.9 -41.34 86.98 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.568 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.0 m -63.88 -41.13 97.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 0.0 111.289 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.463 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -82.11 -27.64 32.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.029 0.443 . . . . 0.0 110.469 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.513 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 71.8 t80 -57.31 -54.59 45.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.398 177.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.52 ' HA ' ' HB2' ' A' ' 23' ' ' GLU . 26.2 mmt180 -71.36 -21.65 62.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.117 -177.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.65 -44.21 74.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.915 -175.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.63 ' CD1' HG12 ' A' ' 39' ' ' ILE . 52.6 m-85 -106.44 17.16 23.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.473 0.654 . . . . 0.0 110.124 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.576 ' HG2' ' N ' ' A' ' 24' ' ' THR . 10.2 tt0 -71.43 152.84 42.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.334 -172.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.576 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.4 OUTLIER 75.05 138.1 0.06 OUTLIER Pre-proline 0 CA--C 1.534 0.341 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 158.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -88.74 -43.42 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 123.588 2.858 . . . . 0.0 111.652 172.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -156.02 25.08 0.37 Allowed 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 121.671 0.748 . . . . 0.0 109.415 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 101.59 63.36 0.76 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.592 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.1 t -105.46 -30.1 9.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.921 0.391 . . . . 0.0 110.763 -178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.58 -11.36 66.71 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.488 -0.863 . . . . 0.0 111.873 -178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.734 ' HB2' ' OD2' ' A' ' 66' ' ' ASP . 3.3 mpt_? -110.95 172.22 7.0 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.476 HG23 ' HA ' ' A' ' 23' ' ' GLU . 12.8 p -108.03 129.59 61.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-O 121.941 0.877 . . . . 0.0 110.201 177.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.444 ' HA ' ' HB3' ' A' ' 66' ' ' ASP . 44.3 t -57.25 141.3 47.1 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 113.593 -1.64 . . . . 0.0 111.856 -175.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.544 ' HB ' HG12 ' A' ' 56' ' ' ILE . 28.4 p -67.74 -19.37 65.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.407 -178.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -76.2 -21.78 56.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.317 0.579 . . . . 0.0 109.758 175.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.506 ' HB3' ' HB3' ' A' ' 22' ' ' PHE . 34.1 mm-40 -91.96 -21.65 20.44 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.939 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.675 HG22 HD22 ' A' ' 40' ' ' LEU . 71.3 mt -54.68 -46.67 73.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.673 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.98 -22.5 68.72 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.261 178.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.607 ' O ' HG13 ' A' ' 42' ' ' VAL . 25.8 mt -77.86 -54.85 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.737 ' HA ' HG13 ' A' ' 42' ' ' VAL . 36.5 mt -60.92 -37.89 77.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.203 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.675 HD22 HG22 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -60.49 -24.64 65.45 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.09 0.472 . . . . 0.0 110.181 176.191 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.518 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 39.2 tt0 -82.56 -39.73 21.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.819 172.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.737 HG13 ' HA ' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -62.03 -31.45 51.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 CA-C-O 121.771 0.796 . . . . 0.0 110.865 177.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.454 HD11 ' HZ ' ' A' ' 72' ' ' PHE . 50.8 mt -92.79 -6.35 49.13 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.958 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.01 39.49 96.46 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.494 -0.775 . . . . 0.0 113.518 176.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pt -113.35 -83.41 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.34 179.67 3.32 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 121.558 0.694 . . . . 0.0 112.672 -174.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -102.05 -171.0 1.9 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.552 -175.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.44 ' O ' HG12 ' A' ' 52' ' ' ILE . 14.3 t -62.81 -179.46 0.27 Allowed 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -52.28 -34.57 47.15 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -170.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.1 m -52.19 -40.2 61.18 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.152 0.501 . . . . 0.0 111.049 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 53.4 m -81.75 -34.59 30.36 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.659 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 48' ' ' THR . 42.0 mm -64.67 -27.38 42.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.283 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.9 mmm180 -57.5 -32.99 67.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.98 176.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 47.7 mm-40 -65.66 -49.44 68.6 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 176.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.645 HD11 ' CE2' ' A' ' 79' ' ' PHE . 3.0 mm? -53.67 -52.43 59.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.994 178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.544 HG12 ' HB ' ' A' ' 33' ' ' THR . 60.2 mt -63.26 -44.84 99.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.409 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -59.59 -30.96 69.03 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.189 0.519 . . . . 0.0 110.757 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -84.21 -51.71 6.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.208 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.447 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 80.3 m-85 -90.59 -17.18 27.39 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -172.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.45 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 51.6 t0 -129.55 65.88 75.71 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 121.069 0.461 . . . . 0.0 110.88 175.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 22.9 Cg_exo -70.06 -17.25 36.32 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.913 2.409 . . . . 0.0 111.419 175.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -80.09 -17.86 51.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.116 -176.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.97 40.73 73.3 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.778 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -76.0 -41.39 51.33 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.098 0.475 . . . . 0.0 110.423 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 117.83 -33.96 4.69 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.112 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.734 ' OD2' ' HB2' ' A' ' 30' ' ' ARG . 2.3 p-10 -139.47 148.43 42.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.151 0.501 . . . . 0.0 111.004 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.493 ' O ' ' HB3' ' A' ' 30' ' ' ARG . 44.1 pt -114.34 143.66 23.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.036 -174.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.459 ' HA ' ' HG3' ' A' ' 30' ' ' ARG . 1.9 p30 -74.36 174.08 9.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.826 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.412 ' O ' ' N ' ' A' ' 73' ' ' LYS . 5.0 t80 -63.55 -37.81 88.73 Favored 'General case' 0 C--O 1.214 -0.809 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.119 -175.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.497 ' O ' HG13 ' A' ' 74' ' ' ILE . 38.3 t70 -61.64 -42.68 99.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.925 0.393 . . . . 0.0 110.628 -176.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.7 m -65.53 -42.86 91.52 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.331 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.454 ' HZ ' HD11 ' A' ' 43' ' ' LEU . 75.8 t80 -69.11 -32.27 71.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.465 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 69' ' ' PHE . 40.8 ttmt -63.29 -44.04 96.18 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.61 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 70' ' ' ASP . 64.7 mt -62.29 -40.75 88.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.127 0.489 . . . . 0.0 110.05 176.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.6 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 78.6 mt -58.22 -51.09 75.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.128 175.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.514 ' CA ' HD23 ' A' ' 80' ' ' LEU . . . -62.52 -41.55 99.78 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.3 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.483 ' CB ' ' HG ' ' A' ' 7' ' ' LEU . . . -65.35 -25.72 67.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.953 0.406 . . . . 0.0 111.591 -174.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.6 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 11.8 ptm180 -93.08 -12.67 29.95 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.768 -176.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.645 ' CE2' HD11 ' A' ' 55' ' ' LEU . 23.9 m-85 -120.71 -37.35 3.01 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -174.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.514 HD23 ' CA ' ' A' ' 76' ' ' GLY . 3.2 mm? -48.65 -76.38 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -173.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 44.69 45.46 8.79 Favored Glycine 0 C--N 1.331 0.256 0 O-C-N 123.84 0.712 . . . . 0.0 112.471 -175.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.66 ' HG2' HE21 ' A' ' 11' ' ' GLN . 11.0 pt-20 -82.05 18.06 1.44 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.046 0.451 . . . . 0.0 111.023 -176.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -80.21 90.61 5.51 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-O 121.701 0.762 . . . . 0.0 110.864 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.7 t -128.98 77.92 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.371 176.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.502 ' ND2' ' H ' ' A' ' 87' ' ' GLU . 4.6 t30 -85.89 138.95 34.96 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.034 -0.984 . . . . 0.0 110.771 -171.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 5.4 Cg_exo -75.27 -22.09 14.71 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.929 3.086 . . . . 0.0 111.808 -175.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.502 ' H ' ' ND2' ' A' ' 85' ' ' ASN . 13.3 mp0 -95.62 19.56 10.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.908 178.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -79.74 118.25 21.37 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 177.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 24.7 ptm 45.61 30.79 0.83 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.657 -169.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -139.56 148.29 42.36 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 175.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.504 ' HA ' ' HE1' ' A' ' 150' ' ' MET . 40.1 mt-30 54.56 27.5 8.54 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.507 0.504 . . . . 0.0 111.045 -173.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -61.05 -18.67 59.11 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.534 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.654 HD22 ' H ' ' A' ' 93' ' ' LEU . 1.2 mm? -52.65 -28.11 20.07 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.126 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.649 ' HD3' ' HE2' ' A' ' 97' ' ' PHE . 30.7 mmt180 -57.0 -51.39 69.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.063 0.459 . . . . 0.0 111.361 177.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -77.74 -21.7 51.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.059 0.456 . . . . 0.0 110.327 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.536 ' HB3' ' HA ' ' A' ' 93' ' ' LEU . . . -77.51 -13.73 59.85 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.048 178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.649 ' HE2' ' HD3' ' A' ' 94' ' ' ARG . 21.0 m-85 -61.4 -48.23 82.16 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.641 176.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 36.4 mtm-85 -67.17 -23.73 65.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.205 0.526 . . . . 0.0 110.386 178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.9 tp -67.76 -37.31 81.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.753 176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.688 ' O ' ' HD2' ' A' ' 102' ' ' LYS . 85.6 m-85 -104.12 -5.7 21.78 Favored 'General case' 0 C--O 1.222 -0.379 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.122 -176.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -78.27 80.32 4.68 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.461 0.648 . . . . 0.0 111.528 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.688 ' HD2' ' O ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -60.71 -39.75 89.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.002 173.27 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -72.27 -37.13 69.12 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.498 -169.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 96.18 48.46 2.23 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.91 175.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -113.18 -17.22 12.41 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.973 0.416 . . . . 0.0 110.526 -179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.12 -24.91 13.69 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -170.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.535 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 4.0 m-85 -109.37 150.9 27.35 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 173.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.683 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 14.8 pt -91.81 131.17 39.63 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.748 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.5 m -69.3 170.05 11.04 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.312 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.435 ' HB ' ' CG2' ' A' ' 133' ' ' ILE . 36.8 p -67.59 -23.72 65.42 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 121.846 -0.534 . . . . 0.0 110.724 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 114' ' ' ARG . 29.6 m-20 -62.43 -50.49 71.29 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 176.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.683 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.4 p -71.69 -35.0 54.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.719 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.657 ' SD ' HG11 ' A' ' 144' ' ' VAL . 2.9 tpt -57.37 -40.06 77.34 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 111' ' ' ASP . 76.0 mtt180 -53.04 -56.9 12.6 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.636 175.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 112' ' ' VAL . 13.3 pt-20 -65.23 -30.4 71.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.433 -175.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 112' ' ' VAL . 57.1 mt -63.43 -47.72 90.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.705 0.288 . . . . 0.0 110.798 176.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 113' ' ' MET . 9.6 mt -58.49 -55.63 32.55 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.168 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.435 ' HB2' HD11 ' A' ' 129' ' ' LEU . . . -49.19 -37.77 23.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.408 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -65.23 -56.57 12.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.909 0.385 . . . . 0.0 110.751 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -66.76 -44.53 81.18 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.079 0.466 . . . . 0.0 111.19 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.556 ' HB3' HD23 ' A' ' 124' ' ' LEU . 5.7 m-20 -119.46 88.01 2.85 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.531 -178.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -76.02 23.0 0.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.321 0.581 . . . . 0.0 111.589 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.443 ' H ' ' C ' ' A' ' 121' ' ' ASP . 39.6 p -102.77 -13.46 17.02 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 121.916 0.865 . . . . 0.0 109.227 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' A' ' 121' ' ' ASP . 4.0 mm? -85.06 115.63 22.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.373 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.458 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 42.7 m -77.08 172.19 13.62 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 176.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.9 p -56.75 -43.49 80.79 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.692 0.282 . . . . 0.0 111.581 -174.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -68.8 -40.08 79.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.0 110.751 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.448 ' HB3' ' CD1' ' A' ' 124' ' ' LEU . 5.6 m-20 -59.34 -42.36 91.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.465 176.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.618 ' O ' HG12 ' A' ' 133' ' ' ILE . 95.8 mt -54.63 -43.39 72.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.75 175.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.482 ' O ' ' HB ' ' A' ' 133' ' ' ILE . 31.5 t70 -63.2 -40.25 96.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.268 -178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -68.2 -40.58 82.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.164 177.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 9.1 mtt -57.77 -43.51 85.54 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 173.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.618 HG12 ' O ' ' A' ' 129' ' ' LEU . 21.5 mm -51.69 -49.94 33.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.066 176.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -58.98 -43.32 91.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.733 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -72.11 -35.02 69.06 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 114.746 -1.116 . . . . 0.0 111.567 -176.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.612 HD11 HD21 ' A' ' 117' ' ' LEU . 67.6 mt -65.81 -58.79 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.983 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -68.22 93.78 0.48 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.581 0.705 . . . . 0.0 110.102 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.91 -29.51 50.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.961 -175.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -88.19 -14.4 38.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.274 0.559 . . . . 0.0 110.862 -174.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 69.22 28.29 72.88 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.273 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 6.5 t -80.67 -18.28 48.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.083 0.468 . . . . 0.0 110.15 -175.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 100.71 -31.31 8.73 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.287 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 21.9 p -114.87 143.14 45.6 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.657 HG11 ' SD ' ' A' ' 113' ' ' MET . 61.0 t -89.04 118.3 34.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.535 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 28.5 t70 -144.17 -73.26 0.27 Allowed 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.762 -178.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.633 ' O ' ' HG2' ' A' ' 150' ' ' MET . 0.1 OUTLIER -79.28 -97.17 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.122 -166.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -82.95 -11.78 57.87 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 121.583 -0.698 . . . . 0.0 110.94 -173.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.613 ' CD ' ' H ' ' A' ' 148' ' ' GLU . 3.9 mp0 -61.81 -58.42 8.06 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.9 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.629 ' HA ' HG12 ' A' ' 152' ' ' VAL . 10.7 t80 -73.82 -46.73 43.37 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.677 -176.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . 0.633 ' HG2' ' O ' ' A' ' 146' ' ' PHE . 46.8 mmm -61.12 -18.41 57.84 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.742 0.306 . . . . 0.0 110.964 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -95.97 -20.3 26.41 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.945 -0.645 . . . . 0.0 113.066 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.629 HG12 ' HA ' ' A' ' 149' ' ' PHE . 9.1 p -95.72 -36.31 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 117.314 0.557 . . . . 0.0 111.067 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.468 ' SD ' HG23 ' A' ' 154' ' ' THR . 0.9 OUTLIER -90.74 -47.55 7.57 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.055 -177.307 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.468 HG23 ' SD ' ' A' ' 153' ' ' MET . 25.6 p -114.22 41.51 2.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.039 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -84.72 -35.84 12.76 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.84 -174.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.41 76.54 1.3 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.511 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.16 -46.57 79.26 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.075 0.55 . . . . 0.0 111.87 -177.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.272 -173.179 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' A' ' 1' ' ' MET . 21.0 ptp . . . . . 0 N--CA 1.481 1.122 0 CA-C-O 121.434 0.635 . . . . 0.0 110.466 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 147.3 62.13 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.175 -177.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.808 ' HB3' ' HB3' ' A' ' 6' ' ' LYS . 11.7 m-20 -79.88 69.01 6.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.724 0.297 . . . . 0.0 110.231 177.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.8 t -57.8 -48.39 83.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -170.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.1 m -85.15 4.99 31.84 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.145 0.498 . . . . 0.0 111.235 -177.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.808 ' HB3' ' HB3' ' A' ' 3' ' ' ASP . 0.8 OUTLIER -96.25 -25.98 15.59 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.457 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.452 HD12 ' HB2' ' A' ' 11' ' ' GLN . 4.4 mm? -57.26 121.82 11.03 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.547 175.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 68.3 m -85.54 44.75 1.13 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -170.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.9 m 71.45 -41.83 0.52 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -56.42 -50.7 70.88 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 111.714 0.265 . . . . 0.0 111.714 -174.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.638 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 8.1 mm100 -60.46 -41.44 94.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.515 0.674 . . . . 0.0 109.754 178.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.434 ' HA ' HD12 ' A' ' 15' ' ' LEU . 26.8 t -62.01 -35.55 69.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.066 -178.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -62.16 -47.45 84.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.661 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.53 -45.21 92.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.904 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.665 HD21 ' CD1' ' A' ' 80' ' ' LEU . 84.5 mt -56.08 -52.7 63.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.773 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 19' ' ' PHE . 27.4 tt0 -62.52 -38.86 91.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.773 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 91.0 m -59.03 -52.21 66.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.735 0.302 . . . . 0.0 110.483 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.499 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -69.55 -33.77 73.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.139 0.495 . . . . 0.0 110.366 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.742 ' CE1' HG22 ' A' ' 31' ' ' VAL . 86.1 t80 -53.67 -58.78 5.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.584 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -61.27 -31.62 71.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.799 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -69.09 -43.91 73.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.834 0.35 . . . . 0.0 111.245 -175.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.482 ' CD2' HG12 ' A' ' 39' ' ' ILE . 56.0 m-85 -100.64 8.69 43.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.342 0.592 . . . . 0.0 110.132 -179.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.564 ' HA ' HG13 ' A' ' 31' ' ' VAL . 3.9 tt0 -69.25 154.12 42.55 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.19 -177.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.806 HG23 ' H ' ' A' ' 27' ' ' GLY . 0.6 OUTLIER 79.75 131.78 0.04 OUTLIER Pre-proline 0 N--CA 1.437 -1.118 0 O-C-N 124.301 1.001 . . . . 0.0 112.863 161.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -84.86 -34.7 0.19 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.328 2.686 . . . . 0.0 111.163 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -165.52 32.1 0.05 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.041 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.806 ' H ' HG23 ' A' ' 24' ' ' THR . . . 98.32 66.41 0.88 Allowed Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.831 -175.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.7 t -111.68 -31.09 7.09 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.814 0.34 . . . . 0.0 111.002 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.02 -14.21 65.71 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.523 -175.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.558 ' HG3' ' HA ' ' A' ' 68' ' ' ASP . 4.8 mpt_? -106.72 172.49 6.79 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 177.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.742 HG22 ' CE1' ' A' ' 19' ' ' PHE . 0.1 OUTLIER -105.19 129.93 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.568 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.272 172.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.6 t -54.0 138.88 36.05 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.994 -1.457 . . . . 0.0 108.723 171.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.581 ' HB ' HG12 ' A' ' 56' ' ' ILE . 2.9 p -67.03 -12.86 61.08 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.056 -174.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -72.05 -42.59 66.09 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.663 ' HA ' HD13 ' A' ' 38' ' ' ILE . 33.3 mm-40 -74.03 -16.22 61.06 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.438 -174.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.736 HG22 HD22 ' A' ' 40' ' ' LEU . 47.1 mt -59.01 -34.21 52.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.429 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -74.17 -36.98 49.77 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.328 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.663 HD13 ' HA ' ' A' ' 35' ' ' GLN . 1.3 mp -58.79 -55.28 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-O 121.5 0.666 . . . . 0.0 109.762 174.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.499 HG23 ' HB1' ' A' ' 18' ' ' ALA . 53.7 mt -63.14 -43.54 98.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.966 -1.016 . . . . 0.0 111.451 -176.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.736 HD22 HG22 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -61.91 -27.42 68.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.935 0.398 . . . . 0.0 110.713 177.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.66 -43.61 46.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.175 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 38' ' ' ILE . 64.0 t -54.78 -47.72 73.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.56 176.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.596 HD13 HD23 ' A' ' 15' ' ' LEU . 58.0 mt -86.58 4.3 40.73 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.682 -1.145 . . . . 0.0 111.358 -173.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.24 41.71 99.57 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.19 -0.914 . . . . 0.0 113.71 172.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 pt -116.12 -77.3 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.591 ' HG2' HD21 ' A' ' 55' ' ' LEU . 0.7 OUTLIER -81.57 -176.49 6.07 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 121.418 0.627 . . . . 0.0 112.46 -176.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.418 ' HB2' ' CB ' ' A' ' 51' ' ' THR . 45.2 mt-30 -110.62 -170.38 1.63 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.505 -174.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.465 ' O ' HG12 ' A' ' 52' ' ' ILE . 13.5 t -56.89 176.97 0.09 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.491 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 63.0 mttm -52.24 -35.31 49.4 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 122.85 0.46 . . . . 0.0 112.155 -173.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.8 m -54.6 -34.31 61.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.251 0.548 . . . . 0.0 111.185 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.418 ' CB ' ' HB2' ' A' ' 47' ' ' GLN . 60.5 m -85.98 -34.23 20.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.483 0.658 . . . . 0.0 110.41 177.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.847 ' HA ' HD23 ' A' ' 55' ' ' LEU . 44.1 mm -63.4 -23.53 33.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.343 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.491 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 34.5 mmt180 -50.8 -38.69 49.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.558 173.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.475 ' HA ' ' OD2' ' A' ' 57' ' ' ASP . 7.3 mm-40 -60.54 -43.83 96.77 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.713 0.633 . . . . 0.0 110.653 176.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.847 HD23 ' HA ' ' A' ' 52' ' ' ILE . 3.1 mm? -62.21 -46.33 89.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.386 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.581 HG12 ' HB ' ' A' ' 33' ' ' THR . 64.1 mt -66.81 -47.66 82.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.304 -176.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.475 ' OD2' ' HA ' ' A' ' 54' ' ' GLN . 1.7 p30 -66.28 -19.75 65.91 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.059 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -85.11 -53.75 5.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.37 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.414 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 89.1 m-85 -95.1 -17.0 22.22 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -171.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.409 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 21.0 t0 -128.22 68.25 76.35 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-O 121.09 0.471 . . . . 0.0 111.317 176.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.414 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 24.3 Cg_exo -69.75 -17.83 37.42 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.504 2.136 . . . . 0.0 110.492 171.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -69.88 -17.96 63.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.993 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.32 30.39 77.4 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 -176.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -81.36 -27.31 34.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.273 -0.464 . . . . 0.0 110.868 -173.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.5 -19.44 39.41 Favored Glycine 0 CA--C 1.509 -0.312 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.122 173.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -145.83 158.02 43.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.89 0.376 . . . . 0.0 110.933 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.457 ' HB ' ' HB2' ' A' ' 71' ' ' SER . 28.8 pt -126.92 142.54 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.556 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.558 ' HA ' ' HG3' ' A' ' 30' ' ' ARG . 0.5 OUTLIER -75.13 175.94 7.76 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.514 -176.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -60.66 -39.69 89.31 Favored 'General case' 0 C--O 1.213 -0.829 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.081 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.489 ' O ' HG13 ' A' ' 74' ' ' ILE . 19.7 t70 -60.75 -39.91 90.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.997 0.427 . . . . 0.0 109.964 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.457 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 17.0 m -67.61 -43.62 80.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.749 176.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -69.38 -32.46 71.5 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.259 0.552 . . . . 0.0 110.223 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.435 ' HB3' ' HE2' ' A' ' 73' ' ' LYS . 34.9 ttpt -62.32 -42.4 99.34 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.099 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 70' ' ' ASP . 67.2 mt -65.41 -40.19 87.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.027 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.578 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 66.8 mt -56.38 -53.03 45.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.249 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.94 -41.05 99.62 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.52 -0.848 . . . . 0.0 112.151 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.04 -26.07 66.57 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 122.578 -0.366 . . . . 0.0 111.44 -174.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.578 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 15.8 ptm180 -89.92 -18.56 25.88 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.758 ' HE2' HD11 ' A' ' 55' ' ' LEU . 23.6 m-85 -108.52 -43.85 4.21 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.272 -174.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.665 ' CD1' HD21 ' A' ' 15' ' ' LEU . 2.4 mp -59.16 -67.97 0.32 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 120.459 0.171 . . . . 0.0 110.858 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 42.46 28.97 0.64 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 116.042 1.177 . . . . 0.0 116.042 169.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -97.09 22.49 8.43 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -58.22 105.85 0.32 Allowed 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 114.199 -1.364 . . . . 0.0 111.09 -175.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.434 HG12 ' H ' ' A' ' 84' ' ' VAL . 2.2 p -68.18 89.92 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 113.734 -1.576 . . . . 0.0 110.359 176.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.545 ' ND2' ' HD2' ' A' ' 86' ' ' PRO . 1.5 t30 -47.76 138.29 9.59 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 114.416 -1.265 . . . . 0.0 110.139 174.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.545 ' HD2' ' ND2' ' A' ' 85' ' ' ASN . 89.3 Cg_exo -50.98 -47.22 26.61 Favored 'Trans proline' 0 CA--C 1.528 0.214 0 C-N-CA 124.547 3.498 . . . . 0.0 115.077 -165.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.435 ' HA ' ' HG2' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -104.49 -12.94 16.23 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.588 0.233 . . . . 0.0 111.488 -172.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -60.65 -32.96 72.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.926 -173.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.5 ttt -125.92 46.3 2.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.33 0.585 . . . . 0.0 110.815 -178.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.461 ' HB3' ' HG3' ' A' ' 92' ' ' GLU . 15.4 mm100 -95.07 -70.66 0.7 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.766 175.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 38.98 48.57 1.44 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.856 0.836 . . . . 0.0 111.325 -173.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.461 ' HG3' ' HB3' ' A' ' 90' ' ' GLN . 42.7 mt-10 -61.48 -18.88 61.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.486 -1.234 . . . . 0.0 110.262 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.916 HD22 ' HE1' ' A' ' 149' ' ' PHE . 44.7 mt -42.74 -41.59 3.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.62 -1.173 . . . . 0.0 112.269 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.769 ' HD2' ' HE2' ' A' ' 97' ' ' PHE . 18.5 mmm180 -59.53 -39.96 85.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -176.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -86.07 -18.28 32.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.125 0.488 . . . . 0.0 110.249 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.499 ' HA ' HD12 ' A' ' 99' ' ' LEU . . . -80.25 -19.9 45.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.678 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.769 ' HE2' ' HD2' ' A' ' 94' ' ' ARG . 23.0 m-85 -59.1 -44.45 91.96 Favored 'General case' 0 C--O 1.219 -0.545 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 98' ' ' ARG . 57.8 mtp180 -70.96 -13.06 61.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.822 0.344 . . . . 0.0 111.358 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 96' ' ' ALA . 97.0 mt -86.92 -27.55 23.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.89 0.376 . . . . 0.0 110.772 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.463 ' O ' HG21 ' A' ' 112' ' ' VAL . 76.2 m-85 -103.69 -14.63 16.03 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 97' ' ' PHE . 55.2 t0 -64.57 86.53 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.83 0.824 . . . . 0.0 111.197 -176.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -64.27 -18.33 64.46 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.239 -1.346 . . . . 0.0 111.655 176.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -96.18 -36.87 10.79 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.975 0.417 . . . . 0.0 112.119 -171.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.424 ' H ' ' CG ' ' A' ' 101' ' ' ASP . . . 92.08 39.46 5.44 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.491 175.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -114.82 -15.33 11.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.871 0.367 . . . . 0.0 111.807 -176.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.83 -22.31 35.79 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.198 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -100.22 167.55 10.37 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 172.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.61 ' HB ' HG13 ' A' ' 112' ' ' VAL . 8.3 pt -111.03 118.85 58.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.291 166.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 15.2 m -62.73 166.53 5.37 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.952 -176.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 12.7 p -57.29 -32.91 67.13 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.9 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.507 ' O ' ' HG3' ' A' ' 115' ' ' GLU . 28.0 m-20 -61.59 -50.19 73.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.046 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.61 HG13 ' HB ' ' A' ' 108' ' ' ILE . 1.8 p -68.65 -37.43 77.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.854 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.691 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 2.8 tpt -56.66 -43.29 80.21 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 174.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.495 ' HA ' HD12 ' A' ' 117' ' ' LEU . 15.9 ttt180 -55.22 -48.52 73.77 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.448 175.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 111' ' ' ASP . 47.3 mt-10 -60.33 -41.73 94.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.684 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 70.6 mt -59.17 -50.34 80.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.03 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.691 ' HG ' ' O ' ' A' ' 113' ' ' MET . 11.0 mt -56.58 -60.18 3.91 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.43 179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.01 -22.01 47.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.746 -177.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -82.51 -41.08 20.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.676 0.274 . . . . 0.0 110.876 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.7 mp -79.52 -47.66 15.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.049 0.452 . . . . 0.0 110.762 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.675 ' HB3' HD23 ' A' ' 124' ' ' LEU . 3.1 m-20 -105.84 99.37 8.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.057 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -84.56 4.34 32.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.338 -173.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 71.0 p -90.38 -10.97 41.98 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.376 0.608 . . . . 0.0 110.203 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.784 ' HB3' HD22 ' A' ' 129' ' ' LEU . 3.7 mm? -77.14 146.33 37.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.071 177.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.473 ' HB2' ' OD1' ' A' ' 128' ' ' ASP . 21.4 m -115.68 171.7 7.58 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.254 177.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.8 m -47.31 -46.34 25.11 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -173.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -79.32 -32.43 43.39 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.814 0.34 . . . . 0.0 111.2 -176.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.473 ' OD1' ' HB2' ' A' ' 125' ' ' SER . 2.7 m-20 -64.61 -40.32 95.29 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.784 HD22 ' HB3' ' A' ' 124' ' ' LEU . 2.7 mm? -51.66 -43.24 62.61 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.148 173.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -65.22 -42.48 93.39 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.612 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -59.42 -45.52 91.3 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-O 121.361 0.6 . . . . 0.0 110.032 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 58.0 mmm -54.9 -53.73 51.7 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 114.664 -1.153 . . . . 0.0 109.681 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 20.1 mm -55.02 -46.39 77.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.583 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -56.44 -41.2 76.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.774 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -79.49 -31.04 42.21 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.161 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.423 HG12 ' CG2' ' A' ' 152' ' ' VAL . 49.3 mt -67.74 -58.39 6.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.134 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -69.76 93.87 0.77 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.592 0.71 . . . . 0.0 110.288 -177.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.57 -40.26 42.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.807 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -82.85 -13.97 55.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.204 0.526 . . . . 0.0 111.065 -173.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 70.89 24.34 77.16 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -177.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.8 t -74.79 -18.26 60.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.387 0.613 . . . . 0.0 109.853 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 90.56 -26.97 9.25 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 25.3 p -114.59 128.92 56.58 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 175.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.675 HG11 ' SD ' ' A' ' 113' ' ' MET . 64.2 t -83.34 119.33 32.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.266 -179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.431 ' HB3' ' CD1' ' A' ' 146' ' ' PHE . 8.0 t70 -145.59 -55.58 0.3 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.128 0.489 . . . . 0.0 111.437 -175.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.431 ' CD1' ' HB3' ' A' ' 145' ' ' ASP . 0.4 OUTLIER -105.55 -97.14 0.34 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.815 -168.653 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -38.33 90.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.794 0.331 . . . . 0.0 111.069 -178.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.663 ' CD ' ' H ' ' A' ' 148' ' ' GLU . 3.4 mp0 -50.46 -53.09 32.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.222 177.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.916 ' HE1' HD22 ' A' ' 93' ' ' LEU . 31.8 t80 -76.93 -38.74 52.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.013 -175.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 42.2 tpp -62.68 -43.57 98.46 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.375 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -70.26 -16.11 73.0 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 121.019 -0.61 . . . . 0.0 113.496 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.423 ' CG2' HG12 ' A' ' 136' ' ' ILE . 12.1 p -101.41 -40.57 7.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 117.391 0.595 . . . . 0.0 111.805 -178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.449 ' HG2' HD21 ' A' ' 93' ' ' LEU . 15.4 tpt -81.18 -49.14 11.17 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -172.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 80.5 p -93.72 15.51 16.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.142 0.496 . . . . 0.0 110.843 -175.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -75.96 79.08 1.17 Allowed Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.152 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 156.5 148.4 5.06 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.291 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.02 -58.31 3.35 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 36.1 mm-40 . . . . . 0 C--O 1.248 0.987 0 O-C-N 124.456 1.098 . . . . 0.0 112.16 172.966 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.2 ttt . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 121.473 0.654 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.595 ' N ' ' HA ' ' A' ' 78' ' ' ARG . . . 121.96 50.07 0.25 Allowed Glycine 0 CA--C 1.506 -0.472 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.742 ' HB3' ' HB2' ' A' ' 6' ' ' LYS . 5.8 m-20 -104.08 78.66 1.54 Allowed 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.858 -0.671 . . . . 0.0 110.969 -170.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.3 t -65.85 127.51 27.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.469 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 72.1 m 64.76 14.1 8.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.936 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.742 ' HB2' ' HB3' ' A' ' 3' ' ' ASP . 13.8 mptt -93.84 -19.62 20.82 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 165.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 mp -72.32 117.07 13.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.999 174.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.6 t -75.0 167.16 22.47 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.91 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.0 p -51.79 -38.21 54.69 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -171.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -54.12 -48.89 70.29 Favored 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.082 0.239 . . . . 0.0 111.406 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.435 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 9.3 mm100 -62.36 -45.95 90.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.697 0.761 . . . . 0.0 109.989 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.3 t -68.66 -31.5 51.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.441 -174.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.51 ' HD2' ' HA ' ' A' ' 13' ' ' LYS . 27.1 tptt -61.14 -41.34 96.55 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-O 120.756 0.312 . . . . 0.0 111.543 176.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.424 HD13 ' HA ' ' A' ' 14' ' ' LEU . 4.4 mm? -67.41 -42.58 83.01 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 174.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.749 HD21 HD13 ' A' ' 80' ' ' LEU . 84.3 mt -58.3 -48.96 78.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.869 177.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -57.32 -54.98 40.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.326 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.577 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 27.8 m -59.83 -41.24 90.93 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.358 -175.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.715 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -74.83 -37.89 62.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.761 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.447 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 54.6 t80 -56.32 -59.19 5.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.979 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.11 -12.61 61.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.148 -0.933 . . . . 0.0 112.047 -174.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.577 ' HB2' ' O ' ' A' ' 17' ' ' THR . 2.1 t70 -80.29 -40.04 27.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.942 0.401 . . . . 0.0 110.531 -175.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.451 ' CD2' HG12 ' A' ' 39' ' ' ILE . 87.3 m-85 -105.99 6.9 31.68 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.408 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.45 ' HA ' HG23 ' A' ' 31' ' ' VAL . 3.8 tm-20 -62.82 152.49 35.92 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.006 -0.997 . . . . 0.0 112.262 -176.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.44 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER 86.24 130.86 0.03 OUTLIER Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 114.29 -1.323 . . . . 0.0 113.219 166.388 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -86.71 -40.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 123.441 2.761 . . . . 0.0 110.797 169.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -159.91 33.69 0.18 Allowed 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.148 176.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.417 ' H ' HG23 ' A' ' 24' ' ' THR . . . 94.41 67.59 1.03 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.411 -176.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.5 t -112.22 -24.82 9.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.869 0.366 . . . . 0.0 111.328 -175.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.09 -14.49 61.98 Favored Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -175.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.53 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 86.1 mtt180 -112.09 163.08 14.7 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-N 115.014 -0.593 . . . . 0.0 110.041 177.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.522 HG21 HD11 ' A' ' 39' ' ' ILE . 13.7 p -105.99 126.7 61.46 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 121.501 0.667 . . . . 0.0 110.093 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 8.2 t -53.6 139.51 31.6 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.267 -1.333 . . . . 0.0 111.029 -177.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.562 ' HB ' HG12 ' A' ' 56' ' ' ILE . 1.7 p -63.05 -18.85 63.81 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.04 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -73.8 -28.71 61.78 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.234 0.54 . . . . 0.0 110.375 177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 34.1 mm-40 -86.98 -16.88 34.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.532 -177.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.739 HG22 HD22 ' A' ' 40' ' ' LEU . 52.6 mt -55.39 -41.4 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.817 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.432 ' CA ' HG13 ' A' ' 52' ' ' ILE . . . -61.97 -38.73 96.53 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.413 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.639 ' O ' HG23 ' A' ' 42' ' ' VAL . 31.5 mt -63.56 -52.18 61.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.302 0.572 . . . . 0.0 109.595 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.715 HG23 ' HB1' ' A' ' 18' ' ' ALA . 69.6 mt -60.09 -44.49 95.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.52 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.739 HD22 HG22 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -60.63 -25.41 66.27 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.808 178.55 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -80.02 -40.6 27.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.001 174.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 38' ' ' ILE . 43.1 t -53.88 -43.91 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.924 0.868 . . . . 0.0 109.79 174.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.7 mt -86.38 -4.02 59.1 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.939 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.9 39.48 89.48 Favored Glycine 0 C--N 1.333 0.387 0 CA-C-N 115.444 -0.798 . . . . 0.0 113.705 173.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pt -116.17 -84.8 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.443 ' HG2' HD21 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -78.25 -171.42 2.38 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.248 0.547 . . . . 0.0 112.41 -177.341 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -123.33 -170.79 2.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.434 -172.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.1 t -54.94 170.87 0.16 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.835 0.826 . . . . 0.0 112.968 -176.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -51.32 -34.52 33.89 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 114.344 -1.298 . . . . 0.0 113.204 -167.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 m -58.94 -32.39 69.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.084 0.468 . . . . 0.0 110.845 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.3 m -82.42 -32.76 28.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.392 0.615 . . . . 0.0 110.018 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.906 ' HA ' HD23 ' A' ' 55' ' ' LEU . 44.4 mm -68.7 -23.62 27.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.221 -177.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 -50.17 -30.98 12.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.42 173.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -65.92 -55.19 18.18 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.306 0.574 . . . . 0.0 109.834 174.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.906 HD23 ' HA ' ' A' ' 52' ' ' ILE . 2.5 mm? -52.76 -50.06 64.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.435 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.562 HG12 ' HB ' ' A' ' 33' ' ' THR . 61.0 mt -63.52 -46.89 93.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.926 -177.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -61.39 -24.68 66.67 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.508 0.671 . . . . 0.0 110.727 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.477 ' CD ' HH12 ' A' ' 78' ' ' ARG . 29.6 tt0 -87.98 -51.28 5.91 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.226 -177.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.498 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 90.1 m-85 -94.53 -17.1 22.72 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -173.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.463 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 46.5 t0 -129.99 62.67 65.23 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-O 121.171 0.51 . . . . 0.0 110.181 176.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.498 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 31.3 Cg_exo -63.11 -24.86 73.14 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.032 2.488 . . . . 0.0 112.159 -178.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -76.68 -17.29 59.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.569 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.28 41.32 59.56 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.688 -178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -67.71 -39.89 84.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.673 0.273 . . . . 0.0 110.751 -176.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 119.18 -22.31 9.04 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.672 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 1.6 m-20 -139.79 178.49 7.21 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 27.2 pt -142.12 143.73 26.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.886 0.374 . . . . 0.0 110.331 177.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.53 ' HA ' ' HG2' ' A' ' 30' ' ' ARG . 25.6 t70 -83.39 166.9 18.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.807 176.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.481 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -56.09 -27.35 53.36 Favored 'General case' 0 C--O 1.223 -0.328 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 176.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -49.35 -51.44 34.54 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.87 0.367 . . . . 0.0 111.256 174.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 23.2 m -82.41 -36.88 26.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.924 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.481 ' HB3' ' HA ' ' A' ' 69' ' ' PHE . 89.8 t80 -64.83 -36.28 83.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.123 -178.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -62.32 -38.6 90.04 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 116.526 -0.306 . . . . 0.0 110.219 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.427 ' HB ' ' CE1' ' A' ' 59' ' ' PHE . 40.7 mt -69.48 -40.1 79.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.84 0.352 . . . . 0.0 110.105 177.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.605 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 78.1 mt -57.3 -48.48 82.37 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.161 0 CA-C-O 121.41 0.624 . . . . 0.0 109.717 173.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.503 ' HA2' ' CD1' ' A' ' 80' ' ' LEU . . . -62.48 -45.19 96.39 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.065 177.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.97 -20.39 65.04 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -174.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 9.9 ptm180 -91.28 -16.7 27.13 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.527 -177.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.493 ' CE2' HD11 ' A' ' 55' ' ' LEU . 21.1 m-85 -118.34 -46.49 2.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.754 0.311 . . . . 0.0 110.921 -178.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.749 HD13 HD21 ' A' ' 15' ' ' LEU . 3.2 mp -73.76 -20.09 60.59 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.329 0.585 . . . . 0.0 111.199 178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.83 9.29 77.09 Favored Glycine 0 N--CA 1.44 -1.076 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.453 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -91.49 21.74 4.41 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -88.52 100.04 12.76 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.846 -172.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 p -117.55 72.85 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.252 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.518 ' ND2' ' HD2' ' A' ' 86' ' ' PRO . 1.8 t30 -83.64 141.81 42.09 Favored Pre-proline 0 C--N 1.318 -0.794 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.568 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.518 ' HD2' ' ND2' ' A' ' 85' ' ' ASN . 57.2 Cg_exo -53.53 -61.52 0.44 Allowed 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 123.343 2.695 . . . . 0.0 112.354 -171.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -91.28 27.23 1.97 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.625 -174.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.515 ' HB3' ' HB3' ' A' ' 85' ' ' ASN . 34.7 tt0 -124.49 -55.54 1.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.865 -177.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 14.3 tpt -102.57 -31.11 10.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.782 -172.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -127.0 -166.22 1.57 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.378 -175.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 38.68 48.95 1.39 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.557 1.143 . . . . 0.0 112.825 -176.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.49 -19.29 46.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.826 174.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.647 HD22 ' H ' ' A' ' 93' ' ' LEU . 0.9 OUTLIER -54.27 -26.93 31.77 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.302 -179.7 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.733 ' HD2' ' HE2' ' A' ' 97' ' ' PHE . 28.9 mmm180 -59.74 -35.63 74.95 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 120.807 0.337 . . . . 0.0 111.583 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -86.53 -26.93 24.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.253 0.549 . . . . 0.0 109.899 176.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.485 ' HB3' ' HA ' ' A' ' 93' ' ' LEU . . . -72.73 -11.05 60.47 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.937 -177.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.733 ' HE2' ' HD2' ' A' ' 94' ' ' ARG . 21.3 m-85 -61.72 -52.22 65.15 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.727 -0.389 . . . . 0.0 109.963 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 98' ' ' ARG . 42.2 mtm180 -65.66 -17.96 64.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.212 0.529 . . . . 0.0 110.88 177.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 99' ' ' LEU . 12.4 tp -73.6 -38.63 65.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.826 177.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.667 ' O ' ' HD2' ' A' ' 102' ' ' LYS . 77.2 m-85 -100.16 -24.55 14.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.906 -176.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -69.3 82.68 0.37 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.413 0.625 . . . . 0.0 111.223 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.667 ' HD2' ' O ' ' A' ' 100' ' ' TYR . 9.8 mptt -56.53 -45.78 80.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.913 173.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.53 ' HB2' ' ND2' ' A' ' 105' ' ' ASN . 41.6 mt-10 -66.65 -37.23 84.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.432 -168.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.53 47.41 2.55 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.419 177.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.53 ' ND2' ' HB2' ' A' ' 103' ' ' GLU . 39.8 m-80 -100.1 -17.46 17.43 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.692 0.282 . . . . 0.0 110.68 -178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.9 -24.99 15.16 Favored Glycine 0 N--CA 1.453 -0.188 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 -172.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -113.53 162.38 16.24 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 171.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.678 ' HB ' HG13 ' A' ' 112' ' ' VAL . 10.2 pt -97.22 128.16 48.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.298 173.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.466 ' HA ' HG22 ' A' ' 143' ' ' THR . 49.1 m -69.45 166.97 17.64 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.317 -177.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.2 p -62.95 -24.88 68.09 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.664 -0.414 . . . . 0.0 110.992 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -64.78 -51.8 60.33 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.258 176.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.678 HG13 ' HB ' ' A' ' 108' ' ' ILE . 2.0 p -68.72 -35.06 68.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.727 0.299 . . . . 0.0 110.36 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.591 ' SD ' HG11 ' A' ' 144' ' ' VAL . 2.8 tpt -58.3 -40.18 81.31 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.099 0.476 . . . . 0.0 109.8 173.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.531 ' HG2' ' CD2' ' A' ' 129' ' ' LEU . 17.7 ttp180 -58.88 -46.03 88.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.162 176.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.471 ' OE1' ' HA ' ' A' ' 112' ' ' VAL . 34.6 mt-10 -60.68 -50.47 73.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.58 177.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 112' ' ' VAL . 63.6 mt -56.25 -53.6 37.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.43 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.599 HD11 ' SD ' ' A' ' 132' ' ' MET . 1.0 OUTLIER -57.33 -53.31 59.59 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.005 -178.316 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.523 ' HB2' HD22 ' A' ' 129' ' ' LEU . . . -64.33 -17.54 63.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.03 -178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -83.8 -53.26 5.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.682 0.277 . . . . 0.0 110.319 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -67.58 -44.04 79.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.991 0.424 . . . . 0.0 110.313 176.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.67 ' HB3' HD23 ' A' ' 124' ' ' LEU . 6.2 m-20 -112.19 84.85 2.04 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.254 0.549 . . . . 0.0 109.969 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -79.79 12.63 2.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.626 0.727 . . . . 0.0 110.908 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 69.8 p -95.44 -5.56 42.82 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.194 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.67 HD23 ' HB3' ' A' ' 121' ' ' ASP . 4.2 mm? -78.82 149.42 32.57 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.315 174.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.423 ' H ' ' HB2' ' A' ' 128' ' ' ASP . 24.0 m -116.93 170.18 8.82 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.6 p -48.1 -48.43 33.75 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -73.45 -40.05 64.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.727 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.423 ' HB2' ' H ' ' A' ' 125' ' ' SER . 14.4 m-20 -67.41 -43.42 81.28 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.649 0.738 . . . . 0.0 110.077 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.531 ' CD2' ' HG2' ' A' ' 114' ' ' ARG . 45.2 tp -63.33 -38.4 91.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.925 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -63.28 -41.46 99.0 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.897 0.379 . . . . 0.0 110.223 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -61.86 -45.69 92.66 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.331 176.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.599 ' SD ' HD11 ' A' ' 117' ' ' LEU . 33.5 mtt -60.38 -42.98 97.0 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.385 178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.515 HD11 ' HA ' ' A' ' 114' ' ' ARG . 21.2 mm -54.44 -50.21 59.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.081 0.467 . . . . 0.0 110.647 174.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -55.15 -44.7 75.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.788 177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -80.78 -26.42 37.24 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.83 -175.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.494 HG12 ' CG2' ' A' ' 152' ' ' VAL . 51.9 mt -64.38 -54.81 26.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.73 0.3 . . . . 0.0 110.589 176.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -76.63 85.12 3.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.966 0.888 . . . . 0.0 109.554 177.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.58 -35.0 53.46 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.465 -1.243 . . . . 0.0 112.319 -173.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -91.58 -10.59 40.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.042 0.449 . . . . 0.0 110.851 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 81.58 38.7 13.62 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.197 176.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.49 -18.75 56.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.263 0.554 . . . . 0.0 110.495 -177.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.29 -40.9 3.08 Favored Glycine 0 C--O 1.23 -0.106 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.216 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.466 HG22 ' HA ' ' A' ' 109' ' ' SER . 13.0 p -114.77 137.68 51.65 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 173.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.623 HG13 ' HB2' ' A' ' 148' ' ' GLU . 57.8 t -82.06 124.98 39.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 O-C-N 123.611 0.57 . . . . 0.0 109.8 -176.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -145.53 -78.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.222 0.534 . . . . 0.0 112.206 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -76.74 -86.31 0.05 Allowed 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -168.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -94.35 -14.39 25.4 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.983 -172.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.623 ' HB2' HG13 ' A' ' 144' ' ' VAL . 3.0 mp0 -64.24 -50.05 69.49 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 121.108 0.48 . . . . 0.0 109.945 174.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.564 ' HA ' HG12 ' A' ' 152' ' ' VAL . 19.1 t80 -75.43 -42.62 53.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.584 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . 0.539 ' HE2' ' HA ' ' A' ' 150' ' ' MET . 0.0 OUTLIER -55.85 -46.17 78.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.935 0.398 . . . . 0.0 110.121 178.007 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 155' ' ' GLY . . . -69.64 -28.46 72.18 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.965 -0.561 . . . . 0.0 113.506 -177.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.564 HG12 ' HA ' ' A' ' 149' ' ' PHE . 14.6 p -87.62 -37.18 10.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 117.359 0.58 . . . . 0.0 111.495 -176.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -86.64 -53.92 4.68 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.006 -174.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 50.1 p -91.21 -34.11 15.12 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.148 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.471 ' O ' ' HA2' ' A' ' 151' ' ' GLY . . . 106.55 -122.23 6.93 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.018 177.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -118.94 32.71 5.03 Favored Glycine 0 C--N 1.318 -0.436 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.228 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -83.13 70.49 10.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.992 0.425 . . . . 0.0 111.049 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 . . . . . 0 C--O 1.246 0.913 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.05 177.716 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.477 0.885 0 CA-C-O 120.979 0.418 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 162.4 48.4 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -80.67 88.07 5.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.106 0.479 . . . . 0.0 111.589 -173.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 31.2 m -64.8 -19.31 25.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.468 178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.7 p -92.48 -8.79 43.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.231 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.516 ' HD3' ' C ' ' A' ' 6' ' ' LYS . 12.8 tmtt? -93.24 -37.27 12.16 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.92 HD22 ' HG3' ' A' ' 11' ' ' GLN . 10.1 mt -70.25 102.79 2.19 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.215 173.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.405 ' C ' ' H ' ' A' ' 10' ' ' ASN . 0.9 OUTLIER -88.42 64.86 7.71 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.135 -167.391 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.4 m 69.09 -33.41 0.25 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.744 0.818 . . . . 0.0 113.024 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 8' ' ' SER . 21.3 p-10 -58.3 -49.73 76.11 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -176.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.92 ' HG3' HD22 ' A' ' 7' ' ' LEU . 6.3 mm100 -75.33 -38.55 60.13 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.759 0.79 . . . . 0.0 109.769 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.674 ' HA ' HD22 ' A' ' 15' ' ' LEU . 39.6 t -63.09 -30.22 49.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 114.473 -1.24 . . . . 0.0 110.943 -177.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HD2' ' HA ' ' A' ' 13' ' ' LYS . 37.8 tptt -55.5 -52.34 63.99 Favored 'General case' 0 N--CA 1.425 -1.702 0 C-N-CA 123.106 0.562 . . . . 0.0 111.347 174.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.405 HD13 ' HA ' ' A' ' 14' ' ' LEU . 3.7 mm? -63.53 -37.66 88.15 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.674 HD22 ' HA ' ' A' ' 12' ' ' VAL . 3.0 mp -52.99 -59.36 4.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.487 173.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -58.38 -39.0 78.46 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.085 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.2 m -60.05 -46.08 90.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.941 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.557 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -80.05 -29.63 39.25 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.553 -178.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.537 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 57.7 t80 -56.91 -56.01 27.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.192 178.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.423 ' HA ' ' HB2' ' A' ' 23' ' ' GLU . 23.2 mmt180 -71.7 -20.04 61.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.572 -175.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -72.33 -35.12 68.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.862 0.363 . . . . 0.0 110.864 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.502 ' CD2' HG12 ' A' ' 39' ' ' ILE . 71.9 m-85 -115.5 16.88 16.57 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.26 0.552 . . . . 0.0 110.574 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.548 ' HA ' HG23 ' A' ' 31' ' ' VAL . 2.9 tt0 -76.45 152.21 36.24 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.459 -172.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.522 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER 78.8 133.64 0.04 OUTLIER Pre-proline 0 N--CA 1.444 -0.755 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.642 159.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -87.07 -53.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.347 2.698 . . . . 0.0 111.127 172.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 26' ' ' GLU . 15.6 tt0 -129.4 3.43 5.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.653 0.739 . . . . 0.0 109.592 176.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.79 67.73 0.51 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -169.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -109.15 -6.78 15.46 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.609 0.243 . . . . 0.0 111.028 -172.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.6 0.08 52.5 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.09 -178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.461 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 93.7 mtt180 -124.59 164.12 20.49 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.588 HG21 HD11 ' A' ' 39' ' ' ILE . 11.3 p -104.94 131.34 54.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 121.536 0.684 . . . . 0.0 109.495 177.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.0 t -59.39 140.17 56.38 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.851 -175.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.554 ' HA ' HG13 ' A' ' 36' ' ' ILE . 3.5 p -62.7 -19.87 64.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.024 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -75.94 -18.37 59.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.456 177.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.5 ' OE1' HD12 ' A' ' 38' ' ' ILE . 78.3 mm-40 -96.54 -15.8 21.44 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.585 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.755 HG22 HD22 ' A' ' 40' ' ' LEU . 55.8 mt -57.02 -41.87 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.61 -175.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.433 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -64.27 -38.38 95.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.022 178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.627 ' O ' HG23 ' A' ' 42' ' ' VAL . 15.9 mt -61.47 -52.09 65.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.204 0.526 . . . . 0.0 109.648 176.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.588 HD11 HG21 ' A' ' 31' ' ' VAL . 66.8 mt -59.79 -42.62 89.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.5 178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.755 HD22 HG22 ' A' ' 36' ' ' ILE . 0.5 OUTLIER -65.5 -22.1 66.7 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.053 0.454 . . . . 0.0 110.763 -179.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 15.4 tp10 -78.49 -42.85 28.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.347 172.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 38' ' ' ILE . 47.0 t -53.08 -46.01 54.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.865 0.84 . . . . 0.0 110.161 175.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.5 mt -85.61 -6.51 59.15 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.637 -174.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.52 43.27 87.01 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.641 -0.709 . . . . 0.0 113.598 174.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.508 HD13 HD22 ' A' ' 80' ' ' LEU . 1.9 pt -119.6 -73.28 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -176.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.404 ' H ' HG13 ' A' ' 45' ' ' ILE . 0.6 OUTLIER -87.76 -175.05 5.02 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -173.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -107.08 -170.52 1.72 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.866 -174.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.521 ' O ' HG12 ' A' ' 52' ' ' ILE . 14.8 t -60.47 177.45 0.28 Allowed 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -176.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.416 ' HA ' ' HB ' ' A' ' 52' ' ' ILE . 37.2 mtmm -55.11 -34.57 63.8 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -172.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 17.7 m -53.96 -37.78 64.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.871 0.367 . . . . 0.0 110.862 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 87.1 m -82.0 -34.18 29.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.374 176.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.54 ' HA ' HD23 ' A' ' 55' ' ' LEU . 49.3 mm -65.79 -24.31 34.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.873 -176.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.526 ' HA ' HD12 ' A' ' 56' ' ' ILE . 12.2 tpp180 -62.12 -28.51 69.68 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 177.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -68.0 -44.9 75.52 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.389 0.614 . . . . 0.0 109.685 173.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.616 HD11 ' CE2' ' A' ' 79' ' ' PHE . 3.1 mm? -54.66 -47.31 73.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.528 174.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.54 HG12 ' HB ' ' A' ' 33' ' ' THR . 61.7 mt -62.2 -47.58 92.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.828 177.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -55.71 -32.56 63.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.149 0.5 . . . . 0.0 110.819 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -76.36 -54.33 6.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.832 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.525 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 98.4 m-85 -100.64 -11.4 20.04 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -169.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.425 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 48.2 t0 -125.54 66.81 56.23 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-O 121.335 0.588 . . . . 0.0 110.612 176.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.525 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 27.2 Cg_exo -67.9 -23.9 40.51 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.83 2.354 . . . . 0.0 111.755 177.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -78.74 -19.59 51.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.174 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.56 38.62 51.3 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -175.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 -71.56 -33.94 69.54 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 122.469 0.308 . . . . 0.0 110.945 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 103.85 -21.02 39.57 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.003 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -139.85 167.11 22.87 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.1 pt -129.27 143.87 39.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.02 0.438 . . . . 0.0 110.108 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.461 ' HA ' ' HG2' ' A' ' 30' ' ' ARG . 18.1 t70 -78.1 165.94 23.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.522 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -58.64 -33.26 69.87 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 118.521 0.6 . . . . 0.0 109.759 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.483 ' O ' HG13 ' A' ' 74' ' ' ILE . 29.0 t70 -52.79 -43.5 65.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.728 178.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.515 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 28.6 m -79.08 -40.49 31.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.199 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -69.67 -32.33 70.9 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.947 0.403 . . . . 0.0 110.654 -177.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -62.35 -39.62 93.72 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.676 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 70' ' ' ASP . 44.3 mt -65.69 -38.7 82.91 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-O 121.132 0.491 . . . . 0.0 109.86 176.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.524 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 58.6 mt -57.11 -56.12 16.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.391 175.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.701 ' HA2' HD23 ' A' ' 80' ' ' LEU . . . -62.48 -35.19 91.39 Favored Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 120.153 -1.022 . . . . 0.0 112.016 177.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.697 ' HA ' ' CD1' ' A' ' 7' ' ' LEU . . . -69.61 -25.89 64.17 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 122.608 -0.349 . . . . 0.0 111.385 -176.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 15.0 ptm180 -91.93 -14.42 29.6 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.78 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.616 ' CE2' HD11 ' A' ' 55' ' ' LEU . 22.9 m-85 -117.76 -44.1 2.75 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 120.324 -0.55 . . . . 0.0 111.991 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.701 HD23 ' HA2' ' A' ' 76' ' ' GLY . 4.2 mm? -61.94 -26.89 68.46 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.01 0.433 . . . . 0.0 111.207 -178.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -61.28 -18.91 56.59 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.411 -0.813 . . . . 0.0 114.292 -177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 79' ' ' PHE . 12.4 pt-20 -62.77 -27.65 69.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.491 0.646 . . . . 0.0 109.764 176.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 23.96 99.06 0.0 OUTLIER 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.05 1.74 . . . . 0.0 115.145 172.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.9 t -140.78 79.97 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.385 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.494 177.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.597 ' HB3' ' HB3' ' A' ' 88' ' ' GLN . 4.7 t30 -79.31 136.65 56.56 Favored Pre-proline 0 C--N 1.318 -0.784 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.491 175.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 52.3 Cg_exo -54.37 -54.35 4.78 Favored 'Trans proline' 0 C--N 1.331 -0.35 0 C-N-CA 123.581 2.854 . . . . 0.0 113.22 -167.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -99.03 10.79 40.74 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.773 0.32 . . . . 0.0 111.596 -175.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.597 ' HB3' ' HB3' ' A' ' 85' ' ' ASN . 51.9 tp60 -102.85 -35.17 8.71 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 177.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 40.7 tpp -87.49 -17.78 31.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.031 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -117.42 -163.69 0.94 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.512 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 55.74 36.73 27.8 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.295 0.569 . . . . 0.0 111.208 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.44 -20.27 59.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.232 -0.894 . . . . 0.0 111.029 178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.706 HD22 ' H ' ' A' ' 93' ' ' LEU . 0.5 OUTLIER -52.81 -36.44 58.44 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.655 -178.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.836 ' HD2' ' HE2' ' A' ' 97' ' ' PHE . 25.7 mmm180 -62.69 -32.55 73.65 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.874 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -86.09 -32.45 21.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.063 0.458 . . . . 0.0 109.912 177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.784 ' HA ' HD23 ' A' ' 99' ' ' LEU . . . -66.59 -18.44 65.37 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.692 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.836 ' HE2' ' HD2' ' A' ' 94' ' ' ARG . 21.5 m-85 -58.55 -46.06 87.63 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.05 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 98' ' ' ARG . 33.7 mtp180 -70.85 -14.34 62.36 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.857 0.361 . . . . 0.0 110.908 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.784 HD23 ' HA ' ' A' ' 96' ' ' ALA . 0.5 OUTLIER -81.21 -37.21 29.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.806 176.249 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -95.82 -28.82 14.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.608 -178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.89 78.53 1.63 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 122.121 0.962 . . . . 0.0 110.929 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -76.97 -6.5 52.83 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.304 171.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -83.89 -37.37 22.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.983 -175.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.65 46.6 1.38 Allowed Glycine 0 C--O 1.228 -0.26 0 C-N-CA 121.098 -0.573 . . . . 0.0 113.259 171.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.417 ' C ' ' H ' ' A' ' 107' ' ' TYR . 21.3 m-80 -113.92 -17.92 11.89 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.777 0.323 . . . . 0.0 110.66 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.5 -20.78 12.65 Favored Glycine 0 C--O 1.228 -0.233 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 -170.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.793 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 4.4 m-85 -116.71 147.54 41.9 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.688 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 9.3 pt -92.56 131.13 40.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.266 176.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 18.0 m -71.44 171.01 12.04 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.296 -176.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.517 ' HB ' HG23 ' A' ' 133' ' ' ILE . 16.4 p -61.78 -28.14 69.24 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.0 0.429 . . . . 0.0 110.721 178.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -60.36 -57.22 13.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.069 179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.688 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.2 p -63.94 -35.45 73.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.815 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.61 ' SD ' HG11 ' A' ' 144' ' ' VAL . 0.7 OUTLIER -59.39 -40.08 85.44 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.754 176.639 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 114' ' ' ARG . 19.6 ttt180 -51.98 -50.93 60.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.812 176.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.22 -42.94 96.37 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.094 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 58.2 mt -57.1 -48.99 80.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 121.071 0.462 . . . . 0.0 110.24 178.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.503 HD11 ' SD ' ' A' ' 132' ' ' MET . 0.8 OUTLIER -57.29 -54.17 49.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.438 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.57 -15.86 63.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.853 -176.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -78.63 -29.43 45.85 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 10.8 mp -80.63 -61.63 1.91 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.615 173.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.582 ' CG ' HD23 ' A' ' 124' ' ' LEU . 9.4 t70 -92.01 139.46 30.62 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.054 0.454 . . . . 0.0 110.498 -176.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -108.68 -2.54 18.6 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.683 -178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 75.4 p -104.08 -22.69 13.39 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 121.359 0.599 . . . . 0.0 109.516 -174.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.582 HD23 ' CG ' ' A' ' 121' ' ' ASP . 4.1 mm? -62.81 100.86 0.22 Allowed 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.609 169.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.424 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 15.5 t -71.69 171.89 10.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.56 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.8 p -53.51 -44.3 69.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.978 0.418 . . . . 0.0 110.884 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -66.3 -41.1 90.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.935 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.527 ' HB3' HD13 ' A' ' 124' ' ' LEU . 6.1 m-20 -66.29 -43.33 86.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.654 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.546 ' O ' HG12 ' A' ' 133' ' ' ILE . 95.7 mt -51.36 -44.4 62.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.961 172.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.414 ' O ' ' HB ' ' A' ' 133' ' ' ILE . 11.9 t70 -61.64 -41.26 97.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.892 0.377 . . . . 0.0 110.44 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -69.01 -37.04 78.45 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.382 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.503 ' SD ' HD11 ' A' ' 117' ' ' LEU . 7.1 mtt -65.82 -32.15 73.51 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.665 175.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 129' ' ' LEU . 19.4 mm -59.13 -45.87 92.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.954 0.407 . . . . 0.0 110.306 175.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -64.73 -35.53 81.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.891 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -72.23 -42.86 65.21 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.987 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.412 HG12 ' CG2' ' A' ' 152' ' ' VAL . 62.7 mt -65.36 -56.57 14.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.01 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.515 ' HA ' ' CG ' ' A' ' 148' ' ' GLU . 46.8 t0 -80.64 82.97 6.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 122.005 0.907 . . . . 0.0 109.374 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -69.27 -35.9 76.54 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.967 -1.469 . . . . 0.0 112.336 -173.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -87.07 -13.56 43.93 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.246 0.546 . . . . 0.0 110.99 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 72.07 42.83 50.4 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.506 -1.037 . . . . 0.0 110.506 -175.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 30.0 t -83.14 -17.83 41.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.394 0.616 . . . . 0.0 109.966 -176.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.15 -33.42 4.72 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.366 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 39.5 p -114.23 141.88 46.99 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 121.001 0.429 . . . . 0.0 110.096 176.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.61 HG11 ' SD ' ' A' ' 113' ' ' MET . 46.6 t -99.26 109.22 23.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.793 ' HB3' ' HB3' ' A' ' 107' ' ' TYR . 4.8 p-10 -153.91 -42.98 0.09 Allowed 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.404 -171.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.603 ' HD2' ' HG2' ' A' ' 147' ' ' GLU . 2.9 p90 -96.63 -93.07 0.22 Allowed 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 119.202 -0.999 . . . . 0.0 112.205 -176.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.603 ' HG2' ' HD2' ' A' ' 146' ' ' PHE . 22.0 mm-40 -81.19 -28.89 34.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.362 0.601 . . . . 0.0 109.947 -175.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.515 ' CG ' ' HA ' ' A' ' 137' ' ' ASP . 25.9 mp0 -60.14 -51.82 67.96 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.939 -178.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.621 ' HA ' HG12 ' A' ' 152' ' ' VAL . 16.0 t80 -72.15 -38.12 69.25 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.07 -47.64 71.46 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.599 176.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -76.1 -22.07 74.65 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.893 -175.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 149' ' ' PHE . 11.7 p -92.13 -37.34 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 117.545 0.672 . . . . 0.0 111.327 -176.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.505 ' CE ' ' HA ' ' A' ' 153' ' ' MET . 2.4 tpt -89.53 -56.81 3.1 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.827 0.346 . . . . 0.0 110.672 -176.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 35.8 p -94.41 41.42 1.09 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.31 0.576 . . . . 0.0 110.354 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -100.64 101.4 2.29 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.096 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.67 -27.05 21.99 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.74 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 61.97 49.16 4.78 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.505 0.669 . . . . 0.0 110.15 -176.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 . . . . . 0 C--O 1.248 0.994 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.79 179.986 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 121.025 0.441 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.14 54.01 29.91 Favored Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 -175.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.71 ' HB3' ' HB2' ' A' ' 6' ' ' LYS . 3.0 m-20 -74.65 72.09 1.94 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.077 -0.562 . . . . 0.0 111.479 -173.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.7 p -66.8 -34.26 68.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.898 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.9 m -75.59 -22.56 56.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.015 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.71 ' HB2' ' HB3' ' A' ' 3' ' ' ASP . 2.6 mptm? -76.57 -21.49 55.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.717 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.465 ' HG ' ' CB ' ' A' ' 11' ' ' GLN . 3.3 mp -70.66 112.82 7.18 Favored 'General case' 0 CA--C 1.514 -0.435 0 CA-C-O 121.254 0.55 . . . . 0.0 110.786 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.4 p -85.51 -179.23 6.87 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.024 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.8 m -60.68 -33.98 73.65 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.547 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -57.59 -53.1 62.0 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.762 0.315 . . . . 0.0 110.954 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.583 HE22 ' HB2' ' A' ' 82' ' ' GLU . 5.4 mm100 -59.52 -46.48 88.72 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.636 0.732 . . . . 0.0 109.977 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.3 t -67.94 -28.52 41.6 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.754 0 CA-C-N 114.454 -1.248 . . . . 0.0 111.695 -176.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -67.57 -37.75 83.08 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 14' ' ' LEU . 4.4 mm? -62.56 -44.27 96.74 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 172.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.43 ' HB3' ' HE2' ' A' ' 72' ' ' PHE . 85.5 mt -59.99 -45.63 92.09 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.838 -1.074 . . . . 0.0 110.671 175.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -64.94 -46.28 82.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.632 -175.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.9 m -61.31 -34.98 76.13 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.079 -178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.591 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -81.1 -38.5 27.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.331 177.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.553 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 51.7 t80 -54.8 -55.03 34.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.72 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -67.39 -21.89 65.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.131 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -77.31 -36.4 54.1 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.856 0.36 . . . . 0.0 111.098 -174.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.459 ' CD2' HG12 ' A' ' 39' ' ' ILE . 65.9 m-85 -110.74 16.2 21.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.283 0.563 . . . . 0.0 110.423 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.607 ' HG2' ' N ' ' A' ' 24' ' ' THR . 4.3 tt0 -78.67 156.44 29.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.22 -172.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.607 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER 80.25 127.15 0.03 OUTLIER Pre-proline 0 N--CA 1.444 -0.762 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.334 160.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 24' ' ' THR . 66.4 Cg_endo -90.12 -45.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.79 2.993 . . . . 0.0 111.947 173.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -142.77 24.69 1.85 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.38 62.84 1.14 Allowed Glycine 0 N--CA 1.45 -0.372 0 N-CA-C 111.016 -0.834 . . . . 0.0 111.016 -174.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.0 t -100.35 -28.04 13.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.927 0.394 . . . . 0.0 111.109 -172.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.19 -16.16 56.45 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -172.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.473 ' HG2' ' HA ' ' A' ' 68' ' ' ASP . 92.8 mtt180 -103.43 164.23 11.78 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 114.896 -0.652 . . . . 0.0 109.874 175.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.589 HG23 ' HA ' ' A' ' 23' ' ' GLU . 13.6 p -108.05 131.77 57.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-O 121.384 0.612 . . . . 0.0 109.639 177.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.1 t -62.69 144.39 56.39 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.372 -175.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.567 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . 2.8 p -66.52 -18.35 65.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.851 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -70.73 -36.11 73.01 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.307 0.575 . . . . 0.0 109.934 176.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -89.23 -14.48 35.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.533 -175.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.658 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 71.3 mt -53.35 -47.75 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.764 0.316 . . . . 0.0 110.644 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.442 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -58.54 -38.49 91.33 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.756 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.667 ' O ' HG23 ' A' ' 42' ' ' VAL . 36.8 mt -61.25 -49.46 84.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.25 0.547 . . . . 0.0 109.604 176.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.591 HG23 ' HB1' ' A' ' 18' ' ' ALA . 65.5 mt -60.43 -45.41 96.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.578 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.784 HD12 HD12 ' A' ' 52' ' ' ILE . 46.2 mt -61.7 -25.09 67.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.364 0.602 . . . . 0.0 110.761 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.518 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 8.6 tp10 -76.49 -42.22 44.28 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.719 173.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.667 HG23 ' O ' ' A' ' 38' ' ' ILE . 39.4 t -54.22 -42.71 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 121.888 0.851 . . . . 0.0 109.878 174.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 29.1 mt -83.49 -11.46 57.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.153 -176.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.57 32.22 67.69 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.578 -0.737 . . . . 0.0 113.362 175.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 pt -109.74 -61.36 2.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -177.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.7 -177.75 4.16 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -174.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.404 ' HB2' ' CB ' ' A' ' 51' ' ' THR . 27.9 mm-40 -104.74 -170.61 1.79 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.909 -1.041 . . . . 0.0 111.004 -172.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.557 ' O ' HG12 ' A' ' 52' ' ' ILE . 15.2 t -62.04 179.06 0.31 Allowed 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -57.74 -29.8 65.05 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -172.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.0 m -52.39 -45.55 65.88 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.297 0.57 . . . . 0.0 110.691 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.404 ' CB ' ' HB2' ' A' ' 47' ' ' GLN . 91.6 m -77.43 -34.3 54.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.474 179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.784 HD12 HD12 ' A' ' 40' ' ' LEU . 42.1 mm -64.84 -24.49 35.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.31 -178.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -51.52 -38.09 52.48 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 172.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -75.16 -38.16 61.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.265 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.512 HD11 ' CE2' ' A' ' 79' ' ' PHE . 2.2 mm? -56.01 -48.42 75.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.226 174.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.545 HG12 ' HB ' ' A' ' 33' ' ' THR . 59.8 mt -62.96 -45.84 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.917 176.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -56.77 -29.81 62.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.273 0.559 . . . . 0.0 110.718 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -77.04 -54.51 6.45 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.55 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -101.24 -13.47 18.08 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -170.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.452 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 48.1 t0 -134.18 64.67 66.49 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.172 0.511 . . . . 0.0 111.194 176.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 24.6 Cg_exo -69.0 -18.42 40.6 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.769 2.313 . . . . 0.0 111.493 175.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -78.88 -17.51 55.47 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.244 -176.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.74 40.08 46.45 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.215 -177.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.412 ' HB2' ' OD1' ' A' ' 60' ' ' ASP . 1.2 t-20 -66.18 -43.97 85.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.917 0.487 . . . . 0.0 110.687 -176.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.91 -22.28 14.67 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.623 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 51.4 p30 -149.39 171.44 16.54 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.945 0.402 . . . . 0.0 110.377 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.405 ' C ' ' HD3' ' A' ' 30' ' ' ARG . 30.0 pt -135.27 145.42 31.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.56 ' HB3' ' HB3' ' A' ' 70' ' ' ASP . 15.2 t70 -83.01 171.55 13.69 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.487 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -62.18 -22.67 66.09 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 173.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.56 ' HB3' ' HB3' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -45.41 -53.23 8.97 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.597 170.617 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 50.7 m -87.38 -33.77 19.02 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.968 0.413 . . . . 0.0 111.249 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.487 ' HB3' ' HA ' ' A' ' 69' ' ' PHE . 73.4 t80 -65.29 -33.14 75.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.365 -176.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -65.28 -37.26 86.62 Favored 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.073 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.2 mt -68.1 -37.56 78.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.975 0.417 . . . . 0.0 109.928 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.56 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 61.2 mt -58.15 -53.62 43.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.004 174.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.516 ' CA ' HD23 ' A' ' 80' ' ' LEU . . . -60.96 -39.64 97.3 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.207 177.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.92 -28.83 69.8 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 120.906 0.384 . . . . 0.0 111.68 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.56 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 16.3 ptm180 -90.68 -13.04 34.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.009 -175.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.512 ' CE2' HD11 ' A' ' 55' ' ' LEU . 23.8 m-85 -119.35 -37.01 3.24 Favored 'General case' 0 C--N 1.333 -0.117 0 C-N-CA 120.131 -0.627 . . . . 0.0 112.547 -175.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.516 HD23 ' CA ' ' A' ' 76' ' ' GLY . 4.1 mm? -53.67 -73.64 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 O-C-N 123.218 0.324 . . . . 0.0 111.101 -177.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.16 29.46 72.96 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.593 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.583 ' HB2' HE22 ' A' ' 11' ' ' GLN . 24.1 mm-40 -80.68 53.31 1.86 Allowed 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 175.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -121.41 67.16 0.88 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.706 -170.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.5 t -143.4 80.52 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.209 0.528 . . . . 0.0 111.683 -172.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.497 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 0.7 OUTLIER -116.19 127.04 27.07 Favored Pre-proline 0 C--N 1.321 -0.66 0 CA-C-O 121.356 0.598 . . . . 0.0 110.054 173.192 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 13.4 Cg_exo -70.54 -47.12 0.74 Allowed 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 124.058 3.172 . . . . 0.0 113.551 -170.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -102.04 -43.87 5.64 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.877 0.37 . . . . 0.0 110.192 -173.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.476 ' HB2' ' HB3' ' A' ' 85' ' ' ASN . 13.6 mm-40 -50.62 -36.8 36.92 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 26.0 mmt -111.19 -2.02 15.93 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -173.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -129.31 -78.39 0.55 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.112 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -85.17 57.33 4.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.358 0.599 . . . . 0.0 110.194 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -57.14 -21.57 33.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.545 177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.743 HD23 ' HE1' ' A' ' 150' ' ' MET . 0.9 OUTLIER -58.58 -34.4 71.03 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.985 -177.145 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.733 ' HA ' ' CE2' ' A' ' 97' ' ' PHE . 52.7 mmm-85 -62.72 -36.9 84.47 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.084 -177.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -84.55 -15.12 46.87 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.094 0.473 . . . . 0.0 110.86 177.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.479 ' HA ' HD12 ' A' ' 99' ' ' LEU . . . -82.55 -14.04 55.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.008 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.733 ' CE2' ' HA ' ' A' ' 94' ' ' ARG . 20.9 m-85 -62.46 -46.24 89.41 Favored 'General case' 0 C--O 1.215 -0.711 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 176.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -66.83 -12.41 58.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.82 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.479 HD12 ' HA ' ' A' ' 96' ' ' ALA . 96.3 mt -83.66 -43.78 15.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.954 175.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -93.12 -24.01 18.42 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.417 -175.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -71.89 80.19 0.9 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.922 0.868 . . . . 0.0 110.1 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -74.67 -16.93 60.75 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.476 177.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.486 ' HB2' ' ND2' ' A' ' 105' ' ' ASN . 22.7 mt-10 -83.61 -37.59 22.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.964 -173.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.25 34.83 3.29 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.763 177.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.486 ' ND2' ' HB2' ' A' ' 103' ' ' GLU . 21.1 m-80 -88.91 -18.74 26.91 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.895 0.378 . . . . 0.0 110.523 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 83.4 -25.79 4.83 Favored Glycine 0 N--CA 1.454 -0.147 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 -171.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.488 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 1.7 m-85 -111.33 173.45 6.34 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 171.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.631 ' HB ' HG13 ' A' ' 112' ' ' VAL . 11.8 pt -109.39 126.64 66.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 119.364 -0.935 . . . . 0.0 109.611 171.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.438 ' HA ' HG22 ' A' ' 143' ' ' THR . 33.1 m -64.44 165.01 10.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.684 -177.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 22.1 p -59.65 -31.98 70.03 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.779 -0.576 . . . . 0.0 110.206 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -58.23 -51.62 69.0 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.699 178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.631 HG13 ' HB ' ' A' ' 108' ' ' ILE . 2.3 p -69.73 -36.02 68.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.531 ' SD ' HG11 ' A' ' 144' ' ' VAL . 1.3 tpt -58.27 -45.1 88.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.049 0.452 . . . . 0.0 110.243 176.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.576 ' HG2' HD13 ' A' ' 129' ' ' LEU . 33.2 ttp180 -51.56 -50.79 59.4 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.975 175.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -65.18 -39.37 92.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.084 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 112' ' ' VAL . 43.6 mt -58.99 -46.32 91.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 111.173 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.477 HD12 ' HG ' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -63.65 -54.0 42.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.162 0.506 . . . . 0.0 109.946 -178.411 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.43 ' HB2' HD21 ' A' ' 129' ' ' LEU . . . -63.92 -19.86 65.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.713 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -69.03 -40.56 78.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.94 0.4 . . . . 0.0 110.258 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -75.84 -51.32 12.82 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.01 174.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.586 ' HB3' HD23 ' A' ' 124' ' ' LEU . 2.1 m-20 -107.73 96.82 6.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.431 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -79.72 15.14 1.45 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.511 -171.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 41.7 p -112.34 -4.65 14.25 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.493 0.663 . . . . 0.0 110.882 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.586 HD23 ' HB3' ' A' ' 121' ' ' ASP . 3.7 mm? -70.09 114.27 8.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.65 174.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 10.3 m -90.3 176.5 6.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.002 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.7 p -52.49 -44.37 65.61 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.872 0.367 . . . . 0.0 111.691 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -65.14 -41.4 94.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.954 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.46 ' HB3' HD13 ' A' ' 124' ' ' LEU . 34.3 m-20 -69.85 -49.77 49.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.448 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.576 HD13 ' HG2' ' A' ' 114' ' ' ARG . 79.2 mt -56.28 -38.28 70.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.685 176.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -55.95 -46.28 78.58 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.988 0.423 . . . . 0.0 110.704 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.66 -41.44 98.2 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.101 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 48.8 mtt -68.88 -38.97 80.02 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.006 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 133' ' ' ILE . 13.6 mm -59.02 -45.89 92.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 121.133 0.492 . . . . 0.0 110.005 174.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -55.34 -43.61 75.15 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.744 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -73.08 -45.64 56.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.246 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.621 HG12 HG13 ' A' ' 152' ' ' VAL . 69.8 mt -59.53 -57.1 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.729 -178.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -76.71 82.57 3.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 122.033 0.921 . . . . 0.0 109.83 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.39 -35.39 54.39 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.663 -1.153 . . . . 0.0 112.238 -174.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -90.31 -10.53 43.79 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.383 -175.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 72.79 37.49 57.21 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.742 175.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.3 m -83.3 -19.29 36.53 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 121.418 0.628 . . . . 0.0 110.733 -178.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 93.42 -29.99 7.75 Favored Glycine 0 CA--C 1.51 -0.257 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.494 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.438 HG22 ' HA ' ' A' ' 109' ' ' SER . 2.7 p -118.39 132.59 56.25 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 174.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.531 HG11 ' SD ' ' A' ' 113' ' ' MET . 96.5 t -82.76 115.89 26.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.767 -177.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.488 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 22.3 t70 -139.12 -61.53 0.56 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.028 0.442 . . . . 0.0 111.661 -174.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.598 ' O ' ' HG2' ' A' ' 150' ' ' MET . 2.3 p90 -94.84 -112.74 0.12 Allowed 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.519 -172.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.5 ' H ' ' HD1' ' A' ' 146' ' ' PHE . 6.3 mp0 -64.71 -11.22 33.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.904 0.383 . . . . 0.0 111.265 -176.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -66.84 -52.07 48.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.332 176.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.49 ' O ' HG23 ' A' ' 152' ' ' VAL . 14.3 t80 -77.19 -33.8 56.33 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.009 0.433 . . . . 0.0 110.303 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . 0.743 ' HE1' HD23 ' A' ' 93' ' ' LEU . 6.9 mmt -64.13 -23.44 67.32 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -79.25 -21.93 66.38 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.687 -0.688 . . . . 0.0 112.66 -178.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.621 HG13 HG12 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -91.31 -71.82 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 CA-C-O 121.813 0.816 . . . . 0.0 110.727 -178.41 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 47.5 tpp -83.49 -37.45 23.09 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.8 -166.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.587 ' OG1' ' HA ' ' A' ' 150' ' ' MET . 0.2 OUTLIER -80.01 -23.15 41.72 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.219 -179.64 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -81.03 51.57 4.36 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.961 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -90.56 -69.41 1.2 Allowed Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 175.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.2 t70 51.16 64.76 1.71 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.339 0.59 . . . . 0.0 110.493 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.686 -0.674 . . . . 0.0 109.993 -176.556 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.4 ttm . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 121.412 0.625 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -164.18 124.07 1.23 Allowed Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.37 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.702 ' HB3' ' HB2' ' A' ' 6' ' ' LYS . 29.8 m-20 -68.35 63.73 0.1 Allowed 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 122.755 0.422 . . . . 0.0 111.74 176.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.529 ' HB ' ' HE2' ' A' ' 73' ' ' LYS . 21.1 m -62.56 -31.3 51.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.449 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.9 m -78.5 -15.31 58.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.963 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.702 ' HB2' ' HB3' ' A' ' 3' ' ' ASP . 1.7 mptm? -90.19 -32.71 16.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.001 -176.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.672 HD11 ' HA ' ' A' ' 77' ' ' ALA . 14.7 mt -65.61 113.3 4.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.062 0.458 . . . . 0.0 109.862 175.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.2 m -83.07 47.67 1.26 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.615 -171.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.3 t 70.28 -35.64 0.33 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.85 0.86 . . . . 0.0 112.468 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.3 p-10 -54.58 -56.86 14.54 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.635 ' HG3' HD22 ' A' ' 7' ' ' LEU . 6.5 mm100 -62.91 -30.77 71.8 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.58 0.705 . . . . 0.0 110.14 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.437 ' HA ' HD12 ' A' ' 15' ' ' LEU . 59.8 t -72.72 -30.03 32.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.871 -177.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -70.37 -37.48 74.58 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.009 173.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.0 mp -58.7 -48.92 79.47 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 169.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.529 HD11 ' HA3' ' A' ' 76' ' ' GLY . 84.8 mt -54.76 -47.85 73.39 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.758 175.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.71 -49.69 75.43 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.2 -178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.6 m -59.69 -41.3 90.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.968 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.667 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -76.27 -39.78 53.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.554 -179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.401 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 33.2 t80 -53.43 -56.14 19.31 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.643 175.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.448 ' HD2' ' OE1' ' A' ' 23' ' ' GLU . 28.1 mmm180 -66.96 -16.91 64.66 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.356 -174.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -87.6 -34.88 18.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.918 0.39 . . . . 0.0 111.354 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.457 ' HB2' HD11 ' A' ' 39' ' ' ILE . 78.8 m-85 -109.69 13.2 23.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.282 0.563 . . . . 0.0 110.227 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.708 ' HG2' ' HB ' ' A' ' 24' ' ' THR . 27.0 tt0 -71.21 148.28 47.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.811 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.708 ' HB ' ' HG2' ' A' ' 23' ' ' GLU . 0.4 OUTLIER 78.8 140.88 0.07 OUTLIER Pre-proline 0 N--CA 1.447 -0.623 0 O-C-N 124.664 1.227 . . . . 0.0 113.527 162.505 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -84.62 -36.69 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.265 2.643 . . . . 0.0 110.014 166.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -178.07 47.59 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.39 174.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 96.2 63.7 0.95 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.186 -1.007 . . . . 0.0 111.849 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.8 t -107.24 -18.29 13.92 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.005 0.431 . . . . 0.0 111.003 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.72 12.92 84.0 Favored Glycine 0 C--N 1.333 0.41 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -175.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 62.9 mtm-85 -140.54 168.46 19.75 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.567 -0.817 . . . . 0.0 109.597 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.547 HG23 ' HA ' ' A' ' 23' ' ' GLU . 12.3 p -107.7 127.66 63.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 173.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 13.8 m -55.45 138.5 46.04 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.852 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.564 ' HA ' HG13 ' A' ' 36' ' ' ILE . 1.5 p -64.53 -26.96 68.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.196 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -65.63 -27.85 68.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.109 0.48 . . . . 0.0 110.256 178.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -92.15 -13.52 30.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.47 -176.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.704 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 69.7 mt -53.86 -48.71 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 O-C-N 123.215 0.322 . . . . 0.0 110.773 -178.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.416 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -59.73 -34.73 83.51 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.613 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.66 ' O ' HG23 ' A' ' 42' ' ' VAL . 50.3 mt -62.66 -49.71 82.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.4 0.619 . . . . 0.0 109.581 175.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.667 HG23 ' HB1' ' A' ' 18' ' ' ALA . 71.3 mt -61.64 -45.92 97.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.667 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.922 HD12 HD12 ' A' ' 52' ' ' ILE . 41.1 mt -61.91 -24.62 67.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.341 0.591 . . . . 0.0 110.423 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -75.97 -43.92 42.29 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.268 173.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.66 HG23 ' O ' ' A' ' 38' ' ' ILE . 47.8 t -53.85 -44.35 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.687 0.756 . . . . 0.0 110.264 175.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 39' ' ' ILE . 22.2 mt -81.14 -12.1 59.31 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.478 -1.237 . . . . 0.0 111.275 -175.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.59 40.61 66.72 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.825 176.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.411 HG12 ' HB2' ' A' ' 43' ' ' LEU . 1.3 pt -118.76 -76.85 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.594 ' HG2' HD11 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -80.72 177.08 9.26 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -174.458 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.423 ' HB3' ' OE1' ' A' ' 158' ' ' GLU . 22.0 mm-40 -100.27 -171.18 1.99 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.126 -170.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.1 t -52.15 165.85 0.2 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.705 0.764 . . . . 0.0 111.762 178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.537 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 59.4 mtpt -61.92 -20.56 63.92 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.349 -171.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.0 m -61.95 -31.21 71.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.208 0.528 . . . . 0.0 110.455 174.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 54.6 m -84.77 -31.48 23.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.334 176.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.922 HD12 HD12 ' A' ' 40' ' ' LEU . 28.3 mm -67.51 -25.3 32.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.009 -176.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -46.21 -45.28 16.82 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.922 173.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -62.29 -49.74 74.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.131 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.686 HD12 ' HA ' ' A' ' 52' ' ' ILE . 1.0 OUTLIER -58.14 -38.4 76.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.396 178.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.532 HG23 HG21 ' A' ' 33' ' ' THR . 75.2 mt -65.95 -46.67 87.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.044 177.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -62.42 -27.65 69.25 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.195 0.521 . . . . 0.0 110.289 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -76.0 -54.85 6.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.528 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.568 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 87.4 m-85 -97.57 -15.36 20.54 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -171.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.401 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 39.8 t0 -122.72 68.7 33.29 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 121.222 0.534 . . . . 0.0 110.358 174.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.568 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 20.7 Cg_exo -71.87 -18.12 28.39 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.032 2.488 . . . . 0.0 111.756 176.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -79.88 -17.62 52.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.712 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.38 37.46 53.98 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.781 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -72.59 -43.3 63.55 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.784 0.326 . . . . 0.0 111.237 -176.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.97 -16.09 20.8 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.893 -178.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 5.5 m-20 -137.19 176.69 8.48 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.0 pt -136.9 152.64 28.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.894 0.378 . . . . 0.0 110.272 174.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -90.07 166.59 13.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.844 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.434 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -63.0 -21.69 66.32 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 178.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -57.61 -52.35 65.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.027 0.442 . . . . 0.0 109.986 174.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.492 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 3.4 m -70.72 -44.96 65.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.526 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.434 ' HB3' ' HA ' ' A' ' 69' ' ' PHE . 84.5 t80 -64.5 -34.77 79.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.651 -176.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.529 ' HE2' ' HB ' ' A' ' 4' ' ' VAL . 89.1 tttt -64.81 -35.84 82.39 Favored 'General case' 0 C--O 1.224 -0.288 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 65.6 mt -67.46 -43.9 87.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 176.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.58 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 88.8 mt -55.08 -47.55 77.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.275 175.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.801 ' HA2' HD23 ' A' ' 80' ' ' LEU . . . -67.52 -43.9 84.92 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.608 -0.805 . . . . 0.0 112.524 178.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.672 ' HA ' HD11 ' A' ' 7' ' ' LEU . . . -64.55 -24.33 67.57 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.894 0.378 . . . . 0.0 111.701 -174.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.58 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 10.7 ptm180 -89.1 -15.16 34.58 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.844 -175.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -124.34 -36.75 2.61 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.406 -0.518 . . . . 0.0 112.139 -177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.801 HD23 ' HA2' ' A' ' 76' ' ' GLY . 4.6 mm? -66.35 -27.24 67.73 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -173.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -80.99 -55.21 3.36 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 120.009 -1.091 . . . . 0.0 112.76 -175.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.19 50.41 1.64 Allowed 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.511 0.672 . . . . 0.0 109.264 175.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -67.98 97.69 0.69 Allowed 'General case' 0 N--CA 1.431 -1.398 0 CA-C-O 123.379 1.561 . . . . 0.0 111.251 -173.278 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.8 t -135.3 96.06 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 113.738 -1.574 . . . . 0.0 109.475 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.48 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 4.9 t30 -45.9 135.61 6.47 Favored Pre-proline 0 N--CA 1.47 0.563 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.482 174.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 16.3 Cg_exo -67.87 -36.33 18.5 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 124.215 3.277 . . . . 0.0 113.042 -169.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -90.94 -84.04 0.25 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.65 176.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 55.01 26.16 7.71 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.152 0.501 . . . . 0.0 110.586 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 23.7 ttt 56.96 42.01 26.88 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.89 -176.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.492 ' HB3' ' HG2' ' A' ' 92' ' ' GLU . 14.3 mm100 -87.04 -70.42 0.62 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.228 174.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 52.04 43.09 30.69 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.554 0.692 . . . . 0.0 110.683 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.492 ' HG2' ' HB3' ' A' ' 90' ' ' GLN . 5.0 mm-40 -60.52 -20.6 60.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.113 178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.763 HD22 ' H ' ' A' ' 93' ' ' LEU . 0.9 OUTLIER -62.02 -35.58 78.99 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.894 -173.108 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.569 ' HD3' ' CE2' ' A' ' 97' ' ' PHE . 29.5 mmt180 -62.48 -41.69 98.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.086 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -74.62 -30.91 61.82 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.204 0.526 . . . . 0.0 110.818 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.509 ' HA ' HD12 ' A' ' 99' ' ' LEU . . . -74.95 -20.22 59.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.935 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.569 ' CE2' ' HD3' ' A' ' 94' ' ' ARG . 17.0 m-30 -56.57 -44.62 81.18 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.372 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 28.3 mtm-85 -72.02 -19.52 61.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.027 0.442 . . . . 0.0 110.906 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 96' ' ' ALA . 94.2 mt -80.09 -43.87 21.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.654 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.655 ' O ' ' HD2' ' A' ' 102' ' ' LYS . 79.9 m-85 -89.59 -5.61 57.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.397 -177.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 97' ' ' PHE . 55.8 t0 -76.82 76.28 3.43 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.512 178.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.655 ' HD2' ' O ' ' A' ' 100' ' ' TYR . 0.2 OUTLIER -57.04 -42.33 80.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.601 174.548 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -67.75 -36.75 81.1 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.214 -171.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.96 37.15 7.97 Favored Glycine 0 N--CA 1.451 -0.34 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -171.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -96.06 -18.37 20.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.49 -0.855 . . . . 0.0 111.174 -168.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.9 -24.91 10.83 Favored Glycine 0 CA--C 1.517 0.194 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -175.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.445 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 4.2 m-85 -116.75 176.93 4.89 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 173.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.617 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 6.3 pt -117.84 121.94 68.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.239 169.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 143' ' ' THR . 66.3 m -65.91 174.75 2.28 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.149 0.5 . . . . 0.0 111.556 -175.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.2 p -67.36 -26.76 66.64 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.953 0.406 . . . . 0.0 110.754 -177.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -60.59 -58.09 9.95 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.851 176.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.617 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.4 p -63.26 -38.36 81.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.843 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.542 ' SD ' HG11 ' A' ' 144' ' ' VAL . 2.7 tpt -56.5 -40.89 75.73 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.827 0.346 . . . . 0.0 110.648 177.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -61.02 -45.19 95.79 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.991 178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -58.99 -46.49 88.0 Favored 'General case' 0 C--N 1.329 -0.285 0 O-C-N 123.411 0.444 . . . . 0.0 110.215 178.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 63.7 mt -57.45 -53.83 38.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.567 177.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.4 tp -54.66 -60.29 3.56 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.36 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.08 -27.15 52.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.761 -1.109 . . . . 0.0 112.433 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -75.45 -44.15 45.75 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.616 0.246 . . . . 0.0 110.348 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.32 -55.7 7.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.141 176.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.663 ' HB3' HD23 ' A' ' 124' ' ' LEU . 5.3 m-20 -103.01 111.97 24.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.478 0.656 . . . . 0.0 110.649 -178.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.502 ' H ' ' CD ' ' A' ' 122' ' ' GLU . 0.3 OUTLIER -89.17 -5.41 57.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.717 -173.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 74.7 p -88.61 -2.98 58.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.339 0.59 . . . . 0.0 110.765 -174.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.663 HD23 ' HB3' ' A' ' 121' ' ' ASP . 4.2 mm? -84.87 129.03 34.87 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.854 176.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.491 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 92.0 p -89.69 -179.01 5.67 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 175.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.5 t -58.75 -48.49 81.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.692 0.282 . . . . 0.0 110.795 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -71.08 -35.86 72.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.828 0.347 . . . . 0.0 111.161 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.424 ' HB2' ' H ' ' A' ' 125' ' ' SER . 68.4 m-20 -66.28 -38.14 87.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.45 178.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.509 ' O ' HG12 ' A' ' 133' ' ' ILE . 85.5 mt -58.65 -44.46 90.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.151 172.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -58.99 -46.24 88.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.616 177.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.45 -42.71 98.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.723 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.508 ' O ' HG13 ' A' ' 136' ' ' ILE . 9.0 mtt -64.06 -37.26 86.8 Favored 'General case' 0 C--O 1.215 -0.731 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.923 177.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 129' ' ' LEU . 15.8 mm -57.41 -43.88 83.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.188 0.518 . . . . 0.0 110.419 174.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.4 -36.98 84.04 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.262 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -72.79 -39.5 66.65 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.517 -1.219 . . . . 0.0 111.242 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 132' ' ' MET . 66.8 mt -71.11 -57.11 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.993 -176.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -75.64 63.58 1.58 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 122.396 1.094 . . . . 0.0 108.621 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -78.37 -22.33 48.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.489 -1.232 . . . . 0.0 112.161 -174.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -88.23 -11.99 45.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.368 0.604 . . . . 0.0 110.202 -178.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 79.53 34.99 30.3 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.488 174.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.431 ' C ' ' H ' ' A' ' 143' ' ' THR . 46.9 t -78.74 -21.16 48.42 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.197 0.522 . . . . 0.0 110.406 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 82.67 -28.36 3.54 Favored Glycine 0 C--O 1.234 0.121 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 -177.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.431 ' H ' ' C ' ' A' ' 141' ' ' SER . 19.5 p -124.3 128.27 48.87 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 172.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.542 HG11 ' SD ' ' A' ' 113' ' ' MET . 58.8 t -80.71 127.3 39.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -173.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.445 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 17.8 t70 -157.2 -77.63 0.08 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.872 0.844 . . . . 0.0 110.176 -175.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.439 ' HB3' HH22 ' A' ' 94' ' ' ARG . 20.7 p90 -92.65 136.42 33.24 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.072 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 64.86 -54.44 0.3 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.526 0.73 . . . . 0.0 112.204 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -54.66 -51.02 66.78 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.818 0.847 . . . . 0.0 112.144 -176.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.662 ' HE1' HD12 ' A' ' 93' ' ' LEU . 11.4 t80 -75.41 -37.0 60.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.125 0.488 . . . . 0.0 110.341 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . 0.573 ' CE ' HD23 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -58.14 -43.15 87.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.347 178.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.425 ' HA2' ' O ' ' A' ' 155' ' ' GLY . . . -73.24 -35.62 56.73 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.455 -177.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 149' ' ' PHE . 9.3 p -75.59 -38.9 39.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 117.112 0.456 . . . . 0.0 111.511 -175.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 16.0 tpt -93.88 -39.92 10.44 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.879 -174.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.446 HG21 HD21 ' A' ' 93' ' ' LEU . 64.9 p -122.78 24.55 9.04 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 -172.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.425 ' O ' ' HA2' ' A' ' 151' ' ' GLY . . . 77.43 -59.45 3.68 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.778 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 138.67 -160.16 25.56 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 121.141 -0.552 . . . . 0.0 111.985 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -99.11 81.06 2.53 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.423 ' OE1' ' HB3' ' A' ' 47' ' ' GLN . 24.6 tt0 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.503 -0.76 . . . . 0.0 109.994 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.2 mtt . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 121.571 0.701 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.429 ' O ' HG13 ' A' ' 4' ' ' VAL . . . -125.85 108.69 1.07 Allowed Glycine 0 N--CA 1.439 -1.163 0 N-CA-C 109.082 -1.607 . . . . 0.0 109.082 170.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.468 ' HB3' ' HD3' ' A' ' 6' ' ' LYS . 6.0 m-20 -37.66 89.09 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -173.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 2' ' ' GLY . 14.9 m -80.96 -15.55 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.557 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.4 m -84.28 -16.23 43.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.283 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.468 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 5.0 mptp? -84.58 -32.51 23.75 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.963 175.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.531 HD22 ' HB2' ' A' ' 77' ' ' ALA . 8.2 mp -75.56 104.62 6.19 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.766 0.794 . . . . 0.0 110.373 177.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 33.1 t -125.33 68.16 1.14 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.518 -178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.0 t 71.54 -42.07 0.52 Allowed 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.157 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 23.5 p-10 -57.33 -58.84 6.49 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -174.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.506 ' CD ' ' HG2' ' A' ' 82' ' ' GLU . 3.4 mt-30 -72.55 -32.64 66.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.692 0.758 . . . . 0.0 109.212 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.436 HG13 ' CE2' ' A' ' 69' ' ' PHE . 89.2 t -63.88 -29.61 47.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.327 -1.306 . . . . 0.0 111.07 -178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.486 ' HD3' ' C ' ' A' ' 13' ' ' LYS . 1.1 tmtp? -62.82 -40.93 98.92 Favored 'General case' 0 N--CA 1.422 -1.844 0 C-N-CA 123.181 0.592 . . . . 0.0 110.854 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.43 ' N ' ' HD3' ' A' ' 13' ' ' LYS . 6.4 mp -69.92 -42.45 73.31 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 176.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.65 HD21 ' CD1' ' A' ' 80' ' ' LEU . 80.8 mt -59.97 -53.98 51.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.624 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.428 ' HA ' ' HE1' ' A' ' 69' ' ' PHE . 37.7 tt0 -64.65 -35.89 82.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.359 -175.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 85.1 m -59.82 -42.16 92.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.929 0.395 . . . . 0.0 110.745 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.558 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -80.48 -33.12 36.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.146 0.498 . . . . 0.0 110.278 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.452 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 35.7 t80 -56.44 -55.04 38.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.35 177.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -69.08 -19.79 64.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.522 -174.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -76.61 -42.86 40.86 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.744 0.307 . . . . 0.0 110.908 -177.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -103.77 14.01 31.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.137 0.494 . . . . 0.0 110.444 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.709 ' HG2' ' HB ' ' A' ' 24' ' ' THR . 10.3 tt0 -71.85 154.65 41.12 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.38 -176.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.709 ' HB ' ' HG2' ' A' ' 23' ' ' GLU . 0.5 OUTLIER 76.01 137.77 0.05 OUTLIER Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-O 122.462 1.125 . . . . 0.0 113.812 158.637 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.32 -52.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.911 2.408 . . . . 0.0 109.835 168.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -138.83 -25.81 0.88 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.625 172.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.66 50.0 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -176.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.0 t -89.78 -29.77 18.44 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.807 0.337 . . . . 0.0 111.39 -174.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.88 -6.33 75.03 Favored Glycine 0 N--CA 1.453 -0.179 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 -175.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.403 ' HB3' ' O ' ' A' ' 67' ' ' ILE . 61.0 mtt85 -115.25 163.7 15.29 Favored 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.207 -0.496 . . . . 0.0 109.745 178.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.572 HG21 HD11 ' A' ' 39' ' ' ILE . 13.3 p -106.18 126.61 61.76 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-O 121.86 0.838 . . . . 0.0 110.269 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 65' ' ' GLY . 31.1 m -53.79 140.61 29.45 Favored 'General case' 0 N--CA 1.428 -1.535 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.847 178.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.583 ' HB ' HG12 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -66.69 -25.31 66.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.85 -174.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -69.36 -26.08 64.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.589 0.709 . . . . 0.0 109.727 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 10.4 mm100 -82.06 -22.4 36.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.661 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.545 HG22 HD22 ' A' ' 40' ' ' LEU . 60.2 mt -55.61 -43.33 72.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 120.959 0.409 . . . . 0.0 110.143 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.429 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -65.24 -25.43 71.11 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.634 177.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.649 ' O ' HG23 ' A' ' 42' ' ' VAL . 39.3 mt -75.21 -51.97 19.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 175.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.572 HD11 HG21 ' A' ' 31' ' ' VAL . 63.5 mt -60.96 -44.83 98.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.839 -178.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.545 HD22 HG22 ' A' ' 36' ' ' ILE . 1.6 mp -57.54 -39.26 76.23 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.352 0.596 . . . . 0.0 109.685 176.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -65.64 -38.44 89.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.769 177.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 38' ' ' ILE . 60.8 t -60.69 -50.38 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 121.622 0.725 . . . . 0.0 110.671 175.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 66.5 mt -83.35 -1.54 53.59 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.653 -171.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.55 35.19 42.12 Favored Glycine 0 N--CA 1.45 -0.42 0 CA-C-N 115.995 -0.548 . . . . 0.0 113.403 172.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.5 pt -129.02 166.65 26.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.628 0.214 . . . . 0.0 110.468 176.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.29 -166.67 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 41.4 mm-40 -120.22 -171.88 2.25 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.975 -173.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.9 t -63.7 171.33 2.74 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.451 0.643 . . . . 0.0 111.437 178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.446 ' HA ' ' HB ' ' A' ' 52' ' ' ILE . 7.3 mtpm? -59.0 -24.6 62.92 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.005 -0.998 . . . . 0.0 113.317 -165.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.3 t -57.29 -44.8 84.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.931 0.396 . . . . 0.0 110.35 173.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 55.3 m -72.26 -34.42 68.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.433 0.635 . . . . 0.0 110.293 176.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.446 ' HB ' ' HA ' ' A' ' 49' ' ' LYS . 44.9 mm -63.41 -24.42 35.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.479 -176.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -50.83 -38.02 46.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.886 172.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.917 HE21 ' HA ' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -74.44 -28.82 61.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.051 -179.051 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 52' ' ' ILE . 2.3 mm? -65.35 -43.34 91.14 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 173.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.583 HG12 ' HB ' ' A' ' 33' ' ' THR . 71.8 mt -65.2 -45.42 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.96 177.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.03 -27.99 22.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.294 0.569 . . . . 0.0 111.076 176.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -83.31 -53.65 5.59 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.663 -178.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.459 ' CE2' HG12 ' A' ' 75' ' ' ILE . 97.1 m-85 -100.87 -10.66 20.48 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -169.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.482 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 51.3 t0 -136.25 63.82 51.03 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 121.208 0.527 . . . . 0.0 110.458 174.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.482 ' HD3' ' N ' ' A' ' 60' ' ' ASP . 24.6 Cg_exo -68.42 -20.56 41.87 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.841 2.361 . . . . 0.0 111.592 177.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -78.45 -17.48 56.28 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.757 -176.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.97 43.02 50.65 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.518 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -74.89 -38.04 61.97 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.216 0.532 . . . . 0.0 109.942 -179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . 110.68 -5.37 29.43 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.961 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -161.32 175.77 11.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 71' ' ' SER . 34.6 pt -143.19 146.71 21.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.371 -177.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -75.88 163.19 27.46 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.934 176.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.436 ' CE2' HG13 ' A' ' 12' ' ' VAL . 16.0 t80 -56.49 -35.65 68.23 Favored 'General case' 0 C--O 1.214 -0.772 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.075 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -62.18 -22.41 65.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.869 0.366 . . . . 0.0 111.029 -175.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.42 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 40.3 m -85.82 -41.26 15.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.905 0.383 . . . . 0.0 110.504 174.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.439 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 89.7 t80 -70.1 -30.56 67.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.467 0.651 . . . . 0.0 109.717 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -55.51 -50.53 69.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.871 174.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.8 mt -63.0 -42.82 98.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.364 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.607 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 65.5 mt -54.34 -55.45 14.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.482 0.658 . . . . 0.0 110.068 176.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.69 -42.86 99.82 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.259 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.531 ' HB2' HD22 ' A' ' 7' ' ' LEU . . . -64.06 -28.03 69.51 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.854 0.359 . . . . 0.0 111.16 -174.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.607 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 13.8 ptm180 -89.64 -10.74 44.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.867 -176.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.514 ' CD1' ' HG3' ' A' ' 78' ' ' ARG . 22.6 m-85 -116.28 -40.14 3.3 Favored 'General case' 0 C--N 1.337 0.061 0 C-N-CA 120.66 -0.416 . . . . 0.0 112.105 -176.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.65 ' CD1' HD21 ' A' ' 15' ' ' LEU . 2.3 mp -69.37 -65.66 0.68 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.912 0.387 . . . . 0.0 110.828 176.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 60.85 11.99 26.52 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.785 -0.643 . . . . 0.0 114.312 175.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.506 ' HG2' ' CD ' ' A' ' 11' ' ' GLN . 29.4 mm-40 54.7 16.47 1.39 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 122.993 0.517 . . . . 0.0 111.767 -173.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -129.99 113.75 14.96 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.849 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.7 p -82.03 73.15 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 122.473 1.13 . . . . 0.0 110.993 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.432 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 0.7 OUTLIER -115.56 147.69 39.38 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 114.909 -1.042 . . . . 0.0 109.693 177.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 31.7 Cg_exo -62.11 -58.77 0.33 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.404 2.07 . . . . 0.0 111.625 -176.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.493 ' HB2' ' HG2' ' A' ' 90' ' ' GLN . 5.8 mm-40 -133.55 16.53 4.0 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.867 176.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 66.81 -50.14 0.46 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.946 -1.024 . . . . 0.0 112.166 -176.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 19.8 mmt -81.99 3.41 26.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.211 0.529 . . . . 0.0 110.516 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.493 ' HG2' ' HB2' ' A' ' 87' ' ' GLU . 13.9 mm100 -89.31 156.39 18.75 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.146 177.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.409 ' OE1' ' HB3' ' A' ' 90' ' ' GLN . 10.1 mp0 56.62 40.24 29.42 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 123.862 0.726 . . . . 0.0 111.868 179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -56.16 -33.83 65.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.539 175.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.671 HD13 ' CD1' ' A' ' 149' ' ' PHE . 77.6 mt -57.83 -38.29 75.34 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.731 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.737 ' HA ' ' CD2' ' A' ' 97' ' ' PHE . 5.6 mpt_? -58.84 -46.27 88.09 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.755 0.312 . . . . 0.0 111.689 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -76.03 -17.08 59.82 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.13 0.49 . . . . 0.0 110.291 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -86.19 -18.04 33.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.182 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.737 ' CD2' ' HA ' ' A' ' 94' ' ' ARG . 22.4 m-85 -59.57 -45.5 91.66 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.431 HH11 ' HD3' ' A' ' 98' ' ' ARG . 47.8 mtp180 -69.68 -13.86 62.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.156 0.503 . . . . 0.0 111.033 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 89.4 mt -84.35 -35.51 23.17 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.501 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -96.38 -11.55 25.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.182 0.515 . . . . 0.0 110.298 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -72.54 77.56 1.06 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.877 0.846 . . . . 0.0 110.337 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -75.65 -9.49 58.63 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.923 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -88.88 -37.11 15.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.654 -177.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.95 30.55 7.05 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.676 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -98.96 -17.48 18.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.848 0.356 . . . . 0.0 111.544 -175.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.57 -26.18 4.18 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.521 -0.631 . . . . 0.0 111.521 -174.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.526 ' HD2' ' CB ' ' A' ' 145' ' ' ASP . 30.5 m-85 -103.92 144.77 31.07 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 171.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.642 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 7.0 pt -93.11 120.8 43.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 C-N-CA 118.591 -1.243 . . . . 0.0 108.977 174.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.5 m -67.76 172.12 5.7 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.96 -174.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 34.3 p -60.79 -29.06 69.21 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.211 0.529 . . . . 0.0 110.845 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.601 ' O ' ' HB2' ' A' ' 114' ' ' ARG . 2.0 t70 -62.97 -50.72 69.67 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.403 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.642 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.4 p -70.82 -35.28 59.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.933 -179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.728 ' SD ' HG11 ' A' ' 144' ' ' VAL . 1.4 tpt -59.66 -37.72 79.51 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.763 0.316 . . . . 0.0 110.205 176.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.601 ' HB2' ' O ' ' A' ' 111' ' ' ASP . 36.7 mtt180 -50.55 -59.55 3.93 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.407 172.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.0 -41.69 92.66 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.768 -176.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 53.6 mt -58.09 -46.89 88.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.148 0.499 . . . . 0.0 110.9 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.419 HD12 ' CD2' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -70.57 -47.39 60.5 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.128 -179.257 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.864 ' HB2' HD21 ' A' ' 129' ' ' LEU . . . -53.21 -25.81 15.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.753 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -68.34 -26.68 65.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.195 0.521 . . . . 0.0 110.247 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.4 mp -89.55 -47.77 7.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.022 174.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.897 ' HB3' ' HB2' ' A' ' 124' ' ' LEU . 1.3 m-20 -90.57 93.57 9.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.3 0.572 . . . . 0.0 110.471 177.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -79.61 -13.84 59.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.728 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 76.5 p -96.79 -14.04 22.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 122.724 1.25 . . . . 0.0 108.607 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.923 ' HG ' HD22 ' A' ' 129' ' ' LEU . 36.9 tp -69.83 116.21 9.96 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-N 112.991 -1.913 . . . . 0.0 110.426 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 93.9 p -91.61 -179.71 5.43 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.622 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 24.9 m -58.73 -37.36 75.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.889 0.376 . . . . 0.0 110.911 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -74.58 -42.05 59.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.634 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.65 ' CB ' HD12 ' A' ' 124' ' ' LEU . 59.4 m-20 -64.35 -50.46 67.63 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.923 HD22 ' HG ' ' A' ' 124' ' ' LEU . 0.2 OUTLIER -42.25 -48.41 4.93 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.835 169.646 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -62.19 -41.31 98.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.662 0.268 . . . . 0.0 111.219 -175.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -63.89 -41.6 97.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.101 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.409 ' O ' HG13 ' A' ' 136' ' ' ILE . 36.2 mtt -63.05 -39.21 94.05 Favored 'General case' 0 C--O 1.213 -0.853 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.624 176.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.494 HG12 ' O ' ' A' ' 129' ' ' LEU . 24.5 mm -57.91 -45.2 87.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.144 0.497 . . . . 0.0 110.382 175.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -61.02 -34.92 75.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.43 177.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -73.87 -38.52 64.4 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.849 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.53 HG12 ' HB ' ' A' ' 152' ' ' VAL . 59.8 mt -70.43 -49.41 53.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.385 -176.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.73 95.93 0.93 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 123.023 1.392 . . . . 0.0 110.713 -174.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.29 -54.95 5.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.208 -1.36 . . . . 0.0 112.337 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -84.23 -10.35 57.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.441 0.639 . . . . 0.0 110.979 -174.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 61.55 40.95 99.41 Favored Glycine 0 N--CA 1.451 -0.331 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.621 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.1 t -89.89 5.04 48.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.079 0.466 . . . . 0.0 110.66 -176.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 87.56 -31.01 4.68 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.229 -0.51 . . . . 0.0 112.177 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 35.3 p -117.81 143.27 46.42 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.439 -0.381 . . . . 0.0 109.998 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.728 HG11 ' SD ' ' A' ' 113' ' ' MET . 71.7 t -91.88 111.41 24.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.526 ' CB ' ' HD2' ' A' ' 107' ' ' TYR . 22.6 t70 -146.37 -69.16 0.26 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.687 0.756 . . . . 0.0 111.574 -175.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.858 ' HD2' ' HG2' ' A' ' 147' ' ' GLU . 4.0 p90 -97.92 -53.44 3.4 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.322 -0.854 . . . . 0.0 113.02 -164.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.858 ' HG2' ' HD2' ' A' ' 146' ' ' PHE . 40.2 mm-40 -98.86 -36.17 9.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.496 0.665 . . . . 0.0 110.157 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 148' ' ' GLU . 40.9 mp0 -63.5 -54.95 28.37 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.038 -175.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.671 ' CD1' HD13 ' A' ' 93' ' ' LEU . 2.3 t80 -66.27 -45.98 78.6 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.793 -175.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' A' ' 146' ' ' PHE . 52.4 mmm -61.47 -19.53 62.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.278 177.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -90.92 -17.54 51.11 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.878 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.53 ' HB ' HG12 ' A' ' 136' ' ' ILE . 6.6 p -98.31 -47.26 12.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 117.019 0.41 . . . . 0.0 111.393 -179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 49.9 tpp -81.08 -56.46 4.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.881 0.372 . . . . 0.0 110.785 -176.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 22.1 p -97.2 26.63 4.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.78 -178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -122.25 54.1 0.7 Allowed Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.464 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -77.39 -2.52 79.87 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.997 -0.62 . . . . 0.0 112.972 -176.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 38.4 t70 58.2 68.99 0.77 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.589 0.709 . . . . 0.0 109.732 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.674 -173.758 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.5 ttp . . . . . 0 N--CA 1.484 1.244 0 CA-C-O 121.262 0.553 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.87 -49.99 0.36 Allowed Glycine 0 CA--C 1.502 -0.74 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.826 ' HB3' ' HB2' ' A' ' 6' ' ' LYS . 3.7 m-20 59.37 41.73 19.17 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 124.474 0.749 . . . . 0.0 111.783 168.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.6 p -66.81 -23.81 31.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.324 0.583 . . . . 0.0 110.159 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.0 m -95.05 5.05 52.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.495 178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.826 ' HB2' ' HB3' ' A' ' 3' ' ' ASP . 4.9 mptp? -97.23 -35.42 10.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.176 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.576 ' HA ' ' OE1' ' A' ' 11' ' ' GLN . 5.6 mp -59.14 113.46 2.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.578 0.704 . . . . 0.0 111.578 -176.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.4 t -81.44 56.34 2.9 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.764 -172.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.5 m 65.15 -54.19 0.32 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 175.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -54.73 -45.87 74.15 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 122.838 0.455 . . . . 0.0 111.183 -176.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.576 ' OE1' ' HA ' ' A' ' 7' ' ' LEU . 8.9 mt-30 -64.08 -31.46 72.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.764 0.793 . . . . 0.0 110.032 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.463 HG23 ' HB3' ' A' ' 7' ' ' LEU . 99.1 t -76.13 -33.79 25.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.462 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.46 ' HA ' ' HD2' ' A' ' 13' ' ' LYS . 12.0 tptt -61.64 -42.64 99.18 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-O 120.782 0.325 . . . . 0.0 110.642 173.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.9 mt -57.23 -48.7 78.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.426 0.631 . . . . 0.0 109.617 173.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 11' ' ' GLN . 67.9 mt -56.18 -51.34 68.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.261 176.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -61.08 -41.87 97.45 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.652 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.8 m -61.24 -39.28 89.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.063 -178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.538 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -84.2 -31.33 25.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.931 0.396 . . . . 0.0 110.616 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.591 ' O ' ' HB2' ' A' ' 23' ' ' GLU . 65.3 t80 -57.95 -56.79 17.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.411 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -71.95 -0.96 12.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.468 -176.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -93.79 -52.43 4.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.788 0.327 . . . . 0.0 110.746 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.611 ' CD1' HG12 ' A' ' 39' ' ' ILE . 64.5 m-85 -95.71 11.11 34.6 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.02 0.438 . . . . 0.0 110.455 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.615 ' HA ' HG23 ' A' ' 31' ' ' VAL . 11.1 tt0 -62.32 155.12 25.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.513 -174.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.579 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.4 OUTLIER 77.81 138.52 0.06 OUTLIER Pre-proline 0 N--CA 1.45 -0.433 0 CA-C-N 114.128 -1.396 . . . . 0.0 113.737 161.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -88.32 -44.25 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.553 2.835 . . . . 0.0 110.799 170.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -164.3 47.03 0.11 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.494 176.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.78 66.67 1.27 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.808 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.0 t -113.14 -27.19 8.1 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -176.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.13 -4.76 82.45 Favored Glycine 0 C--N 1.333 0.373 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -171.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.448 ' HD2' ' OD2' ' A' ' 66' ' ' ASP . 25.5 mtt85 -115.25 160.22 20.03 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 114.068 -1.066 . . . . 0.0 109.565 179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.615 HG23 ' HA ' ' A' ' 23' ' ' GLU . 10.2 p -106.8 126.98 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 121.697 0.76 . . . . 0.0 109.099 177.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 66' ' ' ASP . 32.8 t -55.63 140.64 40.53 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 113.941 -1.481 . . . . 0.0 111.372 -177.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.598 ' HB ' HG12 ' A' ' 56' ' ' ILE . 7.0 p -66.5 -19.63 65.83 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.01 -178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.416 ' O ' ' HE2' ' A' ' 49' ' ' LYS . 32.9 t70 -70.9 -27.39 63.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.72 176.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.682 ' HA ' HD13 ' A' ' 38' ' ' ILE . 15.8 mm100 -95.06 -13.96 24.7 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.05 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.719 HG22 HD22 ' A' ' 40' ' ' LEU . 63.1 mt -56.93 -34.06 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.614 0.245 . . . . 0.0 110.665 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.437 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -73.12 -36.1 56.81 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.319 -0.943 . . . . 0.0 111.338 -177.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.682 HD13 ' HA ' ' A' ' 35' ' ' GLN . 1.3 mp -59.81 -56.13 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 174.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.78 ' HA ' HG13 ' A' ' 42' ' ' VAL . 36.0 mt -64.08 -39.24 84.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.645 -176.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.719 HD22 HG22 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -60.83 -23.71 65.31 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.301 -0.56 . . . . 0.0 109.992 176.337 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 35.0 tt0 -81.74 -41.63 20.96 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.402 173.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.78 HG13 ' HA ' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -58.78 -38.74 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 121.572 0.701 . . . . 0.0 110.406 177.563 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.479 ' HG ' HG22 ' A' ' 42' ' ' VAL . 45.6 mt -83.52 -11.9 56.87 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.841 -178.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.91 32.52 56.76 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.563 -0.744 . . . . 0.0 113.269 175.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.5 pt -110.96 -86.09 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -177.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -79.03 177.34 8.88 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.257 0.551 . . . . 0.0 112.362 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -100.79 -171.95 2.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.371 -174.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.2 t -64.38 175.81 1.24 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.444 0.64 . . . . 0.0 111.862 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 96.8 mttt -53.61 -30.42 42.48 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -165.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.4 m -55.7 -33.48 64.22 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.073 0.463 . . . . 0.0 111.058 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.7 m -84.25 -33.77 23.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.557 0.694 . . . . 0.0 110.3 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.437 HG13 ' HA3' ' A' ' 37' ' ' GLY . 36.9 mm -66.92 -23.98 31.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.497 -175.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 30.7 mmt180 -52.71 -33.1 46.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.923 0.392 . . . . 0.0 110.742 176.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -70.86 -51.05 28.84 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.164 0.507 . . . . 0.0 109.735 175.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.473 HD11 ' CE2' ' A' ' 79' ' ' PHE . 3.3 mm? -51.26 -45.92 62.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.249 177.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.598 HG12 ' HB ' ' A' ' 33' ' ' THR . 73.1 mt -62.97 -50.0 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.486 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -62.92 -25.39 68.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.197 0.523 . . . . 0.0 110.713 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -69.24 -55.02 11.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.236 178.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.546 ' HB3' ' HB3' ' A' ' 71' ' ' SER . 94.6 m-85 -100.92 -20.76 15.32 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -171.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -126.67 67.59 67.5 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-O 121.2 0.524 . . . . 0.0 110.615 176.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.456 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 31.3 Cg_exo -62.66 -17.16 57.34 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.862 2.374 . . . . 0.0 111.628 177.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -69.74 -18.34 63.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.279 -178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 63.9 32.44 84.19 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -173.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -75.41 -40.93 57.19 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.928 -0.636 . . . . 0.0 111.087 -170.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 120.01 -14.95 10.33 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.017 -1.087 . . . . 0.0 113.788 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.448 ' OD2' ' HD2' ' A' ' 30' ' ' ARG . 5.7 p-10 -154.75 157.9 38.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 117.171 0.486 . . . . 0.0 110.875 179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.8 pt -133.59 149.11 30.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.255 -175.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -81.11 167.99 19.09 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.657 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.416 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . 0.5 OUTLIER -56.3 -26.63 52.79 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.124 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -42.89 -54.29 4.26 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.468 172.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.546 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 13.5 m -86.51 -37.17 18.5 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.819 -176.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.416 ' HB3' ' HA ' ' A' ' 69' ' ' PHE . 92.3 t80 -63.94 -35.26 80.1 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.129 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -63.87 -36.27 83.36 Favored 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.443 ' HB ' ' CE1' ' A' ' 59' ' ' PHE . 34.6 mt -72.44 -37.25 57.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 177.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.565 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 61.7 mt -57.78 -51.21 73.16 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.285 0.564 . . . . 0.0 109.654 173.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.499 ' O ' HD23 ' A' ' 80' ' ' LEU . . . -63.18 -42.78 99.32 Favored Glycine 0 N--CA 1.44 -1.034 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.893 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.464 ' HA ' ' CD2' ' A' ' 7' ' ' LEU . . . -57.95 -37.58 74.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.385 0.612 . . . . 0.0 111.329 -175.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 15.0 ptm180 -81.83 -9.3 59.65 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.969 -173.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.473 ' CE2' HD11 ' A' ' 55' ' ' LEU . 22.2 m-85 -124.02 -31.56 3.36 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.72 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.499 HD23 ' O ' ' A' ' 76' ' ' GLY . 4.1 mm? -69.86 -26.08 64.03 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.155 0.503 . . . . 0.0 110.904 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -73.46 49.01 1.56 Allowed Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.481 -0.781 . . . . 0.0 113.657 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -94.8 27.82 2.94 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.398 0.618 . . . . 0.0 109.687 174.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -82.67 92.04 7.1 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.505 -177.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.6 t -127.58 84.42 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.548 177.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.503 ' HA ' ' HD3' ' A' ' 86' ' ' PRO . 4.7 t30 -98.25 141.72 23.41 Favored Pre-proline 0 C--N 1.318 -0.792 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.42 -175.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.503 ' HD3' ' HA ' ' A' ' 85' ' ' ASN . 23.5 Cg_exo -65.93 -52.09 1.05 Allowed 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.597 2.865 . . . . 0.0 112.236 -176.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -89.1 25.64 1.8 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.019 -178.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 85' ' ' ASN . 35.0 tt0 -61.14 111.46 1.72 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.825 0.345 . . . . 0.0 111.015 -176.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.403 ' O ' ' HG2' ' A' ' 89' ' ' MET . 48.8 ttm 63.91 18.82 11.42 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.42 178.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -97.35 -25.02 15.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.981 0.42 . . . . 0.0 110.533 176.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -81.21 47.19 0.99 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.277 0.56 . . . . 0.0 110.555 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -62.8 -19.72 64.32 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.116 178.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.65 HD22 ' H ' ' A' ' 93' ' ' LEU . 0.6 OUTLIER -56.81 -38.18 72.23 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.037 -176.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.704 ' HA ' ' CE2' ' A' ' 97' ' ' PHE . 30.1 mmm180 -62.44 -34.85 77.59 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.485 -176.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -86.96 -23.44 25.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.881 0.372 . . . . 0.0 110.652 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.0 -16.03 62.06 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.608 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.704 ' CE2' ' HA ' ' A' ' 94' ' ' ARG . 20.1 m-85 -61.71 -40.86 96.51 Favored 'General case' 0 C--O 1.218 -0.561 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -66.46 -17.74 64.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.323 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 91.2 mt -88.06 -30.72 19.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.321 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -104.28 -24.12 13.15 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -175.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -72.97 79.88 1.18 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.562 0.696 . . . . 0.0 109.982 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -69.72 -19.43 63.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.628 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.466 ' HB2' ' ND2' ' A' ' 105' ' ' ASN . 12.5 mt-10 -90.91 -37.01 13.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.279 -172.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.81 42.15 3.66 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.024 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.466 ' ND2' ' HB2' ' A' ' 103' ' ' GLU . 24.5 m-80 -87.53 -19.65 27.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 0.0 110.693 -176.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.54 1.9 82.86 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -169.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.552 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 4.7 m-85 -148.22 165.26 31.47 Favored 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 177.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.668 ' HB ' HG13 ' A' ' 112' ' ' VAL . 11.3 pt -102.46 120.48 52.27 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 C-N-CA 119.278 -0.969 . . . . 0.0 109.1 170.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 49.6 m -60.97 161.59 8.11 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.685 -176.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 15.0 p -58.34 -26.61 63.32 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.765 -0.584 . . . . 0.0 110.642 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -62.05 -51.03 69.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.78 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.668 HG13 ' HB ' ' A' ' 108' ' ' ILE . 2.1 p -70.37 -36.71 67.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.156 178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.633 ' SD ' HG11 ' A' ' 144' ' ' VAL . 2.7 tpt -59.23 -38.34 79.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.103 0.477 . . . . 0.0 109.782 175.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -56.34 -53.48 56.83 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.125 177.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -69.62 -29.42 66.91 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.996 -178.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.6 HG13 ' O ' ' A' ' 112' ' ' VAL . 57.4 mt -63.52 -50.2 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 121.205 0.526 . . . . 0.0 110.021 174.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.62 HD11 ' SD ' ' A' ' 132' ' ' MET . 0.7 OUTLIER -58.7 -50.61 73.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.835 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.65 -27.82 68.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.775 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -69.97 -39.92 75.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.911 0.386 . . . . 0.0 110.14 177.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -71.44 -56.72 5.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.828 175.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.619 ' CG ' HD23 ' A' ' 124' ' ' LEU . 7.5 t70 -102.82 119.97 39.78 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.077 0.465 . . . . 0.0 110.881 -177.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -101.87 15.79 27.92 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.805 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 61.8 p -116.17 -17.0 10.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.477 0.656 . . . . 0.0 109.767 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.619 HD23 ' CG ' ' A' ' 121' ' ' ASP . 1.4 mm? -55.42 146.85 18.73 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.909 169.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.474 ' H ' ' HB2' ' A' ' 128' ' ' ASP . 27.3 t -107.85 162.46 13.98 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.199 -0.91 . . . . 0.0 108.601 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.1 m -51.76 -36.51 47.6 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 118.204 0.456 . . . . 0.0 111.396 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -76.38 -45.69 30.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.295 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.474 ' HB2' ' H ' ' A' ' 125' ' ' SER . 3.0 m-20 -63.35 -42.51 98.91 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.053 0.454 . . . . 0.0 110.487 179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.616 HD11 ' HB3' ' A' ' 117' ' ' LEU . 26.6 tp -56.39 -39.5 73.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.528 176.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.455 ' O ' ' HB ' ' A' ' 133' ' ' ILE . 23.7 t70 -63.88 -41.7 97.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.234 177.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.48 -38.06 89.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.686 176.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.62 ' SD ' HD11 ' A' ' 117' ' ' LEU . 28.7 mtt -65.23 -34.04 77.43 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.59 175.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.459 HD13 ' HA ' ' A' ' 133' ' ' ILE . 15.2 mm -58.54 -47.79 87.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.978 0.418 . . . . 0.0 110.312 173.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.66 -45.08 77.74 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.409 175.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -66.95 -37.12 83.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.253 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.452 HG21 ' SD ' ' A' ' 113' ' ' MET . 51.9 mt -69.41 -58.65 5.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.16 -178.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -71.29 96.26 1.41 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.7 0.762 . . . . 0.0 110.206 -176.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -75.19 -42.97 54.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.736 -175.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -81.94 -15.14 54.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.491 0.662 . . . . 0.0 110.979 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 70.71 26.03 74.73 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.195 -178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.0 t -74.68 -18.25 60.55 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.428 0.633 . . . . 0.0 109.723 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 92.22 -23.94 24.64 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.552 ' HB ' ' HB2' ' A' ' 107' ' ' TYR . 24.6 p -116.93 128.92 55.69 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 175.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.633 HG11 ' SD ' ' A' ' 113' ' ' MET . 94.1 t -86.13 121.92 37.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.292 -176.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.535 ' CB ' ' HD2' ' A' ' 107' ' ' TYR . 22.7 t70 -150.43 -68.99 0.19 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.325 0.584 . . . . 0.0 111.867 -178.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 146' ' ' PHE . 0.6 OUTLIER -85.23 -88.28 0.11 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.067 -167.185 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -78.31 -28.22 47.4 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.063 0.459 . . . . 0.0 110.823 -175.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.664 ' CD ' ' H ' ' A' ' 148' ' ' GLU . 3.0 mp0 -57.94 -64.11 1.02 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.588 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.546 ' CD2' HD11 ' A' ' 108' ' ' ILE . 19.8 t80 -66.97 -43.74 82.3 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.979 -174.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 40.7 tpp -62.43 -33.56 75.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.152 0.501 . . . . 0.0 109.797 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -74.55 -26.81 66.72 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-N 116.033 -0.53 . . . . 0.0 113.133 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.502 HG12 ' HA ' ' A' ' 149' ' ' PHE . 6.5 p -89.17 -42.51 14.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 117.238 0.519 . . . . 0.0 111.665 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -82.34 -57.89 3.17 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.543 -174.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 45.3 p -86.35 -39.4 16.48 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.501 -0.479 . . . . 0.0 110.585 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 123.17 -8.24 9.1 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 129.77 -110.45 1.05 Allowed Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -112.38 -73.98 0.65 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 175.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.294 -0.86 . . . . 0.0 109.16 179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.7 mtp . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 121.114 0.483 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -163.44 44.77 0.33 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.506 ' HB3' ' HD3' ' A' ' 6' ' ' LYS . 1.4 m-20 -73.31 106.58 5.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.967 0.413 . . . . 0.0 111.721 -175.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 14.9 p -72.02 -18.61 19.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.006 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.6 t -89.67 -17.15 28.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.546 -176.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.506 ' HD3' ' HB3' ' A' ' 3' ' ' ASP . 14.5 mptt -91.27 -10.19 42.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.807 0.337 . . . . 0.0 111.284 -177.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.675 ' HG ' ' HA ' ' A' ' 77' ' ' ALA . 4.3 mm? -90.45 114.13 26.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.196 0.522 . . . . 0.0 110.282 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.0 t -85.05 173.38 10.54 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.803 -175.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.3 m -54.9 -42.29 71.97 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -170.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -58.49 -43.11 88.88 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.782 0.325 . . . . 0.0 111.515 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.422 ' H ' ' HG2' ' A' ' 11' ' ' GLN . 7.0 mm100 -64.34 -42.23 96.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.804 0.811 . . . . 0.0 109.86 177.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.42 ' O ' ' HB2' ' A' ' 15' ' ' LEU . 93.3 t -72.17 -27.27 26.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 114.706 -1.133 . . . . 0.0 111.403 -177.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.466 ' HD2' ' HA ' ' A' ' 13' ' ' LYS . 11.9 tptt -62.08 -42.51 99.28 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-O 120.886 0.374 . . . . 0.0 111.223 177.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.6 mt -60.41 -41.61 94.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.407 0.622 . . . . 0.0 109.491 174.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.922 HD21 HD13 ' A' ' 80' ' ' LEU . 77.3 mt -61.16 -49.27 77.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.692 176.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -61.34 -43.47 98.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.461 -178.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 57.9 m -58.6 -38.27 77.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.116 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.566 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -86.0 -35.67 20.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.042 0.449 . . . . 0.0 110.382 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.693 ' CE1' HG22 ' A' ' 31' ' ' VAL . 88.0 t80 -55.15 -49.58 71.46 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.096 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.415 ' HA ' ' HB2' ' A' ' 23' ' ' GLU . 23.7 mmt180 -81.35 -6.52 58.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.765 -175.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -87.58 -46.47 9.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.09 0.472 . . . . 0.0 110.318 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.582 ' HB3' ' HB3' ' A' ' 35' ' ' GLN . 68.4 m-85 -98.97 25.74 6.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.81 0.814 . . . . 0.0 109.461 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.964 ' HG2' ' HB ' ' A' ' 24' ' ' THR . 1.7 tt0 -78.42 139.48 38.74 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.249 -1.341 . . . . 0.0 112.8 -172.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.964 ' HB ' ' HG2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER 76.27 144.69 0.1 Allowed Pre-proline 0 N--CA 1.446 -0.633 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 155.515 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 24' ' ' THR . 7.1 Cg_exo -74.8 -53.71 0.1 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.531 2.821 . . . . 0.0 110.084 165.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -136.5 -39.61 0.65 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.69 176.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -177.3 38.55 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.9 t -76.37 -27.18 56.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.374 -0.413 . . . . 0.0 111.161 -174.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.93 4.6 86.97 Favored Glycine 0 C--N 1.335 0.479 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 -178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.457 ' HB2' ' OD2' ' A' ' 66' ' ' ASP . 11.8 mtt180 -122.06 168.3 12.1 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.758 -0.721 . . . . 0.0 110.305 -175.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.693 HG22 ' CE1' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -105.66 127.34 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.536 0 CA-C-O 121.446 0.641 . . . . 0.0 110.926 174.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.418 ' HB3' ' HG2' ' A' ' 35' ' ' GLN . 6.0 t -53.74 139.32 33.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.797 -1.547 . . . . 0.0 109.1 171.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.628 HG21 HG23 ' A' ' 56' ' ' ILE . 3.9 p -70.46 -13.04 61.96 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.869 0.366 . . . . 0.0 111.586 -176.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.71 -29.47 62.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.717 172.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.582 ' HB3' ' HB3' ' A' ' 22' ' ' PHE . 84.3 mm-40 -81.56 -23.54 37.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.977 -177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.52 HG22 HD22 ' A' ' 40' ' ' LEU . 61.0 mt -57.18 -44.34 83.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.524 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -66.82 -20.73 70.7 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.366 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.618 ' O ' HG23 ' A' ' 42' ' ' VAL . 15.0 mt -81.9 -51.36 15.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 176.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.566 HG23 ' HB1' ' A' ' 18' ' ' ALA . 73.2 mt -57.66 -46.57 86.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.499 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.52 HD22 HG22 ' A' ' 36' ' ' ILE . 1.3 mp -56.81 -40.91 76.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.246 0.546 . . . . 0.0 109.928 177.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.5 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 32.8 tt0 -61.28 -43.96 98.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.566 175.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 38' ' ' ILE . 78.8 t -55.57 -48.03 77.99 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 CA-C-O 121.814 0.816 . . . . 0.0 110.552 175.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.2 mt -83.14 -2.45 55.49 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.355 -1.293 . . . . 0.0 111.365 -172.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 77.8 26.84 59.84 Favored Glycine 0 N--CA 1.453 -0.188 0 CA-C-N 115.944 -0.571 . . . . 0.0 113.129 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.9 pt -122.45 167.74 15.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 O-C-N 122.708 -0.29 . . . . 0.0 111.066 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 50.62 -171.37 0.02 OUTLIER 'General case' 0 C--O 1.233 0.227 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -178.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -119.6 -170.88 2.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.938 -173.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.3 t -56.51 167.38 0.72 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.324 0.583 . . . . 0.0 111.149 175.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.507 ' HA ' ' CG1' ' A' ' 52' ' ' ILE . 55.9 mttp -57.36 -23.66 50.39 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -166.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.4 t -54.73 -47.84 73.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.093 0.473 . . . . 0.0 110.358 175.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.7 m -70.39 -35.27 73.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.63 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.507 ' CG1' ' HA ' ' A' ' 49' ' ' LYS . 44.4 mm -60.54 -29.2 44.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.359 -177.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.528 ' HA ' HD12 ' A' ' 56' ' ' ILE . 34.5 mmt180 -56.5 -28.2 59.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.155 176.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -75.2 -35.22 61.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.884 0.373 . . . . 0.0 110.611 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 52' ' ' ILE . 2.7 mm? -62.6 -43.82 97.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.416 0.627 . . . . 0.0 109.484 175.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.628 HG23 HG21 ' A' ' 33' ' ' THR . 52.6 mt -63.6 -43.64 98.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.839 176.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -55.75 -35.5 66.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.19 0.519 . . . . 0.0 110.897 176.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.412 ' HG2' ' CE2' ' A' ' 59' ' ' PHE . 4.5 tp10 -71.68 -54.68 9.57 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.735 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.508 ' CE2' HG12 ' A' ' 75' ' ' ILE . 96.0 m-85 -100.62 -12.9 18.82 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -169.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -128.1 66.9 73.5 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-O 121.063 0.458 . . . . 0.0 110.606 175.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.458 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 33.1 Cg_exo -62.6 -29.75 78.37 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.795 2.33 . . . . 0.0 112.338 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -77.34 -17.62 58.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.387 -175.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.35 47.08 60.1 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -175.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -78.92 -26.98 43.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.111 0.482 . . . . 0.0 110.131 -174.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.3 -25.35 13.95 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.847 175.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.457 ' OD2' ' HB2' ' A' ' 30' ' ' ARG . 53.1 p-10 -146.06 168.48 20.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.918 0.39 . . . . 0.0 110.536 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.457 ' HB ' ' HB2' ' A' ' 71' ' ' SER . 36.6 pt -138.82 147.41 25.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.344 -178.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.441 ' HA ' ' HG2' ' A' ' 30' ' ' ARG . 28.7 t70 -80.8 170.27 16.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.316 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.415 ' HA ' ' HB3' ' A' ' 72' ' ' PHE . 0.1 OUTLIER -57.26 -26.56 61.0 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 176.086 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -48.1 -52.89 18.47 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.822 173.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.464 ' HB3' ' HB3' ' A' ' 59' ' ' PHE . 2.2 m -78.3 -43.46 27.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.663 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.415 ' HB3' ' HA ' ' A' ' 69' ' ' PHE . 87.0 t80 -63.11 -36.76 84.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.599 -175.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -66.67 -35.45 80.17 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 56.2 mt -69.74 -39.2 77.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 176.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.625 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 62.6 mt -58.14 -52.57 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-O 121.373 0.606 . . . . 0.0 109.594 173.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.404 ' HA2' ' CD1' ' A' ' 80' ' ' LEU . . . -62.14 -38.89 96.88 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.237 178.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.675 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . . . -66.06 -30.18 70.65 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.82 0.343 . . . . 0.0 111.427 -174.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.625 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 16.4 ptm180 -85.14 -7.48 59.05 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.787 -175.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.449 ' CE1' ' HG3' ' A' ' 78' ' ' ARG . 19.9 m-85 -124.97 -48.58 1.75 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 120.874 -0.331 . . . . 0.0 111.047 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.922 HD13 HD21 ' A' ' 15' ' ' LEU . 3.3 mp -71.93 -25.06 61.74 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.47 0.652 . . . . 0.0 111.591 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.82 35.52 3.5 Favored Glycine 0 N--CA 1.441 -1.02 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.762 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -73.78 -8.66 56.89 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.367 -0.417 . . . . 0.0 110.731 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -60.0 -72.12 0.11 Allowed 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.1 p 37.41 58.7 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 124.631 1.207 . . . . 0.0 111.964 176.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.437 ' CG ' ' HD2' ' A' ' 86' ' ' PRO . 2.6 t30 -72.43 150.08 91.46 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.729 -176.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.532 ' HG3' HE21 ' A' ' 90' ' ' GLN . 10.1 Cg_endo -53.39 -60.19 0.76 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.045 2.496 . . . . 0.0 111.568 -177.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -126.75 7.23 6.78 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.625 -1.17 . . . . 0.0 111.363 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 59.53 19.46 7.95 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.616 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 52.2 ttp -172.25 80.84 0.06 Allowed 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.532 HE21 ' HG3' ' A' ' 86' ' ' PRO . 96.2 mt-30 -77.62 -78.83 0.13 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.23 -172.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -138.14 25.63 2.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.423 0.63 . . . . 0.0 110.404 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.32 -19.44 35.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.227 175.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.606 HD22 ' H ' ' A' ' 93' ' ' LEU . 0.6 OUTLIER -51.02 -32.14 20.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.913 177.256 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.743 HH11 ' HE2' ' A' ' 97' ' ' PHE . 0.2 OUTLIER -58.22 -44.44 88.18 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.989 0.423 . . . . 0.0 111.618 179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -71.67 -29.72 64.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.178 0.513 . . . . 0.0 110.241 176.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.412 ' HA ' HD12 ' A' ' 99' ' ' LEU . . . -75.56 -19.31 59.39 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.877 -175.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.743 ' HE2' HH11 ' A' ' 94' ' ' ARG . 22.6 m-85 -59.19 -48.99 79.55 Favored 'General case' 0 C--O 1.216 -0.665 0 CA-C-O 120.844 0.354 . . . . 0.0 110.084 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -70.47 -12.9 61.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.527 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 96' ' ' ALA . 85.5 mt -83.63 -27.37 29.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.832 176.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -105.14 -25.28 12.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.511 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -72.26 82.12 1.02 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.797 0.808 . . . . 0.0 111.099 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -72.39 -15.75 61.85 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.927 173.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -78.98 -35.99 42.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.339 -175.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 92.0 44.32 4.18 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.754 174.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -107.77 -18.44 13.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.064 0.459 . . . . 0.0 110.339 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.29 -24.44 27.18 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -172.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.59 ' HB2' ' HB ' ' A' ' 143' ' ' THR . 6.3 m-85 -109.9 152.25 26.04 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 173.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.677 ' HB ' ' CG1' ' A' ' 112' ' ' VAL . 13.1 pt -92.44 124.66 44.98 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.6 177.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.56 ' HA ' HG22 ' A' ' 143' ' ' THR . 21.7 m -65.39 165.89 11.1 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.627 -175.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.8 p -62.33 -27.14 68.85 Favored 'General case' 0 C--N 1.318 -0.775 0 O-C-N 121.74 -0.6 . . . . 0.0 111.154 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -60.56 -49.79 76.13 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.667 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.677 ' CG1' ' HB ' ' A' ' 108' ' ' ILE . 2.6 p -70.73 -38.39 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 C-N-CA 121.252 -0.179 . . . . 0.0 110.598 -178.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.4 ' HE2' ' HA ' ' A' ' 113' ' ' MET . 4.0 tpp -58.36 -43.12 88.24 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 174.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.54 ' O ' HD21 ' A' ' 129' ' ' LEU . 23.0 ttp180 -53.25 -40.36 64.53 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.669 177.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -74.37 -38.43 63.18 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.307 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 112' ' ' VAL . 59.3 mt -63.58 -52.67 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 120.945 0.402 . . . . 0.0 110.608 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.552 ' HB3' HD11 ' A' ' 129' ' ' LEU . 0.8 OUTLIER -54.02 -53.91 46.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.312 179.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.599 ' HB2' HD22 ' A' ' 129' ' ' LEU . . . -58.69 -27.52 64.92 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.257 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.22 -50.74 17.82 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.4 -48.96 71.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.802 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.645 ' HB3' HD23 ' A' ' 124' ' ' LEU . 4.8 m-20 -103.59 94.69 5.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.6 0.714 . . . . 0.0 110.189 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -73.92 -5.06 38.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.052 -0.977 . . . . 0.0 112.653 -171.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 66.9 p -94.85 -2.93 49.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.398 0.618 . . . . 0.0 111.359 -173.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.645 HD23 ' HB3' ' A' ' 121' ' ' ASP . 4.4 mm? -80.71 148.02 30.33 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.223 177.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 56.2 m -121.68 173.35 7.5 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 173.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.7 m -48.15 -47.53 34.79 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -174.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -68.81 -54.26 16.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.712 0.291 . . . . 0.0 111.227 -177.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -58.93 -44.89 91.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.725 0.774 . . . . 0.0 110.372 -178.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.599 HD22 ' HB2' ' A' ' 118' ' ' ALA . 61.3 tp -60.57 -38.12 83.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.693 -1.14 . . . . 0.0 111.711 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.443 ' O ' ' HB ' ' A' ' 133' ' ' ILE . 5.6 t70 -69.35 -33.55 73.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.023 0.439 . . . . 0.0 110.251 -178.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.91 -42.63 94.58 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.963 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.471 ' SD ' HD11 ' A' ' 117' ' ' LEU . 38.1 mtt -60.24 -36.34 77.51 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.262 175.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.508 HD11 ' HA ' ' A' ' 114' ' ' ARG . 17.0 mm -59.05 -47.2 90.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.835 0.35 . . . . 0.0 110.853 175.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -60.34 -39.79 88.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.229 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -70.03 -43.99 70.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.703 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 57.7 mt -57.98 -54.31 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 123.163 0.585 . . . . 0.0 112.519 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -73.65 91.59 1.89 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.587 0.708 . . . . 0.0 110.507 -178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.58 -41.97 36.89 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.0 -1.0 . . . . 0.0 112.521 -174.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -84.85 -13.47 50.9 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.934 -172.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 78.59 26.82 58.34 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.895 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.9 m -73.66 -18.03 61.08 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.363 0.601 . . . . 0.0 110.609 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 84.54 -13.6 51.05 Favored Glycine 0 CA--C 1.509 -0.307 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.096 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.59 ' HB ' ' HB2' ' A' ' 107' ' ' TYR . 3.0 p -132.8 131.15 40.75 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 114.726 -0.737 . . . . 0.0 109.223 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.433 HG12 ' HB2' ' A' ' 149' ' ' PHE . 52.8 t -84.73 111.81 20.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.938 -175.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.423 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 11.0 t70 -139.46 -72.2 0.39 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.38 0.609 . . . . 0.0 110.913 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.577 ' O ' ' HG2' ' A' ' 150' ' ' MET . 0.7 OUTLIER -82.99 -98.46 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.517 -169.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.503 ' HG2' ' CD2' ' A' ' 146' ' ' PHE . 9.1 pt-20 -67.87 -29.49 68.63 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 122.259 -0.276 . . . . 0.0 111.118 -175.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.1 mp0 -59.68 -51.05 71.45 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.4 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.601 ' HA ' HG12 ' A' ' 152' ' ' VAL . 9.4 t80 -79.66 -33.91 40.86 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 120.695 -0.402 . . . . 0.0 111.416 -174.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . 0.602 ' CE ' HD23 ' A' ' 93' ' ' LEU . 10.3 mmt -62.53 -45.34 93.4 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.502 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -66.95 -33.32 83.55 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.976 -0.63 . . . . 0.0 113.251 -177.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.601 HG12 ' HA ' ' A' ' 149' ' ' PHE . 8.1 p -81.71 -36.55 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 111.598 -176.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 52.1 tpp -96.85 -56.07 2.68 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -173.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 69.0 p -97.49 -13.7 21.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.971 0.415 . . . . 0.0 111.551 -173.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 96.65 -24.04 32.57 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.879 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 72.04 -135.39 22.78 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.018 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -104.33 -38.32 6.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.252 0.549 . . . . 0.0 110.3 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 C--O 1.243 0.753 0 CA-C-O 118.386 -0.816 . . . . 0.0 110.389 -177.679 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.7 mtm . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 121.181 0.515 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -86.79 60.74 4.44 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 172.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.461 ' HB2' ' HB2' ' A' ' 6' ' ' LYS . 20.4 m-20 -61.13 110.11 1.29 Allowed 'General case' 0 CA--C 1.512 -0.5 0 CA-C-O 121.202 0.525 . . . . 0.0 111.924 -173.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.0 p -74.58 -9.69 13.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.505 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.2 p -91.44 -21.23 21.06 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.859 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 3' ' ' ASP . 5.6 mptp? -76.39 -27.97 56.56 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.908 0.385 . . . . 0.0 110.088 177.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.749 ' HG ' ' HA ' ' A' ' 77' ' ' ALA . 5.1 mt -59.78 114.83 2.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.659 173.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.406 ' HB2' ' HG3' ' A' ' 11' ' ' GLN . 20.4 m -79.98 149.99 30.6 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 175.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.6 m -51.35 -41.17 60.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.7 0.286 . . . . 0.0 111.557 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -57.46 -39.74 77.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.32 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.551 ' HB2' HD22 ' A' ' 7' ' ' LEU . 8.2 mt-30 -70.26 -42.27 72.36 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.443 0.64 . . . . 0.0 109.357 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.609 HG22 HD13 ' A' ' 7' ' ' LEU . 57.4 t -63.22 -31.44 52.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.603 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.538 ' HD3' ' C ' ' A' ' 13' ' ' LYS . 5.5 tmtm? -66.01 -40.3 90.97 Favored 'General case' 0 N--CA 1.416 -2.143 0 C-N-CA 123.277 0.631 . . . . 0.0 110.043 177.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.7 mt -64.53 -43.26 94.58 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 175.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.66 HD21 HD13 ' A' ' 80' ' ' LEU . 80.1 mt -55.99 -50.26 71.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.614 175.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.574 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 6.8 tp10 -54.13 -53.62 50.75 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.79 177.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 96.3 m -63.58 -39.42 94.33 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.521 ' HB1' HG23 ' A' ' 39' ' ' ILE . . . -77.66 -27.21 50.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.103 0.477 . . . . 0.0 110.564 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.756 ' HD1' ' HD2' ' A' ' 20' ' ' ARG . 45.4 t80 -62.63 -51.75 66.04 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.139 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.756 ' HD2' ' HD1' ' A' ' 19' ' ' PHE . 23.3 mmm-85 -70.34 -27.37 64.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.32 -172.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -65.76 -45.63 81.82 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.937 0.399 . . . . 0.0 110.715 -176.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.457 ' CD2' HG12 ' A' ' 39' ' ' ILE . 68.6 m-85 -103.45 14.19 31.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.129 0.49 . . . . 0.0 110.573 -178.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.572 ' HG2' ' N ' ' A' ' 24' ' ' THR . 16.9 tt0 -72.4 152.26 42.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.803 -176.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.572 ' N ' ' HG2' ' A' ' 23' ' ' GLU . 0.4 OUTLIER 76.08 133.91 0.04 OUTLIER Pre-proline 0 N--CA 1.451 -0.415 0 CA-C-N 114.752 -1.113 . . . . 0.0 113.266 163.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -83.22 -47.03 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.025 2.483 . . . . 0.0 110.727 171.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -163.84 46.5 0.12 Allowed 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.455 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.26 59.99 0.92 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.259 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.7 t -106.83 -31.52 8.35 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.988 0.423 . . . . 0.0 110.608 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.01 -14.91 60.73 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.429 -0.891 . . . . 0.0 111.467 -176.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.58 ' HG3' ' HA ' ' A' ' 68' ' ' ASP . 6.6 mpt_? -109.87 170.7 7.9 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.538 HG23 ' HA ' ' A' ' 23' ' ' GLU . 12.0 p -107.6 129.14 62.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 121.758 0.79 . . . . 0.0 109.918 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.472 ' HB3' ' HG2' ' A' ' 35' ' ' GLN . 15.8 t -59.45 143.67 49.2 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.377 -175.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.587 ' HB ' HG12 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -67.51 -19.45 65.31 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.045 -0.979 . . . . 0.0 112.838 -174.389 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -83.8 -22.26 31.87 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.308 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.472 ' HG2' ' HB3' ' A' ' 32' ' ' SER . 11.9 mm100 -83.24 -20.4 34.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.531 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.678 HG22 HD22 ' A' ' 40' ' ' LEU . 52.9 mt -53.96 -42.58 54.65 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.261 176.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.439 ' HA3' HG13 ' A' ' 52' ' ' ILE . . . -61.72 -39.28 97.22 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.157 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.65 ' O ' HG23 ' A' ' 42' ' ' VAL . 39.7 mt -63.36 -50.76 77.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.192 0.52 . . . . 0.0 109.872 178.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.521 HG23 ' HB1' ' A' ' 18' ' ' ALA . 64.5 mt -61.46 -45.67 98.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.583 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.678 HD22 HG22 ' A' ' 36' ' ' ILE . 0.6 OUTLIER -58.42 -28.69 65.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.009 0.433 . . . . 0.0 110.64 177.066 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.504 ' HB3' ' O ' ' A' ' 38' ' ' ILE . 38.4 tt0 -74.51 -41.38 60.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.428 174.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.65 HG23 ' O ' ' A' ' 38' ' ' ILE . 38.7 t -56.07 -51.7 58.84 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.294 0 CA-C-O 121.84 0.829 . . . . 0.0 109.733 175.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.6 mt -74.75 -24.8 58.76 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 114.117 -1.401 . . . . 0.0 111.34 -175.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.97 42.25 6.04 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.154 173.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 pt -119.06 -83.88 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -177.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.466 ' HG2' HD21 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -75.3 179.95 4.84 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 121.334 0.588 . . . . 0.0 112.26 -175.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -103.41 -170.35 1.77 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.862 -173.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.507 ' O ' HG12 ' A' ' 52' ' ' ILE . 15.0 t -60.01 177.27 0.25 Allowed 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 53' ' ' ARG . 66.4 mttm -52.32 -38.54 58.81 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.903 0.481 . . . . 0.0 112.108 -172.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.5 m -54.56 -34.04 61.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.102 0.477 . . . . 0.0 111.248 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.8 m -84.46 -31.52 24.52 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.51 0.671 . . . . 0.0 110.266 176.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.799 ' HA ' HD23 ' A' ' 55' ' ' LEU . 46.9 mm -68.84 -24.19 28.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.559 -177.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 29.4 mmt180 -57.91 -25.73 61.26 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.822 0.344 . . . . 0.0 110.598 176.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -66.18 -56.38 11.63 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 172.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.799 HD23 ' HA ' ' A' ' 52' ' ' ILE . 2.8 mm? -49.6 -48.4 48.89 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.119 178.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.587 HG12 ' HB ' ' A' ' 33' ' ' THR . 68.6 mt -63.37 -52.8 53.69 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.453 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.891 -177.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -64.53 -23.0 67.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.255 0.55 . . . . 0.0 110.583 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -80.37 -54.35 5.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.697 178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.535 ' C ' ' HD3' ' A' ' 61' ' ' PRO . 72.0 m-85 -91.59 -22.38 20.35 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -173.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.432 ' N ' ' HD3' ' A' ' 61' ' ' PRO . 44.6 t0 -125.8 63.62 47.62 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 121.075 0.464 . . . . 0.0 110.092 175.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.535 ' HD3' ' C ' ' A' ' 59' ' ' PHE . 32.1 Cg_exo -61.65 -23.82 76.92 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.09 2.527 . . . . 0.0 112.382 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -76.08 -17.16 59.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.892 -177.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.72 45.21 66.62 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.92 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -73.33 -46.09 51.4 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.656 0.265 . . . . 0.0 110.414 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 127.96 -18.82 5.87 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.167 -1.016 . . . . 0.0 112.668 178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 2.8 p30 -147.87 164.36 33.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.703 0.287 . . . . 0.0 110.751 178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.525 ' O ' ' HB3' ' A' ' 30' ' ' ARG . 35.1 pt -132.2 145.71 34.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.533 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.58 ' HA ' ' HG3' ' A' ' 30' ' ' ARG . 3.5 p-10 -76.75 171.07 15.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.142 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.566 ' HE1' ' HA ' ' A' ' 16' ' ' GLU . 21.3 t80 -55.21 -42.75 73.74 Favored 'General case' 0 C--O 1.214 -0.768 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.55 -178.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.462 ' O ' HG13 ' A' ' 74' ' ' ILE . 15.3 t70 -59.11 -45.08 91.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.756 0.312 . . . . 0.0 110.829 -174.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.449 ' HB2' ' HB ' ' A' ' 67' ' ' ILE . 22.1 m -65.19 -31.83 73.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.629 177.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -80.21 -30.99 38.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.306 0.574 . . . . 0.0 109.77 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -66.39 -39.06 88.82 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.717 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 70' ' ' ASP . 61.7 mt -64.95 -43.5 96.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.056 0.455 . . . . 0.0 109.822 175.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.586 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 79.3 mt -55.87 -50.9 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.815 173.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.413 ' HA2' ' CD1' ' A' ' 80' ' ' LEU . . . -61.01 -43.33 99.58 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.585 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.749 ' HA ' ' HG ' ' A' ' 7' ' ' LEU . . . -64.92 -30.1 71.08 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.981 0.42 . . . . 0.0 111.452 -174.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.586 ' HG2' ' O ' ' A' ' 75' ' ' ILE . 15.2 ptm180 -87.63 -11.02 49.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.781 -175.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.493 ' CD1' ' HG3' ' A' ' 78' ' ' ARG . 22.5 m-85 -120.29 -42.83 2.55 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.899 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.66 HD13 HD21 ' A' ' 15' ' ' LEU . 2.5 mp -69.3 -10.56 58.39 Favored 'General case' 0 CA--C 1.511 -0.544 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -62.14 98.36 0.19 Allowed Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.571 -0.823 . . . . 0.0 111.498 174.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -80.01 -24.02 41.09 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.443 0.64 . . . . 0.0 109.713 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -83.51 73.37 10.21 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.759 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.7 t -144.34 79.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.544 0.688 . . . . 0.0 111.682 -176.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.566 ' HB3' ' HB3' ' A' ' 88' ' ' GLN . 12.2 t30 -71.23 141.14 85.8 Favored Pre-proline 0 C--N 1.316 -0.881 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 166.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -51.3 -41.24 59.69 Favored 'Trans proline' 0 CA--C 1.52 -0.224 0 C-N-CA 123.164 2.576 . . . . 0.0 112.897 -167.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.427 ' HG2' ' HB2' ' A' ' 92' ' ' GLU . 23.7 mt-10 -125.58 50.82 1.78 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.052 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.566 ' HB3' ' HB3' ' A' ' 85' ' ' ASN . 28.7 pt20 -67.67 -42.26 82.44 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.327 -178.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 14.3 tpt -132.0 39.38 3.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.625 0.726 . . . . 0.0 109.667 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.631 ' HB3' ' HG2' ' A' ' 92' ' ' GLU . 50.9 mt-30 -127.4 133.62 49.98 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.138 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.552 ' HA ' HD22 ' A' ' 93' ' ' LEU . 44.8 mt-30 -81.63 29.99 0.37 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.383 0.611 . . . . 0.0 110.781 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.631 ' HG2' ' HB3' ' A' ' 90' ' ' GLN . 13.3 mm-40 -66.4 -16.52 64.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.521 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.584 HD12 ' HE1' ' A' ' 149' ' ' PHE . 0.4 OUTLIER -42.34 -41.37 2.81 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 123.721 0.638 . . . . 0.0 110.824 178.415 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.494 ' HA ' ' CE1' ' A' ' 97' ' ' PHE . 36.1 mmt180 -45.72 -42.0 11.3 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 124.038 0.837 . . . . 0.0 111.555 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.634 ' O ' ' HG ' ' A' ' 99' ' ' LEU . 43.2 mt-10 -85.82 -32.71 21.61 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.668 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.602 ' O ' ' HB2' ' A' ' 99' ' ' LEU . . . -84.39 -39.85 18.54 Favored 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 120.502 -0.479 . . . . 0.0 111.475 -167.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.494 ' CE1' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -77.66 -19.71 54.96 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 118.546 -1.262 . . . . 0.0 110.895 178.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -76.74 -12.09 59.94 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.55 169.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 95' ' ' GLU . 73.4 mt -84.43 -18.09 37.12 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.973 168.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TYR . . . . . 0.59 ' HD1' ' O ' ' A' ' 96' ' ' ALA . 37.1 m-85 -105.29 -2.78 23.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.035 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -72.37 80.87 1.03 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.588 0.709 . . . . 0.0 111.135 -172.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -54.19 -46.32 72.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.937 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -84.07 -28.35 27.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.15 -168.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.08 63.8 1.43 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.404 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -114.7 -17.98 11.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.006 0.431 . . . . 0.0 110.536 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 91.85 -21.36 36.92 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -168.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.754 ' HB3' ' HB2' ' A' ' 145' ' ' ASP . 2.3 m-85 -116.53 164.85 13.96 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 172.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.721 ' HB ' HG13 ' A' ' 112' ' ' VAL . 3.3 pt -103.49 127.6 57.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.986 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.4 ' HA ' HG22 ' A' ' 143' ' ' THR . 45.9 m -66.56 168.82 8.55 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.944 -177.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.509 ' HB ' ' CG2' ' A' ' 133' ' ' ILE . 72.5 p -61.77 -31.75 71.97 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 121.544 0.687 . . . . 0.0 110.308 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.16 -34.29 77.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.107 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.721 HG13 ' HB ' ' A' ' 108' ' ' ILE . 2.2 p -87.15 -34.82 7.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.191 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . 0.718 ' SD ' HG11 ' A' ' 144' ' ' VAL . 2.5 tpt -55.03 -38.81 68.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.036 0.446 . . . . 0.0 110.503 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.731 ' HB2' ' HB3' ' A' ' 129' ' ' LEU . 5.9 ptp180 -66.9 -49.63 64.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.545 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.499 ' HG2' ' HA ' ' A' ' 112' ' ' VAL . 15.3 pt-20 -63.4 -27.54 69.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.745 0.307 . . . . 0.0 111.071 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.516 HD12 HD13 ' A' ' 108' ' ' ILE . 19.9 mt -66.26 -48.24 81.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.174 0.511 . . . . 0.0 110.148 173.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.569 HD12 ' HG ' ' A' ' 124' ' ' LEU . 1.2 tm? -61.06 -51.52 68.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.718 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.554 ' HB2' HD11 ' A' ' 129' ' ' LEU . . . -60.13 -22.18 62.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.302 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -68.14 -45.92 72.27 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.5 mp -77.47 -53.62 7.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.353 0.597 . . . . 0.0 109.852 177.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.619 ' HB3' HD23 ' A' ' 124' ' ' LEU . 18.0 m-20 -96.47 90.12 5.27 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.931 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -76.89 15.35 0.68 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.06 -173.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 78.8 p -103.83 -13.7 16.31 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.503 0.668 . . . . 0.0 110.35 -177.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.619 HD23 ' HB3' ' A' ' 121' ' ' ASP . 4.1 mm? -75.32 119.18 19.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.64 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 21.9 t -89.94 177.84 6.37 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.1 t -57.1 -45.38 83.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.752 0.31 . . . . 0.0 110.863 -176.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 128' ' ' ASP . 3.0 pm0 -66.55 -38.36 86.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.054 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.493 ' HB3' HD13 ' A' ' 124' ' ' LEU . 40.9 m-20 -63.4 -49.74 72.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.157 0.503 . . . . 0.0 110.013 178.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.731 ' HB3' ' HB2' ' A' ' 114' ' ' ARG . 74.4 mt -56.74 -38.23 72.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.544 178.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -62.37 -39.74 94.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.861 0.363 . . . . 0.0 110.273 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.19 -43.35 70.94 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.552 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 27.2 mtt -61.13 -37.33 82.45 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.591 178.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.509 ' CG2' ' HB ' ' A' ' 110' ' ' THR . 10.1 mm -59.7 -47.32 91.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.078 0.466 . . . . 0.0 110.744 175.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -55.01 -39.04 68.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.791 0.805 . . . . 0.0 110.457 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.26 -44.99 23.98 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.407 -1.27 . . . . 0.0 111.831 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.441 HG21 ' HG2' ' A' ' 113' ' ' MET . 60.1 mt -59.76 -57.3 12.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 123.305 0.642 . . . . 0.0 112.21 -177.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.18 94.71 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.784 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -77.37 -53.92 7.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.421 -175.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -82.25 -12.99 57.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.352 0.596 . . . . 0.0 110.888 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 64.35 38.42 95.81 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.352 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.4 m -66.94 -14.81 63.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.343 0.592 . . . . 0.0 111.133 -178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 99.72 -16.81 58.28 Favored Glycine 0 CA--C 1.504 -0.595 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.526 ' HB ' ' HB2' ' A' ' 107' ' ' TYR . 2.3 p -140.99 135.45 31.16 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 114.491 -0.855 . . . . 0.0 109.27 175.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.718 HG11 ' SD ' ' A' ' 113' ' ' MET . 51.0 t -81.65 124.17 38.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.754 ' HB2' ' HB3' ' A' ' 107' ' ' TYR . 14.5 t70 -146.43 -64.21 0.3 Allowed 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 120.045 -0.662 . . . . 0.0 111.777 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.586 ' HD2' ' H ' ' A' ' 147' ' ' GLU . 1.2 p90 -94.12 -97.98 0.15 Allowed 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.704 -166.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.586 ' H ' ' HD2' ' A' ' 146' ' ' PHE . 54.1 mt-10 -70.67 -22.05 62.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.002 0.43 . . . . 0.0 110.554 -177.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.448 ' CB ' HG13 ' A' ' 144' ' ' VAL . 5.9 mp0 -65.76 -53.77 36.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.172 0.51 . . . . 0.0 110.182 176.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.635 ' CD2' HD11 ' A' ' 108' ' ' ILE . 24.4 t80 -72.91 -39.2 66.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.379 -179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' MET . . . . . . . . . . . . . 16.3 ttm -56.05 -51.69 66.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.191 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -58.68 -41.99 96.05 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.082 -178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 149' ' ' PHE . 14.7 p -77.27 -37.3 25.4 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 111.927 0.344 . . . . 0.0 111.927 -176.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . . . . . . . . . 50.0 tpp -92.0 -49.72 6.07 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -173.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 29.4 p -79.92 -15.59 57.01 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.113 -173.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 78.0 -55.7 3.91 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.82 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 94.36 27.79 11.45 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.357 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -76.47 98.46 4.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.12 0.486 . . . . 0.0 110.618 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 . . . . . 0 C--O 1.248 0.978 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.403 -179.768 . . . . . . . . 0 0 . 1 stop_ save_